	sourceLang	targetLang	sourceString	targetString	en-mt
0	en	ti	 about how long have these symptoms been going on? 	 እዞም ምልክታት ካብ ዝጅምሩ ክንደይ ጊዜ ኮይኑዎም? 	How long have these symptoms been on?
1	en	ti	 and all chest pain should be treated this way especially with your age 	 ኩሉ ዓይነት ናይ ደረት ቃንዛ ብኸምዚ ዓይነቱ እዩ ክሕከም ዝግብኦ፣ ብተለይ ብናትካ/ኪ ዕድመ 	This is how all types of chest pain should be treated, especially at your age
2	en	ti	 and along with a fever 	 ምስ ረስኒ ብሓደ 	together with fever
3	en	ti	 and also needs to be checked your cholesterol blood pressure 	 ብተወሳኺ ናይ ኮሌስትሮልካን ናይ ደም ጸቕጢኻን እውን ክልካዕ ኣለዎ 	Your cholesterol and blood pressure should also be measured
4	en	ti	 and are you having a fever now? 	 ሐዚ ረስኒ ኣለካ/ኪ ዶ? 	Do you have a fever now?
5	en	ti	 and are you having this chest pain now? 	 እሞ ሐዚ እዚ ናይ ደረት ቃንዛ ኸ ይስመዓካ/ኪ ዶ ኣሎ? 	So are you feeling this chest pain now?
6	en	ti	 and besides do you have difficulty breathing 	 ብተወሳኺ ናይ ምትንፋስ ጸገም ከ ኣለካ/ኪ ዶ? 	Do you also have breathing problems?
7	en	ti	 and can you tell me what other symptoms are you having along with this? 	 እሞ ምስ እዚ ካላኦት እተርእዮም ምልክታት እንተሃልዮም ዶ ክትነግረኒ/ርኒ? 	So can you tell me/me if there are any other symptoms you show with this?
8	en	ti	 and how high has your fever been 	 እቲ ረስኒኻ/ኺ ኸ ክሳብ ክንደይ ከይዱ ነይሩ 	How far had your cough gone?
9	en	ti	 and i have a cough too 	 ስዓል እውን ኣለኒ 	I also have a cough
10	en	ti	 and i have a little cold and a cough 	 ንእሽተይ ጉንፋዕን ሰዓልን እውን ኣለኒ 	I also have a little flu and a cold
11	en	ti	 and i'm really having some bad chest pain today 	 ሎሚ ብጣዕሚ ሓያል ናይ ደረት ቃንዛ እውን ይስመዓኒ ኣሎ 	I am also experiencing very strong chest pain today
12	en	ti	 and is this the right time for your hay fever 	 እሞ ሐዚ እዚ ን ናይ ሃይ ረስኒኻ ትኽክለኛ ጊዜ ድዩ 	So now is this the right time for your high fever
13	en	ti	 and it get the chest pain 	 ካብኡ ናይ ደረት ቃንዛ ረኸበ 	He got chest pain from it
14	en	ti	 and i think i have a little bit of a fever 	 ንእሽተይ ረስኒ ዘለኒ እውን ይመስለኒ 	I also think I have a little nausea
15	en	ti	 and i want you to describe where the chest pain is 	 እቲ ናይ ደረት ቃንዛ ኣበይ ከምዘሎ እውን ክትገልጸለይ/ጽለይ ይድሊ እዬ 	I also need you to explain/pray for me where the chest pain is
16	en	ti	 and they're having some fevers as well 	 ንሳቶም እውን ዝተወሰነ ረስኒ ኣለዎም 	They have a certain rust too
17	en	ti	 and with your history of diabetes 	 ምስ ናይ ሽኮርያ ታሪኽካ/ኪ እውን 	Also with your diabetes history
18	en	ti	 and you know it feels like my chest is like gonna crush 	 ትፈልጥ ዲኻ ደረተይ ክፍንድእ ዝበለ ዓይነት ኮይኑ እዩ ዝስመዓኒ 	You know, I kind of feel like my chest is going to explode
19	en	ti	 and you know people cough on me all the time 	 ሰባት ኩልሻብ ከምዝስዕሉለይ ትፈልጥ ኢኻ/ኺ 	You know that people draw me all the time
20	en	ti	 and you're having chest pain 	 ናይ ደረት ቃንዛ እውን ኣልካ/ኪ 	You also have chest pain
21	en	ti	 and you said this is a pressure in your chest 	 እዚ ጸቕጢ ኣብ ደረት እዩ ኢልካ ኣለኻ/ኺ 	You have said that this pressure is at the limit
22	en	ti	 anyone in the family have a heart problem heart disease heart attack high cholesterol high blood pressure 	 ዝኾነ ካብ ቤተሰብ ናይ ልቢ ጸገም፣ ልቢ ሕማም፣ ልቢ ድኻም፣ ልዑል ኮሌስትሮልን ልዑል ናይ ደም ጸቕጢ ዘለዎ ኣሎ 	Anyone in the family has heart problems, heart disease, heart failure, high cholesterol and high blood pressure
23	en	ti	 any other symptoms or problems that you notice with the muscle aches? 	 ምስ እቲ ናይ ጭዋዳ ቃንዛ ዝኾኑ ዝተዓዘብካዮም/ክዮም ኻልኦት ምልክታት ዋላ ጸገማት ኣለዉ ዶ? 	Are there any other symptoms or problems you have noticed with the muscle pain?
24	en	ti	 are there other people sick as you at home with your same symptoms? 	 ክም እዚ ከማኻ/ኺ ተመሳሳሊ ምልክት ዘለዎም ካልኦት ሰባት ኣብ ገዛ ኣለዉ ዶ? 	Are there other people in the household with the same symptoms as you?
25	en	ti	 are you having any other symptoms? 	 ካልኦት ምልክታት ይርኣየካ/ኪ ኣሎ ዶ? 	Are you experiencing other symptoms?
26	en	ti	 are you having any shortness of breath? 	 ዝኾነ ናይ ትንፋስ ምሕጻር ኣለካ/ኪ ዶ? 	Do you have any shortness of breath?
27	en	ti	 are you still having the chest pain 	 ሐዚ እውን እቲ ናይ ደረት ቃንዛ ይስመዓካ/ኪ ዶ ኣሎ 	Do you still feel the chest pain
28	en	ti	 because this is flu season 	 ምኽንያቱ ድማ እዚ ናይ ፍሉ ወቕቲ እዩ 	Because this is flu season
29	en	ti	 but also we shouldn't be put aside for the heart cardiac origin chest pain 	 ክምኡ እውን ነቲ ካብ ናይ ልቢ ጸገም ዝብገስ ናይ ደረት ቃንዛ ክንገድፎ የብልናን 	Nor should we give up the chest pain caused by heart problems
30	en	ti	 but a more important problem now is this chest pain 	 ይኹን እምበር ሐዚ እቲ ዝገደደ ጸገም እቲ ናይ ደረት ቃንዛ እዩ 	However, the worst problem now is the chest pain
31	en	ti	 but i have difficulty breathing 	 ናይ ምትንፋስ ጸገም ግና ኣለኒ 	But I have trouble breathing
32	en	ti	 but i know lot of people cough on me 	 ይኹንደኣ እምበር ብዙሓት ሰባት ከምዝሰዐሉለይ ይፈልጥ 	However, I know that many people have coughed for me
33	en	ti	 but we need to treat every chest pain with the utmost seriousness 	 ይኹን እምበር ሕድሕድ ናይ ደረት ቃንዛ ብዝለዓለ ዕቱብነት ክንሕክም ኣለና 	However, we must treat each chest pain very seriously
34	en	ti	 but you're breathing all right right now right? 	 ግና ሐዚ ጽቡቅ ትትንፍስ ኣለኻ/ኺ ትኽክል ዶ? 	But you&#39;re breathing well now, right?
35	en	ti	 'cause of this chest pain i totally forgot 	 በዚ ናይ ደረት ቃንዛ ዘተላዓለ መሊእይ ረሲዐዮ 	I forgot about my fill caused by this chest pain
36	en	ti	 does it feel like somebody squeezing your chest 	 ዝኾነ ሰብ ደረትካ/ኪ እንጸሞቖ ዓይነት ከምዝኾነ ድዩ ዚስማዓካ.ኪ? 	Do you feel like anyone is the kind of person we soak your/your limits with?
37	en	ti	 do still feel like shortness of breath 	 ሐዚ እውን ናይ ትንፋስ ምሕጻር ዓይነት ይስመዓኒ ኣሎ 	I still feel kind of short of breath
38	en	ti	 do they complain of being sick similar symptoms? 	 ተመሳሰልቲ ምልክታት ዘርእይ ሕማም ሓሚምና ኢሎም የማርሩ ዶ? 	Do they complain of being sick with similar symptoms?
39	en	ti	 do you have any other chronic like high blood pressure or anything like that? 	 ካሊእ ዝኾነ ሕዱር ዝዓይነቱ ልዑል መጠን ናይ ደም ጸቕጢ ወይ ዝመሳሰል ነገራት ኣለኪ/ካ ዶ? 	Do you have any other chronic high blood pressure or similar?
40	en	ti	 do you have any other diseases chronic medical problems like diabetes? 	 ካለኦት ከም ሕማም ሽኮሪያ ዝበሉ ሕዱር ሕክምናዊ ጸገማት ኣለካ/ኪ ዶ? 	Do you have other chronic medical problems such as diabetes?
41	en	ti	 do you have any shortness of breath with that chest pain? 	 ምስ እቲ ናይ ደረት ቃንዛ ናይ ትንፋስ ምሕጻር ኣለካ/ኪ ዶ? 	Do you have shortness of breath with the chest pain?
42	en	ti	 do you have high blood pressure? 	 ልዑል ናይ ደም ጸቕጢ ኣለካ/ኪ ዶ? 	Do you have high blood pressure?
43	en	ti	 do you have some shortness of breath goes with that? 	 ምስኡ ዝኸድ ገለ ናይ ትንፍስ ሕጽረት ኣለካ ዶ? 	Do you have any shortness of breath that goes with it?
44	en	ti	 do you know what symptoms she was having? 	 እንታይ ምልክታት ከምዝነበሩዋ ትፈልጡ ዶ? 	Do you know what her symptoms were?
45	en	ti	 do you see the image? 	 ነቲ ምስሊ ርኢኻ/ኽዮ ዶ? 	Have you seen the image?
46	en	ti	 drink plenty of fluids today 	 ሎሚ ብዙሕ ፋሳሲታት ውሰዱ 	Take lots of fluids today
47	en	ti	 however i take tests for the diabetes 	 ኮይኑ እውን ንሽኮርያ ምርመራ ይገብር እዬ 	However, I do get tested for diabetes
48	en	ti	 however she has symptoms quite similar to mine 	 ይኹን እምበር ምስ ናተይ ዝመሳሰሉ ምልክታት ኣለዉዋ 	However, she has symptoms similar to mine
49	en	ti	 how high is your fever? 	 ክሳብ ክንደይ እዩ እቲ ረስኒኻ/ኺ? 	How severe is your cough?
50	en	ti	 how' s your blood pressure? 	 ናይ ደም ጸቕጢኻ/ኺ ከመይ እዩ? 	How is your blood pressure?
51	en	ti	 if you continue to have high fevers 	 ልዑል ረስኒ እናርአኻ ትቕጽል እንተ ኾይንካ 	If you continue to have high fever
52	en	ti	 if you have a fever of a hundred and two or higher 	 ሚኢቲ ን ክልተ ሚኢቲን ወይ ካባኡ ንላዕሊ ዝልካዕ መጠን ረስኒ እንተሃሊይኩም 	If you have a fever of 100 to 200 or more
53	en	ti	 if you think that your symptoms or problems warrant a better look 	 እንድሕር ደኣ ምልክታትካ ውይድማ ጸገማትካ ዝሓሸ መልከዕ ክምዘለዎም መረጋገጺ ሂብካ 	If you have given assurance that your symptoms or problems will look better
54	en	ti	 i got a fever yesterday 	 ትማሊ ኣተኲስኒ 	He shot me yesterday
55	en	ti	 i got a slight fever too 	 ንእሽተይ ረስኒ እውን ኣለኒ 	I also have a slight rash
56	en	ti	 i had a fever yesterday 	 ትማሊ ረስኒ ኔሩኒ 	I had a cold yesterday
57	en	ti	 i have a sharp pain here in the chest 	 ኣብ እዚ ኣብ ደረተይ ዚወግእ ቃንዛ አለኒ 	Here I have a stabbing pain in my chest
58	en	ti	 i have some difficulty breathing too 	 ንእሽተይ ናይ ምትንፋስ ጸገም እውን ኣለኒ 	I also have slight breathing problems
59	en	ti	 i'll send you an image 	 ምስሊ ክሰደልካ/ኪ እየ 	I will send you/you an image
60	en	ti	 i'm having some chest pain today 	 ሎሚ ንእሽተይ ናይ ደረት ቃንዛ ይስመዓኒ ኣሎ 	I am having a little chest pain today
61	en	ti	 i'm just having some headaches and some fever today 	 ሎሚ ንእሽትይ ረስኒን ናይ ርእሲ ሕማምን ይስመዓኒ ኣሎ 	I am feeling a little nauseous and headache today
62	en	ti	 in my opinion it is flu 	 ክምናተይ ኣትሓሳስባ ሕማም ኢንፍሉዌንዛ እዩ 	My thoughts are influenza
63	en	ti	 in my opinion this is a little flu 	 ብ ናትይ ኣራእያ እዚ ንእሽተይ ፍሉ እዩ 	In my opinion, this is a small flu
64	en	ti	 is it like some heavy heavy person sitting on your chest? 	 ዝኾነ ኣዝዩ ከቢድ ሰብ ኣብ ደረትካ/ኪ ከምዝተቐመጠ ዓይነት ድዩ? 	Is it kind of like any very heavy person has been placed on your/your lap?
65	en	ti	 it all started with the headaches and with the fever about the same time 	 ኩሉ ምስ ሕማም ርእሲን ረስኒን እዩ ብሓደ ጀሚሩ 	It all started together with headaches and nausea
66	en	ti	 it hurts in the middle of my chest 	 ኣብ ማእኸል ደረተይ ቃንዛ ኣለኒ 	I have pain in the middle of my thigh
67	en	ti	 it is a pressure like chest pain 	 ክም ጸቕጢ ዝበለ ናይ ደርት ቃንዛ እዩ 	It&#39;s like a pressure-like dert pain
68	en	ti	 it is in my chest 	 ኣብ ደረተይ እዩ 	It is on my lap
69	en	ti	 it is in the center of my chest 	 ኣብ ማእኸል ደረተይ እዩ 	It is in the middle of my lap
70	en	ti	 it is in the center of the chest 	 ኣብ ማእከል እቲ ደረት እዩ 	It is in the middle of the threshold
71	en	ti	 i've got pain in my chest 	 ኣብ ደረተይ ቃንዛ ይስመዓኒ ኣሎ 	I feel pain in my chest
72	en	ti	 i've very concerned of this chest pain 	 ብዛዕባ እዚ ናይ ደረት ቃንዛ ስካፋት ኣለኒ 	I have chest pain scuffs about this
73	en	ti	 i want you to tell me in describing this chest pain 	 ነዚ ናይ ደረት ቃንዛ ገሊጽካ/ኪ ክትነግረኒ/ርኒ ይድሊ እየ 	I need you to describe this chest pain
74	en	ti	 like high blood pressure or diabetes 	 ከም ልዑል ናይ ደም ጸቕጢ ወይ ሽኮርያ 	such as high blood pressure or diabetes
75	en	ti	 like right in the center of the chest 	 ልከዕ ኣብ ማእኸል ደረተይ 	Right in the middle of my lap
76	en	ti	 now for the fever you can take a tachipirina sweet 	 ሐዚ ነቲ ረስኒ ናይ ተችፐሪና ከረሜላ (tachipirina sweet) ምውሳድ ትኽእል/ሊ ኢኻ/ኺ 	Now you can take the fever of tachipirina sweet
77	en	ti	 now mary how many days have you had the symptoms 	 ሜሪ ሐዚ እቶም ምልክታት ንኽንደይ መዓልቲ ተራእዮምኺ ኣለዉ 	Mary, how many days have you had the symptoms now?
78	en	ti	 now you said you have a chest pain 	 ሐዚ ናይ ደረት ቃንዛ ከምዘለካ/ኪ ተዛሪብካ/ኪ ኣለኻ/ኺ 	You have now mentioned that you have chest pain
79	en	ti	 occasionally i have some chest pain 	 ሓሓሊፉ ንእሽተይ ናይ ደረት ቃንዛ ኣለኒ 	Occasionally I have a little chest pain
80	en	ti	 okay are you having any other symptoms along with this other than just the pain 	 ጽቡቕ ምስ እዚ ካብ እቲ ቃንዛ ወጻኢ ካሎኦት ምልክታት ኣለውኻ/ኺ ዶ? 	Well with this do you have any other symptoms besides the pain?
81	en	ti	 or somebody sitting on your chest? 	 ወይ ዝኾነ ሰብ ኣብ ደረትካ ከምዝተቐመጠ? 	Or that anyone has been placed on your lap?
82	en	ti	 pretty much the same with the fever and the cough headache and muscle pains 	 ዳርጋ ምስ ረስኒ፣ ሰዓል፣ ርእሲ ሕማምን ናይ ጭዋዳ ቃንዛታት ተመሳሳሊ እዩ 	It is almost identical to fever, cough, headache and muscle aches
83	en	ti	 right in the middle of my chest 	 ልክዕ ኣብ ማእኸል ደረተይ 	Right in the middle of my lap
84	en	ti	 show me on this image where you feel the pain 	 ኣብ እዚ ምስሊ እዚ እቲ ቃንዛ ኣበይ ይስመዓካ/ኪ ከምዘሎ ኣርእየኒ/ይኒ 	Show me where you are feeling the pain in this image
85	en	ti	 since you have a fever 	 ረስኒ ስለዘለካ/ኪ 	Because you have a fever
86	en	ti	 so do you think that some of these symptoms could be related to being pregnant? 	 እሞ ገለ እዞም ምልክታት ምስ ምጽናስ ዝተሓሓዙ ዶ ይመስለካ/ኪ? 	So do you think some of these symptoms are related to pregnancy?
87	en	ti	 so your children are having some of the same symptoms? 	 እሞ ደቅኻ እውን ዝተወሰኑ ተመሳሳልቲ ምልክታት የርእዩ ኣለዉ? 	So your kids are showing certain same symptoms?
88	en	ti	 tell me about your chest pain 	 ብዛዕባ ናይ ደረትካ ቃናዛ ንገረኒ 	Tell me about your chest pain
89	en	ti	 the fever increases at night 	 እቲ ረስኒ ምሸት ይውስኽ እዩ 	The cough increases in the evening
90	en	ti	 the fever i've had for the last two days 	 ኣብ እተን ዝሓለፉ ክልተ መዓልቲታት ረስኒ ነይሩኒ እዩ 	I have had a fever the last couple of days
91	en	ti	 the fever started to increase last night 	 እቲ ረስኒ ካብ ትማሊ ምሸት እንዳወሰኸ ከይዱ 	The fever has been getting worse since last night
92	en	ti	 this is doctor porter in the emergency room triage center 	 ዶክተር ፖርተር ይበሃል ካብ ህጹጽ ክፍሊ ትሪያጅ ማእኸል 	His name is Dr. Porter from the emergency room triage center
93	en	ti	 well can you tell me a little bit more about your chest pain? 	 እሞ ብዛዕባ እቲ ናይ ደረትካ/ኪ ቃንዛ ንእሽተይ ክትነግረኒ/ርኒ ትክእል/ሊ ዶ? 	So can you tell me a little bit about your chest pain?
94	en	ti	 well i feel a pain in the front of my body here in my chest 	 ጽቡቕ እሞ፣ ኣብ ቅድሚተይ፣ ኣብ እዚ ኣብ ደረትይ እዩ ቃንዛ ዝስመዓኒ 	Well then, in my forehead, I feel pain here in my lap
95	en	ti	 well i've been having a strong pain in my chest 	 ጽቡቕ፣ ኣብ ደረተይ ክቢድ ቃንዛ እናተሰመዓኒ ነይሩ እዩ 	Well, I was having severe pain in my chest
96	en	ti	 well when i have that pain in my chest 	 ጽቡቕ እሞ፣ እቲ ቃንዛ ኣብ ደረተይ እንትጅምረኒ 	Well, when the pain starts in my chest
97	en	ti	 what kinda pain do you have in your chest? 	 ኣብ ደረትካ/ኪ እንታይ ዓይነት ቃንዛ ኣለካ/ኪ ? 	What kind of pain do you have in your chest ?
98	en	ti	 when this chest pain started? 	 እዚ ናይ ደረት ቃንዛ መዓዝ ጀሚሩ? 	When did this chest pain start?
99	en	ti	 where do you have the pain in the chest? 	 ኣበይ ወገን እዚ ናይ ደረት ቃንዛ ይስመዓካ/ኪ ኣሎ? 	On which side do you feel this chest pain?
100	en	ti	 where you feel this chest pain eel this chest t 	 ኣበይ ወገን ይስምዐካ እዚ ናይ ደረት ቃንዛ 	Where side do you feel this chest pain
101	en	ti	 you feel like tightness on your chest 	 ኣብ ደረትካ/ኪ ዘጨንቕ ስምዒት ይስመዓካ/ኪ ኣሎ 	You are feeling a distressing feeling in your chest
102	en	ti	 you know i got diabetes and stuff 	 ሽኮርያን ካልኦት ነገራትን ክምዘለዉኒ ትፈልጥ/ጢ ኢኻ/ኺ 	You know I have diabetes and other things
103	en	ti	 you said you're having this chest pain 	 እዚ ናይ ደረት ቃንዛ ከምዘለካ ሓቢርካ ኣለኻ 	You have reported that you have this chest pain
104	en	ti	 Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020 	 ካብ ጃኑዋሪ 1 እስካብ ማርች 15 2020 ኣብዘሎ፡ ኣብ ኣውሮፓ ሕብረትን/ናይ ኣውሮፓ ቁጠባዊ ቦታትን ኣብ እንግሊዝን ናይ ኮሮና ቫይረስ ሕማም(COVID-19) ውህሉል ኣጋጣሚታት ብ ቕልጡፍ እናዓበየ እዩ። 	From 1 January to 15 March 2020, the cumulative incidence of the coronavirus (COVID-19) in the European Union and/or European Economic Areas and the UK is growing rapidly.
105	en	ti	 The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, while at a different stage depending on the country, the COVID-19 pandemic is progressing rapidly in all countries. 	 እቲ ዝዋህለለ ናይ ሕማም ኮረና ቫይረስ (COVID-19) ዘጋጠሙ ጉዳያት ኣብ ኣውሮፓ ሕብረት/ኣውሮፓ ቁጠባዊ ዓውዲ ዘለዋ ሃገራት ን ኣብ እንግሊዝን ተመሳሳሊ ዝኾነ ምዕባለ እናርኣየ ይርከብ፡ ኣብ ዝተፈላለዩ ደረጃታት ድማ፡ ከከም ሃገራቱ ናይ COVID-19 ለበዳ ኣዝዩ ቅልጡፍ ብዝኾነ መልክዑ ኣብ ኩለን ሃገራት እናወሰኸ ይርከብ። 	The cumulative cases of the coronavirus (COVID-19) are showing similar developments in the EU/European Economic Area and in the UK, and at various levels, depending on the country the COVID-19 epidemic is very rapid in all countries It is increasing.
106	en	ti	 Based on the experience from Italy, countries, hospitals and intensive care units should increase their preparedness for a surge of patients with COVID-19 who will require healthcare, and in particular intensive care. 	 ብመሰረት ካብ ጣልያን ዝተወሰደ ተመኩሮ፡ ሃገራት፡ ሆስፒታላትን ናይ ጽኑዕ ክንክን ክፍሊታትን ነቶም ክመጹ ዝኽእሉ ናይ ጥዕና ክንክን ዝደልዩ ብፍላይ ድማ ጽኑዕ ክንክን ዝጠልቡ ን ናይ COVID-19 ሕሙማት ዋሕዚ ድልውነቶም ክውሰኹ ይግባእ። 	Based on the experience from Italy, countries, hospitals and intensive care payments should increase their readiness for the flow of COVID-19 patients to those who may need health care, especially those requiring intensive care.
107	en	ti	 On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. 	 ኣብ ዲሰምበር 31 2019 ፡ መምጽኢኦም ዘይፍለጡ ናይ ኒሞንያ ጉዳያት ጉጅለ ካብ ዉሃን ፡ ሁበይ ግዝኣት ፡ ቻይና ተጸብጺቡ። 	On December 31, 2019, a group of pneumonia cases of unknown origin were reported from Wuhan, Hubei Province, China.
108	en	ti	 On 9 January 2020, the China Center for Disease Control and Prevention reported the causative agent as being a novel coronavirus now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 	 ኣብ ጃኑዋሪ 9 2020፡ ናይ China Center for Disease Control and Prevention (ቻይና ማእኸል ምቁጽጻር ን ምክልኻልን ሕማም) እቲ ናይ ሕማም መልዓሊ ኖቨል ኮረና ቫይረስ 2 ኮይኑ ሐዚ ድማ SARS-CoV-2 ተባሂሉ ከምዝጽዋዕ ጸብጺቡ። 	On January 9 2020, the China Center for Disease Control and Prevention reported that the cause of the disease was the novel coronavirus 2, now called SARS-CoV-2
109	en	ti	 Since, the illness resulting from SARS-CoV-2 infection has been named coronavirus disease (COVID-19). 	 በዚ ድማ፣ ብSARS-CoV-2 ዝመፅእ ኢንፌክሽን ሕማም ኮሮና ቫይረስ (COVID-19) ተባሂሉ ተሰይሙ። 	Thus, the infection caused by SARS-CoV-2 was named the coronavirus disease (COVID-19).
110	en	ti	 Evidence to date is that ca 80% of individuals with COVID-19 have a mild disease, i.e. a respiratory tract infection with or without pneumonia, and most of these recover. 	 ክሳብ ሐዚ ብዘሎ መረዳእታታት 80% COVID-19 ዘለዎም ውልቀሰባት ከም ናይ መተንፈሲ ቱቦ ረኸሲ ዝበሉ ናይ ሳንቡእ ወቕዒ ዘለዎምን ዘይብሎምን ፈኲስ ሕማም ዝነበሮም እዮም። 	According to the data available to date, 80% of individuals with COVID-19 have had a mild illness with or without a pulmonary stroke such as a respiratory tract infection.
111	en	ti	 In ca 14% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care. 	 ናይ COVID-19 14% ጉዳያት ለበዳ ሓደገኛ ዝኾነ ናብ ሕክምና ምኽያድ ዘየድልዮ ሕማም እንትኾኑ እቶም ዝተረፉ 6% ጉዳያት ለበዳ ድማ ላዕለዋይ ሓገዝ ዘድልዮም ፅኑዕ ሕሙማት እዮም። 	14% of COVID-19 outbreak cases are serious non-admission cases, while the remaining 6% are critical patients in need of intensive care.
112	en	ti	 The mortality of patients hospitalised due to COVID-19 is ca 4%. 	 ብ CoVID-19 ሕክምና ካብ ዝኣተዉ ሕሙማት 4% ናይ ሞት መጠን ተመዝጊቡ ኣሎ። 	There is a 4% mortality rate among patients admitted to treatment for CoVID-1
113	en	ti	 In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/European Economic Area (EU/EEA) country and the United Kingdom (UK) and compare them to that of Hubei Province, China. 	 ኣብ እዚ መፅናዕቲ ኣብ ሕድሕድ ናይ ኣዉሮፓ ሕብረት/ኣዉሮፓ ቁጠባዊ ቦታ(EU/EEA) ዘለዋ ሃገራትን ዩናይትድ ኪንግደምን (UK) ዝርከቡ ድምር COVID-19 ጉዳያት ለበዳ ምስ ሁቤይ ናይ ቻይና ክፋል ሃገር ዘሎ ምዕባለታት ዳህሲስና ኣለና። 	In this study, we have examined the trends in the total COVID-19 epidemic cases in each EU/European Economic Area (EU/EEA) country and the United Kingdom (UK) with Hubei, part of China.
114	en	ti	 We also compare the current number of COVID-19 cases in EU/EEA countries and the UK with that in Italy during 31 January–15 March 2020. 	 ካብ ጃኑዋሪ 31- ማርች 15 2020 ኣብዘሎ ጊዜ ኣብ EU/EEA ሃገራትን ኣብ እንግሊዝ ዘለዉ ናይ COVID-19 ጉዳያት ምስ ኣብ ጣልያን ዘለው ጉዳያት ኣወዳዲርና ኢና። 	We compared the COVID-19 cases in EU/EEA countries and the UK during the period from January 31- March 15 2020 with those in Italy.
115	en	ti	 COVID-19 cases in EU/EEA countries and the UK 	 ናይ CoVID-19 ጉዳያት ለበዳ ኣብ ናይ EU/EEA ሃገራትን እንግሊዝን 	CoVID-19 cases outbreak in EU/EEA countries and the UK
116	en	ti	 Subsequent to China, COVID-19 underwent further geographical spread and the dynamic of the COVID-19 pandemic in the rest of the world currently follows that of this country. 	 ደድሕሪ ቻይና ድማ COVID-19 ኣብ ተወሳኽቲ ጂኦግራፊያዊ ዝርጋሐታት ዝካየደ እንትኾን፡ ኣብ መላዕ ዓለም ዝረኣይ ናይ COVID-19 ለበዳ ባህሪ ድማ ምስ እታ ሃገር ተመሳሳሊ ኣካይዳ እዩ ዘለዎ። 	Following China, COVID-19 has spread to additional geographical areas, and the nature of the global outbreak is similar to that of the country.
117	en	ti	 On 11 March 2020, the Director General of the World Health Organization (WHO) declared COVID-19 a pandemic. 	 ናይ ውድብ ጥዕና ዓለም (WHO) ዳይሬክተር ጀነራል ን COVID-19 ዓለም ለኻዊ ለበዳ ክብል ኣብ ማርች 11 2020 ኣዊጁ። 	The Director-General of the World Health Organization (WHO) declared COVID-19 a global pandemic on March 11,
118	en	ti	 In the 5 March issue of Eurosurveillance 2020, Spiteri et al. reported on the first European confirmed COVID-19 cases according to the WHO case definition. 	 ኣብ 5 ማርች 2020 ዝተኻየደ ናይ ዩሮሰርቬላንስ ኣኼባ Spiteri et al፣ ውድብ ጥዕና ዓለም(WHO) ዘዉጽኦ ናይ ጉዳይ ለበዳ ትርጉም ብምጥቃም ኣብ ኣውሮፓ ንዝተረኽቡ ናይ መጀመርታ ናይ COVID-19 ጉዳያት ለበዳ ኣፍሊጡ እዩ። 	At the Eurosurveillance meeting on 5 March 2020, Spiteri et al, announced the first COVID-19 cases in Europe using the World Health Organization (WHO) case definition.
119	en	ti	 In the EU/EEA, the first three confirmed cases were reported by France on 24 January 2020 in persons returning from Wuhan, Hubei Province, China. 	 ኣብ EU/EEA፡ እቶም ናይ መጀመሪያ ዝተረጋገጹ ሰለስተ ኣብ ካብ ዉሃን፡ ሁበይ ግዝኣት. ቻይና ዝተመለሱ ሰባት ዝተርኣዩ ሰባት ብ ፍራንስ 24 ኣብ ጃኑዋሪ 2020 ተጽብጺቦም እዮም። 	In the EU/EEA, the first three confirmed cases in from Wuhan, Hubei Province. The sightings of people returning to China were reported by France 24 in January
120	en	ti	 As at 15 March 2020, COVID-19 cases had been detected in all 30 EU/EEA countries and the United Kingdom (UK), whereby between 31 December 2019 and that date included, 39,768 cases and 1,727 deaths had been reported, with 17,750 cases and 1,441 deaths from Italy alone. 	 ኣብ 15 ማርች 2020 ናይ COVID-19 ጉዳያት ለበዳ ኣብ ኩለን እተን 30 ናይ EU/EEA ሃገራትን ኣብ ዩናይትድ ኪንግደምን (UK) ከምዝተረኸበ ይግለፅ። ካብ 31 ዲሰምበር 2019 ጀሚሩ ክሳብ እቲ ዕለት ድማ 39,768 ጉዳያት ለበዳን 1,727 ሞትን ተመዝጊቦም እዮም። ካብዚኦም ድማ እቶም 17,750 ጉዳያት ለበዳ 1,441 ሞትን ካብ ጣልያን ጥራሕ እዮም ተረኺቦም። 	On 15 March 2020, outbreak cases of COVID-19 were reported in all 30 EU/EEA countries and in the United Kingdom (UK). Since December 31, 2019, 39,768 outbreak cases and 1,727 deaths have been registered. Of these, 17,750 cases and 1,441 deaths were reported from Italy alone.
121	en	ti	 Obtaining cumulative number and cumulative incidence of COVID-19 cases 	 ናይ COVID-19 ኬዛት ድምር ቁፅርን ድምር ክስተትን ምርካብ 	Get the total number of COVID-19 cases and total incidence
122	en	ti	 At the European Centre for Disease Prevention and Control (ECDC), the notified COVID-19 case counts in each country worldwide, obtained from only official sources such as the countries’ Ministry of Health, national and regional health authorities and the WHO, are updated each day at 8:00 a.m. 	 ኣብ European Centre for Disease Prevention and Control (ECDC) (ናይ ኣዎሮፓ ሕማም ናይ መከላኸሊን መቆፃፀርን ማእኸል) ናይ ሕድሕድ ናይ ዓለም ሃገራት COVID-19 ስሩዕ መረዳእታ ካብ ዝህቡ ምንጭታት ከም ናይ ጥዕና ሚኒስቴር፣ ብሄራዊን ክልላዊን ናይ ጥዕና ምምሕዳር ከምኡዉን ካብ ውድብ ጥዕና ዓለም(WHO) ዝተወስደ መረዳእታ ብምጥቃም ኩሉ ጊዜ ንግሆ ሰዓት 8፡00 ዝመሓየሽ እዩ። 	The European Center for Disease Prevention and Control (ECDC) provides regular COVID-19 data for each country in the world from sources such as the Ministry of Health, national and regional health administrations and the World Health Organization (WHO). ) is updated every morning at 8:00 am using retrieved data.
123	en	ti	 These data were used for assessing the trends of COVID-19 in EU/EEA and the UK, and comparing them to that in Italy. 	 እዞም ዳታታት እዚኦም ኣብ EU/EEAን ኣብ እንግሊዝን ዘሎ ምዕባለታት COVID-19 ዳህሳስ ብምግባር ምስ ጣልያን ንምንጽጻር ኣብ ጥቕሚ ዝወዓለ እዩ። 	These data were used to survey COVID-19 developments in the EU/EEA and the UK and compare them with Italy.
124	en	ti	 As a proxy of the prevalence of active COVID-19 cases, we calculated the 14-day truncated cumulative incidence of COVID-19 cases, thus taking into account the natural course of COVID-19, in each EU/EEA country and the UK, during the 1 January–15 March 2020 period. 	 ካብ 1 ጃኑዋሪ-15 ማርች 2020 ዘሎ እዋን ኣብ ሕድሕድ ሃገራት EU/EEAን UKን ንCOVID-19 ጉዳያት ለበዳ ክዉክል ዝኽእል ናይ COVID-19 ተፈጥሮኣዊ ጉዕዞ ኣብ ሓሳብ ብምእታው ናይ 14-መዓልቲ ዝተቆረፀ COVID-19 ጉዳያት ለበዳ ድምር ኣስሊሕና ኢና። 	From 1 January-15 March 2020, we calculated the 14-day cut-off sum of COVID-19 cases in each EU/EEA and UK, taking into account the natural journey of COVID-19 cases that may represent the cases.
125	en	ti	 We also presented the cumulative number of notified cases of each country as at 15 March 2020 8:00 a.m. compared with that of Italy for the 31 January–15 March 2020 period. 	 ምስ ካብ 31 ጃንዋሪ-15 ማርች 2020 ዘሎ ናይ ጣልያን ቁፅሪ ኣነፃፂርካ ኣብ 15 መጋቢት 2020 ንጉሆ ሰዓት 8፡00 ዝተገልፀ ናይ ሕድሕድ ሃገር ድምር ኣቕሪብና ኣለና። 	We have presented the country-by-country totals as of 8:00 am on 15 March 2020 compared to the Italian figures for 31 January-15 March
126	en	ti	 Trends of COVID-19 in EU/EEA countries and the UK 	 ናይ CoVID-19 ምዕባለታት ኣብ ሃገራት EU/EEAን Ukን 	CoVID-19 developments in EU/EEA and Uk countries
127	en	ti	 The trends in the 14-day truncated cumulative incidence of COVID-19 cases in EU/EEA countries and the UK generally followed that of Hubei Province (China) (Figure 1). 	 ድሕሪ ናይ ቻይና ሁባይ ቐጠና ኣብ EU/EEA ሃገራትን UKን ዝተርኣዩ ናይ 14 መዓልታት ናይ COVID-19 ልውጥታት (Figure 1) 	14-day COVID-19 changes in EU/EEA countries and UK after China&#39;s Hubei region (Figure 1)
128	en	ti	 For the EU/EEA and the UK overall, the cumulative incidence of COVID-19 started to increase around 21 February and then increased sharply around 28 February 2020 (Supplementary material). 	 ን EU/EEAን ን እንግሊዝን በጠቓላሊ፡ እቲ ውህሉል ናይ COVID-19 ኣጋጣሚታት ካብ ፌብሩዋሪ 21 ንደሓር እዩ ክውስኽ ጀሚሩ፡ ቀጺሉ ድማ ካብ ፌብሩዋሪ 28:2020 ንደሓር ብ ናህሪ ወሲኹ እዩ(ተሓጋጋዚ ናውቲታት)። 	For the EU/EEA and the UK as a whole, the cumulative COVID-19 cases started to increase after 21 February and continued to increase rapidly after 28 February 2020(supporting materials).
129	en	ti	 This was mostly driven by the rapid increase in the number of reported cases from Italy, but all other EU/EEA countries and the UK showed similar increasing trends of the cumulative incidence of COVID-19 (Supplementary material). 	 እዚ መብዛሕቲኡ ግዜ ካብ ጣልያን ብዝጽብጸቡ ዓብዪ ናህሪ ዝነበሮም ወሳኸታት ዝዝወር እዩ ነይሩ፡ ነገር ግን ኩለን ዝተረፋ ናይ EU/EEA ሃገራትን እንግሊዝን ተመሳሳሊ ናይ ወሰኽ ምዕባለታት ውህሉል ናይ COVID-19 ኣጋጣሚታት ኣርኢየን እየን። 	This was often driven by the largest increases reported from Italy, but all other EU/EEA countries and the UK showed similar increases in cumulative COVID-19 cases.
130	en	ti	 Figure 2 shows the cumulative number of COVID-19 cases, in EU/EEA countries and the UK compared with that in Italy for the 31 January–15 March 2020 period. 	 ኣሃዝ 2 ምስ ካብ 31 ጃንዋሪ- 15 ማርች 2020 ዝነበረ ናይ ጣልያን ጉዳያት ለበዳ ብምንፅፃር ኣብ ሃገራት EU/EEAን UKን ዝርከቡ ድምር ጉዳያት ለበዳ COVID-19 ዘርኢ እዩ። 	Figure 2 shows the total number of COVID-19 cases in the EU/EEA and UK compared to the Italian cases from 31 January- 15 March
131	en	ti	 It highlights that, as at 15 March 8:00 a.m., 15 other EU/EEA countries and the UK had already reported a total number of cases comparable to that of Italy just 3 weeks prior or less. 	 ኣብ 15 ማርች ናይ ንግሆ ሳዓት 8፡00 ምስ ቅድሚ 3 ሰሙን ዝተመዝገበ ናይ ጣልያን በዝሒ ጉዳያት ለበዳ ዝነፃፀር ቁፅሪ ኣብ 15 ሃገራት EU/EEAን UKን ተመዝጊቡ ኣሎ። 	As of 8:00 am on March 15, 15 EU/EEA and UK cases have been reported, compared to Italy&#39;s three weeks ago.
132	en	ti	 Our results indicate that the number of notified cases of COVID-19 is rapidly increasing in the EU/EEA and the UK. 	 ዘለዉና ውጽኢታት ዝተፈለጡ ጉዳያት COVID-19 ኣብ EU/EEAን እንግሊዝን ብ ቕልጡፍ እናወሰኹ ከምዝኾኑ ዘርእዩ እዮም። 	Our results show that known cases of COVID-19 are increasing rapidly in the EU/EEA and the UK.
133	en	ti	 The observed trends in the cumulative incidence of COVID-19 suggest that the pandemic is progressing at a comparable speed in all countries. 	 እቲ ዝረአ ዘሎ ጠቕላላ ናይ COVID-19 ክስተት እቲ ለበዳ ኣብ ኩለን ሃገራት ብተነፃፃሪ ፍጥነት ከምዝስፋሕፋሕ ዘሎ ዘረድእ እዩ። 	The total incidence of COVID-19 indicates that the epidemic is spreading at a relatively rapid pace in all countries.
134	en	ti	 This is despite countries being at different stages, variations in national public health responses, and possibly different case definitions in countries and different protocols for selecting patients that must be tested for confirmation of COVID-19, including catch-up testing. 	 እዚ ድማ ኣንጻር እተን ሃገራት ኣብ ዝተፈላለየ ደረጃ ዘለዋ ይኹና፡ ኣብ ናይ ብሄራዊ ህዝባዊ ጥዕና ዘሎ ኣፈላላይ፡ ኣብ ዝተፈላለዩ ሃገራት ክህሉ ዝኽእል ዝተፈላለየ ናይ ጉዳያት ትርጉም ኣዋህባን፡ን ናይ COVID-19 ምርመራ ብቑዓት ዝኾኑ ሕሙማት ኣብ ምምራጽ ዝስዕቡዎ ዝተፈላለየ ፕሮቶኮላት እዩ። 	This is against the differences in national public health status, the differences in case interpretation that may exist in different countries, and the different protocols followed in selecting patients eligible for COVID-19 testing.
135	en	ti	 Early March 2020, doctors in the affected regions of Italy described a situation in which ca 10% of patients with COVID-19 required intensive care and media sources reported that hospitals and intensive care units in these regions had already reached their maximum capacity. 	 ኣብ መጅመሪ ማርች 2020፡ኣብ እተን በዚ ረኽሲ ዝተጠቕዓን ኣብ ካልኦት ኣብ ጣልያን ዝርከባ ክልላት ዘለው ዶክተራት፡ ነቲ ዘሎ ኩነታት፡ማለት እውን ካብቶም ናይ COVID-19 ሕሙማት ውሽጢ 10% ኢድ ዝኾኑ ጽኑዕ ሕክምና ዝደልዩ እዮም፡ ሚድያታታት ከምዝዘገባኦ ድማ፡ እተን ኣብዚ ክልል ዝርከባ ናይ ጽኑዕ ሕክምና ክትትል ክፍሊታት እቲ ክሕዛኦ ዝኽእላ ወሰን ብርኪ በጺሐን ኣለዋ። 	In early March 2020, doctors in the affected and other regions in Italy were seeking intensive treatment for the current situation, that is, within 10% of the COVID-19 patients, media reported that the Intensive treatment monitoring fees have reached the limit of what they can handle.
136	en	ti	 Data on admission of COVID-19 cases in a hospital and/or an intensive care unit are currently available at EU/EEA level for only 6% and 1% cases, respectively (data not shown). 	 ኣብ እዚ ሐዚ እዋን ብ ደረጃ EU/EEA ዘሎ ናይ COVID-19 ቅበላ ዳታ ኣብ ሆስፒታል 6% ኣብ ጽኑዕ ክንክን ድማ 1% ዝርከብ እዩ(ዳታ ኣይቀረበን)። 	Current EU/EEA-level COVID-19 admission data are 6% in hospital and 1% in intensive care (data not available).
137	en	ti	 They should, however, be collected in a systematic fashion to complement current surveillance data that focus on the number of reported cases and the number of deaths. 	 ኣብ ዝተመዝገቡ ቁፅሪ ጉዳያት ለበዳ ሞትን ምስ ዘድህብ ምርምር ንምስምዕማዕ ብስትራቴጂካዊ መንገዲ ክእከቡ ይግባእ። 	They should be clustered strategically to align with research that focuses on the number of recorded cases and epidemiological mortality.
138	en	ti	 A study performed in 2010–11 showed a large variation in the availability of intensive care and intermediate care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 population in Portugal. 	 ኣብ 2010–11 ኣብ ዝተገበረ መፅናዕቲ፣ ኣብ ኣውሮፓ ናይ ጽኑዕ ክንክንን ናይ ማእኸላይ ክንክን ዓራት ህላወ ካብ 29.2 ኣብ ጀርመን ናብ 4.2 ን100,000 ህዝቢ ኣብ ፖርቹጋል ዝኾን ዓብዪ ፍልልይ ከምዘሎ ኣርእዩ እዩ። 	In a 2010–11 survey, the availability of acute care and intermediate care beds in Europe showed a large difference from 29.2 in Germany to 4.2 per 100,000 population in Portugal.
139	en	ti	 This means that countries may have more or less resources than Italy (12.5 intensive care and intermediate care beds per 100,000 population in 2010–11). 	 እዚ ማለት ድማ ሃገራት ካብ ጣልያን (12.5 ጽኑዕ ክንክን ማእኸለዋይ ክንክን ዓራታት ብ 100000 በዝሒ ህዝቢ ኣብ 2010-11) ንላዕሊ ወይድማ ዝነኣሰ ናይ ሃብቲ መጠን ክህልወን ይኽእል እዩ። 	This means that countries may have more or less wealth than Italy (12.5 intensive care beds per 100,000 population in 2010-11).
140	en	ti	 Modelling scenarios related to healthcare capacity saturation, with estimates for each EU/EEA country and the UK of the prevalence of hospitalised COVID-19 cases associated with a &gt; 90% risk of exceeding intensive care bed capacity, are provided in the sixth update of the ECDC rapid risk assessment on COVID-19. 	 ምስ ናይ ወሰን ዓቕሚ ክንክን ጥዕና ዝተሓሓዙ ናይ ሞደል ተርእዮታት፣ ምስ ሕድሕድ ናይ EU/EEA ሃገራትን እንግሊዝን ዝህሉ ናይ ምስ a &gt ዝተሓሓዙ ኣብ ሆስፒታል ዝርከቡ ናይ COVID-19 ጉዳያት ለበዳ ትንቢት ዝሓዘ፣ 90% ዝኾን ናይ ጽኑዕ ክንክን ዓራት ዓቕሚ ናይ ምሓልፉ ሓደጋ፣ ኣብ እቲ መበል ሻዱሻይ ዝተሓደሰ ናይ ECDC ናይ COVID-19 ቅልጡፍ ናይ ሓደጋ ዳህሳስ ቀሪቡ እዩ። 	Model phenomena associated with marginal healthcare capacity, with a prediction of the outbreak of a &gt; related in-hospital COVID-19 cases with each EU/EEA country and the UK, containing a 90% risk of exceeding intensive care bed capacity, in The sixth updated ECDC COVID-19 Rapid Risk Assessment has been released.
141	en	ti	 Since cases have so far clustered in certain regions in EU/EEA countries and the UK, and hospitals and intensive care units usually serve a defined regional catchment population, information about cases and intensive care beds should preferably be made available at the Nomenclature of territorial units for statistics 2 (NUTS-2) level. 	 ኣብ ሓደሓደ ናይ EU/EEA ሀገራትን እንግሊዝን ውሽጢ ኣብ ዝተወሰኑ ክልላት ዝርከቡ ሕክምናታትን ናይ ጽኑዕ ክንክን ዩኒታት ኣገልግሎት ንካብ ውስን ክፍሊ እቲ ቀጠና ዝመጹ ሰባት ኣገልግሎት ዝህቡ እንትኾኑ ን ሕሙማን፣ ዓራት መረዳእታ ኣብ ዝተመደቡ ናይ ክልል ክፍሊ ንስታቲስቲክስ 2 (NUTS-2) ደረጃ ክርከብ ይግባእ። 	In some EU/EEA countries and the UK, treatments and intensive care units in certain regions provide services to people from a limited part of the region.
142	en	ti	 The experience from Italy and the current trends in other countries show that the COVID-19 pandemic is progressing rapidly in the EU/EEA and the UK. 	 ካብ ጣልያንን ኣብ ካልኦት ዓዲታት ዝተወሰዱ ካልኦት እዋናዊ ምዕባለታት ዝተረኸበ ተሞክሮ ከምዘርእዮ ናይ COVID-19 ለበዳ ኣብ EU/EEA ን ኣብ እንግሊዝን ብ ናህሪ እናዓበየ ይርከብ። 	Experience from Italy and other recent developments in other countries shows that the COVID-19 epidemic is growing rapidly in the EU/EEA and in the UK.
143	en	ti	 Countries, hospitals and intensive care units should thus prepare themselves for a scenario of sustained community transmission of SARS-CoV-2 and an increase in the number of patients with COVID-19 requiring healthcare, and in particular intensive care, such as the one occurring in the affected regions of Italy. 	 ሃገራት፣ ሕክምናታትን ላዕለዋይ ሓገዝ ዝህቡ ክፍልታትን ነቲ ክመፅእ ዝኽእል ቀፃሊ ዝኾነ ናይ SARS-CoV-2 ለበዳን ከምኡውን ቁፅሪ ብCOVID-19 ዝተጠቕዑ ብምዉሳኽ ጥዕና ሓለዋን ከም ኣብቶም ዝተጎድኡ ክፋላት ጣልያን ዘለዉ ላዕለዋይ ሓገዝ ዘድልዮም ቦታታትን ክህልዉ ስለዝኽእሉ ኣድላዪ ምድላው ክግበር ይግባእ። 	Countries, treatments and paramedic departments should be prepared for the possible ongoing SARS-CoV-2 outbreak and the increase in the number of cases of COVID-19 in health care and paramedic areas such as those in the affected parts of Italy.
144	en	ti	 As pointed out in the recent ECDC rapid risk assessment, a rapid, proactive and comprehensive approach is essential to delay the spread of SARS-COV-2, with a shift from a containment to a mitigation approach, as the anticipated rapid increase in the number of cases may not provide decision makers and hospitals enough time to comprehend, accept and adapt their response accordingly if not implemented ahead of time. 	 ኣብ ቀረባ እዋን ዝወፀ ናይ ECDC ስሉጥ ናይ ሓደጋ ምርመራ ቅልጡፍ፣ ህፁፅን ኣጠቓላሊን ዝኾነ ኣቀራርባ ብምጥቃም ምትሕልላፍ SARS-COV-2 ምቕናስ ከምዝከኣል ሓቢሩ።ካብ ምዕጋት ናብ ምቕናስ ብምቕያር ዝግበር ኣከይዳ ቀዲምካ እንተዘይተተሊሙ ነቲ ዝፅበየና ዘሎ ቅልጡፍ ናይ ጉዳያት ለበዳ ምዉሳኽ ዉሳነ ወሃብትን ሕክምናታትን ግቡእ ዝኾነ መልሲ ክህቡ ኣይኽእሉን። 	The recent ECDC Efficient Risk Assessment stated that the transmission of SARS-COV-2 can be reduced by using a fast, urgent and comprehensive approach They cannot give.
145	en	ti	 The rapid risk assessment also lists the public health measures to mitigate the impact of the pandemic. 	 ቅልጡፍ ናይ ሓደጋ ግምገማ ናይ እቲ ለበዳ ፅዕንቶ ንክቕንስ ናይ ህዝቢ ጥዕና ስጉምትታት እውን ይዝርዝር እዩ። 	A rapid risk assessment also lists public health measures to reduce the impact of the outbreak.
146	en	ti	 There is a short window of opportunity during which countries have the possibility to further increase their control efforts to slow down the spread of SARS-CoV-2 and decrease the pressure on healthcare. 	 ሃገራት ናይ SARS-CoV-2 ዝርጋሐ ኣብ ምግታእን ኣብ ናይ ጥዕና ክንክን ዘሎ ጸቕጢ ኣብ ምቕናስን ዘለዎን ቁጽጽር ብዝበለጸ ክውስኻሉ ዝኽእላሉ ሓጺር ናይ ዕድል መሽኮት ኣለወን። 	Countries have a short window of opportunity in which they can best increase the control it has on curbing the spread of SARS-CoV-2 and reducing the pressure on health care.
147	en	ti	 Failing this, it is likely that the healthcare systems of other EU/EEA countries will face a surge of patients that require intensive care within the coming days or weeks. 	 እዚ ምግባር ተዘይተኻኢሉ ኣብ ካልኦት EU/EEA ሃገራት ኣብ ዉሽጢ ተወሰነ ማዓልትታት ወይድማ ሰሙናት እቲ ጥዕና ሓለዋ ላዕለዋይ ሓገዝ ዘድልዮም ሕሙማት ምወሳኽ ከጋጥሞም ይኽእል እዩ። 	If this is not done, other EU/EEA countries may experience an increase in the number of patients in need of high-level health care within a few days or weeks.
148	en	ti	 The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over 3,000 people and infected over 80,000 in China and elsewhere in the world, resulting in catastrophe for humans. 	 እቲ ብ SARS ኮረና ቫይረስ 2 (SARS-CoV-2) ዝተበገሰ ናይ 2019 (COVID-19) ናይ ኮረና ቫይረስ ለበዳ፡እስካብ ሐዚ ካብ 3000 ንላዕሊ ሰባት ብምቕታል እስካብ 80000 ዝኾኑ ድማ ኣጥቂዑ ይርከብ፡ ኣብ ካልኦት ክፋላት ዓለማት ድማ ኣስክሕካሒ ህልቂት እናስዓበ ይርከብ። 	The 2019 (COVID-19) coronavirus pandemic, triggered by SARS coronavirus 2 (SARS-CoV-2), has so far killed more than 3,000 people and infected up to 80,000, and is causing horrific deaths in other parts of the world.
149	en	ti	 Similar to its homologous virus, SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 might also be transmitted from the bats and causes similar symptoms through a similar mechanism. 	 ልክዕ ከም እቲ ኣብ 2003 ኣብ ኣሽሓት ሰባት SARS ዘኸተለ SARS-CoV፣ SARS-CoV-2 እዉን ብተመሳሳሊ መንገዲ ካብ ሎኻኺቶ ተመሓላሊፉ ተመሳሳሊ ምልክታት ከምፅእ ይኽእል እዩ። 	Like SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 can be transmitted from locusts in a similar way and cause similar symptoms.
150	en	ti	 However, COVID-19 has lower severity and mortality than SARS but is much more transmissive and affects more elderly individuals than youth and more men than women. 	 ይኹን ደኣምበር COVID-19 ካብ SARS ዝነኣሰ መጠን ሞት እንትህልዎ ዝበኣሰ ናይ ምምሕልላፍን ካብ መናእሰይ ንላዕሊ ዓበይቲ፣ ካብ ደቂ ኣንስትዮ ንላዕሊ ደቂ ተባዕትዮ ዘጥቅዕ እዩ። 	However, COVID-19 has a lower mortality rate than SARS and is more transmissible and affects more adults than young people, and more men than women.
151	en	ti	 In response to the rapidly increasing number of publications on the emerging disease, this article attempts to provide a timely and comprehensive review of the swiftly developing research subject. 	 ነቶም ኣዝዮም እናወሰኹ ዝኸዱ ዘለው ናይ ሓደሽቲ ሕማማት ሕትመታት መልሲ ኣብ ምሃብ፡ እዚ ኣንቀጽ እዚ ነቲ ብቕልጡፍ እና ማዕበለ ዝኸድ ዘሎ ናይ ምርምር ፕሮጀክት፡ ግዜኡ ዝሓለወን ሓቛፊ ዝኾነን ኣጠቓላሊ ርኢቶ ንምሃብ ፈተነ ዝገበር እዩ። 	In response to the increasing number of new disease publications, this article attempts to provide a timely and comprehensive overview of the rapidly evolving research project.
152	en	ti	 We will cover the basics about the epidemiology, etiology, virology, diagnosis, treatment, prognosis, and prevention of the disease. 	 ብዛዕባ ኢፒዲሞሎጂ(epidemiology)፡ ኢቲዮሎጂ(etiology)፡ ቫይሮሎጂ(virology)፡ ምርመራታት፡ ሕክምና፡ ፕሮጅኖሲስ(prognosis)ን ናይ እቲ ሕማም መከላኸሊን ዝምልከት መሰረታውያን ጉዳያት ክንሽፍን ኢና። 	We will cover basic issues about epidemiology, etiology, virology, diagnoses, treatment, prognosis and prevention of the disease.
153	en	ti	 Although many questions still require answers, we hope that this review helps in the understanding and eradication of the threatening disease. 	 ብዙሓት ሕቶታት መልሲ ዝደልዩ እኳ እንተኾኑ፡ እዚ ኣጠቓላሊ መግለጺ እዚ ነዚ መስካሕክሒ ሕማም ኣብ ምርዳእን ምውጋድን ሓገዝ ከምዝገብር ተስፋ ንገብር። 	While many questions remain to be answered, we hope this overview will help in understanding and avoiding this terrible disease.
154	en	ti	 The Spring Festival on January 25, 2020 has become an unprecedented and unforgettable memory to all Chinese who were urged to stay indoors for all the holiday and for many weeks after due to the outbreak of a novel viral disease. 	 ኣብ 25 ጃኑዋሪ 2020 ዝኽበር ናይ Spring Festival( ፅድያ ባዓል) በቲ ለበዳ ሓድሽ ቫይረስ ምኽንያት ብምግባር ኣብ እቲ እዋን ኣውዳኣመትን ንቀፃሊ ሰሙናት ካብ ገዛ ንከይወፁን ንዝተገብሩ መላእ ቻይናዉያን ተራእዩ ዘይፈልጥን ዘይትርሳዕን ማዓልቲ ኮይና ከምዝሓለፈት ይእመን። 	The Spring Festival on January 25, 2020 is believed to have been an unprecedented and unforgettable day for all Chinese who were forced to stay indoors during the New Year and the coming weeks due to the outbreak of the new virus.
155	en	ti	 The virus is highly homologous to the coronavirus (CoV) that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003; thus, it was named SARS-CoV-2 by the World Health Organization (WHO) on February 11, 2020, and the associated disease was named CoV Disease-19 (COVID-19). 	 እቲ ቫይረስ ምስ እቲ ኣብ 2003 ለበዳ ዘስዓበ SARS ኮረና ቫይረስ ዝዓበየ ተመሳስሊነት ዘለዎ እዩ፡ በዚ ድማ ኣብ ፌብሩዋሪ 11:2020 ብ ውድብ ጥዕና ዓለም SARS-CoV-2 ተባሂሉ ክጽዋዕ ዝኸኣለ እንትኾን ምስ ዝተተሓሓዘ ሕማም ድማ ኮቭ ሕማም-19(ኮቪድ-19) ተባሂሉ እዩ። 	The virus has the greatest similarity to the SARS coronavirus that caused the 2003 pandemic, thus it was designated SARS-CoV-2 by the World Health Organization on February 11:2020 and the associated disease as CoV disease-19(COVID-19). is.
156	en	ti	 The epidemic started in Wuhan, China, and quickly spread throughout the entire country and to near 50 others all over the world. 	 እቲ ለበዳ ኣብ ዉሃን ቻይና ዝጀመረ እንትኸዉን ቀልጢፉ ድማ ናብ መላእ እታ ሃገርን ናብ ካልኦት ከባቢ 50 ሃገራትን ተላቢዱ እዩ። 	The outbreak began in Wuhan, China, and quickly spread across the country and to about 50 other countries.
157	en	ti	 As of March 2, 2020, the virus has resulted in over 80,000 confirmed cases of COVID-19, with more than 40,000 patients discharged and over 3,000 patients who died. 	 ክሳብ ማርች 2, 2020 እቲ ቫይረስ 80,000 ዝተረጋገፁ ናይ COVID-19 ጉዳያት ለበዳ ከምዘለዉ ፣ ልዕሊ 40,000 ሕሙማት ካብ ሕክምና ከምዝወፁን ከምኡውን 3,000 ሕሙማት ከምዝሞቱን ይፍለጥ። 	As of March 2, 2020, the virus has 80,000 confirmed cases of COVID-19 , more than 40,000 patients have been discharged and 3,000 patients have died.
158	en	ti	 WHO warns that COVID-19 is “public enemy number 1” and potentially more powerful than terrorism. 	 COVID-19 ‘’ናይ ህዝቢ ቀዳማይ ፀላኢ 1’’ ከምዝኾነን ካብ ግብረ ሽበራ ዝሓየለ ምዃኑን ውድብ ጥዕና ዓለም (WHO) ኣጠንቂቑ ኣሎ። 	The World Health Organization (WHO) has warned that COVID-19 is &#39;&#39;people&#39;s first enemy 1&#39;&#39; and is stronger than terrorism.
159	en	ti	 According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, over 200 papers have been published on COVID-19 including its virology, epidemiology, etiology, diagnosis, and treatment since the first report on January 7, 2020 that determined the sequence of the virus isolated from multiple patients. 	 ካብ ብዙሓት ሕሙማት ዝተወስዱ ናይ ቫይረስ ቅደም ሳዓብ ካብ ዝወፀሉ 7 ጃኑዋሪ 2020 እዋን ጀሚሩ ብዛዕባ ናይ COVID-19 ቫይሮሎጂ፣ ኢፒደሞሎጂ፣ ኢትዮሊጂ፣ ናይ ምርመራ ከይዲን መድሓኒትን ክልተ ወርሒ ኣብ ዘይመልአ እዋን ልዕሊ 200 ፅሑፋት ተሓቲሞም ይብል PubMed (https://www.ncbi.nlm.nih.gov/pubmed/) 	Since the release of viral sequences from many patients on January 7, 2020, more than 200 articles have been published on the virology, epidemiology, etiology, diagnostic process and treatment of COVID-19 in less than two months, according to PubMed (https://www.ncbi. nlm.nih.gov/pubmed/)
160	en	ti	 This review attempts to summarize the research progress in the new and swiftly developing subject area. 	 እዚ ክለሳ ኣብ እቲ ሓድሽን ብቕልጡፍን ዝዓቢ ዘሎ ርእሰ ጉዳይ ናይ መፅናዕቲ ትምበያ ንምጥቕላል ይፍትን። 	This review attempts to summarize the research forecast on the new and rapidly growing subject.
161	en	ti	 Whenever possible, we will try to compare COVID-19 with SARS and another CoV-caused disease, Middle East respiratory syndrome (MERS, an outbreak in 2012). 	 ኣብዝተኽኣለና ጊዜ COVID-19 ምስ SARSን ካልኦት CoV-caused ሕማማት፣ MERS( ኣብ 2012 ዝተልዓለ ለበዳ) ንምንጽጻር ክንሙክር ኢና። 	Whenever possible, we will try to compare COVID-19 with SARS and other CoV-caused diseases, MERS( the 2012 outbreak).
162	en	ti	 We will also discuss what we have learned so far regarding the prevention and prognosis of the disease as well as some remaining yet urgent questions. 	 ብዛዕባ ናይ እቲ ሕማም መከላኸሊን ትንበያታትን ብዛዕባ ገለ ዝቕርዩ ህጹጻት ሕቶታትን እስካብ ሐዚ እንታይ ክምዝተዛተናን እውን ክንመያየጥ ኢና። 	We will also discuss the prevention and forecasts of the disease, some urgent questions that remain, and what we have discussed so far.
163	en	ti	 CoVs have been traditionally considered nonlethal pathogens to humans, mainly causing approximately 15% of common colds 4. 	 CoVs ብ ልሙድ ን ደቂ-ሳብት ናብ ሞት ዘይብቅዑ ተባሂሎም እዮም ዝውሰዱ፡ ብ ጽግግዕ 15% ዝኸውን ናይ ጉንፋዕ ጸገም ዘብጽሑ እዮም 4። 	CoVs are commonly considered non-lethal in children, causing approximately 15% of flu cases
164	en	ti	 However, in this century, we have encountered highly pathogenic human CoVs twice, i.e., SARS-CoV and MERS-CoV, which caused an outbreak originally in China in 2003 and Saudi Arabia in 2012, respectively, and soon spread to many other countries with horrible morbidity and mortality. 	 ኮይኑ ግና ኣብ እዚ ክፍለዘመን ኣብ ቻይና ብ2003ን ኣብ ስዑድ ዓረብ ድማ ብ2012ን ዘጋጠሙ ዳሓር ድማ ናብ ዝተፈላለዩ ሃገራት ብምስፍሕፋሕ ከቢድ ሕማምን ሞትን ዘስዐቡ ብተኸታታሊ SARS-CoVን MERS-CoVን ዝተብሃሉ ናይ CoVs ክልተ ሕማማት ኣጋጢሞም እዮም። 	However, this century saw two outbreaks of CoVs, SARS-CoV and MERS-CoV, which occurred in China in 2003 and Saudi Arabia in 2012 and then spread to various countries, causing serious illness and death.
165	en	ti	 Therefore, the current COVID-19 is the third CoV outbreak in the recorded history of humans. 	 ስለዚ፡ እዚ እዋናዊ COVID-19 ኣብ ናይ ደቂ-ሰባት ታሪኽ እቲ ሳልሳይ ኮይኑ ዝተመዝገበ ናይ CoV ለበዳ እዩ። 	Therefore, this current COVID-19 is the third recorded CoV outbreak in human history.
166	en	ti	 As shown in Fig. ​Fig.1,1, clusters of pneumonia that had unknown origins were first reported from Wuhan on December 31, 2019 to the China National Health Commission. 	 ኣብ ​Fig.1.1 ከምዝተርኣየ ኣብ ዲሰምበር 31:2019 ዘይተፈልጠ ምንጪ ዘለዎም ናይ ሳንቡእ ወቕዒ ጉጅለታት ንመጀመሪያ ጊዜ ካብ ዉሃን ናብ ቻይና ብሄራዊ ናይ ጥዕና ኮሚሽን ጸብጽብ ቀሪቡ እዩ። 	As shown in Fig.1.1, on December 31, 2019, the first cases of pneumonia of unknown origin were reported to the National Health Commission of China from Wuhan.
167	en	ti	 Seven days later the sequence of the CoV was released. 	 ድሕሪ ሸዉዓተ ማዓልትታት ናይ CoV ቅደም ሰዓብ ተገሊፁ። 	Eight days later, the CoV sequence was determined.
168	en	ti	 On January 15, 2020 the first fatal case from Wuhan was reported. 	 ኣብ ጃኑዋሪ 15:2020 እቲ ናይ መጀመሪያ ሞት ካብ ውሃን ተጸብጺቡ። 	On January 15:2020 the first death was reported from Wuhan.
169	en	ti	 Meanwhile, the epidemic rapidly spread to the neighboring cities, provinces, and countries. 	 ኣብ መጨረሻ፡ እቲ ለበዳ ናብ ጎረባብቲ ከተማታት፡ ግዝኣታትን ሃገራትን ብ ናህሪ እናተጋፈሐ ይርከብ። 	Finally, the epidemic is spreading rapidly to neighboring cities, states, and countries.
170	en	ti	 On January 20, the infection of health-care providers was reported, suggesting that human-to-human transmission was possible. 	 ኣብ ጃኑዋሪ 20፡ ናይ ጥዕና ክንክን ወሃብቲ በቲ ረኽሲ ምጥቃዕ ተጸብጺቡ ነይሩ፡ እዚ ድማ ካብ ሰባት ናብ ሰባት ከምዝመሓላለፍ ዝጠቆመ እዩ ነይሩ። 	On January 20, health care providers were reported infected with the infection, indicating that it was transmitted from person to person.
171	en	ti	 On January 23, the city of Wuhan was locked down with all its public transportation stopped. 	 ኣብ ጃኑዋሪ 23, ከተማ ዉሃን መላእ ናይ ህዝቢ መጎዓዝያ ጠጠው ብምባል ተዓጽያ ነይራ። 	On January 23, Wuhan was closed to all public transportation.
172	en	ti	 On January 24 the first clinical study on the disease reported that, out of 41 patients with confirmed cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source. 	 ምስ እቲ ሕማም ካብ ዘይተፈልጠ እንስሳ ከምዝተጀመረሉ ዝሕሰብ ዉሃን ዕዳጋ መሸጢ ናይ ባሕሪ እንስሳ ቀጥታዊ ርክብ ዝነበሮም ካብቶም ዝተረጋገፁ 41 ሕሙማት እቶም 21 ጥራሕ ከምዝኾኑ ኣብ 24 ጃኑዋሪ ዝተገብረ ፈላማይ ክሊኒካዊ መፅናዕቲ ገሊፁ። 	Only 21 of the 41 confirmed cases had direct contact with the Wuhan seafood market, where the disease is thought to have started from an unknown animal, according to the first clinical study conducted on January
173	en	ti	 On January 30, WHO declared the outbreak a global health emergency. 	 ውድብ ጥዕና ዓለም(WHO) ኣብ ጃንዋሪ 30 ነቲ ለበዳ ዓለምለኸ ሃንደበታዊ ሓደጋ ብምባል ኣዊጁ። 	The World Health Organization (WHO) declared the outbreak a global emergency on January
174	en	ti	 By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig. ​(Fig.2).2). 	 እብ እዋን ናይ እዚ ጽብጻብ፡ እቲ ለበዳ ኣብ መላእ ቻይናን ኣብ መላእ ዓለም ኣብ ካልኦት ናብ 50 ዝጽግዑ ሀገራት ተዘርጊሑ ይርከብ (Fig. ​(Fig.2).2)። 	At the time of this report, the outbreak has spread throughout China and to nearly 50 other countries worldwide (Fig. ​ (Fig.2).2).
175	en	ti	 As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined. 	 እቲ ኩነታት ብቕልጡፍ እናማዕበለ ብምኻዱ ናይ እቲ ለበዳ ወሰን ክግመት ኣይከኣልን። 	The situation is developing rapidly and the extent of the outbreak cannot be predicted.
176	en	ti	 On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA). 	 ኣብ ፌብሩዋሪ 11:2020፡ ኣብ 4021 ዝተረጋገጸ ናይ COVID-19 ጉዳይ ዘልዎም ሕሙማት ዘጠቓለለ ሓዊሱ ኣብ 8866 ሕሙማት ዝተገበረ በዓል ብዙሕ ማእኸል ጽንዓት ብዛዕባ እቲ ለበዳ ዝሓሸ መግለጺ ከምዚ ዝስዕብ ኣሐዲሱ ኣቕሪቡ ኣሎ (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA)። 	On February 11:2020, a multicenter study of 8866 patients, including 4021 confirmed cases, updated the following better description of the outbreak (https://mp.weixin.qq.com/s). /UlBi-HX_rHPXa1qHA2bhdA).
177	en	ti	 SARS-CoV-2 infected people of all ages, but mainly at the age of 30-65. 	 SARS-CoV-2 ንኩሉ ናይ ዕድመ ክልል ዘጥቅዕ እንትኾን ብ በዝሒ ካብ 30-65 ዓመት ንዘልዉ እዩ ዘጥቅዕ። 	SARS-CoV-2 affects all age groups, most commonly those aged 30-6
178	en	ti	 Almost half (47.7%) of the infected individuals were over 50 years old, very few were under 20, and only 14 infected individuals were under the age of 10. 	 እቶም ዝተጠቕዑ ሕሙማት ኣስታት ፍርቂ (47.7%) ዝኾኑ ዕድሚኦም ልዕሊ 50 እንትኾኑ ዝተወሰኑ ድማ ትሕቲ 20 ዕድመ ዘለዎምን 14 ሕሙማት ድማ ትሕቲ 10 ዓመት እዮም። 	About half (47.7%) of the affected patients were over 50 years of age, some were under 20 years of age and 14 patients were under 10 years of age.
179	en	ti	 SARS-CoV-2 infected more men (0.31/100,000) than women (0.27/100,000). 	 SARS-CoV-2 ዝበዝሑ ኣወዳት(0.31/100,000) ካብ ደቂ-ኣንስትዮ(0.27/100,000) ኣጥቂዑ እዩ። 	SARS-CoV-2 affected more boys(0.31/100,000) than girls(0.27/100,000).
180	en	ti	 COVID-19 expanded in clusters mainly in and around Hubei. 	 COVID-19 ኣብ ውሽጢ ሁበይን ከባቢኣን ብ ጉጅለ እዩ ተዛሚቱ። 	COVID-19 has spread in and around Hubei in groups.
181	en	ti	 COVID-19 took an average of 5 (2-9) days from onset to diagnosis. 	 COVID-19 ሕማም ካብ ዝጀመረሉ ክሳብ ዲያግኖሲስ ብማእኸላይ 5 (2-9) ማዓልትታት ይወስድ። 	COVID-19 takes an average of 5 (2-9) days from the onset of illness to diagnosis.
182	en	ti	 The average incubation period was 4.8 (3.0-7.2) days. 	 እቲ ማእኸለዋይ ናይ መፍልፈሊ ጊዜ 4.8 (3.0-7.2) መዓልቲታት እዩ። 	The mean incubation period is 4.8 (3.0-7.2) days.
183	en	ti	 The average time from onset to death was 9.5 (4.8-13) days. 	 እቲ ካብ ዝጅምረሉ እዋን ክሳብ ሞት ብማእኸላይ 9.5 (4.8-13) ማዓልቲታት ይወስድ 	The average time from onset to death is 9.5 (4.8-13) days
184	en	ti	 The basic reproductive number (R0) was 3.77 (95% CI: 3.51-4.05), and the adjusted R0 was 2.23-4.82. 	 እቲ መሰረታዊ ናይ ምፍራይ ቁጽሪ(R0) 3.77 (95% CI: 3.51-4.05) ክኸውን እንከሎ እቲ ዝተስተኻኸለ R0 2.23-4.82 እዩ። 	The baseline reproductive coefficient(R0) was 3.77 (95% CI: 3.51-4.05) while the adjusted R0 was 2.23-4.82.
185	en	ti	 The number of infected people increased exponentially before 23 Jan. 2020, matching the time of massive transportation before the Spring Festival in China. 	 ብምኽንያት ናይ ቻይና ናይ Spring Festival (ጸደይ በዓል) ኣብ ዝነበረ ጽዑቕ ምጉዑዓዝ ኣብ ጃኑዋሪ 23, 2020 በቲ ሕማም ዝተትሓዙ ሰባት ቑጽሪ ብሓይሊ ወሲኹ እዩ። 	The number of cases rose sharply on January 23, 2020, during the rush hour of China&#39;s Spring Festival.
186	en	ti	 The mortality of patients with confirmed cases was 1.44% (95% CI: 1.10-1.86%), and the adjusted mortality of all the patients was 3.06% (95% CI: 2.02-4.59%). 	 ናይ ዝተረጋገፁ ጉዳያት ለበዳ ናይ ሞት መጠን 1.44% (95% CI: 1.10-1.86%) እንትኸዉን ኣብ ኩሎም ሕሙማት ዝተስተኻኸለ ናይ ሞት መጠን ድማ 3.06% (95% CI: 2.02-4.59%) እዩ። 	The outbreak mortality rate of confirmed cases was 1.44% (95% CI: 1.10-1.86%) and the adjusted mortality rate in all patients was 3.06% (95% CI: 2.02-4.59%).
187	en	ti	 Three major risk factors for COVID-19 were sex (male), age (≥60), and severe pneumonia. 	 እቶም ሰለስተ ኣገደስቲ ንCOVID-19 ዘቃልዑ ነገራት ፆታ (ወዲ ተባዕታይ)፣ ዕድመ (≥60) ከምኡውን ሓያል ናይ ሳንቡእ ወቕዒ እዮም። 	The three most important risk factors for COVID-19 are gender (male), age (≥60) and severe pneumonia.
188	en	ti	 CoVs are a subfamily of large and enveloped viruses containing a single strand of sense RNA. 	 CoVs ናይ ሰንስ RNA ነፀላ ስትራንድ ዘለዎም ናይ ዓበይትን ኤንቨሎፕድን ቫይረሳት ንኡስ ስድራ እዩ። 	CoVs are a subfamily of adult and enveloped viruses with single stranded sense RNA.
189	en	ti	 They can be divided into four genera, i.e., alpha, beta, gamma, and delta, of which alpha- and beta-CoVs are known to infect humans. 	 ኣልፋ፣ ቤታ፣ ጋማን ደልታን ተባሂሎም ናብ ኣርባዕተ ጀነራ ይምቀሉ። ካብዚኦም ድማ ኣልፋን ቤታን-CoVs ንወድሰብ ከምዘጥቅዑ ይፍለጥ። 	They are divided into four genera: alpha, beta, gamma and delta. Of these, alpha and beta-CoVs are known to infect humans.
190	en	ti	 The envelope spike (S) glycoprotein binds to its cellular receptors angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then membrane fusion occurs. 	 እቲ ኤንቨሎፕ ስፓይክ (S) ግላይኮፕሮቲን ምስ ናይ angiotensin-converting enzyme 2 (ACE2) (ኣንጂዮቴንሲን-ቀያሪ ኤንዛይም) ከምኡውን ምስ dipeptidyl peptidase 4 (DPP4) ተቐበልቲ ብተኸታታሊ ንSARS-CoVን MERS-CoVን ይጣመር። ድሕሪ እዚ ድማ ናይ መምብሬን ምጥባቕ ይቕፅል። 	The envelope spike (S) glycoprotein couples to the angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) receptors for SARS-CoV and MERS-CoV, respectively. After this, membrane adhesion continues.
191	en	ti	 The viral RNA genome is released into the cytoplasm; after replication of the viral genome, genomic RNA accompanied by envelope glycoproteins and nucleocapsid proteins forms virion-containing vesicles, which then fuse with the plasma membrane to release the virus. 	 ናይ ቫይረስ RNA ጂኖም ወደ ሳይቶፕላዝም ይፍንው ፤ ናይ ቫይረስ ጂኖም ምስተራብሑ ጂኖሚክ RNA ብ ኢንቨሎፕ ግላይኮፕሮቲንን ናኖክካፕሲድ ፕሮቲንን ብሓባር ብምኻድ ምስ እቲ ቫይረስ ንምትሕውዋስ ምስ እቲ ናይ ፕላዝማ ሽፋን ይዋሃዱ። 	The viral RNA genome is secreted into the cytoplasm; Once viral genomes are replicated, genomic RNA is transported together by envelope glycoproteins and nanocapsid proteins to fuse with the plasma membrane to fuse with the virus.
192	en	ti	 The first genomic sequence of SARS-CoV-2 was reported on January 10, 2020. 	 እቲ ናይ መጀመሪያ ጀነቲካዊ ቅደም ሰዓብ SARS-CoV-2 ኣብ ጃኑዋሪ 10፡2020 እዩ ተጸብጺቡ። 	The first genetic sequence of SARS-CoV-2 was reported on January 10:2
193	en	ti	 SARS-CoV-2 was found to be a new type of beta-CoV with more than 99.98% genetic identity among 10 sequenced samples collected from the original site of the outbreak, the Huanan Seafood Market in Wuhan. 	 SARS-CoV-2 ሓዱሽ ናይ beta-CoV ዓይነት ኮይኑ፡ ካብ እቲ መጀመሪያ እቲ ሕማም ዝተረኸብሉ ቦታ ናይ ሁናን ናይ ባሕሪ ምግቢ ዕዳጋ ዝተወሰዱ 10 ተኸታተልቲ መርኣያታት ውሽጢ 99.98% ናይ ጀነቲክ ምምስሳል ዘለዎ እዩ። 	SARS-CoV-2 is a new beta-CoV strain with 99.98% genetic similarity within 10 consecutive specimens taken from the Hunan seafood market, where the disease was first detected.
194	en	ti	 SARS-CoV-2 is genetically more similar to SARS-CoV than to MERS-CoV. 	 SARS-CoV-2 ካብ SaRS-CoV ንላዕሊ ምስ MERS-CoV ብጀነቲክስ ዝመሳሰል እዩ። 	SARS-CoV-2 is more genetically similar to MERS-CoV than SaRS-CoV.
195	en	ti	 Through transmission electron microscopy, SARS-CoV-2 particles were found in ultrathin sections of human airway epithelium. 	 ብኤለክትሮን ማይክሮስኮፒ ናይ SARS-CoV-2 ደቀቕቲ ነገራት ኣብ ናይ ወዲ ሰብ መተንፈሲ ኣካል ኤፒቴሊየም ብ ኣልትራቲን ክፍልታት ይርከብ። 	Electron microscopy of SARS-CoV-2 particles in human respiratory epithelium in ultratin compartments.
196	en	ti	 Human ACE2 was found to be a receptor for SARS-CoV-2 as well as SARS-CoV. 	 ናይ ሰባት ACE2 ን SARS-CoV-2 ከምኡውን ን SARS-CoV ተቐበልቲ ኾይኖም ተረኺቦም ኣለዉ፡፡ 	Human ACE2 have been found to be receptors for SARS-CoV-2 and SARS-CoV.
197	en	ti	 However, the S protein of SARS-CoV-2 binds to human ACE2 more weakly than that of SARS-CoV, which is coincident with the fact that SARS-CoV-2 causes less severe infection in patients than SARS-CoV. 	 ኮይኑ ግና ምስ SARS-CoV እንትነፃፀር ናይ SARS-CoV-2 S ፕሮቲን ምስ ናይ ሰብ ACE2 ዝላሕለሐ ጥምረት ኣለዎ። እዚ ድማ ምስ SARS-CoV እንትነፃፀር ናይ SARS-CoV-2 ቀሊል ሕማም ምስ ናይ ምምፃእ ፀባዩ ዝገጣጠም እዩ። 	However, compared to SARS-CoV, the S protein of SARS-CoV-2 has weaker binding to human ACE2. This is consistent with the milder illness of SARS-CoV-2 compared to SARS-CoV.
198	en	ti	 SARS-CoV-2 can also form a novel short protein encoded by orf3b and a secreted protein encoded by orf8. 	 SARS-CoV-2 ብ ወይ f3b ዝተቐመጠ ሓድሽ ኖቭል ፕሮቲን ከምኡውን ብ orf8 ዝተሓብእ ፕሮቲን ክፍጠር ይኽእል እዩ፡፡ 	SARS-CoV-2 can be produced by a new novel protein encoded by either f3b as well as a secreted protein by orf8.
199	en	ti	 The orf3b of SARS-CoV-2 may play a role in the viral pathogenicity and inhibit the expression of IFNβ; however, orf8 does not contain any known functional domain or motif. 	 ናይ SARS-CoV-2 orf3b ኣብ ቫይራል ሕማም ናይ ምስዓብ ተኽእሎ ከምኡዉን ናይ IFNβ; ምህርቲ ኣብ ምዕጋት ዓቢ ግደ ይፃወት orf8 ግን ክሳብ ሕዚ ዝተፈልጠ ተግባራዊ ዶሜን ወይድማ ንድፊ የብሉን። 	the potential of SARS-CoV-2 orf3b to follow viral disease and that of IFNβ; It plays a major role in inhibiting production but orf8 has no known functional domain or design so far.
200	en	ti	 On February 18, 2020, Zhou, et al., reported the cryo-EM structure of the full-length human ACE2 at 2.9 Å resolution in complex with the amino acid transporter B0AT1. 	 ኣብ 18 ፌብሩዋሪ 2020 Zhou, et al.,ናይ ሙሉእ ቁመት ዘለዎ ሂዩማን ACE2 ኣብ 2.9 Å ሪዞሉሽን ምስ ኣሚኖ ኣሲድ መጎዓዝያ B0AT1 ክራዮ-ኢኤም ህንፀት ከምዘለዎ ገሊፁ። 	On February 18, 2020 Zhou, et al.,described the cryo-EM construction of full-length human ACE2 at 2.9 Å resolution with the amino acid transporter B0AT1.
201	en	ti	 They found that the complex, which had open and closed conformations, was assembled as a dimer and the ACE2-B0AT1 complex can bind two S proteins, which provides evidence for CoV recognition and infection. 	 እቲ ክፉትን ዕፅዉን ኣሰራርሓ ዘለዎ ኮምፕሌክስ ከም ዳይመር ዝተኣከበ ኮይኑ ናይ ACE2-B0AT1 ኮምፕሌክስ ምስ ክልተ S ፕሮቲናት ክጣመር ከምዝኽእል ተፈሊጡ። እዚ ድማ ንCoV ኣፍልጦን ኢንፌክሽንን መረዳእታ የቕርብ። 	The complex with open and closed functionality was assembled as a dimer and it was recognized that the ACE2-B0AT1 complex could bind to two S proteins. This provides data for CoV recognition and infection.
202	en	ti	 B0AT1 may become a therapeutic target for drug screening to suppress SARS-CoV-2 infection. 	 ናይ SARS-CoV-2 ኢንፌክሽን ንምዕጋት B0AT1 ተጠቒምካ ናይ መድሓኒት ምፅራይ ምክያድ የድሊ። 	Inhibition of SARS-CoV-2 infection requires drug screening using B0AT1.
203	en	ti	 The origin and intermediate host 	 እቲ መልዓሊን ማእኸላይ ተሸካሚን 	the hoist and central carrier
204	en	ti	 It has been known that both SARS-CoV and MERS-CoV originated from bats and were transmitted to humans via civet cats and camels, respectively. 	 ክልቲኦም SARS-CoVን MERS-CoV ካብ መንካዓት ዝብገሱን ናብ ደቂ-ሰባት ድማ ብ ሲቨት ደማሙን ብ ግመልን ብቕደም ሰዓብ ከምዝተመሓላለፉ ዝፍለጥ እዩ። 	Both SARS-CoV and MERS-CoV originate from ticks and are known to be transmitted to humans by civet deer and camels, respectively.
205	en	ti	 Through a phylogenetic comparison of SARS-CoV-2 with other CoVs, bats were considered the native host of SARS-CoV-2 as the new virus is 96% identical to two SARS-like CoVs from bats called bat-SL-CoVZX45 and bat-SL-CoVZX21. 	 ፋይሎጀነቲክስ ተጠቒምና SARS-CoV-2 ምስ ካልኦት CoVs እንተነፃፅሮ እዚ ሓድሽ ቫይረስ 96% ምስ ካብ ሎኻኺቶ ዝርከቡ bat-SL-CoVZX45ን bat-SL-CoVZX21ን ዝተብሃሉ ክልተ SARS-like CoVs ተመሳሳሊ ብምዃኑ ናይ SARS-CoV-2 ፈላማይ ተሸካማይ ሎኻኺቶ ከምዝኾነ ተገሚቱ ኣሎ። 	Using phylogenetics, comparing SARS-CoV-2 to other CoVs, this new virus is 96% identical to two SARS-like CoVs from Lochakito, bat-SL-CoVZX45 and bat-SL-CoVZX21, making it the first Lochakito vector of SARS-CoV-2 .
206	en	ti	 However, what intermediate host helped the virus cross the species barrier to infect humans remains unknown, and the transmission route is yet to be elucidated. 	 ይኹን ደኣምበር፡ ነቲ ቫይረስ ካብ ናይ ዘርኢ ሓጹር ሓሊፉ ኣብ ሰባት ረኽሲ ከስዕብ ዝገበሮ ማእኸላይ መማሓላለፊ እንታይ ከምዝኾነ ኣይተፈለጠን፡ እቲ ዝመሓላለፉሉ መስመር እውን ኣይተፈለየን። 	However, the central vector that caused the virus to infect humans beyond the seed barrier is unknown, nor is the route of transmission identified.
207	en	ti	 Ji, et al., proposed snakes as a carrier of the virus from bats to humans which involved homologous recombination within the S protein. 	 Ji, et al., ተመናት ነቲ ቫይረስ ካብ መንካዓት ናብ ሰባት ኣብምምሕልላፍ ተሸከምቲ ክኾኑ ይኸእሉ ክብል ሓሳብ ኣቕሪቡ እዚ ድማ ምስ S ፕሮቲን ናይ ሆሞሎገስ ናይ ጂናት ምውህሃድ ዘሓወሰ እዩ። 	Ji, et al., proposed that snakes may be vectors in transmission of the virus from ticks to humans which involves integration of genes homologous to the S protein.
208	en	ti	 According to a study, researchers in Guangzhou, China, suggested that pangolins - long-snouted, ant-eating mammals often used in traditional Chinese medicine - are the potential intermediate host of SARS-CoV-2 based on 99% genetic homology in a CoV discovered in pangolins and SARS-CoV-2. 	 ኣብ ፓንጎሊን ምስ ዝተረኽበ SARS-CoV-2 99% ናይ ጀነቲክ ምምስሳል ብምህላዉ ኣብ ባህላዊ ናይ ቻይና ሕክምና ዝጠቕሙ ከም ፓንጎሊ ዝበሉ ንብዙሕ ጊዜ ዝዘልቁን ፃፀ ዝበልዑን መጥበውቲ እንስሳት ናይ SARS-CoV-2 ማእኸላይ ተሸከምቲ ምዃኖም ኣብ ቻይና ናይ ጉዋንግዦው ተመራመርቲ ከምዝገለፁ ሓደ መፅናዕቲ ይሕብር። 	Researchers in Guangzhou, China, have found that frequently crawling and ant-eating mammals such as pangolins, which are useful in traditional Chinese medicine, are central carriers of SARS-CoV-2 because of their 99% genetic similarity to SARS-CoV-2 found in pangolins.
209	en	ti	 However, 1% difference spread all over two genomes is still a big difference; thus, conclusive results for concrete evidence are awaited (Fig. ​(Fig.33). 	 ኮይኑ ግና ኣብ ክልተ ጄኖማት ናይ 1% ኣፈላላይ ንባዕሉ ዓቢ ኣፈላላይ ብምዃኑ ጭቡጥ መረዳእታ ንምጥቕላል ናይ መወዳእታ ዉፅኢት ምፅባይ የድሊ እዩ።(Fig. ​(Fig.33). 	However, a difference of 1% in two genomes is a large difference in itself and requires final results to summarize concrete data (Fig. ​ (Fig.33).
210	en	ti	 The physicochemical properties of SARS-CoV-2 are largely not yet known. 	 ናይ SARS-CoV-2 ፊዝዮኬሚካል ፀባይ ክሳብ ሕዚ ኣይተፈልጠን። 	The physiochemical characteristics of SARS-CoV-2 remain unknown.
211	en	ti	 SARS-CoV and MERS-CoV can survive in vitro for 48 hours in a dry environment and up to 5 days under 20 °C and 40%-50% humidity. 	 SARS-CoVን MERS-CoVን ኣብ ኣስቃጥላ ኣብ ንቑፅ ከባቢ ን48 ሳዓታት ዝኣክል ክነብር ይኽእል ኣብ ትሕቲ 20 ዲግሪ ሰልሺየስን 40%-50% ጠሊን ድማ ንኣስታት 5 ማዓልቲታት ክነብር ይኽእል። 	SARS-CoV and MERS-CoV can survive in a dry environment for up to 48 hours in the snow and for about 5 days in temperatures below 20 degrees Celsius and 40%-50% humidity.
212	en	ti	 SARS-CoV-2 may possess similar properties. 	 SARS-CoV-2 ተመሳሳሊ ፀባይ ክዉንን ይኽእል እዩ። 	SARS-CoV-2 may possess similar characteristics.
213	en	ti	 It has been reported that SARS-CoV-2 is sensitive to ultraviolet rays and heat at 56 °C for 30 minutes; ether, 75% ethanol, chlorine-containing disinfectant, peracetic acid, chloroform, and other fatty solvents, but not chlorhexidine, can effectively inactivate the virus. 	 ብSARS-CoV-2 ንኣልትራቫዮሌት ጨረራትን ናይ 30 ደቓይቕ በ 56 ዲግሪ ሴንቲ ግሬድ ናይ ሙቐት መጠን ከምዝዳኸም ጸብጻብ ተገይሩ እዩ፡፡ 75% ኢታኖል ፣ ክሎሪን-ዝሓዙ ፀረ-ተሃዋስያን መድሓኒታት ፣ ፒራክቲክ አሲድ ፣ ክሎሮፎርን ካልኦት ናይ ስብሒ ፈሰስትን፣ ግን chlorhexidine ዝኾኑ ፣ ነቲ ቫይረስ ከዳኽሙ ይኽእሉ እዮም፡፡ 	It has been reported that SARS-CoV-2 is attenuated by ultraviolet radiation and a temperature of 56 degrees Celsius for 30 minutes. 75% ethanol, chlorine-containing antiseptics, pyractic acid, chlorophore, and other fatty acids, but not chlorhexidine, can weaken the virus.
214	en	ti	 The entire human population generally lacks immunity to SARS-CoV-2 and hence is susceptible to the novel virus. 	 ደቂ ሰባት ንSARS-CoV-2 ናይ ምክልኻል ዓቕሞም ትሑት ብምዃኑ ንሓደሽቲ ቫይረሳት ተቓላዕቲ ይገብሮም። 	Humans have low immunity to SARS-CoV-2, making them vulnerable to new viruses.
215	en	ti	 Currently, no detailed study has been reported regarding the immunological response to SARS-CoV-2. 	 ኣብዚ ሐዚ እዋን፡ን SARS-CoV-2 ኣብ ዝህሉ ናይ ሰውነት ናይ ምክልኻል መልሲ ኣወሃባ ዝተገበረ ዝርዝር ጽንዓት ኣይተገበረን። 	Currently, there is no detailed study of the body&#39;s immune response to SARS-CoV-2
216	en	ti	 Thus, we can only refer to previous studies on other CoVs, especially SARS-CoV and MERS-CoV (Fig. ​(Fig.4).4). 	 ብምዃኑ ድማ ነቶም ካልኦት CoVs ብፍላይ ዳማ ናይ SARS-CoVን MERS-CoVን ሕሉፍ መጽናዕቲ ጥራሕ ኢና ክንውከስ ንኽእል(Fig. (Fig.4).4) 	Therefore, we can only refer to past studies of SARS-CoV and MERS-CoV for the other CoVs, especially Dama (Fig. ​ (Fig.4).4).
217	en	ti	 In general, after a virus invades the host, it is first recognized by the host innate immune system through pattern recognition receptors (PRRs) including C-type lectin-like receptors, Toll-like receptor (TLR), NOD-like receptor (NLR), and RIG-I-like receptor (RLR). 	 ብጠቕላላ እቲ ቫይረስ ነቲ ተሸካማይ ድሕሪ ምዉራሩ ፈለማ pattern recognition receptors (PRRs) C-type lectin-like receptors፣ Toll-like receptor (TLR)፣ NOD-like receptor (NLR)፣ and RIG-I-like receptor (RLR) ሓዊስካ በቲ ናይ ተሸካማይ ተፈጥሮኣዊ ሕማም መከላኸሊ ስርዓት ዝልለ እዩ። 	In total, after the virus invades the carrier it first pattern recognition receptors (PRRs) including C-type lectin-like receptors, Toll-like receptor (TLR), NOD-like receptor (NLR), and RIG-I-like receptor (RLR) by the The carrier&#39;s innate immune system is characterized.
218	en	ti	 Through different pathways, the virus induces the expression of inflammatory factors, maturation of dendritic cells, and synthesis of type I interferons (IFNs) which limit the spreading of the virus and accelerate macrophage phagocytosis of viral antigens. 	 ዝተፈላለዩ መንገድታት ብምጥቃም እቲ ቫይረስ ናይ ኢንፍላማቶሪ ፋክተርስ ምፍናው፣ ዴንድራይቲክ ዋህዮታት ምምዕባል ከምኡውን ታይፕ I ኢንተርፌሮንስ (IFNs) ብምፍራይ ናይ እቲ ቫይረስ ምስፍሕፋሕ ንኽቕንስ ይሕግዝ ናይ እቲ ቫይረስ ኣንቲጅን ድማ ብማክሮፌጅ ይወሓጥ። 	Using a variety of pathways, the virus helps reduce the spread of the virus by releasing inflammatory factors, developing dendritic cells and producing type I interferons (IFNs) and the viral antigen is engulfed by macrophages.
219	en	ti	 However, the N protein of SARS-CoV can help the virus escape from the immune responses. 	 ናይ SARS-CoV N ፕሮቲን እቲ ቫይረስ ካብ ሕማም መከላኸሊ ስርዓት ንኸምልጥ ዝሕግዞ እዩ። 	The N protein of SARS-CoV is what helps the virus evade the immune system.
220	en	ti	 Soon, the adaptive immune response joins the fight against the virus. 	 ኣብ እዚ ቀረባ እዋን፣ እቲ ዝተላመደ ናይ ሕማም መከላኸሊ ነቲ ቫይረስ ንምውጋእ ምስቶም ካልኦት ብምዃን ስርሑ ክጅምር እዩ። 	Soon, the adapted immune system will begin working with the others to fight the virus.
221	en	ti	 T lymphocytes including CD4+ and CD8+ T cells play an important role in the defense. 	 ከም CD4+ን CD8+ን ዝመሳሰሉ T ሊምፎሳይት ኣብ እቲ ናይ ምክልኻል ስራሕ ዓቢ ታራ ይፃወቱ እዮም። 	T lymphocytes such as CD4+ and CD8+ play an important role in the immune function.
222	en	ti	 CD4+ T cells stimulate B cells to produce virus-specific antibodies, and CD8+ T cells directly kill virus-infected cells. 	 CD4 + T cell በቲ ቫይረስ ዝተትሓዙ ኣንቲቦዲ ንምምንጫው ናይ B cells የነቃቕሑ። ከምኡውን CD8 + T cell ብቐጥታ በቲ ቫይረስ ዝተትሓዙ ዋህዮታት ይቐትሉ። 	CD4 + T cell stimulate B cells to produce antibodies infected with the virus. and CD8 + T cell directly kill infected cells.
223	en	ti	 T helper cells produce proinflammatory cytokines to help the defending cells. 	 ቲ ሄልፐር ዋህዮታት(T helper cells) ጸረ ረኽሲ ዝኾነ ሳይቶክይነስ(cytokines) ነቶም ዝከላኸሉ ዋህዮታት ንምሕጋዝ ዘፍሪ እዩ። 	T helper cells produce anti-infective cytokines to help the protective cells.
224	en	ti	 However, CoV can inhibit T cell functions by inducing apoptosis of T cells. 	 ይኹን ደኣምበር፡ CoV ን ናይ ቲ-ዋህዮታት( T cell ) ኣስራርሓታት ኣፖፕቶሲስ(apoptosis) ብምትእትታው ከጥቅዑ ይኽእሉ እዮም። 	However, CoV can attack T cell mechanisms by inducing apoptosis.
225	en	ti	 The humoral immunity including complements such as C3a and C5a and antibodies is also essential in combating the viral infection. 	 እቲ ቫይረስ ንምዕጋት ከም C3a፣ C5aን ኣንቲቦዲታትን ዝመሳሰሉ ሂዩመራል መከላኸሊ ሕማም ኣድለይቲ እዮም። 	Humoral immunoglobulins such as C3a, C5a and antibodies are necessary to inhibit the virus.
226	en	ti	 For example, antibodies isolated from a recovered patient neutralized MERS-CoV. 	 ንኣብነት ካብ ዝደሓኑ ሕሙማት ዝተወስዱ ኣንቲቦዲታት ንMERS-CoV ኣዳኺሞሞ እዮም። 	For example, antibodies from surviving patients have attenuated MERS-CoV.
227	en	ti	 On the other hand, an overreaction of the immune system generates a large number of free radicals locally that can cause severe damages to the lungs and other organs, and, in the worst scenario, multi-organ failure and even death. 	 ብ ኻሊእ ወገን፡ ካብ እቲ ስርዓት መከላኸሊ ሰብነትና ዝገብሮ ካብ ዓቐን ንላዕሊ ዝኾነ ግብረ መልሲ ዝተልዓለ ብዙሕ መጠን ዘለዎ ናጻ ራዲካላት ኣብ ሳንቡእ ኣብ ካልኦት ኣካላት ሰብነትን ከቢድ ጉድኣት ከስዕቡ ዘኸእሉ ብምዃኖም ኣብ እቲ ዝገደደ ኩነታት ድማ ካብ ሓደ ንላዕሊ ዝኾኑ ኣካላት ጉድኣት ብምስዓብ ናብ ሞት እውን ከብቅዑ ዝኽእሉ እዮም። 	On the other hand, large amounts of free radicals caused by an overreaction by the immune system can cause serious damage to the lungs and other organs, in the worst cases causing damage to more than one organ and even death are.
228	en	ti	 The SARS-CoV-2 infection, featured by clustering onset, is more likely to affect elderly people with comorbidities and pregnant women. 	 ናይ SARS-CoV-2 ረኽሲ ፡ ብ ጉጅለ ዝጀመረ ምስ ምዃኑ፡ ኣብ ሕዱር ናይ ጥዕና ጸገም ዘለዎም ኣረጋውያንን ጥኑሳትን ብዝበለጸ ጽልዋ ከሕድር ይኽእል። 	SARS-CoV-2 infection , with its group onset, may best affect the elderly and pregnant women with chronic health problems.
229	en	ti	 It is common that for people who are exposed to a large number of viruses or whose immune functions are compromised, they have higher chance to be infected than others. 	 ኣብ እቶም ናብ ብዙሓት ቫይረሳት ዝተጋለጹን ናይ ሰብነቶም ሕማም ናይ ምክልኻል ዓቕሞም ዝተዳኸሙን ሰባት ካብ ካልኦት ዝለዓለ ብ ረኽሲ ናይ ምጥቃዕ ተኸእሎኦም ልሙድ እዩ። 	People who are exposed to many viruses and have weakened immune systems are more likely to get infected than others.
230	en	ti	 The estimated mean incubation period of SARS-CoV-2 is 1-14 days, mostly 3-7 days based on a study of the first 425 cases in Wuhan. 	 ናይ SARS-CoV-2 ናይ መጫጭሒ እዋን ብማእኸላይ 1-14 ማዓልትታት እንትኸዉን ኣብቶም ኣብ ዉሃን ዝተረኽቡ ናይ መጀምርታ 425 ጉዳያት ለበዳ ከምዝተፀንዐ ድማ ብኣብዝሓ 3-7 ማዕልትታት እዩ ዝፀንሕ። 	The incubation period of SARS-CoV-2 averages 1-14 days and lasts a maximum of 3-7 days as studied in the first 425 cases in Wuhan.
231	en	ti	 However, a study on 1,099 cases demonstrates that the incubation period was 3 days on average and ranged from 0 to 24 days. 	 ኮይኑ ግና ኣብ 1,099 ጉዳያት ለበዳ ዝተገብረ መፅናዕቲ ናይ ኢንኩቤሽን እዋን ብማእኸላይ 3 ማዓልቲ እንትኸዉን ካብ 0 ክሳብ 24 ማዓልትታት ድማ ክፀንሕ ከም ዝኽእል ሓቢሩ። 	However, a study of 1,099 outbreak cases found that the incubation period averaged 3 days and could range from 0 to 24 days.
232	en	ti	 A more recent study, as described above, demonstrates that the incubation period was 4.8 (3.0-7.2) days based on the demography of 8,866 cases. 	 ኣብ ላዕሊ ከምዝተገለፀ ኣብ ቀረባ እዋን ኣብ 8,866 ህዝቢ ዝተገብረ መፅናዕቲ ናይ መጫጭሒ እዋን 4.8 (3.0-7.2) ማዕልትታት ምዃኑ ገሊፁ። 	As mentioned above, a recent study of 8,866 populations found that the incubation period was 4.8 (3.0-7.2) days.
233	en	ti	 It is very important for health authorities to adjust the effective quarantine time based on the most accurate incubation period, thus preventing infected but symptomless people from transmitting the virus to others. 	 ን ናይ ሕክምና ሰበ ስልጣን ነቲ ናይ ምውሻብ እዋን ምስ እቲ ኣዝዩ ትኽክለኛ ዝኾነ ናይ መጫጭሒ እዋን ክስተኻኸል ብምግባር ምልክት ዘየርእዩ ሕሙማት ነቲ ሕማም ናብ ካልኦት ከየመሓላልፉ ክግብሩ ኣለዎም። 	Medical authorities should adjust the quarantine period to the most accurate quarantine period to prevent asymptomatic patients from transmitting the disease.
234	en	ti	 As a common practice, individuals exposed to, or infected by, the virus are usually required to be quarantined for 14 days. 	 ከም ልሙድ በቲ ቫይረስ ዝተጠቕዑ ሰባት ን14 ማዓልትታት ክዉሸቡ ይግበር። 	Typically, infected people are quarantined for 14 days.
235	en	ti	 Should the quarantine time be extended to 24 days? 	 እቲ ናይ ውሸባ ጊዜ ናብ 24 መዓልቲታት ክናዋሕ ኣለዎ ዶ? 	Should the quarantine period be extended to 24 days?
236	en	ti	 Fever is often the major and initial symptom of COVID-19, which can be accompanied by no symptom or other symptoms such as dry cough, shortness of breath, muscle ache, dizziness, headache, sore throat, rhinorrhea, chest pain, diarrhea, nausea, and vomiting. 	 ናይ COVID-19 ፈላማይን ኣገዳሲን ምልክት ረስኒ ኮይኑ በይኑ ወይድማ ከም ደረቕ ሳዓል፣ ትንፋስ ምሕፃር፣ ናይ ጭዋዳ ቃንዛ፣ ርእሲ ምዝዋር፣ ሕማም ርእሲ፣ ናይ ጎሮር ቃንዛ፣ ራይኖርያ፣ ናይ ደረት ቃንዛ፣ ተቕማጥ፣ ዕዉልዉል ምባልን ተምላስን ዝመሳሰሉ ካልኦት ምልክታት ሒዙ ክመፅእ ይኽእል እዩ። 	The first and most important symptom of COVID-19 is fever and can come alone or with other symptoms such as dry cough, shortness of breath, muscle aches, dizziness, headache, sore throat, rhinorrhea, chest pain, diarrhea, nausea and vomiting .
237	en	ti	 Some patients experienced dyspnea and/or hypoxemia one week after the onset of the disease. 	 ገለ ሕሙማት በቲ ሕማም ምስተትሓዙ ድሕሪ ሓደ ስሙን ናይ dyspnea ን / ወይ hypoxemia ምልክታት ኣርእዮም እዮም። 	Some patients have had symptoms of dyspnea and / or hypoxemia one week after infection.
238	en	ti	 In severe cases, patients quickly progressed to develop acute respiratory syndrome, septic shock, metabolic acidosis, and coagulopathy. 	 ኣብ ከበድቲ ኩነታት፡ ሕሙማት ክቢድ ናይ መተንፈሲ ጸገም ፡ ሴፕቲክ ሾክ( septic shock)፡ ሜታቦሊክ ኣሲዶሲስ(metabolic acidosis)ን ኮኣጉሎፓቲ(coagulopathy) ብቕልጡፍ የማዕብሉ እዮም። 	In severe cases, patients develop severe respiratory distress , septic shock, metabolic acidosis and coagulopathy rapidly.
239	en	ti	 Patients with fever and/or respiratory symptoms and acute fever, even without pulmonary imaging abnormalities, should be screened for the virus for early diagnosis. 	 ረስኒ ወይድማ ናይ ምስትንፋስ ምልክታትን ሃንደበታዊ ረስኒን ዘለዎም ሕሙማት ነቲ ሕማም ዝገልፅ ናይ ሳምባ ራጂ ዉፅኢት ዋላ ተዘይሃለወ ቅልጡፍ ዲያግኖሲስ ንምርካብ ነቲ ቫይረስ ክምርመሩ ይግባእ እዩ። 	Patients with fever or respiratory symptoms and sudden cough should be tested for the virus for early diagnosis even if there is no lung x-ray result.
240	en	ti	 A demographic study in late December of 2019 showed that the percentages of the symptoms were 98% for fever, 76% for dry cough, 55% for dyspnea, and 3% for diarrhea; 8% of the patients required ventilation support. 	 ኣብ መወዳእታ ወርሒ ዲሴምበር 2019 ዝተገበረ ሓደ ናይ ስነ ሕዝቢ ምርምር ከምዘርእዮ ናይ እቲ ሕማም ምልክታት ንጽጽራዊ መጠን ናይ ረስኒ 98% ፣ ናይ ደረቅ ስዓል 76% ፣ ናይ ድርቀት 55% ፣ ከምኡውን ናይ ተቅማጥ 3% ፣ ካብ ጠቕላላ ሕሙማት 8% ዝኾኑ ድማ ናይ መተንፈሲ ድጋፍ ዝደልዩ እዮም። 	A demographic survey conducted in late December 2019 showed that the comparative rates of symptoms were fever 98%, dry cough 76%, dehydration 55%, and diarrhea 3%, and ventilatory support for 8% of the total patients They are seeking.
241	en	ti	 Similar findings were reported in two recent studies of a family cluster and a cluster caused by transmission from an asymptomatic individual. 	 ኣብ ክልተ ናይ ቀረባ እዋን መፅናዕትታት ናይ ስድራ እኩብን ካሊእ ካብ ሓደ ምልክት ዘይብሉ ሰብ ዝተላገቡ ናይ ሰባት እኩብን ተመሳሳሊ ዉፅኢት ተረኺቡ። 	Similar results were found in two recent studies of a family cohort and another cohort of people infected from an asymptomatic person.
242	en	ti	 Comparably, a demographic study in 2012 showed that MERS-CoV patients also had fever (98%), dry cough (47%), and dyspnea (55%) as their main symptoms. 	 ብተነፃፃሪ፣ ኣብ 2012 ዝተገብረ ናይ ስነ-ህዝቢ መፅናዕቲ ናይ MERS-CoV ሕሙማት ዋና ምልክታት ረስኒ (98%)፣ ደረቕ ሰዓልን (47%) ሕፅረት ምትንፋስን (55%) ምዃኖም ገሊፁ። 	In comparison, a 2012 demographic study of MERS-CoV patients stated that the main symptoms were fever (98%), dry cough (47%) and shortness of breath (55%).
243	en	ti	 However, 80% of them required ventilation support, much more than COVID-19 patients and consistent with the higher lethality of MERS than of COVID-19. 	 ኮይኑ ግና ካብ COVID-19 ንላዕሊ 80% ዝኾኑ ናይ ምስትንፋስ ሓገዝ ዘድልዮም እዮም። ብጣዕሚ ሓደገኛ ብምዃኑ ድማ ካብ ምስ COVID-19 ምስ MERS ይመሳሰል። 	However, more than 80% of COVID-19 patients require ventilatory assistance. It is so dangerous that it is more similar to MERS than to COVID-1
244	en	ti	 Diarrhea (26%) and sore throat (21%) were also observed with MERS patients. 	 ተቕማጥ (26%) ፡ ዝቖሰለ ጉሮሮ( 21%) ኣብ ናይ MERS ሕሙማት እውን ተራእዮም እዮም። 	Diarrhea (26%) and sore throat (21%) were also reported in MERS patients.
245	en	ti	 In SARS patients, it has been demonstrated that fever (99%-100%), dry cough (29%-75%), dyspnea (40%-42%), diarrhea (20-25%), and sore throat (13-25%) were the major symptoms and ventilation support was required for approximately 14%-20% of the patients. 	 ረስኒ (99%-100%)፣ ደረቕ ሰዓል (29%-75%)፣ ሕፅረት ምስትንፋስ (40%-42%)፣ ተቕማጥን (20-25%) ናይ ጎሮሮ ቃንዛን (13-25%) ናይ SARS ሕሙማት ዋናዋና ምልክታት ኮይኖም ናይ ምስትንፋስ ሓገዝ ድማ ንኣስታት 14%-20% ዝኾኑ ሕሙማት ኣድላዪ ኮይኑ ተረኺቡ ኣሎ። 	Fever (99%-100%), dry cough (29%-75%), shortness of breath (40%-42%), diarrhea (20-25%) and sore throat (13-25%) are the main symptoms of SARS patients Ventilatory assistance is necessary for about 14%-20% of patients.
246	en	ti	 By February 14, the mortality of COVID-19 was 2% when the confirmed cases reached 66,576 globally. 	 ክሳብ ፌብሩዋሪ 14፡ ብ ብርኪ ዓለም እቲ ኣጠቓላሊ ጉዳያት ለበዳ 66:576 እንክበጽሕ እንከሎ፡ ናይ COVID-19 ሞት ሓደጋ 2% ነይሩ። 	As of February 14, the total cases globally reached 66:576, with a COVID-19 death risk of 2%.
247	en	ti	 Comparably, the mortality of SARS by November 2002 was 10% of 8,096 confirmed cases. 	 ብተነጻጻሪ፣ ኣብ ኖቨምበር 2002 ናይ SARS ናይ ሞት መጠን ካብ 8,096 ዝተረጋገጹ ጉዳያት 10% ኾይኑ ተረኺቡ ኣሎ። 	In comparison, in November 2002 the SARS mortality rate was found to be 10% of 8,096 confirmed cases.
248	en	ti	 For MERS, based on a demographic study in June 2012, the mortality was 37% of 2,494 confirmed cases. 	 MERS ብዝምልከት፡ ኣብ ጁን 2012 ዝተገበረ ናይ ሰነ-ህዝቢ(demographic ) ጽንዓት መሰረት፡ ብ 2,494 ዝኾኑ ዝተረጋገጹ ጉዳያት ናይ ሞት መጠን 37% እዩ ነይሩ። 	With regard to MERS, based on a June 2012 demographic survey, the mortality rate was 37% with 2,494 confirmed cases.
249	en	ti	 An earlier study reported that the R0 of SARS-CoV-2 was as high as 6.47 with a 95% confidence interval (CI) of 5.71-7.23, whereas the R0 of SARS-CoV only ranged from 2 to 4. 	 ናይ SARS-CoV-2 R0 ክሳብ 6.47 ምስ 5.71-7.23 95% confidence interval (CI) እንትበፅሕ ናይ SARS-CoV R0 ግና ካብ 2 ክሳብ 4 ጥራሕ ምዃኑ ቅድም ክብል ዝወፀ መፅናዕቲ ይሕብር። 	The R0 of SARS-CoV-2 reached up to 6.47 with a 95% confidence interval (CI) of 5.71-7.23, whereas the R0 of SARS-CoV was only 2 to 4, according to a previously published study.
250	en	ti	 A comparison of SARS-CoV-2 with MERS-CoV and SARA-CoV regarding their symptoms, mortality, and R0 is presented in Table ​Table1.1. 	 ብመንጽር ዘርእዩዎ ምልክታት፡ሞትን R0 ኣብ መንጎ SARS-CoV-2 ምስ MERS-CoV ን SARA-CoV ዝተገበረ ንጽጽር ኣብ Table1.1 ቀሪቡ ኣሎ። 	A comparison between SARS-CoV-2 with MERS-CoV and SARA-CoV in terms of symptoms,mortality and R0 is presented in Table1.1.
251	en	ti	 The above figures suggest that SARS-CoV-2 has a higher ability to spread than MERS-CoV and SARS-CoV, but it is less lethal than the latter two. 	 ምስ MERS-CoVን SARS-CoVን ተነፃፂሩ SARS-CoV-2 ዝለዓለ ናይ ምልባዕ ክእለት እንትህልዎ ዝተሓተ ድማ ቀታልነት ከምዘለዎ እቲ ኣብ ላዕሊ ዝተገልፀ ኣሃዝ ይሕብር። 	Compared to MERS-CoV and SARS-CoV, SARS-CoV-2 has the highest infectious ability and the lowest lethality, according to the above figure.
252	en	ti	 Thus, it is much more challenging to control the epidemic of SARS-CoV-2 than those of MERS-CoV and SARS-CoV. 	 ስለዝኾነ ካብ MERS-CoVን SARS-CoVን ንላዕሊ ናይ SARS-CoV-2 ለበዳ ምቁፅፃር ከቢድ እዩ። 	Therefore, the outbreak of SARS-CoV-2 is more difficult to control than MERS-CoV and SARS-CoV.
253	en	ti	 Clustered onset often happens in the same family or from the same gathering or vehicle such as a cruise ship. 	 ናይ ጉጅለ ተበግሶታት ለበዳ ኣብ ተመሳሳሊ ስድራ ቤት ወይድማ ካብ ተመሳሳሊ ምትእኽኻባት ወይድማ ኣብ ከም ናይ መጓዓዚያ መርከብ ዝበሉ ተሽከርከርከርቲ እዩ ዘጋጥም። 	Group initiatives outbreaks occur in the same family or from the same gatherings or in vehicles such as a transport ship.
254	en	ti	 Patients often have a history of travel or residence in Wuhan or other affected areas or contact with infected individuals or patients in the recent two weeks before the onset. 	 ሕሙማት ብኣብዝሓ ናይ ጉዕዞ ታሪኽ ዘለዎም፣ ኣብ ዉሃን ወይድማ ኣብ ካልኦት ዝተጠቕዑ ቦታታት ዝነብሩ፣ ምስ ዝተጠቕዐ ወይከዓ ምስ ሕማም ዘይጀመሮም ሰባት ኣብ ዝሓለፉ ክልተ ሰሙናት ርክብ ዝነበሮም እዮም። 	Patients mostly have travel history, live in Wuhan or other affected areas, and have had contact with infected or non-onset people in the past two weeks.
255	en	ti	 However, it has been reported that people can carry the virus without symptoms longer than two weeks and cured patients discharged from hospitals can carry the virus again, which sends out an alarm to increase the time for quarantine. 	 ይኹን ደኣምበር ሕሙማት ምልክት ከየርኣዩ ንነዊሕ እዋን ክጸንሑ ስለዝኽእሉን ዝሓወዩ ሕሙማት ድማ ን ካልእይ ግዘ እቲ ቫይረስ ክስከሙ ስለዝኽእሉን ናይ ውሸባ እዋን ክነውሕ ከምዝግባእ የረድኡ። 	However, the quarantine period should be extended as patients can remain asymptomatic for a long time and recovered patients can carry the virus a second time.
256	en	ti	 Patients have normal or reduced number of peripheral white blood cells (especially lymphocytes) at the early stage. 	 ኣብ እቲ ናይ መጀመሪያ ደርጃ፡ ሕሙማት ዝተሓተ ወይድማ ልሙድ ናይ ፐሪፈራል ጻዓዱ ናይ ደም ዋህዮታት(ብተለይ ልይሞፎሳይት) ኣለዎም። 	In the early stage, patients have low or normal peripheral white blood cells(especially lymophocytes).
257	en	ti	 For example, lymphopenia with white blood cell count &lt; 4×109/L including lymphocyte count &lt; 1×109/L, and elevated aspartate aminotransferase levels and viremia were found in 1,099 COVID-19 patients. 	 ን ኣብነት፣ ልይምፎፐኒያ ምስ ጻዕዳ ናይ ደም ዋህዮ ቁጽሪ &lt; 4×109/L ን ልይሞፎሳይት ቁጽሪ ሓዊሱ &lt; 1×109/L፣ ምስኡ ድማ መጠኑ ልዕል ዝበለ ናይ ኣስፓራቴት ኣሚኖትራንስፈሬዝ ደረጃታትን ቬሪሚያን ኣብ 1,099 ናይ COVID-19 ሕሙማት ተረኺቦም እዮም። 	For example, lymphopenia with white blood cell count &lt; 4×109/L and lymophocytic count including &lt; 1×109/L, accompanied by moderately elevated aspartate aminotransferase levels and viremia have been reported in 1,099 COVID-19 patients.
258	en	ti	 The levels of liver and muscle enzymes and myoglobin were increased in the blood of some patients, and C-reactive protein and erythrocyte sedimentation were increased in the blood of most patients. 	 መብዛሕቲኦም ሕሙማት ኣብ ደሞም ናይ C-ሪኣክቲቭ ፕሮቲንን ኢራይትሮሳይት ሰድመንቴሽንን መጠን ክብ ከምዝበለን ኣብ ዝተወሰኑ ሕሙማት ድማ ናይ ፀሊም ከብዲን ናይ ጭዋዳ ኤንዛይማት ከምኡውን ናይ ማዮግሎቢን መጠን ኣብ ደሞም ሓፍ ከምዝበለ ይግለፅ። 	Most patients had elevated blood levels of C-reactive protein and erythrocyte sedimentation, and in some patients elevated blood levels of liver and muscle enzymes and myoglobin.
259	en	ti	 In patients with severe cases, the level of D-dimer, a fibrin degradation product present in the blood, was elevated, and lymphocyte count was progressively reduced. 	 ከቢድ ጉዳያት ኣብ ዘለዎም ሕሙማት፡ ናይ D-dimer መጠን፡ ኣብ ደም ዝርከብ ናይ ፊብሪን(fibrin) ፍርያት፡ ወሲኹ እዩ፡ ናይ ልይሞፎሳይት(lymphocyte) ቁጽሪ ድማ ኣዝዩ ቀኒሱ እዩ። 	In patients with severe cases, levels of D-dimer, a product of fibrin in the blood, have increased, and lymphocyte counts have decreased significantly.
260	en	ti	 Abnormalities in chest radiography are found in most COVID-19 patients and featured by bilateral patchy shadows or ground glass opacity in the lungs. 	 ኣብ ናይ ደረት ራድዮግራፊ ዝረኣዩ ዘይልሙዳት ምልክታት ኣብ መብዛሕቲኡ ናይ COVID-19 ሕሙማት ይርከቡ እዮም፣ ኣብ ሳንባ ብዝረኣዩ ኽልተ መዳይ ዝረኣዩ ዝተጣበቑ ጽላሎታት(patchy shadows) ወይድማ ናይ መሬት ብርጭቆ ብርሃን ምኽልካል(ground glass opacity) ዝኣምሰሉ ምልክታት ዝግለጽ እዩ። 	Unusual signs on chest radiography are found in most COVID-19 patients, characterized by patchy shadows or ground glass opacity in the lungs.
261	en	ti	 Patients often develop an atypical pneumonia, acute lung injury, and acute respiratory distress syndrome (ARDS). 	 ብኣብዝሓ ሕሙማት ናብ ዘይንቡር ኒሞኒያ፣ ሃንደበታዊ ጉድኣት ሳምባን ኣክዩት ሪስፓራይቶሪ ዲስትረስ ሲንድሮምን (ARDS) ይቃልዑ። 	Increasingly, patients develop pneumonia, sudden lung injury, and acute respiratory distress syndrome (ARDS).
262	en	ti	 When ARDS happens, uncontrolled inflammation, fluid accumulation, and progressive fibrosis severely compromise the gas exchange. 	 ARDS ካብ ቁፅፅር ወፃእ ዝኾነ ነድሪ፣ ናይ ፈሳሲ ምእካብ ከምኡውን ቀፃሊ ዝኾነ ፋይብሮሲስ ብምፍጣር ናይ ኣየር ምቅይያር ፀገም ዘምፅእ እዩ። 	ARDS causes uncontrolled inflammation, fluid retention and persistent fibrosis resulting in aerobic disorders.
263	en	ti	 Dysfunction of type-I and type-II pneumocytes decreases the surfactant level and increases surface tension, thus reducing the ability of the lungs to expand and heightening the risk of lung collapse. 	 type-Iን type-IIን ኒሞሳይት ብኣግባቡ ምስራሕ እንተዘይክኢሎም መጠን ሰርፋክታንት ስለዝቕንስ ናይ ሳምባ ደጋዊ ወጥሪ ንኽውስኽ ብምግባር እቲ ሳምባ ናይ ምስፋሕ ዓቕሙ ቀኒሱ ንኽዕፆ ይገብር። 	If type-I and type-II pneumocytes fail to function appropriately, the amount of surfactant decreases, causing an increase in lung outer tension, reducing the ability of the lung to expand and causing it to close.
264	en	ti	 Therefore, the worst chest radiographic findings often parallel the most severe extent of the disease. 	 ስለዚ እቲ ዝኸፍአ ናይ ሳንቡእ ራጂ ዉፅኢት እንትንረክብ ብኣብዝሓ ምስ ዝኸፍአ ናይ ሕማም ደረጃ ዝተተኣሳሰረ እዩ። 	Therefore, the worst lung x-ray results are mostly associated with worse disease stage.
265	en	ti	 On February 18, 2020, the first pathological analysis of COVID-19 demonstrated the desquamation of pneumocytes, hyaline membrane formation, and interstitial lymphocyte infiltration, and multinucleated syncytial cells in the lungs of a patient who died of the disease, consistent with the pathology of viral infection and ARDS and similar to that of SARS and MERS patients. 	 ኣብ ፌብሩዋሪ 18, 2020 እቲ ናይ መጀመርታ ናይ COVID-19 ናይ ሕማም ምርመራ ምስ ናይ ካልኦት ናይ ቫይረስ ሕማማትን ARDSን ምስ ናይ SARSን MERSን ምልክታት ብተመሳሳሊ፤ ናይ ሳምባ ምቺ ህውከት፣ ናይ hyaline membraneን ካብ እቲ ሕማም ኣብ ዝሞተ ሰብ ድማ ናይ multinucleated syncytial cellsን ኣብ ሳምባ ውሽጢ ምፍጣርን ዝኣመሰሉ ምልክታት ተራእዮም እዮም። 	On February 18, 2020, the first COVID-19 diagnosis was made with symptoms of other viral diseases and ARDS similar to those of SARS and MERS; Pulmonary chaos, hyaline membrane and in a person who died from the disease multinucleated syncytial cells in the lungs have been observed.
266	en	ti	 The detection of SARS-CoV-2 RNA via reverse-transcriptase polymerase chain reaction (RT-PCR) was used as the major criteria for the diagnosis of COVID-19. 	 ብ ሪቨርስ-ትራንስክሪፕቴዝ-ፖሊሜሬዝ(reverse-transcriptase polymerase) ን ሳርስ(SARS-CoV-2 RNA) ምፍላይ ኣብ ናይ COVID-19 ዝግበር ምርመራ ከም ዋና ሮቕሓ ኣብ ጥቕሚ ውዒሉ ነይሩ። 	Detection of SARS-CoV-2 RNA by reverse-transcriptase polymerase was used as the main criterion in the diagnosis of COVID-1
267	en	ti	 However, due to the high false-negative rate, which may accelerate the epidemic, clinical manifestations started to be used for diagnosis (which no longer solely relied on RT-PCR) in China on February 13, 2020. 	 ኮይኑ ግና ናይ ሓሶት-ኣሉታዊ መጠን ሓፍ ዝበለ ብምዃኑ እቲ ለበዳ ከጋድዶ ስለዝኽእል ኣብ ቻይና ካብ 13 ፌብሩዋሪ፣ 2020 ንዳሓር ክሊኒካዊ ምልክታት ብምጥቃም ዲያግኖስ ምግባር ተጀሚሩ (ኣብ RT-PCR ጥራሕ ኣይድረኽን) ኣሎ። 	However, the high false-negative rate could exacerbate the outbreak and diagnosis using clinical signs has been introduced in China since February 13, 2020 (not driven by RT-PCR alone).
268	en	ti	 A similar situation also occurred with the diagnosis of SARS. 	 ኣብ ናይ SARS ምርመራ እውን ተመሳሳሊ ኩነታት ኣጋጢሙ ነይሩ። 	The same situation occurred in the SARS investigation.
269	en	ti	 Therefore, a combination of disease history, clinical manifestations, laboratory tests, and radiological findings is essential and imperative for making an effective diagnosis. 	 ስለዚ ናይ እቲ ሕማም ታሪኽ፣ ክሊኒካዊ ምልክታት፣ ላብራቶሪ ምርመራታትን ናይ ራጂ ዉፅኢትን ብጠቕላላ ኣብ ዉፅኢታዊ ዝኾነ ዲያግኖሲስ ንምብፃሕ ኣገደስቲ እዮም። 	Therefore, the history of the disease, clinical signs, laboratory tests, and x-ray findings are altogether important to reach an effective diagnosis.
270	en	ti	 On February 14, 2020, the Feng Zhang group described a protocol of using the CRISPR-based SHERLOCK technique to detect SARS-CoV-2, which detects synthetic SARS-CoV-2 RNA fragments at 20 × 10-18 mol/L to 200 × 10-18 mol/L (10-100 copies per microliter of input) using a dipstick in less than an hour without requiring elaborate instrumentation. 	 ኣብ ፌብሩዋሪ 14:2020፡ ናይ ፌንግ ጃንግ ጉጅለ SARS-CoV-2 ንምፍላይ ዝጠቅም ኣብ CRISPR-ዝተመስረተ ናይ SHERLOCK ቴክኒክ ዝምልከት ናይ ኣጠቓቕማ ፕሮቶኮል ዕላዊ ገይሮም እዮም፡ እዚ ድማ፡ ሲንተቲክ ናይ SARS-CoV-2 RNA ክፋላት ንምፍላይ ዘኽእል ብ 20 × 10-18 mol/L to 200 × 10-18 mol/L (10-100 ቅዳሓት ብ ማይክሮሊትር ኣታዊ) ብዝኾነ መጠን ዲፕሲቲክ(dipstick) ብምጥቃም ትሕቲ ሓደ ሰዓት ተወሳኺ መሳርሒ ምጥቃም ከይኣድለየ ንምፍላይ ዘኽእል እዩ። 	On February 14:2020, Feng Zhang&#39;s group announced a use protocol for the CRISPR-based SHERLOCK technique for the detection of SARS-CoV-2, which allows for the detection of synthetic SARS-CoV-2 RNA fractions at 20 × -18 mol/L to 200 × 10-18 mol/L (10-100 copies per microliter input) using a dipstick in less than an hour without the need for additional equipment.
271	en	ti	 Hopefully, the new technique can dramatically enhance the sensitivity and convenience if verified in clinical samples. 	 እቲ ሓዱሽ ቴክኒክ ተዓጻጻፊ ብዝኾነ መልክዑ ናይ ተኣፋፍነትን ምቹውነትን ለውጢ ዘምጽእ ከምዝኾን ተስፋ ኣሎ። 	The new technique is expected to bring about a change in urgency and convenience in a flexible manner.
272	en	ti	 Due to the lack of experience with the novel CoV, physicians can mainly provide supportive care to COVID-19 patients, while attempting a variety of therapies that have been used or proposed before for the treatment of other CoVs such as SARS-CoV and MERS-CoV and other viral diseases (Table ​(Table2).2). 	 ኣብ ኖቭል CoV ናይ ተሞክሮ ሕፅረት ብምህላዉ፣ ሓኻይም ንCOVID-19 ሕሙማት ሓፈሻዊ ሓገዝ ጥራሕ ክህቡ ከምዝኽእሉ ይፍለጥ። ብጎናጎኒ ድማ ከም SARS-CoVን MERS-CoVን ዝመሳሰሉ ዓይነታት CoVs ከምኡዉን ንካልኦት ናይ ቫይረስ ሕማማት ንጥቀመሎም ፈውሲታት ተጠቒምካ ፈተነ ይካየድ ኣሎ።(Table ​(Table2).2). 	Due to a lack of experience in novel CoV, doctors can only provide general care to COVID-19 patients. In parallel, trials are being conducted with CoVs such as SARS-CoV and MERS-CoV as well as treatments for other viral diseases (Table ​ (Table2).2).
273	en	ti	 These therapies include current and potential treatments with antiviral drugs, immunosuppressants, steroids, plasma from recovered patients, Chinese medicine, and psychological support. 	 እዞም ሕክምናታት ኣንቲ ቫይራል መድሓኒት፣ ኢሚኖሳፕረሰንት፣ ስቴሮይድ፣ ካብ ዝደሓኑ ሕሙማት ዝተወስደ ፕላዝማ፣ ናይ ቻይና ሕክምና ከምኡውን ስነልቦናዊ ሓገዝ ዘካተቱ እዮም። 	These treatments include antiviral drugs, immunosuppressants, steroids, plasma from survivors, Chinese medicine and psychological support.
274	en	ti	 Even plasma from recovered patients was proposed to be used for treatment. 	 ካብ ዝደሓኑ ሕሙማት ዝተወስደ ፕላዝማ እዉን ከም ፈውሲ ክንጥቀመሉ ከምእንኽእል ሓሳብ ቀሪቡ ኣሎ። 	It has also been suggested that plasma from survivors can be used as a cure.
275	en	ti	 Pharmaceutical companies are racing to develop antibodies and vaccines against the virus. 	 ናይ መድሓኒት ኩባንያታት ኣንቲ ቦዲን ናይ እቲ ቫይረስ ክትባትን ን ምምዕባል ይጽዕሩ ኣለዉ። 	Pharmaceutical companies are trying to develop antibodies and vaccines against the virus.
276	en	ti	 SARS-CoV-2 mainly attacks the lungs in the beginning and probably also attacks, to a lesser degree, other organs that express ACE2, such as the gastrointestinal system and the kidneys. 	 SARS-CoV-2 ብዋናነት ሳምባ ዘጥቅዕ ኮይኑ ብዝተወሰነ መጠን ድማ ከም ናይ ማዓንጣ ትራክት ስርዓትን ኩላሊትን ዝመሳሰሉ ካልኦት ACE2 ዘለዎም ኣካላት የጥቅዕ። 	SARS-CoV-2 primarily affects the lungs and to a lesser extent other ACE2-containing organs such as the gastrointestinal tract system and the kidneys.
277	en	ti	 Nevertheless, respiratory dysfunction and failure are the major threat to the patients and the major cause of death. 	 ይኹን ደኣምበር፡ ናይ መተንፈሲ ጸገማትን ውድቀትን ን ሕሙማት እቶም ዓበይቲ ሓደጋታትን ሞት ዘስዕቡ ዋና መበገሲታት እዮም። 	However, respiratory problems and failure are the main causes of death for patients.
278	en	ti	 Thus, respiratory support is critical to relieve the symptoms and save lives and includes general oxygen therapy, high-flow oxygen, noninvasive ventilation, and invasive mechanical ventilation depending on the severity of the disease. 	 ስለዚ ድማ፡ ናይ መተንፈሲ ሓገዝ ነቶም ምልክታት ኣብ ምቕናስ ን ህይወት ኣብ ምድሓንን ኣዝዩ ወሳኒ እንትኾን፡ ኣጠቓላሊ ኦክስጅን፡ ከም ፍልልያት ክብደት እቲ ሕማም ድማ ልዑል-ፍሰት ኦክስጅን(high-flow oxygen)፡ ነንኢንቫሲቭ ቨንቲሌሽን(noninvasive ventilation) ን ኢንቫሲቭ መካኒካዊ ቬንቲሌሽን ( invasive mechanical ventilation) ዘጠቓለለ እዩ። 	Therefore, ventilatory assistance is critical in reducing the symptoms and saving lives, while total oxygen, and high-flow oxygen, noninvasive ventilation and invasive mechanical ventilation ( invasive) depending on the severity of the disease mechanical ventilation) included.
279	en	ti	 Patients with severe respiratory symptoms have to be supported by extracorporeal membrane oxygenation (ECMO), a modified cardiopulmonary bypass technique used for the treatment of life-threatening cardiac or respiratory failure. 	 ከቢድ ናይ ምትንፋስ ፀገም ምልክታት ዘለዎም ሕሙማት ብ ኤክስትራኮርፖሪያል መምብሬን ኦክስጅን (ECMO)፣ ከቢድ ናይ ልቢ ወይድማ ናይ ምስትንፋስ ፀገም ንዘለዎም ሕሙማት ንጥቀመሉ ዝተሓደሰ ካርዲዮፐልመናሪ ባይፓስ ቴክኒክ ዝሕገዙ እዮም። 	Patients with severe respiratory failure are treated with extracorporeal membrane oxygen (ECMO), a regenerated cardiopulmonary bypass technique for use in patients with severe cardiac or respiratory failure.
280	en	ti	 In addition, the maintenance of electrolyte balance, the prevention and treatment of secondary infection and septic shock, and the protection of the functions of the vital organs are also essential for SARS-CoV-2 patients. 	 ብተወሳኺ ናይ ኤሌክትሮላይት ሚዛን ምሕላው፣ ኻልኣዊ ሕማምን ሴፕቲክ ሾክን ምክልኻልን ወሰንቲ ክፍሊ ኣካላት ምሕላው ንናይ SARS-CoV-2 ሕሙማት ወሳኒ እዩ። 	In addition, maintaining electrolyte balance, preventing secondary morbidity and septic shock and protecting key organs is critical for SARS-CoV-2 patients.
281	en	ti	 It has been known that a cytokine storm results from an overreaction of the immune system in SARS and MERS patients. 	 እዚ ናይ cytokine storm ናይ SARSን MERSን ሕሙማት ካብ መጠን ንላዕሊ ናይ ሕማም ምክልኻል ምላሽ እንትህቡ ዝመጽእ እዩ። 	This cytokine storm of SARS and MERS results when patients have an excessive immune response.
282	en	ti	 Cytokine storm is a form of systemic inflammatory response featured by the release of a series of cytokines including TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, and MCP-1. 	 ሳይቶካይን ስቶርም ዓይነት systemic inflammatory response (ስርዓታዊ ናይ ረኽሲ ግብረ መልሲ) ኮይኑ ብፈነወ ከም TNFα፣ IL-1β፣ IL-2፣ IL-6፣ IFNα፣ IFNβ፣ IFNγን MCP-1ን ዝመሳሰሉ ዝተፈላለዩ ሳይቶካይናት ዝመፅእ ሕማም እዩ። 	Cytokine storm is a type of systemic inflammatory response caused by the release of various cytokines such as TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ and MCP-1.
283	en	ti	 These cytokines induce immune cells to release a vast number of free radicals which are the major cause of ARDS and multiple organ failure. 	 እዞም ሳይቶካይናት ናይ መከላኸሊ ሕማም ዋህዮታት ፍሪ ራዲካልስ ንከፍርዩ ብምግባር ARDSን ብዙሓት ናይ ዉሽጣዊ ኣካል ፀገምን ከምፅእ ይገብር። 	These cytokines cause immune cells to produce free radicals, leading to ARDS and many internal organ problems.
284	en	ti	 Immunosuppression is essential in the treatment of cytokine storms, especially in severe patients. 	 ኢሙኖሰፕረሽን(Immunosuppression) ን ሳይቶካይን(cytokine ) ጸፍዒታት ብተለይ ን ከበድቲ ሕሙማት ንምሕካም ጠቓሚ እዩ። 	Immunosuppression is useful for treating cytokine plaques, especially in severe patients.
285	en	ti	 Corticosteroids and tocilizumab, an anti-IL6 monoclonal antibody, have been used to treat cytokine storm. 	 anti-IL6 ሞኖክሎናል ኣንቲቦዲ ዝኾነ ቶኪሊዙማብ ከምኡውን ኮርቲኮስተሮይድ ብምጥቃም ሳይቶካይን ስቶርም ንምፍዋስ ተኻኢሉ እዩ። 	The anti-IL6 monoclonal antibody, toquilizumab, and corticosteroids have been used to treat cytokine storm.
286	en	ti	 Other immunosuppression treatments for cytokine storm include the modulation of T cell-directed immune response; the blockade of IFN-γ, IL-1, and TNF; JAK inhibition; blinatumomab; suppressor of cytokine signaling 4; and HDAC inhibitors. 	 ንሳይቶክሲን ስቶርም ካልኦት ናይ ሕማም መከላኸሊ እርምጃታት ብ ዋህዮ-ተኮር ናይ ሕማም ምክልኻል ምላሽ ሞዱለሽን የካትቱ ፣ ናይ IFN-γ ፣ IL-1ን TNFን መአገዲ፤ ናይ ጄ.ኪ. blinatumomab፤ ናይ ሳይቶኪን ምልክት ሲግናሊንግ 4ን ናይ HDAC ኢንሂቢተርስን ዘካትት እዩ። 	For cytoxin storm other immune measures include modulation by cell-specific immune response , inhibition of IFN-γ , IL-1 and TNF; The J.K. blinatumomab; It includes cytokine signaling 4 and HDAC inhibitors.
287	en	ti	 Steroids, as immunosuppressants, were widely used in the treatment of SARS to reduce the severity of inflammatory damage. 	 ስቴርዮድስ(Steroids)፡ ከም ኢሙኖሰፕረሳንት(immunosuppressants)፡ ኣብ ናይ SARS ሕክምና ናይ ረኽሲ ጉድኣት ክብደት ንምቕናስ ብስፍሓት ኣብጥቕሚ ዝውዕሉ እዮም። 	Steroids, such as immunosuppressants, are widely used in the treatment of SARS to reduce the severity of infection damage.
288	en	ti	 However, steroids at high dosages were not beneficial to severe lung injury in SARS and COVID-19 patients. 	 ይኹን ደኣምበር፡ ልዑል መጠን ስቴሮይድስ(steroids ) ምውሳድ ኣብ ናት SARSን COVID-19 ሕሙማት ንዘሎ ከቢድ ናይ ሳንቡእ ጉድኣት ጠቐምቲ ኣይኮኑን። 	However, high doses of steroids are not beneficial for severe lung damage in SARS and COVID-19 patients.
289	en	ti	 Instead, they may cause severe side effects, especially avascular osteonecrosis, dramatically affecting the prognosis. 	 ከም ኣቫስኩላር ኦስቲዮኔክሮሲስ ዝበሉ ሓደገኛ ናይ ጎናዊ ጉድኣት ብምኽታል ናይ እቲ ሕማም ትምቢት ዝቕይሩ እዮም። 	such as avascular osteonecrosis that alter the prognosis of the disease following dangerous side effects.
290	en	ti	 Nevertheless, short courses of corticosteroids at low-to-moderate doses have been recommended to be used prudently for critically ill COVID-19 patients. 	 ይኹን ደኣምበር፡ ኣብ ከቢድ ናይ COVID-19 ሕሙማት ናይ ኮርቲኮስተሮይድስ ሓጸርቲ ኮርስታት ኣብ ካብ ትሑት እስካብ ማእኸላይ ናይ መድሓኒታት መጠን ን ኣብ ጥቕሚ ንክውዕሉ ዝምከር እዩ። 	However, in severe COVID-19 patients short courses of corticosteroids are recommended for use at low to moderate doses.
291	en	ti	 At the time of writing, no effective antiviral therapy has been confirmed. 	 እዚ ኣብ ዝተፃሓፈሉ እዋን ዉፅኢታዊ ዝኾነ ኣንቲ ቫይራል መድሓኒት ኣይተረኽበን። 	At the time of writing, no effective antiviral drugs are available.
292	en	ti	 However, intravenous administration with remdesivir, a nucleotide analog, has been found to be efficacious in an American patient with COVID-19. 	 ይኹን ደኣምበር ናይ nucleotide analog ዝተስትኻኸለ ምርመራ ንሓደ ኣሜሪካዊ ናይ COVID-19 ሕሙም ውጽኢታዊ ኮይኑ ተረኺቡ እዩ። 	However, a nucleotide analog-corrected test has been found to be effective in an American COVID-19 patient.
293	en	ti	 Remdesivir is a novel antiviral drug developed by Gilead initially for the treatment of diseases caused by Ebola and Marlburg viruses. 	 ሬምደሲቪር(Remdesivir) መጅመሪያ ብ ጊሊድ(Gilead) ን ኢቦላ ን ማርልበርግ ቫይረሳትን ዝተፈጠረ ሕማም ንምሕካም ተባሂሉ ዝተፈጠረ ናይ ኖቨል ጸረ ቫይረስ መድሓኒት እዩ። 	Remdesivir is a novel antiviral drug originally developed to treat disease caused by Gilead and Ebola and Marlberg viruses.
294	en	ti	 Later, remdesivir also demonstrated possible inhibition of other single stranded RNA viruses including MERS and SARS viruses. 	 ጸኒሑ፡ሬምደሲቨር(remdesivir) ን MERS ን SARS ቫይረሳት ሓዊሱ ናይ ካልኦት ነጸላ ገመድ ዝኾኑ ናይ RNA ቫይረሳት ንምጥፋእ ከምዝኽእል ኣርእዩ እዩ። 	Later, remdesivir was shown to kill other single-stranded RNA viruses, including MERS and SARS viruses.
295	en	ti	 Based on these, Gilead has provided the compound to China to conduct a pair of trials on SARS-CoV-2-infected individuals, and the results are highly anticipated. 	 ኣብዚኦም ተደሪኽና፡ ጊሊያድ(Gilead) ብ SARS-CoV-2 ዝተጠቕዑ ውልቀሰባት ዝግበሩ ጽምዲ ሙከራታት ንምግባር ዘኽእል ውህድ ናብ ቻይና ዝለኣኸ እንትኾን፡ እቶም ውጽኢታት ድማ ብ ዓብዩ ትጽቢት ዝግበረሎም እዮም። 	Inspired by these, Gilead has shipped a compound to China to conduct pairs of trials on individuals infected with SARS-CoV-2, and the results are highly anticipated.
296	en	ti	 In addition, baricitinb, interferon-α, lopinavir/ritonavir, and ribavirin have been suggested as potential therapies for patients with acute respiratory symptoms. 	 ብተወሳኺ baricitinb፣ interferon-α፣ lopinavir/ritonavirን ribavirinን ንሃንደበታዊ ናይ ምስትንፋስ ፀገም ዘለዎም ሕሙማት ከም ፈውሲ ከገልግሉ ከምዝኽእሉ ተነጊሩ ኣሎ። 	In addition, baricitinb, interferon-α, lopinavir/ritonavir, and ribavirin have been reported as treatments for patients with sudden respiratory distress syndrome.
297	en	ti	 Diarrhea, nausea, vomiting, liver damage, and other adverse reactions can occur following combined therapy with lopinavir/ritonavir. 	 ሎፒናቪር/ሪቶናቪር ብሓንሳብ ምጥቃም ተቕማጥ፣ ዕዉልዉል ምባል፣ ተምላስ፣ ጉድኣት ፀላም ከብዲን ካልኦት ሓደጋታትን ከስዕብ ይኽእል እዩ። 	Concomitant use of lopinavir/ritonavir can cause diarrhea, nausea, vomiting, liver damage and other risks.
298	en	ti	 The interaction of these treatments with other drugs used in the patients should be monitored carefully. 	 ናይ እዞም ሕክምናታት ምስ ካልኦት መድሓኒታት ጠሚርካ ኣብ ሕሙማት ምጥቃም ብ ጥንቃቐ ክተሓዝ ኣለዎ። 	The use of these treatments in combination with other drugs in patients should be handled with caution.
299	en	ti	 Plasma from recovered patients and antibody generation 	 ካብ ዝደሓኑ ሕሙማት ዝተወስደ ፕላዝማን ኣንቲቦዲ ምፍራይን 	Plasma and antibody production from surviving patients
300	en	ti	 The collection of the blood from patients who recovered from a contagious disease to treat other patients suffering from the same disease or to protect healthy individuals from catching the disease has a long history. 	 ካብ ተላባዒ ሕማም ዝደሓኑ ሰባት ደም ተወሲዱ ንካልኦት ዘይዳሓኑ ሕሙማት ከም መድሓኒት፣ ገና ንዘይተጠቕዑ ሰባት ድማ ከም መከላኸሊ ምጥቃም ነዊሕ ታሪኽ ዘለዎ እዩ። 	There is a long history of using blood from infectious disease survivors as a cure for other patients who have not yet survived, and as a preventive measure for those who have not yet been infected.
301	en	ti	 Indeed, recovered patients often have a relatively high level of antibodies against the pathogen in their blood. 	 ብርግፅ፣ ካብ ሕማም ዝደሓኑ ሰባት ኣብ ደሞም ነቲ ሕማም ንምክልኻል ዘኽእል ዝለዓለ ናይ ኣንቲቦዲ መጠን ኣለዎም። 	Indeed, survivors have higher levels of antibodies in their blood to protect against the disease.
302	en	ti	 Antibodies are an immunoglobulin (Ig) produced by B lymphocytes to fight pathogens and other foreign objects and they recognize unique molecules in the pathogens and neutralize them directly. 	 ጸረ ባዕዳውያን ( Antibodies) ብ ናይ B ልይምፎሳይት( B lymphocytes) ዝፈሪ ኢሙኖግሎቢን(immunoglobulin (Ig)) እንትኸውን፡ ሕማም ኣምጻእቲ ተህዋስያንን ካልኦት ን ሰብነትና ባዕዲ ዝኾኑ ነገራት ኣብ ምጥቃዕ፡ ኣብቶም ተሃዋስያን ዝርከቡ ብሕታዊ ሞሎኲላት ብ ምፍላይ ዘምክን ድማ እዩ። 	Antibodies are immunoglobulins (Ig) produced by B lymphocytes that destroy disease-causing bacteria and other foreign substances by detecting and destroying specific molecules in the bacteria.
303	en	ti	 Based on this, plasma was collected from the blood of a group of patients who recovered from COVID-19 and was injected into 10 seriously ill patients. 	 ካብ እዚ ብምብጋስ ካብ COVID-19 ካብ ዝሓወዩ ሕሙማት ናይ ፕላዝማ ደም ብምውሳድ ን 10 ብኽፉእ ዝሓመሙ ሕሙማን ተዋሂቡ እዩ። 	Hence, plasma blood was taken from patients who recovered from COVID-19 and given to 10 seriously ill patients.
304	en	ti	 Their symptoms improved within 24 hours, accompanied by reduced inflammation and viral loads and improved oxygen saturation in the blood. 	 ምልክታቶም ድማ ኣብ ውሽጢ 24 ሰዓታት ክመሓየሽ ክኢሉ እዩ፡ ዝቐነሰ ረኽሲን ዝተሓተ ኣብ ደም ውሽጢ ዝርከብ ናይ ቫረስ መጠን(viral loads ) ን ዝተመሓየሸ ናይ ኦክስጅን ምውህሃድ ኣብ ደምን ዝተዓጀቡ እዮም። 	Their symptoms improved within 24 hours, accompanied by reduced infection, lower viral loads, and improved blood oxygenation.
305	en	ti	 However, verification and clarification are necessary to propose the method for large-scale use before specific therapies are not yet developed. 	 ኮይኑ ግና ቅድሚ ምዕባለ መድሓኒት ብዓቢ ደረጃ ምጥቃም ከምዝከኣል ዝገልፅ መብራህርህን መረጋገፅን ክህልዉ ይግባእ። 	However, there should be explanations and evidence that drugs can be used on a large scale before development.
306	en	ti	 In addition, given the therapeutic effects, some disadvantages associated with the plasma should be considered carefully. 	 ብተወሳኺ ካብ ናይ ሕክምና ተፅዕኖ አንጻር ምስ ፕላዝማ ዝተዛመዱ ሕድሕድ ጉድኣታት ጥንቅቐ ክግበረሎም ይግባእ። 	In addition, care should be taken against plasma-related harms from medical exposure.
307	en	ti	 For example, antibodies can overstimulate the immune response and cause cytokine release syndrome, which is potentially a life-threatening toxicity. 	 ንኣብነት ኣንቲቦዲታት ሕማም ናይ ምክልኻል ስርዓት ብምንቕቓሕ ናይ cytokine release syndrome (ሳይቶካይን ሰደድ ሲንድሮም) ዝበሃል ሓደገኛ ሕማም ከኸትል ይኽእል። 	For example, antibodies can stimulate the immune system, causing a serious disease called cytokine release syndrome.
308	en	ti	 The concentration of antibodies in the blood is usually low, and the demand for the plasma is large to treat critically ill patients. 	 ኣብ ደም ዉሽጢ ናይ ኣንቲቦዲታት ጻዕቒ ብኣብዝሓ ዉሑድ እዩ። ነቶም ኣብ ከቢድ ሕማም ዝርከቡ ሕሙማት ንምሕካም ድማ ናይ ፕላዝማ ጠለብ ዓብዪ እዩ። 	The concentration of antibodies in the blood is usually low. The demand for plasma is huge to treat critically ill patients.
309	en	ti	 It is difficult to develop and produce specific antibodies rapidly enough to fight against a global epidemic. 	 እቲ ለበዳ ንምክልኻል ብቅልጡፍ ፍሉይ ዝኾነ ኣንቲቦዲ ምፍራይ ይኸብድ እዩ። 	It is difficult to produce specific antibodies quickly to prevent the outbreak.
310	en	ti	 Thus, it is more critical and practical to isolate B cells from recovered patients and identify the genetic codes encoding effective antibodies or screen for effective antibodies against essential proteins of the virus. 	 ስለዝኾነ ናይ B ዋህዮታት ካብ ዝደሓኑ ሰባት ብምወሳድ ዉፅኢታዊ ኣንቲቦዲታት ኢንኮድ ዝገብሩ ጀነቲካዊ ኮዳት ወይ ድማ ዋና ናይ እቲ ቫይረስ ፕሮቲን ንምጥፋእ ዝሰርሑ ዉፅኢታዊ ኣንቲቦዲታት ምድላይ ኣገዳሲ እዩ። 	Therefore, it is important to take B cells from survivors and look for genetic codes that encode effective antibodies or effective antibodies that work to destroy the core protein of the virus.
311	en	ti	 This way, we can readily scale up the production of the antibodies. 	 እዚ ብምግባር ናይ ኣንቲቦዲ ፍርያት ክብ ክነብሎ ንኽእል ኢና። 	By doing this, we can increase the production of antibodies.
312	en	ti	 TCM has been used to treat a variety of diseases in China for thousands of years. 	 ንኣሽሓት ዓመታት ኣብ ቻይና TCM ዝተፈላለዩ ሕማምት ንምሕካም ኣብ ጥቕሚ ኣብ ምውዓል ይርከብ። 	For thousands of years, TCM has been in use in China to treat various diseases.
313	en	ti	 However, its effects largely rely on a combination of multiple components in a formula that varies depending on the diagnosis of a disease based on the theories of TCM. 	 ይኹን እምበር እቲ ዉፅኢት ብናይ ሕማም ዲያግኖሲስ ተመስሪቱ ኣብ ናይ TCM ስነሓሳብ ዝተደረኸ ናይ ምቅይያር ቀመር ተጠቒሙ ኣብ ናይ ዝተፈላለዩ ክፍልታት ጥምረት ዝተመስረተ እዩ። 	However, the results are based on a combination of different parts using a permutation formula based on a disease diagnosis and based on TCM ideology.
314	en	ti	 Most of the effective components remain unknown or are vague as it is difficult to extract and verify such components or their optimal combinations. 	 ን ከምዚኦም ዝበሉ ክፋላት ነጺልካ ኣውጺእኻ ንምፍላይ ኣጽጋሚ ብምዃኑ፡መብዛሕቲኦም እቶም ንቑሓት ክፋላት ኣይተፈለጡን ወይድማ ብግልጺ ኣይፍለጡን። 	Because it is difficult to isolate such components, most of the conscious components are unknown or not clearly known.
315	en	ti	 Currently, due to the lack of effective and specific therapy for COVID-19, TCM has become one of the major alternative treatments for patients with light to moderate symptoms or for those who have recovered from severe stages. 	 ኣብ እዚ ሐዚ እዋን፡ ን COVID-19 ዝግበር ሕክምና ስሉጥ ዘይምኻኑን ሓደ ዝተፈለየ ሕክምና ዘይምህላዉን፡ TCM ን ቀሊልን ማእኸላይን ምልክታትን ካብ ከበድቲ ኩነታት ዝሓወዩ ተሓከምቲ ንምሕካም ካብቶም ዋና መማረጺታት እናኾነ ይርከብ። 	Currently, due to the inefficient treatment of COVID-19 and the lack of a separate treatment, TCM is becoming one of the main options to treat patients with mild and moderate symptoms who have recovered from severe conditions.
316	en	ti	 For example, Shu Feng Jie Du capsules and Lian Hua Qing Wen capsules were found to be effective for COVID-19 treatment. 	 ንኣብነት ሹ ፌንግ ጂ ዱ ከምኡውን ሊያን ሁዋ ኪንግ ዌን ዝተብሃሉ ካፕሱላት ኣብ ናይ COVID-19 ሕክምና ኣድማዕቲ ከምዝኾኑ ተፈሊጡ። 	For example, Shu Feng Ji Du and Lian Hua Qing Wen capsules have been shown to be effective in treating COVID-1
317	en	ti	 Top cure rates in the treatment of COVID-19 patients were observed in several provinces in China that used TCM in 87% of their patients, including Gansu (63.7%), Ningxia (50%), and Hunan (50%), whereas Hubei province, which used TCM in only approximately 30% of its COVID-19 patients, had the lowest cure rate (13%). 	 ኣብ ናይ COVID-19 ሕሙማት ሕክምና፡ ብዙሓት ኣብ 87% ሕሙማትን ናይ TCM ሕክምና ዝተጠቐማ፡ ኣብ ጋንግሱ(63.7%)፡ ኒንግሲያ(50%)፡ ኣብ ሁናን(50%) ሓዊሱ ብዙሓት ግዝኣታት ልዑል ናይ ምድሓን ቁጽሪ ዘመዝገባ ኣለዋ፥ ነገር ግን እታ ናይ TCM ሕክምና ኣብ 30% ሕሙማት COVID-19 ጥራሕ ዝተጠቐመት ናይ ሁበይ ግዝኣት እቲ ዝተሓተ ናይ ምድሓን ቁጽሪ(13%) ኑይሩዋ። 	In the treatment of COVID-19 patients, many in 87% of patients and used TCM treatment, there are many states including Gangsu(63.7%), Ningxia(50%), and Hunan(50%) that have recorded high survival rates, but that Hubei Province, which used TCM treatment in only 30% of COVID-19 patients, had the lowest survival rate(13%).
318	en	ti	 However, this is quite a rough comparison as many other impact factors such as the number and severity of the patients should be included in the evaluation. 	 ይኹን ደኣምበር፡ እዚ ማለት ኣዝዩ ትኽክለኛ ዘይኮነ ንጽጽር እዩ ምኽኒያቱም ካልኦት ከም ክብደትን ቁጽሪን ናይ ሕሙማት ኣብ እቲ ገምጋም ኣይተኻተቱን። 	However, this means a very inaccurate comparison because other factors such as weight and number of patients were not included in the assessment.
319	en	ti	 On February 18, 2020, Boli Zhang and coworkers published a study to compare western medicine (WM) treatment alone with combined treatment of WM and TCM. 	 ኣብ ፌብሩዋሪ 18:2020፡ ቦሊ ጃንግን መሳርሕቱን ናይ ምዕራባውያን መድሓኒት(WM) በይኑ ዝግበር ሕክምና ምስ ናይ WM ን TCM ብሓባር ዝግበር ሕክምና ብምውድዳር መጽናዕቲ ኣቕሪቦም ነይሮም። 	On February 18:2020, Bolly Jang and colleagues presented a study comparing Western medicine(WM) treatment alone with WM and TCM combined.
320	en	ti	 They found that the times needed for body temperature recovery, symptom disappearance, and hospitalization were remarkably shorter in the WM+TCM group than in the WM only group. 	 ምስ ጉጅለ WM ጥራሕ ተነፃፂሩ ኣብ ጉጅለ WM+TCM ዝርከቡ ሕሙማት ረስኒ ሰውነት ናብ ንቡር ንክምለስ፣ ምልክታት ንክጠፍኡን ካብ ሕክምና ንምዉፃእን ሓፂር እዋን ጥራሕ እዩ ዝደሊ። 	Compared to the WM alone group, patients in the WM+TCM group required only a shorter period of time for fever to return to normal, for symptoms to disappear, and for discharge.
321	en	ti	 Most impressively, the rate for symptomatic worsening (from light to severe) was remarkably lower for the WM+TCM group than for the WM only group (7.4% versus 46.2%) and the mortality was lower in the WM+TCM group than WM only group (8.8% versus 39%). 	 ብዝገርም ኹነታት ፣ ኣብ WM + TCM ጉጅለ ናይ ሕማም ምልክታት ምብኣስ(ካብ ቀሊል ናብ ከቢድ) ካብ WM ጥራሕ ዘለዎ ጉጅለ ዝነኣሰ እንትኸውን(7.4% ብኣንጻር 46.2%)ን ኣብ WM + TCM ጉጅለ ውሽጢ ዝነበረ ናይ ሞት መጠን ካብ WM ጥራሕ ዘለዎም ጉጅለ ዝተሓተ ነይሩ (8.8% ብኣንጻር 39%)። 	Interestingly , the severity of symptoms in the WM + TCM group(from mild to severe) was lower than in the WM-only group(7.4% versus 46.2%) and the mortality rate within the WM + TCM group was lower than in the WM-only group (8.8% as opposed to 39%).
322	en	ti	 Nevertheless, the efficacy and safety of TCM still await more well-controlled trials at larger scales and in more centers. 	 ናይ TCM ዉፅኢታዉነትን ድሕንነትን ንምርግጋፅ ብደምቢ ዝተቆፃፀረ ፈተነ ብዝዓበየ መንገዲን ኣብ ብዙሓት ማእኸላትን ክካየድ ኣለዎ። 	Well-controlled trials should be conducted on a larger scale and in more centers to ensure the efficacy and safety of TCM.
323	en	ti	 It would also be intriguing to characterize the mechanism of actions and clarify the effective components of TCM treatments or their combinations if possible. 	 ብዝተኽኣለ መጠን እቶም ናይ TCM ሕክምናታት ተግባራዊ መንገድታት ኣብ ምውሳንን ስሉጥ ብዝኾነ መልክዑ ክፋላቶም ኣብ ምውዳድ ተግባር ኣዝዩ ስምዒት ዝስሕብ እዩ። 	The act of determining the viable pathways of the TCM treatments as much as possible and organizing their parts in a seamless manner is very emotionally appealing.
324	en	ti	 Patients with suspected or confirmed COVID-19 mostly experience great fear of the highly contagious and even fatal disease, and quarantined people also experience boredom, loneliness, and anger. 	 ብCOVID-19 ዝተጠርጠሩን ዝተረጋገፁን ሕሙማት ናይ እቲ ሕማም ተላጋቢነትን ሓደገኛነትን ተኸቲሉ ከቢድ ፍርሒ ይስመዖም። ኣብ ምዉሻብ ዝርከቡ ሰባት ድማ ትህኺት፣ ብሕታዉነትን ሕርቃንን ይስመዖም። 	Patients with suspected and confirmed COVID-19 experience severe fear following the contagiousness and danger of the disease. People in quarantine feel tired, lonely and angry.
325	en	ti	 Furthermore, symptoms of the infection such as fever, hypoxia, and cough as well as adverse effects of the treatments such as insomnia caused by corticosteroids can lead to more anxiety and mental distress. 	 ብተወሳኺ ድማ፡ ከም ረስኒ፡ ሃይፕሲያ(hypoxia)ን ምስዓልን ዝኣምሰሉ ናይ እቲ ረኽሲ ምልክታትን ካልኦት ዘይተሓሰቡ ጽልዋታት ከም ብ ካርቲኮስትሮይድ ዝፍጠሩ ናይ ምድቃስ ጸገም( insomnia) ናብ ጭንቅትን ናይ ኣዕምሮ ዘይምርግጋዕን ክወስዱ ይኽእሉ እዮም። 	In addition, symptoms of the infection such as fever, hypoxia and coughing and other unintended effects such as insomnia caused by corticosteroids can lead to anxiety and mental instability.
326	en	ti	 In the early phase of the SARS outbreak, a range of psychiatric morbidities including persistent depression, anxiety, panic attacks, psychomotor excitement, psychotic symptoms, delirium, and even suicidality were reported. 	 ናይ SARS ለበዳ ኣብ መጀመርታ ደረጃ እንተሎ ከም ቀዋሚ ዲፕረሽን፣ ጭንቀት፣ ናይ ሽበራ መጥቃዕቲ፣ ሳይኮሞተር ኤክሳይትመንት፣ ሳይኮቲክ ምልክታት፣ ዲሊሪየም ከምኡዉን ዓርሰ ቅትለት ዝመሳሰሉ ናይ ኣእምሮ ሕማማት ተመዝጊቦም እዮም። 	Mental illnesses such as chronic depression, anxiety, panic attacks, psychomotor excitement, psychotic symptoms, delirium and suicide have been reported in the early stages of a SARS outbreak.
327	en	ti	 Mandatory contact tracing and quarantine, as a part of the public health responses to the COVID-19 outbreak, can make people more anxious and guilty about the effects of the contagion, quarantine, and stigma on their families and friends. 	 ከም ኣካል ን ናይ COVID-19 ለበዳ ዝግበር ናይ ህዝባዊ ጥዕና ግብረ መልሲ፣ ግደን ክግበር ዘለዎ ናይ ርክብ ጽንዓትን ክትትልን ውሸባን፣ ሰባት ብዛዕባ እቲ ምምሕልላፍ፣ ውሸባን ኣብ ቤተሰቦም ኣዕርኽቶምን ዝህሉ ምግላልን ብምሕሳብ ኣዝዮም ክጭነቑን ናይ ጥፍኣት ስምዒት ክስመዖምን ይኽእል እዩ። 	As part of the public health response to the COVID-19 pandemic, the role of communication surveillance and quarantine, people can become very anxious and feel devastated about the transmission, quarantine and isolation from their family and friends.
328	en	ti	 Thus, mental health care should be provided to COVID-19 patients, suspected individuals, and people in contact with them as well as the general public who are in need. 	 ስለዚ ንCOVID-19 ሕሙማት፣ ተጠርጠርትን ምስኦም ርክብ ዘለዎም ሰባትን ከምኡውን ነቲ ሓፈሻዊ ህዝቢ ናይ ስነልቦናዊ ሓገዝ ክወሃቦም ይግባእ። 	Therefore, psychological support should be provided to COVID-19 patients, suspects and their contacts as well as the general public.
329	en	ti	 The psychological support should include the establishment of multidisciplinary mental health teams, clear communications with regular and accurate updates about the SARS-CoV-2 outbreak and treatment plans and the use of professional electronic devices and applications to avoid close contact with each other. 	 እቲ ናይ ሰነ-ኣእምሮኣዊ ድጋፍ ካብ ብዙሕ ሞያታት ዝተዋጽኡ ናይ ኣእምሮ ጥዕና ሰብ ሞያታት ጉጅለታት ምጥያሽ፣ ብዛዕባ ናይ SARS-CoV-2 ለበዳን ናይ ሕክምና መደባት፣ ምስ ሰባት ቅሩብ ርክብ ካብ ምግባር ዓርስኻ ኣብ ምዕቃብ ኣጠቓቕማ ሞያዊ እሌክትሮኒክስ መሳርሕታትን መተግበሪታትን ዝምልከት ግልጺ ዝኾነ ስሩዓትን ትኽክለኛታትን ምምሕያሻት ዘለውዎ ርክብ ዘጠቓለለ እዩ። 	The psychological support Establish teams of multidisciplinary mental health professionals, transparent regular and accurate improvements in the use of professional electronic devices and applications regarding the SARS-CoV-2 outbreak and treatment programs, and keeping yourself away from close contact with people including their relationship.
330	en	ti	 Effective vaccines are essential for interrupting the chain of transmission from animal reservoirs and infected humans to susceptible hosts and are often complementary to antiviral treatment in the control of epidemics caused by emerging viruses. 	 ካብ ተሸከምቲ እንስሳትን ዝተጠቕዑ ሕሙማትን ናብ ጥዕናኦም ዝተሓለወ ሰባት ዝተዘርገሐ ናይ መተሓላለፊ ሰንሰለት ንምብታኽ ዉፅኢታዊ ክትባት ኣድላይ እዩ። እዚ ክትባት ድማ ምስ ኣንቲቫይራል መድሓኒት ብሓባር ብምዃን እቲ ለበዳ ንምቁፅፃር ይሰርሕ። 	Effective vaccines are needed to break the chain of transmission from vector animals and infected patients to healthy people. The vaccine works in conjunction with antiviral drugs to control the outbreak.
331	en	ti	 Efforts have been made to develop S protein-based vaccines to generate long-term and potent neutralizing antibodies and/or protective immunity against SARS-CoV. 	 ናይ ነዊሕ እዋንን ፅቡቕ ዓቕሚ ዘለዎን ከምኡውን ዘዳኽም ኣንቲቦዲን ንSARS-CoV ናይ ምክልኻል ዓቕሚ ክብ ዘብልን ኣብ S ፕሮቲን ዝተደረኸ ክትባት ንምስራሕ ፃዕሪ ይካየድ ኣሎ። 	Efforts are underway to develop S protein-based vaccines that are long-lasting, well-potentiated, and attenuating antibodies that enhance immunity to SARS-CoV.
332	en	ti	 Live-attenuated vaccines have been evaluated in animal models for SARS. 	 ንSARS ዝኾኑ ካብ ዝተዳኸሙ ቫይረሳት ዝተሰርሑ ክትባታት ኣብ እንስሳት ፈተነ ተኻይዱሎም ኣሎ። 	Vaccines made from attenuated viruses for SARS have been tested in animals.
333	en	ti	 However, the in vivo efficacy of these vaccine candidates in elderly individuals and lethal-challenge models and their protection against zoonotic virus infection have yet to be determined before a clinical study is initiated. 	 ኮይኑ ግና እዞም ናይ ክትባት ሕፁያት ኣብ ዓበይቲ ሰባት ዘለዎም ናይ ኢን ቪቮ ዉፅኢታዉነት ከምኡውን ቀታሊ-ፈተና ሞዴላትን ካብ እንስሳ ዝመፁ ቫይረሳት ናይ ምክልኻል ዓቕሙ ቅድሚ ክሊኒካዊ መፅናዕቲ ምጅማሩ ዝዉሰን ይኸዉን። 	However, the in vivo efficacy of these vaccine candidates in adults as well as lethal-assay models and their ability to protect against animal-derived viruses will be determined before clinical studies are initiated.
334	en	ti	 This is probably because SARS died down 17 years ago and no new case has been reported since. 	 እዚ ድማ ቅድሚ 17 ዓመታት SARS ድሕሪ ምጥፋኡ ክሳብ ሕዚ ሓድሽ ጉዳይ ለበዳ ስለዘይተመዝገበ እዩ። 	This is because no new outbreak cases have been reported since the eradication of SARS 17 years ago.
335	en	ti	 In contrast, sporadic cases and clusters of MERS continue to occur in the Middle East and spread to other regions owing to the persistence of zoonotic sources in endemic areas. 	 ብተፃራሪ፣ ዘይስሩዕ ናይ MERS ጉዳያት ለበዳን ክላስተርን ኣብ ማእኸላይ ምብራቕ ብቐጻልነት እናተረኸቡ እዮም፣ ቀጻልነት ዘለዎም ናይ እንስሳት ተሸከምቲ ብምህላዎም ድማ ናብ ካልኦት ከባቢታት ኣብ ምስፍሕፋሕ ይርከቡ። 	Conversely, irregular cases of MERS outbreaks and clusters are consistently reported in the Middle East and are expanding to other areas due to the presence of persistent animal vectors.
336	en	ti	 Vaccination strategies have been developed for MERS by using inactivated virus, DNA plasmids, viral vectors, nanoparticles, virus-like particles and recombinant protein subunits and some have been evaluated in animal models. 	 ንMERS ዝኸዉን ናይ ክትባት ስትራቴጂ ዘይተነቓቕሑ ቫይረሳት፣ DNA ፕላዝሚድ፣ ቫይራል ቬክተርስ፣ ናኖፓርቲክልስ፣ ቫይረስ-ላይክ ፓርቲክልስን ሪኮምቢናንት ፕሮቲን ሳብዩኒትስን ብምጥቃም ተማዕቢሉ። ዝተወሰኑ ድማ ኣብ እንስሳት ፈተነ ተኻይድሎም። 	A vaccine strategy for MERS was developed using inactivated viruses, DNA plasmids, viral vectors, nanoparticles, virus-like particles, and recombinant protein subunits. Some were tested on animals.
337	en	ti	 The development of a safe and effective vaccine against SARS-CoV-2 for non-immune individuals is an urgent and critical task for controlling the ongoing epidemic. 	 እዚ ቀፃሊ ለበዳ ንምቁፅፃር ንSARS-CoV-2 መከላኸሊ ንዘይብሎም ሰባት ዝኸዉን ምዕባለ ድሕንነቱ ዝተሓለወን ዉፅኢታዊ ዝኾነን ክትባት የድሊ። 	The development of safe and effective vaccines for people who are not immune to SARS-CoV-2 is needed to control this ongoing epidemic.
338	en	ti	 However, it is challenging to overcome the difficulty because of the long period of time (averaged 18 months) needed for vaccine development and the dynamic variations of CoVs. 	 ይኹን ደኣምበር፡ ብሰንኪ ተለዋዋጢ ናይ CoVs ባህሪ ዝተልዓለ ክታበት ንምምዕባል ዘድሊ ዝተናወሐ ጊዜ(ብማእኸላይ 18 ኣዋርሕ) ነቲ ጸገም ንምስዓር ኣዝዩ ኣጸጋሚ እዩ። 	However, the prolonged time required to develop a vaccine (18 months on average) due to the variable nature of CoVs makes it very difficult to overcome the problem.
339	en	ti	 As a novel disease, COVID-19 has just started to manifest its full clinical course throughout thousands of patients. 	 COVID-19 ኖቨል ሕማም ብምዃኑ ሕዚ ናይ እቲ ሕማም ሙሉእ ናይ ክሊኒካዊ ኮርስ ኣብ ኣሽሓት ሕሙማት ምርኣይ ጀሚሩ ኣሎ። 	COVID-19 is a novel disease and the full clinical course of the disease is now being seen in thousands of patients.
340	en	ti	 In most cases, patients can recover gradually without sequelae. 	 መብዛሕትኡ ግዘ ሕሙማት ብዘይ ገለ ሕክምና ቀስብቐስ ዝድሕኑ እዮም። 	Patients usually recover slowly without any treatment.
341	en	ti	 However, similar to SARS and MERS, COVID-19 is also associated with high morbidity and mortality in patients with severe cases. 	 ይኹን ደኣምበር፡ ምስ SARS ን MERS ብተመሳሳሊ፡ COVID-19 ምስ ዝለዓለ ኣብቶም ከቢድ ጉዳይ ዘለዎም ሕሙማት ዝለዓለ ናይ ስነ-ኣዕምሮኣዊ ጸገም ምብጻሕን ሞትን ዘስዕብ እዩ። 	However, similar to SARS and MERS, COVID-19 leads to higher incidence of psychiatric disorders and death in patients with severe cases.
342	en	ti	 Therefore, building a prognosis model for the disease is essential for health-care agencies to prioritize their services, especially in resource-constrained areas. 	 ስለዚ ናይ ጥዕና ኤጀንሲታት ብፍላይ ድማ ናይ ሃፍቲ ገደብ ኣብ ዘለዎም ቦታታት ናይ ግልጋሎት ተቐዳምነት ንምሃብ ናይ እቲ ሕማም ትምቢት ዝገልፅ ሞዴል ምህናፅ የድሊ እዩ። 	Therefore, health agencies need to build a predictive model of the disease in order to prioritize services, especially in settings with resource constraints.
343	en	ti	 Based on clinical studies reported thus far, the following factors may affect or be associated with the prognosis of COVID-19 patients (Table ​(Table33): 	 ክሳብ ሕዚ ኣብ ዝተገብሩ ክሊኒካዊ መፅናዕትታት ተደሪኽና እዞም ዝስዕቡ ምኽንያታት ንCOVID-19 ናይ ሕማም ትምቢት ፅዕንቶ ዝገብሩ እዮም (Table ​(Table33): 	Based on clinical studies to date, the following factors influence the prognosis of COVID-19 (Table ​ (Table33):
344	en	ti	 Age: Age was the most important factor for the prognosis of SARS, which is also true for COVID-19. 	 ዕድመ፡ ዕድመ ንSARSን COVID-19ን ናይ እቲ ሕማም ትምቢት ንምርዳእ ኣገዳሲ እዩ። 	Age: Age is important for understanding the prognosis of SARS and COVID-1
345	en	ti	 COVID-19 mainly happened at the age of 30-65 with 47.7% of those patients being over 50 in a study of 8,866 cases as described above. 	 ኣብ 8866 ጉዳያት ዝተገበረ ጽንዓት ከም እቲ ኣብ ላዕሊ ዝተገለጸ ክምዝሕብሮ፡COVID-19 ብ ዋናነት ኣብ ዕድመታት 30-65 እዩ ኣጋጢሙ፡ ካብዚኦም ድማ እቶም 47.7% ዝኾኑ ካብ 50 ንላዕሊ እዮም። 	A study of 8866 cases as mentioned above showed that COVID-19 mainly occurred in the age group 30-65, of which 47.7% were over
346	en	ti	 Patients who required intensive care were more likely to have underlying comorbidities and complications and were significantly older than those who did not (at the median age of 66 versus 51), suggesting age as a prognostic factor for the outcome of COVID-19 patients. 	 ናይ ጽኑዕ ክንክን ኣገልግሎት ዝጽበዩ ሕሙማት ዝጸንሐ ናይ ጥዕና ጸገም ዘለዎምን ብዕድመ ዝዓበዩን (ማእኸላይ ዕድመ 66 ብኣንጻር 51) ብምዃኖም ዕድመ ኣብ ናይ COVID-19 ሕሙማት ናይ ሕማም ጻዕቒ እጃም ከምዘለዎ ዘርኢ እዩ። 	Patients awaiting intensive care services have chronic health problems and are older (mean age 66 versus 51), suggesting that age plays a role in disease severity in COVID-19 patients.
347	en	ti	 Sex: SARS-CoV-2 has infected more men than women (0.31/100,000 versus 0.27/100,000), as described above. 	 ፆታ፡ ኣብ ላዕሊ ከምዝተገለፀ SARS-CoV-2 ካብ ደቂ ኣንስቲዮ ንደቂ ተባዕቲዮ ብዝበለጸ ከምዘጥቅዕ (0.31/100,000 ምስ 0.27/100,000) ዝፍለጥ እዩ። 	Gender: As mentioned above, SARS-CoV-2 is known to affect men more than women (0.31/100,000 vs. 0.27/100,000).
348	en	ti	 Comorbidities and complications: Patients with COVID-19 who require intensive care are more likely to suffer from acute cardiac injury and arrhythmia. 	 ተወሳኺ ሕማማትን ሳዕቤናትን፡ ላዕለዋይ ናይ ሕክምና ሓገዝ ዘድልዮም ብCOVID-19 ዝተጠቕዑ ሕሙማት ምስ ካልኦት እንትነፃፀሩ ብዝላዓለ ኩነታት ናብ ሃንደበታዊ ናይ ልቢ ጉድኣትን ኣሪትሚያን ይቃልዑ እዮም። 	Additional diseases and consequences: Patients with COVID-19 who require advanced medical care are at increased risk of sudden heart attack and arrhythmia compared to others.
349	en	ti	 Cardiac events were also the main reason for death in SARS patients. 	 ኣብ ናይ ሳርስ(SARS) ሞት ምስ ልቢ ዝተተሓሓዙ ጉዳያት እውን ርኡይ ተራ ዝነበሮም እዮም። 	Heart-related issues also played a significant role in SARS deaths.
350	en	ti	 It has been reported that SARS-CoV-2 can also bind to ACE2-positive cholangiocytes, which might lead to liver dysfunctions in COVID-19 patients. 	 ኣብ ናይ COVID-19 ሕሙማት SARS-COV-2 ምስ ACE2-positive cholangiocytes ብምጥማር ናይ ጣፍያ ሕማም ከምጽእ ከምዝኽእል ሓበሬታ ኣሎ። 	In COVID-19 patients, SARS-COV-2 has been reported to combine with ACE2-positive cholangiocytes to cause cholangitis.
351	en	ti	 It is worth noting that age and underlying disease are strongly correlated and might interfere with each other. 	 ዕድመን ናይ ጥዕና ኹነታትን ዝዛመዱን ዝጻረሩን ክኾኑ ከምዝኽእሉ ኣቓልቦ ክወሃቦ ይግባእ። 	Attention should be paid to the fact that age and health status may be related and contradictory.
352	en	ti	 Abnormal laboratory findings: The C-reactive protein (CRP) level in blood reflects the severity of inflammation or tissue injury and has been proposed to be a potential prognostic factor for disease, response to therapy, and ultimate recovery. 	 ካብ ንቡር ወፃኢ ዝኾነ ናይ ላብራቶሪ ዉፅኢት፡ ኣብ ደም ዝርከብ መጠን C-ሪኣክቲቭ ፕሮቲን (CRP) ናይ እቲ ኢንፍላሜሽን ወይድማ ናይ ቲሹ ጉድኣት መጠን ከምዝገልፅን ናይ እቲ ሕማም ትምቢት፣ ንመድሓኒት ዘለዎ መልሲን ናይ እቲ ሕሙም ምድሓንን ክነግረና ይኽእል እዩ። 	Abnormal laboratory results, blood C-reactive protein (CRP) levels indicate the extent of the inflammation or tissue damage and can tell us the prognosis of the disease, response to treatment and the patient&#39;s survival.
353	en	ti	 The correlation of CRP level to the severity and prognosis of COVID-19 has also been proposed. 	 ናይ CRP መጠን ምስ ናይ COVID-19 ትምቢት ክዛመድ ከምዝኽእል እዉን ሓሳብ ቀሪቡ ኣሎ። 	It has also been suggested that CRP levels may be associated with COVID-19 prognosis.
354	en	ti	 In addition, elevated lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatine kinase (CK) may also help predict the outcome. 	 ብተወሳኺ ድማ ሓፍ ዝበለ መጠን ላክቴት ዲሃይድሮጂኔዝ (LDH)፣ ኣስፓርቴት ኣሚኖትራንስፈሬዝ (AST)፣ ኣላናይን ኣሚኖትራንስፈሬዝ (ALT)፣ ከምኡውን ክሪኣቲን ካይኔዝ (CK) ዉፅኢት ንምትንባይ ክሕግዝ ይኽእል እዩ። 	In addition, elevated levels of lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatine kinase (CK) may help predict outcome.
355	en	ti	 These enzymes are expressed extensively in multiple organs, especially in the heart and liver, and are released during tissue damage. 	 እዞም ኣብ እዋን ናይ ክፋል ናይ ሰበነት ኣካል ሓደጋ ዝፍነዉ ኤንዛይማት ኣብ ዝተፈላለዩ ኣካላት ብፍላይ ድማ ኣብ ልቢን ፀሊም ከብድን ብጻዕቒ ዝግለጹ እዮም። 	These enzymes, which are released during partial organ accidents, are highly expressed in various organs, especially the heart and liver.
356	en	ti	 Thus, they are traditional markers for heart or liver dysfunctions. 	 ስለዝኾነ ናይ ልቢ ወይድማ ፀሊም ከብዲ ሕማም ክነግሩና ዝኽእሉ ልሙዳት ሓበርቲ እዮም። 	Therefore, they are common indicators that can tell us about heart or liver disease.
357	en	ti	 Major clinical symptoms: Chest radiography and temporal progression of clinical symptoms should be considered together with the other issues for the prediction of outcomes and complications of COVID-19. 	 ዋና ክሊኒካዊ ምልክታት፡ ናይ ደረት ራድዮግራፊ ን ጊዜያዊ ምዕባለ ናይ ክሊኒካዊ ምልክታት ምስ ካልኦት ኩነታት ብሓደ ኣብ ናይ COVID-19 ናይ ውጽኢት ትንበያታትን ዘምጽኦ ሕልኽላኻት ኣብ ምትንባይ ኣብ ግምት ውሽጢ ክኣትዉ ኣለዎም። 	Key clinical signs, chest radiography and temporal development of clinical signs with other conditions should be taken into consideration in predicting the outcome of COVID-19 and its complications.
358	en	ti	 Use of steroids: As described above, steroids are immunosuppressant commonly used as an adjunctive therapy for infectious diseases to reduce the severity of inflammatory damage. 	 ናይ ስቴርዮድስ (steroids) ጥቕሚ፡ ኣብ ላዕሊ ከምዝተገለጸ፡ ስቴርዮድስ ኢሙኖሰፕረሳንት( immunosuppressant) ኮይኖም ብልሙድ ኣብ ናይ ረኽሲ ሕማማት ናይ እቲ ረኽሲ ጉድኣት ክብደት ንምቕናስ ከም ተተሓሓዚ ሕክምና ኣብ ጥቕሚ ዝውዕሉ እዮም። 	Benefits of Steroids As mentioned above, steroids are immunosuppressants and are commonly used as adjunctive therapy to reduce the severity of the infection in infectious diseases.
359	en	ti	 Since a high dosage of corticosteroids was widely used in severe SARS patients, many survivors suffered from avascular osteonecrosis with life-long disability and poor life quality. 	 ምውሳድ ልዑል መጠን ኮርቲኮስተሮይድስ(corticosteroids) ኣብ ከቢድ ናይ SARS ሕሙማት ይትግበር ብምንባሩ፣ መብዛሕቲኦም ካብ እቲ ሕማም ዝተረፉ ሰባት ብ ኣቫስኩላር ኦስቲዮኔክሮሲስ(avascular osteonecrosis) ዝበሃል ሕማም ብምጥቃዖም፣ ናይ ዕድመ ልክዕ ናይ ኣካል ጉድኣትን ድኹም ናይ ሂይወት ኰነታትን ኣጋጢሙዎም እዩ። 	Because high doses of corticosteroids were used in severe SARS patients, most survivors developed avascular osteonecrosis, with lifelong disability and poor quality of life.
360	en	ti	 Thus, if needed, steroids should be used at low dosage and for a short time in COVID-19 patients. 	 ስለዚ፡ ኣድላዪ እንተኾይኑ፡ ኣብ ናይ COVID-19 ሕሙማት ስቲርዮድስ ብ ትሑት መጠን ኣብ ጥቕሚ ክውዕሉ ኣለዎ። 	Therefore, steroids should be used in low doses in COVID-19 patients if necessary.
361	en	ti	 Mental stress: As described above, during the COVID-19 outbreak many patients have suffered from extraordinary stress as they often endured long periods of quarantine and extreme uncertainty and witnessed the death of close family members and fellow patients. 	 ናይ ኣዕምሮ ጸቕጢ፡ ኣብ ላዕሊ ከምዝተገለፀ ኣብ እዋን ለበዳ COVID-19 ሰባት ንበይኖም እንትውሸቡን ናይ ቐረባ ዘመድን ሕሙማትን ክሞቱ እንትርእዩን ብዙሓት ሕሙማት ብናይ ኣዕምሮ ጸቕጢ እናተሳቐዩ ይርከቡ። 	Depression: As mentioned above, many patients are suffering from depression during the COVID-19 pandemic when people are isolated and close relatives and patients die.
362	en	ti	 It is imperative to provide psychological counseling and long-term support to help these patients recover from the stress and return to normal life. 	 ነዞም ሕሙማት ካብ ጭንቀት ወጺኦም ናብ ንቡር ሂወቶም ንምምላስ፡ ሰነ-ኣዕምሮኣዊ ምኽሪን ናይ ነዊሕ ጊዜ ድጋፍ ምሃብ ከምዝግባእ ርዱእ እዩ። 	Psychological counseling and long-term support are needed to help these patients recover from depression.
363	en	ti	 According to demographic studies so far, COVID-19 seems to have different epidemiological features from SARS. 	 በመሰረት ዝተኻየዱ ናይ ሰነ-ህዝቢ ጽንዓታት፡ COVID-19 ካብ SARS ዝተፈለየ ናይ ኢፒዲሚዮሎጂካል(epidemiological) መርኣያታት ኣለውዎ። 	According to demographic studies, COVID-19 has epidemiological patterns that are different from SARS.
364	en	ti	 In addition to replicating in the lower respiratory tract, SARS-CoV-2 can efficiently replicate in the upper respiratory tract and causes mild or no symptoms in the early phase of infection, similar to other CoVs that cause common colds. 	 SARS-CoV-2 ካብ ኣብ ታሕተዋይ ናይ መተንፈሲ ኣካል ምርባሕ ብተወሳኺ ልክዕ ከም ሳዓል ዘምፁ ካልኦት CoVs ኣብ ላዕለዋይ ናይ መተንፈሲ ኣካል ብምርባሕ ኣብ እቲ ናይ ፈላማይ ደረጃ ቀሊል ዝበሃል ወይድማ ምንም ዓይነት ምልክት ዘይከርእዩ ይኽእሉ እዮም። 	In addition to multiplying in the lower respiratory tract, SARS-CoV-2 can multiply in the upper respiratory tract just like other CoVs that cause coughing and may show mild or no symptoms in the initial stage.
365	en	ti	 Therefore, infected patients at the early phase or incubation period can produce a large amount of virus during daily activities, causing great difficulty for the control of the epidemic. 	 ስለዚህ፡ እቶም ኣብ ናይ መጀመሪያ ድረጃ ወይድማ ናይ ምፍልፋል ደረጃ ዝርከቡ በቲ ረኽሲ ዝተጠቕዑ ሕሙማት፡ኣብ ዕለታዊ ምንቅስቓሳት ብዙሕ መጠን ዘለዎ ቫይረስ ናይ ምፍራይ ተኸእሎ ዘለዎም ብምዃኖም ነቲ ለበዳ ኣብ ምቁጽጻር ዓብዪ ጸገም ዘስዕቡ እዮም። 	Therefore, patients infected in the early or late stages of the infection are likely to produce large amounts of virus during daily activities, posing a major problem in controlling the outbreak.
366	en	ti	 However, the transmission of SARS-CoV was considered to occur when the patients are severely ill, while most transmission did not happen at the early phase. 	 ይኹን ደኣምበር ናይ SARS-CoV ምምሕልላፍ ሕሙማት ብጽኑዕ ካብ ዝሓመሙ ዝለዓለ እንትኾን ኣብ መጀመርታ ብርኪ ካብ ዘለው ሕሙማት ኣዝዩ ዝነኣሰ እዩ። 	However, the incidence of SARS-CoV transmission is higher in severely ill patients and much lower in early stage patients.
367	en	ti	 Thus, the current outbreak of COVID-19 is much more severe and difficult to control than the outbreak of SARS. 	 ስለዝኾነ ድማ ልዕሊ ለበዳ SARS ናይ COVID-19 ለበዳ ብጣዕሚ ሓደገኛ ምዃኑ ይግለፅ። 	Therefore, the COVID-19 pandemic is more dangerous than the SARS pandemic.
368	en	ti	 Great efforts are currently underway in China including the lockdown of Wuhan and surrounding cities and continuous quarantine of almost the entire population in hopes of interrupting the transmission of SARS-CoV-2. 	 ዉሃንን ከባቢኣን ብምዕፃውን እቲ ህዝቢ ክዉሸብ ብምግባርን ለበዳ SARS-CoV-2 ንምቕናስ ኣብ ቻይና ዝተፈላለዩ ፃዕርታት ኣብ ምክያድ ይርከቡ። 	Various efforts are being made in China to reduce the spread of SARS-CoV-2 by closing Wuhan and its surroundings and quarantined the population.
369	en	ti	 Although these actions have been dramatically damaging the economy and other sectors of the country, the number of new patients is declining, indicating the slowdown of the epidemic. 	 ዋላእኳ እዞም ተግባራት ነቲ ቁጠባን ካልኦት ዘርፍታት ናይ እታ ሃገር ዝጎድኡ እንተኾኑ ናይ ሓደሽቲ ሕሙማት ቁፅሪ ይቕንስ ኣሎ እዚ ድማ እቲ ለበዳ ይቕንስ ምህላዉ ዘመላኽት እዩ። 	Although these practices are damaging the economy and other sectors of the country, the number of new cases is decreasing, indicating that the epidemic is decreasing.
370	en	ti	 The most optimistic estimate is that the outbreak will end by March and the downswing phase will last for 3-4 months. 	 እቲ ለበዳ ኣብ ማርች ከምዘቋርፅን ዉሑድ ቁፅሪ ጉዳያት ለበዳ ድማ ን 3-4 ኣዋርሕ ከምዝፀንሑን ይግመት። 	The outbreak is expected to end in March and a small number of cases are expected to last for 3-4 months.
371	en	ti	 However, some other experts are not that optimistic. 	 ይኹን ደኣምበር፡ ገለ ሰብ ሞያ ክንድዚ ኣወንታዊ ኣይኮኑን። 	However, some professionals are not so positive.
372	en	ti	 Paul Hunter, et al., estimated that COVID-19, which seems substantially more infectious than SARS, will not end in 2020. 	 Paul Hunter, et al., ካብ SARS ዝበኣሰ ዝመስል COVID-19 ኣብ 2020 ኣየብቅዕን ኢሉ ይግምት። 	Paul Hunter, et al., predicts that COVID-19, which appears to be worse than SARS, will not end in
373	en	ti	 Ira Longini, et al., established a model to predict the outcome of the epidemic and suggested that SARS-CoV-2 could infect two-thirds of the global population. 	 Ira Longini, et al., ናይ እቲ ለበዳ ዉፅኢት ንምግማት ዘኽእል ሞዴል ብምስራሕ SARS-CoV-2 ናይ ዓለም ክልተ ሲሶ ህዝቢ ከጥቅዕ ከምዝኽእል ሓቢሩ። 	Ira Longini, et al., developed a model to predict the outcome of the pandemic and said that SARS-CoV-2 could affect two-thirds of the world&#39;s population.
374	en	ti	 A Canadian group reported that SARS-CoV-2 was detected in both mid-turbinate and throat swabs of patients who recovered and left the hospital 2 weeks earlier, which indicates that the newly identified virus could become a cyclical episode similar to influenza. 	 ከም ጸብጻብ ሓደ ናይ ካናዳ ጉጅለ SARS-CoV-2 ኣብ ክልቲኡ ማለት እውን ኣብ ቅድሚ 2 ሰሙን ካብ ሆስፒታል ሓዊዮም ዝወጽኡ ሕሙማት ሚድ-ተርቢኔትን ኣብ ናይ ጉሮሮ መሕጸቢ ፋሳሲን እቲ ቫይረስ ክርከብ ክኢሉ እዩ፡ እዚ ድማ እቲ ሐዚ ሓዱሽ ዝተረኸበ ቫይረስ ሳይክላዊ ከም ኢንፍሉዌንዛ ክኸውን ክምዝኽእል ዘርኢ እዩ። 	According to a Canadian team, SARS-CoV-2 has been detected in both mid-turbinate patients discharged from hospital two weeks earlier and in throat lavage fluids, suggesting that the newly discovered virus may be cyclic like influenza It is a seed.
375	en	ti	 However, promising signs have occurred in China based on the declining number of new cases, indicating the current strategies might have been working. 	 ይኹን ደኣምበር፡ ሓደሽቲ ጉዳያት ኣና ቐነሱ ኣብ ዝመጹሉ፡ ኣብ ቻይና ተስፋ ዝህቡ ምልክታት ኣጋጢሞም እዮም፡ እዚ ድማ እዞም ኣብ እዚ ሐዚ እዋን ዘለዉ ስትራቴጂታት እናሰርሑ ክኾኑ ከምዝኽእሉ ዘርኢ እዩ። 	However, as new cases of ANA have declined, there have been promising signs in China, suggesting that these current strategies may be working.
376	en	ti	 Ebola was originally predicted to cause up to a million cases with half a million deaths. 	 ኢቦላ ኣስታት ሓደ ሚልዮን ጉዳያት ለበዳ ከምዘኸትልን ፍርቂ ሚሊዮን ሞት ከምዘምፅን ተተምቢዩ ኔሩ። 	Ebola was predicted to cause about one million cases and half a million deaths.
377	en	ti	 However, via strict quarantine and isolation, the disease has eventually been put under control. 	 ይኹን ደኣምበር፡ ጽኑዕ ውሸባን ዓርሰ ተነጽሎን፡ እቲ ሕማም ኣብ ቁጽጽር ክውዕል ክኢሉ እዩ። 	However, strict quarantine and self-isolation have brought the disease under control.
378	en	ti	 It is possible, similar to SARS-CoV, that SARS-CoV-2 might become weaker in infectivity and eventually die down or become a less pathogenic virus co-existent with humans. 	 ልክዕ ከም SARS-CoV፡ SARS-CoV-2 እውን ኣብ ረኽሲ ናይ ምሳዓብን ሞት ናይ ምስዓብን ተኽእሎኡ ዝተሓተ ክኸውን እንከሎ ኣብ ከይዲ ምስ ደቂ ሰባት ብሓባር ዝነብር፡ ትሑት ሕማም ናይ ምስዓብ ተኽእሎ ዘለዎ ቫይረስ ክኸውን ይኽእል እዩ። 	Like SARS-CoV, SARS-CoV-2 is less likely to cause infection and death and may be a low-risk virus that coexists with humans in the process.
379	en	ti	 A comparison of the epidemic of COVID-19 with that of SARS and MERS is provided below (Fig. ​(Fig.55). 	 ናይ COVID-19 ለበዳ ምስ SARSን MERS ዘለዎ ንጽጽር ኣብ ታሕቲ ዘሎ (Fig. ​(Fig.55) ቀሪቡ ኣሎ። 	A comparison of the COVID-19 outbreak with SARS and MERS is shown below (Fig. 55).
380	en	ti	 SARS-CoV-2 is highly transmittable through coughing or sneezing, and possibly also through direct contact with materials contaminated by the virus. 	 SARS-CoV-2 ብ ምስዓልን ምህንጣስን ኣዝዩ ተመሓላላፋይ እንትኾን፡ ምስ በቲ ቫይረስ ዝተበከሉ ናውቲታት ዝግበር ቀጠተዊ ዝኾነ ምንኽኻእ እውን ክመሓላለፍ ይኽእል እዩ። 	SARS-CoV-2 is highly transmitted by coughing and sneezing, but can also be transmitted by direct contact with contaminated objects.
381	en	ti	 The virus was also found in feces, which raises a new possibility of feces-to-mouth transmission. 	 እቲ ቫይረስ ኣብ ሰገራ እዉን ብምርካቡ ካብ ሰገራ-ናብ-ኣፍ ናይ ምምሕልላፍ ዓቕሚ ክህልዎ ክመዝኽእል ይሕበር። 	The virus is also found in feces and may have the potential for fecal-to-mouth transmission.
382	en	ti	 A recent study on 138 cases reported that 41% of the cases were possibly caused by nosocomial infections, including 17 patients with other prior diseases and 40 health-care providers. 	 ኣብ 138 ጉዳያት ዝተገበረ ናይ ቀረባ እዋን ጽንዓት ከምዝጸብጸቦ፡ 41% ጉዳያት ብ ኖሶኮሚያል(nosocomial) ረኽሲታት ዝተፈጠሩ ከምዝኾኑን ካብዚኦም ድማ 40 ናይ ጥዕና ክንክን ወሃብቲ ሓዊሱ እቶም 17 ሕሙማት ካልኦት ሕማማት ዘልዉዎም እዮም። 	A recent study of 138 cases reported that 41% of cases were caused by nosocomial infections, of which 17 patients, including 40 health care providers, had other diseases.
383	en	ti	 Thus, great precaution should be used to protect humans, especially health-care providers, social workers, family members, colleagues, and even bystanders in contact with patients or infected people. 	 ስለዚ፡ ደቂ-ሰባት ንምሕላው ብፍላይ ድማ ን ናይ ጥዕና ክንክን ወሃብቲ፡ ማሕበራዊ ሰራሕተኛታት፡ ናይ ቤተሰብ ኣባላት፡ መሳርሕቲን ዋላ ኣብ እቲ ዘይምልከቶም ምስ ሕሙማት ንኽከእ ዘለዎም ሰባት እውን እንትኾነ ንምሕላው ዓብዪ ጥንቃቐ ክግበር ኣለዎ። 	Therefore, great care must be taken to protect human beings, especially health care providers, social workers, family members, colleagues and even those who have to interact with patients where they do not belong.
384	en	ti	 The first line of defense that could be used to lower the risk of infection is through wearing face masks; both the use of surgical masks and N95 respirator masks (series # 1860s) helps control the spread of viruses. 	 ናይ እቲ ረኽሲ ሓደጋ ኣብ ምቕንስ እቲ ከም ናይ መጀመሪያ መሰመር ምክልኻል ኣብ ጥቅሚ ክውዕል ዝኽእል ናይ ገጽ መሸፈኒ ማስክ ፡ናይ መጥባሕቲ ማስክ ይኹን ናይ N95 ናይ መተንፈሲ ማስክታት( series # 1860s) ዝበሃሉ ማስክታት ምግባር እንትኸውን፡ እዚኦም ድማ ናይ እቲ ቫይረስ ዝርጋሐ ንምቁጽጻር ዝሕግዙ እዮም። 	In reducing the risk of the infection the first line of defense is to wear a face mask , surgical mask or N95 respiratory masks( series # 1860s) which help to control the spread of the virus.
385	en	ti	 Surgical face masks prevent liquid droplets from a potentially infected individual from traveling through the air or sticking onto surfaces of materials, where they could be passed on to others. 	 ናይ መጥባሕቲ ገጽ መሸፈኒ ማስክታት ካብ በቲ ረኽሲ ዝተጠቕዐ ሰብ ዝወጽኡ ፈሰስቲ ንጣባት ኣብ ኣየር ከይጎዓዙን ኣብ ናይ ነገራት ገጽ ተጣቢቖም ናብ ካልኦት ሰባት ንከይመሓላለፉ ዝከላኸሉ እዮም። 	Surgical face masks prevent liquid droplets from an infected person from traveling in the air and sticking to the surface of objects and spreading to others.
386	en	ti	 However, only N95 (series # 1860s) masks can protect against the inhalation of virions as small as 10 to 80 nm, with only 5% of the virions being able to penetrate completely; SARS-CoV-2 is similar to SARS-CoV in size and both are approximately 85 nm. 	 ኮይኑ ግና 10 to 80 nm ዝኾኑ ኣናእሽተይ ቫይሮናት ንምክልኻል ዘኽእል N95 (series # 1860s) ማስክ ጥራሕ እዩ። ካብዞም ኣናእሽተይ ቫይሮናት 5% ጥራሕ ነቲ ማስክ ጥሒሶም ክኣተዉ ይኽእሉ። መጠን ክልቲኦም SARS-CoV-2ን SARS-CoVን ከባቢ 85 nm እዩ። 	However, only the N95 (series # 1860s) mask can protect against small viruses of 10 to 80 nm. Only 5% of these small viruses can break through the mask. The size of both SARS-CoV-2 and SARS-CoV is around 85 nm.
387	en	ti	 Since particles can penetrate even five surgical masks stacked together, health-care providers in direct contact with patients must wear N95 (series # 1860s) masks but not surgical masks. 	 ባእታትት እስካብ ሓሙሽተ ናይ መጥባሕቲ ማስክታት ዘሊቖም ናይ ምእታው ተኽእሎ ዘለዎም ብምዃኑ፡ ምስ ሕሙማት ቀጥታዊ ርክብ ዘለዎም ናይ ጥዕና ክንክን ወሃብቲ ናይ መጥባሕቲ ማስክ ከይኮነ N95 (series # 1860s) ማስኪታት ክገብሩ ኣለዎም። 	Because elements have the potential to penetrate up to five surgical masks, health care providers in direct contact with patients should wear N95 (series # 1860s) masks rather than surgical masks.
388	en	ti	 In addition to masks, health-care providers should wear fitted isolation gowns in order to further reduce contact with viruses. 	 ካብ ማስክ ሓሊፉ ናይ ጥዕና ባዓል ሞያታት ንዕዖም ዝምጥን ንፁል ጋዎን ብምኽዳን ናይ እቲ ቫይረስ ምምሕልላፍ ምቕናስ የድሊ። 	In addition to masks, health professionals need to wear appropriate gowns to reduce the transmission of the virus.
389	en	ti	 Viruses can also infect an individual through the eyes. 	 ቫይረሳት ን ሓደ ሰብ ብዓይኒ እዉን ከጥቅዑ ይኽእሉ እዮም። 	Viruses can also infect a person&#39;s eyes.
390	en	ti	 On January 22, 2020, a doctor was infected with SARS-CoV-2 although he wore an N95 mask; the virus might have entered his body through his inflammatory eyes. 	 ኣብ ጃንዋሪ 22፣ 2020 ሓደ ሓኪም ዋላ እኳ N95 ማስክ ተጠቒሙ እንተነበረ ብSARS-CoV-2 ተጠቒዑ። እቲ ቫይረስ ብኢንፍላማቶሪ ኣዒንቲ ኣቢሉ ከምዝኣተወ ይግመት። 	On January 22, 2020, a doctor contracted SARS-CoV-2 despite wearing an N95 mask. The virus is thought to have entered through inflammatory eyes.
391	en	ti	 Thus, health-care providers should also wear transparent face shields or goggles while working with patients. 	 ሕሙም ክሕክሙ ከለዉ ናይ ጥዕና ባዓል ሞያታት ብርሃን ዘእቱ ናይ ገፅ መሸፈኒ ወይድማ መነፀር ክጥቀሙ ይግባእ። 	Health professionals should wear reflective face masks or goggles when treating a patient.
392	en	ti	 For the general public in affected or potentially affected areas, it is highly suggested that everybody wash their hands with disinfectant soaps more often than usual, try to stay indoors for self-quarantine and limit contact with potentially infected individuals. 	 ኣብ ዝተጠቕዑ ቦታታት ንዝነብሩ ህዝቢታት ኢድና ብሳሙና ካብ ዝተለመደ ጊዜ ንላዕሊ ምሕፃብ፣ ኣብ ገዛ ምዉሻብን ምስ ዝተጠቕዑ ሰባት ዘለና ርክብ ምቕናስ ኣድላዪ እዩ። 	People living in affected areas need to wash their hands with soap more often than usual, stay at home and reduce contact with affected people.
393	en	ti	 Three feet is considered an appropriate distance for people to stay away from a patient. 	 ሰባት ካብ ሕሙም ሰለስተ እግሪ ዝኣክል ክርሕቑ ኣለዎም። 	People should stay three feet away from a patient.
394	en	ti	 These actions are effective methods to lower the risk of infection as well as prevent the spread of the virus. 	 እዞም ተግባራት ኢንፌክሽን ናይ ምፍጣር ሓደጋ ንምቕናስን እቲ ሕማም ንከይላበድ ንምክልኻልን ዝጠቕሙ ዉፅኢታዊ መንገድታት እዮም። 	These practices are effective ways to reduce the risk of infection and prevent the disease from spreading.
395	en	ti	 Although SARS-CoV-2 came as a new virus to the human world, its high homology to SARS-CoV as reported on 7 January 2020 should have caused high alert to China based on her deep memory of the SARS outbreak in 2003. 	 ዋላኳ SARS-CoV-2 ንወድሰብ ሓድሽ ቫይረስ እንተኾነ ኣብ 7 ጥሪ 2020 ከምዝተገለፀ ኣብ 2003 ብዘጋጠመ ናይ SARS ለበዳ መሰረት ብምግባር እቲ ቫይረስ ምስ SARS-CoV ዘለዎ ተመሳሳልነት ንቻይና ዓቢ መጠንቀቕታ ክኸዉን ኔሩዎ። 	Although SARS-CoV-2 is a new virus to humans, it was announced on January 7, 2020 that the similarity of the virus to SARS-CoV should have been a major warning to China based on the 2003 SARS outbreak.
396	en	ti	 However, not until 19 January 2020 did the director of the Center of Disease Control of Wuhan comfort the citizens by saying that the novel virus has low contagiousness and limited reproductivity from human to human and that it is not a problem to prevent and contain the disease. 	 ይኹን ደኣምበር፡ እስካብ ጃኑዋሪ 19 2020 ናይ ዉሃን ናይ ሕማም ቁጽጽር ማእኽል ዳይሬክተር ነቶም ዜጋታት እቲ ኖቨል ቫይረስ ትሑት ተዛማትነት ከምዘለዎን ካብ ሰብ ናብ ሰብ ድማ ውሱን ተፋራይነት ከምዘለዎን፡ ንምቁጽጻሩ ድማ ኣጸጋሚ ከምዘይኸውን ሓቢሮም ከረጋግኡዎም ኣይከኣሉን ነይሮም። 	However, as of January 19, 2020, the director of Wuhan&#39;s Center for Disease Control had failed to reassure the citizens that the novel virus had low contagiousness, limited human-to-human reproducibility, and would not be difficult to control.
397	en	ti	 This message remarkably relaxed the alarm of the public, especially when the entire country was preparing for the Spring Festival, and the critical time was missed to contain the disease at its minimal scale in Wuhan. 	 እዚ መልእኽቲ ኣብ እቲ ህዝቢ ዝነበረ ፍርሒ ክቕንስ ጌርዎ እዩ ብፍላይ ድማ እታ መላእ ሃገር ነቲ ናይ Spring Festival (ፅድያ ባዓል) እንትዳሎ እቲ ሕማም ገና ኣብ ዉሃን እንተሎ ንምቁፅፃር ዘኽእል ዝነበረ ወሳኒ ጊዜ ሓሊፉ እዩ። 	The message has eased fears among the public, especially as the entire country prepares for the Spring Festival.
398	en	ti	 The disease control agencies in China may take this hard lesson and make critical improvements in the future. 	 ኣብ ቻይና ዝርከብ ናይ ሕማም ቁፅፅር ኤጀንሲ እዚ ከቢድ ትምህርቲ ቀሲሙ ንቀፃሊ ኣገዳሲ ምምሕያሻት ከምፅእ ይኽእል እዩ። 	The disease control agency in China can learn this hard lesson and make important improvements for the future.
399	en	ti	 For example, these agencies should be (1) more careful when making public announcements as every word counts to citizens and can change their attitude and decisions; (2) more sensitive and reactive to unusual information from clinics rather than waiting for formal reports from doctors or officials; (3) more restrictive to contain a potential epidemic at its early stage rather than attempting to comfort the public; and (4) more often to issue targeted and effective drills to increase the public's awareness about epidemic diseases and to test and improve the response system of the society periodically. 	 ንኣብነት፡ እዞም ኤጀንሲታት(1) ናይ ህዝባዊ መግለጺታት ኣብ ዝህብሉ ሰዓት ብዛዕባ ዝጥቀሙዎም ሕድሕድ ቃላት ክጥንቀቑ ኣለዎም ምኽኒያቱም ናይ ዜጋታት ኣመለኻኽታን ውሳነታትን ክቕይር ዝኽእል ብምዃኑ፡ (2) ስሩዕ ናይ ዶክተራት ወይድማ ናይ ሰበ ስልጣናት መግለጺ ካብ ምጽባይ፡ ተኣፍፍነት ን ተዋሃድነትን ዘለዎም ዘይተለመዱ ናይ ክሊኒክ ሓበሬታት (3) እቲ ለበዳ ኣብ ናይ መጀመሪ ደረጃ እናሃለው ዝግባእ ናይ ምክልኻል ስራሕ ምስራሕ ነቲ ህዝቢ ንምርግጋዕ ካብ ምፍታን (4) ናይ ህዝቢ ብዛዕባ እቲ ለበዳ ዘለዎ ንቕሓትን ግንዛበን ንምዕባይ፡ ንጹር ዝኾኑን ሽቶኦም ዝፍለጡን ኣካይዳታት ብምኽታል፡ ናይ እቲ ማሕበረሰብ ምርመራን መልሲ ወሃቢ ስርዓት ስሩዕ ብ ዝኾነ መንገዲ ምምሕያሽ። 	For example, these agencies must (1) be careful about each word they use when making public statements because they can change citizens&#39; attitudes and decisions; (3) Doing appropriate preventive work while the outbreak is in its early stages rather than trying to stabilize the population; Improving the way.
400	en	ti	 The outbreak of COVID-19 caused by the novel virus SARS-CoV-2 started in the end of December 2019. 	 እቲ ብ SARS-CoV-2 ዝተብሃለ ኖቨል ቫይረስ ዝተበገሰ ናይ COVID-19 ለበዳ ኣብ ዲሰምበር 2019 እዩ ጀሚሩ። 	The COVID-19 pandemic, caused by the novel SARS-CoV-2 virus, began in December
401	en	ti	 In less than two months, it has spread all over China and near 50 other countries globally at the time of this writing. 	 እዚ ፅሑፍ ኣብ ዝፀሓፈሉ እዋን ክልተ ኣዋርሕ ኣብዘይመልአ ጊዜ ኣብ መላእ ቻይናን ናብ ልዕሊ 50 ሃገራትን ተላቢዑ እዩ። 	In less than two months at the time of writing, it has spread across China and to more than 50 countries.
402	en	ti	 Since the virus is very similar to SARS-CoV and the symptoms are also similar between COVID-19 and SARS, the outbreak of COVID-19 has created a sense of SARS recurring. 	 እቲ ቫይረስ ምስ SARS-CoV ተመሳሳሊ ብምዃኑን እቶም ምልክታቱ ድማ ኣብ መንጎ COVID-19ን ኣብ SARS እውን ተመሳሰልቲ ብምዃኖም፡ ናይ COVID-19 ለበዳ ልክዕ ከም ናይ SARS ዓይነት ስምዒት ዝፈጠረ እዩ። 	Because the virus is similar to SARS-CoV and the symptoms are similar between COVID-19 and SARS, the COVID-19 pandemic has a SARS-like feel.
403	en	ti	 However, there are some remarkable differences between COVID-19 and SARS, which are essential for containing the epidemic and treating the patients. 	 ይኹን ደኣምበር ኣብ ሞንጎ COVID-19ን SARSን ነቲ ሕማምን ለበዳን ንምቁጽጻር ዘኽእሉ ኣገደስቲ ኣፍላላይ ይርኣዩ እዮም። 	However, there are important differences between COVID-19 and SARS that allow for the control of the disease and epidemic.
404	en	ti	 COVID-19 affects more elderly individuals than youth and more men than women, and the severity and death rate are also higher in elderly individual than in youth. 	 COVID-19 ካብ መንእሰይ ንላዕሊ ንዓበይቲ፣ ካብ ደቂ ኣንስቲዮ ንላዕሊ ድማ ንደቂ ተባዕቲዮ ዘጥቅዕ እዩ። ናይ እቲ ሕማም ሓደገኛነትን ናይ ሞት መጠንን እዉን ካብ መናእሰይ ኣብ ዓበይቲ ይገድድ። 	COVID-19 affects adults more than young people, and men more than women. The risk and mortality rate of the disease is also worse in adults than in young people.
405	en	ti	 SARS has higher mortality than COVID-19 (10.91% versus 1.44%). 	 SARS ምስ COVID-19 እንትነፃፀር ናይ ሞት መጠኑ (10.91% ኣንጻር 1.44%) ዝለዓለ እዩ። 	SARS has a higher mortality rate (10.91% vs. 1.44%) compared to COVID-1
406	en	ti	 COVID-19 patients transmit the virus even when they are symptomless whereas SARS patients do so usually when they are severely ill, which causes much greater difficulty to contain the spread of COVID-19 than SARS. 	 ናይ COVID-19 ሕሙማት ዋላኳ ምልክት ኣየርእዩ ነቲ ቫይረስ ናይ ምምሕልላፍ ተኽእሎ ኣለዎም ፡ ናይ SARS ሕሙማት ግን ኣዝዮም ኣብ ዝሓሙሉ ጊዜ እዩ እዚ ክኸውን ዝኽእል እዚ ድማ፡ ን COVID-19 ምቁጽጻር ካብ SARS ኣዝዩ ዝኸበደ ንክኸውን ይገብሮ። 	COVID-19 patients are likely to transmit the virus even though they show no symptoms , but this can happen when SARS patients are very sick which, makes controlling COVID-19 much more difficult than SARS.
407	en	ti	 This partially explains why SARS-CoV-2 spread much faster and broader than SARS-CoV. 	 እዚ ድማ SARS-CoV-2 ካብ SARS-CoV ብዝሰፍሐ መጠን ንምንታይ ከምዝመሓላለፍ ዘረድእ እዩ። 	This explains why SARS-CoV-2 is transmitted at a greater rate than SARS-CoV.
408	en	ti	 The regular RNA assay for SARS-CoV-2 can be negative in some COVID-19 patients. 	 እቲ ስሩዕ ናይ SARS-CoV-2 ዝኽነ RNA ኣብ ገለ ናይ COVID-19 ሕሙማት ኣሉታዊ ክኸውን ይኽእል እዩ። 	The regular SARS-CoV-2 RNA may be negative in some COVID-19 patients.
409	en	ti	 On the other hand, cured patients can be positive for the virus again. 	 ብኻልእ ወገን ድማ ዝሓወዩ ሕሙማት ን ኻልኣይ ግዘ እቲ ቫይረስ ክርከቦም ይኽእል እዩ። 	On the other hand, recovered patients may become infected a second time.
410	en	ti	 These findings dramatically increase the risk of virus spreading. 	 እዞም ርካቦታት ብቕጽበት ናይ እቲ ቫይረስ ዝርጋሐ ዝውሰኹ እዮም። 	These findings are added immediately after the spread of the virus.
411	en	ti	 Given such rapid progress in research on COVID-19, several critical issues remain to be solved, as follows: 	 እቶም ዝተገብሩ ቅልጡፋት ናይ CoVID-19 ምርመራታት ብምውሳድ ብዙሓት ወሰንቲ ሽግራት ከምዚ ዝስዕብ ፍታሕ ይጽበዩ ኣለው። 	With the rapid CoVID-19 tests done, many critical problems are awaiting resolution as follows.
412	en	ti	 Where did SARS-CoV-2 come from? 	 SARS-CoV-2 ካበይ ዝመጸ እዩ? 	Where did SARS-CoV-2 come from?
413	en	ti	 Although 96% genetic homolog was found between SARS-CoV-2 and two bat SARS-like CoVs, we still cannot conclude that SARS-CoV-2 is from bats. 	 ዋላኳ ኣብ መንጎ SARS-CoV-2 ን ክልተ ናይ መንካዕ SARS-መሰል CoVs 96% ናይ ጀነቲክ ሆሞሎጎ ዝተረኸቡ እንተኾኑ፡ SARS-CoV-2 ካብ መንካዓት ኢልና ምውሳን ኣይንክእልን። 	Although 96% of genetic homologue was detected between SARS-CoV-2 and two tick SARS-like CoVs, we cannot rule out SARS-CoV-2 from ticks.
414	en	ti	 What animal was the intermediate species to transmit the virus from the original host, say bats, to humans? 	 ነቲ ቫይረስ ካብ ዋና ተሸካሚኡ፡ ማለት እውን ካብ መንካዕ ናብ ሰባት ከም ማእኸላይ መማሓላለፋይ ዝኾነ እንስሳ እንታይ እዩ? 	What is the animal that serves as the medium of transmission of the virus from its main carrier, namely, from ticks to humans?
415	en	ti	 Without knowing answers to #1 and 2, we cannot efficiently cut the transmission, and the outbreak can relapse at any time. 	 ናይ #1ን 2ን መልሲ እንተይፈለጥና እቲ ሕማም ሙሉእ ብሙሉእ ክንዓግቶ ኣይንኽእልን በዚ ምኽንያት ድማ እቲ ለበዳ ካሊእ ጊዜ ተመሊሱ ክመፅእ ይኽእል እዩ። 	Without knowing the answers to #1 and 2, we cannot completely prevent the disease and therefore the outbreak may come back another time.
416	en	ti	 Although molecular modeling and biochemical assays have demonstrated that SARS-CoV-2 binds to ACE2, how exactly does the virus enter the airway cells and cause subsequent pathological changes? 	 ናይ ሞለኪል ሞዴሊንግን ባዮኬሚካል ኣሴይን SARS-CoV-2 ምስ ACE2 ከምዝጣመር ዋላ እንተገለፀ እቲ ቫይረስ ናብ ናይ መተንፈሲ ኣካል ዝርከቡ ዋህዮታት ከመይ ጌሩ ኣቲዩ ፓቶሎጂካል ለዉጥታት የምፅእ? 	How does the virus enter cells in the respiratory tract and cause pathological changes, even though molecular modeling and biochemical assays suggest that SARS-CoV-2 binds to ACE2?
417	en	ti	 Does the virus also bind ACE2-expressing cells in other organs? 	 እቲ ቫይረስ ናይ ACE2-EXPRESSING ወህዮታት እውን ዝሓዘ ድዩ? 	Does the virus also contain ACE2-EXPRESSING cells?
418	en	ti	 Without clear answers to these questions, we cannot achieve fast and accurate diagnosis and effective treatment. 	 ነዞም ሕቶታት ዝወሃብ ግልጺ ዝኾነ መልሲ ኣብዘይተውሃበሉ፡ ቅልጡፍን ምርመራን ስሉጥን ሕክምናን ምግባር ኣይንኽእልን። 	Without clear answers to these questions, we cannot provide prompt, diagnosis, and efficient treatment.
419	en	ti	 How long will the epidemic last? 	 እቲ ለበዳ ክሳብ መዓስ ክጸንሕ ይኽእል? 	How long can the outbreak last?
420	en	ti	 How is the virus genetically evolving during transmission among humans? 	 ካብ ሰብ ናብ ሰብ ኣብ ዝላገበሉ እዋን እቲ ቫይረስ ከመይ ጌሩ ጀነቲካዊ ምዕባለታት የርኢ? 	How does the virus make genetic changes during human-to-human transmission?
421	en	ti	 Will it become a pandemic worldwide, die down like SARS or relapse periodically like the flu? 	 ዓለምለኸዊ ለበዳ ክኽዉን ዶ ይኾን፣ ከም SARS ይጠፍእ ወይድማ ከም ኢንፍሉዌንዛ ሓልሓሊፉ ዝኽሰት ይኸዉን? 	Will it become a global pandemic, disappear like SARS or become occasional like influenza?
422	en	ti	 It is essential but may take some time to search for answers to the above and many other questions. 	 ኣገዳሲ ዋላ እንተኾነ ነዞም ኣብ ላዕሊ ዘለዉን ካልኦት ሕቶታትን ንምምላስ ዘድልዩ መፅናዕቲ ንምክያድ ግዜ ከድሊ እዩ። 	Important as it is, time will be needed to conduct the research necessary to answer the above and other questions.
423	en	ti	 However, with whatever expense it may demand, we have no other choice but to stop the epidemic as soon as possible and bring our life back to normal. 	 ይኹን ደኣምበር፡ ዝሓቶ ዝኾነ ይኹን ወጻኢ ወጺኡ፡ ነዚ ለበዳ ብ ዝተኽኣለ መጠን ኣብ ዝሓጸረ ጊዜ ጠጠው ኣቢልናዮ ናብ ልሙድ ሂወትና ክንምለስ ካብ ምግባር ካልእ ኣማራጺ የብልናን። 	However, we have no choice but to stop the epidemic as soon as possible and return to normal life at all costs.
424	en	ti	 Zoonotic origins of human coronaviruses 	 ናይ ደቂ ሰባት ኮሮናቫይረስ ዙኖቲካዊ መበቆል 	The zoonotic origin of human coronaviruses
425	en	ti	 Mutation and adaptation have driven the co-evolution of coronaviruses (CoVs) and their hosts, including human beings, for thousands of years. 	 ንኣሽሓት ንዝቑጸሩ ዓመታት ብምኽንያት ሚዩቴሽንን ምልማድን ንወድሰብ ሓዊሱ ናይ ኮሮና ቫይረሳትን(CoVs) መጸግዒታቶምን ዝግመት ለውጢ ኣምጽዮም እዮም። 	Over thousands of years, mutations and adaptations have brought about predictable changes in humans, including coronaviruses (CoVs) and their hosts.
426	en	ti	 Before 2003, two human CoVs (HCoVs) were known to cause mild illness, such as common cold. 	 ቕድሚ 2003 ክልተ ናይ ሰባት CoVs (HCoVs) ከም ሰዓል ዘበለ ማእኸላይ ሕማም ከምዘስዕቡ ይፍለጥ። 	Prior to 2003, two human CoVs (HCoVs) were known to cause moderate diseases such as influenza.
427	en	ti	 The outbreaks of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) have flipped the coin to reveal how devastating and life-threatening an HCoV infection could be. 	 ናይ ከቢድ ህጹጽ ናይ ስርዓተ ምትንፋስ ሲንድረም (SARS) ለበዳን ናይ ማእኸላይ ምብራቕ ስርዓት ምስትንፋስ (MERS) ለበዳን ናይ HCoV ረኽሲ ክንደየናይ ንህይወት ኣስጋኢ ከምዝኾነ ከርእዩና ክኢሎም ኣለዉ። 	The Severe Acute Respiratory Syndrome (SARS) outbreak and the Middle East Respiratory Syndrome (MERS) outbreak have shown us how life-threatening HCoV infection can be.
428	en	ti	 The emergence of SARS-CoV-2 in central China at the end of 2019 has thrusted CoVs into the spotlight again and surprised us with its high transmissibility but reduced pathogenicity compared to its sister SARS-CoV. 	 SARS-CoV-2 ብኣቆጻጽራ ኣውሮፓ ኣብ መፈጸምታ 2019 ኣብ ማእኸላይ ቻይና ብምርካቡ CoVታት ኣብ ኣተኩሮኣትዮም ነይሮም። CoVs ልዑል ናይ ምምሕልላፍ ክእለት ዋላ’ኳ እንተለዎ ካብ SARS-CoV ግን ዝተሓተ ናይ ሕማም ተኽእሎ የርእይ። 	SARS-CoV-2 was detected in central China in late 2019 and CoVs were in the spotlight. CoVs show a lower disease potential than SARS-CoV, although they have a high transmissibility.
429	en	ti	 HCoV infection is a zoonosis and understanding the zoonotic origins of HCoVs would serve us well. 	 HCoV ረኽሲ ዙኖሲስ እንትኸውን ናይ HCoVs ዙኖቲክ መበቆል ምርዳእ ድማ ብዝግባእ ዝጠቕመና እዩ። 	HCoV is a zoonotic infection and understanding the zoonotic origin of HCoVs is in our best interest.
430	en	ti	 Most HCoVs originated from bats where they are non-pathogenic. 	 መብዛሕትኦም HcoVታት ካብ ለዃኺቶታት ዝመጹ ኮይኖም ሕማም ዘስዕቡ ድማ ኣይኮኑን። 	Most HcoVs are infectious and do not cause disease.
431	en	ti	 The intermediate reservoir hosts of some HCoVs are also known. 	 እቶም መንጎኛ መሕደሪ ናይ HCoVs እውን ፍሉጣት እዮም። 	The intermediate residences of HCoVs are also well known.
432	en	ti	 Identifying the animal hosts has direct implications in the prevention of human diseases. 	 ናይ እንስሳ ፍልፍል ምፍላጥ ናይቲ ሕማም ምክልኻል ኣብ ምርካብ ዓብዪ እጃም ይጻወት። 	Detection of the animal source plays an important role in obtaining immunity.
433	en	ti	 Investigating CoV-host interactions in animals might also derive important insight on CoV pathogenesis in humans. 	 ናይ CoV ቫይረስ ተጠቃዕቲ ምስ እንስሳት ዝነብሮም ርክብ ምጽናዕን ምምርማርን ዝሓሸ መረዳእታ ምምሕልላፍ ነቲ ሕማም ንምርካብ ይሕግዝ። 	Studying and examining the interactions of CoV infected people with animals helps to transmit better data to help detect the disease.
434	en	ti	 In this review, we present an overview of the existing knowledge about the seven HCoVs, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission. 	 ኣብዚ ምርምር ኣብቶም ሸውዓተ HCoVs ዘለና ፍልጠት ብመሰረት ናይ ረኸበ ታሪኽን ካብ እንስሳት ናብ ሰባት ናይ ምምሕልላፍ ኩነትን ነጠቓልል። 	In this investigation we summarize our knowledge on the seven HCoVs according to acquisition history and animal-to-human transmission status.
435	en	ti	 Importantly, we compare and contrast the different HCoVs from a perspective of virus evolution and genome recombination. 	 ብቐንዲ ድማ ናይ ዝተፈላለዩ ዓይነታት HCoVs ብመንጽር ዝግመት ለውጢ ቫይረስን ናይ ጀኖም ጥምረትን ዘለዎም ምምስሳልን ምፍልላይን ንጠቅስ። 	We mainly mention the similarities and differences of different types of HCoVs in terms of predictable changes in virus and genomic cohesion.
436	en	ti	 The current CoV disease 2019 (COVID-19) epidemic is discussed in this context. 	 አዚ ግዜኣዊ CoV ሕማም 2019 (COVID-19) ለበዳ ኣብ እዚ ሓሳብ እዚ ምይይጥ ተገይርዎ እዩ። 	This temporary CoV disease 2019 (COVID-19) pandemic has been discussed in this context.
437	en	ti	 In addition, the requirements for successful host switches and the implications of virus evolution on disease severity are also highlighted. 	 ብተወሳኺ፣ ንዕውት ካብ መሕደሪ ናብ መሐደሪ ምስግጋርን ናይ እዚ ቫይረስ ዕብየት ኣብ እቲ ናይ ሕማም ከቢድነት ብዛዕባ ዘስዕቦ ጽልዋ እውን ትኹረት ተዋሂቡዎም እዩ። 	In addition, attention was also paid to successful transition from residence to residence and the impact of the growth of the virus on the severity of the disease.
438	en	ti	 Coronaviruses (CoVs) belong to the family Coronaviridae, which comprises a group of enveloped, positive-sensed, single-stranded RNA viruses. 	 ኮሮና ቫይረስ(CoVs) ምስ Coronaviridae(ኮሮናቫይሬድ) ዝበሃል ዓሌት ይምደብ። Coronaviridae ድማ enveloped(ዝተዓሸጉ)፣ positive-sensed(ፖዘቲቭ ሴንስድ)፣ single-stranded(ነጸላ ቅርንጫፍ ዘለዎም) ዝበሃሉ ናይ RNA ቫይረስ ጉጅለታት የጠቓልል። 	Coronaviruses(CoVs) belong to the genus Coronaviridae(coronaviruses). Coronaviridae includes enveloped, positive-sensed, and single-stranded RNA virus groups.
439	en	ti	 These viruses harbouring the largest genome of 26 to 32 kilobases amongst RNA viruses were termed “CoVs” because of their crown-like morphology under electron microscope. 	 እዞም ቫይረሳት ካብ 26 ክሳብ 32 ኪሎ ቤዝ ዝኸውን ዓብዪ ጂኖም ዝሕዙን ብዓይኒ ዘይረኣዩ ትሃዋስያን ኮይኖም ብምኽንያት ኣብ ትሕቲ ኤሌክትሮን ማይክሮስኮብ ዘርእዩዎ ዘውዲ መሰል ቕርጺ “CoVs” ብምባል ይጽውዑ። 	These viruses contain a large genome of 26 to 32 kilobases and are invisible to the naked eye.
440	en	ti	 Structurally, CoVs have non-segmented genomes that share a similar organization. 	 ብ መንጽር ኣካላዊ ቅርጺ፣ CoVs ተመሳሳሊ ስርዓት ኣወዳድባ ዝውንኑ ዘይተኸፋፈሉ ጀኖማት ኣለዉዎም። 	In terms of physical structure, CoVs have unsegmented genomes that possess similar organizational systems.
441	en	ti	 Approximately two thirds of the genome contain two large overlapping open reading frames (ORF1a and ORF1b), which are translated into the pp1a and pp1ab replicase polyproteins. 	 ብግምት ክልተ ሰለስታዊ ናይ እዚ ጄኖም ክልተ ዓበይቲ ተደራረብቲ ክፍቲ ተነበብቲ ፍሬማት (ORF1a ን ORF1b ን) ኣለውዎም፣ እዚኦም ድማ ናብ pp1a ን pp1ab ን ሪፕሊኬዝ ፖሊፕሮቲናት ዝትርጎሙ እዮም። 	Approximately two thirds of this genome have two large overlapping open reading frames (ORF1a and ORF1b ), which are translated into pp1a and pp1ab replicase polyproteins.
442	en	ti	 The polyproteins are further processed to generate 16 non-structural proteins, designated nsp1~16. 	 እቶም ፖሊፕሮቲናት nsp1~16 ዝበሃል በዓል 16 ዘይተዋቐሩ ፕሮቲናት ከምርቱ ይግበሩ። 	The polyproteins are made to produce 16 unstructured proteins called nsp1~1
443	en	ti	 The remaining portion of the genome contains ORFs for the structural proteins, including spike (S), envelope (E), membrane (M) and nucleoprotein (N). 	 እቲ ዝተረፈ ክፋል ናይ እቲ ጄኖም፣ spike (S)፣envelope (E)፣membrane (M)ን nucleoprotein (N) ሓዊሱ ነቶም ቅርጻዊ ፕሮቲናት ORF ዝወስድ እዩ። 	The remaining part of the genome, including spike (S),envelope (E),membrane (M) and nucleoprotein (N) carries the ORF for the structural proteins.
444	en	ti	 A number of lineage-specific accessory proteins are also encoded by different lineages of CoVs. 	 ብዙሓት ናይ ዓሌታዊ-መሰረት ዘለዎም መበቆል ፕሮቲናት እውን ብዝተፈላለዩ ናይ CoVs ዓሌታት ሓበሬታት ዝተመልኡ እዮም። 	Many species-based origin proteins are also populated with information on different species of CoVs.
445	en	ti	 Based on the difference in protein sequences, CoVs are classified into four genera (alpha-CoV, beta-CoV, gamma-CoV and delta-CoV), among which the beta-CoV genera contains most HCoVs and is subdivided into four lineages (A, B, C and D). 	 ኣብ ናይ ፕሮቲን መስርዕ ኣፈላላይ ብምምርኳስ CoVs ኣብ ኣርባዕተ (alpha-CoV, beta-CoV, gamma-CoVን delta-CoVን) ይኽፈሉ። ካብዚኣቶም beta-CoV መብዛሕትኦም HCoVs ዝሕዝ ኮይኑ ኣርብዕተ ክፍልታት (A, B, C and D) ኣልዎም። 	Based on protein sequence differences, CoVs are divided into four (alpha-CoV, beta-CoV, gamma-CoV and delta-CoV). Among them, beta-CoV contains most HCoVs and has four classes (A, B, C and D).
446	en	ti	 Phylogenetic evidence has shown that bats and rodents serve as the gene source of most alpha-CoVs and beta-CoVs, while birds are the main reservoir of gamma-CoVs and delta-CoVs. 	 ፓይሎጀኒክ መረዳእታ ለዃኺቶታትን ኣንጭዋታትን ናይ መብዛሕትኦም ኣልፋ-CoVs ን ቤታ -CoVs ን ጂን ምንጪታት እዮም፣ ኣዕዋፍ ድማ ናይ ጋማ-CoVs ን ደልታ-CoVs ዋና መሕደሪታት እየን። 	Pylogenetic Data Mice and rodents are the gene sources for most alpha-CoVs and beta -CoVs, and birds are the principal hosts for gamma-CoVs and delta-CoVs.
447	en	ti	 For thousands of years, CoVs have constantly crossed species barriers and some have emerged as important human pathogens. 	 ንኣሽሓት ዓመታት፣ CoVs ናይ ዓሌታት ገደባት ጥሒሱ ሓሊፉ እዩ ሓደሓዲኦም ድማ ከበድቲ ኣብ ደቂ ሰባት ሕማም ከስዕቡ ዝኽእሉ ኮይኖም መጺኦም ኣለዉ። 	For thousands of years, CoVs have crossed species boundaries and some have become seriously pathogenic in humans.
448	en	ti	 To date, seven human CoVs (HCoVs) are known. 	 ክሳብ ሎሚ፣ ሸውዓተ ናይ ደቂ ሰባት CoVs (HCoVs) ተፈሊጦም ኣለዉ። 	To date, seven human CoVs (HCoVs) have been identified.
449	en	ti	 Among them HCoV-229E and HCoV-NL63 are alpha-CoVs. 	 ካብኣቶም ድማ HCoV-229E ን HCoV-NL63 ን alpha-CoVs እዮም። 	Among them are HCoV-229E and HCoV-NL63, the alpha-CoVs.
450	en	ti	 The other five beta-CoVs include HCoV-OC43, HCoV-HKU1, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-2. 	 እቶም ካልኦት ሓሙሽተ ቤታ-CoVs በዓል HCoV-OC43, HCoV-HKU1፣ ከቢድ ህጹጽ ናይ ስርዓት ምትንፋስ ሲንድረም (SARS-CoV)፣ ናይ ማእኸላይ ምብራቕ ናይ ስርዓተ ምትንፋስ ሲንድረም ኮሮናቫይረስ (MERS-CoV) ከምኡውን SARS-CoV-2 የጠቓልሉ። 	The other five beta-CoVs include HCoV-OC43, HCoV-HKU1, Severe Acute Respiratory Syndrome (SARS-CoV), Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) and SARS-CoV-2
451	en	ti	 HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63 usually cause mild symptoms, like common cold and/or diarrhea. 	 HCoV-229E፣ HCoV-OC43፣ HCoV-HKU1 ከምኡ'ውን HCoV-NL63 መብዛሕትኡ ግዜ ከም ሰዓል ከምኡ'ውን/ወይድማ ተቕማጥን ዝኣምሰሉ ቀለልቲ ምልክታት ሕማም የኸትሉ። 	HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63 usually cause mild symptoms such as fever and/or diarrhea.
452	en	ti	 In contrast, SARS-CoV, MERS-CoV and the newly-identified SARS-CoV-2 are highly pathogenic, causing severe lower respiratory tract infection in relatively more patients with a higher chance to develop acute respiratory distress syndrome (ARDS) and extrapulmonary manifestations. 	 ምስ SARS-CoV፣ MERS-CoV ከምኡውን ምስቲ ሓድሽ ዝተረኸበ SARS-CoV-2 ክነጻጸር ከሎ ኣዝዩ ልዑል ሕማም ናይ ምስዓብ ዓቕሚ ኣለዎ፣ ከቢድ ናይ ታሕተዋይ መተንፈሲ ኣካላት ረኽሲ ብምስዓብ መብዛሕትኦም ሰባት ድማ ናይ ከቢድ ናይ ስርዓተ ምትንፋስ ዲስትረስ ሲንድረም (ARDS) ከምኡውን ካብ ሳንባ ወጻኢ ናይ ሕማም ምልክታት ናይ ምርኣይ ዕድሎም ሰፊሕ እዩ። 	Compared to SARS-CoV, MERS-CoV and the newly discovered SARS-CoV-2, it has a very high morbidity, causing severe lower respiratory tract infections and most people develop severe respiratory distress syndrome (ARDS) and from the lungs They are more likely to show external symptoms.
453	en	ti	 The first HCoV-229E strain, B814, was isolated from the nasal discharge of patients with common cold in mid-1960s. 	 B814 ዝበሃል እቲ ናይ መጀመርያ HCoV-229E ዘርኢ ኣብ መፋርቕ 1960 ካብ ናይ ሰዓል ሕሙም ንፋጥ ተረኺቡ። 	B814, the first HCoV-229E strain, was recovered in the mid-1960s from febrile patient sputum.
454	en	ti	 Since then, more knowledge was accumulated through extensive studies on HCoV-229E and HCoV-OC43, both of which cause self-limiting symptoms. 	 ካብኡ ንዳሓር ኣብቶም ክልተ ዓርሰ ውሱንነት ምልክታት ዘስዕቡ ቫይረሳት HCoV-229Eን HCoV-OC43ን ብዝተገብረ ዓሙቕ መፅናዕቲ ብዙሕ ግንዛበ ክእከብ ተኻኢሉ እዩ። 	Since then, much insight has been gathered through in-depth studies on the two self-limiting symptomatic viruses, HCoV-229E and HCoV-OC43.
455	en	ti	 Indeed, the concept had been widely accepted that infection with HCoVs is generally harmless until the outbreak of SARS. 	 ቅድሚ ለበዳ SARS ምፍጣሩ ብ HCoVs ዝመፅእ ሕማም ጎዳኢ ከምዘይኮነ ይእመን ኔሩ። 	Before the SARS epidemic, disease caused by HCoVs was believed to be harmless.
456	en	ti	 The SARS outbreak occurred in 2003 is one of the most devastating in current history, infecting over 8,000 people with a crude case fatality of approximately 10%. 	 እቲ ኣብ ታሪክ ዝኸፍእ ናይ SARS ለበዳ ኣብ 2003 ተኸሲቱ። በዚ ምኽንያት ድማ ልዕሊ 8,000 ሰባት ተጠቒዖም፤ ካብኦም ድማ 10% ሞየቶም። 	The worst SARS outbreak in history occurred in As a result, more than 8,000 people were affected; Of these, 10% died.
457	en	ti	 Ten years later, the Middle East respiratory syndrome (MERS) outbreak resulted in a persistent epidemic in the Arabian Peninsula with sporadic spreading to the rest of the world. 	 ድሕሪ ዓሰርተ ዓመታት፣ ናይ ማእኸላይ ምብራቕ ስርዓተ ምስትንፋስ ሲንድረም (MERS) ጎንፊ ኣብ ዓረብ ፔኒንሱላ ቀጻላይ ዝኾነ ለበዳ ብምስዓብ፡ ናብ ዝተረፈ ዓለም ድማ ሓሓሊፉ ተዛሚቱ እዩ። 	Ten years later, the Middle East Respiratory Syndrome (MERS) epidemic followed a continuing outbreak in the Arabian Peninsula, and spread occasionally to the rest of the world.
458	en	ti	 The 2019 novel HCoV (2019-nCoV), which has subsequently been renamed SARS-CoV-2, is the causative agent of the ongoing epidemic of coronavirus disease 2019 (COVID-19), which has claimed more than 3,120 lives and infected more than 91,000 people as of March 3, 2020. 	 ኣብ 2019 ዝትርኣየ HCoV (2019-nCoV) SARS-CoV-2 ብምባል ዝተሰየመ ናይዚ ሕጂ ዘሎ ናይ ኮሮና 2019(COVID-19) ሕማም ክሳብ መጋቢት 3, 2020 ናይ ልዕሊ 3,120 ሰባት ሂወት ዝወሰደን ልዕሊ 91,000 ሰባት ዘጥቀዐ ዝኾነ ሕማም መልዓሊ እዩ። 	The 2019 HCoV (2019-nCoV) named SARS-CoV-2 is the trigger of the current coronavirus 2019(COVID-19) pandemic that has claimed the lives of more than 3,120 people and infected more than 91,000 as of March 3,
459	en	ti	 The alarm has been ringing and the world has to prepare for the coming pandemic of SARS-CoV-2. 	 ደወል ተደዊሉ’ሎ ዓለም ድማ ን ናይ SARS-CoV-2 ለበዳ ሕማም ክትዳሎ ኣሎዋ። 	The bell has been rung and the world must prepare for the SARS-CoV-2 pandemic.
460	en	ti	 All seven HCoVs have a zoonotic origin from bats, mice or domestic animals. 	 ኩሎም ሸውዓት ዓይነታት HCoVs ካብ ከም ሎዃኺቶ፣ ኣንጭዋን ካልኦት አንስሳት ዘቤት ዝመጹ እዮም። 	All seven strains of HCoVs come from pets such as rats, mice and other domestic animals.
461	en	ti	 Multiple lines of evidence support an evolutionary origin of all HCoVs from bats, where viruses are well adapted and non-pathogenic but show great genetic diversity. 	 ብዙሓት ናይ መረጋገጺ መስመራት ናይ ኩሎም HCoVs ዝግመታዊ ለውጢ ኣመጻጽኣ ካብ ለዃኺቶ ምዃኑ ዘርእዩ እዮም፣ እቶም ቫይረሳት ድማ ብኣግባቡ ዝተላመዱን ሕማም ዘየስዕቡ ኮይኖም ግን ሰፊሕ ጀነቲካዊ ፍልልይ ዘርእዩ እዮም። 	Multiple confirmation lines of all HCoVs show a presumed tick origin, and the viruses are appropriately adapted and non-pathogenic but exhibit wide genetic variation.
462	en	ti	 The COVID-19 epidemic has presented enormous medical, scientific, social and moral challenges to China and the world. 	 ናይ ኮቪድ-19 ለበዳ ዓብዪ ሕክምናውን፣ ስነፍልጠታዊን/ሳይንሳዊን፣ ማሕበራዊን፣ ከምኡ'ውን ሞራላዊን ማሕለኻታት ኣብ ቻይና ኣብ ዓለምን ኣምጺኡ እዩ። 	The COVID-19 pandemic has brought major medical, scientific, social, and moral challenges in China and around the world.
463	en	ti	 Tracing the zoonotic origins of HCoVs provides a framework to understand the natural history, driving force and restriction factors of species jumping. 	 ናይ HCoVs ዙኖቲክ መበቆላት ንምክትታል ናይ ተፈጥሮኣዊ ታሪክ፣ ዘንቀሳቕሶ ዘሎ ሓይሊን ናይ ዓሌታት ገደብ ምኽንያታት ምርዳእ የድሊ። 	Tracking the zoonotic origins of HCoVs requires an understanding of the natural history, driving forces and species limiting factors.
464	en	ti	 This might also guide or facilitate the search for the reservoir, intermediate and amplifying animal host(s) of SARS-CoV-2, with important implications in the prevention of future spillovers. 	 እዚ ድማ ነቶም መሕደሪ እቲ ቫይረስ ዝኾኑ፡ኣብ መንጎ ዝርከቡን ኣባዛሕቲ ዝኾኑ መሕደሪ(ታት) ናይ SARS-CoV-2 ዝኾኑ እንስሳት ንምርካብ ኣብ ዝግበር ኣለሻ ክመርሕን ከሳልጥን እውን ዝኽእል እዩ፣ ፣ ን ቀጸልቲ ካብ እንስሳት ናብ ሰባት ብምምሕልላፍ ከጋጥሙ ዝኽእሉ ጎንፊታት/ለበዳታት ኣብ ምክልኻል ድማ ጠቐምቲ ኣንፈታት ዘለዎ እዩ። 	This can also lead and facilitate the search for animals that are the host, intermediate and reproductive host(s) of SARS-CoV-2, , in preventing further outbreaks/outbreaks that may occur from animal to human transmission and has useful directions.
465	en	ti	 In this review we present an overview of the zoonotic origins, interspecies transmission and pathogenesis of HCoVs. 	 ኣብ እዚ ክለሳ ናይ HCoVs እንስሳዊ መበቆል፣ ኣብ መንጎ ዓሌታት ዝህሉ ምምሕልላፍን ሕማም ናይ ምምጻእ ዓቕምን ዝድህስስ ርኢቶ ክነቕርብ ኢና። 	In this review we will provide an overview of HCoVs animal origin, interspecies transmission and disease-causing potential.
466	en	ti	 Particularly, we highlight and discuss the common theme that parental viruses of HCoVs are typically non-pathogenic in their natural reservoir hosts but become pathogenic after interspecies transmission to a new host. 	 ብፍላይ፣ ብዛዕባ እቶም ናይ HCoV ዓሌታዊ ቫይረሳት ፍልይ ብዝበለ መልክዑ ኣብቲ ልሙድ መሕደሪኦም ሕማም ዘየስዕቡ ምዃኖምን ኣብ መንጎ ዓሌታት ኣብ ዝህሉ ምምሕልላፍ ግን ሕማም ዘስዕቡ ከምዝኾኑ ትኹረት እንህበሉን ንመያየጠሉን እዩ። 	In particular, we focus on and discuss the fact that the HCoV strains of viruses are uniquely non-pathogenic in their usual habitat but pathogenic in inter-strain transmission.
467	en	ti	 We also review the trend of HCoV evolution in which the increase in transmissibility often comes with the decrease in pathogenicity. 	 ከይዲ ናይ HCoV ዝግመታዊ ኣመጻጽኣ ከይዲ ዝምልከት፡ማለት እውን መብዛሕቲኡ ግዜ ሕማም ናይ ምስዓብ ተኽእሎ ምቕናስ ምስ ወሰኽ ናይ ምምሕልላፍ ተኽእሎ ከምዝመጽእ እውን ንድህስስ ኢና። 	We also explore the process of HCoV hypothesized origin process, that is, that a decrease in the likelihood of disease following usually comes with an increase in the likelihood of transmission.
468	en	ti	 The outcome of the ongoing SARS-CoV-2 outbreak is also discussed in this context. 	 ናይዚ ቀጻሊ SARS-CoV-2 ለበዳ ውጽኢት እውን ኣብዚ ሓሳብ እዚ ምይይጥ ተገይርዎ እዩ። 	The implications of this ongoing SARS-CoV-2 epidemic were also discussed in this context.
469	en	ti	 Animal CoVs have been known since late 1930s. 	 ናይ እንስሳት CoVs ካብ መወዳእታ 1930 ጀሚሮም ፍሉጣት እዮም። 	Animal CoVs have been known since the late 1930s.
470	en	ti	 Before the first isolation of HCoV-229E strain B814 from the nasal discharge of patients who had contracted common cold, different CoVs had been isolated in various infected animals, including turkey, mouse, cow, pig, cat and dog. 	 ቅድሚ እቲ ናይ መጀመርታ ዓይነት HCoV-229E ዝኾነ B814 ካብ ሰዓል ዝሓመመ ሰብ ንፋጥ ምርካቡ፣ ዝተፈላለዩ ኮሮና ቫይረሳት ካብ ዝተፈላለዩ ዝተለኽፉ እንስሳት ከም ታኪን፣ ኣንጭዋ፣ ላሕሚ፣ ድሙን ከልብን ተረኺቦም ኔሮም'ዮም። 	Before the first HCoV-229E strain, B814, was found in the sputum of a person with a cold, various coronaviruses had been found in infected animals such as chickens, ducks, cows, donkeys and dogs.
471	en	ti	 In the past decades, seven HCoVs have been identified. 	 ኣብዘን ዝሓለፉ ዓሰርተታት ዓመታት፣ ሸውዓተ HCoVs ተፈሊጦም ኣለዉ። 	Over the past decades, seven HCoVs have been recognized.
472	en	ti	 A brief summary of the history of HCoV discovery in chronological order (Table ​1) would be informative and instructive. 	 ሓጺር መጠቓለሊ ታሪኽ ኣመጻጽኣ HCoV ብቕደም ሰዓብ (ሰንጠረዥ 1) ሓባሪን መሃሪን ይኸውን። 	A brief summary of the origin history of HCoV is informative and informative, respectively (Table 1).
473	en	ti	 The first HCoV-229E strain was isolated from the respiratory tract of patients with upper respiratory tract infection in the year of 1966, and was subsequently adapted to grow in WI-38 lung cell lines. 	 እቲ ናይ መጀመርያ HCoV-229E ዘርኢ ኣብ 1966 ካብ ናይ ላዕለዋይ ኣካል መተንፈሲ ኣካላት ዝሓመሙ ሰባት ዝተወሰደ እዩ፣ ድሕሪኡ ግን ተላሚዱ ኣብ ናይ ሳንባ ዋህዮ መስመራት WI-38 ክዓቢ ተገይሩ እዩ። 	The first HCoV-229E strain was derived from upper-body respiratory tract patients in 1966, but has subsequently been adapted and grown in the lung cell lines WI-38.
474	en	ti	 Patients infected with HCoV-229E presented with common cold symptoms, including headache, sneezing, malaise and sore-throat, with fever and cough seen in 10~20% cases. 	 እቶም ብ HCoV-229E ዝተለኸፉ ሕሙማት ኣብቶም ካብ 10~20% ዝኾኑ ጉዳያት ለበዳ፡ ን ሕማም ርእሲ ፣ ምህንጣስ፣ ናይ ሕማም ስምዒትን ናይ ጎሮሮ ቃንዛን፣ ረስኒን ሰዓልን ዘጠቓልሉ ልሙዳት ናይ ሰዓል ምልክታት ዘርእዩ እዮም። 	Patients infected with HCoV-229E in 10~20% of the outbreak cases present with typical febrile symptoms including headache , dyspnea, feeling of sickness and sore throat, nausea and fever.
475	en	ti	 Later in 1967, HCoV-OC43 was isolated from organ culture and subsequent serial passage in brains of suckling mice. 	 ኣብ 1967፣ HCoV-OC43 ካብ ናይ ኦርጋን ካልቸr ተረኺቡ ድሕሪኡ ድማ ኣብ ናይ ኣንጭዋ ሓጎል ተረኺቡ። 	In 1967, HCoV-OC43 was isolated from organ cultures and subsequently in mouse brains.
476	en	ti	 The clinical features of HCoV-OC43 infection appear to be similar to those caused by HCoV-229E, which are symptomatically indistinguishable from infection with other respiratory tract pathogens such as influenza A viruses and rhinoviruses. 	 ክሊኒካዊ ዝርአ ረኽሲ ናይ HCoV-OC43 ምስ HCoV-229E ተመሳሳሊ ዝኾነ ምልክታት ሕማም ኣለዎም። እዚኦም ድማ ካብ ካልኦት ናይ ስርዓተ ምትንፋስ ረኽስታት ዘስዕቡ ከም ኢንፍሉዌንዛ ኤን ራይኖቫይረስ ዝመሳስሉ ቫይረሳት ዝተፈለየ ናይ ሕማም ምልክት የብሎምን። 	Clinically visible infections of HCoV-OC43 have clinical manifestations similar to HCoV-229E. These have no illness symptoms unlike other viruses that cause respiratory infections, such as influenza N rhinoviruses.
477	en	ti	 Both HCoV-229E and HCoV-OC43 are distributed globally, and they tend to be predominantly transmitted during the season of winter in temperate climate. 	 HCoV-229E ን HCoV-OC43 ን ብዓለም ለኸ ተሰራጭዮም፣ ኣብዚ ናይ ሓገይ ወቕቲ ኣብ ደጉዓዊ ነባሪ ኣር ኣብ ዘሎሉ ብሰፊሑ ክስፋሕፍሑ ይረኣዩ። 	HCoV-229E and HCoV-OC43 have spread internationally, and appear to be widespread this summer in the presence of resident R in the desert.
478	en	ti	 Generally, the incubation time of these two viruses is less than one week, followed by an approximately 2-week illness. 	 ብሓፈሻ፣ ናይ እዞም ክልተ ቫይረሳት መጫጭሒ ግዘ ትሕቲ ሓደ ሰሙን እዩ፣ ቀጺሉ ድማ ዳርጋ ናይ 2-ሰሙን ሕማም ይስዕብ። 	In general, the incubation period of these two viruses is less than a week, followed by an illness of almost 2 weeks.
479	en	ti	 According to a human volunteer study, healthy individuals infected with HCoV-229E developed mild common cold. 	 ኣብ ፍቓደኛታት ውልቀሰባት ዝተገብረ ምርምር፡ ብ HCoV-229E ዝተጠቕዑ ሰባት ቅልል ዝበለ ናይ ሰዓል ምልክታት ከምዝነበሮም የረድእ። 	In consenting individuals, subjects infected with HCoV-229E had mild febrile symptoms.
480	en	ti	 Only a few immunocompromised patients exhibited severe lower respiratory tract infection. 	 ካብቶም ሕማም ናይ ምክልኻል ዓቕሞም ትሑት ዝኾኑ ሕሙማት እቶም ዉሑዳት ጥራሕ ከቢድ ናይ ታሕተዋይ ስርዓተ ምትንፋስ ረኽሲ ኣጋጢሙዎም። 	Only a minority of immunocompromised patients developed severe lower respiratory infections.
481	en	ti	 SARS, also known as “atypical pneumonia”, was the first well documented HCoV-caused pandemic in human history and the etiological agent is SARS-CoV, the third HCoV discovered. 	 SARS፣ “ዘይልሙድ ኒሞንያ” ተባሂሉ እውን ዝፍለጥ፣ ናይ መጀመርያ ኣብ ደቂ ሰባት ታሪኽ ዓለምለኸዊ ለበዳ ከም ዝፈጠረ ብኣግባቡ ዝተመዝገበ HCoV-እዩ ጠንቁ ድማ SARS-CoV ከምዝኾነን፣ ሳልሳይ HCoV ድማ ከምዝተፈለጠ ይግለጽ። 	SARS, also known as “unusual pneumonia”, is the first HCoV in human history to be significantly documented as causing a global pandemic-caused by SARS-CoV, and the third HCoV identified.
482	en	ti	 The first case of SARS can be traced back to late 2002 in Guangdong Province of China. 	 ናይ መጀመርታ ናይ SARS ጉዳይ ለበዳ ኣብ መወዳእታ 2002 ኣብ ጋንግዶንግ ናይ ቻይና ኣውራጃ እዩ ተራእዩ። 	The first SARS case outbreak occurred in late 2002 in Gangdong, China&#39;s province.
483	en	ti	 The SARS epidemic resulted in 8,096 reported cases with 774 deaths, spreading across many countries and continents. 	 ለበዳ SARS ኣብ ብዙሓት ሃገራትን ኣህጉራትን ብምዝማት ናይ 8,096 ሰባት ጉዳያት ለበዳ ዝተሓበረ እንተኸውን 774 ድማ ንሞት ተቓሊዖም እዮም። 	The SARS outbreak has ravaged many countries and continents with 8,096 cases reported and 774 deaths.
484	en	ti	 Apart from the super-spreaders, it was estimated that each case could give rise to approximately two secondary cases, with an incubation period of 4 to 7 days and the peak of viral load appearing on the 10th day of illness. 	 እቶም ብልዑል መንገዲ ዘመሓላልፉ ገዲፍካ ሕድሕድ ጉዳያት ለበዳ ንኣስታት ክልተ ሓደሽቲ ጉዳያት ለበዳ ክዳርግ ይኽእል። እዚ ድማ ካብ 4 እስካብ 7 ማዓልቲ ዝኸዉን ናይ ኢንኩቤሽን እዋን የድልዮ እቲ ዝለዓለ ናይ ቫይረስ መጠን ድማ ኣብ 10ይ መዓልቲ ይፍጠር። 	Each outbreak can lead to about two new outbreaks, except for those that are highly transmissible. This requires an incubation period of 4 to 7 days and the maximum viral load occurs on the 10th day.
485	en	ti	 Patients infected with SARS-CoV initially present with myalgia, headache, fever, malaise and chills, followed by dyspnea, cough and respiratory distress as late symptoms. 	 ብSARS-CoV ዝተጠቕዑ ሰባት ናይ ጨዋዳ ቓንዛ፣ ሕማም ርእሲ፣ ረስኒ፣ ድኻምን ቑሪን፣ ሕጽረት ኣየር፣ ሰዓልን ናይ መተንፈሲ ኣካል ሕማምን ምልክታት የርእዩ። 	People infected with SARS-CoV show symptoms of muscle aches, headache, fever, fatigue and chills, shortness of breath, fever and respiratory illness.
486	en	ti	 Lymphopenia, deranged liver function tests, and elevated creatine kinase are common laboratory abnormalities of SARS. 	 ሊምፎፒንያ፣ ዝተዛበዐ ናይ ጉበት ስራሕ ምርመራታት፣ ልዑል ናይ ክሬቲን ካይኔዝ ልሙዳት ናይ SARS ኣብ ቤተ ፈተነ ዘርእዮም ዘይልሙዳት ተርእዮታት እዮም። 	Lymphopenia, distorted liver function tests, and elevated creatine kinase are common uncommon laboratory manifestations of SARS.
487	en	ti	 Diffuse alveolar damage, epithelial cell proliferation and an increase of macrophages are also observed in SARS patients. 	 ዲፊዩዝ ናይ ኣሊቪዮላር ጉድኣት፣ ናይ ኢፒቴልያል ዋህዮ ምብርባርን ናይ ማክሮፌጃት ምብዛሕን ኣብ ናይ SARS ሕሙማት ዝተረኣዩ እዮም። 	Diffuse alleviolar damage, epithelial cell scraping, and proliferation of macrophages have been reported in SARS patients.
488	en	ti	 Approximately 20-30% of patients subsequently require intensive care and mechanical ventilation. 	 ዳርጋ 20-30% ዝኾኑ ሕሙማት ጽኑዕ ክንክንን ሜካኒካዊ ventilation(ምጽራይ ኣየር) ዝሓቱ እዮም። 	Almost 20-30% of patients require intensive care and mechanical ventilation.
489	en	ti	 In addition to lower respiratory tract, multiple organs including gastrointestinal tract, liver and kidney can also be infected in these severe cases, usually accompanied with a cytokine storm, which might be lethal particularly in immunocompromised patients. 	 ካብ ታሕተዋይ ስርዓተ ምትንፋስ ብተወሳኺ ከም ማዓንጣ፣ ፀላም ከብድን ኩላሊትን ዝመሳሰሉ ክፍለኣካላት እዉን ከቢድ ሕማም እንተጋጥም ክጥቅዑ ይኽእሉ እዮም። ኣብ ከምዚ ዓይነት ኩነታት ብዝሒ ሳይቶካይን ስለዝህሉ ሕማም ናይ ምክልኻል ዓቕሞም ትሑት ዝኾኑ ሕሙማት ዝኸፍአ ፀግም ከምፅእ ይኽእል። 	In addition to the lower respiratory tract, organs such as the intestines, liver and kidneys can also be affected in the event of severe illness. In such cases, the abundance of cytokines can lead to worse problems in immunocompromised patients.
490	en	ti	 The virus was first isolated from the open lung biopsy of a relative of the index patient who travelled to Hong Kong from Guangzhou. 	 እዚ ቫይረስ መጀመርያ ካብ ግዋንግዡ ናብ ሆንግኮንግ ዝተጎዓዘ ሕሙም ብመጥባሕቲ ካብ ሳንባ ብዝተወሰደ ባየፕሲ ዝተፈለየ እዩ። 	The virus was first isolated from a surgical lung biopsy from a patient who traveled to Hong Kong from Guangzhou.
491	en	ti	 Since then, tremendous efforts have been dedicated to HCoV research. 	 ድሕሪኡ፣ ብዙሓት ጻዕሪታት ንናይ HCoV መጽናዕቲ ክውዑል ተገይሩ እዩ። 	Since then, many efforts have been devoted to HCoV research.
492	en	ti	 HCoV-NL63 was isolated from a 7-month-old child from the Netherlands during late 2004. 	 HCoV-NL63 ኣብ መወዳእታ 2004 ካብ 7-ወርሒ ዝዕድሚኣ ኔዘርላንዳዊት ህጻን ተወሲዱ። 	HCoV-NL63 was obtained in late 2004 from a 7-month-old Dutch child.
493	en	ti	 It was initially found to be prevalent in young children, the elderly and immunocompromised patients with respiratory illnesses. 	 መጀመርያ ኣብ ህጻናት፣ ሽማግለታትን ኣብ ብናይ መተንፈሲ ኣካል ሕማም ዝተጠቕዑ ሕሙማትን ናይ ምክልኻል ዓቕሞም ዝተዳኸመ ሰባትን እዩ ብብዝሒ ዝርአ ኾይኑ ተረኺቡ። 	It was first found to be more common in children, the elderly, and in patients with respiratory diseases and people with weakened immune systems.
494	en	ti	 Presentation of coryza, conjunctivitis, fever, and bronchiolitis is common in the disease caused by HCoV-NL63. 	 ናይ ኮሪዛ፣ ኮንጃክቲቫይቲስ፣ ረስኒን ብሮንኮላይትስን ምልክታት ኣብ ብ HCoV-NL63 ዝምዕብሉ ሕማማት ልሙዳት እዮም። 	Symptoms of coryza, conjunctivitis, rash, and bronchiolitis are common in cases developed with HCoV-NL63.
495	en	ti	 Another independent study described the isolation of the same virus from a nasal specimen from an 8-month-old boy suffering from pneumonia in the Netherlands. 	 ካልኦት ዓርሶም ዝኸኣሉ መጽናዕቲታት ኣብ ኔዘርላንድስ ካብ 8-ወርሒ ዝዕድሚኡ ብኒሞንያ ዝተጠቐዐ ህጻን ካብ ናይ ኣንቻ ስዋብ ናሙና ዝተወሰደ ተመሳሳሊ ቫይረስ ክረኽቡ ምኽኣሎም ገሊጾም። 	Other independent studies in the Netherlands have found the same virus in an ancha swab sample from an 8-month-old child with pneumonia.
496	en	ti	 Although it was identified in Netherlands, it is actually distributed globally. 	 ዋላኳ ኣብ ኔዘርላንድስ ዝተፈልጠ እንተኾነ ብዓለም ደረጃ ተስፋሕፊሑ እዩ። 	Although known in the Netherlands, it has spread worldwide.
497	en	ti	 It has been estimated that HCoV-NL63 accounts for approximately 4.7% of common respiratory diseases, and its peak incidence occurs during early summer, spring and winter. 	 HCoV-NL63 ክሳብ 4.7% ዝኾኑ ልሙዳት ናይ ስርዓተ ምስትንፋስ ሕማማት ዘስዐበ እዩ፣ ዋና ኣጋጣሚታቱ ድማ ኣብ ክረምቲ መጀመርያ፣ ኣብ ጽድያን ሓጋይን እዮም ዝፍጠሩ። 	HCoV-NL63 caused up to 4.7% of common respiratory illnesses, with principal episodes occurring in winter first, in spring and summer.
498	en	ti	 HCoV-NL63 is associated with obstructive laryngitis, also known as croup. 	 HCoV-NL63 ምስ ክሩፕ(croup) ዝበሃል ምዕጋት ነድሪ ላንቃ ይተሓሓዝ። 	HCoV-NL63 is associated with croup, an inhibitor of laryngeal inflammation.
499	en	ti	 In the same year, HCoV-HKU1 was isolated from a 71-year-old man who had been hospitalized with pneumonia and bronchiolitis in Hong Kong. 	 ኣብ እቲ ዓመት HCoV-HKU1 ኣብ ወዲ 71 ዓመት ዝኮነ ብምኽንያት ኒሞንያንያን ብሮንካይተስን ናብ ሕክምና ዝኣተወ ሰብኣይ ኣብ ሆንግ ኮንግ ተረኺቡ። 	That year, HCoV-HKU1 was detected in a 71-year-old man in Hong Kong who was admitted to hospital for pneumonia and bronchitis.
500	en	ti	 Besides community-acquired pneumonia and bronchiolitis, HCoV-HKU1 was reported to be associated with acute asthmatic exacerbation. 	 HCoV-HKU1 ካብ ናይ ማሕበረሰብ ኒሞንያን ብሮንካይተስን ብተወሳኺ ምስ ኣክዩት ኣዝማ ጥምረት ኣለዎ። 	HCoV-HKU1 is associated with acute asthma in addition to community pneumonia and bronchitis.
501	en	ti	 Similar to HCoV-NL63, HCoV-229E and HCoV-OC43, HCoV-HKU1 was found worldwide, causing mild respiratory diseases. 	 ምስ HCoV-NL63፣ HCoV-229E፣ ከምኡውን HCoV-OC43 ብተመሳሳሊ፣ HCoV-HKU1 ቀለልቲ ናይ ስርዓት ምትንፋስ ሕማማት ብምስዓብ፣ እውን ኣብ ዓለም ሙሉእ ተራእዩ። 	Similarly to HCoV-NL63, HCoV-229E, and HCoV-OC43, HCoV-HKU1 caused mild respiratory illnesses, also occurred worldwide.
502	en	ti	 All these four community-acquired HCoVs have been well adapted to humans and are generally less likely to mutate to cause highly pathogenic diseases, though accidents did occur for unknown reasons as in the rare case of a more virulent subtype of HCoV-NL63, which has recently been reported to cause severe lower respiratory tract infection in China. 	 እዞም ኣርባዕተ ካብ ከባቢ ዝውሰዱ HCoVs ምስሰባት ብጽቡቕ ተላሚዶም እዮም ከቢድ ሕማም ንምስዓብ ሚችዌት ናይ ምግባር ክእለቶም ድማ ትሑት እዩ፣ ብዘይተፈለጡ ምኽንያታት ሓደጋታታት ኣጋጢሞም ዋላ እንተኾኑ ብዙሓት ዓይነታት HCoV-NL63፣ ኣብ ቀረባ ግዘ ኣብ ቻይና ከቢድ ናይ ታሕተዋይ መተንፈሲ ኣካላት ሕማም ኣስዒቦም እዮም። 	These four locally derived HCoVs have adapted well to humans and have low ability to cause severe disease. Although accidents have occurred for unknown reasons, many strains of HCoV-NL63 have recently caused severe lower respiratory disease in China.
503	en	ti	 Generally, when these HCoVs acquire the abilities to transmit efficiently and to maintain themselves continuously within humans, they also become less virulent or pathogenic. 	 ብጠቕላላ HCoVs ናይ ምትሕልላፍን ኣብ ሰብነትና ኣቲዩ ናይ ምንባርን ዓቕሙ ክብ እንተብል ጉድኣት ናይምብፃሕ ክእለቱ ይቕንስ። 	Overall, the ability of HCoVs to transmit and survive in the body increases, decreasing their ability to cause harm.
504	en	ti	 MERS-CoV was first isolated in 2012 from the lung of a 60-year-old patient who developed acute pneumonia and renal failure in Saudi Arabia. 	 MERS-CoV ንመጀመርያ ግዜ ኣብ 2012 ኣብ ሳዑዲ ዓረብያ ከቢድ ናይ ሳምባ ምቺን ናይ ኩላሊት ሕማም ኣብ ዝሓዞም ወዲ 60 ዓመት ሕሙም ተረኺቡ። 	MERS-CoV was first detected in 2012 in a 60-year-old patient with severe pneumonia and kidney disease in Saudi Arabia.
505	en	ti	 Whereas most of the laboratory-confirmed cases originate from the Middle East, imported cases with occasional secondary spreads to close contacts have been reported in various European countries and Tunisia. 	 መብዛሕትኦም ብቤተ ፈተነ ዝተረጋገጹ ጉዳያት ለበዳ ካብ ማእኸላይ ምብራቕ ዝመጹ እዮም፣ ካብ ደገ ዝኣተዉ ጉዳያት ለበዳ ምስ ሓሓሊፉ ዘጋጠሙ ቀረባ ርክባት ዝግበሩ ናይ ካልኣይ ደረጃ ምልባዓት ካብ ዝተፈላለዩ ናይ ኣውሮፓ ሃገራትን ቱኒዝያን ጸብጻብ ተገይሮም እዮም። 	Most laboratory-confirmed outbreak cases originated from the Middle East, imported outbreak cases with occasional close contacts secondary outbreaks have been reported from various European countries and Tunisia.
506	en	ti	 Another secondary outbreak occurred in South Korea in 2015 with 186 confirmed cases. 	 ኣብ 2015 ኣብ ደቡብ ኮርያ ብ186 ዝተረጋገጸ ኩነት ካልኣይ ደረጃ ለበዳ ተመዝጊቡ። 	In 2015, there were 186 confirmed cases of secondary outbreaks in South Korea.
507	en	ti	 Clinical manifestations of MERS resemble those of SARS, characterized by progressive acute pneumonia. 	 ናይ MERS ክሊካላዊ ምልክታት ናይ SARS እዮም፣ ብእንዳገደደ ዝኸይድ ከቢድ ኒሞንያ የስዕቡ። 	The clinical symptoms of MERS are those of SARS, causing progressively more severe pneumonia.
508	en	ti	 Unlike SARS, many patients with MERS also developed acute renal failure, which is thus far unique for MERS among HCoV-caused diseases. 	 ካብ SARS ፍልይ ብዝበለ መንገዲ፡ ብዙሕሓት ብMERS ዝተጠቕዑ ሕሙማት ሃንደበታዊ ናይ ኩላሊት ሕማም የጋጥሞም። እዚ ፀባዩ ድማ ካብ ካልኦት ብHCoV- ዝመፁ ሕማማት ፍሉይ ይገብሮ። 	Unlike SARS, many patients with MERS develop sudden kidney disease. This characteristic sets it apart from other HCoV- caused diseases.
509	en	ti	 More than 30% of patients present with gastrointestinal symptoms, such as diarrhea and vomiting. 	 ልዕሊ 30% ዝኾኑ ሕሙማት ከም ተቕማጥን ንዓቐብ ምባልን ዝበሉ ናይ ከስዐ መዓንጣ ምልክታት ዝቐርቡ እዮም። 	More than 30% of patients present with gastrointestinal symptoms such as diarrhea and cramping.
510	en	ti	 As of February 14, 2020, over 2500 laboratory confirmed cases were reported with a high case fatality of 34.4%, making MERS-CoV one of the most devastating viruses known to humans. 	 ካብ ፌብሩዋሪ 14, 2020 ጀሚሩ፣ ልዕሊ 2500 ኣብ ቤተ ፈተነ ዝተረጋገጹ ጉዳያት ለበዳ ልዑል ናይ ሞት ንጽጽራዊ መጠን 34.4% ኣረእዮም እዮም፣ ን MERS-CoV ኣብ ሰባት ካብ ዝፈለጡ ኣዝዮም ክፉኣት ቫይረሳት ክኾኑ ጌርዎም እዩ። 	Since February 14, 2020, more than 2,500 laboratory-confirmed cases have shown a high comparative mortality rate of 34.4%, making MERS-CoV one of the most deadly viruses known in humans.
511	en	ti	 During middle to late December 2019, clusters of pneumonia patients retrospectively known to be associated with SARS-CoV-2 infection were detected in Wuhan, Hubei Province, China. 	 ኣብ ዲሰምበር 2019 ማእኸል፣ ምስ SARS-CoV-2 ረኽሲ ብዝተተሓሓዘ ኒሞንያ ዝሓመሙ ሕሙማት ኣብ ውሃን፣ ሁቤይ ኣውራጃ ቻይና ተራእዮም። 	In December 2019, the Center reported cases of pneumonia associated with SARS-CoV-2 infection in Wuhan, Hubei Province, China.
512	en	ti	 World Health Organization declared the ongoing outbreak of lower respiratory tract infection caused by SARS-CoV-2 a Public Health Emergency of International Concern and also named the disease COVID-19. 	 ዉድብ ጥዕና ዓለም ነዚ ብSARS-CoV-2 ዝመፅእ ቀፃሊ ዝኾነ ናይ ታሕተዋይ ስርዓተ ምትንፋስ ረኽሲ ጎንፊ ፣ ናይ ዓለምለኸ ህዝቢ ጥዕና ናብ ሓደጋ ዝዳርግ ብምባል ሽሙ ድማ COVID-19 ብምባል ኣዊጁ። 	The World Health Organization (WHO) has declared the ongoing lower respiratory infection pandemic caused by SARS-CoV-2 , a global public health threat, and named it COVID-1
513	en	ti	 As of March 3, 2020, 90,053 cases have been confirmed worldwide, with a crude case fatality of 3.4%. 	 ክሳብ መጋቢት 3 2020 ብዓለም ደረጃ 90,053 ዝኾኑ ናይዚ ሕማም ኩነታትን 3.4% ሞትን ተመዝጊቡ። 	As of March 3 2020, there have been 90,053 cases and 3.4% deaths worldwide.
514	en	ti	 Notably, the case fatality in Hubei, China is 4.2%, whereas the one outside of it is 1.2%. 	 ብፍላይ ኣብ ሁበይ በዚ ሕማም ጥራይ ዝተከስተ መጠን ሞት 4.2% ክኸውን ከሎ፣ ካብኣ ወጻኢ ግን 1.2% እዩ። 	In particular, the death rate from the disease alone in Hubei is 4.2%, compared to 1.2% outside it.
515	en	ti	 SARS-CoV-2 causes severe respiratory infection like SARS-CoV and MERS-CoV, presented as fever, cough and dyspnea. 	 SARS-CoV-2 ከም SARS-CoV ከምኡ'ውን MERS-CoV ብረስኒ፣ ሰዓልን ሕጽረት ትንፋስን ዝግለጽ ከቢድ ናይ ስርዓተ ምትንፋስ ረኽሲ የስዕብ። 	SARS-CoV-2, like SARS-CoV and MERS-CoV, causes severe respiratory infections manifested by fever, cough, and shortness of breath.
516	en	ti	 Diarrhea is also seen in some patients. 	 ተቕማጥ ኣብ ገለ ሕሙማት ተራእዩ እዩ። 	Diarrhea was seen in some patients.
517	en	ti	 Pneumonia is one of the most severe symptoms and can progress rapidly to acute respiratory distress syndrome. 	 ኒሞንያ ካብቶም ከበድቲ ምልክታቱ ሓደ እዩ ብቕልጡፍ ድማ ናብ ከቢድ ናይ ስርዓተ ምትነፋስ ዲስተረስ ሲንድረም ክዓቢ ይኽእል። 	Pneumonia is one of its most serious symptoms and can rapidly progress to severe respiratory distress syndrome.
518	en	ti	 Although SARS-CoV and SARS-CoV-2 are very similar due to high nucleotide sequence homology of 82%, they cluster into different branches in the phylogenetic tree. 	 ዋላ'ኳ SARS-CoV ከምኡ'ውን SARS-CoV-2 ብናይ ልዑል ኒኩሎታይድ ሲኬንስ ሆሞሎጂ 82% ተመሳሰልቲ እዮም፣ ኣብ ዝተፈላለዩ ፓይሎጀኒክ ጨንፈራት እዮም ግን ዝቕመጡ። 	Although SARS-CoV and SARS-CoV-2 are 82% identical by high nucleotide sequence homology, they are located on different pylogenic branches.
519	en	ti	 SARS-CoV-2 is apparently less pathogenic but more transmissible compared to SARS-CoV and MERS-CoV. 	 SARS-CoV-2 ምስ SARS-CoV ከምኡ'ውን MERS-CoV እንትነጻጸር ዝነኣሰ ናይ ሕማም ምምጻእን ዝለዓለ ናይ ምምሕልላፍ ዕድል ኣለዎ። 	SARS-CoV-2 has lower disease emergence and higher transmission potential compared to SARS-CoV and MERS-CoV.
520	en	ti	 Asymptomatic subjects infected with SARS-CoV-2 have been reported and might contribute to its rapid spreading around the world. 	 ብ SARS-CoV-2 ዝተለኸፉ ሰባት ምልክት ዘየርእዩ ሰባት ሪፖርት ተገይሮም እዮም ከምኡ'ውን ኣብ መላእ ዓለም ንዘሎ ፈጣን ስርጭት ኣስተዋጽኦ ይገብሩ ይኾኑ እዮም። 	Asymptomatic cases of SARS-CoV-2 infection have been reported and may be contributing to the rapid spread around the world.
521	en	ti	 Comparing and contrasting SARS-CoV-2 with the other six HCoVs reveal similarities and differences of great interest. 	 SARS-CoV-2 ምስ እቶም ካልኦት ሽዱሽተ ናይ HCoVs ቫይረሳት ምንጽጻር ብልዑል ተገዳስነት ዝርኣዩ ተመሳሳልነትን ፍልልይን የርእዩ። 	Comparisons of SARS-CoV-2 with the other six HCoVs show similarities and differences of high interest.
522	en	ti	 First, the incubation period and the duration of the course of HCoV disease are very similar. 	 መጀመርታ፣ እቲ ናይ መራብሒ ግዘን ናይ HCoV ሕማም ከይዲን ኣዝዮም ተመሳሰልቲ እዮም። 	First, the reproductive period and the course of HCoV disease are very similar.
523	en	ti	 In this regard, SARS-CoV-2 follows the general trend of the other six HCoVs. 	 ነዚ ብዝምልከት፣ SARS-CoV-2 ናይ ካልኦት ሽድሽተ HCoVs ሓፈሻዊ መገዲ እዩ ዝኸተል። 	In this regard, SARS-CoV-2 follows the general pathway of the other six HCoVs.
524	en	ti	 Second, the severity of symptoms of COVID-19 lies between SARS-CoV and the four community-acquired HCoVs (i.e. HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63). 	 ካልኣይ፣ ናይ ኮቪድ-19 ምልክታት ከቢድነት ኣብ መንጎ SARS-CoV ን እቶም ኣርባዕተ ካብ ማሕበረሰብ-ዝውሰዱ HCoVs (ንኣብነት፣ HCoV-229E፣ HCoV-OC43፣ HCoV-HKU1 ን HCoV-NL63 ) ዝርከብ እዩ። 	Second, the severity of COVID-19 symptoms is intermediate between SARS-CoV and the four community-acquired HCoVs (e.g., HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63 ).
525	en	ti	 On one hand, SARS-CoV-2 infection exhibits features that are more commonly seen during infection with community-acquired HCoVs, including the presentation of non-specific, mild or even no symptoms. 	 በቲ ሓደ ወገን፣ ናይ SARS-CoV-2 ረኽሲታት መብዛሕትኡ ግዘ፣ ዘይንጹር፣ ቀሊል ምልክት ወይ ምንም ምልክት ዘይምርኣይ እውን ሓዊሱ፣ ኣብቶም ካብ ማሕበረሰብ ዝውሰዱ HCoVs ዘለዉ ባህርያታት የርኢ እዩ። 	On the other hand, SARS-CoV-2 infections often show characteristics of community-acquired HCoVs, including vague, mild or no symptoms.
526	en	ti	 On the other hand, a small subset of severe cases of COVID-19 can also be seen as in the case of SARS-CoV infection, although the ratio is a bit lower. 	 ብካልእ ገጹ፣ ዋላ እቲ ንጽጽራዊ መጠን ትሑት እንተኾነ፣ ከም ናይ SARS-CoV ረኽሲ ግዳያት ንእሽተይ ክፋል ካብ ናይ ኮቪድ-19 ከቢድ ሕማም ዘለዎም ግዳያት ክረአ ይኽእል እዩ። 	On the other hand, even if the comparative rate is low, it may be seen as a small proportion of victims of SARS-CoV infection than victims of severe COVID-1
527	en	ti	 Third, the transmission of SARS-CoV-2 also shows interesting patterns characteristic of both community-acquired HCoVs and SARS-CoV. 	 ሳልሳይ፣ ናይ SARS-CoV-2 ምምሕልላፍ ዘገርሙ ናይ ካብ ማሕበረሰብ ዝውሰድ HCoVs ን SARS-CoV ን ባህርያዊ ምምስሳላተ እውን ዘርኢ እዩ። 	Third, the transmission of SARS-CoV-2 also shows remarkable characteristic similarities between community-acquired HCoVs and SARS-CoV.
528	en	ti	 On one hand, the transmissibility of SARS-CoV-2 is at least as high as that of community-acquired HCoVs. 	 በቲ ሓደ ወገን፣ ናይ SARS-CoV-2 ተመሓላላፍነት ክንዲ እቶም ካብ ማሕበረሰብ ዝውሰዱ HCoVs ልዑል እዩ። 	On the one hand, the transmissibility of SARS-CoV-2 is as high as that of community-acquired HCoVs.
529	en	ti	 On the other hand, it remains to be verified whether the transmissibility of SARS-CoV-2 decreases after passages in humans as in the cases of SARS-CoV and MERS-CoV. 	 ብኻልእ መዳይ ድማ፣ ልክዕ ከም SARS-CoVን MERS-CoVን ናይ SARS-CoV-2 ካብ ሰብ ናብ ሰብ ናይ ምትሕልላፍ ዓቕሙ ከምዝቕንስ ገና ኣይተፈልጠን። 	On the other hand, it is not yet known whether SARS-CoV-2, like SARS-CoV and MERS-CoV, reduces its ability to be transmitted from person to person.
530	en	ti	 Finally, same as the other HCoVs, SARS-CoV-2 can be detected in fecal samples. 	 ኣብ መወዳእታ፣ ከም ካልኦት HCoV፣ SARS-CoV-2 ኣብ ናይ ቀልቀል ናሙናታት ውሽጢ ክርከቡ ይኽእሉ ፡፡ 	Finally, like other HCoVs, SARS-CoV-2 can be found in sprout samples.
531	en	ti	 Whether fecal-oral transmission of SARS-CoV-2 plays an important role as in the case of SARS-CoV at least under some circumstance remains to be clarified by future studies. 	 ናይ SARS-CoV-2 ካብ ቀልቀል ናብ ኣፍ ምምሕልላፍ፣ ከም ናይ SARS-Co V፣ ብውሑዱ ኣብ ትሕቲ ሓደሓደ ኩነታት፣ ወሳኒ ግደ ኣሎዎዶ የብሉን ዝብል ኣብ ቀጻሊ ብዝግበሩ ምርምራት ክበርህ ትጽቢት ዝግበረሉ'ዩ። 	Whether oral transmission of SARS-CoV-2, like SARS-Co V, plays a critical role, at least under certain circumstances, is expected to be clarified in future research.
532	en	ti	 It is also of particularly great interest to see whether SARS-CoV-2 might exhibit seasonality as in the cases of community-acquired HCoVs. 	 ኣብ ዝተፈላለዩ ወቕትታት ዓመት SARS-CoV-2 ዘርእዮ ለውጢ ካብ ብ HCoVs ዝተጠቕዑ ሕብረተ ሰብ ክርከብ ትጽቢት ይግበር። 	Changes in SARS-CoV-2 during different seasons of the year are expected to be found in communities infected with HCoVs.
533	en	ti	 Nevertheless, the features of SARS-CoV-2 including its transmissibility, pathogenicity and sustainable spreading after passages in humans will be influential on the ultimate fate of the ongoing outbreak of COVID-19. 	 እንተኾነግን ባህርታት SARS-CoV-2፣ ከም ናይ ምትሕልላፍ ዓቕሙ፣ ሓደገኛነቱን ቀጻልነት ዝርግሐኡ ኣብ ሰባት ድሕሪ ምሕላፉን ሓዊስካ፣ ኣብ ልዕሊ ናይዚ ቀጻሊ ለበዳ COVID-19 ናይ መወዳእታ ዕጫ ጽልዋ ክህልዎም'ዩ። 	However, the characteristics of SARS-CoV-2, including its ability to transmit, its danger and its continued spread after passing on to humans, will have an impact on the ultimate fate of this ongoing COVID-19 pandemic.
534	en	ti	 All four community-acquired HCoVs causing mild symptoms have been well adapted to humans. 	 እቶም ኣርባዕተ ካብ ማሕበረሰብ ዝርከቡ HCoVs ቀሊል ናይ ሕማም ምልክታት ዘርእዩ እንትኾኑ ምስ ደቂ ሰባት ድማ ብዝግባእ ዝተለማመዱ እዮም። 	The four community-acquired HCoVs exhibit mild disease symptoms and are well adapted to humans.
535	en	ti	 From another perspective, it might also be true that humans have been well adapted to these four HCoVs. 	 ብኻልእ ኣጠማምታ ክርአ ኸሎ፣ ደቂ ሰባት ምስዞም ኣርባዕተ HCoVs ጽቡቕ ጌሮም ተላሚዶም ክኾኑ ከምዝኽእሉ ሓቂ ክኸውን ይኽእል'ዩ። 	From another perspective, it may be true that humans may have adapted well to these four HCoVs.
536	en	ti	 In other words, both could be the survivors of ancient HCoV pandemics. 	 ብካልእ ኣበሃህላ፣ ክልቲኦም ካብ እቶም ጥንቲ ዝተራእዩ ናይ HCoV ለበዳታት ብህይወት ዝተረፉ ክኾኑ ይኽእሉ እዮም። 	In other words, both may be survivors of ancient HCoV outbreaks.
537	en	ti	 HCoVs that cause severe diseases in humans and humans who developed severe HCoV diseases have been eliminated. 	 ኣብ ወዲ ሰብ ከቢድ ሕማም ዘምፅኡ HCoVs ከምኡ'ውን ብምኽንያት HCoV ኣዝዩ ከቢድ ሕማም ዘማዕበሉ ሰባት ተወጊዶም'ዮም። 	HCoVs that caused severe disease in humans and people who developed very serious disease due to HCoV were excluded.
538	en	ti	 For this to happen, HCoVs have to replicate in humans to sufficient extent to allow the accumulation of adaptive mutations that counteract host restriction factors. 	 እዚ ንክኾን፣ HCoVs ናይ መዕቆቢ እንስሳ ደረትቲ ረቛሒታት ንምምካት ዘኽእል ምእካብ ናይ ዝተለምዱ ለውጥታት (adaptive mutations) ብዝፈቅድ መንገዲ ኣብ ደቂሰባት ብእኹል መጠን ክራብሑ ኣለዎም። 	For this to occur, HCoVs must replicate in humans in sufficient quantities in a manner that allows the accumulation of adaptive mutations to counteract the limiting factors of a host animal.
539	en	ti	 In this sense, the longer the SARS-CoV-2 outbreak persists and the more people that it infects, the greater chance that it will fully adapt to humans. 	 በዚ ምኽንያት እዚ፣ እዚ ናይ SARS-CoV-2 ለበዳ ብዝቐጸለ ቁጽሪ ከምኡድማ ብዙሓት ሰባት እንዳለኸፈ ብዝኸደ ቁጽሪ፣ ምስ ሰባት መሉእ ንሙሉእ ናይ ምልማድ ዕድሉ ሰፈሕ እዩ። 	For this reason, the more this SARS-CoV-2 outbreak continues and the more people it infects, the more likely it is to become fully infected with people.
540	en	ti	 If it adapts well, its transmission in humans would be difficult to stop by quarantine or other infection control measures. 	 ብግቡእ እንተድኣ ተላሚዱ፣ ብውሸባ ወይ ብካልኦት ናይ ረኽሲ መቆጻጸሪ ስጉምትታት ምግታእ ኸቢድ ይኸውን። 	If properly adapted, it becomes difficult to control with quarantine or other infection control measures.
541	en	ti	 For many years, the four community-acquired CoVs circulate in human populations, triggering common cold in immunocompetent subjects. 	 ንብዙሕ ዓመታት እቶም ኣርባዕተ ኣብ ማሕበረሰብ ዝርከቡ CoVs ኣብ ደቂ ሰባት እናተዘዋወሩ ንጥዕናኦም ዝተሓለወ ሰባት ብምጥቃዕ ሰዓል የምጽኡ እዮም። 	For many years, the four community-acquired CoVs have circulated in humans, affecting healthy individuals and causing fever.
542	en	ti	 These viruses do not need an animal reservoir. 	 እዞም ቫይረሳት ናይ እንስሳ መሕደሪ ኣየድልዮምን። 	These viruses do not require animal shelter.
543	en	ti	 In contrast, highly pathogenic SARS-CoV and MERS-CoV have not adapted to humans well and their transmission within humans cannot be sustained. 	 ብንጽጽር፣ ልዑል ሕማም ናይ ምስዓብ ተኽእሎ ዘለዎም SARS-CoV ን MERS-CoVን ምስ ሰባት ብኣግባቡ ኣይተላመዱን ኣብ መንጎ ሰባት ዘለዎም ምትሕልላፋት እውን ቀጻልነት ክህልዎ ኣይኽእልን እዩ። 	In contrast, SARS-CoV and MERS-CoV, which are highly pathogenic, have not adapted significantly to humans and their interhuman transmissions may not be sustainable.
544	en	ti	 They need to maintain and propagate in their zoonotic reservoirs and seek the chance to spillover to susceptible human targets, possibly via one or more intermediate and amplifying hosts. 	 ኣብ እንስሳዊ መዕቖቢታቶም ብምጽናሕን ብምብዛሕን፣ ቀጺሎም ድማ ሓደ ወይ ካብኡ ንላዕሊ መንጎኛን መባዛሕቲን መሕደሪታት ብምጥቃም ናብ ብቐሊሉ ተጠቃዕቲ ግዳያት ዝኾኑ ደቂ ሰባት ናይ ምፍሳስ ዕድል ድማ ክጽበዩ ኣለዎም። 	They must expect the opportunity to spread to vulnerable human victims by staying and breeding in their animal shelters and then using one or more intermediate and breeding habitats.
545	en	ti	 SARS-CoV-2 has features that are similar to both SARS-CoV/MERS-CoV and the four community-acquired HCoVs. 	 SARS-CoV-2 ምስ SARS-CoV/MERS-CoVን ምስ እቶም ካልኦት ኣርባዕተ ካብ ማሕበረሰብ-ዝውሰዱ HCoVs ተመሳሳሊ ባህርያታት ኣለዎ። 	SARS-CoV-2 shares characteristics with SARS-CoV/MERS-CoV and with the other four community-acquired HCoVs.
546	en	ti	 It is highly transmissible like community-acquired HCoVs, at least for the time being. 	 እንተነኣሰ ንግዜኡ፣ ከምቲኦም ካብ ማሕበረሰብ-ዝርከቡ HCoVs፣ ብሉዕል መጠን ዝመሓላለፍ እዩ። 	At least temporarily, it is highly transmissible, as are community-acquired HCoVs.
547	en	ti	 However, it is more pathogenic than community-acquired HCoVs and less pathogenic than SARS-CoV or MERS-CoV. 	 ኮይኑ ግና፣ ብ ሕማም ኣምጸኣይነቱ፣ ካብ ኣብ ማሕበረሰብ ዝተረኽበ HCoVs ዝበኣሰን ካብ SARS-CoV ወይ MERS-CoV ድማ ዝሓሸን እዩ። 	However, in terms of pathogenicity, it is worse than community-acquired HCoVs and better than SARS-CoV or MERS-CoV.
548	en	ti	 It remains to be seen whether it will adapt fully to humans and circulate within humans without a reservoir or intermediate animal host. 	 ሙሉእ ንሙሉእ ናብ ሰባት ክላመድ ድዩ ወይስ ኣብ ውሽጢ ሰባት ብዘይ መዐቖቢ ወይ መንጎኛ እንስሳ መሕደሪ ክዘዋወር ይኽእል ድማ ዝብል ገና ኣይተፈለጠን። 	It remains to be seen whether it will fully adapt to humans or whether it can move within humans without a shelter or intermediate animal shelter.
549	en	ti	 Before discussing the animal origins of HCoVs, it will serve us well to discuss the definitions and characteristics of evolutionary, natural, reservoir, intermediate and amplifying hosts of HCoVs. 	 ቅድሚ ናይ HCoVs እንስሳዊ መበቆላት ምግላጽና፣ ናይቶም ብዝግመታዊ ለውጢ ዝማዕበሉ፣ ባህርያውያን፣ በቲ ሕማም ዘይጥቅዑ (reservoir)፣ ሞንጎኛታትን አጋደድቲ መዕቆብቲ ትርጉማትን ጠባያትን ምግላጽ ይጠቅም። 	Before describing the animal origins of HCoVs, it is useful to describe the definitions and characteristics of the natural, reservoir, intermediate, and aggravating reservoirs that have evolved through hypothetical changes.
550	en	ti	 An animal serves as the evolutionary host of an HCoV if it harbours a closely related ancestor sharing high homology at the level of nucleotide sequence. 	 ሓደ እንስሳ ከም ብዝግመታዊ ለውጢ ዝማዕበለ (evolutionary) ናይ HcoV መሕደሪ ኮይኑ ዘገልግል፣ ብደረጃ ኣሰራርዓ ኒዩክሎታይ (nucleotide sequence) ልዑል መበቆላዊ ምምስሳል ዘለዎ ብቐረባ ዝዛመዶ ቅዱም ወለዶ/ኣበው ምስዘዕቁብ እዩ። 	An animal serves as an evolutionary host for HcoV when it harbors a closely related ancestor with high ancestral similarity at the nucleotide sequence level.
551	en	ti	 The ancestral virus is usually well adapted and non-pathogenic in this host. 	 እዚ ካብ ዘርኢ ዝውረስ ቫይረስ መብዛሕቲኡ ግዜ ኣብ መሕደሪኡ ብጽቡቕ ኩነት ዝተላመደን ሕማም ዘየስዕብን እዩ። 	This seed-borne virus is usually well adapted to its habitat and does not cause disease.
552	en	ti	 Likewise, a reservoir host harbours HCoV continuously and for long term. 	 ብተመሳሳሊ፣ ሓደ በቲ ቫይረስ ዘይጥቃዕ መዕቆቢ እንስሳ ብቐጻልነትን ንነዊሕ ግዘን ናይ HcoV መጸግዒ ኮይኑ ክጸንሕ ይኽእል እዩ። 	Similarly, a shelter animal that is not infected with the virus may remain a harbor of HcoV on a continuous and long-term basis.
553	en	ti	 In both cases, the hosts are naturally infected and are the natural hosts of HCoV or its parental virus. 	 ኣብ ክልቲኦም ጉዳያት፣ እዞም መሕደሪታት እዚኦም ብተፈጥሮ ዝልከፉ ኮይኖም ናይ HCoV ወይ ናይ ዘርኣዊ ቫይረስ ተፈጥሮኣዊ መሕደሪ እዮም። 	In both cases, these hosts are naturally infectious and are the natural host of HCoV or the seminal virus.
554	en	ti	 In contrast, if the HCoV is newly introduced to an intermediate host right before or around its introduction to humans, it is not well adapted to the new host and is often pathogenic. 	 ብምንጽጻር ክርአ ኸሎ፣ እቲ HCoV ቀቅድሚ ንደቂ ሰባት ምጥቃዕ ምጅማሩ ወይድማ ኣብቲ ከባቢ ከጥቅዓሉ ዝጀመረ እዋን ንመጀመርያ ግዘ እንተድኣ ንሓደ መንጎኛ መዕቆቢ ኣጥቂዑ፣ ምስዚ ሓድሽ መዕቆቢ ብጽቡቕ ስለዘይተላመደ መብዛሕትኡ ግዘ ሕማም የስዕብ እዩ። 	In comparison, if the HCoV first infects an intermediate host before it begins to infect humans or when it begins to infect the environment, it often causes illness because it is not well adapted to this new host.
555	en	ti	 This intermediate host can serve as the zoonotic source of human infection and play the role of an amplifying host by allowing the virus to replicate transiently and then transmitting it to humans to amplify the scale of human infection. 	 እቲ ማእኸላይ ተሸካማይ እቲ ቫይረስ ዝኾነ እንስሳ ከም ምንጪ ረኽሲ ናይ ወድሰብ ኮይኑ የገልግል ብተወሳኺ ድማ እቲ ቫይረስ ንሓፂር እዋን ኣብ ዉሽጢ እቲ ተሸካሚ/መዕቆቢ ክራባሕ ብምፍቃድ ደሓር ድማ ናብ ሰባት ኣማሓላሊፉ መጠን ዝልከፉ ሰባት ከምዝዓቢ ብምግባር ናይቲ ቫይረስ ናይ ምጥቃዕ ዓቕሙ ንኽጎልሕ ዓቢ እጃም ይፃወት። 	The central carrier of the virus serves as a source of human infection and also plays a major role in enhancing the infectivity of the virus by allowing the virus to multiply within the carrier/shelter for a short time and then transmit it to humans.
556	en	ti	 An HCoV can undergo a dead-end infection if it cannot sustain its transmission within the intermediate host. 	 ሓደ HCoV ኣብ ውሽጢ እቲ መንጎኛ መሕደሪ ኮይኑ ተመሓላላፍነቱ ክቕጽል እንተዘይክኢሉ፣ ናይ ምልካፍ ዓቕሙ ኣብ ሞት ዝመወዳእታኡ ኩነት ክበጽሕ ይኽእል እዩ። 	If an HCoV cannot continue to be transmitted within the intermediate host, its infectivity may reach a fatal state.
557	en	ti	 On the contrary, HCoVs can also adapt to the intermediate host and even establish long-term endemicity. 	 ብካልእ ገጹ ድማ፣ HCoVs ምስቲ መንጎኛ መሕደሪ ክላመድ ይኽእል፣ ዋላ'ውን ነዊሕ ግዘ መጽንሒ ክገብሮም ይኽእል። 	On the other hand, HCoVs can adapt to the intermediate host, even making them persistent for a long time.
558	en	ti	 In this case, the intermediate host becomes a natural reservoir host. 	 ኣብዚ ጉዳይ እዚ፣ እቲ መንጎኛ መዕቆቢ ባህርያዊ በቲ ሕማም ዘይልከፍ መዕቆቢ (reservoir host) ይኸውን። 	In this case, the intermediate host is a naturally non-infectious reservoir host.
559	en	ti	 Epidemiological data revealed retrospectively that the index case of SARS had a contact history with game animals. 	 ናይ ሕማም ዝርገሐ፣ ጠንቂ፣ ናይ ሓደጋ ረቛሒታት እኩብ ሓበሬታ (epidemiological data) ንድሕሪት ተመሊሱ ከምዝሕብሮ እቲ ናይ መጀመርያ ናይ SARS ሕሙም (index case) ምስ ናይ መዘናግዒ እንስታታት ናይ ርክብ ታሪኽ ከምዝነበሮ ገሊጽዎ'ዩ። 	Epidemiological data on disease prevalence, causes, and risk factors retrospectively showed that the first SARS patient (index case) had a history of contact with recreational animals.
560	en	ti	 Subsequent seroprevalence investigations indicated that animal traders had a higher prevalence of anti-SARS-CoV IgG compared with that of the general population. 	 ተኸታተልቲ ናይ ኣብ ህዝቢ ዘሎ መጠን ቫይረስ (seroprevalence) ምርመራታት ከምዘርእዩዎ፣ ናይ እንስሳት ነጋዴታት ምስ እቲ ሓፈሻዊ በዝሒ ህዝቢ ክነጻጸሩ ከለዉ ልዑል ናይ ጸረ-SARS-CoV IgG ተሸከምቲ እዮም። 	Consecutive seroprevalence tests have shown that animal traders are high carriers of anti-SARS-CoV IgG compared to the general population.
561	en	ti	 Masked palm civets (Paguma larvata) and a racoon dog in live animal markets were first identified to carry SARS-CoV-like viruses that are almost identical to SARS-CoV. 	 ኣብ እንስሳት ብህይወቶም ዝሽየጥሉ ዕዳጋታት ዝነበሩ ዝተሸፈኑ ዝባዳት (ፓጉማ ላርቫታ)ን ራኩን ኣኻልብን ዳርጋ ምስ SARS-CoV ሓደ ዝኾኑ SARS-CoV ዝመስሉ ቫይረሳት ከምዝሸከሙ ንመጀመርያ ጊዜ ተለልዮም። 	Covered zebras (paguma larvata) and raccoon dogs in live animal markets were identified for the first time as carrying SARS-CoV-like viruses that were almost identical to SARS-CoV.
562	en	ti	 This was indirectly supported by the fact that no further SARS was reported after killing all civets in the markets. 	 ነዚ ሓቂ'ዚ ብተዘዋዋሪ መንገዲ ዘረጋግጽ ጭብጢ ድማ፣ ኣብተን ዕዳጋታት ዝነበሩ ኩሎም ዝባዳት ድሕሪ ምቕታሎም ዝኾነ ተወሳኺ ሕማም SARS ክርአ ዘይምኽኣሉ'ዩ። 	Indirect evidence of this fact is that no further SARS cases were reported after all the zebras in the markets were killed.
563	en	ti	 However, it has been reported that masked palm civets from the wild or farms without exposure to the live animal markets were largely negative for SARS-CoV, suggesting that masked palm civets might only serve as the intermediate amplifying host but not the natural reservoir of SARS-CoV. 	 እንተኾነ ግን፣ ዝተሸፈኑ ናይ በረኻ ወይ ናይ ሕርሻ ዝባዳት ብዘይ ናይ ብሂወት ዘለዉ ናይ እንሰሳት ዕዳጋ ምቅላዕ ብሰፊሑ ን SARS-CoV ኔጌቲቭ እዮም ኔሮም፣ እዚ ድማ ዝተሸፈኑ ዝባዳት ከም መንጎኛ መባዛሕቲ መሕደሪታት እምበር ከም ማእኸላይ መዕቖብቲ SARS-CoV ከምዘይኮኑ የርኢ። 	however, covered wild or agricultural grasslands were broadly negative for SARS-CoV without live animal market exposure, indicating that covered grasslands act as intermediate multiplicative habitats and not as central reservoirs for SARS-CoV.
564	en	ti	 Notably, since 80% of the different animals in the markets in Guangzhou have anti-SARS-CoV antibodies, the possibilities that multiple species of small mammals might also serve as intermediate amplifying hosts of SARS-CoV cannot be excluded. 	 ብግልጺ፣ ካብ 80% ናይ እዞም ዝተፈላለዩ ኣብ ናይ ግዋንግዙ ዕዳጋ ዘለዉ እንስሳት ጸረ-SARS-CoV ኣንቲቦዲታት ስለዘለዎም፣ ናይ ዝተፈላለዩ ዓሌታት ኣናእሽተይ መጥወብቲ ከም መንጎኛ መራብሕቲ መሕደርቲ ናይ SARS-CoV ናይ ምዃን ተኽእሎታት ከምዘሎ ኣብ ግምት ክኣቱ ኣለዎ። 	Apparently, since more than 80% of these different animals in the Guangzhou market have anti-SARS-CoV antibodies, it must be considered that small mammals of different breeds have the potential to act as intermediate breeding grounds for SARS-CoV.
565	en	ti	 All of these appear to be dead-end hosts of SARS-CoV. 	 ኩሎም እዚኦም እቶም ናይ መወዳእታ ናይ SARS-CoV መሕደሪ ይመስሉ። 	All of these appear to be the ultimate residence of SARS-CoV.
566	en	ti	 Subsequent search for the natural animal host of SARS-CoV unveiled a closely related bat CoV, termed SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), which exists in Chinese horseshoe bats. 	 ን ናይ SARS-CoV ተፈጥሮኣዊ እንስሳ መሕደሪ ንምርካብ ኣብ ዝግበሩ ተኸታተልቲ ኣለሻታት፣ ኣብ ናይ ቻይና ናይ ፈረስ ጫማ ለዃዂቶታት ዝርከብ፣ SARS-ዝዛመዱ ርሂኖሎፈስ ለዃዂቶታት CoV HKU3 (SARSr-Rh-BatCoV HKU3) ተባሂሉ ዝጽዋዕ፣ ቀረባ ዝምድና ዘለዎ ናይ ለዃዂቶ CoV ገሊጾም እዮም። 	In a series of searches for the natural animal habitat of SARS-CoV, they have described a closely related mosquito CoV, called SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), which is found in Chinese horseshoe rats.
567	en	ti	 These bats are positive for anti-SARS-CoV antibodies and genome sequence of SARSr-Rh-BatCoV HKU3. 	 እዞም ለዃኺቶታት ንናይ ጸረ-SARS-CoV ኣንቲቦዲታትን ናይ ጄኖም ተኸታታሊ SARSr-Rh-BatCoV HKU3 ፖዚቲቭ እዮም። 	These mice are positive for anti-SARS-CoV antibodies and the genomic sequence SARSr-Rh-BatCoV HKU3.
568	en	ti	 This and other bat CoVs share 88-92% nucleotide sequence homology with SARS-CoV. 	 እዚን ካልኦት ናይ ለኻኺቶ CoVs ምስ SARS-CoV 88-92% ዝመሳሰል ናይ ኒክሎታይድ ኣሰራርዓ ኣካላዊ ተመሳሳሊነት ኣለዎም። 	This and other infectious CoVs have 88-92% physical similarity to SARS-CoV in their nicklotide arrangement.
569	en	ti	 These studies have laid the foundation for the new concept that bats host emerging human pathogens. 	 እዞም መጽናዕቲታት ለዃኺቶታት ኣብ ምምጻእ ዝርከቡ ኣብ ደቂ ሰባት ሕማም ከስዕቡ ዝኽእሉ ባእታት ከሕድሩ ከምዝኽእሉ ዘርኢ ሓድሽ ሓሳብ መሰረት ኣንቢሮም ኣለዉ። 	These studies have laid the foundation for a new idea that insects can infect emerging pathogens in humans.
570	en	ti	 Several SARS-like CoVs (SL-CoVs) have also been identified from bats, but none except for one designated WIV1 can be isolated as live virus. 	 ብተወሳኺ ብዙሓት SARS ዝመስሉ CoVs (SL-CoVs) ካብ ለኻኺቶታት ተለልዮም ክርከቡ ኺኢሎም እዮም፣ እንተኾነ ግን ካብዚእቶም ብዘይካ ሓደ WIV1 ዝተባህለ እንተዘይኮይኑ ካልእ ብህይወቱ ፈሊኻ ክውሰድ ዝተኻለ የለን። 	In addition, many SARS-like CoVs (SL-CoVs) have been identified from infectious agents, but none of these have been isolated alive except for one, WIV1
571	en	ti	 Human angiotensin converting enzyme 2 (ACE2) is known to be the receptor of SARS-CoV. 	 ናይ ደቂ ሰብ ኣንጂዮቴንሲን ቀያሪ ኤንዛይም 2 (ACE2) ናይ SARS-CoV ተቐባሊ ተባሂሉ ዝፍለጥ እዩ። 	Human angiotensin converting enzyme 2 (ACE2) is the well-known host of SARS-CoV.
572	en	ti	 WIV1 derived from fecal sample of bats was demonstrated to use bat, civet and human ACE2 as receptor for cell entry. 	 ካብ ናይ ለኻኺቶታት ናይ ሰገራ ናሙና ዝተወስደ WIV1፣ ናይ ለኻኺቶ፣ ዝባድን ወዲሰብን ACE2 ከም ናይ ዋህዮ መእተዊ ተቐበልቲ ከምዝጥቀም ተራእዩ እዩ። 	WIV1 from insect fecal samples, insect, worm and human ACE2 have been shown to use as cell entry receptors.
573	en	ti	 Intriguingly, sera of convalescent SARS patients were capable of neutralizing WIV1. 	 ብዝገርም መንገዲ፣ ካብ SARS ዝሓወዩ ሕሙማት ዝተረኽበ ደም (ሴራ) ን WIV1 ከጥፍእዎ ክኢሎም እዮም። 	Interestingly, blood (sera) from SARS recovered patients were able to eradicate WIV1.
574	en	ti	 Thus far, WIV1 represents the most closely related ancestor of SARS-CoV in bats, sharing 95% nucleotide sequence homology. 	 ክሳብ እዚ እዋን፣ WIV1 እቲ ኣዚዩ ዝቐረበ ዝምድና ዘለዎ ናይ ለኻኺቶ SARS-CoV ኣበው ክውክል ከሎ፣ 95% ናይ ኒዩክሎታይድ ኣሰራርዓ ምምስሳል ኣለዎ። 	To date, WIV1 represents the most closely related ancestor of the infectious SARS-CoV, with 95% nucleotide sequence similarity.
575	en	ti	 Albeit the high homology between these two viruses, it is generally believed that WIV1 is not the immediate parental virus of SARS-CoV and bats are not the immediate reservoir host of SARS-CoV. 	 ኣብ መንጎ እዞም ክልተ ቫይረሳት ልዑል ምምስሳል ዋላ እንተሃለወ፣ WIV1 ናይ SARS-CoV ቀዳማይ ወላዲ ቫይረስ ከምዘይኮነ ብሓፈሽኡ ይእመን ከምኡ ድማ ለኻኺቶታት ናይ SARS-CoV ቀዳማይ ወለዶ/ቀጥታዊ በቲ ሕማም ዘይጥቅዓ መሕደርቲ ኣይኮናን። 	Despite the high similarity between these two viruses, it is generally believed that WIV1 is not the primary parent virus of SARS-CoV and that infections of SARS-CoV are not first-generation/directly non-infectious hosts.
576	en	ti	 Phylogenetic analysis clusters MERS-CoV to the same group as bat CoV-HKU4 and bat CoV-HKU5. 	 ናይ ወለዶታት ዘገምታዊ ለውጢ ዝምድናታት (Phylogenetic) ትንተና ን MERS-CoV ምስ ናይ ለኻኺቶ CoV-HKU4 ን ናይ ለኻኺቶ CoV-HKU5 ጉጅለ ይምድቦ። 	Phylogenetic analysis classifies MERS-CoV with the infectious CoV-HKU4 and infectious CoV-HKU5 groups.
577	en	ti	 Bat CoV-HKU4 and MERS-CoV utilize the same host receptor, dipeptidyl peptidase 4 (DPP4), for virus entry. 	 ናይ ለኻኺቶ CoV-HKU4ን MERS-CoVን ናብ መዕቆቢ እንስሳ ዝኣትወሉ፣ dipeptidyl peptidase 4 (DPP4) ዝበሃል ሓደ ዓይነት መቐበሊ (receptor) ይጥቀሙ። 	Infectious CoV-HKU4 and MERS-CoV use the same receptor, dipeptidyl peptidase 4 (DPP4), to enter animal shelters.
578	en	ti	 RNA-dependent RNA polymerase sequences of MERS-CoV are phylogenetically closer to counterparts in bat beta-CoVs identified from Europe and Africa. 	 ናይ MERS-CoV ናይ RNA-dependent RNA polymerase ኣሰራርዓ ምስ ኣብ ኣፍሪካን ኣውሮፓን ዝርከቡ ናይ ለኻኺቶ beta-CoVs ዘሎ ናይ ወለዶታት ዘገምታዊ ለውጢ ዝምድናታት (phylogenetic) ምምስሳል ኣለዎም። 	The RNA-dependent RNA polymerase mechanisms of MERS-CoV are similar to the phylogenetic relationships of infectious beta-CoVs in Africa and Europe.
579	en	ti	 Up to now, no live MERS-CoV can be found in wild bats. 	 ክሳብ ሕዚ፣ ኣብ ናይ በረኻ ለዃኺቶታት ዋላ ሓደ MERS-CoV ብህይወት ክርከብ ኣይከኣለን። 	To date, no MERS-CoV has been detected alive in wild boars.
580	en	ti	 MERS-CoV and its closest relative bat CoV-HKU25 share only 87% nucleotide sequence homology. 	 MERS-CoV ን እቲ ናይ ቀረባ ዘመዱ ዝኾነ ናይ ለኻኺቶ CoV-HKU25 ን 87% ጥራይ ናይ ኒክሎታይድ ኣሰራርዓ ተመሳሳልነት ኣለዎም። 	MERS-CoV and its closest relative, the infectious CoV-HKU25, have only 87% nicklotide sequence identity.
581	en	ti	 Thus, bats might not be the immediate reservoir host of MERS-CoV. 	 ስለዚ፣ ለኻኺቶታት ናይ MERS-CoV ቀዳማይ ወለዶ/ቀጥታዊ በቲ ሕማም ዘይጥቅዓ መሕደርቲ ክኾና ይኽእላ እየን። 	Therefore, infections of MERS-CoV may be first-generation/directly non-infectious hosts.
582	en	ti	 On the other hand, studies in Middle East have shown that dromedary camels are seropositive for MERS-CoV-specific neutralizing antibodies, same as camels of Middle East origin in multiple African countries. 	 በቲ ካልእ ወገን፣ ኣብ ማእኸላዊ ምብራቕ ዝተኻየዱ መጽናዕቲታት፣ ናይ ኣዕራብ/ሶማል ኣግማል (dromedary camels) ልክዕ ከምቶም መበቆሎም ካብ ማእኸላይ ምብራቕ ዝኾኑ ኣብ ሓያለ ናይ ኣፍሪካ ሃገራት ዝርከቡ ኣግማል፣ ን MERS-CoV ብፉሉይ ዘምክኑ ኣንቲቦዲታት ከምዝተረኽቦም (ሴሮፖዚቲቭ ከምዝኾኑ) ኣርእዮሞ እዮም። 	On the other hand, studies in the Middle East have shown that dromedary camels, like camels of Middle Eastern origin in several African countries, are seropositive for antibodies that specifically neutralize MERS-CoV.
583	en	ti	 Live MERS-CoV identical to the virus found in humans was isolated from the nasal swabs of dromedary camels, further indicating that camels serve as the bona fide reservoir host of MERS-CoV. 	 ምስ ኣብ ደቂ ሰባት ዝተረኸበ ቫይረስ ሓደ ዓይነት ዝኾነ ሂወታዊ MERS-CoV ካብ ናይ ኣዕራብ/ሶማል ኣግማል ኣፍንጫ ንምርመራ ዝተወስዱ ቫይረስ (nasal swabs) ተለልዩ ክርከብ ተኻኢሉ ክኸውን ከሎ፤ እዚ ድማ ኣግማል ከም ናይ MERS-CoV ሓቀኛ በቲ ቫይረስ ዘይጥቅዑ መሕደርቲ ኮይኖም ከምዘገልግሉ ዘመልክት'ዩ። 	Live MERS-CoV, identical to the virus found in humans, has been identified from nasal swabs of Arabian/Somali camels. This suggests that camels serve as true MERS-CoV-free habitats.
584	en	ti	 It is also noteworthy that generally mild symptoms but massive virus shedding were observed in camels experimentally infected with MERS-CoV. 	 ኣብ ንፈተነ ብ MERS-CoV ዝተለኸፉ ኣግማል ብሓፈሻ ቀለልቲ ምልክታት ምስ ጽዑቕ ናይ ቫይረስ ስርጭት ከምዝተረኣየ ምግላጽ እውን ኣገዳሲ እዩ። 	It is also important to note that in camels experimentally infected with MERS-CoV generally mild symptoms were observed with intense viral transmission.
585	en	ti	 Notably, infected camels shed viruses not only through respiratory route but also through fecal-oral route, which is also the main route for virus shedding from bats. 	 ብግልጺ፣ ዝተለኸፉ ኣግማል ነቲ ቫይረስ ብ ናይ መተንፈሲ መንገዲ ጥራሕ ዘይኮነስ ብካብ መቐመጫ-ናብ-ኣፍ መንገዲ እውን የመሓላልፍዎ እዮም፣ እዚ ድማ ለኻኺቶታት ነዚ ቫይረስ ዘላባዓሉ ዋና መገደን እዩ። 	Clearly, infected camels transmit the virus not only by the respiratory route but also by the seat-to-mouth route, which is the main route by which insects spread the virus.
586	en	ti	 However, questions still remain since many confirmed cases of MERS have no contact history with camels prior to symptom onset, plausibly ascribed to human-to-human transmission or unknown transmission routes involving unrecognized animal species that harbour MERS-CoV. 	 ይኹን ደኣምበር፣ ብዙሓት ዝተረጋገጹ ናይ MERS ሕሙማት ቅድሚ ስሚዒታት ሕማም ምኽሳቱ ምስ ኣግማል ናይ ምንኽካእ ታሪኽ ዘይብሎም ብምዃኑ፣ ሕዚ'ውን ሕቶታት ይሃልዉ ድኣምበር፣ ካብ ሰብ ናብ ሰብ ምምሕልላፋት ውይድማ ን MERS-CoV ዝሽከሙ ዘይተፈልጡ ናይ እንስታታት ዓሌት ዘለውዎ ዘይተፈልጠ ናይ ምምሕልልፋ መስመር ክህሉ ይኽእል እዩ ዝብል ከም ክውንነታዊ ዝኾነ ውሁብ ምኽንያት ይውሰድ። 	However, since many confirmed MERS patients have no history of contact with camels before symptoms develop, there may still be questions about human-to-human transmissions or an unknown transmission route with unknown animal species carrying MERS-CoV is taken as a realistic given.
587	en	ti	 SARS-CoV-2 shares 96.2% nucleotide homology with a bat CoV RaTG13 isolated from Rhinolophus affinis bats. 	 SARS-CoV-2 ምስ ካብ ራይኖለፈስ ኣፊንስ ለኻኺቶታት ዝተወሰደ ናይ ለኻኺቶ CoV RaTG13 96.2% ናይ ኒኩሎታይድ ምምስሳል ኣለዎ። 	SARS-CoV-2 has 96.2% nucleotide identity with infectious CoV RaTG13 from Rhinolephus affins infections.
588	en	ti	 As in the cases of SARS-CoV and MERS-CoV, the sequence divergence between SARS-CoV-2 and RaTG13 is too great to assign parental relationship. 	 ከምቲ ኣብ ናይ SARS-CoV ከምኡ'ውን MERS-CoV ዘሎ ኩነታት፣ ኣብ መንጎ SARS-CoV-2 ከምኡ'ውን RaTG13 ዘሎ ናይ ኣሰራርዓ ፍልልይ ስፍሓት (sequence divergence) ብጣዕሚ ገፊሕ ብምዃኑ ናይ ወላዲን-ውሉድን ዝምድና ኣለዎም ክትብል ዘኽእል ኣይኮነን። 	As in the case of SARS-CoV and MERS-CoV, the sequence divergence between SARS-CoV-2 and RaTG13 is too extensive to suggest a parent-child relationship.
589	en	ti	 That is to say, bats might not be the immediate reservoir host(s) of SARS-CoV-2 unless almost identical bat CoVs are found in future. 	 እዚ ማለት፣ ኣብ መጻኢ ዳርጋ ሓደ ዓይነት ዝኾኑ ናይ ለኻኺቶ CoVs እንተዘይተረኺቦም፣ ለኻኺቶታት ናይ SARS-CoV-2 ቀጥታዊ በቲ ሕማም ዘይልከፋ መሕደርቲ ዘይክኾና ይኽእላ እየን። 	This means that, unless nearly identical infectious CoVs are found in the future, SARS-CoV-2 infections may not be direct non-infectious hosts.
590	en	ti	 Presumably, the intermediate animal hosts of SARS-CoV-2 should be among the wildlife species sold and killed at the Huanan Seafood Wholesale Market, with which many of the initial cases of COVID-19 were associated, indicative of a probable animal-to-human transmission event. 	 እቶም ናይ SARS-CoV-2 ሞንጎኛ መዕቆብቲ እንስታታት ምናልባት ካብቶም ኣብ ሁናን ዝርከብ ናይ ጅምላ ዕዳጋ ዝተሸጡን ዝተሓርዱን ዝተፈላለዩ ዓሌት እንስሳታት ዘገዳም ክኾኑ ኣለዎም፤ ብዙሓት ካብቶም ናይ መጀመርታ ናይ COVID-19 ሕሙማት ምስዚ ዕዳጋ ዝተኣሳስሩ እዮም፣ እዚ ድማ ካብ እንስሳ ናብ ሰብ ዝተመሓላለፈሉ ኣጋጣሚ ክኸውን ከምዝኽእል ዘመልክት'ዩ። 	The SARS-CoV-2 intermediate reservoir animals must probably be from different species of wildlife that were sold and slaughtered at a wholesale market in Hunan; Many of the first cases of COVID-19 were associated with this market, suggesting that it may have been an occasion for animal-to-human transmission.
591	en	ti	 Several recent studies based on metagenomic sequencing have suggested that a group of endangered small mammals known as pangolins (Manis javanica) could also harbour ancestral beta-CoVs related to SARS-CoV-2. 	 ብዙሓት ኣብ ቀረባ ግዘ ዝተገበሩ ኣብ ሜታጂኖሚካዊ ኣሰራርዓ (beta-CoVs) ዝተመርኮሱ መጽናዕቲታት ከምዘርእይዎ፣ ሓደ ጽንተት ዘንጸላልዎ ዘሎ ማንጎሊንስ [pangolins (Manis javanica)] ዝበሃል ጉጅለ ንኣሽቶ መጥበውቲ እንስታታት ን ምስ SARS-CoV-2 ዝዛመድ ኣበው beta-CoVs ከጸግዕ ይኽእል'ዩ። 	Many recent studies based on metagenomic approaches (beta-CoVs) have shown that an endangered group of small mammals called pangolins [pangolins (Manis javanica)] may rely on ancestral beta-CoVs associated with SARS-CoV-2 .
592	en	ti	 These novel pangolin CoV genomes share 85-92% nucleotide sequence homology with SARS-CoV-2. 	 እዞም ሓደሽቲ ናይ ፓንጎሊን CoV ጂኖማት ምስ SARS-CoV-2 85-92% ናይ ኒኩሎታይድ ኣሰራርዓ ተመሳሳልነት ኣለዎም። 	These new pangolin CoV genomes share 85-92% nucleotide sequence similarity with SARS-CoV-2.
593	en	ti	 However, they are equally closely related to RaTG13 with about 90% identity at the level of nucleotide sequence. 	 ነገር ግን፣ ንሳቶም'ውን ብደረጃ ናይ ኑክሊዮታይድ ኣሰራርዓ 90% ምምሳል (identity) ብምርኣይ ምስ RaTG13 ብማዕረ ናይ ቀረባ ዝምድና ኣለዎም። 	However, they are also equally closely related to RaTG13, showing 90% identity at the nucleotide arrangement level.
594	en	ti	 They cluster into two sub-lineages of SARS-CoV-2-like viruses in the phylogenetic tree, one of which share a more similar receptor binding domain (RBD) with SARS-CoV-2, with 97.4% amino acid sequence identity. 	 ንሳቶም ኣብቲ ናይ ወለዶታት ሓረግ (phylogenetic tree) ናብ ክልተ ን SARS-CoV-2 ዝመስሉ ንኡሳን-ሓረጋት ወለዶ ዝጉጀሉ ክኾኑ ከለዉ፣ ሓደ ካብእቶም ድማ 97.4% ናይ ኣሚኖ ኣሲድ ኣሰራርዓ ተመሳሳልነት ብምርኣይ፣ ምስ SARS-CoV-2 ዝያዳ ተመሳሳሊ ሪሰፕተር ባይንዲንግ ዶሜይን [receptor binding domain (RBD)] ኣለዎ። 	They cluster in the phylogenetic tree into two SARS-CoV-2-like sub-lineages, one of which shows 97.4% amino acid arrangement similarity, with the most similar receptor binding domain to SARS-CoV-2 [ 1 ]. receptor binding domain (RBD)].
595	en	ti	 In stark contrast, the RBDs of SARS-CoV-2 and RaTG13 are more divergent, albeit a higher degree of sequence homology genome-wide. 	 ኣብ ክቱር ንጽጽር፣ ዋላ ልዑል ዲግሪ ናይ ጄኖም ኣሰራርዓ ተመሳሳልነት(sequence homology) ይሃልዎም፣ ናይ SARS-CoV-2 ን RaTG13 ን RBD ታት ፍልልዮም እናገፍሐ ዝኸዱ እዮም። 	In extreme contrast, despite their high degree of sequence homology, the RBDs of SARS-CoV-2 and RaTG13 differ widely.
596	en	ti	 An earlier study on diseased pangolins also reported the detection of viral contigs from lung samples, which turn out to be similarly related to SARS-CoV-2. 	 ኣቐዲሙ ኣብ ዝሓመሙ ፓንጎሊናት ዝተገበረ መጽናዕቲ እውን ካብ ናይ ሳንቡእ ናሙና viral contig ምርካቡ ጸብጺቡ እዩ፣ እዚ ድማ ምስ SARS-CoV-2 ተመሳሳልነት ዘለዎ እዩ። 	An earlier study in sick pangolins also reported the detection of viral contig from a lung sample, with similarities to SARS-CoV-2.
597	en	ti	 This study adopted different assembly methods and manual curation to generate a partial genome sequence comprising about 86.3% of the full-length viral genome. 	 እዚ መጽናዕቲ ዝተፈላለዩ መተኣኻኸቢ መንገድታን ኣመራርፃን ብምጥቃም ክፋል ናይ'ቲ ጀኖም ሲክወንስ ፈጢሩ። እዚ ድማ 86.3% ናይቲ ሙሉእ ቁመት ናይቲ ቫይረስ ጀኖም ይዉንን። 	This study used various assembly methods and selections to create part of the genome sequence. This accounts for 86.3% of the entire length of the virus genome.
598	en	ti	 We cannot exclude the possibility that pangolin is one of the intermediate animal hosts of SARS-CoV-2. 	 ፓንጎሊን ናይ SARS-CoV-2 መንጎኛ ናይ እንስሳ መዕቖቢ ናይ ምዃን ዕድል ኣለዎ። 	Pangolins have the potential to be an intermediate animal reservoir for SARS-CoV-2.
599	en	ti	 However, currently there is no evidence in support of a direct pangolin origin of SARS-CoV-2 due to the sequence divergence between SARS-CoV-2 and pangolin SARS-CoV-2-related beta-CoVs. 	 እንተኾነ ግን፣ ኣብ'ዚ ሕዚ እዋን ብምኽንያት ኣብ መንጎ SARS-CoV-2ን ፓንጎሊን ምስ SARS-CoV-2-ዝተተሓሓዙ ቤታ-CoVs ዘሎ ናይ ኣሰራርዓ/ሲክወንስ ፍልልይ፣ SARS-CoV-2 ብቐጥታ ካብ ፓንጎሊን ከምዝመጸ ዝነግር መረዳእታ የለን። 	However, there is currently no evidence that SARS-CoV-2 originated directly from pangolins due to sequence differences between SARS-CoV-2 and pangolins and SARS-CoV-2-associated beta-CoVs.
600	en	ti	 In addition, the distance between SARS-CoV-2 and RaTG13 is even shorter than that between SARS-CoV-2 and pangolin SARS-CoV-2-related beta-CoVs. 	 ብተወሳኺ ኣብ ሞንጎ SARS-CoV-2ን RaTG13 ዘሎ ርሕቐት ካብ ኣብ ሞንጎ SARS-CoV-2ን ምስ ናይ ፓንጎሊን SARS-CoV-2-ዝመሳሰል beta-CoVsን ይሓጽር። 	In addition, the distance between SARS-CoV-2 and RaTG13 is shorter than between SARS-CoV-2 and pangolin SARS-CoV-2-like beta-CoVs.
601	en	ti	 The evolutionary pathway of SARS-CoV-2 in bats, pangolins and other mammals remains to be established. 	 ናይ SARS-CoV-2 ኣብ ለኻኺቶን ፓንጎሊናትን ካልኦት መጥበውቲን ኢቮልሽናዊ መገዱ ክሳብ ሕዚ ኣይተፈለጠን። 	The evolutionary pathway of SARS-CoV-2 in leeches, pangolins, and other mammals remains unknown.
602	en	ti	 Whereas the highest sequence homology has been found in the RBDs between SARS-CoV-2 and pangolin, SARS-CoV-2-related beta-CoVs, SARS-CoV-2 and RaTG13 share the highest genome-wide sequence homology. 	 እቲ ዝለዓለ ናይ ሲክወንስ ተመሳሳልነት ድማ ኣብ RBD ኣብ መንጎ SARS-CoV-2 ን ፓንግልዮንን ዝተረኸበ ኮይኑ፣ SARS-CoV-2-ዝተተሓሓዘ ቤታ-CoVs, SARS-CoV-2 ን RaTG13 ን ድማ ልዑል ናይ መላእ ጄኖም ኣሰራርዓ/ሲክወንስ ተመሳሳልነት ኣለዎም። 	The highest sequence similarity was found in the RBD between SARS-CoV-2 and Panglion, while SARS-CoV-2-associated beta-CoVs, SARS-CoV-2 and RaTG13 have high whole-genome arrangement/sequence similarity.
603	en	ti	 It is highly speculative that the high degree of similarity between the RBDs of pangolin SARS-CoV-2-related beta-CoVs and SARS-CoV-2 is driven by selectivity-mediated convergent evolution. 	 ኣብ ናይ ፓንጎሊ SARS-CoV-2-ዝተተሓሓዘ beta-CoVs RBD ን SARS-CoV-2 ን ዘሎ ልዑል ምምስሳል፣ብ selectivity-mediated (ተመሪጹ-ዝመሓላለፍ) convergent evolution (እናጸበበ ዝኸድ ዝግመታዊ ለውጢ) ዝመጽእ እዩ። 	The high similarity in Pangoli&#39;s SARS-CoV-2-associated beta-CoVs RBD to SARS-CoV-2,is caused by selectivity-mediated (selectively-transmitted) convergent evolution.
604	en	ti	 A counter-proposal is in favour of a recombination between a pangolin SARS-CoV-2-related beta-CoV and RaTG13 in the third wild animal species. 	 ኣብ መንጎ ናይ ፓንግሊዮን ምስ SARS-CoV-2-ዝተተሓሓዘ beta-CoV ን RaTG13 ን ኣብ ሳልሳይ እንስሳ ዘገዳም ዓሌት recombination(ጀነቲካዊ ምድቓል) ንክካየድ ካለእ ሓሳብ የድሊ እዩ። 	Another consideration is needed for recombination between Panglion&#39;s SARS-CoV-2-associated beta-CoV and RaTG13 in a third wildlife species.
605	en	ti	 As a driving force in evolution, recombination is widespread among beta-CoVs. 	 ከም ናይ ግምታዊ ለውጢ(evolution) ዝገንሕ ሓይሊ፣ ምድቓል ናይ ቤታ-CoVs ተስፋሕፊሑ። 	As a rebuking force of hypothetical evolution, the hybridization of beta-CoVs has expanded.
606	en	ti	 The jury is still out on the immediate zoonotic origin of SARS-CoV-2. 	 ናይ SARS-CoV-2 ቀጥታዊ ዙኖቲካዊ መበቆል ገና ኣይተፈልጠን። 	The direct zoonotic origin of SARS-CoV-2 remains unknown.
607	en	ti	 Besides the highly pathogenic HCoVs, the zoonotic origin of HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 have also been studied. 	 ካብቲ ልዑል ናይ ሕምም ናይ ምሳዓብ ክእለት ዘለዎ HcoVs ብተወሳኺ፣ ናይ HCoV-229E, HCoV-OC43, HCoV-NL63 ን HCoV-HKU1 ን ዙኖቲክ መበቆሎም መጽናዕቲ ተገይርሎም እዩ። 	In addition to the HcoVs with high disease-causing ability, the zoonotic origins of HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 have been studied.
608	en	ti	 Phylogenetic evidence indicated that both HCoV-NL63 and HCoV-229E might have originated from bat CoVs, while the parental viruses of HCoV-OC43 and HCoV-HKU1 have been found in rodents. 	 ፋይሎጀኒቲካዊ መረዳእታ HCoV-NL63 ን HCoV-229E ን ካብ ናይ ለኻኺቶ CoVs መጽዮም ከምዝኾኑ የርኢ፣ ናይ HCoV-OC43 ን HCoV-HKU1 ን ድማ ካብ ኣናጹ እዮም መጽዮም። 	Phylogenetic data indicate that HCoV-NL63 and HCoV-229E are derived from infectious CoVs, whereas those of HCoV-OC43 and HCoV-HKU1 are derived from monkeys.
609	en	ti	 It has been reported that a bat CoV termed ARCoV.2 (Appalachian Ridge CoV) detected in North American tricolored bat displayed close relationship with HCoV-NL63. 	 ኣብ ሰሜን ኣሜሪካዊ- ሰለስተ ዝሕብሩ ለኻኺቶ ዝተረኽበ ARCoV.2 (Appalachian Ridge CoV) ዝተባህለ ናይ ለኻኺቶ CoV ምስ HCoV-NL63 ምምስሳል ከምዘለዎ ይሕበር። 	ARCoV.2 (Appalachian Ridge CoV), a tick CoV detected in a North American- three-colored tick, is reported to have similarities to HCoV-NL63.
610	en	ti	 On the other hand, HCoV-229E was genetically related to another bat CoV, termed Hipposideros/GhanaKwam/19/2008, which was detected in Ghana, while camelids have also been suspected as its intermediate host. 	 ብኻልእ ወገን፣ HCoV-229E ምስ ካልእ Hipposideros/GhanaKwam/19/2008 ተባሂሉ ዝፍለጥ፣ ኣብ ጋና ዝተረኸበ ናይ ለኻኺቶ CoV ጀነቲካዊ ምትሕሓዝ ዝነበሮ እዩ፣ ኣግማል ድማ መንጎኛ መዕቆቢ ክኾና ይኽእላ እየን ዝብል ጥርጣረ ኣሎ። 	On the other hand, HCoV-229E was genetically related to another infectious CoV known as Hipposideros/GhanaKwam/19/2008, detected in Ghana, and it is suspected that camels may be an intermediate host.
611	en	ti	 For clarity, the current knowledge on animal origins of known HCoVs is summarized in Figure ​1 and Table 2. 	 ንንጹር መግለጺ፣ ናይ HCoVs ናይ እንስሳ መበቆሉ ክሳብ ሕዚ ዘሎ ፍልጠት ኣብ ስእሊ 1ን ሰንጠረዥ 2 ይርክብ። 	For a clear description, the knowledge to date of the animal origin of HCoVs is found in Figure 1 and Table 2 .
612	en	ti	 Phylogenetic analysis has provided evidence for interspecies transmission events of HCoVs in the history. 	 ፋይሎጀነቲክ ትንተና ኣብ መንጎ ዓሌታት ብዛዕባ ዘሎ ናይ HCoVs ናይ ምምሕልላፍ መረዳእታታት ኣብ ታሪክ ከምዘሎ ይሕብር። 	Phylogenetic analysis reveals that data on the transmission of HCoVs among species are available in history.
613	en	ti	 When HCoV-OC43 crossed species to infect humans from domestic livestock around 1890, a pandemic of respiratory infection was recorded. 	 HCoV-OC43 ካብ እንስሳ ዘቤት ሓሊፉ ንወድሰብ ከጥቅዕ ምስጀመረ ኣብ 1890 ናይ ስርዓተ ምትንፋስ ረኽሲ ለበዳ ተኸሲቱ። 	An epidemic of respiratory infections occurred in 1890 when HCoV-OC43 began to affect humans beyond domestic animals.
614	en	ti	 The interspecies transmission history of HCoV-229E is less clear. 	 ታሪኽ ናይ ኣብ ሞንጎ ዝተፈላለዩ ዓሌታት እንስሳ ናይ HCoV-229E ምምሕልላፍ ንጹር ኣይኮነን። 	The history of interspecies transmission of HCoV-229E is unclear.
615	en	ti	 Bat alpha-CoVs closely related to HCoV-229E have been found. 	 ናይ ሎዃኺቶ alpha-CoVs ምስ HCoV-229E ዝለዓለ ምምስሳል ሃሊዎም ተረኺቡ ኣሎ። 	Local alpha-CoVs have been found to have the highest similarity to HCoV-229E.
616	en	ti	 Between them there is an alpaca alpha-CoV. 	 ኣብ መንጎኦም alpaca alpha-CoV ኣሎ። 	Among them is alpaca alpha-CoV.
617	en	ti	 Several lines of evidence support the transmission of virus from bats to humans directly. 	 እቲ ቫይረስ ብቐጥታ ካብ ለኻኺቶ ናብ ሰባት ከምዝትሓላለፍ መረዳእታት ይሕብሩ። 	Evidence suggests that the virus is transmitted directly from infected persons to humans.
618	en	ti	 First, humans but not alpacas might have contact with bats in a shared ecological niche. 	 ቅድሚ ኣልፓካስ፣ ሰባት ምስ ለኻኺቶ ኣብ ተመሳሳሊ ናይ ስነ ምህዳር ሰፈር ምትንኽኻፍ ነይርዎም። 	Before alpacas, people had contact with leeches in the same ecosystem.
619	en	ti	 Instead, humans have close contact with alpacas. 	 ኣብ ክንድኡ፣ ሰባት ምስ ኣልፔካታት ቀረባ ርክብ ኣለዎም። 	Instead, people have a close relationship with alpecas.
620	en	ti	 Second, HCoV-229E-related bat alpha-CoVs are diverse and non-pathogenic in bats, whereas alpaca alpha-CoV caused an outbreak of respiratory disease in infected animals. 	 ካልኣይ፣ ምስ HCoV-229E-ዝተተሓሓዙ ናይ ለኻኺቶ alpha-CoVs ኣብ ለኻኺቶ ፍሉያትን ሕማም ዘየስዕቡን እዮም፣ ይኹን ደኣምበር alpaca alpha-CoV ኣብ ዝተለኸፉ እንስሳት ናይ መተንፈሲ ኣካላት ሕማም ለበዳ የስዕብ እዩ። 	Second, HCoV-229E-associated tick alpha-CoVs are specific to ticks and do not cause disease, however alpaca alpha-CoV causes respiratory disease outbreaks in infected animals.
621	en	ti	 Finally, alpaca alpha-CoV has not been found in feral animals. 	 ኣብ መወዳእታ፣ alpaca alpha-CoV ኣብ ኣራዊት እንስሳት ኣይተረኸበን። 	Finally, alpaca alpha-CoV has not been detected in feral animals.
622	en	ti	 Thus, the possibility cannot be excluded that alpacas obtain the HCoV-229E-related alpha-CoV from humans. 	 ስለዝኾነ ድማ፣ ኣልፔካታት ነዚ ምስ HCoV-229E-ዝተተሓሓዘ alpha-CoV ካብ ደቂ ሰባት ሓሊፍዎም ክኸውን እውን ይኽእል እዩ ዝብል ሓሳብ ክንጸግ ኣይክእልን። 	Therefore, the possibility that alpecas may have passed on this HCoV-229E-associated alpha-CoV from humans cannot be ruled out.
623	en	ti	 In fact, bats are the direct source of human pathogenic viruses including rabies virus, Ebola virus, Nipah virus and Hendra virus. 	 ብሓቂ፣ ለዃኺቶታት ናይ ሰባት ሕማም መምጽኢ ቫይረሳት ቀጥተኛ ምንጪታት እዮም ከም ራቢስ ቫይረስ፣ ኢቦላ ቫይረስ፣ ኒፋ ቫይረስን ሄንድራ ቫይረስን ሓዊስካ። 	In fact, ticks are direct sources of human disease-causing viruses, including rabies virus, Ebola virus, Nipha virus, and Hendra virus.
624	en	ti	 It is therefore not too surprising that bats might transmit HCoV-229E to humans directly. 	 በዚ ድማ ለዃኺቶታት HCoV-229E ብቐጥታ ናብ ሰባት ከመሓላልፋ ምኽኣለን ዘገርም ኣይኮነን። 	Thus, it is not surprising that ticks can transmit HCoV-229E directly to humans.
625	en	ti	 Alternatively, whereas bat alpha-CoVs serve as the gene pool of HCoV-229E, alpacas and dromedary camels might serve as intermediate hosts that transmit viruses to humans, exactly as in the case of MERS-CoV. 	 ዋላ'ኳ ናይ ለኻኺቶ alpha-CoVs ናይ HCoV-229E ምጸገዕቲ እንተኾኑ ከም ኣልፓካስን ናይ ዓረብ ገመልን ዝኣመሰሉ እንስሳት MERS-CoV ከመሓላልፉ ይኽእሉ እዮም። 	Although infectious alpha-CoVs are dependent on HCoV-229E, animals such as alpacas and Arabian camels can transmit MERS-CoV.
626	en	ti	 MERS-CoV serves as an excellent example of interspecies transmission from bats to dromedary camels and from dromedary camels to humans. 	 MERS-CoV ከም ብሉጽ ኣብነት ናይ መንጎ ዓሌታዊ ምምሕልላፍ ካብ ለኻኺቶ ናብ ድሮሜዳሪ ኣግማል ከምኡ'ውን ካብ ድሮሜዳሪ ኣግማል ናብ ሰባት ክውሰድ ይከኣል እዩ። 	MERS-CoV can be considered as an excellent example of interspecific transmission from insects to dromedary camels and from dromedary camels to humans.
627	en	ti	 The evolutionary origin of MERS-CoV from bats is known at its initial identification and has also been strengthened by subsequent findings. 	 ናይ MERS-CoV መበቆላዊ ኣመጻጽኣ ካብ ለኻኺቶ ምዃኑ ካብ ፋልማይ ዝተለለየሉ ግዘ ኣትሒዙ ዝፍለጥ ኮይኑ፣ እዚ ከኣ ድሒሮም ዝተረኽቡ መረዳእታታት እናተጠናኸረ መጽዩ። 	The origin of MERS-CoV has been known to be infectious since it was first identified, and this has been reinforced by subsequent evidence.
628	en	ti	 It is obvious that bats provide a rich pool of virus species for interspecies exchange of genetic fragments and interspecies transmission. 	 ለኻኺቶታት ን ኣብ መንጎ ዓሌታት ዝግበር ናይ ጀነቲካዊ ባእታታት ልውውጥን፣ ምምሕልላፍትን፣ ብዙሓት ናይ ቫይረሳት ዓሌታት ሒዞም ከምዝርከቡ ግልጺ እዩ። 	Infections and the exchange of genetic elements between species, transmission, obviously carry many strains of viruses.
629	en	ti	 Longevity, densely packed colonies, close social interaction and strong ability to fly are all favourable conditions for bats to be an ideal 'virus spreader'. 	 ለኻኺቶ ናይ'ዚ ቫይረስ ቀንዲ መመሓላለፊ ዝኾነሉ ምኽንያት ነዊሕ ዕድመ፣ ጽዑቕ መንበሪ፣ ምቅርራብን ናይ ምብራር ዓቕምን ስለዘለዎ እዩ። 	The leukemia is the main vector of the virus because of its longevity, dense residence, proximity and ability to fly.
630	en	ti	 On the other hand, MERS-CoV has been introduced to dromedary camels for decades. 	 ብካልእ ገጹ ድማ፣ MERS-CoV ንዓሰርተታት ዓመታት ናብ ድሮሜዳሪ ኣግማል ተኣታትዩ እዩ። 	On the other hand, MERS-CoV has been introduced into dromedary camels for decades.
631	en	ti	 It is well adapted to these camels that have turned from an intermediate host to a stable and natural reservoir host. 	 ምስዞም ኣግማል ብዕዉት ዝተላመደ ብምዃኑ፣ እዞም ኣግማል ካብ ግዝያዊ ናብ ቀዋሚ መቐመጢ ተለዊጦም። 	Having successfully adapted to these camels, these camels were converted from temporary to permanent residences.
632	en	ti	 MERS-CoV causes very mild disease and maintains a relatively low mutation rate in these animals. 	 ኣብዞም እንስሳት MERS-CoV ቀሊል ሕማም እዩ ዘምጽእ; ምልውዋጥ(mutation) ናይ ምክያድ ክእለቱ ድማ ትሑት አዩ። 	In these animals, MERS-CoV causes mild disease; Its ability to mutate is low.
633	en	ti	 Its sporadic transmission to humans is an accident and humans remain a dead-end host of MERS-CoV as its transmission cannot be sustained. 	 ናይ'ዚ ሕማም ዘይስሩዕ ምትሕልላፉ ናብ ሰብ ወዝቢ ብምዃኑን፣ ወድ ሰብ ናይ MERS-CoV ናይ መወዳእታ ተሸካሚ ስለዝኾነን እቲ ዝርግሐ/ለበዳ ቀጻልነቱ ድሩት እዩ። 	Because of the irregular transmission of the disease to humans, and because humans are the ultimate carriers of MERS-CoV, the spread/outbreak is limited in continuity.
634	en	ti	 In contrast to the role of camels in the transmission of MERS-CoV, the role of pangolins, if there is any, in the transmission of SARS-CoV-2 is different. 	 በንጻሩ ድማ ኣብ ናይ MERS-CoV-2ምምሕልላፍ ፓንጎሊናት ዝጻወትዎ ተራ(ናይ ብሓቂ ተራ እንተሃልይዎ) ካብ ናይ ኣግማል ተራ ዝተፈልየ እዩ። 	Conversely, the role(if any) of pangolins in MERS-CoV-2 transmission is different from that of camels.
635	en	ti	 Particularly, pangolin beta-CoVs are highly pathogenic in pangolins. 	 ብፍላይ፣ ፓንጎሊን ቤታ -CoVs ኣብ ፓንጎሊናት ልዑል ሕማም ናይ ምስዓብ ክእለት ዘለዎም እዮም። 	Specifically, pangolin beta -CoVs are capable of causing high disease in pangolins.
636	en	ti	 They might be a dead-end host for SARS-CoV-2-related beta-CoVs, similar to civets in the case of SARS-CoV. 	 ልክዕ ከም ናይ SARS-CoV ዝባድ ኬዛት፣ ናይ መወዳእታ መሕደሪ ናይ SARS-CoV-2-ዝተተሓሓዘ ቤታ-CoVs ክኾኑ ይኽእሉ። 	Like severe cases of SARS-CoV, they can be the final residence of SARS-CoV-2-associated beta-CoVs.
637	en	ti	 Several possibilities for interspecies transmission of SARS-CoV-2 from animals to humans have to be ruled in or ruled out in future studies. 	 ዝተፈላለዩ ናይ SARS-CoV-2 ካብ እንስሳታት ናብ ሰባት ምምሕልላፍ መገድታት ኣብ ቐጻሊ ምርምራት ክትንተኑ ትጽቢት ይግበር። 	Various animal-to-human transmission routes of SARS-CoV-2 are anticipated to be analyzed in ongoing investigations.
638	en	ti	 First, bats could be the reservoir host of a SARS-CoV-2-related virus almost identical to SARS-CoV-2. 	 መጀመርያ፣ ለኻኺቶ ምስ ን SARS-CoV-2 ዝመስል ምስ SARS-CoV-2 ዝዛመድ ቫይረስን መሕደሪ ኮይኑ ከገልግል ይኽእል እዩ። 	First, the infection can serve as a host for SARS-CoV-2-like and SARS-CoV-2-related viruses.
639	en	ti	 Humans might share the ecological niche with bats through butchering or coal mining. 	 ሰባት ብምሕራድ ወይ ፈሓም ዕደና ምስ ለኻኺቶታት ኢኮሎጂካዊ ኒች ክካፈሉ ይኽእሉ። 	People can share ecological niches with insects through slaughter or charcoal mining.
640	en	ti	 Second, pangolins could be one of intermediate amplifying host to which a SARS-CoV-2-related virus had been newly introduced. 	 ብተወሳኺ ድማ ፓንጎሊን ዝተብሃለ እንስሳ ካብቶም ናይቲ ቫይረስ ዓቕሚ ዘጉልሑ ናይ ማእኸላይ ቫይረስ ተሸከምቲ እንሳታት ሓደ ብምዃኑ ንSARS-CoV-2 ዝመስል ቫይረስ ተረኺብዎ። 	In addition, the pangolin was found to be one of the intermediate vector animals highlighting the potential of the virus, resulting in the detection of a SARS-CoV-2-like virus.
641	en	ti	 Humans contract the virus through butchering and consumption of game meat. 	 እቲ ቫይረስ ናብ ሰባት ስጋ ኣብ ዝሓርድሉን ዝበልዕሉን ግዘ እዩ ዝሓልፎም። 	The virus is passed on to people when they slaughter and eat meat.
642	en	ti	 It is possible that many mammals including domestic animals are susceptible to SARS-CoV-2. 	 ዘቤታውያን እንስሳት ሓዊስካ ብዙሓት መጥወብቲ እንስሳት ን SARS-CoV-2 ተቓላዕቲ ክኾኑ ይኽእሉ እዮም። 	Many mammals, including domestic animals, may be susceptible to SARS-CoV-2.
643	en	ti	 A survey of domestic and wild animals for antibodies is warranted. 	 ኣብ ናይ ዱር እንስሳትን እንስሳት ዘቤትን ናይ ጸረ-ነፍሳት መጽናዕቲ ምግባር ኣድላዪ እዩ። 	Antibiotic studies in wildlife and domestic animals are necessary.
644	en	ti	 Third, as mentioned above, recombination and adaptation of SARS-CoV-2 might have occurred in a third species that has contact with both bats and pangolins. 	 ሳልሳይ፣ ኣብ ላዕሊ ከምዝተጠቐሰ፣ ናይ SARS-CoV-2 ምትሕውዋስን(recombination) ምልማድን ኣብ ሳልሳይ ዓሌት ዝተፈጠረ ክኸውን ይኽእል፣ ማለት ምስ ክልኢቶም ለኻኺቶን ፓንጎሊንን ርክብ እንተነይርዎ። 	Third, as mentioned above, SARS-CoV-2 recombination may have occurred in a third species, ie if it had contact with both the tick and the pangolin.
645	en	ti	 The search for the animal origins of SARS-CoV-2 is still on. 	 ናይ SARS-CoV-2 መበቆል እንስሳ ምድላይ ክሳብ ሕዚ ኣብ መስርሕ ይርከብ። 	The search for the animal of origin of SARS-CoV-2 is still in progress.
646	en	ti	 Apart from different types of the animal hosts, three major factors on the viral side are also important in facilitating CoVs to cross species barriers. 	 ካብ እዞም ዝተፈላለዩ ዓይነታት ናይ እንስሳ መዕቖቢ፣ CoVs ናብ ካልእ ዓሌት ንከይሰግር ንምግዳብ ሰለስተ ዓበይቲ ሜላታት ኣለዉ። 	From these different types of animal shelters, there are three major methods to limit the spread of CoVs to another species.
647	en	ti	 First of all, their relatively high mutation rates in RNA replication. 	 ቅድሚ ኹሉ፣ ኣብ RNA ምርባሕ(replication) ዘለዎም ልዑል ናይ ጀነቲካዊ ለውጢ(mutation) ንጽጽራዊ መጠን። 	First of all, their relatively high rate of genetic mutation in RNA replication.
648	en	ti	 In comparison to other single-stranded RNA viruses, the estimated mutation rates of CoVs could be regarded as “moderate” to “high” with an average substitution rate being ~10-4 substitution per year per site 2, depending on the phase of CoV adaptation to novel hosts. 	 ምስ ካልኦት ንጽል ገመድ ዘለዎም(single stranded) RNA ቫይረሳት ክወዳደር ከሎ፣ ናይ CoVs ምልዋወጥ መጠን(mutation rate) ካብ ማእኸላይ ክሳብ ዝለዓለ ከምዝኾነ ይሕሰብ። ኣብ ሳይት 2 ብኣቨሬጅ ኣብ ዓመት ~10-4 ናይ ምትካእ ፍጥነት ኣለዎ፣ ነዚ ድማ CoV ምስ'ቲ ሓድሽ ተሸካማይ ዘለዎ ምልምማድ ይዉስኖ። 	Compared to other single stranded RNA viruses, the mutation rate of CoVs is thought to be moderate to high. Site 2 has an average replacement rate of ~10-4 per year, which is determined by CoV&#39;s adaptation to the new carrier.
649	en	ti	 CoVs have a proof-reading exoribonuclease, deletion of which results in exceedingly high mutability and attenuation or even inviability. 	 CoVs proof-reading exoribonuclease ኣለዎም። ናይዚ ምጥፋእ ድማ ዝለዓለ ምልማድን ምቅይያርን ዋላ'ውን ሞት የስዕብ። 	CoVs have a proof-reading exoribonuclease. The loss of this leads to increased habituation and changes and even death.
650	en	ti	 Interestingly, the nucleotide analogue Remdesivir is known to suppress CoV replication through inhibition of this exoribonuclease and the RNA-dependent RNA polymerase. 	 እቲ ረምዲስቪር(Remdesivir) ተባሂሉ ዝጽዋዕ ናይ ኒኩሎታይድ ኣናሎግ ንኢክዞራይቦኒዩክሊዝን (exoribonuclease) ናይ RNA ጽግዕተኛ RNA ፖሊመሬዝን(RNA-dependent RNA polymerase) ደው ብምባል ምርባሕ CoVs ይከላኸል። 	The nucleotide analog remdesivir prevents the reproduction of CoVs by inhibiting exoribonuclease and RNA-dependent RNA polymerase.
651	en	ti	 Remdesivir is one of most promising anti-SARS-CoV-2 agents to be tested in clinical trials. 	 ካብ'ቶም ኣብ ክሊንካዊ መጽናዕቲ ዘለዉ ጸረ SARS-CoV-2 መድሃኒታት፣ እቲ ዝለዓለ ተስፋ ዘለዎ Remdesivir እዩ። 	Of the anti-SARS-CoV-2 drugs in clinical trials, the most promising is Remdesivir.
652	en	ti	 Nevertheless, mutation rates of CoVs are about a million times higher than those of their hosts. 	 እንተኾነ እውን፣ ናይ CoVs መጥነ ምልውዋጥ(mutation rate) ልዕሊ ናይ መሕደሪታቶም ብሚልዮናት ይበልጹ። 	However, the mutation rate of CoVs is millions of times higher than that of their hosts.
653	en	ti	 In addition, mutation rate is often high when CoVs are not well adapted to the host. 	 ብተወሳኺ ምስ መጸገዕቲ ዘይምልማድ ኣብዝህሉ ግዘ፣ CoVs ልዑል መጠነ ምልውዋጥ ይህልዎም። 	In addition, when there is no adaptation to dependencies, CoVs have a high degree of variability.
654	en	ti	 Compared to SARS-CoV with a high mutation rate, the mutation rate of SARS-CoV-2 is apparently lower, suggestive of a higher level of adaptation to humans. 	 ምስ ልዑል መጠነ ምልውዋጥ ዘለዎ SARS-CoV ምስዝወዳደር፣ ናይ SARS-CoV-2 መጠነ ምልውዋጥ ትሑት እዩ፣ እዚ ድማ ልዑል ምስ ሰባት ናይ ምልማድ ዓቅሚ ከመዘለዎ የርኢ። 	Compared to SARS-CoV, which has a high mutation rate, SARS-CoV-2 has a low mutation rate, indicating a high adaptability to humans.
655	en	ti	 Presumably, it has already been adapted to another host close to humans. 	 ምናልባት ናብ ሰባት ካብ ምስ ሰባት ምቅርራብ ዘለዎም እንስሳት ቀዲሙ ተመሓላሊፉ ክኸውን ይኽእል። 	It may have been transmitted to humans earlier than animals close to humans.
656	en	ti	 In addition to SARS-CoV-2, this also applies to MERS-CoV, which is well adapted to dromedary camels. 	 ልክዕ ከም SARS-CoV-2፣ እዚ እንኮላይ ን MERS-CoV እውን ይምልከት። MERS-CoV ምስ ድሮሜዳሪ ኣግማል ብጽቡቕ ዝተላመደ እዩ። 	Just like SARS-CoV-2, this even applies to MERS-CoV. MERS-CoV is well adapted to dromedary camels.
657	en	ti	 Theoretically, it is unlikely that genetic drift would render vaccines and antivirals against SARS-CoV-2 ineffective quickly. 	 ብዓይኒ ስነ ሓሳብ ብምራእ፣ እቲ ናይ ጀነቲክስ ኣፈላላይ ንSARS-CoV-2 ዝስራሕ ክታበት ወይ ድማ ጸረ-ቫይረስ መድሃኒታት ዘይዉጽኢታዊ ኣይገብሮን። 	From a theoretical point of view, the genetic differences do not make SARS-CoV-2 vaccines or antiviral drugs ineffective.
658	en	ti	 Second, the large RNA genome in CoVs exerts extra plasticity in genome modification for mutations and recombination, thereby increasing the probability for interspecies co-evolution, which is advantageous for the emergence of novel CoVs when the conditions become appropriate. 	 ካልኣይ፣ እቲ ኣብ CoVs ዘሎ ዓብዪ ናይ RNA ጄኖም፣ ኣብ ንጀነቲካዊ ለውጢ(mutations)ንጀነቲካዊ ምድቓል(recombination) ዝግበሩ ናይ ጄኖም ምምሕያሻት ተወሳኺ ተለጣጢነት ብምስዓብ፣ በዚ ድማ ዕድል ናይ ካብ ዓሌት ናብ ዓሌት ዝግበር ሓባራዊ ለውጢ(evolution) ይውስኽ፣ ኩነታት ኣብ ዝጥዕሙሉ እቲ ሓድሽ CoVs ንኽምዕብል ድማ ይጥዕሞ። 	Second, the large RNA genome in CoVs results in increased flexibility in genome modifications for mutations and recombination, thereby increasing the likelihood of species-to-species co-evolution, where conditions are favorable It suits the development of new CoVs.
659	en	ti	 This is supported by the copious unique open reading frames and protein functions encoded towards the 3′ end of the genome. 	 እዚ ድማ ኣብ ናይ 3’ ጫፍ ናይቲ ጄኖም ዝተቐመጡ ብዙሓት ፈለምቲ ናይ ንባብ ሳንዱቕ(reading frames)ን ስራሕ ፕሮቲንን ዝድግፍዎ ሓቂ እዩ። 	This is a fact supported by many pioneering reading frames and protein functions positioned at the 3&#39; end of the genome.
660	en	ti	 Third, CoVs randomly and frequently switch templates during RNA replication through a unique “copy-choice” mechanism. 	 ሳልሳይ ድማ ኣብ እዋን ምርባሕ RNA፣ CoVs ሃንደበታውን ብብዝሕን ቅርጾምን ቦትኦምን ይቕይሩ። 	Third, during RNA replication, CoVs abruptly and massively change their shape and position.
661	en	ti	 In a host that serves as the mixing vessel, strand switching occurs frequently during CoV RNA transcription. 	 ኣብ'ቲ መተሓዋወሲ ኮይኑ ዘገልግል መዕቖቢ እንስሳ፣ ኣብ እዋን CoV RNA ትራንስክሪፕሽን ናይ ስትራንድ ምቅይያር ብተደጋጋሚ ይፍጠር እዩ። 	In the host animal that serves as a mixture, strand changes occur frequently during CoV RNA transcription.
662	en	ti	 Highly homologous full-length and subgenomic RNAs could recombine to generate new CoVs. 	 ብጣዕሚ ዝመሳሰሉ ሙሉእ ቁመትን ሳብጀኖሚክን ዝኾኑ RNA ተጣሚሮም ሓድሽ CoVs ይፈጥሩ። 	Highly similar full-length and subgenomic RNAs are paired to form new CoVs.
663	en	ti	 Phylogenetic evidence of natural recombination has been found in both HCoV-HKU1 and HCoV-OC43, as well as animal CoVs such as bat SL-CoV and batCoV-HKU9. 	 ኣብ HCoV-HKU1ን HCoV-OC43ን ከምኡ'ዉን ኣብ ከም ለኻኺቶ SL-CoV and ለኻኺቶ CoV-HKU9 ዝኣመሰሉ ንእንስሳ ዘጥቅዑ CoVs ቫይረሳት ናይ ተፈጥራዊ ሪኮምብኔሽን ፋይሎጀነቲክስ መረዳእታ ተረኺቡ። 	Natural recombination phylogenetic data were obtained in HCoV-HKU1 and HCoV-OC43 and in animal-infecting CoVs viruses such as infectious SL-CoV and infectious CoV-HKU9.
664	en	ti	 Virus-host interaction in relation to transmission 	 ኣብ መንጎ መዕቖብን ቫይረስን ዘሎ ርክብ ምስ ተመሓላለፍነት ክነጻጸር ከሎ 	Relationship between host and virus compared to transmissibility
665	en	ti	 Besides three viral factors stated above, viral interaction with host receptor is another key factor influential on interspecies transmission. 	 ከም ተወሳኺ ናይ'ቶም ኣብ ላዕሊ ዝተጠቐሱ ሰለስተ ናይ ቫይረስ ረቛሒታት፣ እቲ ቫይረስ ምስ ናይ መሕደሪኡ ተቐበልቲ ዘለዎ ርክብ ንመንጎ ዓሌታዊ ተመሓላላፍነቱ ዝውስን ዓቢ ረቛሒ እዩ። 	In addition to the three viral factors mentioned above, the virus&#39;s relationship with its hosts is a major factor in determining its interracial transmission.
666	en	ti	 Herein, recombination of SARS-CoV is taken as a typical example, which also showed evidence of positive selection during interspecies transmission events. 	 ናይ SARS-CoV ጥምረት ከም ኣብነት ምዉሳድ ይከኣል እዩ። እዚ ድማ ኣብ እዋን መንጎ ዓሌታዊ ተመሓላላፍነት ኣወንታዊ ምርጫ ከምዝካየድ የረድእ። 	The SARS-CoV combination is an example. This suggests positive selection during interracial transmission.
667	en	ti	 Based on the comparative analysis between isolates of human and civet SARS-CoVs, SARS-CoV is thought to undergo rapid adaptation in different hosts, particularly with mutations at the RBD of the S protein. 	 ኣብ መንጎ ናይ ሰባትን ዝባድን SARS-CoVsዝተገበረ ንጽጽር , SARS-CoV ኣብ ዝተፈላለዩ መሕደሪታት ብቐሊሉ ከምዝለማመድ ኣርእዩ፣ ብፍላይ ናይ RBD ናይ S ፕሮቲን ጀነቲካዊ ለውጢ (mutations) ብምጥቃም። 	A comparison between human and zebrafish SARS-CoVs , showed that SARS-CoV readily adapts to a variety of niches, specifically using genetic mutations of the RBD of the S protein.
668	en	ti	 Generally, the RBD in the S protein of a CoV interacts with the cellular receptor and is intensely selected by the host antibody response. 	 ብሓፈሻ፣ ኣብ ናይ CoV S ፕሮቲን ዘሎ RBD ምስ እቲ ዋህዮኣዊ ተቐባሊ ይራኸብ እዩ፣ በቲ ናይ እቲ መሕደሪኡ ኣንቲቦዲ ምላሽ ድማ እዩ ዝምረጽ። 	Generally, the RBD in the CoV S protein interacts with the cellular host, and is selected by the antibody response of its host.
669	en	ti	 In SARS-CoV, the RBD is in the 318th to 510th amino acids on the S1 fragment, which binds to the human ACE2 as well as its coreceptors for viral entry. 	 ኣብ SARS-CoV፣ RBD ኣብ መበል 318 ክሳብ 510 ኣሚኖኣሲድ ኣብ S1 ፍራግመንት እዩ ዝርከብ፣ ምስ ናይ ሰባት ACE2 ን ተሓባበርቲ ተቐበልቱን ብምጥባቕ ድማ ንምእታው ቫይረስ ይሕግዝ። 	In SARS-CoV, the RBD is located at the 318th to 510th amino acids in the S1 fragment, and aids virus entry by binding to human ACE2 and its co-receptors.
670	en	ti	 The RBD of SARS-CoV is capable of recognizing the ACE2 receptors of various animals, including bat, civet, mouse and raccoon dog, allowing interspecies transmission of the virus. 	 እቲ ናይ SARS-CoV ዝኾነ RBD፣ ናይ ለኻኺቶ፣ ዝባድ፣ ኣንጭዋን ራኩንን ከልቢን ዘጠቓልል ዝተፈላለዩ እንስሳት ACE2 ተቐበልቲ ናይ ምፍላጥ ተኽእሎ ኣለዎ፣ እዚ ድማ መንጎ ዓሌታዊ ምምሕልላፍ ዘፍቅድ እዩ። 	The RBD of SARS-CoV has the potential to recognize ACE2 receptors of a variety of animals, including leeches, zebrafish, mice, and raccoons and dogs, allowing for interspecies transmission.
671	en	ti	 In fact, only 6 amino acid residues were observed to be different from human and civet viral isolates in the RBD and 4 of them locate in the receptor-binding motif for interaction with the ACE2 receptor. 	 ብርግጽ ኣብ'ቲ RBD ናይ ካብ ሰባትን ዝባድን ዝተወስዱ ቫይረሳትን፣ 6 ናይ ኣሚኖ ኣሲድ ጽራር(residue) ፍልልያት ጥራሕ ከምዘለዎ ተራእዩ፣ እቶም 4 ድማ ምስ ናይ ACE2 ተቐባሊ ዘራኽብ ሰፈር እዮም ዝርከቡ። 	Indeed, in the RBD of viruses derived from humans and Zbad, it was found to have only 6 amino acid residue differences, 4 of which are located in the neighborhood that binds to the ACE2 receptor.
672	en	ti	 Civet SARS-CoV has K479N and S487T mutations in its RBD, which might increase the affinity of the interaction of spike protein with human ACE2 receptor. 	 ናይ ዝባድ SARS-CoV K479N ን S487T ን ጀነቲካዊ ለውጢ(mutations) ኣብ RBD ኣለዎ፣ እዞም ስፓይክ ፕሮቲናት ምስ ናይ ሰብ ACE2 ተቐበልቲ ናይ ምትእትታው ዓቕሙ ልዑል ክገብሮ ይኽእል እዩ። 	Zbad SARS-CoV has K479N and S487T genetic changes(mutations) in the RBD, these spike proteins may enhance its ability to interact with human ACE2 receptors.
673	en	ti	 In other words, these two amino acid substitutions might be critical to viral adaption to humans. 	 ብካልእ ኣበሃህላ፣ እዞም ክልተ ናይ ኣሚኖ ኣሲድ ተተካእቲ ናይ'ቲ ቫይረስ ምስ ሰባት ዘለዎ ተለማማድነት ወሰንቲ ክኾኑ ይኽእሉ እዮም። 	In other words, these two amino acid substituents may be critical to the virus&#39; adaptability to humans.
674	en	ti	 It is noteworthy that SARS-CoV-2 shares the same cellular receptor with SARS-CoV. 	 SARS-CoVs-2 ምስ SARS-CoV ሓደ ዓይነት ናይ ዋህዮ ተቐባሊ ከምዘለዎም ትኹረት ክወሃቦ ይግባእ። 	It should be emphasized that SARS-CoVs-2 share the same cellular receptor as SARS-CoV.
675	en	ti	 A 30% difference between SARS-CoV-2 and SARS-CoV in the S1 unit of the S protein implicates that the binding affinity of its S protein with human ACE2 might have altered. 	 ኣብ S1 ዩኒት ናይ S ፕሮቲን ናይ 30% ፍልልይ ኣብ መንጎ SARS-CoV-2 ን SARS-CoV ን ዘሎ፣ S ፕሮቲኑ ምስ ናይ ሰባት ACE2 ናይ ምትሕሓዝ ዓቕሙ ከምዝልውጦ የርኢ። 	The 30% difference in the S1 unit of the S protein between SARS-CoV-2 and SARS-CoV, shows that its S protein modulates its ability to interact with human ACE2.
676	en	ti	 Indeed, a cryo-EM study indicates a 10- to 20-fold higher affinity of this binding than that between human ACE2 and SARS-CoV S protein. 	 ኣብ cryo-EM ዝተገብረ መጽናዕቲ ካብ ኣብ ሰባት ዝርከብ ACE2ን ናይ SARS-CoV S ፕሮቲን ዘለዎ ጥምረት ብ10 ክሳብ 20 ዕጽፊ ይልዕል። 	in cryo-EM studies is 10- to 20-fold higher than the combination of ACE2 and the SARS-CoV S protein in humans.
677	en	ti	 It will also be of interest to determine whether any other coreceptor might be required for SARS-CoV-2 transmission. 	 SARS-CoV-2 ንኽመሓላለፍ ካልእ ተወሳኺ ተቐባሊ ዘድሊ ምዃኑ እዉን ክነረጋግጽ ይግባእ። 	We should also confirm that another additional host is required for SARS-CoV-2 to be transmitted.
678	en	ti	 Intriguingly, HCoV-NL63 also binds to ACE2 but with a different part of S. 	 ብዘገርም ኩነታት፣ HCoV-NL63 ብዝተፈለየ ናይ S ክፋል ምስ ACE2 እውን ይተሓሓዝ እዩ። 	Surprisingly, HCoV-NL63 also binds to ACE2 through a separate S segment.
679	en	ti	 There exist many other HCoV receptors, such as aminopeptidase N for HCoV-229E, and 9-O-acetylated sialic acid for HCoV-OC43. 	 ብዙሓት ናይ HCoV ተቐበልቲ ኣለዉ ከም ኣሚኖፔፕቲዴዝ ኤን ን HCoV-229E ከምኡ ድማ 9-O-acetylated sialic acid ን HCoV-OC43። 	There are many HCoV receptors such as aminopeptidase N for HCoV-229E and 9-O-acetylated sialic acid for HCoV-OC43.
680	en	ti	 They might also account for successful adaptation of these CoVs in humans after interspecies transmission from their animal hosts. 	 ካብ ዝተፈላለዩ እንስሳት ናብ ደቂ ሰባት ዝሓልፉ CoVs ዕዉት ምልማድ ክህልዎም ይኽእል። 	CoVs passed from different animals to humans can have successful adaptation.
681	en	ti	 In addition to cellular receptors, the outcome of interspecies transmission of HCoVs is also governed by other host dependency and restriction factors. 	 ኣብ ናይ ዋህዮ ተቐበልቲ ብተወሳኺ፣ ካልኦት ናይ መዕቖቢ ጽግዕተኝነትን እገዳን ረቛሒታትንውጽኢታውነት ናይ መንጎ ዓሌታዊ ተመሓላላፍነት ናይ HcoVs ይጸልውዎ እዮም። 	In addition to cellular hosts, other host dependence and restriction factors affect the efficacy of interspecies transmission of HcoVs.
682	en	ti	 The divergence of these host proteins between humans and natural reservoir hosts of HCoVs such as bats, dromedary camels and rodents might constitute a barrier to interspecies transmission. 	 ኣብ መንጎ ሰባትን ተፈጥሮኣዊ መዕቖቢታት ናይ HCoVs ከም ለኻኺቶታት፣ ድሮሜዳሪ ኣግማልን ኣናጹን ዘሎ ናይ መዕቖቢ ፕሮቲን ፍልልያት፣ ንመንጎ ዓሌታዊ ምትሕልላፍ ዕንቅፋት ክኾኖ ይኽእል እዩ። 	Host protein differences between humans and natural hosts of HCoVs such as rodents, dromedary camels, and monkeys, may hinder interspecies transmission.
683	en	ti	 HCoVs have to usurp host dependency factors and subvert host restriction factors for a successful interspecies transmission. 	 HcoVs ዕዉት መንጎ ዓሌታዊ ምትሕልላፍ ንክህልዎ፣ ኣብ መዕቖቢ እንስሳ ዘለዉ ንጽግዕተኛነት ወሰንቲ ጉዳያትን ክቆጻጸርን ንገደብ ወሰንቲ ጉድያት ድማ ክስዕሮም ኣለዎ። 	For HcoVs to have successful interspecies transmission, dependency and key issues in shelter animals must be controlled and restrictive key issues must be overcome.
684	en	ti	 In this regard, molecular determinants in this important area of virus-host interaction remain to be identified and characterized. 	 በዚ ምኽንያት ኣብ'ቲ ናይ ቫይረስን መዕቆቢኡን ዘሎ ዝምድና፣ ኣብ ሞለኲላር ደረጃ ወሰንቲ ዝኾኑ ረቛሒታት ከነለልዮምን ከነጽንዖምን ይግባእ። 	For this reason, we need to identify and study the factors that are critical in the relationship between the virus and its host, at the molecular level.
685	en	ti	 An unbiased genome-wide screening of host dependency and restriction factors for SARS-CoV-2 using the state-of-the-art technology of CRISPR might be fruitful. 	 ናይ CRISPR ስልጡን ቴክኖሎጂ ብምጥቃም፣ ሚዛናዊ ዝኾነ ናይ እቲ መዕቆቢ ጄኖም-ሙሉእ ብምምርማር፣ ንSARS-CoV-2 ወሰንቲ ዝኾኑ ናይ ጽግዕተኝነትን ገደባትን ረቛሒታት ምፍታሽ ውጽኢታዊ ክኸውን ይኽእል እዩ። 	Using the hybrid technology of CRISPR, screening a balanced genome-whole of the host may be cost-effective to screen for the dependence and restrictive factors that are key to SARS-CoV-2.
686	en	ti	 Emergence of novel HCoVs: back to ground zero 	 ናይ እዚ ሓድሽ HcoVs ኣመጻጽኣ: ናብ መበገሲኡ ተመሊስካ ምኻድ 	The origins of this new HcoVs: going back to the origins
687	en	ti	 The diversity of bat CoVs provides ample opportunities for the emergence of novel HCoVs. 	 ኣብ መንጎ ናይ ለኻኺቶ CoVs ዝርከብ ፍልልያት ንኣመጻጽኣ ሓድሽ HcoVs ገፊሕ ዕድል ዝህብ እዩ። 	Differences among infectious CoVs provide ample opportunities for the emergence of new HcoVs.
688	en	ti	 In this sense, bat CoVs serve as the gene pool of HCoVs. 	 እዚ ማለት፣ ናይ ለኻኺቶ CoVs ከም መራብሒ ጂን ፑል ናይ HCoVs ክኾኑ ይኽእሉ ማለት እዩ። 	This means that, infectious CoVs can act as a breeding gene pool of HCoVs.
689	en	ti	 In addition, rapid mutation and genetic recombination also drive HCoV evolution and serve as two important steps in this process. 	 ብተወሳኺ፣ ቅልጡፍ ጀነቲካዊ ለውጢ(mutation)ን ጀነቲካዊ ምድቓላት( genetic recombination) ናይ HcoV ግመታዊ ለውጢ ብምኽታል፣ ኣብ'ዚ መስርሕ ክልተ ኣገደስቲ ስጉምትታት ኮይኖም የገልግሉ። 	In addition, rapid mutation and genetic recombination serve as two important steps in this process, following the hypothetical changes of HcoV.
690	en	ti	 For example, the acquisition or loss of novel protein-coding genes has the potential to drastically modify viral phenotypes. 	 ንኣብነት፣ ሓደሽቲ ፕሮቲን-ኮዲንግ ጂናት ምእካብ ወይ ምስኣን ነቲ ፌኖታይፓት ናይ'ቲ ቫይረስ ብሰፊሑ ክለዋውጥ የኽእሎ። 	For example, the accumulation or loss of new protein-coding genes allows the virus&#39;s phenotype to vary widely.
691	en	ti	 Among SARS-CoV accessory proteins, ORF8 has been thought to be important in adaptation to humans, as SARS-CoV-related bat viruses were isolated but found to encode divergent ORF8 proteins. 	 ORF8 ሓደ ካብ'ቶም ናይ SARS-CoV ተሓጋገዝቲ ፕሮቲናት ኮይኑ፣ ኣብ ሰባት ንምልምማድ ኣገዳሲ ምዃኑ ይግመት። ስለምንታይ፣ ዋላ'ኳ ORF8 ፕሮቲን ኣብ ናይ ለኻኺቶ SARS-CoV እንተተረኽበ፣ ዓይነቱ ዝተፈልየ እዩ። 	ORF8 is one of the SARS-CoV accessory proteins, thought to be important for adaptation in humans. Why, although the ORF8 protein is found in the infectious SARS-CoV, it is of a different type.
692	en	ti	 A 29-nucleotide deletion characteristic of SARS-CoVs has been found in strains isolated at the beginning of the human epidemic. 	 ናይ SARS-CoVs 29-ኒክሎታይድ ምድምሳስ ባህርያት ኣብ'ቶም መፈለምታ ናይ ደቂ ሰባት ለበዳ ዝተረኽቡ ዝተፈለዩ ስትረይናት ዝርከብ እዩ። 	The 29-nucleotide deletion characteristics of SARS-CoVs are found in various strains found in the early human outbreaks.
693	en	ti	 This deletion splits ORF8 into ORF8a and ORF8b and is thought to be an adaptive mutation that promotes the switch of hosts. 	 እዚ ምድምሳስ ንORF8 ናብ ORF8aን ORF8bን ይገምዖ፣ እዚ ድማ ነቲ ቫይረስ ካብ ሓደ መዕቆቢ ናብ ካልእ ንክመሓላለፍ ዝሕግዝ ናይ ምልማድ ሙቴሽን እዩ። 	This deletion splits ORF8 into ORF8a and ORF8b, which are acclimation mutations that facilitate the translocation of the virus from one host to another.
694	en	ti	 Besides, SARS-CoV has a possible recombination history with lineages of alpha- and gamma-CoVs, where a large number of smaller recombinant regions were identified in the RNA-dependent RNA polymerase. 	 SARS-CoV ምስ ናይ ኣልፋን ጋማን መስመር ናይ ምትሕውዋስ ታሪኽ ኣለዎም። ኣብ RNA ጽግዕተኛ ዝኾነ RNA ፖሊመሬዝ ድማ ነነእሽቱ ናይ ምትሕውዋስ ሰፈራት(recombination regions) ብብዝሒ ተረኺቡ። 	SARS-CoV have a history of coinfection with the alpha and gamma lines. Small recombination regions were abundant in RNA-dependent RNA polymerase.
695	en	ti	 Recombination locations were also identified in the nsp9, most of nsp10, and parts of nsp14. 	 ከምኡ'ውን ኣብ nsp9፣ መብዛሕትኡ nsp10ን ሓደሓደ ክፋል nsp14ን ናይ ምትሕውዋስ ሰፈራት ተፈልዮም ይርከቡ። 	Also in nsp9, most of nsp10 and some part of nsp14 hybridization nests are isolated.
696	en	ti	 Likewise, it has been shown that the epidemic MERS-CoV experienced recombination events between different lineages, which occurred in dromedary camels in Saudi Arabia. 	 ብተመሳሳሊ፣ ኣብ ናይ MERS-CoV ለበዳ ዝተፈላለዩ ዓሌታት ምትሕውዋሳት ከምዘጋጠምዎ ተራእዩ እዩ፣ እዚ ድማ ኣብ ናይ ስዑዲ ዓረብ ዲሪሞንድሪ ኣግማል ዝተረኣየ እዩ። 	Similarly, it has been shown that mixtures of different breeds have occurred in MERS-CoV outbreaks, which has been observed in Saudi Arabian dirimundry camels.
697	en	ti	 Besides SARS-CoV and MERS-CoV, recombination events have also been observed in other HCoVs, in which the HCoVs recombine with other animal CoVs in their non-structural genes. 	 ካብ SARS-CoVን MERS-CoVን ሓሊፉ'ውን ናይ ምትሕውዋስ መስርሕ ኣብ ካልኦት HCoVs እዉን ይርአ እዩ። HCoVs ምስ ኣብ እንስሳ ዝርከቡ CoVs በቲ ዘይተዋቐረ ጅን ምትሕውዋስ የካይድ እዩ። 	In addition to SARS-CoV and MERS-CoV, the process of infection is also seen in other HCoVs. HCoVs do replicate with CoVs in animals by the unstructured gene.
698	en	ti	 It should also be cautioned that artificial selection can contribute to unintended changes in viral genomes, most likely resulting from relieving viruses from selection pressures exerted, such as by the host immune system. 	 ከምኡ'ውን ኣርቴፍሻል ሰሌክሽን ዘይተደልዩ ናይቲ ቫይረስ ናይ ጄኖም ለውጥታት ክፈጥሩ ይኽእሉ። እዚ ድማ ብመዕቖቢ ዝፍጠሩ ካብ ሕማም ዝከላኸሉ ባእታታት ብዝፈጥርዎ ጽዕነት ክፍጠር ይኽእል። 	Artificial selection can also cause unwanted changes in the virus&#39;s genome. This can be caused by the loading of immune components produced by preservatives.
699	en	ti	 An example of these effects is the loss of a full-length ORF4 in the HCoV-229E prototype strain, owing to a two-nucleotide deletion. 	 ናይዚኦም ተጽዕኖታት ኣብነት ብክልተ-ኒዮክሳይድ ስረዛ ምኽንያት HCoV-229E ፕሮቶታይፕ ሙሉእ ቁመት ORF4 ምስኣን እዩ። 	An example of these effects is the loss of the HCoV-229E prototype full-length ORF4 due to a two-neuoxide deletion.
700	en	ti	 While intact ORF4 could be observed in bat and camel viruses related to HCoV-229E, the alpaca alpha-CoV displays a single nucleotide insertion, resulting in a frameshift. 	 ዘይተተንከፈ ORF4 ኣብ ለኻኺቶን ገመልን ዝርከቡ ንHCoV-229E ዝመስሉ ቫይረሳት ክርከብ ይኽእል። alpaca alpha-CoV ነጸላ ኑክሊዮታይድ ኢንሰርሽን ዘርኢ ኮይኑ ፍሬምሺፍት ድማ ይፈጥር። 	An unaffected ORF4 can be found in leopard and camel HCoV-229E-like viruses. alpaca alpha-CoV displays single nucleotide insertions and generates frameshifts.
701	en	ti	 Last but not least, the evolution of novel HCoVs is also driven by the selection pressure in their reservoir hosts. 	 ኣብ መወዳእታ ድማ፣ ናይ ሓድሽ HCoVs ግምታዊ ለውጢ(evolution) ብሰንኪ ናይ መዕቖቢኦም ጸቕጢ ምርጫ ስለዝካየድ እዩ። 	Finally, the hypothetical evolution of new HCoVs is due to their host pressure selection.
702	en	ti	 Asymptomatic or only mild symptoms were detected when bats were infected with CoVs, indicating the mutual adaptation between CoVs and bats. 	 ለዃኺቶታት ብ CoVs እንትልከፉ ምልክት ዘይምርኣይ ወይ ቀሊል ምልክት ጥራሕ ምርኣይ ተራእዩ ኔሩ፣ እዚ ድማ ናይ CoVs ለዃኺቶን ክልተኣዊ ልምምድ ዘርኢ እዩ። 	Mice were asymptomatic or only mildly symptomatic when infected with CoVs, indicating a bilateral habit of CoVs infection.
703	en	ti	 It appeared that bats are well adapted to CoVs anatomically and physiologically. 	 ለኻኺቶታት ምስ CoVs ብ ኣናቶሚካዊን(anatomically) ፊዝዮሎጂያዊን(physiologically) ብሰፊሑ ዝተላመዱ ከምዝኾኑ ተራእዩ እዩ። 	Infectious agents have been shown to be widely adapted anatomically and physiologically to CoVs.
704	en	ti	 For example, defects in the activation of pro-inflammatory response in bats efficiently reduce the pathology triggered by CoVs. 	 ንኣብነት፣ ኣብ መንክዓት ቅድመ-ነድሪ ምላሽ ብምንቕቓሕ፣ ብርቱዕ ሕማም ናይ ምምጻእ ክእለት ናይ CoVs የጉድሎ እዩ። 	For example, it reduces the ability of CoVs to cause severe disease by stimulating a pre-inflammatory response in the lungs.
705	en	ti	 Besides, the natural killer cell activity in bats is suppressed due to upregulation of inhibitory natural killer cell receptor NKG2/CD94 and low expression level of major histocompatibility complex class I molecules. 	 ብተወሳኺ ድማ ብሰንኪ ልዑል ዝርግሐ ናይ ከልካሊ NKG2/CD94ን ትሑት ዝርግሐ ናይ ሜጀር ሂስቶኮምፓተብሊቲ ኮምፕሌክስ ክላስ ሞለኲልታትን፣ ናይ ለኻኺቶ ቀተልቲ ዋህዮታት ዘለዎም ንጥፈት ይዕገት። 	In addition, due to the high prevalence of inhibitory NKG2/CD94 and low prevalence of major histocompatibility complex class molecules, the activity of infectious killer cells is inhibited.
706	en	ti	 Moreover, the high level of reactive oxygen species (ROS) generated from high metabolic activity of bats could both suppress CoV replication and affects proofreading by exoribonuclease, thus providing the selection pressure for the generation of virus strains highly pathogenic when introduced into a new host. 	 ብተወሳኺ ድማ፣ ካብ ልዑል ናይ ለኻኺቶ ሜታቦሊክ ንጥፈታት ዝምንጭው ልዑል ናይ ኦክሲጅን ዓሌት ሪኣክቲቬሽን (ROS) ደረጃ፣ ናይ CoV ምብዛሕን የጉድልን ንኤክሶራይቦኒኩለስ'ውን ይጸልዎን እዩ። እዚ ድማ ጽንኩር ናይ ምርጫ ክሊማ ብምፍጣር፣ ናብ ሓድሽ መዕቆቢ ምስኣተዉ ሕማም ናይ ምስዓብ ልዑል ክእለት ዘለዎም ቫይረሳት ከምስዝርሑ ይገብር። 	In addition, high levels of oxygen species reactivation (ROS) resulting from high insect metabolic activity reduce CoV replication and affect exoribonuclease. This creates a harsh selection climate, causing viruses with high potential to spread disease once they enter a new host.
707	en	ti	 More pathogenic CoV strains might also evolve by recombination, leading to the acquisition of novel proteins or protein features for host adaptation. 	 ሕማም ናይ ምስዓብ ልዑል ክእለት ዘለዎም ናይ CoV ዓሌታት ፕሮቲኖም ወይ ናይ ፕሮቲን ባህሪ ብምቕያር ከጥቅዑ ይኽእሉ። 	CoV strains with a high ability to cause disease can attack by changing their protein or protein behavior.
708	en	ti	 Thus, it is not by chance that three novel HCoVs have emerged in the past two decades. 	 ስለ'ዚ ኣብ'ዘን ዝሓለፋ ዕስራ ዓመታት፣ ሰለስተ ሓደሽቲ HCoVs ምፍጣሮም ናይ ኣጋጣሚ ነገር ኣይኮነን። 	So it&#39;s no coincidence that in the last twenty years, three new HCoVs have emerged.
709	en	ti	 CoVs are non-pathogenic or cause mild symptoms in their reservoir hosts such as bats and camels. 	 CoVs ሕማም ዘየምጹ ወይ ድማ ቀሊል ዝበሃል ምልክት ዘምጹ ተሃዋስያን ኮይኖም ኣብ ለኻኺቶን ገመልን ተጸጊዖም ዝነብሩ እዮም። 	CoVs are allergens that do not cause disease or cause mild symptoms and rely on ticks and camels.
710	en	ti	 They replicate robustly without eliciting a strong host immune response. 	 ሓያል ናይ ሕማም ምክልኻል ዓቕሚ እንተዘየለ ብቕልጡፍ ይራብሑ:: 	They multiply quickly in the absence of a strong immune system.
711	en	ti	 Herein lie the secrets of why asymptomatic carriers are seen and what causes the severe cases in human infection. 	 ምልክት ዘየርእዩ ግን ዝተለኽፉ ሰባት ንምንታይ ኣልዉን ኣብ ሰባት ድማ ንምንታይ ከቢድ ረኽሲ ይፈጥር ኣሎን ንዝብሉ ምስጢራት መፍቲሒኦም ኣብ'ዚ ይርከብ። 	Here are the solutions to the mysteries of why there are asymptomatic but infected people and why it is causing serious infections in people.
712	en	ti	 The severe symptoms are mainly due to the hyperactivation of immune response and the cytokine storm wherein the stronger the immune response, the more severe the lung damage. 	 ጠንቂ መነገሲ ናይ'ዞም ከበድቲ ምልክታት መብዛሕትኡ ግዘ ብሰንኪ ናይ ስርዓተ-ምክልኻል ሕማም ልዕሊ ዓቐን ምንቕቓሕን ዝስዕብ ናይ ሳይቶካይን ማዕበል እዩ፣ በዚ ድማ ሕማም ናይ ምክልኻል ዓቕሚ ጥንኩር ኣብ ዝኾኑሉ ናይ ሳንባ ጉድኣት ከቢድ ይኸውን። 	The cause of the onset of these severe symptoms is often due to an overstimulation of the immune system and a subsequent wave of cytokines, thus making lung damage more severe when the immune system is strong.
713	en	ti	 In contrast, in asymptomatic carriers, the immune response has been de-coupled from CoV replication. 	 ብተጸራሪ ምልክት ዘየርእዩ ተሸከምቲ እቲ ቫይረስ፣ እቲ ናይ ኣካለ-ምክልኻል ግብረመልሲ ካብ'ቲ ምርባሕ ናይ CoV ዝተነጸለ እዩ። 	In asymptomatic carriers of the virus, the immune response is isolated from the reproduction of CoV.
714	en	ti	 The same strategy of delinking the immune response might have beneficial effects in anti-SARS-CoV-2 therapy. 	 ብተመሳሳሊ ወገን ምስ ናይ ሕማም ምክልኻል ዓቕሚ ከምዝንጸል ምግባር ኣብ ናይ ጸረ-SARS-CoV-2 ሕክምና ጠቐምቲ ጽልዋታት ከሕድር ይኽእል እዩ። 	On the other hand, its isolation with the immune system may have beneficial effects on anti-SARS-CoV-2 treatment.
715	en	ti	 The interferon response is particularly strong in bats. 	 እዚ ናይ ኢንተርፌሮን(interferon) ግብረመልሲ ብፍላይ ኣብ ለኻኺቶ ጥንኩር እዩ። 	This interferon reaction is particularly strong in infection.
716	en	ti	 Thus, administration of type I interferon at least in the early phase of SARS-CoV-2 infection in humans should be beneficial. 	 ስለዝኾነ ተነኣሰ ኣብ ፈለማ ደረጃ ዝርከቡ ወድሰብ ዘጥቅዑ ናይ SARS-CoV-2 ረኽስታት ታይፕ ኢንተርፌሮን ምሃብ ጠቓሚ ይኸዉን። 	Therefore, it is useful to give interferon type at least in the early stages of human SARS-CoV-2 infections.
717	en	ti	 In addition, NLRP3 inflammasome activation in bats is defective. 	 ብተወሳኺ፣ NLRP3 ናይ ነድሪ ምላሽ ምንቕቓሕ ኣብ ለኻኺቶታት ኣይሰርሕን። 	In addition, NLRP3 stimulation of inflammatory responses does not function in infections.
718	en	ti	 By this reasoning, inhibition of NLRP3 inflammasome with MCC950 might be useful in the treatment of COVID-19. 	 በዚ ምኽንያት MCC950 ብምጥቃም ንNLRP3 ዝስዕብ ነድሪ ምዕጋት ኣብ ናይ COVID-19 ሕክምና ጠቓሚ ክኸውን ይኽእል። 	For this reason, inhibition of NLRP3-induced inflammation using MCC950 may be useful in the treatment of COVID-19.
719	en	ti	 The emergence of SARS-CoV-2 follows the general theme by which SARS-CoV and MERS-CoV arose. 	 ናይ SARS-CoV-2 ኣመጻጽኣ፣ SARS-CoV ን MERS-CoV ን ዝተለዓሉሉ ሓፈሻዊ ኣካይዳ ዝተኸተለ እዩ። 	The origin of SARS-CoV-2 followed the same general pattern in which SARS-CoV and MERS-CoV emerged.
720	en	ti	 Whereas a bat beta-CoV sharing 95% nucleotide homology with SARS-CoV has been found, there also exists a bat-CoV sharing 96% nucleotide homology with SARS-CoV-2. 	 ከምኡ'ውን ናይ ለኻኺቶ beta-CoV ምስ ናይ SARS-CoV ኒዩክሎታይድ ናይ 95% ምምስሳል፣ ምስ SARS-CoV-2 ድማ ናይ 96% ምምስሳል ኣለዎ። 	and infectious beta-CoV has 95% identity to SARS-CoV nucleotides, and 96% identity to SARS-CoV-2
721	en	ti	 Whereas civets and other animals in the markets have been found to harbour viruses identical to SARS-CoV, immediate intermediate hosts for SARS-CoV-2 have not been identified. 	 ኣብ'ቲ ዕዳጋ ዝነበሩ እንስሳት ምስ SARS-CoV ተመሳሳሊ ቫይረስ ሒዞም ዝተረኸቡ ዋላ'ኳ እንተኾኑ፡ ናይ SARS-CoV-2 ማእከላይ ቀጥተኛ መምሓላለፊ ግን ክሳብ ሕዚ ኣይተረኽበን። 	Although the animals in the market were found to be carrying the same virus as SARS-CoV, the central direct transmission of SARS-CoV-2 has not yet been identified.
722	en	ti	 Pangolin beta-CoVs strikingly homologous to SARS-CoV-2 have been found, indicating that pangolins might serve as one of intermediate hosts or pangolin beta-CoVs could contribute gene fragments to the final version of SARS-CoV-2. 	 ናይ ፓንጎሊን ቤታ-CoVs ብዝገርም መንገዲ ምስ SARS-CoV-2 ተመሳሳሊ(homologous) ኮይኖም ተረኺቦም፣ እዚ ድማ ፓንጎሊናት ከም መንጎኛ መዕቆቢ ኮይኖም ከገልግሉ ከምዝኽእሉ ወይ ፓንጎሊን ቤታ-CoVs ንናይ SARS-CoV-2 ናይ መወዳእታ ክፋል ናይ ጂን ፍራግመንትታት ኣስተዋጽኦ ይገብር እዩ ማለት እዩ። 	Pangolin beta-CoVs were found to be strikingly identical(homologous) to SARS-CoV-2, suggesting that pangolins may serve as intermediate hosts or that pangolin beta-CoVs contribute gene fragments to the final portion of SARS-CoV-2 is.
723	en	ti	 Although questions remain, there is no evidence that SARS-CoV-2 is man-made either deliberately or accidentally. 	 ዘይተመለሱ ሕቶታት ዋላ እንተሃለዉ፣ SARS-CoV-2 ብኣጋጣሚ ይኹን ኮነ ተባሂሉ ብሰብ ከምዝተሰርሐ ዘርእይ መረጋገጺ የለን። 	Despite the unanswered questions, there is no evidence that SARS-CoV-2 was accidentally or deliberately man-made.
724	en	ti	 CoVs have returned to the limelight due to the recent outbreak of SARS-CoV-2. 	 CoVs ተፈላጥነቶም ምስ'ዚ ሕዚ ዝርአ ዘሎ ናይ SARS-CoV-2 ለበዳ ዳግማይ ክምለስ ክኢሉ። 	CoVs recognition has been restored with the current SARS-CoV-2 outbreak.
725	en	ti	 The study of CoVs in bats and other animals has drastically changed our perception of the importance of zoonotic origins and animal reservoirs of HCoVs in human transmission. 	 ኣብ ልዕሊ ናይ ለኻኺቶን ካልኦት እንስሳታትን CoVs ዝተኻየደ መጽዕናቲ፣ ኣገዳስነት ናይ ዙኖቲክ መበቆላትን ናይ እንስሳት መዕቖቢነትን ናይ HCoVs ኣብ ልዕሊ ናብ ሰብ ዘለዎ ተመሓላላፍነት ክንርዳእ ጌርና እዩ። 	Studies on infectious and other animal CoVs have helped us understand the importance of zoonotic origins and animal reservoirs of HCoVs on human transmission.
726	en	ti	 Pervasive evidence has shown that SARS-CoV, MERS-CoV and SARS-CoV-2 have a bat origin and are transmitted to humans via intermediate hosts. 	 SARS-CoV, MERS-CoV ከምኡ'ውን SARS-CoV-2 መበቆሎም ካብ ለኻኺቶ ከምዝኾነን ናብ ሰባት ድማ ብካልእ መንጎኛ መዕቖቢ ኣቢሎም ከምዝመሓላለፉን መረዳእታ ኣሎ። 	There is evidence that SARS-CoV, MERS-CoV and SARS-CoV-2 originate from insects and are transmitted to humans through other intermediate hosts.
727	en	ti	 Given that SARS-CoV infection originates from the contact between humans and civets in the markets, closing wet markets and killing civets therein could have effectively ended the SARS epidemic. 	 ምንጪ ናይ SARS-CoV ረኽሲ ካብ ኣብ መንጎ ሰባትን ዝባዳትን ኣብ ዕዳጋ ዘጋጥም ርክብ ምዃኑ ካብ ፈለጥና፣ ጥሉል ዕዳጋታት(wet markets) ምዕጻውን ዝባዳት ምቕታልን ናይ SARS ለበዳ ብብቕዓት ክዛዝሞ ይኽእል እዩ። 	Once we know that the source of SARS-CoV infection is from contact between people and pests in the market, closing wet markets and killing pests can efficiently end the SARS outbreak.
728	en	ti	 By the same reasoning, pangolins should be removed from wet markets to prevent zoonotic transmission, in view of the discovery of multiple lineages of pangolin beta-CoVs closely related to SARS-CoV-2. 	 ብተመሳሳሊ ምኽንያት ከምኡ'ውን ምስ SARS-CoV-2 ዝተተሓሓዙ ዝተፈላለዩ ሊኒዬጃት ናይ ፓንጎሊን ቤታ-CoVs ስለዝተረኽቡ፣ ፓንጎሊናት ዙኖቲክ ምምሕልላፋት ንምክልኻል ካብ ዕዳጋ ክውገዱ ኣለዎም። 	For the same reason and because different lineages of pangolin beta-CoVs have been found associated with SARS-CoV-2, pangolins should be removed from the market to prevent zoonotic transmissions.
729	en	ti	 However, whether and how SARS-CoV-2 is transmitted to humans through pangolins and other mammals remain to be clarified in future investigations. 	 እንተኾነ ግን፣ SARS-CoV-2 ካብ ፓንግሊናትን ካልኦት መጥወብትን ናብ ሰባት ይመሓለለፍ ድዩን ብኸመይ ይመሓላለፍን ንዝብሉ ሕቶታት ኣብ መጻኢ ብምርመራታት ክጻረዩ ኣለዎም። 	however, whether and how SARS-CoV-2 is transmitted from panglians and other mammals to humans needs to be investigated in the future.
730	en	ti	 On the other hand, MERS-CoV has existed in dromedary camels for a long time. 	 ብካልእ ገጹ፣ MERS-CoV ኣብ ድሮሜዳሪ ኣግማል ንነዊሕ ግዘ ጸኒሑ እዩ። 	On the other hand, MERS-CoV has been present in dromedary camels for a long time.
731	en	ti	 These camels serve as an important tool for transportation as well as a main source of meat, milk, leather and wool products for the local people. 	 እዞም ኣግማል ከም መጓዕዝያን ናይ ስጋ፣ ጸባ፣ ሌዘርን ናይ ቆርበት ፍርያማትን ምንጪታት ንሰባት የገልግሉ። 	These camels serve as transportation and sources of meat, milk, leather and leather products for people.
732	en	ti	 They are widely distributed across the Middle East and Africa. 	 ኣብ ማእኸላይ ምብራቕን ኣፍሪካን ብሰፊሑ ኣስፋሕፊሖም እዮም። 	They have spread widely in the Middle East and Africa.
733	en	ti	 It is therefore impossible to sacrifice all camels for the control of MERS, as what was done in wild animal markets in China to prevent the spreading of SARS-CoV and SARS-CoV-2. 	 ስለዚ ድማ MERS ንምቁጽጸር ተባሂሉ ኩሎም ኣግማል ከተጥፍኦም ኣይከኣልን እዩ፣ ልክዕ ከም'ቲ ኣብ ቻይና ናይ SARS-CoV ን SARS-CoV-2 ን ምስፍሕፋሕ ደው ንምባል ኣብ ናይ በረኻ እንስሳት ዕዳጋ ዝተኻየደ ማለትዩ። 	Therefore, it is not possible to exterminate all camels to control MERS, just as it was done in China to stop the spread of SARS-CoV and SARS-CoV-2 in the wildlife market.
734	en	ti	 To stop the recurrent outbreaks of MERS, a comprehensive approach should be taken to develop effective vaccines against MERS-CoV for camels, in combination with other infection control measures. 	 ነዚ ናይ MERS ተደጋጋሚ ለበዳታት ደው ንምባል፣ ኣንጻር ናይ ኣግማል MERS-CoV ብቑዕ ክትባት ንምምዕባል፣ ምስ ካልኦት ናይ ረኽሲ ቁጽጽር ስጉምቲታት ብምሕዋስ ሓፈሻዊ ኣቀራርባ ኣድላዪ እዩ። 	To stop these recurring outbreaks of MERS, a holistic approach in combination with other infection control measures is necessary to develop an efficient vaccine against equine MERS-CoV.
735	en	ti	 As we are not able to eliminate these viruses, new genotypes might emerge to cause outbreaks. 	 ነዞም ቫይረሳት ክነወግዶም ስለዘይከኣልና፣ ለበዳ ከስዕቡ ዝኽእሉ ሓደሽቲ genotypes(ተመሳሳሊ ጀነቲካዊ ቅርጺ ዝውንኑ ድቀቕቲ ህይውታውያን) ክመጹ ይኽእሉ እዮም። 	Because we cannot eliminate these viruses, new genotypes(tiny organisms with similar genetic makeup) may emerge that can cause epidemics.
736	en	ti	 A variety of zoonotic CoVs are circulating in the wild. 	 ዝተፈላለዩ ዙኖቲክ CoVs ኣብ ሞንጎ እንስሳት ዘገዳም ይዘዋወሩ እዮም ። 	Various zoonotic CoVs circulate among wildlife .
737	en	ti	 Particularly, bat CoVs with zoonotic potential are so diverse. 	 ብፍሉይ ድማ ናብ ሰባት ክመሓላለፉ ዝኽእሉ ናይ ለኻኺቶ CoVs ብዙሓት እዮም። 	In particular, there are many infectious CoVs that can be transmitted to humans.
738	en	ti	 There are plenty of opportunities that these zoonotic CoVs evolve and recombine, resulting in the emergence of new CoVs that are more transmissible and/or deadly in humans in future. 	 እዞም ናይ እንስሳት CoVs ኣብ ቐጻሊ ተራቢሖምን ማዕቢሎምን ዝዓበየ ናይ ምልባድ ዓቕሚ ዘለዎን ንደቂሰብ ሓደገኛ ዝኾኑን CoVs ክፍጠሩ ይኽእሉ። 	These animal CoVs can continue to reproduce and evolve to form CoVs with greater infectious potential and dangerous to humans.
739	en	ti	 The culture of eating wild animals in some places of China should be abandoned to reduce unnecessary contact between humans and animals. 	 ኣብ መንጎ ሰባትን እንስሳትን ዘሎ ርክብ ንምቕናስ ኣብ ገለ ናይ ቻይና ቦታታት ዘሎ ናይ በረኻ እንስሳት ምብላዕ ባህሊ ክእገድ ኣለዎ። 	The culture of eating wild animals in some parts of China should be banned to reduce contact between people and animals.
740	en	ti	 With the ordeals of SARS, MERS and COVID-19, a better preparedness and response plan should be in place. 	 ናይ SARS, MERSን COVID-19ን ጸገም ንምግታእ፣ ዝሓሸ ድልውነትን ግብረመልስን ክህሉ ይግባእ። 	To contain the problem of SARS, MERS and COVID-19, there should be better preparedness and response.
741	en	ti	 In fact, many viruses have existed in the planet for a very long time. 	 ብሓቂ፣ ብዙሓት ቫይረሳት ኣብ እዛ ፕላኔት ንኣዝዩ ነዊሕ ግዘ ዝነበሩ እዮም። 	In fact, many viruses have been around on this planet for a very long time.
742	en	ti	 They stay in their own natural reservoirs until there is a chance for spillover. 	 ናይ ምፍሳስ ዕድል ክሳብ ዝርከብ ኣብ ናይ ባዕሎም ተፈጥሮኣዊ መቐመጢ ይጸንሑ። 	They remain in their own natural habitat until there is an opportunity for dissolution.
743	en	ti	 Although bats have many features that favours the spreading of viruses, the chance for humans to be in contact with bats and other wildlife species can be minimized if people are educated to stay away from them. 	 ለኻኺቶታት ነቲ ቫይረስ ከመሓላልፍዎ ዘኽእልዎም ባህሪያት ዋላ እንተሃለወን፣ ሰባት ምስ ለኻኺቶ ኮነ ካልኦት ናይ በረኻ እንስሳት ዘለዎም ርክብ ንኽጎድል ኣፍልጦኦም ክብ ምባል ኣድላዪ እዩ። 	Although ticks have characteristics that allow them to transmit the virus, it is necessary to raise awareness to reduce contact with ticks or other wildlife.
744	en	ti	 Continuous surveillance in mammals is necessary for better understanding of the ecology of CoVs and their natural hosts, which will prove useful in preventing animal-to-human transmission and future outbreaks. 	 ንቐጻሊ ካብ እንስሳት ናብ ሰባት ሕማም ናይ ምትሕልላፍ ዕድል ንምቕናስን ናይ መጻኢ ለበዳታት ንምውጋድን፣ ኣብ ኣጥበውቲ እንስሳት ጥቡቕ ቁጽጽር ክግበር ይግባእ። 	To reduce the chance of continued transmission of disease from animals to humans and to avoid future outbreaks, mammals should be strictly controlled.
745	en	ti	 To conclude, the most effective way to prevent viral zoonosis is for humans to stay away from the ecological niches of the natural reservoirs of the zoonotic viruses. 	 ከም መደምደምታ፣ ካብ እንስሳ ናብ ሰብ ዝሓልፍ ሕማም ንምክልኻል እቲ ውጽኢታዊ መንገዲ ካብ መዕቖቢ ሓደገኛ ቫይረስ ዝኾኑ እንስሳት ዝነብርሉ ስነ ምህዳር ምርሓቕ እዩ። 	In conclusion, the most effective way to prevent animal-to-human disease is to avoid environments where animals harbor dangerous viruses.
746	en	ti	 Several pieces in the puzzle of the zoonotic origin of SARS-CoV-2 are still missing. 	 ኣብ ናይ ኣመጻጽኣ SARS-CoV-2 ሕንቅልሕንቅሊተይ ዛጊድ እውን ዘይተፈልጡ ዛዕባታት ይርከቡ። 	There are still unknown issues in the puzzle of the origin of SARS-CoV-2
747	en	ti	 First, if bats transmit an ancestral virus of SARS-CoV-2 to pangolins, it will be of interest to see under what circumstances bats and pangolins could share the same ecological niche. 	 መጀመርታ፣ ለዃኺቶታት ናይ SARS-CoV-2 ዓሌታዊ መበቆል ዘለዎ ቫይረስ ናብ ፓንጎሊን ዘመሓላልፉ እንተኾይኖም፣ ኣብ ከመይ ዝበሉ ኩነታት እዩ ለዃኺቶታትን ፓንጎሊንን ተመሳሳሊ ኢኮሎጂያዊ ኒች ዝውንኑ ኢልካ ምርኣይ ኣገዳሲ እዩ። 	First, if ticks transmit a virus of SARS-CoV-2 species origin to pangolins, it is important to consider under what circumstances ticks and pangolins possess similar ecological niches.
748	en	ti	 Second, if bats play a more direct role in human transmission, how humans get into contact with bats should be determined. 	 ካልኣይ ነገር እዚ ሕማም ናብ ሰብ ንክሓልፍ ለኻኺቶ ዓቢ እጃም ብምህላዉ፣ ደቂሰባት ምስቲ እንስሳ ዘለዎም ርክብ ክዉሰን ይግባእ። 	Secondly, as infectious agents play a major role in the transmission of the disease to humans, human contact with the animal should be determined.
749	en	ti	 Third, if a third mammal acts as the true intermediate host, how it interacts with the different species including humans, bats and pangolins has to be clarified. 	 ሳልሳይ፣ ሳልሳይ መጥበዊ እንስሳ ከም ትኽክለኛ መንጎኛ መዕቆቢ እንተኾይኑ፣ ምስ ዝተፈላለዩ ዓሌታት ሰባት፣ ለኻኺቶታትን ፓንጎሊንን ሓዊሱ ከመይ ከምዝተኣታቶ ክጻረ ኣለዎ። 	Third, if a third mammal is to be used as a valid intermediate refuge, how it is introduced with different species including humans, rodents and pangolins must be investigated.
750	en	ti	 Finally, since many mammals including domestic animals might be susceptible to SARS-CoV-2, both surveillance and experimental infection should be conducted. 	 ኣብ መወዳእታ፣ ዘቤታውያን እንስሳት ሓዊስካ ብዙሓት መጥወብቲ እንስሳት ን SARS-CoV-2 ተቓላዕቲ ክኾኑ ይኽእሉ እዮም፣ ናይ ቀረባ ክትትልን ናይ ፈተነኣዊ ረኽስታት ክካየዱ ኣለዎም። 	Finally, many mammals, including domestic animals, may be susceptible to SARS-CoV-2, and close surveillance and experimental infections should be conducted.
751	en	ti	 Should it be a bat, a pangolin or another mammal, it is expected that SARS-CoV-2 or its parental viruses that are almost identical will be identified in its natural hosts in future. 	 ዋላ ኣብ ለኻኺቶ፡ ፓንጎሊን ኮነ ካልእ መጥበዊ እንስሳ እንተኾነ፡ SARS-CoV-2 ወይ ድማ ወለዱ ኣብ ቀጻሊ ኣብ ናይ ተፈጥራዊ መጸግዒ ከም ዝርከብ ይእመን። 	Even in a mosquito, pangolin or other mammal, SARS-CoV-2 or its parents are believed to continue to be found in natural habitats.
752	en	ti	 Continued investigations in this area will elucidate the evolutionary pathway of SARS-CoV-2 in animals, with important implications in the prevention and control of COVID-19 in humans. 	 ኣብዚ ጉዳይ ዝግበር ቀጻሊ ምርመራ፣ ኣብ ናይ እንስሳት SARS-CoV-2 መንገድታት ናይ ግምታዊ ለውጢ(evolutionary) ከመይ ምዃኑ ከጻርይ ኣለዎ፣ ስለምንታይ እዚ ጉዳይ'ዚ ኣብ ሰባት ናይ COVID-19 ምክልኻልን ምቁጽጻርን ዓቕሚ ዓቢ ጽልዋ ስለዘለዎ። 	Further research on this issue should investigate the evolutionary patterns of SARS-CoV-2 in animals, as this issue has a major impact on the ability to prevent and control COVID-19 in humans.
753	en	ti	 Updating the diagnostic criteria of COVID-19 “suspected case” and “confirmed case” is necessary 	 ናይ COVID-19 ‘’ዝተጠርጠረ ጉዳይ ለበዳ’’ ከምኡዉን ‘’ዝተረጋገፀ ጉዳይ ለበዳ’’ ምርመራ ሮቑሓ በብጊዜኡ ክመሓየሽ ይግባእ። 	The COVID-19 &#39;&#39;suspected outbreak case&#39;&#39; and &#39;&#39;confirmed outbreak case&#39;&#39; diagnostic criteria should be updated from time to time.
754	en	ti	 On 6 February 2020, our team had published a rapid advice guideline for diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infection, and this guideline provided our experience and make well reference for fighting against this pandemic worldwide. 	 ኣብ ፌብሩዋሪ 6 2020፣ ጉጅለና ዘሐተሞ ጽሑፍ ናይ ኮሮና ኖቭል 2019 (2019-nCoV) ኢንፌክሽን ንምምርምርን ንምምኻርን ቕልጡፍ መምርሒን ተመኩሮታትን ብምቕራብ ብ ብርኪ ዓለም ነዚ ለበዳ ንምውጋእ ንጡፍ ምስክር ዝህብ እዩ። 	On February 6 2020, our team published an article providing quick guidelines and experiences for diagnosing and counseling for coronavirus novel 2019 (2019-nCoV) infection and providing active testimony to fighting this pandemic globally.
755	en	ti	 However, the coronavirus disease 2019 (COVID-19) is a new disease, our awareness and knowledge are gradually increasing based on the ongoing research findings and clinical practice experience; hence, the strategies of diagnosis and treatment are also continually updated. 	 ግና ሕማም ኮሮናቫይረስ 2019(ኮቪድ-19) ሓድሽ ሕማም እዩ። መጽናዕትታትን ኣብ ባይቶ ዘሎ ክምናዊ ተመክሮታት ንኣፍልጦና በብቁሩብ እናስፍሖ ይመጽእ ኣሎ። ስለዚ ናይ መርመራን ሕክምናን ስትራተጂታት ቀጻሊ እናተመሓየሹ ክመጹ’ዮም። 	But the 2019 coronavirus (COVID-19) is a new disease. Studies and experiences in parliament are gradually expanding our knowledge. Therefore, screening and treatment strategies will continue to improve.
756	en	ti	 In this letter, we answered one comment on our guideline and provided the newest diagnostic criteria of “suspected case” and “confirmed case” according to the latest Diagnosis and Treatment Guidelines for COVID-19 (seventh version) that issued by the National Health Committee of the People’s Republic of China. 	 ኣብዚ ደብዳበ፡ ኣብ መምርሒና ዘሎ ሓደ ርእይቶ ግብረመልሲ ብምሃብ፡ በቲ ናይ ቻይና ህዝባዊ ናይ ጥዕና ኮሚቴ ዝወጸ ሓድሽ ናይ ሕክምናን ክትትልን ምርሒታት COVID-19 (ሻውዓይ ሕታም) ዝተቐየደ ን”ጥርጡራት”ን ”ዝተረጋገጹ ሕሙማትን” ምርመራ ዝምልከት ሓደሽቲ መምርሒታት ኣውጺና። 	In this letter, in response to a comment in our guidelines, we have issued new guidelines for the testing of “suspected” and “confirmed patients” in accordance with the new COVID-19 treatment and surveillance guidelines issued by the Chinese Public Health Committee (Seventh Edition).
757	en	ti	 In December 2019, the 2019 novel coronavirus (2019-nCoV) has caused an outbreak, which is now officially named as the coronavirus disease 2019 (COVID-19) and the virus has been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 	 ኣብዚ እዋን ብሕማም ኮሮና 2019(ኮቪድ-19) ዝፍለጥ ሓድሽ ኮሮናቫይረስ 2019(2019-nCoV) ኣብ ታሕሳስ 2019 ክዝርጋሕ ጀሚሩ፡ እቲ ቫይረስ ከኣ ከቢድ ኣኪዩት ናይ ስርዓተ ምትንፋስ ሲንድረም ኮሮናቫይረስ 2(SARS-CoV-2) ይበሃል። 	The new coronavirus 2019(2019-nCoV), currently known as coronavirus 2019(COVID-19), began to spread in December 2019. The virus is called Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2).
758	en	ti	 On 11 March 2020, WHO characterized COVID-19 as a pandemic. 	 ኣብ ማርች 11 2020፣ ወድብ ጥዕና ዓለም(WHO) COVID-19 ዓለምለኸ ለበዳ ከምዝኾነ ኣዊጁ። 	On March 11 2020, the World Health Organization(WHO) declared COVID-19 a global pandemic.
759	en	ti	 In order to fight against the SARS-CoV-2 infection, our team has developed a rapid advice guideline and that has been published online in Military Medical Research on 06 February 2020. 	 ኣንጻር SARS-CoV-2መልከፍቲ ክንዕወት እንተኮይና ብቅልጡፍ ዝርከብ ናይ ምኽሪ መምርሒ ኣዳሊና ብ06 ፌብሩዋሪ 2020 ኣብ ናይ ውትድርና ሕክምና መጽናዕቲ ብመርበብ ኢንተርነት ዘርጊሕናዮ ኣለና። 	If we are to succeed against SARS-CoV-2infection, we have developed a readily available advisory guide and published it online on 06 February 2020 in the Military Medical Research.
760	en	ti	 It has attracted a great attention since published. 	 ካብ ዝሕተም ብዙሕ ኣተኩሮ ስሒቡ ኣሎ። 	It has attracted much attention since it was published.
761	en	ti	 Note however that COVID-19 is a new disease, our awareness and knowledge is gradually increasing based on the ongoing research findings and clinical practice experience; hence, the strategies of diagnosis and treatment are also continually updated. 	 ይኹን እምበር COVID-19 ሓድሽ ሕማም ምዃኑ ኣብ ግምት ብምእታው፣ ንቕሓትናን ፍልጠትናን ኣብቲ ዝካየድ ዘሎ መጽናዕታዊ ርኽበታትን ተሞክሮ ክሊኒካዊ ልምምዳትን ብምምርኳዝ በብቁሩብ ይዓቢ ኣሎ፣ ስለዚ እቲ ናይ ምምርማርን ምሕካምን ስትራቴጂ ብቐጻሊ ይሕደስ ኣሎ። 	However, given that COVID-19 is a new disease, our awareness and knowledge is gradually growing based on ongoing research findings and clinical experience, so the screening and treatment strategy is constantly being updated.
762	en	ti	 For instance the Diagnosis and Treatment Guidelines for COVID-19 issued by the National Health Committee of the People’s Republic of China (http://www.nhc.gov.cn/), among 16 January 2020 to 3 March 2020, has issued a total of seven editions with some contexts being substantively changed. 	 ከም ኣብነት፡ ብሃገራዊ ኮሚሽን ጥዕና ቻይና ናይ COVID-19 ምርመራን ሕክምናን መምርሒ ካብ 16 ጥሪ 2020 ክሳብ 3 መጋቢት 2020 ገለ ትሕዝቶታቱ ቀይሩ ብሓፈሻ ሸውዓተ ሕታማት (http://www.nhc.gov.cn/) ኣሕቲሙ ኣሎ። 	For example, the National Health Commission of China has published a total of eight editions (http://www.nhc.gov.cn/) of the COVID-19 diagnosis and treatment guidelines with some changes from January 16, 2020 to March 3,
763	en	ti	 Now our guideline received a comment by Zhou et al., they introduced a simple scoring proposal based on their clinical experience. 	 ሐዚ መምርሒና ካብ Zhou et al. ርኢቶ ተቐቢሉ ኣሎ፣ ኣብ ክሊኒካዊ ተሞክሮኦም መሰረት ዝገበረ ቀሊል እማመ ድማ ኣተኣታትዮም ኣለዉ። 	Our current guide is adapted from Zhou et al. Comment has been received, and they have introduced a simple proposal based on their clinical experience.
764	en	ti	 Their work added new evidence for our guideline and also make valuable reference for this pandemic worldwide. 	 ስርሖም ንመምርሒና ሓድሽ መረዳእታ ዝወሰኸ እንትኾን ብ ብርኪ ዓለም ድማ ዋጋ ዘለዎ መነጻጸሪ ሰሪሑ እዩ። 	Their work added new insights to our guidelines and provided valuable comparisons globally.
765	en	ti	 We endorse their significant work and express our thanks. 	 ምስጋናና እናገለጽና ነዚ ኣገዳሲ ስርሖም ንድግፎ። 	We express our gratitude and support their important work.
766	en	ti	 However, their work also needs update according to the latest Diagnosis and Treatment Guidelines for COVID-19 (Trial seventh version) and recently studies. 	 ይኹን እምበር በቲ ሓድሽ ናይ COVID-19 (Trial seventh version) ምርመራን ሕክምናን መመርሒን ሓደሽቲ መፅናዕትታን መሰረት እቲ ስርሖም ምምሕያሽ ዘድልዮ እዩ። 	However, their work needs to be improved based on the new COVID-19 (Trial seventh version) diagnosis and treatment guidelines and new research.
767	en	ti	 According to the seventh edition (3 March 2020), to confirm the suspected case needs to combine any one item of epidemiological history features with two items of clinical manifestations to make a comprehensive analysis, or needs to meet three items of clinical manifestations if without clear epidemiological history: 	 ብመሰረት እቲ ሻውዓይ ሕትመት (3 መጋቢት 2020)፣ ነቶም ተጠርጢሮም ዘለዉ ናይ ኬዛት ድሌታት ንምርጋግጽ ሓደ ኣቕሓ መልክዕ ናይ ስነ-ሕማም ለበዳ ታሪኽን ክልተ ኣቑሑት ናይ ክሊኒካዊ መርኣያታት ብምሕዋስ ርዱእ ዝኾነ መጽናዕቲ ንምስራሕ፣ ወይ ሰለስተ ኣቑሑት ናይ ክሊኒካዊ መረዳእታ እንድሕር ንጹር ስነ-ሕማም ለበዳዊ ታሪኽ ዘየለ። 	According to the seventh edition (March 3, 2020), to verify the needs of suspected cases, combine one item of epidemiological history and two items of clinical specimens to make a comprehensive study, or three items of clinical data if a clear epidemiological history Nonexistent.
768	en	ti	 Epidemiological history: (1) a history of travel or residence in Wuhan city and surrounding areas, or other communities where COVID-19 cases had been reported in the last 14 days before symptom onset; (2) a history of contact with SARS-CoV-2 infectious cases (with positive nucleic acid test); (3) a history of contacting with patients with fever or respiratory symptoms from Wuhan city and surrounding areas, or other communities where COVID-19 had been reported in the last 14 days before symptom onset; (4) a history of contacting with cluster of confirmed cases (≥ 2 cases with fever and/or respiratory symptoms occurred within 2 weeks in small areas, such as home, office, class of school, etc). 	 ስነ-ለበዳዊ ታሪኽ፥ (1)ናይ ጉዕዞ ታሪኽ፡ ተቀማጢ ከተማ ዉሃንን ከባቢኣን ተቀማጢ ኣብ ዝሓለፈ 14 መዓልታት ቅድሚ ምልክታት ምርኣዮም ናይ COVID-19 መልከፍቲ ዝተመዝገሎም ቦታታት፡ (2) ታሪኽ ርክብ ምስ SARS-CoV-2 ዝሓመሙ ሰባት(ብኑክለዪክ ኣሲድ መርመራ ዝተረጋገጸ)፡ (3) ታሪኽ ርክብ ምስ ረስኒ ወይ ካልኦት ምልክታት ምስትንፋስ ዘለዎ ተቀማጢ ከተማ ዉሃንን ከባቢኣን ወይ ተቀማጢ ኣብ ዝሓለፈ 14 መዓልታት ቅድሚ ምልክታት ምርኣዮም ናይ COVID-19 መልከፍቲ ዝተመዝገሎም ቦታታት፡ (4) ታሪኽ ርክብ ምስ ጉጅለ ዝተረጋገጹ ሕሙማት(≥ 2 ኣብ ውሽጢ 2 ሰሙን ረስኒን/ወይ ካልኦት ምልክታት ምስትንፋስ ዘለዎም ሕሙማት ብፍላይ ድማ ኣብ ጸበብቲ ባታታት ከም ገዛ፡ ቤት-ጽሕፈት ወይ ክፍሊ ቤት-ትምህርትታት…ወዘተ) 	Epidemiological history: (1)Travel history, resident of Wuhan and surrounding area resident of places where COVID-19 infection was recorded in the past 14 days prior to symptoms, (2) history of contact with SARS-CoV-2 patients(confirmed by nucleic acid testing ), (3) history of contact with a resident of Wuhan and surrounding areas with cough or other respiratory symptoms or a resident of places where COVID-19 infection was recorded in the past 14 days prior to symptoms, (4) history of contact with a group of confirmed patients(≥ 2 within Patients with cough and/or other respiratory symptoms, especially in cramped spaces such as home, office or school classroom...etc.
769	en	ti	 Clinical manifestations: (1) fever and/ or respiratory symptoms; (2) with imaging features of COVID-19 infection; (3) total white blood cell counts showing normal, decreased, or reduced lymphocyte count in the early onset stage. 	 ክሊኒካዊ ምልክታት፣ (1) ረስኒን ወይ ምልክታት ምስትንፋስን፣ (2) ምስ ምስሊ ባህሪ ረኽሲ COVID-19፣ (3) ቁጽሪ ድምር ጻዓዱ ዋህዮታት ደም ንቡር፣ ጎዲሉ፣ ወይ ዝጎደለ ቁጽሪ ሊምፈሳይት ኣብ ናይ መጀመርያናይ መልከፍቲ ደረጃ። 	Clinical signs, (1) fever and or respiratory symptoms, (2) with the characteristic features of COVID-19 infection, (3) normal total white blood cell count, decreased, or decreased lymphocyte count at the initial stage of infection.
770	en	ti	 Diagnosing the confirmed case should base on suspected case with any one item of pathogenic or serological evidence as following: (1) real-time PCR test positive for SARS-CoV-2; (2) viral whole genome sequencing showing high homogeneity to the known novel coronaviruses; (3) positive for the specific IgM antibody and IgG antibody to SARS-CoV-2 in serum test; or a change of the SARS-CoV-2-specific IgG antibody from negative to positive, or titer rising ≥4 times in the recovery phase above that in the acute phase. 	 በዞም ዝስዕቡ ፓቶጀኒክ ወይ ሴሮሎጂክ መርመራታት ጥርጡራት ብመርመራ ምርግጋጽ፥ (1) real-time PCR test positive ንሳርስ-ኮቭ-2: (2) viral whole genome sequencing ምስቶም ዝተፈልጡ ኮሮናቫይረሳት high homogeneity ምስዘርኢ፥ (3)ናይ ሳርስ-ኮቭ-2 specific IgM antibodyን IgG antibodyን positive ምስዝመጽእ፡ ወይ ድማ SARS-CoV-2-specific IgG antibody ካብ ኔጌቲቭ ናብ ፐዘቲቭ ምስዝልወጥ፡ ወይ ኣብ ናይ መገገሚ ክፍለ ግዜ ካብቲ ኣኪዩት ክፍለ ግዜ ብ≥4 ግዜ ምስዝዛይድ። 	Confirm suspects by the following pathogenic or serological tests: (1) real-time PCR test positive for SARS-CoV-2: (2) when viral whole genome sequencing shows high homogeneity with the known coronaviruses, (3) SARS-CoV-2 specific IgM antibody and IgG antibody positive, or SARS-CoV-2-specific IgG antibody changes from negative to positive, or increases ≥4 times during the recovery period than during the acute period.
771	en	ti	 We can see that the real-time PCR test for nucleic acid in respiratory tract or blood samples was added to the second (18 January 2020) and third (22 January 2020) editions. 	 Real-time PCR for nucleic acid ሳምፕላት ናይ ስርዓተ-ምስትንፋስን ደምን ኣብቲ ካልኣይን(18 ጥሪ 2020) ሳልሳይን(22 ጥሪ 2020) ሕታማት ወጽዮም። 	Real-time PCR for nucleic acid samples of respiratory tract and blood were published in the second(January 18, 2020) and third(January 22, 2020) editions.
772	en	ti	 The pathogenic detection of blood sample was added to the fourth (27 January 2020) and fifth (8 February 2020) editions; and then the serological evidence was added to the seventh edition. 	 ምልላይ ጠንቂ ሕማም ናይ ደም መርኣያ ኣብቲ ራብዓይን (27 ጥሪ 2020) ሓሙሻይን (8 ለካቲት 2020) ሕትመታት ተጠቓሊሉ ኔሩ፣ ብድሕሪ እዚ እቲ ሴሮሎጂካዊ ጭብጢ ናብቲ ሻውዓይ ሕታም ተወሲኹ። 	The diagnosis of the blood specimen was included in the fourth (January 27, 2020) and fifth (February 8, 2020) editions, after which the serological evidence was added to the seventh edition.
773	en	ti	 These modifications based on the researchers continued work that to search for an optimal nucleic acid detection kit for rapid diagnosis, as well as the samples from respiratory tract including blood sampling, which increased the availability of different specimens, and supported bringing the specific antibody positive result into the confirmed criteria. 	 እዘን ለውጥታት ኣብ ስሉጥ ናይ ኑክለይክ ኣሲድ ዲተክሽን ኪት ንምርካብ ጻዕርታት ተመራመርቲ ዝተመርኮሰ’ዩ። ብተወሳኺ ዝበለጸ ናይ ደምን ስርዓተ-ትንፋስን ሳምፕላት ኣብ ምርካብን ኣዎንታዊ ውጽኢታት ጸረ-ነፍሳት ናብ ዝተረጋገጸ መምዘኒታት ንምእታው ኣብ ምድጋፍን ይምርኮስ። 	These changes are based on researchers&#39; efforts to develop efficient nucleic acid detection kits. It also relies on obtaining the best blood and respiratory samples and supporting the inclusion of positive antibiotic results into validated criteria.
774	en	ti	 Besides, there are more and more evidence that remind us to caution with the atypical symptomatic and asymptomatic patients. 	 ምስ እዚ ጎኒ ን ጎኒ፣ ኣብ እቶም ዘይልሙድ ምልክታት ዘለዎምን ምንም ምልክት ኣብ ዘየርእዩን ሰባት ትኹረት ምግባር ከምዘድልየና ዘዘኻኽሩ መረዳእታት ብዙሓት መረዳእታት ኣለዉ። 	Alongside this, there is a lot of evidence that reminds us that we need to focus on people with unusual symptoms and those who show no symptoms.
775	en	ti	 Hence, the flow chart of Zhou et al. should be updated, as they classified the person without clinical symptoms as “low risk”. 	 ስለዚ ናይ Zhou et al. flow chart ምልክታት ዘይብሎም ሰባት “ኣብ ትሑት ሓደጋ ኣለዉ” ዝብል ክመሓየሽ ኣለዎ። 	Therefore, the Zhou et al. flow chart People without symptoms “are at low risk” should be updated.
776	en	ti	 The score system also needs to be verified in further clinical practice and studies. 	 እዚ ምእራም መንገዲ ተወሳኺ ግብራውን መጽናዕታውን ምርግጋጽ ከድልዮ’ዩ። 	This correction will require further practical and research verification.
777	en	ti	 To conclude, we hope more direct evidence coming up and call for readers to provide their comments. 	 ንምጥቕላል ዝኣክል፣ ንፁር ዝኾነ መረዳእታ ንኽንረክብን መንበብትና ስልኪ ደዊሎም ርኢቶኦም ክህቡናን ተስፋ ንገብር። 	To summarize, we hope to get clear data and our readers to call us and give us their feedback.
778	en	ti	 For the diagnosis of “suspected case” and “confirmed case”, we suggest to trace and obey the newest guidelines of their home countries. 	" ኣብ ""ዝተጠርጠረ ጉዳይ ለበዳ"" ን ""ዝተረጋገፀ ጉዳይ ለበዳ"" ን ብ ምርመራ ኣብ ምፍላይ፣ ናይ እቲ ዝነብሩሉ ዓዲ ሓዱሽ መምርሒ ክትጥቀሙ ንላበው። "	In distinguishing between “suspected outbreak cases” and “confirmed outbreak cases” by diagnosis, we recommend that you use the new guidelines of your country of residence.
779	en	ti	 Our team will also timely update our guideline to offer help. 	 ጉጅለና እውን ሓገዝ ንምሃብ ጊዜኡ ሓልዩ ነቲ መምርሒ ክሕድስ እዩ። 	Our team will also update the guidelines in a timely manner to provide assistance.
780	en	ti	 Bangladesh reports five new deaths due to COVID-19, a daily highest 	 ባንግላዲሽ ኣብ መዓልቲ እቲ ዝለዓለ ዝበሃል ሓሙሽተ ብኮቪድ-19 ሰባት ከምዝሞቱ ሓቢራ። 	Bangladesh has reported a record five deaths a day from the virus.
781	en	ti	 Yesterday, Bangladesh has confirmed five new deaths due to COVID-19 on the day. 	 ትማሊ፣ ባንግላዲሽ ኣብ እቲ መዓልቲ ብምኽንያት ኮቪድ-19 ሓሙሽተ ሰባት ከምዝሞቱ ኣረጋጊጻ። 	Yesterday, Bangladesh confirmed five deaths from the virus on the day.
782	en	ti	 This is the highest number of fatalities in a day due to the virus. 	 እዚ በዚ ቫይረስ ምኽንያት ንመዓልቲ ዝለዓለ ቁጽሪ ሞት እዩ። 	This is the highest daily death toll from the virus.
783	en	ti	 As of yesterday, Bangladesh's Institute of Epidemiology, Disease Control and Research (IEDCR) reported the number of recorded infected cases included 114 active cases and 33 recovered cases who were staying home. 	 ክሳብ ትማሊ ጥራሕ፣ ካብ'ቶም ዝተለኽፉ 114 ንጡፋት ኬዛትን 33 ዝሃወዩን ኣብ ገዝኦም ዝጸንሑ ዘለዉ ኬዛትን ከምዘለዉ ናይ ባንግላዲሽ ትካል ናይ ኢፒደሞሎጂ፣ ናይ ሕማም ቁጽጽርን መጽናዕቲን (IEDCR) ሓቢሩ። 	As of yesterday alone, there are 114 active cases and 33 recovered cases at home, according to the Bangladesh Institute of Epidemiology, Disease Control and Research (IEDCR).
784	en	ti	 A total of 17 deaths have been recorded. 	 ብሓፈሻ ዝተመዝገበ ቁጽሪ ሞት ድማ 17 እዩ። 	The total number of deaths recorded is
785	en	ti	 In an online news briefing, the director of IEDCR, Dr Meerjady Sabrina Flora, said the fatalities included four males and one female. 	 ኣብ ናይ ኦንላይን ዜና መግለጺ፣ ናይ IEDCR ዳይሬክተር፣ Dr Meerjady Sabrina Flora፣ እቶም ዝሞቱ ኣርባዕተ ደቂ ተባዕትዮን ሓንቲ ኣንስተይትን ዝሓዘ እዩ ኢላ። 	In an online news release, IEDCR director, Dr Meerjady Sabrina Flora said the dead included four men and one woman.
786	en	ti	 According to Dr Meerjady, two cases were aged above 60, two between 51 and 60, and one 41-50 years old. 	 ብመሰረት Dr Meerjady ዝበለቶ፣ ክልተ ካብ'ቶም ግዳያት ናይ'ቲ ለበዳ ዝኾኑ ዕድሚኦም ልዕሊ 60፣ ክልተ ድማ ኣብ መንጎ 51 ን 60 ን፣ ሓደ ድማ 41-50 ዓመቱ እዩ ነይሩ። 	According to Dr Meerjady, two of the victims were over 60, two were between 51 and 60 and one was 41-5
787	en	ti	 She also said two of the victims were from Dhaka. 	 ክልተ ካብ'ቶም ግዳያት ካብ ዳካ ዝመጹ እዮም ድማ ኢላ። 	Two of the victims were from Dhaka, she said.
788	en	ti	 The World Health Organization (WHO) declared COVID-19 a pandemic on March 11. 	 ናይ ውድብ ጥዕና ዓለም (WHO) ንኮቪድ-19 ዓለምለኻዊ ለበዳ ክብል ኣብ መጋቢት 11 ኣዊጁ። 	The World Health Organization (WHO) declared COVID-19 a global pandemic on March
789	en	ti	 A hospital official told Anadolu Agency, a local news outlet, that one of the deceased was Jalal Saifur Rahman, a director of Bengali Anti-Corruption Commission, who was cared for at the Kuwait Maitree Hospital. 	 ናይ ሆስፒታል በዓል ስልጣን ን ኣናዶሉ ኤጀንሲ፣ ዞባዊ ናይ ዜና ፈነወ ጣብያ፣ ኣብ ዝሃቦ ቃል፣ ካብ'ቶም ዝሞቱ እቲ ሓደ ናይ ቤንጋሊ ጸረ ግዕዝይና ኮሚሽን ዳይሬከክተር፣ ጃላል ሳይፉር ራህማን ከምዝነበረን ኣብ ናይ ኩዌት ሜትሪ ሆስፒታል ክትትል ክግበረሉ ከምዝጸንሐን ሓቢሮም። 	A hospital official told Anadolu Agency, a regional news station, that one of the deceased was Bengal Anti-Corruption Commission Director Jalal Saifur Rahman, who was being treated at Kuwait&#39;s Metri Hospital.
790	en	ti	 On Saturday, in an online video announcement, Bangladeshi Road Transport and Bridges Minister Obaidul Quader said public transport would be shut down for longer than initially planned, until this coming Saturday. 	 ብቀዳም፣ ኣብ ናይ ኦንላይን ቪድዮ ኣዋጅ፣ ባንግላዲሽ ናይ መንገዲ ትራንስፖርትን ናይ ቢንቶታትን ምኒስተር ኦባይዱል ቋደር፣ ህዝባዊ መጎዓዓዝያ ክሳብ ዝመጽእ ዘሎ ቀዳም፣ ካብ እቲ መጀምርያ ዝተተለሞ ንዝነውሕ ግዘ ከምዝዕጾ ሓቢሮም። 	On Saturday, in an online video announcement, Bangladesh&#39;s Road Transport and Bridges Minister Obaidul Qader said public transport would be closed for longer than originally planned until next Saturday.
791	en	ti	 This public transport shutdown had initially started on March 26 and was planned to end on Saturday, April 4. 	 እዚ ናይ ህዝባዊ መጎዓዓዝያ ምዕጻው ብቀዳም መጋቢት 26 እዩ ተጀሚሩ ፣ ሚያዝያ 4 ክውዳእ ድማ እዩ ትጽቢት ዘሎ። 	The public transportation closure began on Saturday, March 26 , and is expected to end on April
792	en	ti	 Transport of essential goods -- medical, fuel and food -- was still allowed. 	 ናይ መሰረታዊ ኣቑሑት -- ናይ ሕክምና፣ ነዳዲን መግቢን --መጎዓዓዝያ ሕዚ እውን ፍቑድ እዩ። 	Transportation of basic goods -- medical, fuel and food --is still permitted.
793	en	ti	 The first recorded incidents of COVID-19 infection in Bangladesh were on March 8, in two people who returned from Italy and also the wife of one of them. 	 እቲ ናይ መጀመርያ ኣብ ባንግላዲሽ ዝተመዝገበ ናይ ኮቪድ-19 ኣጋጣሚ ኣብ መጋቢት 8 ፣ ኣብ ካብ ጣልያን ዝተመለሱ ክልተ ሰባትን ናይ ሓዲኦም ድማ በዓልቲ ቤትን እዩ ነይሩ። 	The first case of COVID-19 in Bangladesh was reported on March 8 , in two people returning from Italy and one of them&#39;s wife.
794	en	ti	 As of March 19, these three had already recovered. 	 ካብ መጋቢት 19 ጀሚሩ፣ እዞም ሰለስተ ሰባት ሓውዮም ኣለዉ። 	Since March 19, these three people have recovered.
795	en	ti	 SARS-CoV-2 surpasses one million infections worldwide 	 ቁጽሪ ብSARS-CoV-2 ዝተለኽፉ ብ ዓለምለኻዊ ደረጃ ካብ ሓደ ሚልዮን ሓሊፉ ኣሎ። 	The number of SARS-CoV-2 infections worldwide has passed one million.
796	en	ti	 On Thursday, the total number of cases of the SARS-CoV-2 coronavirus infections surpassed one million worldwide, Johns Hopkins University data indicated. 	 ብሓሙስ፣ ናይ Johns Hopkins University ሓበሬታ ከምዘርእዮ፣ ብ SARS-CoV-2 ኮሮናቫይረስ ረኽሲ ዝተታሓዙ ሓፈሻዊ ቁጽሪ ግዳያት ለበዳ ኣብ መላእ ዓለም ካብ ሓደ ሚልዮን ሓሊፉ ኣሎ። 	On Thursday, Johns Hopkins University data showed that the total number of pandemic victims worldwide infected with the SARS-CoV-2 coronavirus infection has passed one million.
797	en	ti	 At least 52 thousand deaths were linked to COVID-19, the disease caused by the coronavirus. 	 ምስ እቲ ብኮሮናቫይረስ ዝመጽእ ሕማም፣ ኮቪድ -19 ዝተተሓሓዙ ቁጽሪ ምዉታን ድማ ብውሕዱ 52 ኣሽሓት ይበጽሕ። 	The death toll from the coronavirus has risen to at least 52,0
798	en	ti	 The milestone came the same day Malawi confirmed its first coronavirus infections and Zambia had its first coronavirus-related death. 	 እዚ እምነ ምዕራፍ ማላዊ ናይ መጀመርያ ናይ ኮሮናቫይረስ ዝተረጋገጸ ረኽሲ ኣብ ዝሓበረትሉን፣ ኣብ ዛምቢያ ድማ ናይ መጀመርያ ብኮሮናቫይረስ ምኽንያት ሞት ዝተመዝገበሉን መዓልቲ እዩ መጽዩ። 	The milestone came on the day Malawi reported its first confirmed case of the virus and Zambia recorded its first death from the virus.
799	en	ti	 North Korea claimed, as of Thursday, it was one of the few countries remaining free of coronavirus infections. 	 ሰሜን ኮርያ፣ ካብ ሓሙስ ጀሚራ፣ ካብ ኮሮናቫይረስ ነጻ ካብ ዘለዋ ውሑዳት ሃገራት ሓንቲ ከምዝኾነት ሓቢራ። 	North Korea, as of Thursday, said it was one of the few countries free of the virus.
800	en	ti	 By yesterday, the World Health Organization reported 1,051,635 confirmed cases, including 79,332 cases in the twenty four hours preceding 10 a.m. Central European Time (0800 UTC) on April 4. 	 ክሳብ ትማሊ፣ ውድብ ጥዕና ዓለም 1,051,635 ዝተረጋገጹ ኬዛት ለበዳ ዝጸብጸበ እንትኾን፣ 79,332 ኬዛት ብ ዕስራን ኣርባዕተን ሰዓታት ን 10 a.m. ናይ ማእኸላይ ናይ ኣውሮፓ ሰዓት (0800 UTC) ቀዲሞም ኣብ ሚያዝያ 4 ዝተመዝገቡ እዮም። 	As of yesterday, the World Health Organization reported 1,051,635 confirmed cases of the outbreak, with 79,332 cases registered in the twenty-four hours prior to 10 am Central European Time (0800 UTC) on April
801	en	ti	 In the United States, over 244 thousand coronavirus cases were recorded, linking to at least 5,900 deaths. 	 ኣብ ሕቡራት መንግስቲታት ኣሜሪካ፣ እንተንኢሱ 5,900 ሞት ሓዊሱ ፣ ልዕሊ 244 ሽሕ ናይ ኮሮናቫይረስ ጉዳያት ለበዳ ተመዝጊቦም እዮም። 	In the United States, there have been more than 244,000 outbreak cases , including at least 5,900 deaths.
802	en	ti	 CBS News reported, citing Johns Hopkins University data, there were over 1,000 US deaths on Wednesday caused by coronavirus infections. 	 CBS ዜና ከምዝሓበሮ፣ ናይ Johns Hopkins University ዳታ ከምዝበሎ፣ ልዕሊ 1,000 ዝኾኑ ናይ ኣሜሪካ ሞታት ብ ሮቡዕ ብኮሮናቫይረስ ተመዝጊቦም ኣዮም። 	According to CBS News, Johns Hopkins University data showed that more than 1,000 American deaths were recorded on Wednesday from the virus.
803	en	ti	 Around the world, countries announced stricter measures to inhibit the disease from spreading. 	 ኣብ መላእ ዓለም፣ እዚ ሕማም ንከይጋፋሕ ሃገራት ጥንኩራት ገደባት ኣዊጀን ይርከባ። 	Around the world, countries have imposed strict restrictions to prevent the spread of the disease.
804	en	ti	 On Thursday, Sergei Sobyanin, the mayor of Moscow, extended the city lockdown to May 1. 	 ብዕለተ ሓሙስ፣ Sergei Sobyanin፣ ናይ ሞስኮ ከንቲባ፣ ነቲ ናይ እታ ከተማ ምዕጻው ክሳብ ግንቦት 1 ኣናዊሖሞ። 	On Thursday, Sergei Sobyanin, the mayor of Moscow, extended the city&#39;s closure until May
805	en	ti	 Nationally, President Vladimir Putin declared Russians would continue to be paid without going to work until April 30. 	 ብሃገራዊ ደረጃ፣ ፕረዚዳንት Vladimir Putin ሩስያውያን ክሳብ ሚያዝያ 30 ናብ ስራሕ ከይከዱ ክፍሊቶም ምቕባል ክቕጽሉ ከምዝኾኑ ሓቢሮም። 	Nationally, President Vladimir Putin said Russians will continue to receive their pay without going to work until April
806	en	ti	 The parliament of Portugal voted to extend the national state of emergency by 15 days; the vote passed with 215 votes in favor, ten abstentions, and one vote against. 	 ፓርላማ መንግስቲ ፖርችጋል ብ215 ናይ ስምምዕ ድምጺ፣ ዓሰርተ ድምጸ ተኣቅቦ ሓደ ተቓውሞን ሃገራዊ ኣውጅ ህጹጽ ጊዜ ብ15 መዓልታት ከናውሕ ወሲኑ። 	The Portuguese parliament decided to extend the state of emergency by 15 days with 215 votes in favour, 10 abstentions and one against.
807	en	ti	 Saudi Arabia extended curfews in the holy cities of Mecca and Medina to last the entire day; previously, the curfew was only in effect between 3 p.m. and 6 a.m. 	 ሳዑዲ ዓረብያ ናይ ቅዱሳት ቦታታቶም መካን መዲናን ሙሉእ መዓልቲ ብግዘ ናብ ገዛኻ እቶ ዝብል ትእዛዝ ኣናዊሖምዎ፣ ኣቀድም ኣቢሉ እዚ ትእዛዝ ካብ 3 ድ.ቀ. ክሳብ 6 ቅ.ቀ. እዩ ኔሩ። 	Saudi Arabia has extended the curfew for its holy sites of Mecca and Medina throughout the day. until 6 a.m. It was the 1990s.
808	en	ti	 Thailand planned to implement a curfew between 10 p.m. and 4 a.m. 	 ታይላንድ ካብ 10 ድ.ቀ. ክሳብ 4 ቅ.ቀ. ብግዘ ናብ ገዛኻ ምእታው ክተጽድቕ ወጢና ኣላ። 	Thailand from 10 p.m. until 4 p.m. She plans to approve timely entry into your home.
809	en	ti	 The governor of Ohio, Mike DeWine, announced the state had extended its stay-at-home order until May 1. 	 ናይ ኦሃዮ ኣመሓዳሪ፣ Mike DeWine፣ እታ ግዝኣት ናይ ኣብ ገዛኹም ጽንሑ ኣዋጃ ክሳብ ግንቦት 1 ከምዘናወሐቶ ገሊጾም። 	Ohio Governor Mike DeWine said the state has extended the stay-at-home order until May
810	en	ti	 Stores in Australia lower toilet paper limits per transaction 	 ኣብ ኣውስትራልያ፡ ድኳናት ኣብ ሓደ እዋን ክግዛእ ዝኽእል ብዝሒ ናይ ሽቓቅ ሶፍት ኣጉዲሎሞ። 	In Australia, stores have reduced the number of toilet sofas that can be bought at a time.
811	en	ti	 On Sunday and Saturday evening, Australian store chains Woolworths and Coles lowered their purchase restrictions on toilet paper to two and one package per transaction in all stores on national level, respectively. 	 ኣብ ሰንበትን ቀዳምን ምሸታት፡ ናይ ኣውስትራሊያ ናይ መደብራት ሰንሰለት ዎልዎርትስ ን ኮልስን ኣብ ናይ ሽቓቕ ወረቐት ኣብ ሕድሕድ ልውውጣት ሓደ ውይድማ ከለት ፓኬት ክብላ ኣንቢረናኦ ዝነበራ እገዳታት ትሕት ክብል ገይረን ኣለዋ። 	On Saturday and Saturday nights, Australian store chains Walworth and Coles eased restrictions on toilet paper packets per exchange.
812	en	ti	 ALDI also introduced a one-pack limit, on Monday. 	 ብሰኑይ’ውን ALDI ሓደ ባኮ ጥራይ ዝብል ዕገዳ ኣተኣታትዩ። 	On Monday, ALDI also introduced a one-bacon ban.
813	en	ti	 These limitations were posted as messages on the checkouts, and on the chains' Facebook pages. 	 እዞም ወሰናት እዚኦም ኣብ መውጽኢታት ን ኣብ ፌስቡክን ክም መልእኽቲታት ተጠቒዖም እዮም። 	These boundaries have been posted in outlets and on Facebook as messages.
814	en	ti	 Buyers were reportedly stocking up due to fears of COVID-19 in case people need to self-isolate. 	 ብሰንኪ COVID-19 ዝትላዕለ ነብሰ-ውሸባ ከድሊ እዩ ብዝብል ስግኣት ፡ ልዕሊ መጠን ዕድጊ ክካየድ ከምዝጸንሐ ይሕበር። 	Over-purchasing has been reported due to fears of self-quarantine being required due to COVID-1
815	en	ti	 On Wednesday, Woolworths also limited toilet paper purchases for home delivery to one pack per order. 	 ኣብ ሓሙስ፡ ዎልዎርትስ ናብ ገዛ ኣብዝለኣኽ ናይ ሽንትቤት ወረቐት መሸጣ ብሕድሕድ ትእዛዝ ሓደ ፓኬት ንክኾን ወሰን ገይራ። 	On Thursday, Walworth limited home delivery toilet paper sales to one packet per order.
816	en	ti	 These changes followed the previous four-pack per transaction restriction introduced by Woolworths and Coles on March 4 and 5 respectively. 	 እዞም ለውጥታት ብድሕሪ’ቲ ዝጸንሐ ብዉልዎርዝስን ኮልስን ብ4ን 5ን ማርች ዘውጽእዎ ‘ልዕሊ ኣርባእተ ባኮ ብሓንሳብ ምግዛእ ክልኩል’ ዝብል ዕገዳ እዩ መጽዩ። 	The changes follow a ban imposed by Woolworths and Coles on March 4 and
817	en	ti	" Coles, in its March 8 media release, reported that with the four-pack restriction in place, ""many stores are still selling out within an hour of delivery"", and called the demand ""unprecedented"", while ALDI, in a Facebook post on Tuesday, called it ""unexpected"". "	 ኮልስ፡ ኣብቲ ብ ማርች 8 ዘቕረቦ መግለጺ፡ ዕገዳ ናይ ዝያዳ ኣርባዕተ ባኮ ዕድጊ ኣብ ቦትኡ ከሎ፥”ብዙሓት ድኳናት ሸቀጦም ኣብ ውሽጢ ሓደ ሰዓት ናይ ምብጻሕ ከም ዝውዳእ ዘሎ” ይሕብር። ነዚ ጠለብ ድማ “ተራእዩ ዘይፈልጥ” ኢሉ ክገልጾ ከሎ፡ ALDI ከኣ ”ዘይተጸበናዮ” ኢሉ ኣብ ፌስቡክ ብሰሉስ ፖስት ገይርዎ ይርከብ። 	Coles said in a statement on March 8 that while the ban on more four-pack purchases remains in place, “many stores are running out of goods within an hour of delivery.” He described the demand as “unprecedented” and ALDI posted it on Facebook on Tuesday as ”unexpected”.
818	en	ti	" Sales went up in a ""sharp increase"" last week, according to a Woolworths spokesperson. "	 ሓደ ወኪል ዉልዎርዝስ ከምዝበሎ፡ ኣብ ዝሓለፈ ሰሙን ዕዳጋታት ልዑል ወሰኽ ኣርእየን። 	A Woolworths representative said markets were up last week.
819	en	ti	 Costco's store in Canberra also limited the allowed amount to two packs last week. 	 ኣብ ካንበራ ዝርከብ ናይ ኮስትኮ መደብር ካብቲ ዝሓለፈ ሰሙን ኣትሒዙ እቲ ዝፍቀድ መጠን ክልተ ፓኬት ገይሮም። 	The Costco store in Canberra has increased the allowed size to two packets since last week.
820	en	ti	 To further alleviate the shortage, Coles ordered bigger packages from suppliers and increased delivery frequency, Woolworths ordered extra stock, while ALDI made stocks for a planned Wednesday special available early. 	 ነቲ ሕጽረት ብዝበለጸ ንምብዳህ፣ ኮልስ ዓበይቲ ፓኬጃት ካብ ኣቕረብቲ ብምእዛዝ፣ናይ ምብጻሓት ድግግም ወሲኹ፣ ዉልዎርዝስ ድማ ተወሳኺ ቀረብ ኣዚዙ፣ALDI ድማ ነቲ ዝተወጠነ ናይ ረቡዕ ስፒሻል ቀረብ ኣቐዲሙ ከምዝርከብ ገይሩ። 	To better overcome the shortage, Coles increased the frequency of deliveries by ordering larger packages from suppliers, Woolworths ordered more supplies, and ALDI made the planned Wednesday special supplies available earlier.
821	en	ti	 Russell Zimmerman, executive director of the Australian Retailers Association, said that retailers try to raise stock, but local council restrictions on the timing of truck-deliveries make it hard. 	 ራስል ዚመርማን፣ ናይ Australian Retailers Association (ኣውስትራሊያ ናይ ሸቃጦ ማሕበር) ዋና ጸሓፊ፣ ሸቃጦ ናይ ሸቐጥ ቀረብ መጠን ልዕል ከብሉዎ ፈቲኖም፣ እንተኾነ ግን ብ ናይ እቲ ከባቢያዊ ባይቶ ኣብ ናይ ኣቑሑ መብጻሕቲ መኻይን ዝተነበረ ናይ ግዜ/ሰዓት ክልከላታት ከቢድ ገይርዎ እዩ። 	Russell Zimmerman, secretary-general of the Australian Retailers Association, said retailers tried to increase supply, but it was made difficult by the local council&#39;s time/hour restrictions on delivery vehicles.
822	en	ti	 He expects rising production costs, as suppliers try to meet demand, and fewer specials. 	 ድኳናት ጠለብ ከማልኡ መታን ናይ ፍርያታት ዋጋ ክውስኽ ይጽበዮ። 	He expects stores to raise prices to meet demand.
823	en	ti	 On Tuesday, ALDI announced that following the early release of stock, some stores can't run the Wednesday special. 	 ብሰሉስ፡ ALDI ብሰንኪ ቅልጡፍ ዕደላ ቀረብ ገለ ድኳናት እቲ ናይ ረቡዕ ፍሉይ ዕዳግኦም ከሰላስሉ ዘይምኽኣሎም ገሊጹ። 	On Tuesday, ALDI said some stores were unable to process their Wednesday special due to rapid supply distribution.
824	en	ti	 In a News.com.au report, Dr Gary Mortimer, retail expert from Queensland University of Technology, said the stores fill the stock every night. 	 ብመሰረት ናይ News.com.au ሪፖርት፣ ዶ/ር ጋሪይ ሞርቲመር፣ ኣብ ኩዊንስ ላንድ ቴክኖሎጂ ዩኒቨርሲቲ ናይ ምችርቻር በዓል ሞያ ክምዝበሉዎ፣ እቶም መድብራት ኩል ግዜ ምሸት መድብሮም እናመልኡ እዮም። 	According to News.com.au, Dr Gary Mortimer, a retail specialist at Queensland University of Technology, said the shops are always filling up in the evening.
825	en	ti	 He remarked toilet paper is a bulky item, leading to low quantity of stocks in numbers, and, when sold out, leaves vast shelf spaces empty, hardening the feeling of a shortage. 	 ናይ ሽቓቕ ሶፍት ብበዝሒ ዝርከብ ከምዝኾነ፣ ኣብ መሸጣ ኣዝዩ ትሑት ብዝሒ ክህሉ ዝገብር፣ ከምኡ እውን፣ ኩሉ ምስተሸጠ፣ ኣዝዩ ብዙሕ ናይ መሸጢ ቦታ ጥራሖም ከምዝገብር፣ እዚ ድማ ነቲ ናይ ሕጽረት ስምዒት ከምዘጋድዶ ኣመልኪቱ። 	He pointed out that toilet sofas are available in large quantities, leading to very low quantities in sales, and, when all is sold, leaving very much of their sales space empty, which exacerbates the sense of scarcity.
826	en	ti	" ""Coles and Woolworths have a view [that] if there was plenty of stuff on the shelf, if product like toilet rolls and sanitiser could be [bought] and are there in quantities, you would probably minimise the panic"" said Russell Zimmerman per ABC News. "	" ""ክም ምልከታ ኮልስን ዎልዎርትስን፣ ኣብ እቲ ሼልፍ ብዙሕ ዓቁሑ ምሃለዉ፣ ክም ናይ ሽንት ቤት ወረቐትን ከም ሳኒታይዘርን ዝበሉ ምህርቲታት ክዕደጉን ብበዝሒ ዝርከቡን እንተደኣ ኾይኖም ፣ ምናልባት ነቲ ድንጋጸ ምቕናስ ይከኣል ይኸውን"" ኢሉ ራሰል ዚመርማን ካብ ABC News ተዛሪቡ። "	&quot;According to Coles and Walworths, there would be more items on the shelf, and if products like toilet paper and sanitizer were available in large quantities, it might be possible to reduce the sympathy,&quot; said Russell Zimmerman of ABC News.
827	en	ti	 Recycled toilet paper producer Who Gives a Crap said on last Wednesday they'd run out of stock. 	 ሪሳይክል ዝተገበረ ናይ ሽንትቤት ወረቐት መፍረዪ ኣብ ዝሓለፈ ሓሙስ ምህርቲ ክውድኡ ክምዝኽእሉ ሓቢሩ። 	He said the recycled toilet paper mill could finish production last Thursday.
828	en	ti	 Kimberly-Clark, which makes Kleenex Toilet Tissue, and Solaris Paper which makes Sorbent, emphasized they were working 24/7 to maintain the supply, according to the News.com.au report. 	 ናይ ሽቓቕ ወረቀት ክሊነክስ ዘዳሉ ኪምበርሊ-ክላርክን ሶርበንት ተዳሉ ሶላሪስ ወእቐትን ቀረብ ንምሕላው ብምባል 24/7 ይሰርሑ ከምዘለዉ ኣብ News.com.au ሓቢሮም። 	Toilet paper maker Kimberly-Clark and sorbent maker Solaris Weket are working 24/7 to maintain supply, they told News.com.au.
829	en	ti	 Domain.com, a real estate site, reported some property sellers offering free toilet paper to the first bidder on auctions in Melbourne, when fewer auctions were held because of buyers having time off on the long weekend of Labour Day. 	 Domain.com ዝተብሃለ ናይ ሪል እስቴት ድህረ ገጽ፣ ገለ ሸየጥቲ ብ ሰንኪ ዝተናውሑ ናይ መዓልቲ ሸቃሎ ባዓላት ን ናይ ሰሙን መጨረሻ ምስ ምዃኑ ወሑዳት ጨረታታት እንትካየዱ ከለው ኣብ ሜይልቦርን ኣብ ዝተኻየደ ጨረታ ዝተሳተፉ ናይ መጅመሪያ ተጫረትቲ ናጻ ናይ ሽንት ቤት ወረቐት ሂቦም። ክብል ጽብጺቡ። 	Real estate website Domain.com offered free toilet paper to the first bidders at a Melbourne auction as some sellers held fewer bids due to extended Labor Day holidays and the weekend. he reported.
830	en	ti	 The Thursday edition of NT News, a daily printed in Darwin, included an eight-page insert meant to be cut up and used as toilet paper. 	 NT News ዝተባህለ ኣብ ዳርዊን ዝሕተም መዓልታዊ ጋዜጣ፡ ኣብ ናይ ሓሙስ ሕታሙ ተቆሪጹ ከም ናይ ሽቓቕ ወረቐት ከገልገል ዝኽእል ሸሞንተ ገጻት ዝሓዘ ክፋል ኣሕቲሙ። 	The NT News, a Darwin daily newspaper, published an eight-page section in its Thursday edition that could have been cut and served as toilet paper.
831	en	ti	 The stores were originally reluctant to impose restrictions, according to a report from ABC Australia on March 3 in which they said they had no plans to introduce restrictions on the purchases. 	 ብ መሰረት ናይ ማርች 3 ናይ ABC ኣውስትራሊያ ጸብጻብ ፣እቶም መደብራታ መጀምሪያ ኣብ ዕድጊት ኣቑሑት ናይ መጠን ወሰናት ናይ ምግባር መድብ ከምዝየብሎም ብምሕባር ነቲ እገዳ ንምፍጻም ምዝሕሓል የርእዩ ነይሮም። 	According to a March 3 ABC Australia report ,its stores were initially slow to implement the ban, saying they had no plans to impose quantity limits on purchases.
832	en	ti	 Russell Zimmerman added that other products are also in high demand, including masks, sanitiser, dried goods, handwash and flour. 	 ራስል ዚመርመን ን ማስክታት፣ ናይ ንጽህና ፈሳሲ፣ ዝነቐጹ ኣቑሑት፣ ኤድ መሕጸብን ሑሩጭን ሓውስካ፣ ካልኦት ምህርትታት እውን ኣብ ልዑል ጠለብ ከምዝርከቡ ገሊጹ። 	Russell Zimmerman said other products, including masks, hygiene liquids, dry goods, ed baths and flour, are also in high demand.
833	en	ti	 Similarly, outside of Australia, on Sunday evening online British supermarket Ocado was observed limiting purchases of Andres toilet paper to two 12-roll packs. 	 በተመሳሳሊ፣ካብ ኣውስትራሊያ ወጻኢ ፣ ኣብ ሰንበት ምሸት ናይ እንግሊዝ ኦንላይን ሱፐር ማርኬት ኦካዶ ኣብ ናይ ኣንድሬይስ ናይ ሽንት ቤት ወረቐት ዕድጊት ናይ 12 ሮል ፓኬት ወሰን ክገብር ተራእዩ ኣሎ። 	Similarly,outside Australia , British online supermarket Ocado was seen limiting Andreas&#39; toilet paper purchases on 12-roll packets on Saturday night.
834	en	ti	 World Health Organization declares COVID-19 pandemic 	 ውድብ ጥዕና ዓለም ኮቪድ-19 ለበዳ ኢሉ ኣዊጅዎ። 	The World Health Organization has declared COVID-19 an epidemic.
835	en	ti	 On Wednesday, the World Health Organization (WHO) declared the ongoing outbreak of COVID-19 — the disease caused by coronavirus SARS-CoV-2 — to be a pandemic. 	 ብረቡዕ ውድብ ጥዕና ዓለም(WHO) ነዚ ለብዒ COVID-19- ኮሮናቫይረስ SARS-CoV-2 ዘስዕቦ ሕማም- ለበዳ ምዃኑ ኣዊጁ። 	On Wednesday, the World Health Organization (WHO) declared the COVID-19- coronavirus SARS-CoV-2 pandemic.
836	en	ti	" Although the word ""pandemic"" only refers to how widely a disease has spread, not how dangerous specific cases are, the WHO noted the need to drive governments to action: "	" ምንም እኳ ""ለበዳ"" ዝብል ቃል እቲ ሕማም ክንደየናይ ከምዝተላበደ እምበር ክንደየናይ ሓደገኛ ከምዝኾነ ዝውክል እንተዘይኮነ፡ WHO መንግስታት ናብ ተግባር ክኣትዉ ከምዘለዎም ኣቐሚጡ። "	Although the term &quot;epidemic&quot; represents how widespread the disease is, not how dangerous it is, the WHO stipulates that governments must act.
837	en	ti	" ""All countries can still change the course of this pandemic. "	 “ኩለን ሃገራት መንገዲ ናይዚ ለበዳ ዋላ ሕጂ’ውን ክልውጥኦ ይኽእላ እየን።” 	“All countries can change the course of this epidemic even now.”
838	en	ti	" If countries detect, test, treat, isolate, trace and mobilize their people in the response,"" said Tedros Adhanom Ghebreyesus, the Director-General of the WHO. "	 ናይ WHO ዋና ዳይሬክተር፣ Tedros Adhanom Ghebreyesus፣ ሃገራት መልሲ ኣብ ምሃብ ንህዝበን ኣብ ምልላይ፣ ምምርማር፣ ምንጻል፣ ምክትታልን ምጉዕዓዝን እንተጌረን” ኢሉ። 	WHO Director-General, Tedros Adhanom Ghebreyesus, said if countries respond by identifying, testing, isolating, monitoring and transporting their people.”
839	en	ti	" ""We are deeply concerned both by the alarming levels of spread and severity and by the alarming levels of inaction."" "	 “እዚ ዘሰቅቕ መጠነ ዝርግሐን ጽኑዕነትን ከምኡ’ውን ኣሻቓሊ መጠን ሸለልትነት ብዙሕ የተሓሳስበና ኣሎ።” 	“We are very concerned about this alarming level of prevalence and persistence and the worrying level of neglect.”
840	en	ti	" According to Dr. Tom Frieden, formerly the director of the United States' Centers for Disease Control and Prevention, the pandemic is ""unprecedented."" "	" ብ መሰረት ዶ/ር ቶም ፍሬይደን፡ ኣብ ሕሉፍ እዋን ናይ ዩናይትድ ስቴትስ ማእኸል ቁጽጽርን ምክልኽልን ሕማም ዳይሬክተር ዝነበሩ፡ እቲ ለበዳ ""ዘይተሓሰበ"" ክብሉ ኣቐሚጦሞ። "	According to Dr. Tom Freiden, former director of the US Centers for Disease Control and Prevention, the outbreak was &quot;unexpected.
841	en	ti	" He said, in remarks published by CNN in February, ""other than influenza, no other respiratory virus has been tracked from emergence to continuous global spread."" "	" ብ መሰረት ናይ CNN ናይ ፈብሩዋሪ ሕታም፣ ''ካብ ኢንፍሉዌንዛ ወጻኢ፣ ካብ መልዓሊኡ እስካብ ዓለምለኻዊ ዝርጋሐኡ ኣሰሩ ዝተጸንዐ ናይ መተንፈሲ ቫይረስ የለን።"" ክብል ገሊጹ። "	According to CNN&#39;s February issue, &quot;Other than influenza, no respiratory virus has been traced from its outbreak to its global spread.
842	en	ti	" Ghebreyesus expressed a similar view, saying ""we have never before seen a pandemic sparked by a coronavirus."" "	 ገብረየሱስ “ ከምዚ ዝመሰለ ብኮሮናቫይረስ ዝተላዕለ ለበዳ ተራዕዩ ኣይፈልጥን” ክብል ተመሳሳሊ ርእይቶ ሂቡ። 	Gebreyesus said, “ There has never been such an outbreak caused by the coronavirus.”
843	en	ti	" He continued, ""and we have never before seen a pandemic that can be controlled at the same time."" "	 ''ቅድሚ ሐዚ ኣብ ተመሳሳሊ እዋን ኣብ ቁጽጽር ክውዕል ዝኽእል ለበዳ ርኢና ኣይንፈልጥን' ኢሉ ድማ ቀጸለ 	“We have never seen an outbreak that can be controlled at the same time before,” he said
844	en	ti	 The new status as a pandemic follows the WHO's decision in January to declare the outbreak a public health emergency of international concern. 	 እቲ ሓድሽ ቅዋም ነቲ ናይ ጥሪ ናይ WHO ናይ ላብዕ ውሳኔ ተኸቲሉ፣ ነዚ ዓለምለኸ ትኹረት ዘድልዮ ህዝባዊ ናይ ጥዕና ህጹጽ ኣዋን ክብል ኣዊጁ። 	The new constitution followed the January WHO pandemic decision, declaring it a public health emergency that required international attention.
845	en	ti	" The United States' National Institute of Allergy and Infectious Disease's director, Dr. Anthony Fauci, said of the outbreak, ""bottom line, it's going to get worse."" "	" ናይ ዩናይትድ ስቴትስ ብሄራዊ ናይ ሕማም ኣለርጂን ረኽሲን ዳይሬክተር ዶ/ር ኣንቶኒ ፋውሲ ""ናይ መጨረሻ መስመር፣ ኣዝዮ እናገደደ ክኸይድ እዩ"" ኢሎም። "	&quot;The bottom line, it&#39;s going to get much worse,&quot; said Dr. Anthony Fauci, director of the US National Director of Allergy and Infection.
846	en	ti	 As of Thursday, Associated Press reported there were at least 126,000 cases of COVID-19 worldwide, resulting in over 4,600 deaths. 	 ብሓሙስ ኣሶስየትድ ፕርስ ኣብ ዓለም ብውሕዱ 126,000ሕሙማት ኮቪድ-19 ከምኡ’ውን 4,600ሰባት ከም ዝሞቱ ሓቢሩ። 	On Thursday, the Associated Press reported at least 126,000 cases and 4,600 deaths worldwide.
847	en	ti	 The 2019–20 coronavirus pandemic is an ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 	 እዚ ኣብ 2019-20 ዝተኸስተ ለበዳ ኮሮናቫይረስ ከም መቀጸልታ ናይ 2019 ለበዳዊ ሕማም ኮሮናቫይረስ( COVID-19) ኮይኑ፡ብ ስቪር ኣኲት ረስፒራቶሪ ሲንድሮም ኮሮናቫይረስ 2(ሳርስ-ኮቭ-2) ዝተባህለ ቫይረስ ዝመጽእ እዩ። 	The 2019-20 pandemic is a continuation of the 2019 pandemic of the coronavirus ( COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
848	en	ti	 The outbreak was identified in Wuhan, China, in December 2019, declared to be a Public Health Emergency of International Concern on 30 January 2020, and recognized as a pandemic on 11 March 2020. 	 እቲ ለበዳ ዲሰምበር 2019 ኣብ ዉሃን፣ ቻይና ተፈሊጡ፣ ፌብሩዋሪ 30 2020 ደማ ህጹጽ ዓለምለኽዊ ሓደጋ ተባሂሉ ተኣዊጁ፣ ክም ለበዳ ድማ ኣብ ማርች 11 ፣2020 ኣፍልጦ ተዋሂቡዋ። 	The outbreak was detected in December 2019 in Wuhan, China, declared a global emergency on February 30 2020, and recognized as an outbreak on March 11 ,2
849	en	ti	 As of 10 April 2020, approximately 1.61 million cases of COVID-19 have been reported in 210 countries and territories, resulting in approximately 97,000 deaths. 	 ካብ 10 ኤፕሪል 2020 ጀሚሩ ኣስታት 1.61 ሚልዮን ኮቪድ-19 ሕሙማት ኣብ 210 ሃገራትን ግዝኣታትን ተመዝጊቦም ይርከቡ። 97,000 ከኣ ሞይቶም። 	As of April 10, 2020, there are approximately 1.61 million registered cases in 210 countries and territories. 97,000 died.
850	en	ti	 About 364,000 people have recovered. 	 ከባቢ 364000 ዝኾኑ ሰባት ሓውዮም ኣለዉ። 	About 364,000 people have recovered.
851	en	ti	 The case fatality rate has been estimated to be 4% in China, while globally ranging from 13.04% in Algeria to .08% in New Zealand. 	 እቲ ናይ ሞት ደረጃ ኣብ ቻይና 4%፣ ኣብ ዓለምለኻዊ ድማ ካብ 13.04% ኣብ ኣልጀሪያ ክሳብ .08% ኣብ ኒውዚላንድ ከምዝኸውን ተገሚቱ ነይሩ እዩ። 	The mortality rate was estimated to be 4% in China and 13.04% in Algeria to .08% in New Zealand internationally.
852	en	ti	 Common symptoms include fever, cough and shortness of breath. 	 እቶም ዝተለመዱ ምልክታት ረስኒ፡ ሰዓል ን ናይ ምስትንፋስ ሕጽረት ዘጠቓለሉ እዮም። 	Common symptoms include fever, cough and shortness of breath.
853	en	ti	 Complications may include pneumonia and acute respiratory distress syndrome. 	 ሕልኽላኻት ከም እኒ ናይ ሳንቡእ ወቕዒ ከምኡ እውን ከቢድ ናይ ምትንፋስ ጸቕጢ ምልክት ዘጠቓለሉ ክኾኑ ይኽእሉ እዮም። 	Complications may have included such as pulmonary stroke as well as severe respiratory distress syndrome.
854	en	ti	 The time from exposure to onset of symptoms is typically around five days, but may range from two to fourteen days. 	 ካብ እዋን ተጋላጽነት ስጋብ ምልክታት ምርኣይ ዘሎ ጊዜ ሓሙሽተ መዓልቲታት ክኾንከሎ፡ ይኹን ደኣምበር ካብ ክለተ እስካብ ዓሰርተ ኣርባዕተ መዓልቲታት ክዛይድ ይኽ እል እዩ። 	The time from exposure to symptoms is five days, but can be longer than two to fourteen days.
855	en	ti	 There is no known vaccine or specific antiviral treatment. 	 ክሳብ ሎሚ ዝተፈልጠ ክታበት ወይ’ውን ውሱን ጸረ-ቫይረስ መድሃኒት የለን። 	To date, there is no known vaccine or specific antiviral drug.
856	en	ti	 Primary treatment is symptomatic and supportive therapy.Recommended preventive measures include hand washing, covering one's mouth when coughing, maintaining distance from other people, and monitoring and self-isolation for people who suspect they are infected. 	 መጀመርያ ዝወሃብ ምልክታውን ደገፋውን ሕክምና እዩ።ኢድ ምሕጻብ፡ ኣፍካ ሸፊንካ ምስዓል፡ማሕበራዊ ርሕቀትካ ምሕላው፡ ንዝተጠርጠሩ ሕሙማት ድማ ፈሊኻ ምክትታል ገለ ኣብነታት ከም ቅድመ-ሕክምና ክግበሩ ዝኽእሉ ጥንቃቄታት`ዮም። 	It is the first symptomatic and supportive treatment.Hand washing, covering your mouth and coughing, maintaining social distance, and isolating suspected patients are some examples of precautions that can be taken as pre-treatment.
857	en	ti	 Authorities worldwide have responded by implementing travel restrictions, quarantines, curfews, workplace hazard controls, and facility closures. 	 ኣብ መላእ ዓለም ዝርከቡ ሰበ ስልጣን ግብረመልሲ በዚ ዝስዕብ መንገዲ ሂቦም ናይ ጉዕዞ ክልከላታት፣ ውሸባ፣ እዋን እቶእቶ፣ ናይ ስራሕ ቦታ ምክልኻል መጉዳእቲ፣ ከምኡ ውን ምዕጻው ትካል ብምፍጻም መልሲ ሂቦም እዮም። 	Authorities around the world have responded by imposing travel bans, quarantines, curfews, workplace injury prevention, and closures.
858	en	ti	 The pandemic has led to severe global socioeconomic disruption, the postponement or cancellation of sporting, religious, political and cultural events, and widespread shortages of supplies exacerbated by panic buying. 	 እዚ ለበዳ ብዙሓት ዓለምለኻዊ ማሕበራዊን ቁጠባዊን ምፍርራስ ንኽምርሑ ዝገበረ እንትኾን፣ ናይ ስፖርታዊ ጸወታታት፣ ሃይማኖታዊ ጉዳያት፣ ፖለቲካዊን ባህላዊን ምድላዋት ፣ጊዜ ምምሕልላፍ ውይድማ ስረዛን ምስ ናይ ድንጋጸ ዕድጊት ዓቑሑት ተተሓሒዙ ናይ ቀረባት ሕጽረት እውን ኣጋጢሙ እዩ። 	The pandemic has led to many global social and economic disruptions, including sporting events, religious affairs, political and cultural events, cancellations and shortages of supplies related to compassionate purchases.
859	en	ti	 Schools and universities have closed either on a nationwide or local basis in 193 countries, affecting approximately 99.4 percent  of the world's student population. 	 ትምህርትታትን ትካላት ላዕለዋይ ትምህርትን ብሃገር ደረጃ ወይ’ውን ብዞባዊ ደረጃ ኣብ 193 ሃገራት ተዓጽየን። እዚ ከኣ ንኣስታት 99.4 ምኢታዊት ናይ ዓለም ተመሃሮ ዝጸሉ’ዩ። 	Schools and higher education institutions were closed nationally or regionally in 193 countries. This affects about 99.4 percent of the world&#39;s students.
860	en	ti	 Misinformation about the virus has spread online, and there have been incidents of xenophobia and discrimination against Chinese people, other people of East and Southeast Asian descent and appearance, and others from areas with significant virus cases. 	 ብ መንገዲ ናይ ኢንተርኔት መርበብ ኣቢሉ ብዛዕባ እቲ ቫይረስ ዝተጋገየ ሓበሬታ ተዘርጊሑ እዩ፡ ናብ ናይ ቻይና ህዝቢታትን፡ ናብ ካልኦት ናይ ምብራቕን ደቡብ ምብራቕ ኤሽያ ዝኾኑ ሰባትን ዝመስሉን ናብ ካብ ብቲ ቫይረስ ዝተጠቕዐ ቦታ ዝመጹ ሰባት ዘቕነዐ ናይ ዜኖፎቢያን ምግላላልን ኣጋጣሚታት ነይሮም እዮም። 	Misinformation about the virus has been spread through the Internet, and there have been instances of xenophobia and discrimination against Chinese people, other East and Southeast Asians, and people from affected areas.
861	en	ti	 Due to reduced travel and closures of heavy industry, there has been a decrease in air pollution and carbon emissions. 	 ብሰንኪ ውሑድ ጉዕዞን ናይ ከበድቲ ኢንዱስትሪታት ምዕጻዉን፣ ኣብ ብኽለት ኣየር ን ናይ ካርቦን ልቀትን ቀኒሱ እዩ። 	Due to less travel and the closure of heavy industries, air pollution and carbon emissions have decreased.
862	en	ti	 Health authorities in Wuhan, China (the capital of Hubei province) reported a cluster of pneumonia cases of unknown cause on 31 December 2019, and an investigation was launched in early January 2020. 	 ኣብ ዉሃን፣ ቻይና(ናይ ሁበይ ግዝኣት ዋና ኸተማ) ዝርከቡ ናይ ጥዕና ሰብ ስልጣናት፣ ድሕሪ ኣብ ዲሰምበር 31 2019 መልዓሊኦም ዘይፍለጡ ናይ ኒሞኒያ ጉጅለ ግዳያት ጸብጻብ ምቕራቦም፣ ኣብ መጀመሪያ ወርሒ ጃኑዋሪ 2020 ምርመራ ምክያድ ተጅሚሩ። 	Health officials in Wuhan, China(the capital of Hubei province) began investigating in early January 2020 after a group of pneumonia cases of unknown origin were reported on December 31,
863	en	ti	 The cases mostly had links to the Huanan Seafood Wholesale Market and so the virus is thought to have a zoonotic origin. 	 መብዛሕቲኦም ጉዳያት ምስ ሁዋናን ናይ ባሕሪ ምግቢ ጅምላ መሸጢ ዕዳጋ ርክብ ዝነበሮም እዮም በዚድማ እቲ ቫይረስ ካብ እንስሳት ዝተበገስ ክምዝኸውን ይሕሰብ። 	Most of the cases were related to Huanan seafood wholesale markets, so the virus is thought to have originated from animals.
864	en	ti	 The virus that caused the outbreak is known as SARS-CoV-2, a newly discovered virus closely related to bat coronaviruses, pangolin coronaviruses, and SARS-CoV.The earliest known person with symptoms was later discovered to have fallen ill on 1 December 2019, and that person did not have visible connections with the later wet market cluster. 	 ነዚ ለበዳ ዘምጽኦ SARS-CoV-2 ዝተባህለ ሓድሽ ቫይረስ ኮይኑ ምስ ኣብ መንካዕ ዝርከቡ ኮሮናቫይረሳት፡ ፓንጎሊን ኮሮናቫይረሳትን ሳርስ-ኮቭን ዝመሳሰል’ዩ። እቲ መጀመርታ ምልክታት ዘርኣየ ሰብ ብ1ዲሰምበር 2019 ከምዝሓመመ ድሒሩ ተፈሊጡ። እዚ ሰብ ከኣ ምስቶም ብድሕሪኡ ዝተረኽቡ ናይ ዕዳጋ ዓሳን ካልእን ጉጅለ ርኡይ ርክብ ከምዘይብሉ’ዩ ዝፍለጥ። 	The outbreak is caused by a new virus called SARS-CoV-2, which is similar to the mosquito-borne coronaviruses, pangolin coronaviruses and SARS-CoV. The person who first showed symptoms was later diagnosed on December 1, The man is known to have no apparent connection to the subsequent group of fish marketers and others.
865	en	ti	 Of the early cluster of cases reported in December 2019, two-thirds were found to have a link with the market. 	 ክልተ ሲሶ ካብቶም ቀዳሞት ብታሕሳስ 2019 ዝተረኽቡ ጉጅለ ሕሙማት ምስቲ ቦታ ዕዳጋ ርክብ ነይርዎም። 	Two-thirds of the first group of patients seen in December 2019 had contact with the marketplace.
866	en	ti	 On 13 March 2020, an unverified report from the South China Morning Post suggested that a case traced back to 17 November 2019, in a 55-year-old from Hubei province, may have been the first.On 26 February 2020, the WHO reported that, as new cases reportedly declined in China but suddenly increased in Italy, Iran, and South Korea, the number of new cases outside China had exceeded the number of new cases within China for the first time. 	 ኣብ ማርች 13 2020፣ ሓደ ምንጩ ዘይተፈለጠ ጸብጻብ ከምዝሓበሮ ናብ ኖቨምበር 17 2019 ብምምላስ፣ ኣብ ሓደ ወዲ 55 ዓመት ናይ ሁበይ ግዝኣት ነባሪ ዘጋጠመ ጉዳይ እቲ ናይ መጀምሪያ ክኾን ከምዝኽእል ጥቆማ ሂቡ። ኣብ ፌብሩዋሪ 26 2020 ዝተገበረ ናይ WHO ጸብጻብ ክምዝሕበሮ፣ ኣብ ቻይና ዝርከቡ ሓደሸቲ ጉዳያት እናቐነሱ ኣብ ዝኸዱሉ፣ ኣብ ጣላያን፣ ኢራን ን ደቡብ ኮሪያን ሃንደበት ብምውሳኹ፣ ካብ ቻይና ወጻኢ ዘጋጥሙ ሓደሽቲ ጉዳያት ንመጀመሪያ ካብቶም ኣብ ቻይና ውሽጢ ዝረኣዩ በሊጾም ተራእዮም እዮም። 	On March 13, 2020, an unsourced report suggested that going back to November 17, 2019, a case involving a 55-year-old resident of Hubei province could be the first. According to a WHO report on February 26 2020, while new cases in China were declining, new cases outside China initially outnumbered those inside China with a sudden increase in Italy, Iran and South Korea.
867	en	ti	 There may be substantial underreporting of cases, particularly among those with milder symptoms. 	 በተላይ ኣብ መንጎ እቶም ቀሊል ምልክት ዘርኣዩ ተተሓሒዙ ኣዝዩ ብዙሕ ቁጽሪ ዘለዎ ናይ ጉዳያት ኣትሒትካ ጸብጻብ ምግባር ክህሉ ይኽእል እዩ። 	There may be a very large number of underreporting cases, especially among those who showed mild symptoms.
868	en	ti	 By 26 February, relatively few cases had been reported among youths, with those 19 and under making up 2.4% of cases worldwide.The United Kingdom's chief scientific adviser, Patrick Vallance, estimated that 60% of the British population would need to become infected before effective herd immunity could be achieved. 	 ብ ፌብሩዋሪ 26 ኣብ መንእሰያት ዝወሓደ ቁጽሪ ሕሙማት ተራእዩ፡ 19ን ትሕቲኡን ዝዕድሚኦም 2.4% ናይ ዓለም ቁጽሪ ሕሙማት ነይሮም። Herd immunity ክምዕብል እንተኾይኑ፡ 60% ህዝቢ ብሪተይን በቲ ቫይረስ ክልከፉ ከምዘለዎም ናይ ብሪተይን ቀንዲ ኣማኻሪ ሳይንስ ፓትሪክ ቫላንስ ይትንትን። 	On February 26, the lowest number of cases was seen in young people, with 2.4% of the world&#39;s cases aged 19 and under. If herd immunity is to develop, 60% of the UK population must be infected, according to UK chief science adviser Patrick Vallance.
869	en	ti	 Cases refers to the number of people who have been tested for COVID-19, and whose test has been confirmed positive according to official protocols. 	 ግዳይ ክበሃል ከሎ ቁጽሪ ናይቶም COVID-19 ዝተመርመሩን፡ ውጽኢት መርመርኦም ከኣ በቲ መሰረት ዝተዳለወ ፕሮቶኮል ሕማም ከምዘለዎም ምስዝረጋገጽ’ዩ። 	A victim is the number of people who have been tested for COVID-19 and whose test results confirm that they have the disease according to the protocol.
870	en	ti	 As of 23 March, no country had tested more than 3% of its population, and many countries have had official policies not to test those with only mild symptoms, such as Italy, the Netherlands, Spain, and Switzerland. 	 ኣብ 23 ማርች፡ ልዕሊ 3% ህዝቦም ዝመርመሩ ወላሓደ ሃገር ኣይነበርን። ብዙሓት ሃገራት ከም በኣል ጥልያን፡ ነዘርላንድስ፡ ስፓኛን ስዊዘርላንድን ውሑድ ምልክታት ንዘለዎም ከይምርምሩ ወግዓዊ ፖሊሲታት ነይርወን። 	On March 23, no country tested more than 3% of its population. Many countries, such as Italy, the Netherlands, Spain, and Switzerland, had official policies not to test for those with few symptoms.
871	en	ti	 A study published on 16 March found that in China, up to 23 January, an estimated 86% of COVID-19 infections had not been detected, and that these undocumented infections were the infection source for 79% of documented cases. 	 ኣብ ቻይና ክሳብ 23 ጃኑዋሪ ኣስታት 86% ናይ ኮቪድ-19 መልከፍቲ ብመርመራ ከምዘይተረኽበን እዞም ዘይተመዝገቡ መልከፍቲ ከኣ ኣብ 79% ናይ እቶም ዝተረኽበሎም ሰባት ከም መበገሲ ናይ እዚ ለብዒ ከምዝነበረ ብ16 ማርች ዝተዘርግሐ መጽናዕቲ ይሕብር። 	About 86 percent of China&#39;s COVID-19 cases were undetected as of January 23, and these unrecorded cases were the trigger for 79 percent of those diagnosed, according to a study released on March
872	en	ti	 A statistical analysis published 30 March estimated that numbers of infections in Italy were considerably greater than the reported cases. 	 ብ30 ማርች ዝተሓትመ ጸብጻብ ብዘርእዮ ብዝሒ ሕሙማት ኣብ ዓዲ ጥልያን ካብቲ ዝተሓበረ መጠን ከም ዝዛይድ ተገምጊሙ። 	A report published on March 30 shows that the number of cases in Italy is higher than reported.
873	en	ti	 The initial estimates of the basic reproduction number (R0) for COVID-19 were 1.4 to 2.4. 	 እቶም ናይ ፈለማ ናይ COVID-19መሰረታዊ ቁጽሪ ምርባሕ(R0) ኣመልኪቱ ዝነበሩ ግምታት 1.4 እስካብ 2.4 እዮም ነይሮም። 	The initial estimates for the COVID-19 baseline reproduction number(R0) were 1.4 to
874	en	ti	 A study published by the US Center for Disease Control and Prevention has concluded that it may be 5.7. 	 ብ ናይ US ማእኸል ቁጽጽር ሕማምን ምክልኻልን ዝተሓተመ ጽንዓት ምናልባት 5.7 ክኸውን ይኽእል እዩ እሉ መደምደምታ ገይሩ። 	A study published by the US Centers for Disease Control and Prevention concluded that it was probably
875	en	ti	 Most people with COVID-19 recover. 	 ብዙሓት COVID-19 ዝሓመሙ ሰባት ይሓውዩ’ዮም። 	Many people with COVID-19 recover.
876	en	ti	 For those who do not, the time from development of symptoms to death has been between 6 and 41 days, with the most common being 14 days. 	 ኣብቶም ዘይኮኑ፡ ካብ ናይ ምልክታት ምዕባለ ጀምሩ እስካብ ሞት ዘሎ ጊዜ ካብ 6 ክሳብ 41 መዓልቲታት ኮይኑ እቲ ኣዝዩ ዝተለመደ ግን 14 መዓልቲታት እዩ። 	In those who are not, the time from symptom development to death ranges from 6 to 41 days, but the most common is 14 days.
877	en	ti	 As of 10 April 2020, approximately 97,000 deaths had been attributed to COVID-19. 	 ካብ ኣፕሪል 10 2020 ጅሚሩ፣ክባቢ 97,000 ዝኾኑ ሞታት ብሰንኪ COVID-19 እዮም ኣጋጢሞም። 	As of April 10 2020,around 97,000 deaths have occurred as a result of COVID-1
878	en	ti	 In China, as of 5 February about 80% of deaths were in those over 60, and 75% had pre-existing health conditions including cardiovascular diseases and diabetes.Official tallies of deaths from the COVID-19 pandemic generally refer to dead people who tested positive for COVID according to official protocols. 	 ኣብ ቻይና፣ ካብ ፈብሩዋሪ 5 ጀሚሩ ክባቢ 80% ዝኾኑ ሞታት ኣብቶም ካብ 60 ዓመት ንላዕሊ ዝኾኑ እንትኾን እቶም 75% ድማ ን ናይ ልቢ ሕማማትን ናይ ሽኮሪያን ሓዊሱ ካልኦት ዝጸንሐ ናይ ጥዕና ኩነታት ዘለዎም እዮም። እቶም ዕላው ዝተገበሩ ናይ ብ COVID-19 ለበዳ ዝሞቱ ሰባት ማለት እቶም ብ ኦፊሳላዊ ፕሮቶኮላት ዝተረጋገጹ COVID ዝተረኸቦም ዝሞቱ ሰባት ማለት እዩ። 	In China, since February 5, about 80% of deaths have been in people over the age of 60, and 75% have other pre-existing health conditions, including heart disease and diabetes. The announced deaths from the COVID-19 outbreak are those deaths from COVID confirmed by official protocols.
879	en	ti	 The number of true fatalities from COVID-19 may be much higher, as it may not include people who die without testing - e.g. at home, in nursing homes, etc. 	 ሓቀኛ ቁጽሪ ሞት ካብ ኮቪድ-19 ነቶም ከይተመርመሩ ኣብ ገዛ፡ ኣብ ክንክን ቦታታት...ወዘተ. ዝሞቱ ኣብ ግምት ዘእተወ ስለዘይኮነንዝያዳ ክኽውን ተኽእሎ ኣሎ። 	The true number of deaths from COVID-19 for those who are not tested at home, in care facilities...etc. It is likely to be more because it does not take into account the dead.
880	en	ti	 Partial data from Italy found that the number of excess deaths during the pandemic exceeded the official COVID death tally by a factor of 4-5x. 	 ኣብ ዓዲ ጥልያን ዝተረኽበ ሓበሬታ ከምዝረኽቦ፡ ኣብቲ ግዜ ለበዳ ዝነበረ ቁጽሪ ዝያዳ ሞት ነቲ ወግዓዊ ናይ ኮቪድ ቁጽሪ ሞት ብ4-5x ይበልጾ። 	Data in Italy show that the number of deaths during the pandemic is 4-5x the official death toll.
881	en	ti	" A spokeswoman for the U.S. Centers for Disease Control and Prevention (CDC) acknowledged ""We know that [the stated death toll] is an underestimation"", a statement corroborated by anecdotal reports of undercounting in the U.S. Such underestimation often occurs in pandemics, such as the 2009 H1N1 swine flu epidemic.The first confirmed death was in Wuhan on 9 January 2020. "	" ናይ U.S. ማእኽል ምቁጽጽር ሕማምን ምክልኻልን( CDC) ቃል ኣቐባሊ ""እቲ ናይ ሞት ትምበያ ኣትሒትና ገሚትናዮ ኢና"" ክብሉ ኣሚኖም፡ እዚ ድማ፡ ብ ናይ U.S. ናይ ትሕተ ግምት ቁጽሪታት ክም ናይ 2009 H1N1 ዝበሉ ናይ ስዋይን ፍሉ ለበዳታት ዝተውሃቦም ትሕተ ግምት ዝጠናኸር ኣገላልጻ እዩ። እቲ ናይ መጀምሪያ ዝተረጋገጥጸ ጉዳይ ኣብ ዉሃን ጃኑዋሪ 9 2020 እዩ ነይሩ። "	A spokesman for the US Centers for Disease Control and Prevention (CDC) admitted that &quot;we underestimated the death forecast,&quot; a statement reinforced by US underestimates of swine flu pandemics such as the 2009 H1N1 The first confirmed case was in Wuhan on January 9,
882	en	ti	 The first death outside mainland China occurred on 1 February in the Philippines, and the first death outside Asia was in France on 14 February. 	 ካብ ሜይን ላንድ ቻይና ወጻኢ ዝተመዝገበ ናይ መጀምሪያ ሞት፡ኣብ ፊሊፒንስ ፈብሩዋሪ 1 እዩ ኣጋጢሙ፡ ካብ ኤሽያ ወጻኢ እቲ ናይ መጀመሪያ ሞት ድማ ፈብሩዋሪ 14 ኣብ ፈረንሳይ ዘጋጠመ እዩ። 	The first death outside Mainland China occurred in the Philippines on February 1, and the first death outside Asia occurred on February 14 in France.
883	en	ti	 By 28 February, outside mainland China, more than a dozen deaths each were recorded in Iran, South Korea, and Italy. 	 ኣብ ፌብሩዋሪ 28፣ ካብ ቻይና ሜይን ላንድ ወጻኢ፣ ኣብ ኢራን፣ ደቡብ ኮሪያን ጣልያንን ኣብ ሐሕድሕደን ካብ ደርዝን ንላዕሊ ሞት ኣመዝጊበን። 	On February 28, outside China&#39;s mainland, Iran, South Korea and Italy recorded more than a dozen deaths each.
884	en	ti	 By 13 March, more than forty countries and territories had reported deaths, on every continent except Antarctica.Several measures are commonly used to quantify mortality. 	 ብ ማርች 13 ልዕሊ ኣርብዓ ሃገራትን ግዝኣታትን ካብ ኩለን ኣህጉራት ብዠይካ ኣንታርቲካ ቅትለት/ሞት ሓቢረን። መጠነ-ሞት ብዙሕ መለክዒታት ኣለዎ። 	On March 13, more than forty countries and territories from all continents reported deaths from Antarctica. Mortality rates have many dimensions.
885	en	ti	 These numbers vary by region and over time, and are influenced by the volume of testing, healthcare system quality, treatment options, time since initial outbreak, and population characteristics such as age, sex, and overall health.The death-to-case ratio reflects the number of deaths divided by the number of diagnosed cases within a given time interval. 	 እዞም ቁጽሪታት ብክልላትን ብጊዜን ዝፈላለዩ እንትኾኑ፣ ብዝግበሩ ናይ ምርመራታት መጠን፣ ናይ ጥዕና ክንክን ስርዓታት ጽርየት፣ ናይ ሕክምና ኣማራጺታት፣ ካብ እቲ ናይ መጀምሪያ ለበዳ ኣትሒዙ ዘሎ ግዜ፣ ከምኡውን ከም ዕድመ፣ ጾታን ኣጠቓላሊ ጥዕናን ዝኣምሳሉ ናይ ህዝቢ መግለጺታት ዝጽለዉ እዮም። 	These numbers vary by region and over time, and are influenced by testing rates, cleanliness of health care systems, treatment options, time since the first outbreak, and demographic factors such as age, gender, and overall health.
886	en	ti	 Based on Johns Hopkins University statistics, the global death-to-case ratio is 6.0% (97,039/1,617,204) as of 10 April 2020. 	 ዓለምለኻዊ መጠነ-ዝምድና ሞትን ሕማምን 6.0%(97,039/1,617,204) ምዃኑ ናይ 10 ኤፕሪል 2020 Johns Hopkins University (ጆን ሆፕኪንስ ዩኒቨርስቲ) ስታቲስቲክስ የርኢ። 	The global mortality-morbidity ratio is 6.0%(97,039/1,617,204), according to April 10, 2020 Johns Hopkins University statistics.
887	en	ti	 The number varies by region. 	 እቲ ቁጽሪ ብ ክልላት ይፍላለ እዩ። 	The number varies by region.
888	en	ti	 In China, estimates for the death-to-case ratio decreased from 17.3% (for those with symptom onset 1–10 January 2020) to 0.7% (for those with symptom onset after 1 February 2020).Other measures include the case fatality rate (CFR), which reflects the percent of diagnosed people who die from a disease, and the infection fatality rate (IFR), which reflects the percent of infected (diagnosed and undiagnosed) who die from a disease. 	 ኣብ ቻይና መጠነ-ዝምድና ምዉታንን ሕሙማትን ካብ 17.3%(ነቶም ካብ ዕለት 1-10 ጥሪ 2020 ምልክታት ንዘርኣዩ)ናብ 0.7%(ድሕሪ ዕለት 1 የካቲት 2020 ምልክታት ንዘርኣዩ)ጎዲሉ። ካልኦት ዓቐናት ከም ናይ ሕሙማት መጠን ሞት፡ማለት መጠነ ሞት ናይቶም ዝሓመሙ ብሚእታዊት ዘርኢ ከምኡ’ውን ናይ ዝተበከሉ መጠነ ሞት፡ማለት መጠነ ሞት ናይቶም ብመርመራ ዝተፈልጡን ዘይተመርመሩን ዝተለኽፉ ብሚእታዊት ዘርኢ’ውን ኣለዉ። 	In China, the death-to-case ratio decreased from 17.3% (for those who showed symptoms from January 1-10, 2020) to 0.7% (for those who showed symptoms after February 1, 2020). There are also other measures such as patient mortality, i.e., the percentage of deaths of those who are sick, and infected mortality, i.e., the percentage of those who are infected who are known and undiagnosed.
889	en	ti	 These statistics are not timebound and follow a specific population from infection through case resolution. 	 እዞም እስታትስቲክሳት ኣብ ጊዜ ዝተወሰኑ ኣይኮኑን፣ ናይ ህዝቢታት ብዝሓት ብመንጽር ናይ እቲ ረኽሲ ጉዳያት ዝድረኹ እዮም። 	These statistics are not time-bound, population sizes are driven by the infection issues.
890	en	ti	 A number of academics have attempted to calculate these numbers for specific populations. 	 ብዙሓት ምሁራት ኣብ ዝተወሰነ በዝሒ ህዝቢ፣ ነዞም ቁጽሪታት ንምስራሕ ሙከራ ገይሮም እዮም። 	Many scholars have attempted to work out these numbers in a given population.
891	en	ti	 The University of Oxford's Centre for Evidence-Based Medicine estimates that the infection fatality rate for the pandemic as a whole is between 0.1% and 0.39%. 	 ናይ ኦክስፎርድ ዩኒቨርሲቲ( University of Oxford) ናይ ኣብ መርዳእታ ዝተደረኸ ሕክምና ማእኸል( Centre for Evidence-Based Medicine) ናይ እቲ ለበዳ ናይ ረኽሲ ሞት ናይ ምስዓብ መጠን ኣብ መንጎ 0.1% ን 0.39% እዩ ክብል ግምቱ ኣቐሚጡ። 	The University of Oxford&#39;s Center for Evidence-Based Medicine estimated the infection death rate of the epidemic to be between 0.1% and 0.39%.
892	en	ti	 The upper estimate of this range is consistent with the results from the first random testing for COVID-19 in Germany, and a statistical study analysing the impact of testing on CFR estimates. 	 ናይ እዚ ሬንጅ እዚ ላዕለዋይ ግምት ምስ ውጽኢታት እቲ ኣብ ጀርመን ዝተኻየደ ሃንደበታዊ ናይ COVID-19 ምርመራታት ን ኣብ CFR ምርመራ ምግባር ዘለዎ ጽልዋ ዘጽንዕ ናይ እስታቲክሳዊ ጽንዓት ሓቢሮም ዝኸዱ እዮም። 	The upper estimates of this range are consistent with the results of the statistical analysis of random COVID-19 tests in Germany and the effect of testing on CFR.
893	en	ti	 The WHO asserts that the pandemic can be controlled. 	 WHO እዚ ለበዳ ኣብ ትሕቲ ቑጽጽር ክውዕል ይኽእል እዩ ኢሉ ኣቐሚጡ እዩ። 	The WHO has stated that the outbreak is controllable.
894	en	ti	 The peak and ultimate duration of the outbreak are uncertain and may differ by location. 	 እቲ ዝጠንከረ እዋን ናይ’ዚ ለበዳ ከምኡ’ውን ክሳብ መዓስ ክቅጽል’ዩ ኣይተፈልጠን። ካብ ቦታ ናብ ቦታ’ውን ይፈላለ። 	The peak of the outbreak and how long it will last is unknown. It also varies from place to place.
895	en	ti	" Maciej Boni of Penn State University stated, ""Left unchecked, infectious outbreaks typically plateau and then start to decline when the disease runs out of available hosts. "	 Maciej Boni of Penn State University (ማሲየጅ ቦኒ ካብ ፐን ስቴት ዩኒቨርስቲ) “ብዘይ ዝኾነ ቁጽጽር ዋላ እንተኾነ፡ ተላባዕቲ ሕማማት ጥርዚ ዝርግሐ ድሕሪ ምብጽሖም ዝልከፉ ሰባት ምስ ሰኣኑ ክጎድሉ ይጅምሩ” ኢሉ። 	“Even without any control, infectious diseases start to decline after they reach a peak of prevalence when there are no more people to be infected,” said Maciej Boni of Penn State University.
896	en	ti	" But it's almost impossible to make any sensible projection right now about when that will be"". "	 ይኹን ደኣምበር ኣብዚ ሒዚ ሰዓት እዚ መዓስ ክኽውን ከምዝኽእል ዘርኢ ትኽክለኛ ትንበያ ምሃብ ኣይከኣልን። 	However, it is not possible to give an accurate prediction of when this will happen at this time.
897	en	ti	" The Chinese government's senior medical adviser Zhong Nanshan argued that ""it could be over by June"" if all countries can be mobilized to follow the WHO's advice on measures to stop the spread of the virus. "	" ናይ መንግስቲ ቻይና ነባር ናይ ሕክምና ኣማኻሪ ጆንግ ናንሻን እንድሕር ደኣ ኩለን ሃገራት ብመሰረት ነዚ ለበዳ ቫይረስ ጠጠው ንምባል ብዛዕባ ክውሰዱ ዝግበኦም ስጉምቲታት ናይ ውድብ ጥዕና ዓለም ምኽሪ ንምስዓብ እንድሕር ተለዓዒለን ""ስጋብ ሰነ ክጠፍእ ይኽእል እዩ"" ኢሎም ክርክር ኣልዒሎም። "	Former Chinese government medical adviser Zhong Nanshan argued that &quot;it could be eradicated by June&quot; if all countries are moved to follow the WHO&#39;s advice on measures to stop the outbreak.
898	en	ti	" On 17 March, Adam Kucharski of the London School of Hygiene &amp; Tropical Medicine stated that SARS-CoV-2 ""is going to be circulating, potentially for a year or two"". "	 አብ ማርች 17፣ ናይ ለንደን ቤት ትምህርቲ ጥዕና አዳም ኩቻርስኪ &amp፤ ትሮፒካዊ መድሓኒት ከም ዘመልከቶ SARS-CoV-2 “ ንሓደ ወይከዓ ንክልተ ዓመት ዝአክል ከዘዋወር ወይከዓ ክሰራጨው ይኽእል እዩ ኢሉ”። 	On March 17, London School of Health Adam Kucharski &amp;; Tropical Medicine indicated that SARS-CoV-2 “ can circulate or spread for one or two years”.
899	en	ti	" According to the Imperial College study led by Neil Ferguson, physical distancing and other measures will be required ""until a vaccine becomes available (potentially 18 months or more)"". "	 ብመሰረት ብ ኔይል ፈርጉሰን ዝተመርሐ መጽናዕቲ ናይ ኢምፐሪያል ኮሌጅ ኣካላዊ ምርሕሓቕ ን ካልኦት ስጉምቲታትን “እስካብ ከታበት ዝርከብ(ኣብ ውሽጢ 18 ኣዋርሕ ውይድማ ካብኡ ንላዕሊ)” ኣድለይቲ እዮም ክብል ገሊጹ። 	According to a study led by Neil Ferguson of Imperial College, physical distancing and other measures are necessary “until vaccine is available(within 18 months of age or older)”.
900	en	ti	" William Schaffner of Vanderbilt University stated, ""I think it's unlikely that this coronavirus—because it's so readily transmissible—will disappear completely"" and it ""might turn into a seasonal disease, making a comeback every year"". "	" ዊልያም ሻፍነር ካብ ቫንደርቢት ዩኒቨርሲቲ() "" እዚ ኮረና ቫይረስ እዚ፣ ብ ቕልጡፍ ዝምሓላለፍ ብምዃኑ መሊኡ ኣይክጠፍእን እዩ"" ኢሉ ብምግላጽ ""ወቕቲ እናሓለወ ዝመጽእ፣ በቢዓመቱ ዝመለስ ክኸውን ይኽእል እዩ"" ክብል ሓሳቡ ገሊጹ። "	William Schaffner of Vanderbilt University() said, &quot; This coronavirus, because it is transmitted quickly, will not be completely eradicated.
901	en	ti	 The virulence of the comeback would depend on herd immunity and the extent of mutation. 	 መሊስካ ናይ ምትሳእ ጉዳይ ኣብ ናይ ማሕበረሰብ ምክልኻል ሕማምን ኣብ ዝርግሐ ናይ እቲ ለበዳን ዝተሞርኮሰ እዩ። 	The issue of recovery depends on community immunity and the spread of the epidemic.
902	en	ti	 Symptoms of COVID-19 can be relatively non-specific and infected people may be asymptomatic. 	 ናይ COVID-19 ምልክታት ብ ኣንጻራዊነት ዓርሶም ክኢሎም ዝፍለዩ ኣይኮኑን፣ በቲ ቫይረስ ዝተለኸፉ ሰባት ድማ ምንም ዓይነት ምልክት ዘይከርእዩ ይኽእሉ። 	The symptoms of COVID-19 are not relatively independent, and people infected with the virus may not show any symptoms.
903	en	ti	 The two most common symptoms are fever (88%) and dry cough (68%). 	 ረስንን(88%) ደረቕ ሰዓልን(68%) እቶም ብብዝሒ ዝረኣዩ ምልክታት’ዮም። 	Cough(88%) and dry cough(68%) were the most common symptoms.
904	en	ti	 Less common symptoms include fatigue, respiratory sputum production (phlegm), loss of the sense of smell, shortness of breath, muscle and joint pain, sore throat, headache, chills, vomiting, hemoptysis, diarrhea, or cyanosis.The WHO states that approximately one person in six becomes seriously ill and has difficulty breathing. 	 ብዙሕ ልሙዳት ዘይኮኑ ምልክታት ድኻም፡ ካብ ናይ መተንፈሲ ኣካል ዝወጽእ ዓኽታ (ፋልጀም)፡ ናይ ምጭናው ተኽእሎ ምስኣን፡ ሕጽረት ምስትንፋስ፡ ናይ ጭዋዳታትን ናይ መገጣጠምን ቃንዛ፡ ዝቖሰለ ጉሮሮ፡ ሕማም ርእሲ ፡ ምንቅጥቃጥ፡ ተምላስ፡ ሄሞፕትይሲስ፡ ውጽኣት ውይድማ ሳያኖሲስ ዘጠቓለሉ እዮም። WHO ከምዘቕምጦ ካብ ሹዱሽተ ሰባት እቲ ሓደ ኣዝዩ ብኸቢድ ክሓምምን ናይ ምትንፋስ ጸገም ከጋጥሞ ይኽእል። 	Less common symptoms include fatigue, coughing from the respiratory tract, loss of ability to cough, shortness of breath, muscle and joint pain, sore throat, headache , tremors, vomiting, hemoptysis, diarrhea and cyanosis. According to the WHO, one in six people can become very seriously ill and have difficulty breathing.
905	en	ti	 The U.S. Centers for Disease Control and Prevention (CDC) lists emergency symptoms as difficulty breathing, persistent chest pain or pressure, sudden confusion, difficulty waking, and bluish face or lips; immediate medical attention is advised if these symptoms are present.Further development of the disease can lead to severe pneumonia, acute respiratory distress syndrome, sepsis, septic shock and death. 	 ናይ U.S. ማእከል ምቁጽጻርን ምክልኻልን ተላባእቲ ሕማማት (CDC)ዝርዝር ናይ ሕጹጽነት ምልክታት ከም ሕጽረት ትንፋስ፡ ዘየቋርጽ ቃንዛ ወይ ጸቅጢ ኣፍልቢ፡ሓንደበታዊ ምድንጋር፡ኣብ ምንቅስቃስ ምሽጋርን ሰመያዊ ከናፍር ወይ ገጽ ዘጠቃለለ ኣውጽዩ። እዘን ምልክታት ኣብ ዝረኣየሉ እዋን ሕጹጽ ሕክምና ከምዘድሊ’ውን ይመክር። እቲ ሕማም እናማዕበለ ምስዝኸይድ ብርቱዕ ረኽሲ ሳንቡእ፡ሓንደበታዊ ሕጽረት ምስትንፋስ፡ረኽሲ ደም፡ሕጽረት ዝውውር ደምን ሞትን ከስዕብ ይኽእል’ዩ። 	The US Centers for Disease Control and Prevention (CDC) issued a list of emergency symptoms that included shortness of breath, persistent pain or chest tightness, sudden confusion, difficulty moving and blue lips or face. He also recommends immediate treatment when these symptoms appear. As the disease progresses, it can lead to severe pneumonia, sudden shortness of breath, blood infections, lack of circulation and death.
906	en	ti	 Some of those infected may be asymptomatic, with no clinical symptoms but with test results that confirm infection, so researchers have issued advice that those with close contact to confirmed infected people should be closely monitored and examined to rule out infection. 	 ገለ ካብቶም ዝተለኸፉ ምንም ዓይነት ምልከት ዘይከርእዩ ይኽእሉ፣ እዚ ማለት ድማ ምንም ዓይነት ክሊኒካዊ ምልክት ኣየርእዩን ግን ድማ ምርመራት ህላወ ረኽሲ ዘረጋግጹ እዮም። ስለዚ፣ ተመራመርቲ ነቶም ምስ እቲ ዝተረጋገጸ ጉዳይ ዘለዎ ሰብ ናይ ቀረባ ምንኽኻእ ዘልዎም ሰባት ብቐረባ ክትትል ክግበረሎም ክምዘለዎን ናይ እቲ ረኽሲ ህላወ ንምፍላጥ ዝግበሩ ምርመራታት ክገብሩ ከምዘለዎም ይምኽሩ። 	Some of those infected may show no recognition, which means they show no clinical signs but tests confirm the presence of infection. Therefore, researchers recommend that people who have close contact with the confirmed case should be closely monitored and tested for the presence of the infection.
907	en	ti	 Chinese estimates of the asymptomatic ratio range from few to 44%. 	 ቻይና ናይ ምልክት ዘይርኣዩ ካብ ውሑዳት እስካብ 44% ክምዝበጽሕ ተምቢያ። 	China predicts asymptomatic rates of minority to 44%.
908	en	ti	 The usual incubation period (the time between infection and symptom onset) ranges from one to 14 days; it is most commonly five days.As an example of uncertainty, the estimate of the fraction of people with COVID-19 who lost their sense of smell was initially 30% and later fell to 15%. 	 ዝበዝሐ ግዜ እቲ መራብሒ ግዘ ( ኣብ መንጎ መልከፍትን ምልክት ሕማም ዝረኣየሉ ዘሎ ግዜ) ዝበዝሐ ግዜ ሓሙሽተ መዓልታት ዋላ እንተኮነ፡ ካብ ሓደ ክሳብ 14 መዓልታት ይፈላለ። ከም ኣብነት ናይ ዘይርጉጽነት፡ ገምጋም ናይቶም COVID-19 ዝሓዞም’ሞ ናይ ሽታ ምልላይ ክእለቶም ዘጥፍኡ መጀመርያ 30% ዝነበረ ናብ 15% ወሪዱ። 	The incubation period (between infection and symptoms) usually varies from one to 14 days, although it is usually five days. As an example of uncertainty, the estimate of those who contract COVID-19 and lose their sense of smell has dropped from an initial 30% to 15%.
909	en	ti	 Some details about how the disease is spread are still being determined. 	 እዚ ሕማም ብዝርዝር ብኸመይ ከምዝመሓላለፍ ገና ኣብ መጽናዕቲ ኣሎ። 	The details of how this disease is transmitted are still under study.
910	en	ti	 The disease is believed to be primarily spread during close contact and by small droplets produced during coughing, sneezing, or talking; with close contact being within 1 to 2 metres (3 to 6 feet). 	 እቲ ሕማም ቀንዲ ብቀረባ ርክብ ኣብ ዝህሉን፡ ቀረባ ማለት ትሕቲ 1-2 ሜትሮ(3-6 feet)፡ ወይ ድማ ብዓይኒ ዘይረኣዩ ኣብ ግዜ ምስዓል፡ ምሕንጣስ ወይ ምዝራብ ዝስወጹ ደቀቅቲ ባእታታት እዩ ዝመሓላለፍ። 	The disease is mainly transmitted through close contact, close i.e. less than 1-2 meters(3-6 feet), or invisible particles that are absorbed during coughing, sneezing or talking.
911	en	ti	 Studies have found that an uncovered coughing can lead to droplets travelling up to 4.5 metres (15 feet) to 8.2 metres (27 feet). 	 መጽናዕቲታት ክምዝሕብሩዋ ካብ ዘይተሸፈነ ምስዓል ዝወጽኡ ንጣባት ካብ 4.5 ሜትር (15 ፊት) እስካብ 8.2 ሜትር(27 ፊት) ክጎዓዙ ይኽእሉ እዮም። 	Studies show that droplets from uncovered coughing can travel from 4.5 meters (15 feet) to 8.2 meters (27 feet).
912	en	ti	 Some have proposed that the virus may also be transmitted by small droplets that stay for more prolonged periods in the air, that may be generated during speech.Respiratory droplets may also be produced during breathing out, including when talking, though the virus is not generally airborne. 	 ዋላኳ እቲ ቫይረስ ብ ኣጠቓላሊ ኣየር ወለድ እንተዘይኮነ፣ዝተወሰኑ ሰባት እቲ ቫይረስ ብ ኣናኡሽተይ፡ ኣብ እዋን ዘረባ ክፍጠሩ ዝኽእሉ፡ ኣብ ኣየር ን ዝነውሐ ጊዘ ዝጸንሑ ንጣባት ክመሓላለፍ ክምዝኸእል ርእይቶ የቕርቡ። ናይ መተንፈሲ ኣካላት ንጣባት ኣብ እዋን ን ደገ ምንፋስ፡ ኣብ ዘረባ ሰዓት ሓዊሱ ክፍጠሩ ይኽእሉ እዮም። 	Although the virus is not generally airborne, some people suggest that the virus can be transmitted by tiny, longer-lasting droplets that can form during speech. Respiratory droplets can form during external breathing, including during speech.
913	en	ti	 The droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. 	 እዞም ባእታታት ኣብ ኣፍ ወይ ኣፍንጫ ብቀረባ ዝርከቡ ሰባት ክዓልቡ ወይ ድማ ንውሽጢ ሳናቡእ ክኣትዉ ይኽእሉ’ዮም። 	These elements can land in people&#39;s mouths or noses or enter the lungs.
914	en	ti	 Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may cause respiratory secretions to be aerosolized and thus result in airborne spread. 	 ገለገለ ሕክምናዊ መስርሂታት ከም በዓል ኢንቱቤሽንን Cardiopulmonary Resuscitation(CPR) ነቲ ኣብቲ ስርዓተ ምስትንፋስ ዝጸንሕ ኣኽታ ምስ ኣየር ብምሕዋስ ኣብ ኣየር ዝርግሐ ቫይረስ የስዕቡ። 	Some medical procedures such as intubation and Cardiopulmonary Resuscitation(CPR) cause the spread of virus in the air by mixing the air in the respiratory tract.
915	en	ti	 It may also spread when one touches a contaminated surface, including skin, and then touches their eyes, nose, or mouth. 	 ዝተበከለ ንብረት ወይ ኣካል ከም ቆርበት ተንኪፍካ ዓይንኻ፡ ኣፍንጫኻ ወይ ኣፍካ ብምሓዝ እቲ ቫይረስ ክመሓላለፍ ይኽእል’ዩ። 	The virus can be transmitted by touching contaminated objects or body parts such as skin and touching your eyes, nose or mouth.
916	en	ti	 While there are concerns it may spread by faeces, this risk is believed to be low. 	 ብ ዓይኒ ምድሪ ክመሓላለፍ ይኽእል እዩ ዝብሉ ስግኣታት እኳ እንተሃለዉ፣ እዚ ሓደጋ ግን ኣዝዩ ዝተሓተ እዩ። 	Although there are concerns that it can be transmitted by the earth, this risk is very low.
917	en	ti	 The Government of China denied the possibility of faecal-oral transmission of SARS-CoV-2.The virus is most contagious during the first three days after onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease. 	 ናይ ቻይና መንግስቲ ናይ SARS-CoV-2 ብ መንገዲ ዐይኒ ምድሪ ናይ ምምሓልላፍ ትኽእሎኡ ክሒዶሞ እዮም። እቲ ቫይረስ ካብ'ቲ ምልክት ዝረኣየሉ ጊዜ ጀሚሩ ዘለዋ ናይ መጀምሪያ ሰለስተ መዓልቲታት ኣዝዩ ተምሓላላፋይ ዝኾነሉ እዩ ይኹን ዳኣመበር እቶም ምልክታት ቅድሚ ምርኣዮም ን ኣብቶም ቀጸልቲ ናይ'ቲ ሕማም እዋናትን 'ውን ምዝማቱ ክቕጽል ይኽእል እዩ። 	The Chinese government has denied the possibility of SARS-CoV-2 being transmitted through the eye. The virus is most contagious for the first three days from the time of symptoms however it can continue to spread before the symptoms appear and during the following periods of the disease.
918	en	ti	 People have tested positive for the disease up to three days before onset of symptoms suggesting transmission is possible before developing significant symptoms. 	 ሰልስተ መዓልታት ቅድሚ ምልክታት ምምዕባሎም ሰባት ብመርመራ ሕማም ከምዘለዎም ክረጋገጽ ይከኣል’ዩ። እዚ ማለት ከኣ ብዘይ ዝኾነ ምልክት ተላባዕነት ከም ዘሎ ይሕብር። 	People can be diagnosed with the disease three days before symptoms develop. This means that there is no sign of infection.
919	en	ti	 Only few reports of laboratory-confirmed asymptomatic cases exist, but asymptomatic transmission has been identified by some countries during contact tracing investigations. 	 ብላባራቶሪ ዝተረጋገጹ ናይ ሕማም ምልክት ዘይብሎም ሰባት ውሑዳት’ዮም፡ ግን ኣብ ውሱናት ሃገራት ብዘይ ዝኾነ ምልክታት ሕማም ከመሓላልፉ ከምዝኽእሉ ዝተኻየዱ መጽናዕትታት ይሕብሩ። 	Few people have laboratory-confirmed symptoms, but studies have shown that they can transmit the disease without any symptoms in certain countries.
920	en	ti	 The European Centre for Disease Prevention and Control (ECDC) states that while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.The virus survives for hours to days on surfaces. 	 ናይ ኣውሮፓ ማእኸል ምክልኻልን ምቁጽጽርን ሕማም( ECDC) ምንም እኳ እቲ ሕማም ብምንታይ መንገዲ ብቐሊሉ ከምዝመሓላለፍ እንተ ዘይተፈልጠ፡ሓደ ሰብ ግን በ ኣጠቓላሊ ክልተ ወይድማ ሰልስተ ሰባት ክብክል ይኽእል እዩ ኢሉ የቕምጥ። እቲ ቫይረስ ካብ ሰዓታት ኣትሒዙ እስካብ መዓልቲታት ኣብ ናይ ኣካላት ገጽ ይጽንሕ እዩ። 	The European Center for Disease Prevention and Control ( ECDC) states that although it is not known how the disease is easily transmitted, one person can infect two or three people in total. The virus stays on the body surface for hours to days.
921	en	ti	 Specifically, the virus was found to be detectable for up to three days on plastic (polypropylene) and 304 stainless steel, for one day on cardboard, and for up to four hours on copper. 	 ግልጺ ብዥኮነ መልክዑ. እቲ ቫይረስ ኣብ ፕላስቲክ(ፖሊፕሮፓይሊን) ስጋብ ሰለስተ መዐልቲታት ክረኣ ክምዝኽእልን፡ 304 ድማ ኣብ ስተይንለስ ስቲል፡ ኣብ ካርቶን ድማ ን ሓደ መዓልቲ ፡ ኣብ ኮፐር ድማ ስጋብ ኣርባዕተ ሰዓታት ክፍለ ይኽእል እዩ። 	OBVIOUS BZCONE APPEARANCES. The virus can be detected in plastic(polypropylene) for up to three days, 304 in stainless steel, and in cardboard for one day , and in copper for up to four hours.
922	en	ti	 This, however, varies based on the humidity and temperature.Pets and other animals have tested positive for COVID-19. 	 እዙይ ግን፣ ኣብ ራሕሲን መጠን ሙቐትን ዝተደረኸ እዩ። ናይ ገዛ እንስሳትን ካልኦት እንስሳትን COVID-19 ተረኺቡዎም እዩ። 	This, however, depends on the roof and temperature. Pets and other animals have tested positive for COVID-1
923	en	ti	 There is no evidence animals can pass the virus on to humans, though British authorities advise washing one's hands after contact with animals, like after contact with other surfaces infected people could have touched. 	 ናይ ብሪጣንያ ሰበ-ስልጣን ድሕሪ እንስሳታት ምሓዝ ልክዕ ከምቲ ዝተለኽፈ ንብረት ድሕሪ ምሓዝካ ኣእዳውካ ተሓጸብ ዋላ’ኳ እንተበሉ፡እቲ ቫይረስ ካብ እንስሳታት ናብ ሰባት ከምዝመሓላለፍ ዘርኢ መረዳእታ የልቦን። 	Although British authorities recommend washing your hands after handling animals as well as after handling infected property, there is no evidence that the virus is transmitted from animals to humans.
924	en	ti	 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus, first isolated from three people with pneumonia connected to the cluster of acute respiratory illness cases in Wuhan. 	 SARS-CoV-2 ኖቨል ቫይረስ 2 ኮይኑ፣ ካብ ሰለስተ ኒሞኒያ ዘለዎም ምስ ኣብ ዉሃን ዘጋጠሙ ክበድቲ ናይ መተንፈሲ ኣካላት ጸገም ዝተሓሓዙ ሰባት እዩ ንመጀምሪያ ጊዜ ተነጺሉ። 	SARS-CoV-2 is a novel virus 2, first isolated from three pneumonia patients associated with severe respiratory problems in Wuhan.
925	en	ti	 All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.Outside the human body, the virus is killed by household soap, which dissolves its protective envelope.SARS-CoV-2 is closely related to the original SARS-CoV. 	 ኩሉ መልክዓት ናይዚ ሓድሽ ዝተቐላቐለ ሳርስ-ኮቭ-2 ቫይረስ ኣብ ተመሳሰልቲ ተፈጥሮኣዊ ኮሮናቫይረሳት ይርከቡ። ካብ ሰውነት ወጻኢ ሳምና ነቲ ዝከላኸሎ ሽፋን ብምሕቓቕ ነዚ ቫይረስ ክቐትሎ ይኽእል። ሳርስ-ኮቭ-2 ምስቲ ነበር ሳርስ-ኮቭ ብቀረባ ይመሳሰል። 	All forms of this newly isolated SARS-CoV-2 virus are found in similar natural coronaviruses. Outside the body, soap can kill the virus by absorbing the protective membrane. SARS-CoV-2 closely resembles the former SARS-CoV.
926	en	ti	 It is thought to have a zoonotic origin. 	 ካብ እንስሳታት ዝተበገሰ ክምዝኸውን ይእመን። 	It is believed to have originated from animals.
927	en	ti	 Genetic analysis has revealed that the coronavirus genetically clusters with the genus Betacoronavirus, in subgenus Sarbecovirus (lineage B) together with two bat-derived strains. 	 ናይ ጄነቲክ ምርምራት ከምዘጋለጹዎ ኮረና ቫይረስ ብ ጄኒቲክ ምስ ቤታኮረና ቫይረስዝምደብ እዩ፡ኣብ ደረጃ ክፋል ናይ ዓሌት ድማ ምስ ካልኦት ካብ መንካዕ ዝብገሱ ቫይረሳትን ምስ ሰበጅነስ ሳርብኮቫይረስ (ላይኔጅ B)) ዝምደብ እዩ። 	Genetic studies have revealed that the coronavirus is genetically classified with the betacoronavirus, and at the genus level with other tick-borne viruses and with the subgenus sarcovirus (lineage B)).
928	en	ti	 It is 96% identical at the whole genome level to other bat coronavirus samples (BatCov RaTG13). 	 ምስ ካልኦት ናይ መንካዕ ኮርና ቫይረሳት(BatCov RaTG13) ኣብ ሙሉእ ናይ ጄነም ደረጃታት 96% ዝመሳሰል እዩ። 	It is 96% similar to other bat coronaviruses(BatCov RaTG13) at full genome levels.
929	en	ti	 In February 2020, Chinese researchers found that there is only one amino acid difference in certain parts of the genome sequences between the viruses from pangolins and those from humans. 	 ኣብ መንጎ ኣብ ሰባትን ፓንጎሊን ዝተብሃሉ እንስሳታትን ዝርከቡ ቫይረሳት፡ ናይ ሓደ ኣሚኖ ኣሲድ ፍልልይ ጥራይ ከምዘለዎም ብቻይናውያን ተመራመርቲ ብ ፌብሩዋሪ 2020 ተረኺቡ። 	In February 2020, Chinese researchers discovered that there is only one amino acid difference between viruses in humans and pangolins.
930	en	ti	 Whole-genome comparison to date has found at most 92% of genetic material shared between pangolin coronavirus and SARS-CoV-2, which is insufficient to prove pangolins to be the intermediate host. 	 ሙሉእ ናይ ጀነቲክ ምምስሳላት ክምዘርእዩዎ ብንኡሱ 92% ናይ ጀነቲክ ባእታታት ኣብ መንጎ ፓንጎሊን ኮሮናቫይረስ ን SARS-CoV-2 በተመሳሳሊ ዝርከቡ እዮም፡ እዚ ድማ ፓንጎሊን ከም ማእኸለዋይ ተሸካሚ ኢልካ ንምርግግጋጽ እኹል ኣይኮነን። 	Full genetic similarities show that at least 92% of the genetic elements are similar between pangolin coronavirus and SARS-CoV-2, which is not enough to confirm pangolin as a central carrier.
931	en	ti	 Infection by the virus can be provisionally diagnosed on the basis of symptoms, though confirmation is ultimately by reverse transcription polymerase chain reaction (rRT-PCR) of infected secretions or CT imaging. 	 በዚ ቫይረስ መልከፍቲ ብምልክታቱ ክፍለጥ’ኳ እንተተኻእለ ብናይ ኣኽታ reverse transcription polymerase chain reaction(rRT-PCR) መርመራታት ወይ ድማ ብCT ምስሊ ክረጋገጽ ኣልዎ። 	Infection with this virus can be diagnosed by symptoms but must be confirmed by ACT reverse transcription polymerase chain reaction(rRT-PCR) tests or CT imaging.
932	en	ti	 A study comparing PCR to CT in Wuhan has suggested that CT is significantly more sensitive than PCR, though less specific, with many of its imaging features overlapping with other pneumonias and disease processes. 	 CT ካብ PCR ንላዕሊ ነቲ ሕማም ናይ ምርካብ ክእለት ከምዘለዎ ግን ከዓ ምስ ካልኦት ዓይነታት ኒሞንያን ሕማማትን ክፈልዮ ከምዘይክእል ኣብ ዉሃን ዝተኻየደ ንPCRን CTን ዘወዳድር መጽናዕቲ የመልክት። 	CT is more capable of detecting the disease than PCR but cannot distinguish it from other types of pneumonia and diseases, according to a study in Wuhan comparing PCR and CT.
933	en	ti	" As of March 2020, the American College of Radiology recommends that ""CT should not be used to screen for or as a first-line test to diagnose COVID-19"". "	" ካብ ማርች 2020 ጅሚሩ፡ ናይ ኣሜሪካ ራዲዮሎጂ ኮሌጅ "" CT ን COVID-19 ክም ናይ መጀመሪያ ናይ ምጻረዪ ምርመራ ኣብ ጥቕሚ ክውዕል የብሉን"" ክብሉ ተላቢዮም። "	As of March 2020, the American College of Radiology has recommended that &quot; CT should not be used as a primary screening test for COVID-1
934	en	ti	 The WHO has published several RNA testing protocols for SARS-CoV-2, with the first issued on 17 January. 	 ዝተፈላለዩ ፕሮቶኮላት ምርመራ ናይ ሳርስ-ኮቭ-2 RNA ብWHO ተዘርጊሑ። እቲ ፋልማይ ብ ጃኑዋሪ 17 ተዘርጊሑ። 	Different protocols for the testing of SARS-CoV-2 RNA were published by the WHO. The first was released on January 17th.
935	en	ti	 The test uses real-time reverse transcription polymerase chain reaction (rRT-PCR). 	 እቲ መርመራ ዝጥቀመሉ real-time reverse transcription polymerase chain reaction(rRT-PCR)ይበሃል። 	The test used is called real-time reverse transcription polymerase chain reaction(rRT-PCR).
936	en	ti	 The test can be done on respiratory or blood samples. 	 እዚ መርመራ ኣብ ኣካለ ምስትፋንስ ወይ’ውን ደም ክግበር ይከኣል። 	This test can be done in the respiratory tract or blood.
937	en	ti	 Results are generally available within a few hours to days. 	 ብሓፍሻ ውጽኢታት ኣብ ውሽጢ ውሑዳት ሰዓታት ክሳብ መዓልታት ይርከብ። 	Results are generally available within a few hours to days.
938	en	ti	 Generally this test is carried out on a nasopharyngeal swab though a throat swab may also be used.A number of laboratories and companies are developing serological tests, which detect antibodies. 	 ብሓፈሻ እዚ መርመራ ብኣፍንጫን ሶርኖን ዝኣቱ ስዋብ ዋላ’ውን ናይ ጎሮሮ ስዋብ ክግበር ይከኣል’ዩ።ኣብ ደም ጸረ-ነፍሲ ዘለልዩ መርመራታት’ውን ብውሱናት ላባራቶሪታትን ካምፓኒታትን ይስርሑ ኣለዉ። 	Generally, this test can be done with a nasal swab and even a throat swab.Tests that detect antibodies in blood are also being done by a few laboratories and companies.
939	en	ti	 As of 6 April 2020, none of these has been proved sufficiently accurate to be approved for widespread use. 	 ካብ ኣፕሪል 6 2020፡ ጀሚሩ ካብዚ'ም ዋላ ሓደ ብገፊሑ ኣብ ጥቕሚ ንክወዕል ብዝግባእ ዝተረጋገጸ ሓቅነት ክህልዎ ኣይከኣለን። 	As of April 6 2020, none of these have been properly validated for widespread use.
940	en	ti	 In the US a serological test developed by Cellex has been approved for emergency use by certified laboratories only. 	 ኣብ US ብCellex ዝስራሕ ዘሎ ናይ ጸረ ቫይርስ መርመራ ብውሕስነቶም ዝተረጋገጸ ላባራቶሪታት ንህጹጽ ኣገልግሎት ኣብ ጥቕሚ ክውዕል ተፈቒዱ። 	Cellex&#39;s antiviral test in the US has been approved for emergency use by laboratories that have been certified safe.
941	en	ti	 Characteristic imaging features on radiographs and computed tomography (CT) of people who are symptomatic include asymmetric peripheral ground glass opacities and absent pleural effusions. 	 ናይ እቶም ምልክት ዘየርኣዩ ሰባት ዝተልዓሉ ናይ ራድዮ ግራፊን CT ምስሊታት ከምዘርእዩዎ asymmetric peripheral ground glass opacities and absent pleural effusions ዝበሉ ምልክታት የርእዩ እዮም። 	Raised radiographine and CT images of asymptomatic subjects do show asymmetric peripheral ground glass opacities and absent pleural effusions.
942	en	ti	 The Italian Radiological Society is compiling an international online database of imaging findings for confirmed cases. 	 ብዓለምለኻዊ መርበብ ኢንተርነት ዝዝርጋሕ ናይ ዝተረጋገጹ ሕሙማት ስእላዊ ውጺእታት ብናይ ጥልያን ማሕበር ራድዮሎጂ ይዳለው ኣሎ። 	Imaging results of confirmed patients are being prepared by the Italian Society of Radiology.
943	en	ti	 Due to overlap with other infections such as adenovirus, imaging without confirmation by PCR is of limited specificity in identifying COVID-19. 	 ምስ ካልኦት ተላባዕቲ ሕማማት ከም ኣደኖቫይረስ ክመሳሰል ስለዝኽእል፡ ን COVID-19 ብዘይ PCR ብምርኣይ ጥራይ ክፍለጥ ኣይክእልን’ዩ። 	Because it can be similar to other infectious diseases such as adenoviruses, COVID-19 cannot be diagnosed without PCR alone.
944	en	ti	 A large study in China compared chest CT results to PCR and demonstrated that though imaging is less specific for the infection, it is faster and more sensitive, suggesting its consideration as a screening tool in epidemic areas. 	 ናይ ኣፍ ልቢ CT ውጽኢታት ምስ PCR ክወዳደር ከሎ ነዚ ለበዳ ካብ ካልኦት ሕማማት ናይ ምፍላይ ክእለቱ ዋላ’ኳ ትሑት እንተኾነ፡ ስሉጥን ሕማም ናይ ምልላይ ክእለቱ ልዑል ምዃኑን፡ ኣብ ቻይና ብዝተኻየደ ሰፊሕ መጽናዕቲ ተራእዩ። እዚ ከኣ ኣብ ለበዳዊ ቦታታት ከም ናይ መርመሪ መሳርሒ ክንጥቀመሉ ከም እንኽእል ይጥቁም። 	Although the ability of oral cardiac CT to distinguish this epidemic from other diseases is low compared with PCR, it is efficient and has a high diagnostic ability, as shown by a large-scale study in China. This suggests that we can use it as a screening tool in epidemic areas.
945	en	ti	 Artificial intelligence-based convolutional neural networks have been developed to detect imaging features of the virus with both radiographs and CT. 	 ብ ክልቲኦም ራድዮግራፍን CT ዝተልዓሉ ናይ እቲ ቫይረስ ናይ ምስሊ መግለጺታት ንምርኣይ ዘኽእሉ ኣብ ኣርተፊሻል ኢንተለጀንስ ዝድረኹ ናይ ኮንቩሉሽናል ኒዩውራል ኔትዎርክታት(convolutional neural networks) ኣብ ምዕባለ ይርከቡ። 	Artificial intelligence-driven convolutional neural networks are under development that enable visualization of the virus&#39;s image manifestations elicited by both radiography and CT.
946	en	ti	 Strategies for preventing transmission of the disease include maintaining overall good personal hygiene, washing hands, avoiding touching the eyes, nose, or mouth with unwashed hands, and coughing or sneezing into a tissue and putting the tissue directly into a waste container. 	 ኣካላዊ ንጽህና ምህላው ኣእዳው ምህጻብ፡ብረሳሕ ኣእዳው ዓይንኻ፡ኣፍንጫኻ ወይ’ውን ኣፍካ ዘይምትንካፍ፡ናብ ሶፍት ምስዓል ወይ ምሕንጣስ ብድሕሪኡ ድማ ነቲ ሶፍት ብግቡእ ምድርባይ ገለ ካብቶም ምልባዕ ዘወግዱ ስጉምትታት’ዮም። 	Physical hygiene Washing hands, not touching your eyes, nose or mouth with dirty hands, coughing or sneezing into a soft drink and then disposing of the soft tissue properly are some of the steps to prevent infection.
947	en	ti	 Those who may already have the infection have been advised to wear a surgical mask in public. 	 እቶም በቲ ርኽሲ ተጠቒዖም ክኾኑ ዝኽእሉ ሰባት ኣብ ህዝባዊ ቦታት ኣብ ዝኽኮኑሉ ሰዓት ናይ ሰርጀሪ ማስክ ንኽገብሩ ይምከሩ። 	Those who may be infected are advised to wear a surgical mask when in public places.
948	en	ti	 Physical distancing measures are also recommended to prevent transmission.Many governments have restricted or advised against all non-essential travel to and from countries and areas affected by the outbreak. 	 ናይ ኣካላዊ ምርሕሓቕ ስጉምቲታት ምትሕልላፋት ንምክልኻል ዝምከሩ ኮይኖም መብዛሕቲኦም መንግስቲታት ኩሎም ካብ ን ናብን ሃገራትን በቲ ለበዳ ዝተጠቕዑ ቦታታ ዝግበሩ ኣገድስቲ ዘይኮኑ ጉዕዞታት ኣጊዶም እዮም ውይድማ ንኸይግበሩ ለበዋ ገይሮም እዮም። 	Physical distancing measures are recommended to prevent transmission and most governments have banned all non-essential travel to and from affected countries and recommended not to do so.
949	en	ti	 However, the virus has reached the stage of community spread in large parts of the world. 	 ይኹን ደኣምበር፡ እቲ ቫይረስ ኣብ ኣብዝሓ ሃገራት ናይ ዓለም ኣብ ብሕብረተሰብ ደረጃ ዝዛመተሉ ደረጃ በጺሑ ኣሎ። 	However, the virus has reached a community-wide spread in most countries of the world.
950	en	ti	 This means that the virus is spreading within communities, and some community members don't know where or how they were infected.Health care providers taking care of someone who may be infected are recommended to use standard precautions, contact precautions, and eye protection.Contact tracing is an important method for health authorities to determine the source of an infection and to prevent further transmission. 	 እዚ ማለት ድማ እቲ ቫይረስ ኣብ ውሽጢ ማሕበረሰባት እናተዛመተ እዩ ማለት እዩ፣ ገለ ናይ ማሕበረሰብ ኣባላት ድማ ኣብይን ብ ኸመይን ክምዝተለኽፉ ኣይፈልጡን። እቶም ን በቲ ሕማም ዝተለኸፈ ስብ ዝሕክሙ ሰብ ሞያ ጥዕና ግቡእ ጥንቃቐታት ንኽገብሩ ይምከሩ፣ ክም ናይ ንኽክእ ጥንቃቐታትን ናይ ዓይኒ መጠንቀቕታታትን። ናይ ኣስር ንኽክእ ምድላይ ን ስብ ጥዕና ናይ እቲ ረኽሲ መበገሲ ኣብ ምፍላጥን ቀጸልቲ ምትሕልላፋት ንምክልኻል ኣዝዩ ኣድላዪ እዩ። 	This means that the virus is spreading within communities, and some community members do not know where and how they are infected. Health professionals treating an infected person are advised to take appropriate precautions, such as contact precautions and eye warnings. Detection of asthma is essential for healthy people to determine the origin of the infection and prevent further transmissions.
951	en	ti	 The use of location data from mobile phones by governments for this purpose has prompted privacy concerns, with Amnesty International and over 100 other organizations issuing a statement calling for limits on this kind of surveillance. 	 መንግስቲታት ናይ ካባቢያዊ ሓበሬታ ዳታ ካብ ሞባይል ስልኪታት ምጥቃሞም ናይ ወልቃውነት ሕቶ ዘልዓለ ኮይኑ ኣሎ፡ ን ኣምነስቲ ኢንተርናሽናል ሓዊሱ ካልኦት 100 ዝኾኑ ትካላት ነዚ ከምዚ ዝ ኣምሰለ ሰለላታት ወሰን ንኽቅመጠሉ ዝጽውዑ መገለጺታት ኣውጺኦም እዮም። 	Governments&#39; use of local information data from mobile phones has raised privacy issues, and some 100 other organizations, including Amnesty International, have issued statements calling for such spying to be limited.
952	en	ti	 Various mobile apps have been implemented or proposed for voluntary use, and as of April 7, 2020, over a dozen expert groups were working on privacy-friendly solutions, such as using Bluetooth to log a user's proximity to other cellphones. 	 ዝተፋላለዩ ናይ ሞባይል መተግበሪታት ኣብ ተግባር ውዒሎም እዮም ወይድማ ን ወለንታዊ ምጥቃም ቀሪቦም እዮም፣ ካብ ኣፕሪል 7,2020 ጀሚሩ፣ ካብ ደርዘን ንላዕሊ ዝኮኑ ናይ ሰብ ሞያ ጉጅለታት ክም ብሉቱዝ ተጠቒምካ ናይ ተጠቃማይ ቅርበት ናብ ካለኦት ስልኪታት ምምዝጋብ ዝኣምሰሉ ኣብ ወልቃውነት ጸገም ዘይፈጥሩ መፍትሒታት ኣነሰርሑ ይርከቡ። 	Various mobile applications have been implemented or offered for voluntary use, and as of April 7,2020, more than a dozen teams of professionals are working on privacy-free solutions such as recording user proximity to other phones using Bluetooth.
953	en	ti	 Users then receive a message if they've been in close contact with someone who has tested positive for COVID-19.Misconceptions are circulating about how to prevent infection; for example, rinsing the nose and gargling with mouthwash are not effective. 	 ብድሕሪኡ፡ ተገልገልቲ ምስ ሓደ ብ COVID-19 ዝተለኽፈ ሰብ ናይ ቀረባ ርክብ እንተነይርዎ መልዕኽቲ ይበጽሆ። መልከፍቲ ንምውጋድ ብዝምልከት ዝዘሩ ዘለዉ ጌጋዊ ኣተሓሳስባታት፡ ከም ኣብነት ኣፍንጫ ብማይ ምሕጻብ፡ ዓፍ ብማውዝዋሽ ምጉጽጓጽ ውጽኢታዊ ኣይኮኑን። 	Clients then receive a message if they have had close contact with someone infected with COVID-1 Misconceptions about preventing infection, such as rinsing the nose with water and rubbing the mouth with mouthwash, are not effective.
954	en	ti	 There is no COVID-19 vaccine, though many organizations are working to develop one. 	 ዋላኳ ብዙሓት ትካላት ንምምዕባል ኣብ ምስራሕ ዝርከባ ይኹና ፣ ናይ COVID-19 ክታበት ግን ዛጊድ የለን። 	Although many companies are working to develop , there is no vaccine for COVID-19 yet.
955	en	ti	 Hand washing is recommended to prevent the spread of the disease. 	 ኢድ ምሕጻብ ናይ እቲ ቫይረስ ምዝማት ንምክልኻል ዝምከር እዩ። 	Hand washing is recommended to prevent the spread of the virus.
956	en	ti	 The CDC recommends that people wash hands often with soap and water for at least twenty seconds, especially after going to the toilet or when hands are visibly dirty; before eating; and after blowing one's nose, coughing, or sneezing. 	 CDC ከምዝሕብሮ ሰባት ኣእዳዎም ብሳሙናን ማይን ብውሕዱ ንእስራ ካልኢት ቀጻሊ ብምሕጻብ፡ ብፍላይ ድማ ድሕሪ ሽንቲቤት ምጥቃም ወይ’ውን ብዓይኒ ዝርአ ርስሓት እንተልይወን፡ ቅድሚ ምግቢ ምብላዕን ድሕሪ ፊጥ ምባል፡ ምስዓል ወይ’ውን ምሕንጣስ። 	The CDC recommends that people wash their hands with soap and water for at least twenty seconds continuously, especially after using the toilet or if they have visible dirt, before eating and after sneezing, coughing or sneezing.
957	en	ti	 This is because outside the human body, the virus is killed by household soap, which bursts its protective bubble. 	 እዚ ድማ ነቲ ቫይረስ ካብ ኣካል ወዲ ሰብ ወጻኢ፣ ናይ ኣቑሑ ሳሙና ናይ መከላኸሊ ሰውነቱ ብምትኳስ ክቕተሎ ይኽእል እዩ፣ 	This can kill the virus outside the human body, by shooting the dish soap of its immune system,
958	en	ti	 CDC further recommended using an alcohol-based hand sanitizer with at least 60% alcohol by volume when soap and water are not readily available. 	 CDC ወሲኹ ድማ ማይን ሳሙናን ኣብዘይርከበሉ ሰዓት፣ብውሑዱ 60% ኣልኮል ዝተሓወሶ ናይ ኣልኮል ሳኒታይዘር ምጥቃም ክብል ምኽሩ ይህብ። 	The CDC adds that when soap and water are not available,use an alcohol sanitizer with at least 60% alcohol.
959	en	ti	 The WHO advises people to avoid touching the eyes, nose, or mouth with unwashed hands. 	 WHO ዓይንኻ፡ ኣፍንጫኻ ወይ`ውን ኣፍካ ብረሳሕ ኣእዳውካ ኣይትሓዝ ኢሉ ንሰባት ይመክር። 	WHO advises people not to touch their eyes, nose or mouth with dirty hands.
960	en	ti	 Surfaces may be decontaminated with a number of solutions (within one minute of exposure to the disinfectant for a stainless steel surface), including 62–71% ethanol, 50–100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, and 0.2–7.5% povidone-iodine. 	 ናይ ኣካላት ገጽታት ብዝተፈላለዩ ኬሚካላት(ን ስቴይንልስ ስቲል ኣብ ውሽጢ ሓደ ደቒቓ ድሕሪ በቲ ጸረ-ታህዋስያን ምውልዋል) ካብ ታህዋስያን ነጻ ክኾኑ ይኽእሉ እዮም፡ 62-71% ኢታኖል፡50-100% ኢይሶፕሮፓኖል፡0.1% ሶድየም ሃይፖክሎራይት፡0.5% ሃይድሮጅን ፐርኦክሳይድ ን 0.2-7.5% ዝኾን ከዓ ፖቪዶን ኣዮዳይን( povidone-iodine) ዝሓወሱ ክኾኑ ኣለዎም: 	Body surfaces can be disinfected with various chemicals(for stainless steel within one minute after welding with the disinfectant): 62-71% ethanol,50-100% isopropanol,0.1% sodium hypochlorite,0.5% hydrogen peroxide and 0.2 -7.5% should be a mixture of povidone-iodine:
961	en	ti	 Other solutions, such as benzalkonium chloride and chrohexidine gluconate, are less effective. 	 ካልኦት ከም ቤንዛልኮኒየም ክሎራይድ( benzalkonium chloride) ን ክሮሄክሲዳይን ግሉኮስ( chrohexidine gluconate) ዝበሉ ብጽባጻት ዝተሓተ ንጥፈት ዘለዎም እዮም። 	Others, such as benzalkonium chloride and chrohexidine gluconate, are less active in tablets.
962	en	ti	 The CDC recommends that if a COVID case is suspected or confirmed at a facility such as an office or day care, all areas such as offices, bathrooms, common areas, shared electronic equipment like tablets, touch screens, keyboards, remote controls, and ATM machines used by the ill persons, should be disinfected. 	 CDC ናይ COVID ኣብ ዝኾነ ትካል፣ ኣብ ከም ቢሮ ውይድማ ናይ ህጻናት መሕብሐቢ ቦታ፣ ኩሎም ክም ቢሮታት፣ ሽንት ቤታት፣ ናይ ሓባር ቦታት፣ ብሓባር ኣብ ጥቕሚ ዝውዕሉ ምም ታብሌት፣ ተች ስክሪናት፣ ኪይቦርዳት፣ ሪሞት ኮንትሮላት ን ATM ማሺናት ዝበሉ ናይ ኤሌክትሮኒክስ ኣቑሑ ብዝሓመመ ሰብ ኣብ ጥቕሚ ኣብ ዝውዕሉሉ ሰዓት፣ ጸረ-ታህዋስያን ክግበረሎምን ክ ጸርዩን ኣለዎም። 	CDC of COVID in any facility, such as an office or child care facility, all electronic devices such as offices, restrooms, common areas, shared tablets, touch screens, keyboards, remote controls and ATM machines by a sick person When in use, they must be disinfected and cleaned.
963	en	ti	 Health organizations recommended that people cover their mouth and nose with a bent elbow or a tissue when coughing or sneezing, and disposing of any tissue immediately. 	 ሰባት ክስዕሉ ወይ ከሕንጥሱ ከለዉ ኣፎምን ኣፍጭኦምን ብብርኪ ኢዶም ክሽፍኑን ዝተጠቀሙሉ ሶፍት ብኣግኡ ክጉሕፉን ውዱባት ጥዕና ይመኽሩ። 	Health organizations recommend that people cover their mouths and noses with their palms when coughing or sneezing and dispose of used soap early.
964	en	ti	 Surgical masks are recommended for those who may be infected, as wearing a mask can limit the volume and travel distance of expiratory droplets dispersed when talking, sneezing, and coughing. 	 ዝሓመሙ ሰባት ናይ ሕክምንና ማስክ ክገብሩ ይምከሩ። ማስክ ምልባስ ኣብ ግዜ ምዝራብ፡ ምሕንጣስ ንምስዓልን ብዝሕን ርሕቀትን ናይ`ቶም ኣብ ትንፋስ ዘለዉ ነጠብጣባት ንምግታእ ይጠቅም። 	Sick people are advised to wear medical masks. Wearing a mask is useful for speaking, coughing, and controlling the number and distance of droplets in the breath.
965	en	ti	 The WHO has issued instructions on when and how to use masks. 	 መዓስን ከመይን ናይ ኣፍን ኣፍንጫን መሸፈኒ ማስክ ትጥቀም ብዝምልከት WHO መምርሒታት ኣውጺኡ። 	WHO has issued guidelines on when and how to wear a mask.
966	en	ti	" According to Stephen Griffin, a virologist at the University of Leeds, ""Wearing a mask can reduce the propensity [of] people to touch their faces, which is a major source of infection without proper hand hygiene.""Masks have also been recommended for use by those taking care of someone who may have the disease. "	 ናይ University of Leeds (ሊድስ ዩኒቨርሲቲ) ቫይሮሎጂስት ስቲፈን ግሪፊን “ብዘይጽሩያት ኣእዳው ገጽ ምትንካፍ ቀንዲ መተሓላላፊ መንግዲ ብምዃኑ፥ ማስክ ምልባስ ንሰባት ገጾም ከይተናኽፉ የተባብዖም።” ይብል። ሕሙማት ዝኣልዩ ሰባት’ውን ማስክ ክገብሩ ይምከሩ። 	University of Leeds virologist Stephen Griffin said: “Wearing a mask encourages people not to touch their faces as touching the face with unclean hands is the main route of transmission.” he says. Caregivers are also advised to wear masks.
967	en	ti	 The WHO has recommended the wearing of masks by healthy people only if they are at high risk, such as those who are caring for a person with COVID-19, although they also acknowledge that wearing masks may help people avoid touching their face. 	 WHO ዋላኳ ናይ ገጽ መሸፈኒ ማስክ ምግባር ሰባት ገጾም ንኸይንኸኡ ዝገብር ክምዝኾነ ዝኣምኑሉ ጉዳይ እተኾነ፣ ኣብ ሙሉእ ጥዕና ዝርከቡ ሰባት ፣ ከም COVID-19 ዝሓመመ ክንክን ዝገብሩ ተጋላጽነቶም ዓብዪ ኣብዝኾነሉ ጥራሕ ናይ ገጽ መሸፈኒ ማስክ ንኽገብሩ ይላበዉ። 	Although the WHO believes that wearing a face mask prevents people from touching their faces, it recommends that people in good health , such as those caring for a COVID-19 patient, wear a face mask only when their exposure is high.
968	en	ti	 Several countries have started to encourage the use of face masks by members of the public. 	 ብዙሓት ሃገራት ናይ ኣባላት ናይ ሕብረተሰብ ናይ ገጽ ማስክ ንኽጥቀሙ የበረታትዓ ኣለዋ። 	Many countries are encouraging the use of face masks by members of the public.
969	en	ti	 In the U.S., the CDC recommends wearing non-medical face mask made out of cloth.China has specifically recommended the use of disposable medical masks by healthy members of the public, particularly when coming into close contact (1 metre (3 ft) or less) with other people. 	 ኣብ U.S.፡ CDC ሕክምናዊ ዘይኮኑ ካብ ጨርቂ ዝተሰርሑ ናይ ገጽ መሸፈኒታት ምጥቃም ክብል ይላቦ። ቻይና ድማ ብፍላይ በቶም ኣብ ምሉእ ጥዕና ዝርከቡ ናይ ሕብረተሰብ ኣባላት ተጠቒምካ ዝድርበዩ ናይ ሕክምናይ መሸፈኒ ማስክታት በተልይ ካዓ ምስ ካልኦት ሰባት ኣብ ቅረባ ንኽከእ(1 ሜትር (3ፊት)ወይ ዝነኣሰ) ኣብ ጥቕሚ ነክውዕሉ ትላቦ። 	In the US, the CDC recommends the use of non-medical fabric face masks. China recommends the use of disposable medical masks, especially those used by healthy community members, especially in close contact with others (1 meter (3 feet) or less).
970	en	ti	 Hong Kong recommends wearing a surgical mask when taking public transport or staying in crowded places. 	 ሆንግ ኮንግ፣ ኣብ ህዝባዊ መጎዓዝያ ኣብ ዝኾኑሉ ሰዓት ውየድማ ኣብ ብዙሕ ህዝቢ ዝእከበሉ ቦታ ኣብ ዝኾነሉ ሰዓት፣ ናይ ስረጀሪ ማስክ ምግባር ካምዘ ድሊ ትመክር። 	Hong Kong, when on public transport and when in crowded places, Kamze Dli recommends wearing a screening mask.
971	en	ti	 Thailand's health officials are encouraging people to make cloth facemasks at home and wash them daily. 	 ክኢላታት ሕክምና ታይላንድ ሰባት ኣብ ገዛ ባዕሎም ናይ ገጽ ማስክ ክሰርሑን እናሓጸቡ ክጥቅሙሉን ኣተባቢኡ። 	Thai medical experts have encouraged people to make their own face masks at home and use them while washing.
972	en	ti	 The Czech Republic and Slovakia banned going out in public without wearing a mask or covering one's nose and mouth. 	 ቼክ ሪፐብሊክን ስሎቫኪያን ማስክ ከይገበሩ ውይድማ ኣፍን ኣፍንጫን ከይሸፈኑ ናብ ህዝባዊ ቦታት ምውጻእ ከልኪለን ኣለዋ። 	The Czech Republic and Slovakia have banned people from going out without wearing a mask or covering their mouths and noses.
973	en	ti	 On 16 March, Vietnam requested everyone to wear a face mask when going to public areas in order to protect themselves and others. 	 ኣብ ማርች 16፣ ቬትናም ኩሉ ናብ ህዝባዊ ቦታት ዝኸዱ ሰባት ዓርሶም ካልኦትን ንምሕላው ናይ ገጽ ማስክ ንኽገብሩ ጻውዒት ኣቕሪባ። 	On March 16, Vietnam called on all people going to public places to wear face masks to protect themselves and others.
974	en	ti	 The Austrian government mandated that everyone entering a grocery store must wear a face mask. 	 ናይ ኦስትሪያ መንግስቲ ዝኮነ ናብ ናይ መስተ ግሮሰሪ ዝኣቱ ሰብ ናይ ገጽን ኣፍንጫን መሸፈኒ ማስክ ክገብር ኣለዎ ክብል ኣዚዙ። 	The Austrian government has ordered that anyone entering a beverage grocery store must wear a face and nose mask.
975	en	ti	 Israel has asked all residents to wear face masks when in public. 	 እስራኤል ንኩሎም ተቀማጦ ኣብ እኩባት ናይ ገጽ ማስክ ክገብሩ ሓቲታ። 	Israel requires all residents to wear face masks in crowds.
976	en	ti	 Taiwan, which has been producing ten million masks per day since mid-March, required passengers on trains and intercity buses to wear face masks on 1 April. 	 ካብ መፋርቕ ማርች ኣትሒዛ ዓሰርተ ሚልዮን ማስክታ ንመዕልቲ ክትሰርሕ ዝጸንሐት ታይዋን ካብ 1 ኤፕሪል ንኹሎም ተሳፈርቲ ባቡራትን ናይ ከተማ ኣቶቡሳትን ማስክ ንኽገብሩ ኣገዲዳ። 	Taiwan, which has been making 10 million masks a day since mid-March, has required all train and city bus passengers to wear masks since April
977	en	ti	 Panama has made it obligatory to wear a face mask whenever going outside, while also recommending the manufacture of a homemade face mask for those who cannot purchase face masks. 	 ፓናማ ናብ ደገ ኣብ ዝውጹሉ ሰዓት ናይ ገጽ መሸፈኒ ማስክ ምግባር ኣገዳዲ ክኸውን ብምግባር፣ ነቶም ናይ ገጽ መሸፈኒ ማስክ ክገዝኡ ዘይኽእሉ ዝኾን ኣብ ገዛ ዝስራሕ ማስክ ንክሳለጥ ተላቢያ። 	Panama has made wearing a face mask mandatory when going out, and has urged homemade masks for those who cannot afford them.
978	en	ti	 Face masks have also been widely used in Japan, South Korea, Malaysia, and Singapore. 	 ናይ ገጽ መሽፈኒ ማስክታት ኣብ ጃፓን ፣ ደቡብ ኮሪያን ማሌይዢያን ሲንጋፖርን እውን ብሰፊሑ ኣብ ጥቕሚ ይውዕል ኣሎ። 	Face masks are also widely used in Japan , South Korea and Malaysia and Singapore.
979	en	ti	 Social distancing (also known as physical distancing) includes infection control actions intended to slow the spread of disease by minimizing close contact between individuals. 	 ማሕበራዊ ርሕቀት (ማለት ኣካላዊ ርሕቀት) ናይ ቀረባ ርክብ ብምውጋድ ናይ`ቲ ሕማም ዝርግሐ ንምቅናስ ዝግበር መቆጻጸሪ ተላባዕነት ዘጠቓለለ እዩ። 	Social distancing (i.e., physical distancing) includes infection control measures to reduce the spread of the disease by avoiding close contact.
980	en	ti	 Methods include quarantines; travel restrictions; and the closing of schools, workplaces, stadiums, theatres, or shopping centres. 	 ውሸባ፡ ናይ ጉዕዞ ዕገዳታት፡ ከምኡ’ውን ዕጻወ ቤት-ትምህርትታት፡ ቦታ ስራሕ፡ ስታድየም፡ ሲነማታትን ሸቀጥ ቦታታትን ገለ ካብቶም ክውሰዱ ዝክእሉ ስጉምትታት እዮም። 	Quarantine, travel restrictions, and the closure of schools, workplaces, stadiums, cinemas and shopping malls are some of the measures that can be taken.
981	en	ti	 Individuals may apply social distancing methods by staying at home, limiting travel, avoiding crowded areas, using no-contact greetings, and physically distancing themselves from others. 	 ውልቀ ሰባት ኣብ ገዛ ብምጽናሕ፡ ጉዕዞታት ብምቕንሳ፡ ናብ ሰባት ዝእከቡሉ ቦታ ካብ ምኻድ ዓርሶም ብምዕቃብ፡ ምንኽኻእ ዘይብሎም ሰላምታታት ብምልውዋጥ፡ ካብ ካልኦት ድማ ኣካልዊ ርሕቐቶም ብምሕላው ናይ ማሕበራዊ ርሕቐት መንገዲታት ከተግብሩ ይኽእሉ እዮም ። 	Individuals can implement social distancing measures by staying at home, reducing travel, avoiding public places, exchanging touch-free greetings, and maintaining physical distance from others
982	en	ti	 Many governments are now mandating or recommending social distancing in regions affected by the outbreak. 	 ብዙሓት መንግስቲታት ኣብ በቲ ለበዳ ዝተጠቕዓ ቦታት ማሕበራዊ ርሕቐት ክም ኣገዳዲ መምርሒ ኣውርዲን ኣለዋ ወይድማ ይላበዋ። 	Many governments have issued or recommend social distancing as a mandatory guideline in affected areas.
983	en	ti	 The maximum gathering size recommended by US government bodies and health organizations was swiftly reduced from 250 people (if there was no known COVID-19 spread in a region) to 50 people, and later to 10 people. 	 ብ ናይ ሕቡራት መንግስቲታት ኣሜሪካ ናይ ጥዕና ትካላትን ዝምከር ልዑል መጠን ናይ ምትእኽኻብ ካብ 250 ሰባት(ኣብ እቲ ክልል ዝተረጋገጸ ናይ COVID-19 ጉዳይ እንተዘይ ሃልዩ ) ብቕልጡፍ ናብ 50 ሰባት ክወርድ ክኢሉ እዩ፣ጽኒሑ ድማ ናብ 10 ሰባት ወሪዱ እዩ። 	The maximum crowd recommended by the US health agencies and was able to quickly drop from 250 people(unless there is a confirmed case of COVID-19 in the state ) to 50 people, and later to 10 people.
984	en	ti	" On 22 March 2020, Germany banned public gatherings of more than two people.Older adults and those with underlying medical conditions such as diabetes, heart disease, respiratory disease, hypertension, and compromised immune systems face increased risk of serious illness and complications and have been advised by the CDC to stay home as much as possible in areas of community outbreak.In late March 2020, the WHO and other health bodies began to replace the use of the term ""social distancing"" with ""physical distancing"", to clarify that the aim is to reduce physical contact while maintaining social connections, either virtually or at a distance. "	 ብ22 ማርች 2020 ጀርመን ኣብ ደገ ካብ ክልተ ሰባት ንላዕሊ ምእካብ ከልኪላ። ብዕድመ ዝደፍኡን ውሽጥዊ ሕዱር ሕማማት ከም ሽኮርያ፡ ልቢ ድኻም፡ ሕማም ምስትንፋስ፡ ጸቅጢ ደምን ድኹም ስርዓተ-ምክልኻልን ዘለዎም ሰባት ዝያዳ ክሓሙን ክጥቅዑን ይኽእሉ’ዮም። ስለዚ ብፍላይ ኮማዊ ለበዳ ኣብ ዘለወን ቦታታት ብዝተካእለ መጠን ኣብ ገዝኦም ክጸንሑ ብሲ.ዲ.ሲ. ተሓቢሮም። ኣብ መወዳእታ ማርች 2020፡ ው.ጥ.ዓ.ን ካልኦት ትካላት ጥዕና ኣብ ክንዲ “ማሕበራዊ ርሕቀት” “ኣካላዊ ርሕቀት” ምባል ጀሚሮም። ምኽንያት’ዚ ከኣ ማሕበራዊ ርክባት ብኣካል ወይ’ውን ብርሕቀት ከየቋረጽካ ኣካላዊ ምቅርራብ ምጉዳል ንምምልካት’ዩ። 	On March 22, 2020, Germany banned gatherings of more than two people outside. Older people and people with chronic internal diseases such as diabetes, heart failure, respiratory disease, high blood pressure and weakened immune systems are more likely to get sick and affected. Therefore, the CDC urges people to stay at home as much as possible, especially in areas with communal outbreaks. They were informed. In late March 2020, WTA and other health facilities began calling it “physical distancing” instead of “social distancing”. This is to indicate a lack of physical intimacy without interrupting social contacts in person or at a distance.
985	en	ti	" The use of the term ""social distancing"" had led to implications that people should engage in complete social isolation, rather than encouraging them to stay in contact with others through alternative means.Some authorities have issued sexual health guidelines for use during the pandemic. "	 ናይ “ማሕበራዊ ርሕቀት” ቃል ኣጠቓቕማ፣ ኣብክንዲ ብኻልኦት ኣማራጺታት ተተቒሞም ምስ ካልኦት ሰባት ርክቦም ዝቕጽሉ፣ ሰባት ናብ ምንጽጻል ዝብል ኣተሓሳስባ ንኽኣትዉ ገይርዎም እዩ። ገለ ሰበ ስልጣናት ናይ ጾታዊ ርክብ ጥዕና መምርሒታት ኣብ እዚ ናይ ለበዳ ኣዋን ኣብ ጥቕሚ ንኽውዕሉ ኣዚዞም። 	The use of the term “social distancing” has led people to adopt a comparative attitude instead of using other options to continue communicating with others. Some officials have ordered sexual health guidelines to be used during the pandemic.
986	en	ti	 These include recommendations to only have sex with someone you live with, who does not have the virus or symptoms of the virus. 	 ጾታዊ ርክብ ምሳኻ ምስዝቕመጥን እቲ ቫይረስ ወይ ምልክት ናይቲ ቫይረስ ዘይብሉ ሰብ ጥራይ ክኸውን ኣለዎ ኢሎም ይመኽሩ። 	They recommend that sex should only be with someone who lives with you and does not have the virus or symptoms of the virus.
987	en	ti	 Self-isolation at home has been recommended for those diagnosed with COVID-19 and those who suspect they have been infected. 	 ነቶም ብ COVID-19 ዝተለኸፉን ውይድማ ተለኺፎም ክኾን ይኽእል ኢሎም ነብሶም ዝጥርጥሩን ኣብ ገዛ ዓርሰኻ ምንጻል ዝምከር እዩ። 	Home isolation is recommended for those who are infected with COVID-19 and suspect themselves of being infected with the virus.
988	en	ti	 Health agencies have issued detailed instructions for proper self-isolation.Many governments have mandated or recommended self-quarantine for entire populations living in affected areas. 	 ናይ ጥዕና ኤጀንሲታት ን ዓርሰ ምንጻል ዝኾኑ ዝርዝር መምርሒታት ኣውጺኦም። ብዙሓት መንግስቲታት ንኹሎም ኣብ በቲ ረኽሲ ዝተጠቕዓ ቦታት ዝነብሩ ሰባት ዓርሰ ተነጽሎ ንኽገብሩ ተላብዮም እዮም ወይድማ ትእዛዝ ኣመሓላሊፎም እዮም። 	Health agencies have issued detailed guidelines for self-isolation. Many governments have recommended or ordered self-isolation for all people living in affected areas.
989	en	ti	 The strongest self-quarantine instructions have been issued to those in high risk groups. 	 እቲ ዝሓየለ ናይ ነብሰ-ዉሸባ መምርሒታት ነቶም ኣብ ልዑል ሓደጋ ዘለዉ ጉጅለታት እዩ ተኣዊጁ። 	The strongest self-quarantine guidelines have been issued for high-risk groups.
990	en	ti	 Those who may have been exposed to someone with COVID-19 and those who have recently travelled to a country or region with widespread transmission have been advised to self-quarantine for 14 days from the time of last possible exposure. 	 ሕማም COVID-19 ምስዘለዎ ሰብ ርክብ ዝንበሮምን ካብ ሕማም ብዝሒ ዘለዎ ሃገር ውይ ቦታ ብቀረባ ዝተመልሱን ካብታ ንመወዳእታ ርክብ ዝነበሮም ግዜ ኣትሒዞም ን 14 መዓልታት ኣብ ገዝኦም ክውሸቡ ይምከሩ። 	Those who have been in contact with a person with COVID-19 and have recently returned from a country or place with a high incidence of the disease are advised to undergo home quarantine for 14 days from the time of their last contact.
991	en	ti	 Strategies in the control of an outbreak are containment or suppression, and mitigation. 	 ን ለበዳ ንምቁጽጽር ዘኽእሉ ስጉምቲታት፣ ን ከይጋፍሕ ምግባር ውይድማ ምቁጽጻርን ምዝሕሓልን እዮም። 	Measures to control the outbreak are to prevent the spread of the outbreak and to slow it down.
992	en	ti	 Containment is undertaken in the early stages of the outbreak and aims to trace and isolate those infected as well as introduce other measures of infection control and vaccinations to stop the disease from spreading to the rest of the population. 	 ኣብ ናይ እቲ ለበዳ መጀመርታ ደረጃ ምግታእ ከም ስጉምቲ ተወሲዱ እዚ ድማ እቶም ዝተለኽፉ ሰባት ንምክትታልን ንምግላልን ዝዓለመ ኾይኑ፣ ነቲ ሕማም ናብ እቲ ዝተረፈ ህዝቢ ካብ ምልባዕ ጠጠው ንምባል ካልኦት ናይ ብከላ ምቁጽጻር ዘኽእሉ ስጉምትታትን ክታበታትን እውን ኣለው እዮም። 	Containment was taken in the early stages of the outbreak to monitor and isolate infected people, and there are other contamination control measures and vaccines to stop the disease from spreading to the rest of the population.
993	en	ti	 When it is no longer possible to contain the spread of the disease, efforts then move to the mitigation stage: measures are taken to slow the spread and mitigate its effects on the healthcare system and society. 	 ነቲ ናይ ቫይረስ ዝርጋሐ ምቁጽጻር ኣብ ዘይከኣለሉ ግዜ፣ እቶም ጻዕሪታት ናብ ምዝሕሓል ደረጃ ይመጹ እሞ፣ ዝውሰዱ ስጉምቲታት ትላባድነት ንምዝሓልን ኣብ'ቲ ናይ ጥዕና ክንክን ስርዓትን ኣብ ሕበረተሰብ ዘሕድሮ ጽልዋ ን ምቕናስ ዝግበሩ እዮም። 	When the spread of the virus cannot be controlled, the efforts slow down and measures are taken to slow the spread and reduce its impact on the health care system and the community.
994	en	ti	 A combination of both containment and mitigation measures may be undertaken at the same time. 	 ምቁጽጻርን ምርድዳእን ብምጥቃም ብሓንሳብ ክስራሓሉ ይከኣል’ዩ። 	It can be worked on together using control and consensus.
995	en	ti	 Suppression requires more extreme measures so as to reverse the pandemic by reducing the basic reproduction number to less than 1.Part of managing an infectious disease outbreak is trying to decrease the epidemic peak, known as flattening the epidemic curve. 	 ናይ እቲ ቫይረስ ምርባሕ ከም እቲ ንቡር ትሕቲ 1 ክኸውንን ነቲ ቫይረስ ንምጥፋእን ጽዑቕ ስጉምትታት የድልዮ። ገለ ክፋል ናይ ምቁጽጻሩ ከኣ ነቲ ጥርዚ ናይ እቲ ለበዳ ምጉዳል፡ ወይ’ውን ናይ እቲ ለበዳ ጥውዮ ምጽፋሕ ዘጠቓለለ’ዩ። 	The reproduction of the virus is normally less than 1 and requires intensive measures to eradicate the virus. Part of its control involved reducing the peak of the epidemic, or widening the curve of the epidemic.
996	en	ti	 This decreases the risk of health services being overwhelmed and provides more time for vaccines and treatments to be developed. 	 እዚ ድማ ናይ ጥዕና ግልጋሎታት ካብ ዓቕመን ንላዕሊ ዝኾነ ግልጋሎት ናይ ምሃብ ሓደጋ ብምቕናስ ክትባትን ሕክምናታትትን ንኸማዕብሉ ተወሳኺ ግዜ ዝህብ እዩ። 	This will give health services more time to develop vaccines and treatments, reducing the risk of overcapacity.
997	en	ti	 Non-pharmaceutical interventions that may manage the outbreak include personal preventive measures, such as hand hygiene, wearing face-masks, and self-quarantine; community measures aimed at physical distancing such as closing schools and cancelling mass gathering events; community engagement to encourage acceptance and participation in such interventions; as well as environmental measures such surface cleaning.More drastic actions aimed at containing the outbreak were taken in China once the severity of the outbreak became apparent, such as quarantining entire cities and imposing strict travel bans. 	 ብዘይ መድሓኒት ዝወሃቡ መከላከሊ ሜላታት ነዚ ለበዳ ኣብ ምቁጽጻር ብዙሕ ተራ ኣለወን። እዘን ሜላታት ብውልቀሰባት ክውሰዱ ዝኽእሉ ጥንቃቀታት ከም ኢድ ምሕጻብ፡ ማስክ ምልባስን ነብሰ-ውሸባን፡ ብኮም ማሕበራዊ ርሕቀት ንምሕላው ዝግበሩ ከም ዕጽዋ ቤት-ትምህርትታትን ምትእኽካብን ከምኡ’ውን ግዳማዊ ጽሬት ምሕላውን የጠቓልላ። ዝሓየለ ጥንቃቀታት ከም ዕጽዋት ከተማታትን እገዳ ጉዕዞን ከኣ ኣብ ቻይና ተጽዕኖ ናይዚ ለበዳ ምስበዝሐ ዝተወስዳ ስጉምትታት’የን። 	Drug-free preventive measures play a major role in controlling this epidemic. These techniques include precautions that can be taken by individuals such as hand washing, wearing masks and self-quarantine, social distancing by the community such as school closures and gatherings and maintaining external hygiene. Stronger precautions such as city closures and travel bans were taken as the impact of the outbreak increased in China.
998	en	ti	 Other countries also adopted a variety of measures aimed at limiting the spread of the virus. 	 ካልኦት ሃገራት’ውን ዝርግሐ ናይዚ ቫይረስ ዝገትኡ ዝተፈላለዩ መምርሒታት ይሰርሓሉ ኣለዋ። 	Other countries are also working on various guidelines to curb the spread of the virus.
999	en	ti	 South Korea introduced mass screening and localized quarantines, and issued alerts on the movements of infected individuals. 	 ደቡብ ኮሪያ ናይ ጅምላ ምጽራይን ክባቢያዊ ኳራንታይን ብምትእትታው ኣብ ናይ ውልቀ ሰባት ምንቅስቓሳት መጠንቀቕታ ኣሕሊፋ። 	South Korea has introduced mass screenings and local quarantines and issued warnings on individual movements.
1000	en	ti	 Singapore provided financial support for those infected who quarantined themselves and imposed large fines for those who failed to do so. 	 ሲንጋፖር ነቶም ዝተለኽፉን ነቶም ን ዓርሶም ኳርንታይን ዝገበሩን ናይ ገንዝብ ድጋፍ እንትትገብር ኣብ ልዕሊ እቶም ክምኡ ዘይገበሩ ድማ ክቢድ ናይ ገንዘብ ቅጽዓት ኣንቢራትሎም ኣላ። 	Singapore provides financial support to those infected and those who quarantine themselves, while imposing heavy fines on those who do not.
1001	en	ti	 Taiwan increased face mask production and penalized hoarding of medical supplies.Simulations for Great Britain and the United States show that mitigation (slowing but not stopping epidemic spread) and suppression (reversing epidemic growth) have major challenges. 	 ታይዋን ናይ ገጽ መሸፈኒ ማስክ ፍርያታት ብምውሳኽ፣ ኣብቶም ናይ ሕክምናዊ ቀረባት ዝሓብኡ ድማ ቅጽዓት ኣንቢራ። ን እንግሊዝን ን ሕቡራት መንግስቲታት ኣሜሪካን ዝምልከቱ መርእዪታት ክምዘርኣዩዎ ምዝሕሓላት (ናይቲ ለበዳ ምዝማት ዝቕንሱ ግን ጠጠው ዘየብሉ) ን ዓፈናታት(ናይ'ቲ ለበዳ ዕብየት ብ ተጻራሪ ክኸይድ ዝገብሩ) ዝበሉ ዓብይቲ ፈተናታት ክጋጥመን እዩ። 	Taiwan has increased the production of face masks and imposed penalties on those who hide medical supplies. Indicators for the UK and the US will face major challenges such as slowdowns (which reduce but do not stop the spread of the epidemic) and repressions (which reverse the growth of the epidemic).
1002	en	ti	 Optimal mitigation policies might reduce peak healthcare demand by 2/3 and deaths by half, but still result in hundreds of thousands of deaths and health systems being overwhelmed. 	 እቶም ዝተመጣጠኑ ናይ ምኽልኻል ፖሊሲታት ንጠለብ ሕክምና ብ2/3፡ መጠነ ሞት ድማ ብፍርቂ ዘግዱሉ’ዮም። እዚ ክንሱ ኣማኢት ኣሽሓት ሞትን ሕክምናታት ልዕሊ ዓቕሞም ክሰርሑን ይርአ ኣሎ። 	The balanced prevention policies reduce the demand for treatment by 2/3 and the mortality rate by half. Despite this, hundreds of thousands of deaths and treatments are overworked.
1003	en	ti	 Suppression can be preferred but needs to be maintained for as long as the virus is circulating in the human population (or until a vaccine becomes available, if that comes first), as transmission otherwise quickly rebounds when measures are relaxed. 	 ዕፋናታት ኣድላዪ ክኸውን ይኽእል እዩ፣ ግን ድማ እስካብ እቲ ቫይረስ ኣብ ውሽጢ ህዝቢታት ምዝውዋሩ ጠጠው ዘብል ክቕጽል ኣለዎ፣ (ወይድማ ከታበት እስካብ ዝርከብ፣ ቀዲሙ እንተ ብጺሑ)፣ ምኽኒያቱም ክልከላታት ክልሕልሑ ከለው እቲ ለበዳ መሊሱ ክደግስ ስለዝኽእል። 	Repression may be necessary, but it must continue until the virus stops spreading within populations (or until a vaccine is available, if it arrives earlier), because the outbreak can recur as restrictions are relaxed.
1004	en	ti	 Long-term intervention to suppress the pandemic causes social and economic costs. 	 ነዚ ለበዳ ንምቅናስ ክግበር ዘለዎ ስጉምትታት ማሕበራውን ቁጠባውን ሓስያታት ከምጽእ ይኽእል’ዩ። 	Measures to reduce the outbreak can have social and economic consequences.
1005	en	ti	 There are no specific antiviral medications approved for COVID-19, but development efforts are underway, including testing of existing medications. 	 ኣብ እዚ እዋን ኣንጻር COVID-19 ዝሰርሕ ጸረ-ቫይረስ መድሃኒት የለን፡ ግን ንምምዕባሎምን ብዝነበሩ መድሃኒታት ፈተናታት ይግበር ኣሎ። 	There are currently no antiviral drugs that work against COVID-19, but they are being developed and tested with existing drugs.
1006	en	ti	 Taking over-the-counter cold medications, drinking fluids, and resting may help alleviate symptoms. 	 ናይ ጉንፋዕ መድሃኒታት ምውሳድ፡ ፈሰስቲ ምውሳድ፡ ከምኡ’ውን ዕረፍቲ ምውሳድ ንምልክታቱ ከዕግሶ ይኽእል’ዩ። 	Taking flu medicines, fluids, and rest can help relieve symptoms.
1007	en	ti	 Depending on the severity, oxygen therapy, intravenous fluids, and breathing support may be required. 	 ኣብ መጠን ክብደት ብምድራኽ፡ ናይ ኦክስጅን ሕክምና፡ናብ ቬን ዝኣትዉ ፈሰስቲን ናይ መተፈሲ ሓገዝ ከድሊ ይኽእል እዩ። 	Depending on weight gain, oxygen therapy, intravenous fluids and ventilator assistance may be required.
1008	en	ti	 The use of steroids may worsen outcomes. 	 ናይ ስቴርዮድ ምጥቃም ውጽኢታት ከጋድድ ይኽእል እዩ። 	may exacerbate the effects of steroid abuse.
1009	en	ti	 Several compounds that were previously approved for treatment of other viral diseases are being investigated for use in treating COVID-19. 	 ንካልኦት ቫይረሳት ቅድሚ ሕጂ ዝተፈቅዱ ጸረ-ቫይረስ ምድሃኒታት ኣብ ምሕካም ኮቪድ-19 ዘለዎም ተራ ኣብ መጽናዕቲ ኣሎ። 	Previously approved antiviral drugs for other viruses are being studied for their role in treating COVID-1
1010	en	ti	" The WHO also stated that some ""traditional and home remedies"" can provide relief of the symptoms caused by SARS-CoV-19. "	" ውድብ ጥ ዕና ዓለም ""ገለ ባህላዊን ናይ ገዛ ውሽጢ ክም ምፍትሒ ሕማም ዝውሰዱ ነገራት"" ብ SARS-CoV-19 ዝተበገሱ ምልክታት ኣብ ምርሃው ተራ ክህልዎም ይኸእል እዩ ክብል ገሊጹ። "	The World Health Organization (WHO) says &quot;some traditional and home remedies&quot; may play a role in relieving symptoms caused by SARS-CoV-1
1011	en	ti	 Increasing capacity and adapting healthcare for the needs of COVID-19 patients is described by the WHO as a fundamental outbreak response measure. 	 ዓቕሚ ምዕባይን ን ናይ ጥዕና ክንክን ማእኸላት ናይ COVID-19 ሕሙማት ድልየት ብዘማልእ መልክዑ ክመዓራረዩን ምግባር WHO ብመሰረት ዝገለጾ ነቲ ለበዳ መልሲ ኣብ ምሃብ ክም ወሳኒ ንጥቢ ዝረኣይ እዮም። 	Capacity building and adapting health care facilities to meet the needs of COVID-19 patients are seen as critical points in responding to the pandemic according to WHO.
1012	en	ti	 The ECDC and the European regional office of the WHO have issued guidelines for hospitals and primary healthcare services for shifting of resources at multiple levels, including focusing laboratory services towards COVID-19 testing, cancelling elective procedures whenever possible, separating and isolating COVID-19 positive patients, and increasing intensive care capabilities by training personnel and increasing the number of available ventilators and beds. 	 ECDCን ናይ WHO ቤት-ጽሕፈት ኣብ ኤሮጳ ንሆስፒታላትን ትካላት ጥዕናን ዝምልከት መምርሒታት ሰኒዱ። ትካላት ጥዕና ኣብ ምርመራ COVID-19 ዘተኮረ ኣገልግሎት ላባራቶሪ ኣብ ምሃብ፡ ዘይህጹጽ መጥባሕቲታት ምስራዝ፡ COVID-19 ዘለዎም ሕሙማት ፈሊኻ ምሕካምን ናይ ጽዑቕ ክንክን ዓቕሚ ሰቦምን ቁጽሪ ዓራትን ቨንቲሌተራትን ክብ ኣብ ምባልን፡ ብሓጺሩ ንዘለዎም ሃብቲ ብኸመይ ይጥቀሙሉ ዝነግር ሰነድ እዩ። 	The ECDC and the WHO Office in Europe have documented guidelines for hospitals and health facilities. It is a document that summarizes how health facilities are using their resources to provide laboratory services focused on COVID-19 testing, cancel non-emergency surgeries, isolate and treat patients with COVID-19 and increase their intensive care staffing capacity and number of beds and ventilators.
1013	en	ti	 There are various theories about where the very first case (the so-called patient zero) may have originated. 	 እቲ ናይ ፈለማ ሕሙም (ማለት ሕሙም ዜሮ ተባሂሉ ዝጽዋዕ) ካበይ ከምዝተበገሰ ብዙሕ ጥርጣረታት ኣሎ። 	There is much doubt as to where the first case (i.e. referred to as patient zero) originated.
1014	en	ti	 The first known case of the novel coronavirus may trace back to 1 December 2019 in Wuhan, Hubei, China. 	 እቲ ናይ መጀመርታ ብሓድሽ ኮሮናቫይረስ ከምዝተለኽፈ ዝተፈልጠ ሰብ ኣብ ዉሃን፡ ሁበይ፡ ቻይና ብ1 ዲሰምበር 2019 ተረኪቡ። 	The first confirmed case of the new coronavirus was reported in Wuhan, Hubei, China on December 1,
1015	en	ti	 Within a month, the number of coronavirus cases in Hubei gradually increased. 	 ኣብ ውሽጢ ሓደ ወርሒ፣ ኣብ ሁበይ ዝነበረ ቁጽሪ ናይ ኮሮናቫይረስ ጉዳያት ቀስ እንዳበለ ወሲኹ። 	Within a month, the number of coronavirus cases in Hubei has slowly increased.
1016	en	ti	 These were mostly linked to the Huanan Seafood Wholesale Market, which also sold live animals, and one theory is that the virus came from one of these kinds of animals; or, in other words, has a zoonotic origin.A pneumonia cluster of unknown cause was observed on 26 December and treated by the doctor Zhang Jixian in Hubei Provincial Hospital, who informed the Wuhan Jianghan CDC on 27 December. 	 እዚኦም ምስ ናይ ሁዋናን መርካቶ ዓሳን ካልኦት እንስሳታትን ዝተኣሳሰሩ’ዮም። እዚ ቫይረስ ካብዚኦም እንስሳታትን’ዩ ነቒሉ ዝብል ሓደ ክልስሓሳብ ኣሎ። ረኽሲ ሳንቡእ ዝሓመሙ ሰባት ብ26 ታሕሳስ ብብዝሒ ብዶክተር ዣንግ ጂክሲያን ናይ ሁበይ ሆስፒታል ተራእዮም ተሓኪሞምን። እዚ ሓኪም ከኣ ብ27 ታሕሳስ ንውሃን ጂያንጋን CDC ሓቢርዎም። 	These are associated with the Huana and Mercato fish and other animals. There is a theory that the virus originated from these animals. A large number of cases of pneumonia were seen and treated by Dr. Zhang Jixian of Hubei Hospital on December 26th. The doctor informed the Wuhan and Jianggan CDC on December
1017	en	ti	" On 30 December, a group of doctors at Wuhan Central Hospital alerted their colleagues of a ""SARS-like coronavirus"". "	 ብ ዲሰምበር 30 ናይ ዉሃን ማእከላዊ ሆስፒታል ጉጅለ ሓካይም ብዛዕባ’ዚ “ንሳርስ ዝመስል ኮሮናቫይረስ” ንመሳርሕቶም ኣጠንቂቖም። 	On December 30, a team of doctors at Wuhan Central Hospital warned their colleagues about the &quot;SARS-like coronavirus.
1018	en	ti	 Eight of these doctors, including Li Wenliang, were admonished by the police for spreading false rumours, and another, Ai Fen, was reprimanded by her superiors for raising the alarm. 	 ሸሞንተ ካብዞም ሓካይም፡ ሊ ወንሊያንግ ብምጥቕላል፡ ዘይሓቀኛ ወረ ዘርጊሕኩም ብምባል ብፖሊስ ተቐጺኦም። ኣይ ፈን’ውን ንዓለም ብምሕባራ ብሓለፍታ ተቐጺኣ። 	Eight of these doctors, summed up Li Wenliang, were fined by the police for spreading untrue rumors. I Fenn was also punished by her superiors for telling the world.
1019	en	ti	 The Wuhan Municipal Health Commission later released a public notice on 31 December and informed the WHO. 	 ኣብ Wuhan Municipal Health Commission (ዉሃን ጥዕና ኮሚሽን ምምሕዳር) ድሒሩ ህዝባዊ ምልክታ ብ31 ታሕሳስ ብምውጻእ ንWHO ሓቢሩ። 	The Wuhan Municipal Health Commission later issued a public notice on December 31 informing the WHO.
1020	en	ti	 Enough cases of unknown pneumonia had been reported to health authorities in Wuhan to trigger an investigation in early January.During the early stages of the outbreak, the number of cases doubled approximately every seven and a half days. 	 ኣብ መጀመሪ ወርሒ ጃኑዋሪ ምርመራታት ንምጅማር ዘኽኣሉ እኹላት ናይ ዘይተፈልጡ ናይ ኒሞኒያ ጉዳያት ናብ ናይ ዉሃን ናይ ጥዕና ሓለፍቲ ጸብጻብ ተገይሮም ነይሮም። ኣብቶም እቲ ለበዳ ዝጀመረሎም ና መጅመሪያ ግዜያት፣ ናይ ጉዳያት ቁጽሪ ኣብ ሸውዓተን ፈረቓን መዓልቲታት ዕጽፊ ይኸውን ነይሩ። 	In early January, enough cases of unknown pneumonia were reported to Wuhan health officials to start investigations. In the early days of the outbreak, the number of cases doubled in seven and a half days.
1021	en	ti	 In early and mid-January 2020, the virus spread to other Chinese provinces, helped by the Chinese New Year migration and Wuhan being a transport hub and major rail interchange. 	 ኣብ መጀመርታን መፋርቕ-ጃንዋሪ 2020, እቲ ቫይረስ ናብ ካልኦት ናይ ቻይና ዞባታት ተላቢዑ፣ እዚ በቲ ናይ ቻይናውያን ሓድሽ ዓመት ዝግበር ጉዕዞ ኮይኑ ብ ዉሃን ድማ ናይ ትራንስፖርት ማእኸልን ናይ ዓበይቲ ባቡር መተሓላለፊ ስለዝኾነት ዝተሓገዘ እዩ። 	In early and mid-January 2020, the virus spread to other regions of China, helped by the Chinese New Year travels and Wuhan&#39;s transportation hub and major rail hub.
1022	en	ti	 On 20 January, China reported nearly 140 new cases in one day, including two people in Beijing and one in Shenzhen. 	 ኣብ 20 ጃንዋሪ፣ ቻይና፣ ክልተ ኣብ ቤጂንግ ከምኡውን ሓደ ኣብ ሸንጀን ሓዊሱ፣ ዳርጋ 140 ሓደሽቲ ጉዳያት ኣብ ሓደ መዓልቲ ኣመዝጊባ። 	On January 20, China reported nearly 140 new cases in a single day, including two in Beijing and one in Shenzhen.
1023	en	ti	 Later official data shows that 6,174 people had already developed symptoms by 20 January 2020.As of 26 March, the United States has overtaken China and Italy with the highest number of confirmed cases in the world.As of 9 April 2020, more than 1.61 million cases have been reported worldwide; more than 97,000 people have died and more than 364,000 have recovered. 	 ድሒሩ ዝመጸ ወግኣዊ ሓበሬታ ከምዘርእዮ ብ ጃኑዋሪ 20 2020 6,174 ሰባት ምልክታት የርእዩ ነይሮም። ብ ማርች 26 ሕብራት መንግስታት ብብዝሒ ናይ ሕሙማት ንቻይናን ጥልያንን በሊጻተን። ብ ኣፕሪል 9 2020 ልዕሊ 1.61 ሚልዮን ሕሙማት ብዓለም ደረጃ ተረኺቦም፥ ልዕሊ 97,000 ሰባት ሞይቶም፥ ልዕሊ 364,000 ሰባት ከኣ ሓውዮም። 	Later official data showed that as of January 20 2020, 6,174 people were showing symptoms. On March 26, the United Nations surpassed China and Italy in the number of cases. As of April 9 2020, more than 1.61 million cases have been reported worldwide, more than 97,000 people have died, and more than 364,000 people have recovered.
1024	en	ti	 Around 200 countries and territories have had at least one case. 	 ናብ 200 ዝኾኑ ሃገራት ን ክልላትን ብ ንኡሱ ሓደ ጉዳይ ኣጋጢምወን ኣሎ። 	About 200 countries and states have experienced at least one issue.
1025	en	ti	 Due to the pandemic in Europe, many countries in the Schengen Area have restricted free movement and set up border controls. 	 ብሰንኪ’ዚ ለበዳ ኣብ ኤሮጳ ብዙሓት ኣባላት ሸንገን ነጻ ምንቅስቓስ ብምክልካል ኣብ ዶባተን ሓለዋ ኣተኣታትየን። 	Because of the outbreak, many Schengen members in Europe have introduced border guards, restricting free movement.
1026	en	ti	 National reactions have included containment measures such as quarantines (known as stay-at-home orders, shelter-in-place orders, or lockdown) and curfews.As of 2 April, nearly 300 million people, or about 90% of the population, are under some form of lockdown in the United States, more than 50 million people are in lockdown in the Philippines, about 59 million people are in lockdown in South Africa, and 1.3 billion people are in lockdown in India. 	 ብሃገር ደረጃ ንምቑጽጻር ዝትግበሩ ዘለዉ ግብረመልስታት፡ ውሸባ (ማለት ኣብ ገዛ ወይ መዕቖቢኻ ምጽናሕ ወይ ምዕጻው ከተማታት) ከምኡ’ውን ቀልጢፍካ ገዛኻ ምእታው የጠቃልሉ። ካብ ዕለት 2 ሚያዝያ ኣትሒዙ ኣስታት 300 ሚልዮን፣ ወይ ከባቢ 90% ህዝቢ ሕቡራት መንግስታት፡ ኣብ ትሕቲ ገለ መልክዕ ናይ ውሸባ ነይሮም። ልዕሊ 50 ሚልዮን ሰባት ኣብ ፊሊፒንስ፡ ኣስታት 59 ሚልዮን ሰባት ኣብ ደቡብ ኣፍሪቃን 1.3 ቢልዮን ሰባት ኣብ ህንድን ኣብ ገዝኦም ተወሺቦም ኣለዉ። 	Responses being implemented to control nationally include quarantine (i.e. staying at home or in shelters or closing cities) and getting home early. Since April 2, about 300 million, or about 90% of the UN population, have been under some form of quarantine. More than 50 million people in the Philippines, about 59 million in South Africa and 1.3 billion in India are under home quarantine.
1027	en	ti	 On 26 March, 1.7 billion people worldwide were under some form of lockdown, which increased to 2.6 billion people two days later—around a third of the world's population. 	 ብ26 ማርች፡1.7 ቢልዮን ሕዝቢ ዓለም ኣብ ትሕቲ ውሸባ ነይሮም። ድሕሪ ክልተ መዓልቲ እዚ ቁጽሪ ናብ 2.6 ቢልዮን-ከባቢ ሓደ ሲሶ ሕዝቢ ዓለም ደይቡ። 	On March 26, 1.7 billion people worldwide were under quarantine. Two days later, the number rose to 2.6 billion—about one-third of the world&#39;s population.
1028	en	ti	 The first confirmed case of COVID-19 has been traced back to 1 December 2019 in Wuhan; one unconfirmed report suggests the earliest case was on 17 November. 	 እቲ ፈላማይ ናይ ኮቪድ-19 ጉዳይ ኣብ ዕለት 1 ዲሰምበር 2019 ኣብ ውሃን ተመዝጊቡ፡ ሓደ ዘይተረጋገጸ ጸብጻብ ከምዘርእዮ ግን እቲ ፈላማይ ጉዳይ ኣብ ዕለት 17 ኖቨምበር ከምዝነበረ እዩ። 	The first case of COVID-19 was registered in Wuhan on December 1, 2019, but an unconfirmed report shows that the first case was on November
1029	en	ti	 Doctor Zhang Jixian observed a cluster of pneumonia cases of unknown cause on 26 December, upon which her hospital informed Wuhan Jianghan CDC on 27 December. 	 ዶ/ር ጃንግ ጂሲያን ኣብ ዲሰምበር 26 ናይ ዝትጎጀሉ ናይ ኒሞኒያ ጉዳያት ተዓዚባ፣ እቲ ትሰርሓሉ ሆስፒታል ድማ ኣብ ዲሰምበር 27 ናብ ዉሃን ጂያንጋን CDC ጽብጻብ ገይሩ። 	Dr. Zhang Jixian observed pneumonia cases on December 26, and her hospital reported them to the Wuhan Jiang CDC on December
1030	en	ti	 Initial genetic testing of patient samples on 27 December 2019 indicated the presence of a SARS-like coronavirus. 	 ብ27 ዲሰምበር 2019 ኣብ ሕሙማት ዝተገብረ ጀነቲክ መርመራታት ምስ ሳ.ር.ስ. ዝመሳሰል ኮሮናቫይረስ ተረኺቡ። 	On December 27, 2019, genetic tests in patients were positive for SARS. a similar coronavirus was found.
1031	en	ti	 A public notice was released by Wuhan Municipal Health Commission on 31 December. 	 ኣብ ዲሰምበር 31 ብ ናይ ውሃን ሙኒሲፓል ናይ ጥዕና ኮሚሽነር ህዝባዊ መግለጺ ሂቦም። 	On December 31, the Wuhan Municipal Health Commissioner made a public statement.
1032	en	ti	 The WHO was informed on the same day. 	 WHO ኣብ ተመሳሳሊ መዓልቲ እዩ ሓበሬታ ረኺቡ። 	WHO received the information on the same day.
1033	en	ti	" As these notifications occurred, doctors in Wuhan were warned by police for ""spreading rumours"" about the outbreak. "	" እዞም መግለጺታት ኣብ ዝወጹሉ ሰዓት ኣብ ዉሃን ዝርከቡ ዶክተራት ""ወረ ትንዝሑ ኣለኹም"" ተባሂሎም ብ ፖሊስ መጠንቀቕታ በጺሑዎም እዩ። "	At the time of these statements, doctors in Wuhan had received a police warning that they were &quot;spreading rumors.
1034	en	ti	" The Chinese National Health Commission initially claimed that there was no ""clear evidence"" of human-to-human transmission. "	 ቻይናዊ ሃገራዊ ኮሚሽን ጥዕና ኣቐዲሙ ንጹር መርትዖ ናይ ካብ ሰብ ናብ ሰብ ምትሕልላፍ ከምዘየለ’ዩ ተዛሪቡ። 	China&#39;s National Health Commission had previously said there was no clear evidence of human-to-human transmission.
1035	en	ti	" In late January, the Chinese government launched a radical campaign later described by the Chinese Communist Party general secretary Xi Jinping as a ""people's war"" to contain the spread of the virus. "	" ኣብ መጨረሻ ጃኑዋሪ፣ ናይ ቻይና መንግስቲ ነቲ ቫይረስ ንምቁጽጻር ዝዓለመ፣ ደሓር ድማ ብ ናይ እቲ ኮሙኒስት ፓርቲ ዋና ጸሓፊ ሲጂፒንግ ዝተገለጸ ""ናይ ህዝቢታት ኩናት"" ዝብል ስያመ ዝተውሃቦ ጎስጓስ ኣበጊሱ ኣሎ። "	In late January, the Chinese government launched a campaign aimed at controlling the virus, later described by Communist Party Secretary-General Xi Jinping as a &quot;war of peoples.
1036	en	ti	" In what has been described as ""the largest quarantine in human history"", a cordon sanitaire was announced on 23 January stopping travel in and out of Wuhan, which was extended to a total of 15 cities in Hubei, affecting a total of about 57 million people. "	" እቲ ""ኣብ ታሪኽ ወዲ ሰብ እቲ ዝዓበየ ውሻበ"" ተባሂሉ ዝተገልጸ፣ ክሊሓለዋ ንጽሕና ኣብ ጃኑዋሪ 23 ተኣዊጁ፣ ካብን ናብን ውሃን ዝግበር ጉዕዞ ጠተው ኣቢሉ፣ እዚ ድማ ናብ ጠቕላላ 15 ከተማታት ሁበይ ተስፋሕፊሑ፣ ብሰንኩ ድማ ኣብ 57 ሚሊዮን ህዝቢ ጽልዋ ኣሕዲሩ። "	The so-called &quot;greatest quarantine in human history&quot; was declared on January 23, suspending travel to and from Wuhan, which spread to a total of 15 cities in Hubei, affecting 57 million people.
1037	en	ti	 Private vehicle use was banned in the city. 	 ኣብታ ከተማ ናይ ውልቀ መኪና ምጥቃም ተኸልኪሉ ነይሩ እዩ። 	The use of private vehicles was prohibited in the city.
1038	en	ti	 Chinese New Year (25 January) celebrations were cancelled in many places. 	 ናይ ቻይና ሓዱሽ ዓመት(ጃኑዋሪ 25) ጽብላት ኣብ ብዙሓት ቦታታት ተሰሪዞም እዮም። 	Chinese New Year(January 25) celebrations have been canceled in many places.
1039	en	ti	 The authorities also announced the construction of a temporary hospital, Huoshenshan Hospital, which was completed in 10 days. 	 ኣብ ውሽጢ 10 መዓልታት ዝተሓንጸ ሁዎሸንሻን ሆስፒታል ዝተበሃለ ግዝያዊ ሆስፒታል ተሰሪሑ ከምዝተወድአ ሰበስልጣናት ሓቢሮም። 	The Huoshenshan Hospital, a makeshift hospital, was completed within 10 days, officials said.
1040	en	ti	 Another hospital was built afterwards, Leishenshan Hospital, to handle additional patients. 	 ዓቕሚ ናይ ሕሙማት ምቅባል ንምድንፋዕ ተባሂሉ ደሓር ካልኣይ ሆስፒታል፡ ለይሸንሻን ሆስፒታል፡ ተሰሪሑ። 	A second hospital, Leishenshan Hospital, was later built to increase patient reception capacity.
1041	en	ti	 In addition to newly constructed hospitals, China also converted 14 other facilities in Wuhan, such as convention centers and stadiums, into temporary hospitals.On 26 January, the government instituted further measures to contain the COVID-19 outbreak, including issuing health declarations for travellers and extending the Spring Festival holiday. 	 ካብቶም ሓደስቲ ዝተሰርሑ ሆስፒታላት ብተወሳኺ፣ ቻይና ካልኦት 14 ኣብ ዉሃን ዝርከቡ ናይ መአከቢ ኣዳራሻትን ስታዲየማትን ዝኣምሰሉ ናይ ግልጋሎት ቦታታት ናብ ጊዜያዊ ሆስፒታላት ቀዪራቶም እያ። ኣብ ጃኑዋሪ 26፣ እቲ መንግስቲ ካልኦት ናይ COVID-19 ለብዳ ንምቁጽጻር የኽእሉ እዮም ዝበሎም ክም ን ተጉዓዝቲ ዝምልከቱ ናይ ጥዕና ኣዋጃት ምእዋጅ ዝበሉን ናይ ስፕሪንግ ፌስቲቫላት ምንዋሕ ዝበሉን ስጉምቲታት ወሲዱ እዩ። 	In addition to the newly built hospitals, China has converted 14 other service areas in Wuhan, such as assembly halls and stadiums, into temporary hospitals. On January 26, the government took other measures it said would help control the COVID-19 outbreak, such as issuing health declarations for travelers and extending the spring festivals.
1042	en	ti	 Universities and schools around the country were also closed. 	 ኣብ መላእ እታ ሃገር ዝርከቡ ዩኒቨርሲቲታትን ቤት ትምህርቲታትን እውን ተዓጽየን እየን። 	Universities and schools across the country were also closed.
1043	en	ti	 The regions of Hong Kong and Macau instituted several measures, particularly in regard to schools and universities. 	 ናይ ሆንግ ኮንግ ክልላትን ማኩን ብዙሓት ብፍላይ ድማ ምስ ቤት ትምህርቲታትን ዩኒቨርሲቲታትን ብዝተትሓሓዘ ስጉምቲታት ወሲዶም እዮም፡ ። 	The Hong Kong and Macku regions have taken many measures, especially in relation to schools and universities.
1044	en	ti	 Remote working measures were instituted in several Chinese regions. 	 ኣብ ቻይና ኣብ ውሱናት ቦታታት ብርሕቀት ናይ ምስራሕ ስጉምትታት ተኣታትዮም። 	In China, remote working measures were introduced in limited locations.
1045	en	ti	 Travel restrictions were enacted in and outside of Hubei. 	 ካብ ናብን ሁበይ ዝካየዱ ጉዕዞታት እግዳታት ተነቢሩሎም እዩ። 	Travel to and from Hubei has been restricted.
1046	en	ti	 Public transport was modified, and museums throughout China were temporarily closed. 	 ህዝባዊ ትራንፖርት ተመሓይሹ፡ ከምኡ’ውን ቤተ-መዘክራት ንግዚኡ ኣብ ቻይና ተዓጽየን። 	Public transportation was improved, and museums were temporarily closed in China.
1047	en	ti	" Control of public movement was applied in many cities, and it has been estimated that about 760 million people (more than half the population) faced some form of outdoor restriction.After the outbreak entered its global phase in March, Chinese authorities took strict measures to prevent the virus from ""importing"" from other countries. "	" ናይ ህዝባዊ ምንቅስቓሳት ቁጽጽር ኣብ ኣብዝሓ ከተማታት ተግባራዊ ዝኾነ እዩ፡ ከባቢ 760 ሚልዮን ሰባት ድማ (ፈርቂ ናይ ህዝቢ ብዝሓት) ገለ ዓይነት ናይ ደገ ክልከላታት ዝገጠሞሞ እዮም። እዚ ለበዳ ቅድሚ ኣብ ማርች ናብ ዓለምለኻዊ ደረጃ ምእታው፣ ናይ ቻይና ሰበ ስልጣናት እቲ ቫይረስ ""ካብ ካል ኦት ሃገራት ከይኣትዎም"" ጥቡቕ ስጉምቲታት ወሲዶም እዮም። "	Controls on public movements are in place in most cities, and about 760 million people (half the population) face some form of external restrictions. Before the outbreak went global in March, Chinese authorities took strict measures to prevent the virus from &quot;entering them from other countries.
1048	en	ti	 For example, Beijing has imposed a 14-day mandatory quarantine for all international travellers entering the city.On 23 March, mainland China only one case had transmitted domestically in the five days prior, in this instance via a traveller returning to Guangzhou from Istanbul. 	 ንምሳሌ፣ ቤጂንግ ን ኹሎም ናብታ ከተማ ዝኣትዉ ዓለምለኻዊ ተጉዓዝቲ 14 መዓልቲ ኣብ ኳራንታይን ጻንሒት ዓቀሚጣ ኣላ። ኣብ ማርች 23፣ ኣብ ሜይን ላንድ ቻይና ኣብ ውሽጢ ሓሙሽተ መዓልቲታት ሓደ ጉዳይ ጥራሕ እዩ ኣብ ሃገር ውሽጢ ምምሕልላፋት ተረኹቡዋ እሱ ድማ ሓድ ካብ ኢስታንቡል ናብ ጓዋንግጁ ዝተመልሰ ወልቀ ሰብ እዩ ነየሩ። 	For example, Beijing has imposed a 14-day quarantine period for all international travelers entering the city. On March 23, Mainland China received only one case of domestic transmissions in five days, an individual who had returned to Guangzhou from Istanbul.
1049	en	ti	 On 24 March 2020, Chinese Premier Li Keqiang reported that the spread of domestically transmitted cases has been basically blocked and the outbreak has been controlled in China. 	 ኣብ ማርች 24 2020፣ ናይ ቻይና ቀዳማይ ሚኒስተር ሊ ከቺያንግ፣ ናይ እቲ ቫይረስ ኣብ ሃገር ውሽጢ ዘሎ ምግፋሕ ብ መሰራታዊነት ጠጠው ክምዝበለን እቲ ለበዳ ኣብ ቻይና ኣብ ትሕቲ ቑጽጽር ክምዝወዓለ ኣፍሊጦም። 	On March 24 2020, Chinese Premier Li Keqiang announced that the domestic spread of the virus had been fundamentally halted and the outbreak was under control in China.
1050	en	ti	 The same day travel restrictions were eased in Hubei, apart from Wuhan, two months after the lockdown was imposed.The Chinese Ministry of Foreign Affairs announced on 26 March 2020 that entry for visa or residence permit holders would be suspended from 28 March onwards, with no specific details on when this policy will end. 	 ካብ ዉሃን ወጻኢ፣ካብ እቲ ምዕጻው ዝትግበር፣ ድሕሪ ክልተ ወርሒ፣ ኣብ ተመሳሳሊ መዓልቲ ኣብ ሁበይ ዝነበሩ ናይ ጉዕዞ እገዳታት ክቐሉ ተገይሮም እዮም፣ ናይ ቻይና ወጻኢ ጉዳያት ሚኒስትር ኣብ ማርች 26 2020 ከምዘፍለጦ ካብ ማርች 28 ጀሚሩ፣ ኩሎም ቪዛ ዘለዎም ይኹኑ ናይ መንበሪ ፍቓድ ዘለዎም ዝገብሩዎም ምእታዋት ክምዝተቛረጹ ብምግላጽ፣ እዚ ፖሊሲ እዚ መዓስ ከምዘብቅዕ ግን ዝርዝር ሓበሬታ ኣይሃቡን። 	Outside of Wuhan, two months after the closure, travel restrictions in Hubei were lifted on the same day, with effect from March 28, the Chinese Foreign Minister announced on March 26 2020, making all visa holders and residence permit holders He said admissions had been suspended, but did not provide details on when the policy would end.
1051	en	ti	 Those who wish to enter China will have to apply for visas in Chinese embassies or consulates. 	 እቶም ናብ ቻይና ንምእታው ዝደልዩ ናብ ቻይና ኤምባሲታትን ቆንስላታትን ናይ ቪዛ ሕቶ ከቕርቡ ኣለዎም። 	Those who wish to enter China must apply for a visa to Chinese embassies and consulates.
1052	en	ti	 The Chinese government encouraged businesses and factories to re-open on 30 March, and provided monetary stimulus packages for firms.The State Council declared a day of mourning to begin with a national three-minute moment of silence on 10:00 4 April, coinciding with Qingming Festival, although the central government asked families to pay their respects online in observance of physical distancing as to avoid a renewed COVID-19 outbreak. 	 መንግስቲ ቻይና ፋብሪካታትን ትካላት ንግድን ብዕለት 30 ማርች ክኸፍታ ፋይናንስያዊ ደገፍ ብምሃብ ኣተባቢዑ። 4 ኤፕሪል ሰዓት 10፤00ናይ ሰለስተ ደቓይቕ ጸጥታ ክትፍለምን መዓልቲ ሓዘን ክትከውንን ብሃገራዊ ቆንስል ተኣዊጁ። ዳግማይ ምልዓል ናይ ኮቪድ-19 ከየምጽእ ስግኣታት ስለዘሎ ግን ማእከላይ መንግስቲ ንስድራቤታት ማሕበራዊ ርሕቀት ንምሕላው ሓዘኖም ብመርበብ ኢንተርኔት ክገልጹ ተመሃጺኑ። 	The Chinese government has encouraged factories and businesses to reopen on March 30 by providing financial support. A three-minute silence will be observed at 10:00 am on April 4 and a day of mourning will be declared by the National Consulate. But as there are fears of a resurgence of the virus, the central government has urged families to express their grief online to maintain social distance.
1053	en	ti	 COVID-19 was confirmed to have spread to South Korea on 20 January 2020 from China. 	 ኮቪድ-19 ናብ ደቡብ ኮሪያ ጃኑዋሪ 20 2020 ካብ ቻይና ክምዝተዛመተ ተረጋጊጹ እዩ። 	COVID-19 was confirmed to have spread to South Korea on January 20 2020 from China.
1054	en	ti	 The nation's health agency reported a significant increase in confirmed cases on 20 February, largely attributed to a gathering in Daegu of a new religious movement known as the Shincheonji Church of Jesus. 	 ናይ እታ ሃገር ናይ ጥዕና ኤጀንሲ ክምዝሓበሮ ብሰንኪ ኣብ ዴይጉ ዝነበረ ሺንቺዮንጂ ናይ እየሱስ ቤተ ክርስቲያን ዝበሃል ናይ ሓዱሽ ሃይማኖታዊ ምትእኽኻብ፣ ኣብ ፈብሩዋሪ 20 ዝተረጋገጹ ጉዳያት በድንቢ ወሲኾም ተራእዮም እዮም። 	The country&#39;s health agency said there was a sharp increase in confirmed cases on February 20 due to a new religious gathering called the Shincheonji Church of Jesus in Daegu.
1055	en	ti	 Shincheonji devotees visiting Daegu from Wuhan were suspected to be the origin of the outbreak. 	 ካብ ዉሃን ንደይጎ ዝበጽሑ ኣመንቲ ሺንቸንጂ ጠንቂ መበገሲ ናይዚ ለበዳ’ዮም ዝብል ጥርጣረታት ኣሎ። 	Shinchenji believers who visited Daigo from Wuhan are suspected of being responsible for the outbreak.
1056	en	ti	 As of 22 February, among 9,336 followers of the church, 1,261 or about 13% reported symptoms.South Korea declared the highest level of alert on 23 February 2020. 	 ካብ ፌብሩዋሪ 22 ጀሚሩ፡ ካብ 9,336 ተኸተልቲ ቤተክርስትያን፡ 1,261 ወይ ድማ 13% ናይ ሕማም ምልክታት ከምዘለዎም ሓቢሮም። ደቡብ ኮርያ ኣብ ዝለዓለ ናይ ጥንቃቀ ግዜ ከም ዘላ ብ23 ለ ፌብሩዋሪ 2020 ኣዊጃ። 	As of Feb. 22, 1,261, or 13%, of 9,336 churchgoers reported symptoms. South Korea declared a state of emergency on 23 b February
1057	en	ti	 On 28 February, more than 2,000 confirmed cases were reported in Korea, rising to 3,150 on 29 February. 	 ብ28 ፌብሩዋሪ ልዕሊ 2,000 ዝተረጋገጹ ሕሙማት ኣብ ኮርያ ተመዝጊቦም። ብ29 ፌብሩዋሪ ከዓ 3,150 በጺሖም። 	On February 28, more than 2,000 confirmed cases were registered in Korea. On February 29, they reached 3,1
1058	en	ti	 All South Korean military bases were quarantined after tests confirmed that three soldiers were positive for the virus. 	 ሰለስተ ወተሃደራት ደቡብ ኮርያ ብመርመራ ቫይረስ ምስ ተረኽቦም ኩሎም ወተሃደራዊ መዓስከራት ደቡብ ኮርያ ኣብ ትሕቲ ውሸባ ኣትዮም። 	All South Korean military bases have been placed under quarantine after three South Korean soldiers tested positive for the virus.
1059	en	ti	 Airline schedules were also affected and therefore they were changed.South Korea introduced what was considered the largest and best-organized programme in the world to screen the population for the virus, and isolate any infected people as well as tracing and quarantining those who contacted them. 	 ናይ መንገዲ ኣየር መደባት እውን ብዝበጽሖም ጽልዋ ተቐዪሮም እዮም። ደቡብ ኮሪያ ኣብ ዓለም እቲ ዝዓበዬን ብሉጽ ዝተወደበ ኣብ ሕዝቢታት ዝግበር ናይ እቲ ቫይረስ ናይ ምጽራይ ምርመራ ምግባርን እቶም በቲ ቫይረስ ዝተጠቕዑ ድማ ተፈልዮም ዝቕመጡሉን ምስ እቶም ዝሓመሙ ርክብ ዝነበሮም ሰባት ኣስር ደሊኻ ናይ ምርካብን ኣብ ምፍላይ ተመኩሮ ኣተኣታትያ ኣያ። 	Airline schedules have also been affected. South Korea has introduced the world&#39;s largest and best-organized population-based screening for the virus, where those infected are isolated and traced to those who have been in contact with the infected.
1060	en	ti	 Screening methods included mandatory self-reporting of symptoms by new international arrivals through mobile application, drive-thru testing for the virus with the results available the next day, and increasing testing capability to allow up to 20,000 people to be tested every day. 	 እቶም ናይ ምጽራይ መንገዲታታ ኣገደስቲ ዝኾኑ ሓደሽቲ ዓለምለኻዊ በጻሕቲ ክግበሩ ዘለዎም ብ ሞባይል መተግበሪ ዝፍጸሙ ናይ ምልክታት ዓርሰ-ጥቆማታት፡ ምርመራ ኣብ ዝተገብረ ኣብ ቀጻሊ መዓልቲ ውጽኢቶም ዝበጽሕ ን ናይ መዓልታዊ ዝግበር ናይ ምምርማር ዓቕሚ ድማ ናብ 20000 ክብ ክብል ዝገብሩ ናይ ጎዳና ኣብ መኪና ከለዉ ዝግበሩ ምርመራታት ዘጠቓልል እዩ። 	Its screening methods include mobile-based self-reports of signs that are important for new international visitors, roadside in-car screenings that deliver results the next day when tested and increase daily screening capacity to 20,0 is.
1061	en	ti	 South Korea's programme is considered to be a success in controlling the outbreak despite not quarantining entire cities.The South Korean society was initially polarized on President Moon Jae-in's response to the crisis. 	 ደቡብ ኮርያ ነዚ ለበዳ ንምቁጽጻር ዝወጠነቶ መደብ፡ ዋላ’ውን ብሃገር ደረጃ ውሸባ እንተዝይተገብረ፡ ክም ዕዉት’ዩ ዝሕሰብ። ሕብረተሰብ ደቡብ ኮርያ ብናይ ፕረዚደንት ሙን ጀይ-ኢን ግብረመልሲ ኣብዚ ግዚ ቕልውላው መጀመርያ ተሓጒሶም። 	South Korea&#39;s plan to contain the outbreak is considered successful, even without a national quarantine. South Korean society was initially pleased with President Moon Jae-in&#39;s response to the crisis.
1062	en	ti	 Many Koreans signed petitions either calling for the impeachment of Moon over what they claimed to be government mishandling of the outbreak, or praising his response. 	 ኣብዝሓ ኮርያውያን ወይ ብምኽኒያት መንግስቲ ነቲ ለበዳ ዝሓዘሉ መንገዲ ን ሙን ብምኽሳስ፣ ውይድማ ብምውዳስ ናይ ፊርማ ምትእኽኻብ ኣብ ምግባር ይርከቡ። 	Most Koreans are collecting signatures either accusing Moon of the government&#39;s handling of the outbreak or praising him.
1063	en	ti	 On 23 March, it was reported that South Korea had the lowest one-day case total in four weeks. 	 ኣብ ማርች 23፣ ደቡብ ኮሪያ ኣብ ውሽጢ ኣርባዕተ ሰሙናት እቲ ዝተሓተ መዓልታዊ ጉዳያት ጽብጻብ ገይራ። 	On March 23, South Korea reported the lowest daily cases in four weeks.
1064	en	ti	 On 29 March it was reported that beginning 1 April all new overseas arrivals will be quarantined for two weeks. 	 ብ29 ማርች፡ ካብ 1 ሚያዝያ ጀሚሩ ኩሎም ሓደሽቲ ወጻእተኛታት በጻሕቲ ንክልተ ሰሙን ከምዝውሸቡ ተሓቢሩ። 	On March 29, it was announced that all new foreign visitors would be quarantined for two weeks from April
1065	en	ti	 Per media reports on 1 April, South Korea has received requests for virus testing assistance from 121 different countries. 	 ብመሰረት ኣብ ኣፕሪል 1 ዝወጹ ናይ ሚድያ ጸብጻባት፣ ደቡብ ኮሪያ ካብ 121 ዝተፈላለያ ሃገራት ናይ ምርመራ ሓገዝ ንኽትገብር ተሓቲታ። 	According to media reports on April 1, South Korea has been asked for investigative assistance from 121 different countries.
1066	en	ti	 Iran reported its first confirmed cases of SARS-CoV-2 infections on 19 February in Qom, where, according to the Ministry of Health and Medical Education, two people died later that day. 	 ኢራን እቲ ኣብ ኮም ዝተረኸበ ናይ መጀምሪያ ዝተረጋገጸ ናይ SARS-CoV-2 ጉዳይ ኣብ ፌብሩዋሪ 19 ዕላው ገይራ፣ ድሕሪኡ ድማ ከም ናይ ጥዕና ሚኒስተርን ሕክምናዊ ትምህርቲን፣ ኣብታ መዓልቲ ክልተ ሰባት ሞይቶም። 	Iran announced the first confirmed case of SARS-CoV-2 in Com on February 19, and then, according to the Minister of Health and Medical Education, two people died that day.
1067	en	ti	 Early measures announced by the government included the cancellation of concerts and other cultural events, sporting events, and Friday prayers, and closures of universities, higher education institutions, and schools. 	 ካብቶም ኣቐዲሞም ብመንግስቲ ዝተወሰዱ ስጉምቲታት ውሽጢ ፡ ኮንሰርታትን ባህላዊ ምርኢታት፡ ናይ ዓርቢ ጸሎት መደባት ስረዛ፡ ናይ ዩኒቨርስቲታት ፡ ላዕለዎት ናይ ትምህርቲ ትካላትን ቤት ትምህርቲታት ድማ ምዕጻው ፡ ዘጠቓልል እዩ። 	Among the previous measures taken by the government , are the cancellation of concerts and cultural performances, Friday prayer programs, and the closure of universities , higher education institutions and schools
1068	en	ti	 Iran allocated five trillion rials to combat the virus. 	 ኢራን ነቲ ቫይረስ ንምውጋእ ሓሙሽተ ትሪልዮን ሪያል መዲባ ኣላ። 	Iran has allocated five trillion riyals to fight the virus.
1069	en	ti	 President Hassan Rouhani said on 26 February 2020 that there were no plans to quarantine areas affected by the outbreak, and only individuals would be quarantined. 	 ፕረዚደንት ሃሳን ሩሃኒ ብ 26 ፌብሩዋሪ 2020 ውልቀሰባት እምበር በዚ ለበዳ ንዝተተንከፉ ቦታታት ናይ ምውሻብ መደባት ከምዘየለ ሓቢሩ። 	President Hassan Rouhani said on February 26, 2020 that there are no plans to quarantine affected areas but individuals.
1070	en	ti	 Plans to limit travel between cities were announced in March, although heavy traffic between cities ahead of the Persian New Year Nowruz continued. 	 ኣብ መንጎ ከተማታት ዝግበር ጉዕዞ ንኽውሰን ዝገብሩ መዳባት ኣብ ወርሒ ማርች ዕላው ተገርይሮም ይኹን ደኣምበር ኣብ መንጎ ከተማታት ዝግበር ጽዑቕ ናይ ትራፊክ ምንቅስቓሳት ካብ ናይ ፐርሺያ ሕዱሽ ዓመት ኣቐዲሙ ክካየድ ጸኒሑ እዩ። 	Intercity travel restrictions were announced in March, but heavy intercity traffic has been occurring before the Persian New Year.
1071	en	ti	 Shia shrines in Qom remained open to pilgrims until 16 March 2020.Iran became a centre of the spread of the virus after China during February. 	 ኣብ ቆም ዝርከቡ ናይ ሽያ ታቦታት ንኣመንቲ ክሳብ 16 ማርች 2020 ተኸፊተን ክጸንሓ’የን። ኣብ ወርሒ ፌብሩዋሪ ኢራን ከም ማእከል ናይ እቲ ለበዳ ብምዃን ድሕሪ ቻይና ክትስራዕ ክኢላ። 	Shia shrines in Qom will remain open to believers until March 16, In February, Iran became the epicenter of the outbreak, second only to China.
1072	en	ti	 Amidst claims of a cover-up of the extent of the outbreak in Iran, more than ten countries had traced their cases back to Iran by 28 February, indicating that the extent of the outbreak may be more severe than the 388 cases reported by the Iranian government by that date. 	 ድሕሪ ብዛዕባ ኣብ ኢራን ዘሎ ለበዳ ዝተገብረ ምሽፈፋን ዝተገብረ ስምዕታታት፣ ኣብ ፌብሩዋሪ 28 ካብ ዓሰርተ ንላዕሊ ዝኾና ሃገራት ናይ ጉዳያተን ኣሰር ናብ ኢራን ወሲዳናኦ ኣለዋ ፣ እዚ ድማ ናይ እቲ ለበዳ ዝርጋሐ ካብቲ ብ ናይ ኢራን መንግስቲ ዝተጠቐሰ 388 ጉዳያት ንላዕሊ ክምዝኾን ዘርኣየ እዩ። 	Following the cover-up and sentiments about the outbreak in Iran, on February 28 more than a dozen countries took their case traces to Iran , indicating that the spread of the outbreak is higher than the 388 cases cited by the Iranian government.
1073	en	ti	 The Iranian Parliament was shut down, with 23 of its 290 members reported to have had tested positive for the virus on 3 March. 	 ፓርላማ ኢራን ስርሑ ኣቋሪጹ።23 ካብቶም 290 ኣባላቱ በቲ ቫይረስ ከምዝተለኽፉ ብዕለት 3 ማርች ብመርመራ ተረጋጊጹ። 	Iran&#39;s parliament has suspended its work. 23 of its 290 members tested positive for the virus on March
1074	en	ti	 On 12 March, the Human Rights Watch urged the Iranian prison authorities to unconditionally release the human rights defenders detained for peaceful dissent, and to also temporarily release all the eligible prisoners. 	 ኣብ ማርች 12፡ ሁማን ራይት ዎች፡ ን ናይ ኢራን እስርቤት ሓለፍቲ፡ ብዘይ ዝኾነ ይኹን ቅድመ ኹነት ንቶም ናይ ሓሳብ ፍልልዮም ብ ሰለማዊ መንገዲ ብ ብምግላጾም ዝተኣሰሩ ሰባት ንኽትፈትሕን፡ እቶም ካልኦት ዝምልከቶም እስረኛታት እውን ብ ጊዜያዊነት ን ኽፈትሑ ሓቲቶም። 	On March 12, Human Rights Watch called on Iranian prison authorities to unconditionally release those arrested for peacefully expressing their differences of opinion and to temporarily release other prisoners.
1075	en	ti	 It stated that there is a greater risk of the virus to spread in closed institutions like detention centres, which also lack adequate medical care. 	 ኣብ ከም እሰር ቤታት ዝበሉ እኹል ሕክምናዊ ክንክን ዘይብሎም ዕጹዋት ትካላት ናይ እቲ ቫይረስ ናይ ምግፋሕ ሓደጋ ዝዓበየ ክምዝኾን የቐምጥ። 	It states that the risk of spreading the virus is greatest in closed institutions without adequate medical care, such as prisons.
1076	en	ti	 On 15 March, the Iranian government reported 100 deaths in a single day, the most recorded in the country since the outbreak began. 	 ብ ማርች 15 መንገስቲ ኢራን 100 ሰባት ብሓንቲ መዓልቲ ከምዝሞቱ ሓቢራ። እዚ ከኣ ካብ ምጅማር ለበዳ ኣትሒዙ ዝበዝሐ ቁጽሪ ምዃኑ’ዩ። 	On March 15, the Iranian monarchy reported 100 deaths in a single day. That&#39;s the highest number since the outbreak began.
1077	en	ti	 At least 12 sitting or former Iranian politicians and government officials had died from the disease by 17 March. 	 ብውሕዱ 12 ኣብ ስልጣን ዘለዉ ዋላ ነበር ኢራናውያን ፖለቲካውያንን ሰበስልጣንን ብሰንኪ እቲ ሕማም ከምዝሞቱ ብ17 ማርች ተሓቢሩ። 	At least 12 incumbent and even former Iranian politicians and officials have died of the disease, it was reported on March
1078	en	ti	 By 23 March, Iran was experiencing 50 new cases every hour and one new death every ten minutes due to coronavirus. 	 ብ23 ማርች ኣብ ኢራን ብምኽንያት ኮሮናቫይረስ፡ኣብ ሰዓት 50 ሓደሽቲ ሕሙማት ከምኡ’ውን ሀደ ሓድሽ ሞት ኣኣብ ሰርተ ደቓይቕን ተራእዩ። 	On March 23, Iran reported 50 new cases per hour and one new death in seventeen minutes due to the coronavirus.
1079	en	ti	 According to a WHO official, there may be five times more cases in Iran than what is being reported. 	 ወኪል WHO ብዝሓበሮ ኣብ ኢራን ብዝሒ ሕሙማት ካብ እቲ ብወግዒ ዝተሓበረ ብሓሙሽተ ዕጽፊ ዝዛየደ ክኸውን ይኽእል’ዩ። 	A WHO representative said the number of cases in Iran may be five times higher than officially reported.
1080	en	ti	 It is also suggested that U.S. sanctions on Iran may be affecting the country's financial ability to respond to the viral outbreak. 	 ብተወሳኺ ድማ እቲ ብ ኣሜሪካ ኣብ ልዕሊ ኢራን ዝተገብረ ማዕቀብ፣ ናይ እታ ሃገር ናይ እቲ ቫይረስ ላብዕ ንምቁጽጻር ቁጠባዊ ክእለት ኣዝዩ ይጸልዎ ከምዘሎ ተገሊጹ። 	In addition, the US sanctions against Iran are severely affecting the country&#39;s economic ability to control the outbreak.
1081	en	ti	 The UN High Commissioner for Human Rights has demanded economic sanctions to be eased for nations most affected by the pandemic, including Iran. 	 ናይ UN ናይ ሰብኣዊ መሰላት ላዕለዋይ ኮሚሽነር ን ኢራን ሓዊሱ በቲ ለበዳ ዝተጠቕዓ ሃገራት ዘለወን ኢኮኖሚያዊ ማዕቀብ ንክቐለለን ጻውዒት ኣቕሪቦም። 	The UN High Commissioner for Human Rights has called for the easing of economic sanctions on countries affected by the outbreak, including Iran.
1082	en	ti	 The outbreak was confirmed to have spread to Italy on 31 January, when two Chinese tourists tested positive for SARS-CoV-2 in Rome. 	 እቲ ለበዳ ናብ ጥልያን ብዕለት 31 ጃኑዋሪ ከምዝኣተወ፡ ድሕሪ ብመርመራ ሳርስ-ኮቭ-2 ዝተረኽቦም ክልተ ቻይናውያን በጻሕቲ ሮም ተረጋጊጹ። 	The outbreak entered Italy on January 31 after two Chinese tourists tested positive for SARS-CoV-2 in Rome.
1083	en	ti	 Cases began to rise sharply, which prompted the Italian government to suspend all flights to and from China and declare a state of emergency. 	 ጉዳያት ብ ፍጥነት ክ ወስኹ ምስጀምሩ፣ ናይ ጣልያን መንግስቲ ኩሎም ናብ ቻይና ዝግበሩ ናይ ኣየር በረራታት ጠጠው ክብሉ ብምግባር ናይ ሕጹጽ ግዜ ኣዋጅ ኣዊጁ። 	As issues began to escalate rapidly, the Italian government declared a state of emergency, suspending all air flights to China.
1084	en	ti	 An unassociated cluster of COVID-19 cases was later detected, starting with 16 confirmed cases in Lombardy on 21 February.On 22 February, the Council of Ministers announced a new decree-law to contain the outbreak, including quarantining more than 50,000 people from 11 different municipalities in northern Italy. 	 16 ዝተረጋገጹ ጉዳያት ኣብ ሎምበርዲ ኣብ ፌብሩዋሪ 21 ምርካቦም ጀሚሩ ፡ ዘይተተሓሓዚ ዝርግሐ ናይ ኮቪድ-19 ጉጀለ ጉዳያት ድሒሩ ተረኺቦም እዮም። ኣብ ፌብሩዋሪ 22 ፣ ቤት ምኽሪ ሚኒስትራት ነቲ ለበዳ ንምቁጽጻር ሓዲሽ ኣዋጅ-ሕጊ ኣውጺኦም፣ እዚ ካብ ዝተፈላለያ 11 ከተማታት ናይ ሰሜን ጣሊያን ዝመጹ 50,000 ዝተወሸቡ ዘጠቓልል እዩ። 	Since 16 confirmed cases were discovered in Lombardy on February 21 , unrelated outbreaks of the COVID-19 group of cases were discovered later. On February 22 , the Council of Ministers passed a new decree-law to control the outbreak, which includes 50,000 quarantines from 11 different cities in northern Italy.
1085	en	ti	" Prime Minister Giuseppe Conte said, ""In the outbreak areas, entry and exit will not be provided. "	 ቀዳማይ ሚኒስተር ጁሰፔ ኮንቴ “ኣብቶም ናይ እቲ ለባዳ ቦታት፣ መእተውን መውጽእን ክፉታት ኣይክኾኑን እዮም” ክብሉ ተዛሪቦም። 	&quot;In the areas of the outbreak, entrances and exits will not be open,&quot; Prime Minister Giuseppe Conte said.
1086	en	ti	" Suspension of work activities and sports events has already been ordered in those areas.""On 4 March, the Italian government ordered the full closure of all schools and universities nationwide as Italy reached 100 deaths. "	" ኣብቶም ከባቢታት ዝነበሩ ምስ ስራሕን ናይ ስፖርታዊ ምንቅስቓሳትን ዝተትሓሓዙ ጥርጣረታት ስርዓት ክሕዙ ተገይሮም እዮም።""ኣብ ማርች 4፣ መንግስቲ ጣልያን ኣብታ ሃገር ዝሞቱ 100 ምስ ምብጻሑ፣ ኣብ መላእ እታ ሃገር ዝርከባ ኩለን ቤት ትምህርቲታን ዩኒቨርሲቲታትን ንኽዕጸዋ ትእዛዝ ኣመሓላሊፎም "" "	Suspicions in the areas related to work and sporting activities were put in order.” On March 4, the Italian government ordered the closure of all schools and universities across the country as the death toll reached
1087	en	ti	 All major sporting events, including Serie A football matches, were to be held behind closed doors until April, but on 9 March, all sport was suspended completely for at least one month. 	 ኩሎም ዋና ናይ ስፖርታዊ ምድላዋት፣ ሴሪኣ ኤ ኹዕሶ እግሪ ጸወታታት፣ እስካብ ኣፕሪል ኣብ ዕጹው ንኽካየዱ፣ ይኽን እምበር ኣብ ማርች 9፣ ኩሎም ስፖርታዊ ጸወታታት ብንኡሱ ንሓደ ወርሒ ተቛሪጾም እዮም። 	All major sporting events, Serie A football matches, were closed until April, but on March 9, all sporting events were suspended for at least a month.
1088	en	ti	 On 11 March, Prime Minister Conte ordered stoppage of nearly all commercial activity except supermarkets and pharmacies.On 6 March, the Italian College of Anaesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) published medical ethics recommendations regarding triage protocols that might be employed. 	 ኣብ ማርች 11፣ ቀዳማይ ሚኒስተር ኮንቴ ብዘይካ ሱፐር ማርኬታትን ፋርማሲታትን ዳርጋ ኩሎም ንግዳዊ ምንቅስቓሳት ጠጠው ንኽብሉ ትእዛዝ ኣመሓላሊፎም። ኣብ ማርች 6፣ ናይ ጣልያን ናይ ኣንስቴዢያ ኮሌጅ( Italian College of Anaesthesia)፣ ኣንልገሲያ( Analgesia)፣ ረሱሳይተሽን ን ጽኑዕ ክንክን ማእኸል( Resuscitation and Intensive Care (SIAARTI)) ምናልባት ኣብ ጥቕሚ ክውዕሉ ዝኽእሉ ናይ ትሪያጅ ፕሮቶኮላት ዝምልከቱ ናይ ሕክምናዊ ስነ-ምግባራት ኣሕቲሞም። 	On March 11, Prime Minister Conte ordered a halt to almost all businesses except supermarkets and pharmacies. On March 6, the Italian College of Anaesthesia, Analgesia, and the Resuscitation and Intensive Care Center (SIAARTI) published medical ethics on triage protocols that may be used .
1089	en	ti	 On 19 March, Italy overtook China as the country with the most coronavirus-related deaths in the world after reporting 3,405 fatalities from the pandemic. 	 ብ ማርች 19 ጥልያን 3,405 ሞት ድሕሪ ምምዝጋባ ብብዝሒ ሞት ካብዚ ለበዳ ንቻይና በሊጻታ። 	On March 19, Italy surpassed China in the number of deaths from the outbreak after recording 3,405 deaths.
1090	en	ti	 On 22 March, it was reported that Russia had sent nine military planes with medical equipment to Italy. 	 ኣብ ማርች 22፣ ሩስያ ትሽዓተ ሕክምናዊ ኣቑሑ ዝጸዓና ወታደራዊ ኣውሮፕላናት ናብ ጣልያን ክምዝለኣኸት ተገሊጹ። 	On March 22, Russia sent nine military planes carrying medical supplies to Italy.
1091	en	ti	 As of 5 April, there were 128,948 confirmed cases, 15,887 deaths, and 21,815 recoveries in Italy, with the majority of those cases occurring in the Lombardy region. 	 ካብ ኤፕሪል 5 ጀሚሩ ኣብ ዓዲ ጥልያን 128,948 ብመርመራ ዝተረጋገጹ ሕሙማት፡ 15,887 ሞትን 21,815 ዝሓወዩ ሰባት ነይሮም፡ዝበዝሑ ድማ ኣብ ሎምባርዲ ዝተባህለ ክልል ነይሮም። 	Since April 5, Italy has reported 128,948 confirmed cases, 15,887 deaths and 21,815 recoveries, mostly in Lombardy.
1092	en	ti	 A CNN report indicated that the combination of Italy's large elderly population and inability to test all who have the virus to date may be contributing to the high fatality rate. 	 ናይ CNN ሪፖርት ከምዘርእዮ፣ ናይ ጣልያን ብዙሕ ቁጽሪ ዘለዎ ናይ ኣረግቶት ህዝቢ ምህላውን ብቕልጡፍ ንኹሎም ቫይረስ ንዘለዎም ሰባት ምርመራ ምግባር ዘይምኽኣልን ነቲ ናይ ዓብዪ ናይ ሞት ደረጃ የበርክቱ ከምዘለዉ ኣመልኪቱ። 	According to a CNN report, Italy&#39;s large elderly population and the inability to quickly test all people with the virus are contributing to the high death rate.
1093	en	ti	 The United Kingdom's response to the virus first emerged as one of the most relaxed of the affected countries, and until 18 March 2020, the British government did not impose any form of social distancing or mass quarantine measures on its citizens. 	 መጅመሪያ እንግሊዝ ነቲ ሕማም ዝሃበቶ መልሲ ዝሑል ዝበሃል እዩ ነይሩ፣ ብዚ ድማ ናይ እግሊዝ መንግስቲ እስካብ 18 ማርች 2020፣ ዝኾነ ዓይነት ናይ ማሕበራዊ ርሕቐት ውይድማ ኣብ ዜጋታቱ ናይ ጅምላ ኳራንታይን ስጉምቲታት ኣይወሰድን ነይሩ። 	Initially, the UK&#39;s response to the disease was cold, with the UK government until 18 March 2020, not taking any social distancing or mass quarantine measures on its citizens.
1094	en	ti	 As a result, the government received criticism for the perceived lack of pace and intensity in its response to concerns faced by the public.On 16 March, Prime Minister Boris Johnson made an announcement advising against all non-essential travel and social contact, suggesting people work from home where possible and avoid venues such as pubs, restaurants, and theatres. 	 ከም ውፅኢት ድማ፣ እቲ መንግስቲ ነቲ ኣብ ማሕበረሰብ ስግኣት ዝፈጠረ ጉዳይ ኣመልኪቱ ዘርኣዮ ናይ መልሲ ኣዋህባ ሕጽረትን ጻዕቒን ዝተልዓለ ወቐሳ ኣጋጢሙዎ እዩ። ኣብ ማርች 16፣ቀዳማይ ሚኒስተር ቦሪስ ጆንሰን ን ኹሎም ኣገደስቲ ዘይኮኑ ጉዕዞታትን ማሕበራዊ ርክባት ጠጠው ብምባል ሰባት ብዝተኽኣለ መጠን ኣብ ገዛኦም ኮይኖም ንኽሰርሑን ናብ ከም እንዳ መስተታት፣ ቤት ምግቢታትን ቲያትርን ካብ ምኻድ ንኽዕቀቡ ለባዋኦም ገሊጾም። 	As a result, the government has faced criticism for its lack of response to the issue. On March 16, Prime Minister Boris Johnson urged people to stay at home as much as possible and avoid going to places such as bars, restaurants and theaters by suspending all non-essential travel and social contacts.
1095	en	ti	 On 20 March, the government announced that all leisure establishments such as pubs and gyms were to close as soon as possible, and promised to pay up to 80% of workers' wages to a limit of £2,500 per month to prevent unemployment in the crisis.On 23 March, the Prime Minister announced tougher social distancing measures, banning gatherings of more than two people and restricting travel and outdoor activity to that deemed strictly necessary. 	 ኣብ ማርች 20፣ መንግስቲ ኩሎም ናይ መዝናግዒ ቦታታት ከም እንዳ መስተታት ፣ ጂምናዚየማት ዝበሉ ትካላት ብዝተኽኣለ መጠን ብቕልጡፍ ንኽዕጸዉ ኣዊጆም፣ ኣብዚ በዳሂ እዋን እዚ ስራሕ ስእነት ንምክልኻል ድማ፣ ንስራሕተኛታት ክሳብ £2,500 ን ዝኾነ ወሰን፣ ናይ ደሞዞም 80% ንምኽፋል ቃል ኣትዮም። ኣብ ማርች 23፣ እቲ ቀዳማይ ሚኒስትር ብዝበለጸ ጥብቕ ዝበሉ ከም ካብ ክልተ ሰባት ንላዕሊ ዝኾኑ ምትእኽኻባት ምኽልካል፣ ናይ ጉዕዞን ኣብ ደገ ዝግበሩ ተግባራት ናይ ማሕበራዊ ርሕቐት ዝምልከቱ ስጉምቲታትን እገዳታት ኣዊጆም። 	On March 20, the government announced the closure of all entertainment venues such as bars , gyms as soon as possible, and pledged to pay workers up to a maximum of £2,500, 80% of their wages, to prevent unemployment during these challenging times. On March 23, the prime minister announced stricter restrictions such as a ban on gatherings of more than two people, travel and outdoor activities and social distancing measures.
1096	en	ti	 Unlike previous measures, these restrictions were enforceable by police through the issuing of fines and the dispersal of gatherings. 	 ካብቶም ሕሉፋት ስጉምቲታት በተጻራሪ፣ እዞም እገዳታት እዚኦም ብዝትግበሩ ናይ ገንዘብ ቅጽዓታትን ምትእኸኻባት ምብታን ብ ፖሊስ ሓይሊ ዝትግበሩ እዮም። 	In contrast to previous measures, these sanctions are enforced by police force through fines and dispersion of gatherings.
1097	en	ti	" Most businesses were ordered to close, with exceptions for businesses deemed ""essential"", including supermarkets, pharmacies, banks, hardware shops, petrol stations, and garages. "	" ዝተኣዘዙ እንትኾኑ፡ ብዘይካ እቶም ከም ሱፐር ማርኬታት፡ ባንኪታት፡ ናይ ሃርድዌር ሹቓት፡ ናይ ፔትሮል ጣቢያታት ን ጋራጃትን ዝበሉ ""ኣገደስቲ"" ተባሂሎም ዝተፈለዩ፣መብዛሕቲኦም ቢዝነሳት ንኽዕጸዉ ትእዛዝ ተሓላሊፉ እዩ። "	Most businesses, except those identified as &quot;essential&quot; such as supermarkets, banks, hardware stores, petrol stations and garages, have been ordered to close.
1098	en	ti	 On 20 January, the first known case of COVID-19 was confirmed in the Pacific Northwest state of Washington in a man who had returned from Wuhan on 15 January. 	 ኣብ ጃኑዋሪ 20፣ እቲ ናይ መጀምሪያ ናይ COVID-19 ሕሙም ኣብ ፓስፊክ ሰሜን ምዕራብ ዋሺንግተን ኣብ ሓደ ካብ ዉሃን ጃኑዋሪ 15 ዝተመልሰ ሰብኣይ እዩ ተረኺቡ። 	On January 20, the first case of COVID-19 was detected in Pacific Northwest Washington in a man who returned from Wuhan on January
1099	en	ti	 The White House Coronavirus Task Force was established on 29 January. 	 ናይ ሗይት ሃውስ ናይ ኮረና ቫይረስ ግብረ ሓይሊ ኣብ ጃኑዋሪ 29 ተጣዪሹ። 	The White House Coronavirus Task Force was established on January 29th.
1100	en	ti	 On 31 January, the Trump administration declared a public health emergency, and placed restrictions on entry for travellers from China. 	 ብ31 ጥሪ ምምሕዳር ትራምፕ ናይ ህዝባዊ ጥዕና ህጹጽነት ኣዊጁ። ኣብ ልዕሊ ካብ ቻይና ዝመጹ መንገደኛታት ድማ ምእታው ተኸልኪሎም። 	On January 31, the Trump administration declared a public health emergency. Travelers from China were denied entry.
1101	en	ti	 On 28 January 2020, the Center for Disease Control—the leading public health institute of the U.S. government—announced they had developed their own testing kit. 	 ኣብ ጃኑዋሪ 28 2020፡ ማእኽል ምቁጽጽር ሕማም- ናይ መንግስቲ ኣሜሪካ እቲ ዝዓበየ ህዝባዊ ናይ ጥዕና ትካል- ናይ ባዕሎም ናይ መመርመሪ ኪት ክምዘማዕበሉ ገሊጾም። 	On January 28, 2020, the Centers for Disease Control—the US government&#39;s largest public health agency—announced that it had developed its own test kit.
1102	en	ti	 Despite doing so, the United States had a slow start in testing, which obscured the true extent of the outbreak at the time. 	 ዋላ’ኳ ከምኡ እንተገበሩ፡ ሕቡራት መንግስታት ምርመራ ደንጒዮም ጀሚሮም። እዚ’ዩ ከኣ ኣብቲ ግዜ ዝነበረ ሓቀኛ ዝርግሐ ናይቲ ለበዳ ዝሓብኦ። 	Despite doing so, the UN investigation began late. This is what hid the true spread of the epidemic at the time.
1103	en	ti	 Testing was marred by defective test kits produced by the federal government in February, a lack of federal government approval for non-government test kits (by academia, companies and hospitals) until the end of February, and restrictive criteria for people to qualify for a test until early March (a doctor's order was required thereafter). 	 እቲ ምርመራ ፣ ብ ሰንኪ ኣብ ወርሒ ፌብሩዋሪ ብ ፌደራል መንግስቲ ዝተሰርሑ ጸገም ዘለዎም ኪትስ ፣ ብ መንግስታዊ ዘይኮኑ ትካላት(ናይ ትምህርቲ ማእኸላት፣ ትካላትን ሆስፒታላት) ዝስርሑ ድማ እስካብ ወርሒ ፈብሩዋሪ መጨረሻ ናይ ፌደራል መንግስቲ መረጋገጺ ዘይምርካብ ፣ ሰባት ነቲ ምርመራ ብቑዕ ንምዃን ኸማልኡ ዘለዉዎም ሮቛሒታት እስካብ ናይ ማርች ወርሒ መጀምሪያ ኣክባቢ ኣዝዮም ጥቡቓት ብምንባሮም( ድሕሪኡ ግን ናይ ዶክተር ትእዛዝ እዩ ዝድለ) ክተኣጓጎል ክኢሉ እዩ። 	The test, due to defective kits made by the federal government in February, and those made by non-governmental organizations(education centers, institutions and hospitals) not getting federal government confirmation until the end of February, people have to meet the requirements to qualify for the test March was disrupted by very tight environments at the beginning( but then a doctor&#39;s order is required).
1104	en	ti	 By 27 February, The Washington Post reported fewer than 4,000 tests had been conducted in the United States. 	 ክሳብ ፌብሩዋሪ 27, ኣብ ሕቡራት መንግስታት ኣሜሪካ ትሕቲ 4,000 መርመራታት ጥራይ ከምዝትኻየደ ኣብ ዋሺንግተን ፖስት ተሓቢሩ። 	As of February 27, there have been just under 4,000 tests in the United States, according to the Washington Post.
1105	en	ti	 By 13 March, The Atlantic reported that less than 14,000 tests had been conducted. 	 ክሳብ ማርች 13፣ ካብ 14000 ዝነኣሰ ምርመራታት ክምዝተገበሩ ዘርኢ ጸብጻብ እትላንቲክ ኣቕሪቡ ። 	As of March 13, the Atlantic reported fewer than 14,000 tests.
1106	en	ti	" On 22 March, the Associated Press reported: ""Many people who have symptoms and a doctor's order have waited hours or days for a test.""After the first death in the United States was reported in Washington state on 29 February, Governor Jay Inslee declared a state of emergency, an action that was soon followed by other states. "	 ብ22 ማርች፡ ኣሶስየትድ ፕረስ“ምልክታትን ትዕዛዝ ሓኪምን ዘለዎም ብዙሓት ሰባት፡ ነቲ መርመራ ንምርካብ ካብ ሰዓታት ክሳብ መዓልታት ይጽበዩ ኣለዉ።”ኢሉ ሓቢሩ።ኣብ ሕቡራት መንግስታት ፋልማይ ዘጋጠመ ሞት ኣብ ዋሺንግተን ስቴት ብ29 ፌብሩዋሪ ድሕሪ ምምዝጋቡ፡ ጋቨርነር ጀይ ኢንስሊ ናይ ህጹጽ ኩነት ኣዊጁ። ካልኦት ሃገራት’ውን ድሕሪ ቁሩብ ሰዓብኦ። 	On March 22, the Associated Press reported“Many people with symptoms and prescriptions are waiting hours to days to get the test.” Governor J. Inslee declared a state of emergency after the first death in the United States was recorded in Washington State on February 29th. Other countries soon followed suit.
1107	en	ti	 Schools in the Seattle area cancelled classes on 3 March, and by mid-March, schools across the country were shutting down.On 6 March 2020, the United States was advised of projections for the impact of the new coronavirus on the country by a group of epidemiologists at Imperial College London. 	 ኣብ ከባቢ ሲያትል ዝርከባ ቤት-ትምህርትታት ብዕለት 3 ማርች ተዓጽየን። ብድሕሪኡ’ውን ኣብ መፋርቅ ወርሒ ማርች ኣብቲ ሃገር ዝርከባ ቤት-ትምህርትታት ክዕጸዋ ጀሚረን። ኣብ ማርች 6, 2020: ሕቡራት መንግስታት ብዛዕባ’ዚ ሓድሽ ኮሮና ቫይረስ ኣብ እቲ ሃገር ከምጽኦ ዝኽእል ጽልዋ ብክኢላታት ስነ-ሕማምለበዳ ካብ ኢምፐርያል ኮሌጅ ላንደን ተመኺራ። 	Schools in the Seattle area were closed on March Schools in the country began closing in mid-March. On March 6, 2020: The United Nations was advised by epidemiologists from Imperial College London on the impact of the new coronavirus on the country.
1108	en	ti	 On the same day President Trump signed the Coronavirus Preparedness and Response Supplemental Appropriations Act, which provided $8.3 billion in emergency funding for federal agencies to respond to the outbreak. 	 ብተመሳሳሊ መዓልቲ፣ ፕረዚደንት ትራምፕ ነቲ ናይ Coronavirus Preparedness and Response Supplemental Appropriations Act ሕጊ ፈሪሙ፣እዚ ድማ ነተን ናይ ፌደራል ኤጀንሲታት ነቲ ለበዳ መመከቲ ዝኸውን $8.3 ቢሊየን ዶላር ናይ ህጹጽ ኩነታት ገንዘብ ዘቕርበ እዩ። 	On the same day, President Trump signed into law the Coronavirus Preparedness and Response Supplemental Appropriations Act, which provides $8.3 billion in emergency funds for federal agencies to fight the pandemic.
1109	en	ti	 Corporations imposed employee travel restrictions, cancelled conferences, and encouraged employees to work from home. 	 ኮርፖሬታት ኣብ ሰራሕተኛታት ናይ ጉዕዞ እገዳታት ኣቐሚጦም, ኮንፈረነንሳት ስሪዞም፡ ስራሕተኛታት ድማ ኣብ ገዛ ኾይኖም ንኽስርሑ ኣብረታቲዖም። 	Corporations imposed travel restrictions on employees, canceled conferences, and encouraged employees to work from home.
1110	en	ti	 Sports events and seasons were cancelled.On 11 March, Trump announced travel restrictions for most of Europe, excluding the United Kingdom, for 30 days, effective 13 March. 	 ናይ ስፖርታዊ ምድላዋትን ወቕቲታት ተሰሪዞም ኣለዉ። ኣብ ማርች 11፣ ትራምፕ ን 30 መዓልቲታት ዝጸንሕ ካብ ማርች 13 ዝጅምር፣ ካብ እንግሊዝ ወጻኢ ንዘለዋ ንመብዛሕቲእን ናይ ኣውሮፓ ሃገራት ዝምልከት ናይ ጉዕዞ እገዳታት ኣዊጆም። 	Sports events and seasons have been cancelled. On March 11, Trump announced a 30-day travel ban on most European countries outside the UK, starting March
1111	en	ti	 The following day, he expanded the restrictions to include the United Kingdom and Ireland. 	 ኣብቲ ቀጻሊ መዓልቲ ነቲ እገዳ ን እንግሊዝን ኣየርላንድን ክሓውስ ገይሩ ኣግፊሕዎ እዩ። 	The following day he expanded the ban to include England and Ireland.
1112	en	ti	 On 13 March, he declared a national emergency, which made federal funds available to respond to the crisis. 	 ኣብ ማርች 13, ህጹጽ እዋን ኣዊጁ፣ እዚ ድማ ናይ ፌደራል ናይ ገንዘብ ድጋፍ ንቅልውላው መልሲ ንክህብ ገቢሩዎ እዩ። 	On March 13, he declared a state of emergency, which led to federal financial support in response to the crisis.
1113	en	ti	 Beginning on 15 March, many businesses closed or reduced hours throughout the U.S. to try to reduce the spread of the virus. 	 ካብ ማርች 15 ጀሚሩ፣ ብዙሓት ናይ ቢዝነስ ትካላት ናይ እቲ ቫይረስ ዝርጋሐ ንምቕናስ ክበሃል፣ ተዓጽዮም እዮም ውየድማ ኣብ መላእ ሕቡራት መንግስታት ኣሜሪካ ናይ ሰራሕ ሰዓተን ቀኒሰን እየን። 	Since March 15, many businesses have been closed and reduced their operating hours across the United States in an effort to reduce the spread of the virus.
1114	en	ti	 By 17 March, the epidemic had been confirmed in all 50 states and in the District of Columbia.On 23 March, it was reported that New York City had 10,700 cases of the coronavirus, more than the total number of cases in South Korea. 	 እስካብ ማርች 17፣ እቲ ለበዳ ኣብ ኩለን እተን 50 ስቴታትን ኣብ ኮለምቢያ ዲስትሪክትን ምህላው ተረጋጊጹ እዩ።ኣብ ማርች 23፣ ኣብ ኔውዮርክ ሲቲ ዘሎ ኣጠቓላሊ ዝተረጋገጹ ጉዳያት ቀጽሪ 10,700 በጺሑ፣ እዚ ድማ ኣብ ደቡብ ኮሪያ ካብ ዘለዉ ኣጠቓላሊ ጉዳያት ዝለዓለ እዩ። 	As of March 17, the outbreak has been confirmed in all 50 states and the District of Columbia.As of March 23, the total number of confirmed campus cases in New York City reached 10,700, the highest total in South Korea.
1115	en	ti	 On 25 March, the governor said that social distancing seemed to be working, as estimates of case doubling slowed from 2.0 days to 4.7 days. 	 ኣብ ማርች 25፡ እቲ ኣመሓዳሪ ምስቲ ናይ ጉዳያት ዕጽፊ ምኻን ካብ 2.0 መ ዓልቲታት ናብ 4.7 መዓልቲታት ክብ ምባሉ ፡እቲ ናይ ማሕበራዊ ርሕቐት እንሰርሐ ይመስል ክብል ገሊጹ ። 	On March 25, the governor said with the doubling of cases from 2.0 days to 4.7 days, the social distancing seems to be working.
1116	en	ti	 As of 28 March, there were 32,308 confirmed cases in New York City, and 672 people had died from the virus.On 26 March, the United States was reported to have more confirmed coronavirus infection cases than any other country in the world, including China and Italy.As of 8 April, 400,335 cases have been confirmed in the United States, and 12,841 people have died. 	 ካብ ማርች 28 ጀሚሩ ኣብ ኔውዮርክ ሲቲ 32,308 ዝተረጋገጹ ጉዳያት ነይሮም፣ 672 ሰባት ድማ በቲ ቫይረስ ሞይቶም። ኣብ ማርች 26፣ ሕቡራት መንግስታት ኣሜሪካ ን ቻይናን ጣልያንን ሓዊሱ፣ካብ ዝኾነ ናይ ዓለምና ሃገር ንላዕሊ ዝተረጋገጹ ጉዳያት ነይሮማ። ካብ ኣፕሪል 8 ጀሚሩ፣ ኣብ ሕቡራት መንግስታት ኣሜሪካ 400,335 ዝተረጋገጹ ጉዳያት እክህለዉ 12,841 ሰባት ድማ ሞይቶም እዮም። 	Since March 28, there have been 32,308 confirmed cases in New York City, and 672 people have died from the virus. On March 26, the United States had more confirmed cases than any other country in the world, including China and Italy. As of April 8, there have been 400,335 confirmed cases and 12,841 deaths in the United States.
1117	en	ti	 Per media reports on 30 March, U.S. President Trump has decided to extend social distancing guidelines until 30 April. 	 ከም ኣብ ማርች 30 ዝነበረ ናይ ሚድያ ጸብጻባት ናይ ሕቡራት መንግስታት ኣሜሪካ ፕሬዝደንት ትራምፕ ናይ ማሕበራዊ ርሕቐት መምርሒታት እስካብ ኣፕሪል 30 ክምዘናውሑዎ ተገሊጹ። 	As per media reports on March 30, US President Donald Trump has extended social distancing guidelines until April
1118	en	ti	 On the same day, the USNS Comfort, a hospital ship with about 1000 beds, made anchor in New York. 	 ኣብ ተምሳሳሊ መዓልቲ፣ USNS Comfort ዝተብሃለ ከባቢ 1000 ዓራታት ዝሓዘ መርከብ ሆስፒታል ኣብ ኔውዮርክ ምዕራፉ ገይሩ። 	On the same day, the USNS Comfort, a 1,000-bed hospital ship, docked in New York.
1119	en	ti	 On 3 April, the U.S. had a record 884 deaths due to the coronavirus in a 24-hour period. 	 ኣብ ኣፕሪል 3, ኣሜሪካ ኣብ ውሽጢ 24-ሰዓት 884 ሞት ብሰንኪ ኮሮናቫይረስ ኣመዝጊባ። 	On April 3, the United States recorded 884 deaths from the virus in 24-hours.
1120	en	ti	 In the state of New York the cases have exceeded 100,000 people on 3 April.The White House has been criticized for downplaying the threat and controlling the messaging by directing health officials and scientists to coordinate public statements and publications related to the virus with the office of Vice-President Mike Pence. 	 ኣብ ግዝኣት ኔውዮርክ እቶም ጉዳያት ኣብ ኣፕሪል 3 ካብ 100000 ሰባት በሊጾም ኣለው። ናይ ዋይት ሃውስ ነቲ ሓደጋ ኣንኢሱ ብምርኣዩ ን ብ ሰበ ስልጣን ጥዕና ን ሳይንቲስታትን ዝግበሩ መግለጺታት ን ምስ'ቲ ቫይረስ ዝተትሓሓዙ ሕትመታት ብ ቢሮ ምክትል ፕሬዝደንት ማይክ ፔንስ ኣቢላ ብምምራሑ ዝውቀሰሉ እዩ። 	In New York State, the cases exceeded 100,000 on April The White House is accused of downplaying the risk and directing statements by health officials and scientists and publications related to the virus through Vice President Mike Pence&#39;s office.
1121	en	ti	 Overall approval of Trump's management of the crisis has been polarized along partisan lines. 	 ኣጠቓላሊ ናይ ትራምፕ ነቲ ቅልውላው ዝሓዙሉ መንገዲ ብዘምልከት ብ ናይ ፓርቲያዊ መሰመር ዝፍለዩ ክልተ መርገጺታት ኣለው። 	Overall, there are two positions on Trump&#39;s approach to the crisis that differ along party lines.
1122	en	ti	 Some U.S. officials and commentators criticized the U.S. reliance on importation of critical materials, including essential medical supplies, from China. 	 U.S. ንእቶት ኣገደስቲ ናውቲ፡ብፍላይ ድማ ናውቲ ሕክምና፡ኣብ ልዕሊ ቻይና ምምርኳሳ ብገለ ናይ U.S. ሓለፍትታትን ጋዜጠኛታትን ተነቒፉ። 	The US&#39;s reliance on China for imports of essential goods, especially medical supplies, has been criticized by some US officials and journalists.
1123	en	ti	 An analysis of air travel patterns was used to map and predict patterns of spread and was published in The Journal of Travel Medicine in mid-January 2020. 	 ቅዲ ናይ ኣየር ጉኦዞ ብምርኣይ ዝርግሐ ናይ እቲ ቫይረስ ንምግማት ዝተገብረ መጽናዕቲ ኣብ ትራቭል መዲስን ጆርናል ኣብ መፋርቅ ጃኑዋሪ 2020 ተሓቲሙ። 	A study to predict the spread of the virus by looking at air travel patterns was published in the Travel Medicine Journal in mid-January
1124	en	ti	 Based on 2018 information from the International Air Transport Association, Bangkok, Hong Kong, Tokyo, and Taipei had the largest volume of travellers from Wuhan. 	 ባንክኮክ፡ ሆንግኮንግ፡ ቶክዮን ታይፐይ ካብ ዉሃን ዝበዝሐ ተመላለስቲ ዘለወን ሃገራት ምዃነን ኣብ 2018 ካብ ማሕበር ዓለምለሃዊ በረራ ዝተዘርግሐ ሓብሬታ ይገልጽ። 	Bangkok, Hong Kong, Tokyo and Taipei have the highest number of travelers from Wuhan in 2018, according to data released by the International Aviation Association.
1125	en	ti	 Dubai, Sydney, and Melbourne were also reported as popular destinations for people travelling from Wuhan. 	 ዱባይ፣ ሲድኒ ን ሜልቦርን ን ካብ ዉሃን ዝብገሱ ሰባት ወሩያት መብጽሒታት ኮይኖም ተጸብጺቦም ኣለዉ። 	Dubai, Sydney and Melbourne have been reported as popular destinations for people departing from Wuhan.
1126	en	ti	 Bali was reported as least able among the 20 most popular destination cities in terms of preparedness, while cities in Australia were considered most able.Australia released its Emergency Response Plan for Novel Coronavirus (COVID-19) on 7 February. 	 ብ መንጽር ድሉውነት ካብተን 20 ህቡባት ናይ በጻሕቲ ከተማታት ባሊ ኣብ ዝተሓተ እንትትቕመጥ፣ ኣብ ኣውስትራሊያ ዝርከባ ከተማታት ድማ ካብተን ብሉጻት ተመዲበን። ኣውስትራሊያ ን ኖቨል ኮርና ቫይረስ (COVID-19) ዝኸውን ናይ ህጹጽ ግዜ መልሲ መውሃቢ መድብ ኣብ ፈብሩዋሪ 7 ዕላው ገይራቶ እያ። 	In terms of readiness, Bali ranked at the bottom of the 20 most popular tourist cities, while cities in Australia were ranked among the best. Australia announced its emergency response plan for the novel coronavirus (COVID-19) on 7 February.
1127	en	ti	 It stated that much was yet to be discovered about COVID-19, and that Australia would emphasize border control and communication in its response to the pandemic. 	 ብዛዕባ ኮቪድ-19 ዝምልከትን ገና ብሕጂ ብዙሕ ዝፍለጥ ጉዳይ ከምዘሎ፣ ከምኡ ውን ኣውስትራሊያ ነዚ ላብዕ ሕማም ንምክልኻል ኣብ ዶብ ምዕጻውን ኣብ ርክባት ምግባርን ኣትኩሮት ብምሃብ ከም እትሰርሕ ተገሊጹ። 	There is still much to be learned about COVID-19, and Australia is working to prevent the spread of the disease by focusing on border closures and communications.
1128	en	ti	 On 21 March, a human biosecurity emergency was declared in Australia. 	 ብ21 ማርች ህጹጽ ኩነት ህዝባዊ ድሕነት ኣብ ኣውስትራልያ ተኣዊጁ። 	On 21 March, a public safety emergency was declared in Australia.
1129	en	ti	 Owing to the effective quarantine of public transport in Wuhan and Hubei, several countries have planned to evacuate their citizens and diplomatic staff from the area, primarily through chartered flights of the home nation, with Chinese authorities providing clearance. 	 ኣብ ውሃን ኣብ ናይ ሕዝባዊ መጎዓዝያታት ኣብዝተነበረ ጽፉፍ ናይ ኳራንታይን ስራሕቲ ዝተልዓለ ብዙሓት ሃገራት ዜጋታትን ናይ ዲፕሎማሲ ስራሕተኛታተን ብ ዋናነት ባዕለን ብዘዳለዋእን ቻርተር ኣውሮፕላናት ዜጋታትን ካብቲ ቦታ ንምውጻኣ መድብ ዝሓዛ እንትኾና ናይ ቻይና ሰብ መዚታት ድማ ሕጋዊ መሰነያታ ከሳልጡ እዮም። 	Due to the tight quarantine measures on public transport in Wuhan, many countries have planned to evacuate their citizens and diplomatic personnel on their own charter planes, while Chinese authorities will provide legal escort.
1130	en	ti	 Canada, the United States, Japan, India, Sri Lanka, Australia, France, Argentina, Germany, and Thailand were among the first to plan the evacuation of their citizens. 	 ካናዳ፡ ሕቡራት መንግስታት ኣሜሪካ፡ ጃፓን፡ ህንዲ፡ ስሪላንካ፡ ኣውስትራልያ፡ ፈረንሳ፡ ኣርጀንቲና፡ ጀርመንን ታይላንድን ካብተን ንደቂ ሃገሮም ንምጥርናፍ ዝተጓየያ ቀዳሞት ሃገራት እየን። 	Canada, the United States, Japan, India, Sri Lanka, Australia, France, Argentina, Germany and Thailand were among the first countries to rush to reunite their compatriots.
1131	en	ti	 Pakistan has said that it will not be evacuating any citizens from China. 	 ፓኪስታን ዝኾኑ ዓይነት ዜጋታት ካብ ቻይና ከምዘይተውጽእ ኣፍሊጣ። 	Pakistan has announced that it will not evacuate any kind of citizens from China.
1132	en	ti	 On 7 February, Brazil evacuated 34 Brazilians or family members in addition to four Poles, a Chinese person, and an Indian citizen. 	 ኣብ ፌብሩዋሪ 7 ብራዚል 34 ብራዚላውያን ውይድማ ናይ ስድራ ቤት ኣባላይ ምስ ኣርባዕተ ፖላንዳውያን፣ ሓደ ቻይናዊን፣ ሓደ ናይ ህንዲ ዜጋን ካብቲ ዝነበሩዎ ናብ ድሕንነቱ ዝተሓለወ ቦታ ኣንቀሳቒሳ። 	On February 7, Brazil evacuated 34 Brazilians, including four Poles, a Chinese and an Indian, to safety.
1133	en	ti	 The citizens of Poland, China, and India deplaned in Poland, where the Brazilian plane made a stopover before following its route to Brazil. 	 ናይ ፖላንድ ፣ ቻይና ን ህንዲን ዜጋታት ድሕሪ እታ ናይ ብራዚል ኣውሮፕላን ቅድሚ ናብ ብራዚል ምኻዳ ኣብ ፖላንድ ጻንሒት ምግባራ ፣ ኣብ ፖላንድ ክጸንሑ ክኢሎም እዮም ። 	Citizens of Poland, China and India were able to stay in Poland after the Brazilian plane made a stopover in Poland before flying to Brazil.
1134	en	ti	 Brazilian citizens who went to Wuhan were quarantined at a military base near Brasília. 	 ካብ ዉሃን ዝተመልሱ ብራዚላውያን ኣብ ጥቓ ብራዚልያ ዝርከብ ወተሓደራዊ መዓስከር ተወሺቦም ኣለዉ። 	Brazilians returning from Wuhan have been quarantined at a military camp near Brasilia.
1135	en	ti	 On the same day, 215 Canadians (176 from the first plane, and 39 from a second plane chartered by the U.S. government) were evacuated from Wuhan to CFB Trenton to be quarantined for two weeks. 	 ሽዑንሽዑ 215 ካናዳውያን(176 ኣብታ ቀዳመይቲ በረራ፡ 39 ድማ ኣብታ ካልኣይቲ ብመንግስቲ U.S. ዝተሓዝአት በረራ) ካብ ዉሃን ኣብ CFB Trenton ንክልተ ሰሙን ክውሸቡ ተወሲዶም። 	Immediately, 215 Canadians (176 on the first flight and 39 on the second US government-booked flight) were taken from Wuhan to CFB Trenton for two weeks of quarantine.
1136	en	ti	 On 11 February, another plane of 185 Canadians from Wuhan landed at CFB Trenton. 	 ብዕለት 11 ፌብሩዋሪ 185 ካናዳውያን ዝሓዘት ካብ ዉሃን ዝተበገሰት ኣየር ኣብ CFB Trenton ዓሊባ። 	On Feb. 11, an airliner carrying 185 Canadians from Wuhan landed at CFB Trenton.
1137	en	ti	 Australian authorities evacuated 277 citizens on 3 and 4 February to the Christmas Island Detention Centre, which had been repurposed as a quarantine facility, where they remained for 14 days. 	 ናይ ኣውስትራሊያ ሰበ ስልጣናት ኣብ ፌብሩዋሪ 3 ን 4 ን 277 ዜጋታት ካብ ካልኦት ሃገራት ናብ ክሪስማስ ኣይስላንድ ማእኸል ህንጸት ኣእትያ እያ። እዚ ናይ ህንጸት ማእኽል ድማ ብድጋሚ ክም ኳራንታይን ፋሲሊቲ ኮይኑ ተስሩሑ እዩ፣ እቶም ዜጋታት ድማ ኣብኡ ን 14 መዓልቲታት ጸኒሖም እዮም። 	Australian authorities brought 277 citizens from other countries to the Christmas Iceland construction center on February 3 and The construction center has been re-operated as a quarantine facility, and the citizens have been there for 14 days.
1138	en	ti	 A New Zealand evacuation flight arrived in Auckland on 5 February; its passengers (including some from Australia and the Pacific) were quarantined at a naval base in Whangaparoa, north of Auckland. 	 ናይ ኒውዝላንድ ናይ ነብሲ ኣድሕን በረራ ኣብ ኣኡክላንድ ኣብ ፌብሩዋሪ 5 በጺሑ፣ እቶም ተጉዓዝቲ (ገለ ካብ ኣውስትራሊያን ካብ ፓሲፊክን ዘጠቓለለ) ኣብ ሰሜናዊ ኡክላንድ ኣብ ዝርከብ ናይ ሓይሊ ባሕሪ ቤዝ ኳራንታይን ተገይሮም ኣለዉ። 	A New Zealand lifeboat flight arrived in Auckland on February 5, the passengers (which included some from Australia and from the Pacific) have been quarantined at a naval base north of Auckland.
1139	en	ti	 On 15 February, the United States announced that it would evacuate Americans aboard the cruise ship Diamond Princess. 	 ኣብ ፈብሩዋሪ 15፡ ዩናይትድ ስቴትስ ኣብ ዳይመንድ ፕሪንሰስ ናይ ተጉዓዝቲ መርክብ ዉሽጢ ዝርከቡ ኣሜሪካዉያን ከም እተውጽእ ኣፍሊጣ። 	On February 15, the United States announced it would evacuate Americans on board the Diamond Princess passenger ship.
1140	en	ti	 On 21 February, a plane carrying 129 Canadian passengers who had been evacuated from Diamond Princess landed in Trenton, Ontario. 	 ኣብ ፌብሩዋሪ 21, 129 ናብ ዓዶም ዝምለሱ ካናዳውያን ዝጸዓነት ኣውሮፕላን ኣብ ትሬንቶን፣ ኦንታርዮ ዓሪፋ። 	On February 21, a plane carrying 129 Canadians returning home crashed in Trenton, Ontario.
1141	en	ti	 In early March, the Indian government began evacuating its citizens from Iran.On 14 March a South African Airways aircraft chartered by the South African Government repatriated 112 South African citizens. 	 ኣብ መጀምሪያ ወርሒ ማርች፣መንግስቲ ህንዲ ዜጋታቱ ካብ ኢራን ምውጻእ ጀሚሩ። ኣብ ማርች 14 በ መንግስቲ ደቡብ ኣፍሪካ ኮንትራት ዝተትሓዘት ናይ መንገዲ ኣየር ደቡብ ኣፍሪካ ኣውሮፕላን 112 ዜጋታት ደቡብ ኣፍሪካ ናብ ሃገሮም መሊሳ። 	In early March, the Indian government began evacuating its citizens from Iran. On March 14, a South African Airlines plane contracted by the South African government repatriated 112 South Africans.
1142	en	ti	 Medical screening was performed prior to departure, and four South Africans who were showing signs of coronavirus were left behind to mitigate risk. 	 ቅድሚ በረራ ሕክምናዊ መርመራ ኣብ ዝተገብረሉ እዋን ኣርባዕተ ደቡብ ኣፍሪቃውያን ምልክታት ኮሮናቫረስ ስለዘርኣዩ ንድሕሪት ተሪፎም። 	Four South Africans were left behind after showing symptoms of the virus during pre-flight medical tests.
1143	en	ti	 Only South Africans who tested negative were repatriated. 	 ብመርመራ ነጻ ዝተብሃሉ ደቡብ ኣፍሪቃውያን ጥራይ’ዮም ንሃገሮም ክምለሱ ተፈቒድሎም። 	Only South Africans who tested positive were allowed to return home.
1144	en	ti	 Test results cleared all the South Africans, including the flight crew, pilots, hotel staff, police and soldiers involved in the humanitarian mission who, as a precautionary measure, all remained under observation and in quarantine for a 14-day period at The Ranch Resort. 	 ናይ ምርመራ ውጽኢታት ናይ በረራ ክሩ፣ ፓይለታት፣ ናይ ሆተል ሰራሕተኛታት፣ ፖሊስን ወታደራትን ሓዊሱ፣ ኣብቲ ሰብኣዊ ልኡኽ ዝተሳተፉ ኹሎም ደቡብ ኣፍሪካውያን ነጻ ምዃኖም ኣረጋጊጹ፣ ክም ኣካል ጥንቃቐ ድማ ፣ኩሎም ን 14 መዓልቲታት ኣብ ራንች ሪዞርት ኣብ ትሕቲ ክትትልን ኳርንታይንን ክጸንሑ ተገይሮም እዮም። 	Test results confirmed that all South Africans involved in the humanitarian mission, including flight crew, pilots, hotel staff, police and soldiers, were free and, as a precaution, they were all placed under surveillance and quarantine for 14 days at the ranch resort.
1145	en	ti	 On 20 March, the United States began to partially withdrawal its troops from Iraq due to the pandemic. 	 ብ20 ማርች፣ ሕብረት መንግስታት ወተሃደራቱ ካብ ኢራቅ ብሰንኪ ለበዳ በብቁሩብ ክስህብ ጀሚሩ። 	On March 20, the United Nations began gradually withdrawing troops from Iraq due to the outbreak.
1146	en	ti	 On 5 February, the Chinese foreign ministry stated that 21 countries (including Belarus, Pakistan, Trinidad and Tobago, Egypt, and Iran) had sent aid to China. 	 ብ5 ፌብሩዋሪ፡ 21 ሃገራት (ቤላሩስ፡ ፓኪስታን፡ ትሪኒዳድን ቶቤጎን፡ ግብጽን ኢራንን ዘጠቃለለ) ናብ ቻይና ረድኤት ከምዝሰደዳ ሚኒስተር ወጻኢ ጉዳያት ቻይና ሓቢሩ። 	On February 5, 21 countries (including Belarus, Pakistan, Trinidad and Tobago, Egypt and Iran) sent aid to China, according to the Chinese foreign minister.
1147	en	ti	 Some Chinese students at American universities joined together to help send aid to virus-stricken parts of China, with a joint group in the greater Chicago area reportedly managing to send 50,000 N95 masks to hospitals in the Hubei province on 30 January.The humanitarian aid organization Direct Relief, in coordination with FedEx, sent 200,000 face masks along with other personal protective equipment, including gloves and gowns, by emergency airlift to the Wuhan Union Hospital by 30 January. 	 ገላ ኣብ ኣሜሪካ ዩኒቨርስቲታት ዝመሃሩ ቻይናውያን ተምሃሮ፣ ናብ በቲ ቫይረስ ዝተጠቕዑ ቦታታት ቻይና ሓገዝ ንምልኣኽ ሓቢሮም። እቲ ዝዓበየ ናይ እቲ ጉጅለ ኣባላይ ኣብ ቺካጎ ኣከባቢ ዘለው እንትኾኑ፣ ናብ ሁበይ ግዝኣት ዝርከባ ሆስፒታላት ኣብ ጃኑዋሪ 30፣ 50,000 N95 ማስክታት ክልእኹ ክኢሎም እዮም። ናይ ሰብኣዊ ሓገዝ ትካል ቀጥታዊ ረድኤት ምስ FedEx ብምትሕግጋዝ ድማ 200000 ናይ ገጽ ማስክታት ግሎቫትን ጋውናትን ሓዊሱ ምስ ካልኦት ናይ ዓርሰ መክላኸሊ ኣቑሑት ናብ ዉሃን ዩኒየን ሆስፒታል ኣብ ጃኑዋሪ 30 ብ ናይ ህጹጽ ናይ ኣየር መጓዓዚ ክልእኹ ከኢሎም እዮም። 	Some Chinese students at US universities have offered to send aid to affected areas in China. The largest member of the group is in the Chicago area, and they were able to send 50,000 N95 masks to hospitals in Hubei province on January Humanitarian aid agency Direct Relief worked with FedEx to send 200,000 face masks, gloves and gowns, along with other protective items, to Wuhan Union Hospital on January 30 by emergency airlift.
1148	en	ti	" On 5 February, Bill and Melinda Gates announced a $100 million donation to the WHO to fund vaccine research and treatment efforts along with protecting ""at-risk populations in Africa and South Asia"". "	 ብ5 ለካቲት ቢልን መሊንዳን ጌትስ $100 ሚልዮን ንWHO ከምዘውፍዩ ሓቢሮም። እዚ ወፈያ ናብ ናይ ክታበት መጽናዕትታትን ናይ መድሓኒት ፈተነታትን ከምኡ’ውን ነቶም “ኣብ ሓደጋ ዘለዉ ህዝብታት ኣፍሪቃን ደቡብ ኤስያን” ንምክልኻል ዝዓለመ ምዃኑ ድማ ሓቢሮም። 	On February 5, Bill and Melinda Gates announced they would donate $100 million to the WHO. The donation is aimed at vaccine research and drug trials and to protect “at-risk peoples in Africa and South Asia,” he said.
1149	en	ti	 Interaksyon reported that the Chinese government donated 200,000 masks to the Philippines on 6 February, after Senator Richard Gordon shipped 3.16 million masks to Wuhan. 	 ሰነተር ሪቻርድ ጎርዶን 3.16 ሚልዮን ናይ ኣፍን ኣፍንጫን መሸፈኒ ማስክ ናብ ዉሃን ድሕሪ ምስዳዱ፡መንግስቲ ቻይና ብ6 ፌብሩዋሪ ንፊሊፒንስ 200,000 ናይ ኣፍን ኣፍንጫን መሸፈኒ ማስክ ከምዝለገሰ ኢንተርኣክስዮን ሓቢሩ። 	The Chinese government donated 200,000 masks to the Philippines on February 6 after Senator Richard Gordon sent 3.16 million masks to Wuhan, InterAction reported.
1150	en	ti	 On 19 February, the Singapore Red Cross announced that it would send $2.26 million worth of aid to China. 	 ኣብ ፌብሩዋሪ 19፣ ናይ ሲንጋፖር ቀይሕ መስቀል ናብ ቻይና $2.26 ሚልዮን ዋጋ ዘውጽእ ርዳእታ ከምዝልእኽ ኣፍሊጡ። 	On February 19, the Singapore Red Cross announced it would send $2.26 million in aid to China.
1151	en	ti	 Japan donated one million face masks to Wuhan, Turkey dispatched medical equipment, Russia sent more than 13 tonnes of medical supplies to Wuhan, Malaysia announced a donation of 18 million medical gloves to China, Germany delivered various medical supplies including 10,000 Hazmat suits, and the United States donated 17.8 tons of medical supplies to China and promised an additional $100 million in financial support to affected countries.After cases in China seemed to stabilize, the country has been sending aid to various nations hit by the pandemic. 	 ጃፓን ሓደ ሚልዮን ናይ ገጽ ማስክ ናብ ዉሃን ለጊሳ። ቱርኪ ናይ ሕክምና ኣቕሑ ልኢኻ። ሩስያ ልዕሊ 13 ቶን ናውቲ ሕክምና ናብ ዉሃን ሰዲዳ። ማሌዥያ 18 ሚልዮን ናይ ሕክምና ጓንቲ ከምዘወፈየት ሓቢራ። ጀርመን ዝተፈላለዩ 10,000 ሃዝማት ሱት ዘጠቃለለ ናውቲ ሕክምና ኣብጺሃ። ከምኡ’ውን ሕቡራት መንግስታት ኣሜሪካ 17.8 ቶን ናውቲ ሕክምና ናብ ቻይና ኣወፊያ፡ ተወሳኺ 100 ሚልዮን ዶላር ፋይናንሳዊ ሓገዝ ድማ ንውጹዓት ሃገራት ከምተወፊ ምሒላ። ድሕሪ ቻይና ምርግጋኣ ድማ፡ እታ ሃገር ነተን ብቫይረስ ዝተጠቅዓ ሃገራት ሓገዝ ትሰድድ ኣላ። 	Japan donates one million face masks to Wuhan. Turkey sent medical supplies. Russia sends more than 13 tons of medical supplies to Wuhan. Malaysia has donated 18 million medical gloves. Germany delivered medical equipment including 10,000 hazmat suits. The United States has also donated 17.8 tons of medical supplies to China and pledged an additional $100 million in financial aid to oppressed countries. After China stabilized, the country is sending aid to the affected countries.
1152	en	ti	 In March, China, Cuba and Russia sent medical supplies and experts to help Italy deal with its coronavirus outbreak. 	 ኣብ ማርች፣ ቻይና፣ ኩባ፣ ከምኡ እውን ሩስያ ናይ ሕክምና ኣቑሑት ድጋፍን ሞያተኛታትን ናብ ጣልያን ነቲ ናይ ኮሮናቫይረስ ለበዳ ንምምካት ሰዲደን። 	In March, China, Cuba, and Russia sent medical supplies and professionals to Italy to fight the coronavirus outbreak.
1153	en	ti	 Businessman Jack Ma sent 1.1 million testing kits, 6 million face masks, and 60,000 protective suits to Addis Ababa, Ethiopia for distribution by the African Union. 	 ነጋዳይ ጃክ ማ 1.1 ሚልዮን ናይ መርመሪ ኣቕሓ፡ 6 ሚልዮን ናይ ገጽ ማስክ ምስ 60,000ናይ መከላከሊ ክዳን ናብ ኣዲስ ኣበባ፡ ኢትዮፕያ ብሕብረት ኣፍሪቃ ንክዝርጋሕ ሰዲዱ። 	Businessman Jack Ma has sent 1.1 million test kits, 6 million face masks and 60,000 protective clothing to Addis Ababa, Ethiopia for distribution by the African Union.
1154	en	ti	 He later sent 5,000 testing kits, 100,000 face masks and 5 ventilators to Panama. 	 ብድሕሪኡ ናብ ፓናማ 5,000 መመርመሪ መሳርሒ፡ 100,000 ናይ ገጽ ማስክን 5 ቨንቲለተራት ሰዲዱ። 	It then shipped 5,000 test kits, 100,000 face masks and five ventilators to Panama.
1155	en	ti	 Ma also donated medical supplies to Canada.The Netherlands, Spain, Turkey, Georgia, and the Czech Republic expressed their concerns over Chinese-made masks and test kits. 	 ማ እውን ንካናዳ ናይ ሕክምና ቀረባት ለጊሱ። ኔዘርላንድስ፣ ስፔይን፣ ቱርኪ፣ ጂዮርጂያ፣ ከምኡ ውን ቼክ ሪፓብሊክ ብዛዕባ እቶም ኣብ ቻይና ዝስርሑ ማስክታትን ናይ መመርመሪ ናውቲ ዘለዎም ሻቕሎት ገሊጾም። 	Ma also donated medical supplies to Canada. The Netherlands, Spain, Turkey, Georgia, and the Czech Republic have expressed concern about Chinese-made masks and test kits.
1156	en	ti	 For instance, Spain withdrew 58,000 Chinese-made coronavirus testing kits with an accuracy rate of just 30%, meanwhile, the Netherlands recalled 600,000 Chinese face masks which were defective. 	 ንምሳሌ ናይ ትኽክለኝነት መጠኖም 30% ዝኾኑ 58,000 ኣብ ቻይና ዝተሰርሑ ናይ መመርመሪ ኪት ኣወጊዳ፣ ኔዘርላንድ ድማ 600,000 ጸገም ዝተረኸቦም ናይ ቻይና ማስክታት መሊሳ ኣላ። 	For example, it has removed 58,000 Chinese-made test kits with an accuracy rate of 30%, and the Netherlands has returned 600,000 defective Chinese masks.
1157	en	ti	 Belgium recalled 100,000 unusable masks, thought to be from China, but were in fact from Colombia. 	 ቤልጀም 100,000 ጥቕሚ ኣልቦ ማስክታት መለሳ። እዘን ማስክትታ መጀመርያ ካብ ቻይና መጽየን ተባሂሉ እንተነበረ ደሓር ግን ካብ ኮሎምብያ ከምዝመጻ ተረጋጊጹ። 	Belgium returned 100,000 useless masks. The masks were originally thought to have come from China but were later identified as coming from Colombia.
1158	en	ti	 On the other hand, Chinese aid has been well-received in parts of Latin America and Africa.On 2 April, the World Bank launched emergency support operations for developing countries. 	 ብ ኻሊእ ወገን ፣ኣብ ገለ ከባቢታት ላቲን ኣሜሪካን ኣፍሪካን ድማ ናይ ቻይና ርዳእታ ብጽቡቕ ተቐባልነት ረኺቡ እዩ።ኣብ ኣፕሪል 2፣ ናይ ዓለም ባንክ ን ኣብ ዕብየት ዝርከባ ሃገራት ዝኽውን ናይ ርዳእታ መድብ ኣበጊሱ። 	Meanwhile ,Chinese aid has been well received in some parts of Latin America and Africa.On April 2, the World Bank launched an aid program for developing countries.
1159	en	ti	 The WHO has commended the efforts of Chinese authorities in managing and containing the epidemic. 	 WHO ነዚ ለብዒ ኣብ ምሓዝን ምቁጽጻርን ንቻይናውያን ሰበስልጣን ኣመስጊኑዎም። 	WHO thanked Chinese authorities for containing and controlling the outbreak.
1160	en	ti	" The WHO noted the contrast between the 2002–2004 SARS outbreak, where Chinese authorities were accused of secrecy that impeded prevention and containment efforts, and the current crisis where the central government ""has provided regular updates to avoid panic ahead of Lunar New Year holidays"". "	 WHO(ውድብ ጥዕና ዓለም) ምስቲ ኣብ 2002-2004 ዝነበረ ለበዳ SARS ንምክልኻልን ምቁጽጻርን ዝዓንቀፈ ምስጢራውነት ክነጻጸር ከሎ ኣብዚ ናይ ሕጂ ቕልውላው እቲ ማእከላይ መንግስቲ “ኣብቲ ዝቀራረብ ዘሎ ናይ ቻይና ሓድሽ ዓመት ረበሻ መታን ከይለዓል ሓበሬታ ቀጻሊ ይዝርግሕ ኣሎ”ይብል። 	The WHO (World Health Organization) says that in the current crisis, the central government is “constantly disseminating information to avoid unrest during the upcoming Chinese New Year” compared to the secrecy that hampered the prevention and control of the 2002-2004 SARS outbreak.
1161	en	ti	" On 23 January, in reaction to the central authorities' decision to implement a transportation ban in Wuhan, WHO representative Gauden Galea remarked that while it was ""certainly not a recommendation the WHO has made"", it was also ""a very important indication of the commitment to contain the epidemic in the place where it is most concentrated"" and called it ""unprecedented in public health history"".On 30 January, following confirmation of human-to-human transmission outside China and the increase in the number of cases in other countries, the WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC), the sixth PHEIC since the measure was first invoked during the 2009 swine flu pandemic. "	" ኣብ 23 ጃንዋሪ፣ ከም ኣብ ውሃን ናይ ጉዕዞ ምእጋድ ዝምልከት ናይ እቶም ማእኸላዊ ሰበ ስልጣናት ውሳነ ግብረመልሲ፣ ወኪል ናይ WHO ጓደን ጋለያ ዋላኳ እዚ WHO ዝወሰዶ ስጉምቲ ዘይምከር እንተኾነ፣ ብተማሳሳሊ ድማ ነዚ ለበዳ ኣብቲ ብጣዕሚ ዝበዝሓሉ ቦታ ንምቁጽጻር ክበሃል ኣገዳሲ ውሳኔ እዩ"" ነዚ ድማ ""ዘይተሓስበ ናይ ህዝቢ ጥዕና ታሪኽ"" ክብል ጸዊዕዎ። ኣብ 30 ጃንዋሪ፣ ነቲ ካብ ሰብ ናብ ሰብ ከምዝተሓላለፍ ካብ ቻይና ወጻኢ ምስተረጋገጸን ኣብ ካልኦት ሃገራት ድማ ምውሳኽ ቁጽሪ ጉዳያት ምስተራእየ፣ WHO ነዚ ለበዳ Public Health Emergency of International Concern (ዓለምለኸ ትኹረት ዘድልዮ ህዝባዊ ናይ ጥዕና ህጹጽ ኣዋን፣PHEIC)፣ ሻድሻይ PHEIC ክብል ሰይምዎ፣ እዚ ካብ 2009 ኣትሒዙ እቲ ስጉምቲ ክወሰድ ጸኒሑ እዩ። "	On January 23, as a reaction to the decision of the central authorities regarding the travel ban in Wuhan, WHO representative Guden Galea said that although this WHO move is not recommended, it is also an important decision to control the outbreak in the most prevalent area On January 30, after the human-to-human transmission was confirmed outside China and an increase in cases in other countries, the WHO declared the outbreak a Public Health Emergency of International Concern. PHEIC), named it the sixth PHEIC, which has been underway since
1162	en	ti	" WHO Director-General Tedros Adhanom said that the PHEIC was due to ""the risk of global spread, especially to low- and middle-income countries without robust health systems. "	 እቲ PHEIC ብሰንኪ ስግኣት ናይ ዓለማዊ ዝርግሐ፡ ብፍላይ ድማ ናብ ትሑትን ማእከላይን እቶት ምስ ድኹም ናይ ሕክምና ዓቕሚ ዘለወን ሃገራት፡ ምዃኑ መራሒ WHO ቴድሮስ ኣድሓኖም ገሊጹ። 	The PHEIC is due to fears of global spread, especially to low- and middle-income countries with poor medical capacity, WHO chief Tedros Adhanom said.
1163	en	ti	" In response to the implementations of travel restrictions, Tedros stated that ""there is no reason for measures that unnecessarily interfere with international travel and trade"" and that the ""WHO doesn't recommend limiting trade and movement."" "	 ከም ግብረመልሲ ናይ ትግባረ ዕገዳታት ጉዕዞ፡ ቴድሮስ”ንጉዕዞን ንግድን ዝዕንቅፉ ስጉምትታት ኣድላዪ ዝኾነሉ ምኽንያት የለን፡ WHO(ውድብ ጥዕና ዓለም) ከዓ ንግድን ምንቅስቃስን ምዕንቃፍ ኣይድግፎን’ዩ” ኢሉ። 	In response to the implementation of travel bans, Tedros said”there is no reason for measures to disrupt travel and trade, and the WHO(World Health Organization) does not support disruption of trade and movement”.
1164	en	ti	" On 5 February, the WHO appealed to the global community for a $675 million contribution to fund strategic preparedness in low-income countries, citing the urgency to support those countries which ""do not have the systems in place to detect people who have contracted the virus, even if it were to emerge"". "	" ኣብ ፊብሩዋሪ 5፣ WHO ን ዓለምለኻዊ ማሕበረስብ ናይ $675 ሚልዮን ሓገዝ ሕቶ ኣቕሪቡ፣ ን ኣብ ትሑት ኣታዊ ዘለውን ሃገራት ስትራቴጂካዊ ድለውነት ናይ ገንዘብ ድጋፍ ንምግባር፣ ""ዋላ እቲ ቫይረስ ይከሰት፣ በቲ ቫይረስ ዝተለኸፉ ሰባት ንምፍላይ ዘኽ እል ዝተርገሐ ስርዓት የብለንን"" ነዘን ሃገራት ዝግበር ደጋፍ ህጹጽ ክኸውን ኣለዎ "	On February 5, WHO requested $675 million in aid from the international community to provide strategic preparedness funding to low-income countries that “do not have a deployed system to identify infected people even if the virus occurs.” Support for these countries is urgent It must be
1165	en	ti	" Tedros further made statements declaring that ""we are only as strong as our weakest link"" and urged the international community to ""invest today or pay more later"".On 11 February, the WHO in a press conference established COVID-19 as the name of the disease. "	 ቀጺሉ ቴድሮስ “ሓይሊ ሰንሰለትና ክንዲ እቲ ዝደኸመ ኣባልና’ዩ” ክብል ኣዊጁ። ከምኡ’ውን ነቲ ዓለምለኻዊ ሕበረተሰብ “ካብ ድሓር ምጥዓስ፡ ሎሚ ምውፋር” ኢሉ ተማህጸነ። ብዕለት 11, ፌብሩዋሪ፣ WHO(ውድብ ጥዕና ዓለም) ኣብ ዘካየዶ ዛዕባ፡ ነዚ ሕማም ኮቪድ-19 ኢሉ ሸየሞ። 	“The strength of our chain is as much as our weakest member,” Tedros then declared. He also urged the international community to “regret later, engage today”. On February 11, WHO(World Health Organization) designated the disease as COVID-1
1166	en	ti	" On the same day, Tedros stated that UN Secretary-General António Guterres had agreed to provide the ""power of the entire UN system in the response"". "	 ብሓደ መዓልቲ ቴድሮስ ሓፈሻዊ ጸሓፋይ UN ኣንቶንዮ ጉተሬስ ነዚ ንምቅላስ “ምሉእ ሓይሊ ናይ UN ክህብ”ከምዝተሰማምአ ገሊጹ። 	One day, Tedros said UN Secretary-General Antonio Guterres had agreed to “give the full force of the UN” to fight this.
1167	en	ti	" A UN Crisis Management Team was activated as a result, allowing coordination of the entire United Nations response, which the WHO states will allow them to ""focus on the health response while the other agencies can bring their expertise to bear on the wider social, economic and developmental implications of the outbreak"". "	 ከም ውጽኢቱ ብUN ናይ ቅልውላው ምሕደራ ጉጅለ ተዳልዩ። እዚ ከኣ ምውህሃድ ናይ UN ግብረመልሲ ዘፍቅድ ኮይኑ ጥቅሙ ከኣ ኣባላት WHO “ኣብቲ ናይ ጥዕና ጸገም ብምትኳር ክሰርሑ’ም ካልኦት ውዱባት ኣብቲ ዝዓበየ ናይ ማሕበራዊ፡ ቁጠባውን ምዕባለኣዊ ጽልዋታት ክእለቶም ከበርክቱ መታን’ዩ።” 	As a result, a crisis management team was organized by the UN. This allows for the coordination of the UN response and the benefit is that WHO members “focus on the health problem so that other organizations can contribute their expertise to the larger social, economic and development impacts.”
1168	en	ti	" On 14 February, a WHO-led Joint Mission Team with China was activated to provide international and WHO experts on the ground in China to assist in the domestic management and evaluate ""the severity and the transmissibility of the disease"" by hosting workshops and meetings with key national-level institutions and to conduct field visits to assess the ""impact of response activities at provincial and county levels, including urban and rural settings"".On 25 February, the WHO declared that ""the world should do more to prepare for a possible coronavirus pandemic,"" stating that while it was still too early to call it a pandemic, countries should nonetheless be ""in a phase of preparedness"". "	 ብ14 ለካቲት ብWHO ዝምራሕ ሓደ ዝዕላምኡ ጉጅለ ምስ ቻይና ተመስሪቱ። ዕላምኡ ድማ ክኢላታት ዓለምን WHOን ብምውፋር ምስ ኣገደስቲ ሰበስልጣን ዎርክሾፕን ኣኼባታትን ብምክያድ፡ ከምኡ’ውን ጽልዋ ናይ ንጥፈታት ብደረጃ ክልላትን ዞባታትን፡ ከተማታትን ገጠራትን ዘጠቓለለ፡ ብኣካል ብምዕዛብ ነቲ ኣብ ውሽጢ ቻይና ዝካየድ ኣተሓሕዛ ንምድንፋዕን ናይቲ ሕማም ክብደትን ተላባዕነትን ንምጽናዕን እዩ። ብ25 ለካቲት WHO “ዓለም ናይዚ ኮሮናቫይረስ ለበዳ ተኽእሎ ንምድላው ዝያዳ ክትጽዕር ኣለዋ” ክብል ኣዊጁ። ምስ’ዚ ኣከቲሉ ድማ ዋላ’ኳ ሽኡ ለበዳ ክበሃል እንትዘይተኻእለ፡ ሃገራት ኣብ ናይ ምድላው ደረጃ ክጸንሃ ከምዘለወን ሓቢሩ። 	On February 14, a WHO-led single-purpose group was formed with China. Its aim is to engage international and WHO experts to conduct workshops and meetings with key officials, and to observe the impact of activities at regional and regional levels, including urban and rural areas. On February 25, the WHO declared that “the world must do more to prepare for the possibility of this coronavirus pandemic”. He went on to say that although it could not be called an epidemic then, countries should remain in a state of preparedness.
1169	en	ti	" In response to a developing outbreak in Iran, the WHO sent a Joint Mission Team there to assess the situation.On 28 February, WHO officials said that the coronavirus threat assessment at the global level would be raised from ""high"" to ""very high"", its highest level of alert and risk assessment. "	" ኣብ ኢራን ኣጋጢሙ ንዘሎ ናይ ለበዳ ምጅማር መልሲ ኣብ ምውሃብ ፣ እቲ ዘሎ ኹነታት ንምግምጋም፣ ወድብ ዓለም ጥዕና( WHO) ናብ ኢራን ጥሙር ልኡኽ ጉጅለ ሰዲዱ። ኣብ ፊብሩዋሪ 28፣ ናይ WHO ሓለፍቲ ክምዝበሉዎ፣ ናይ ኮርና ቫይረስ ስግኣት ኣብ መላእ ዓለም ካብ ""ልዑል"" ናብ ""ኣዝዩ ልዑል"" ክብ ከምዝብል ብምሕባር፣ እዚ ድማ እስካብ ሐዚ ካብ ዝገበሩዋ ናይ ስግኣት ግምገማ እቲ ዝለዓለ መጥንቀቕታ እዩ። "	In response to the outbreak in Iran , the World Health Organization ( WHO) has sent a joint mission to Iran to assess the situation. On February 28, WHO officials said the threat of the coronavirus would rise from &quot;high&quot; to &quot;very high&quot; worldwide, the highest warning in their threat assessment to date.
1170	en	ti	" Mike Ryan, executive director of the WHO's health emergencies program, warned in a statement that ""This is a reality check for every government on the planet: Wake up. "	" ማይክ ርያን፣ ናይ WHO ህጹጽ መደባት ኣፈጻሚ ዳይሬክተር፣ ኣብ ዝሃቡዎ መግለጺ ""ኩሎም ኣብ እዛ ፕላኔት ዘለው መንግስታት ናይ ሓቅነት ፈተነ ዝግብሩሉ እዩ፡ ንቕሑ"" ክብሉ መጠንቀቕታ ሂቦም። "	&quot;It&#39;s a test of reality for all governments on the planet. Stay awake,&quot; Mike Ryan, WHO&#39;s executive director of emergency programmes, warned in a statement.
1171	en	ti	" This virus may be on its way and you need to be ready,"" urging that the right response measures could help the world avoid ""the worst of it"". "	" እዚ ቫይረስ እዚ ኣብ መንገዲ ክህሉ ይኽእል እዩ ድልዋት ክትኮኑ ድማ ኣለኩም፡""ትኽክለኛ መልሲ ንክወሃቡ ምጉስጓስ ድማ"" ዓለም ካብቲ ዝኽፍእ ጋጣሚ ንክትድሕን ክረድእ ይኽእል እዩ። "	This virus could be on the way and you have to be prepared, and &quot;advocating for the right response&quot; can help save the world from the worst.
1172	en	ti	" Ryan further stated that the current data did not warrant public health officials to declare a global pandemic, saying that such a declaration would mean ""we're essentially accepting that every human on the planet will be exposed to that virus."" "	 ራየን ብዝገለጾ እቲ እዋናዊ ሓበሬታ ነዚ ሕማም ዓለምለኻዊ ለበዳ ዘብሎ ኣይኮነን። ከምዚ ዓይነት ኣዋጅ ምእዋጅ ማለት ድማ “ኩሉ ሰብ ኣብዛ ዓለም በቲ ቫይረስ ከምዝጥቓዕ ምቅባል’ዩ” ክብል ቀጺሉ። 	According to Ryan, the latest information does not make the disease a global pandemic. Announcing such a declaration means “accepting that everyone in the world is infected with the virus,” he said.
1173	en	ti	 On 11 March, the WHO declared the coronavirus outbreak a pandemic. 	 ብ11 ማርች WHO ነዚ ናይ ኮሮናቫይረስ ዝርግሐ ለበዳ ምዃኑ ኣዊጁ። 	On March 11, the WHO declared the outbreak an epidemic.
1174	en	ti	" The Director-General said that the WHO was ""deeply concerned both by the alarming levels of spread and severity, and by the alarming levels of inaction"".The WHO has faced significant criticism for what is seen as inadequate handling of the pandemic, including the late declaration of a public health emergency and the classification of the virus as a pandemic. "	" ናይ ወድብ ጥዕና ዓለም( WHO) ዳይሬክተር ጀነራል ""ብ ናይ እቲ ለበዳ ኣስጋኢ ናይ ዝርጋሐ መጠንን ክቢድነት፣ ብ ኣዝዩ ዘተሓሳስብ ስጉምቲ ዘይምውሳድን፣ ኣዝዩ እናተሓሳሰቦም ከምዝርከብ"" ገሊጾም። ወድብ ጥዕና ዓለም( WHO) ነቲ ለበዳ ዝሓዘሉ መንገዲ ደረጃኡ ዘይሓለወ እዩ ብዝብል፣ በተለይ ዝደንጎየ ናይ ዓለምለኽ ስግኣት ጥዕና ኣዋጅ፣ ነቲ ቫይረስ ድማ ለበዳ ኢሉ ኣብ ምስያም ምድንጓያት ኣር ኣዩ ብዝብል ርኡያት ነቐፌታታት ክወሃቡዎ ጸኒሖም እዮም። "	The World Health Organization ( WHO) Director-General said he was &quot;deeply concerned about the alarming scale and severity of the epidemic, and the lack of action of great concern. The World Health Organization ( WHO) has been criticized for its substandard approach to the epidemic, especially the delayed declaration of a global health threat, and the delay in designating the virus as an epidemic.
1175	en	ti	 The backlash included a petition for the WHO Director-General Tedros Adhanom to tender his resignation, signed by 733,000 people as of 6 April. 	 እዚ ተቓውሞ ንሓላፊ WHO ቴድሮስ ኣድሓኖም ካብ ስልጣን ክወርድ ካብ 6 ኣፕሪል ብ733,000 ውልቀሰባት ዝተፈረመ ጻውኢት የጠቓልል። 	The protests include a call signed by 733,000 individuals since April 6 for the resignation of WHO chief Tedros Adhanom.
1176	en	ti	 On 26 March 2020, dozens of UN human rights experts emphasized respecting the rights of every individual during the COVID-19 pandemic. 	 ብ26 መጋቢት 2020, ብዙሓት ናይ UN ተጣበቅቲ ሰብኣዊ መሰላት ኣብ እዋን’ዚ ናይ COVID-19 ለበዳ መሰላት ውልቀሰባት ክኽበር ከምዘለዎ ጸቂጦም ተዛሪቦም። 	On March 26, 2020, many UN human rights defenders stressed that the rights of individuals must be respected during the COVID-19 pandemic.
1177	en	ti	 The expert group stated that everyone is entitled to life-saving interventions and the government holds this responsibility. 	 ጉጅለ ሰብ ሞያታት ኩሉ ሰብ ኣብ ናይ ሂዎት ኣድሕን ጣልቃ ምእታዋት ምስታፍ ክምዝኽእል ብምሕባር ነዚ ሓላፍነት ድማ መንግስቲ ክምዝሕዞ ኣቐሚጦም። 	The group of experts said everyone can participate in life-saving interventions and the government should take responsibility for this.
1178	en	ti	 The group stressed that the lack of resources or health insurance should never serve as a justification for discrimination against a specific group. 	 እቲ ጉጅለ ናይ ሃፍቲታት ሕጽረት ወይድማ ናይ ጥዕና ኢንሹራንስ ዘይምህላው ን ዝኾነ ጉጅለ ን ምግላል ከም ምኽኒያት ክረኣይ ከምዘይብሉ ኣስሚሩሉ እዩ። 	The group stressed that lack of resources or health insurance should not be seen as a reason to exclude any group.
1179	en	ti	 The experts underscored that every individual has the right to health, including people with disabilities, belonging to minority groups, older people, internally displaced people, the homeless, those living in extremely poor conditions, people in detention, as well as refugees and other unspecified groups in need of government support. 	 ክኢላታት ብዝገልጽዎ ዝኾነ ውልቀሰብ፡ ስንኩላትን፡ ኣባላት ንኡስ-ጉጅለ፡ ኣረግቶት፡ ኣብ ውሽጢ ሃገሮም ዝተመዛበሉ፡ ግዳም ሓደር፡ ድኻታት፡ እስረኛታት ዋላ’ውን ስደተኛታትን ካልኦት ዘይተጠቅሱ ጉጅለታት ዋላ እንተኾኑ፡ መሰል ጥዕና ከም ዘለዎ ይገልጹ። 	Experts say that any individual has the right to health, whether they are disabled, minority group members, the elderly, internally displaced persons, outsiders, the poor, prisoners or even refugees and other unspecified groups.
1180	en	ti	 International governmental organizations are addressing the economic and social impacts of the COVID-19 crisis. 	 ዓለምለኻዊ መንግስታዊ ትካላት ፣ COVID-19 ኣብ ዘስዓቦም ቁጠባዊን ማሕበርዊን ጽልዋታት ኣብ ምፍታሕ ይሰርሑ ኣለዉ። 	International government agencies , are working to address the economic and social impacts of COVID-1
1181	en	ti	 The Organisation for Economic Co-operation and Development has launched a platform to provide timely and comprehensive information on policy responses in countries around the world, as well as viewpoints and advice. 	 ማሕበር ቁጠባዊ ምትሕብባርን ምዕባለን፡ ሃገራዊ ፖሊሲን ግብረመልስን ብዝምልከት፡ እዋናውን ዉሕሉልን ሓበሬታ፡ርእይቶን ምኽርን ናይ ምልውዋጥ መድረኽ ከፊቱ። 	The Economic Cooperation and Development Association (ECDA) has opened a forum for the exchange of timely and intelligent information, views and advice on national policy and response.
1182	en	ti	 From policies to strengthen health systems and the world economy to addressing the effects of lockdown and restrictions on travel, the digital hub includes a Country Policy Tracker, and aims to help countries learn from each other and to facilitate a co-ordinated global response to the coronavirus challenge. 	 ን ናይ ጥዕና ስርዓታት ን ናይ ዓለም ቁጠባ ናይ ምጥንኻር ፖሊሲታት ኣትሒዙ እስካብ ናይ ምዕጻው ን ኣብ ጉዕዞታት ዝተገበረ እገዳታት ዘስዓቦም ጽልዋታት ኣብ ምፍታሕ፡ እቲ ዲጂታላዊ ማእኸል ናይ ሃገራዊ ፖሊሲታት መከታተሊ ዘጠቓለለ ኮይኑ፡ ሃገራት ካብ ንንሕድሕደን ንክመሃሃራን ዝተዋደደ ዐልምለኻዊ መልሲ ንምሃብ ዓላማ ገይሩ ሓገዝ ንምግባር ዓላማ ዘለዎ እዩ። 	In addressing the impact of health systems and global economic recovery policies to closures and travel restrictions, the digital hub includes tracking of national policies and aims to help countries learn from each other and provide a coordinated global response .
1183	en	ti	 The Chinese government has been criticized by the United States, UK Minister for the Cabinet Office Michael Gove, and Brazil President Jair Bolsonaro's son Eduardo Bolsonaro for its handling of the pandemic, which began in the Chinese province of Hubei. 	 መንግስቲ ቻይና በቲ ኣታሕዛ ናይ እዚ ኣብ ሁበይ ፕሮቪንሳ ዝተበገሰ ለበዳ ብሕብረት መንግስታት፡ UK ሚኒስተር ካቢነ ምይክል ጎቭን ኤድዋርዶ ዝተባህለ ወዱ ን ፕረዚደንት ብራዚል ጃይር ቦልሶናሮን ነቐፌታታት በጺሑዎ። 	The Chinese government has come under fire from the United Nations, UK Cabinet Minister Michael Gove and his son Eduardo and Brazilian President Jair Bolsonaro for its handling of the outbreak in Hubei province.
1184	en	ti	 A number of provincial-level administrators of the Communist Party of China (CPC) were dismissed over their handling of the quarantine efforts in Central China, a sign of discontent with the political establishment's response to the outbreak in those regions. 	 ዝተወሰኑ ናይ ቻይና ኮሙኒስት ፓርቲ( CPC) ደርጃ ክልል ኣመሓደርቲ ካብ ኣብ ማእኸላዊ ቻይና ኣብ ዝነበረ ናይ ኳራንታይን ጻዕሪታት ኣብ ዘርኣዩዎ ኣተሓሕዛ ምኽኒያት ካብ ሓላፍነቶም ተስጒጎም እዚ ድማ ኣብቲ ክባቢ ኣብ ዝነበረ ነቲ ለበዳ መልሲ ኣወሃህባ እቲ ፖለቲካዊ ኣካል ከምዘይ ተሓጎሰ ዘርኢ ምልክት እዩ። 	Some Chinese Communist Party ( CPC) regional governors have been sacked for their handling of quarantine efforts in central China, a sign of the political body&#39;s dissatisfaction with the response to the outbreak in the region.
1185	en	ti	 Some commentators believe that this move was intended to protect Chinese Communist Party general secretary Xi Jinping from the public's anger over the coronavirus outbreak. 	 ገለ ርኢቶ ወሃብቲ፣ እዚ ስጉምቲ እዚ፣ ናይ እቲ ኮሙኒስት ፓርቲ ዋና ጸሓፊ ዝኾኑ ሲ ጂፒንግ ካብ ብሰንኪ ናይ ኮረና ቫይረስ ለበዳ ክለዓል ዝኽእል ህዝባዊ ቁጣዐ ንምሕላው ተባሂሉ ዝተገበረ ካምዝኾነ ይኣምኑ። 	Some commentators believe the move was taken to protect Communist Party Secretary-General Xi Jiping from public outrage over the coronavirus outbreak.
1186	en	ti	 Some Chinese officials, e.g. Zhao Lijian rejected an earlier acknowledgement of the coronavirus outbreak starting in Wuhan, in favour of conspiracy theories about the COVID-19 originating from the U.S. or Italy. 	 ክም ጃኦ ሊጂያን ዝበሉ ገለ ናይ ቻይና ሰበ ስልጣናት፣ እቶም ቀዲሞም እቲ ቫይረስ ካብ ዉሃን እዩ ተላዒሉ ብምባል ኣፍልጦ ዝተውሃበሎም ኣካይዳታት ብምንጻግ COVID-19 ካብ ሕቡራት መንግስታት ኣሜሪካ ወይድማ ካብ ጣልያን ተላዒሉ ክኸውን ይኽእል እዩ ዝብሉ ናይ ሽርሒ ምልከታት ድማ ድጋፍ ሂቦም። 	Some Chinese officials, such as Zhao Lijian, have rejected previous claims that the virus originated in Wuhan and supported conspiracy theories that COVID-19 may have originated in the United States or Italy.
1187	en	ti	" The U.S. administration of Donald Trump has referred to the coronavirus as ""Chinese virus"" or ""Wuhan virus"" saying that China's ""censorship supercharged a virus that has now turned into a global pandemic"", which has in turn been criticized by some critics as racism and ""distract[ing] from his administration's failure to contain the disease"". "	 ኣብ ምሕደራ ዶናልድ ትራምፕ ትርከብ U.S. ንኮሮናቫይረስ `ቻይናዊ ቫይረስ`ወይ`ውን `ዉሃን ቫይረስ`ብምባል፡ ቻይና ነቲ ቫይረስ ብምሕብኣ ዓለምለሓዊ ለበዳ ንክኸውን ሓጊዛቶ`ያ ትብል። ብዙሓት ከኣ ከም ዘርኣውን ነቲ ሕማም ናይ ምቑጽጻር ውድቀቶም ዘረሳስዕ ሜላታት`ዩ ኢሎም ነቒፎም። 	The US under Donald Trump has called the coronavirus a `Chinese virus` or `Wuhan virus`, saying China has helped it become a global pandemic by hiding the virus. Many criticized it as a race and a tactic that exacerbates their failure to control the disease.
1188	en	ti	" The Daily Beast obtained a U.S. government cable outlining a communications stratagem with apparent origins in the National Security Council, with the strategy being quoted as ""Everything is about China. "	" ዴይሊ ቢስት ርኡይ ብዝኾነ መልክዑ ካብ ናይ ብሄራዊ ደሕንነት ካውስል ዝረኸቦ ናይ መንግስቲ ኣሜሪካ ናይ ኬብል ንድፊታት ከም ዝሕብሩዋ እቲ ስትራቴጂ ""ኩሉ ነገር ብዛዕባ ቻይና ትባሂሎም ክጥቀሱ ዝኽእሉ እዮም። "	According to US government cable drafts obtained by the Daily Beast from the National Security Council, the strategy is &quot;everything about China.
1189	en	ti	" We're being told to try and get this messaging out in any way possible, including press conferences and television appearances.""Outlets such as Politico, Foreign Policy, and Bloomberg have claimed that China's efforts to send aid to virus-stricken countries is part of a propaganda push for global influence. "	 ኒዚ መልእኽቲ ብዝኾነ መንገዲ ንምውጻእ ንኽንሙክር እናተነገረና ይርከብ፣ ክም ዘገባ ብሉምበርግ ድማ፣ ናይ ቻይና ናብ በቲ ቫይረስ ዝተጠቕዑ ቦታታት ርዳእታ ንምልኣኽ ጻዕሪታት ምግባር፣ ን ናይ ዓለምለኻዊ ጽልዋ ክብሃል ዝግበር ፖሮፖጋንዳ ኣካል እዩ ክብል ሓቢሩ። 	We are being told to try to get the Nizi message out anyway, and according to Bloomberg, China&#39;s efforts to send aid to affected areas are part of the propaganda for so-called global influence.
1190	en	ti	" EU foreign policy chief Josep Borrell warned that there is ""a geo-political component including a struggle for influence through spinning and the 'politics of generosity'"". "	 ናይ EU ወጻኢ ፖሊሲታት ሓላፊ ጆሰፕ ቦረል “ብሽፋን ‘ሓገዝ’ ሃገራት ኣብ ጂኦ-ፖለቲክስ ዘለዎም ጽልዋ ንምዕባይ ክቃለሳ ይርአ ኣሎ” ኢሉ መጠንቐታ ኣሕሊፉ። 	EU foreign policy chief Joseph Borrell warned that “under the guise of &#39;aid&#39;, countries are struggling to increase their influence in geopolitics.”
1191	en	ti	" Borrell also said that ""China is aggressively pushing the message that, unlike the US, it is a responsible and reliable partner."" "	 ከምኡ’ውን ቦረል “ቻይና ዘይከም U.S. ሓላፍነታውን ጽኑዕን ብጻይ ከምዝኾነት መልዕኽቲ ቀጻሊ ተመሓላልፍ”ኢሉ። 	“China continues to send a message that unlike the US, it is a responsible and strong partner,” Borrell said.
1192	en	ti	 China has also called for the US to lift its sanctions off of Syria, Venezuela and Iran, while reportedly sending aid to the latter two countries. 	 ቻይና US ኣብ ልዕሊ ሶርያ፡ ቨነዝዌላን ኢራንን ዘለዋ ዕገዳታት ከተልዕሎ ጻውዒት ኣቅሪባ። ናብ እተን ዳሕረዎት ክልተ ሃገራት ከዓ ረድኤት ትሰድድ ኣላ። 	China has called on the US to lift sanctions on Syria, Venezuela and Iran. It is sending aid to the latter two countries.
1193	en	ti	 Jack Ma's donation of 100,000 masks to Cuba was blocked by US sanctions on 3 April. 	 ናይ ጃክ ማ ን ኩባ ብመልክዕ ሓገዝ ዘበርከቶ 100000 ዝኾን ማስክ ብስንኪ ናይ US ማዕቐብ ኣብ ኣፕሪል 3 ከእገድ ክኢሉ እዩ። 	Jack Ma&#39;s 100,000 masks in aid to Cuba were banned on April 3 due to US sanctions.
1194	en	ti	 US authorities have also been accused of diverting aid meant for other nations to their own country. 	 ናይ ሕቡራት መንግስታት ኣሜሪካ ሰበ ስልጣናት እውን ናብ ካልኦት ሃገራት ዝስደድ ርዳእታ ናብ ባዕሎም ብምጥዋይ እናተኽሰሱ ይርከቡ። 	US officials are also being accused of diverting aid to themselves.
1195	en	ti	 And there have been mask-related disputes reported between other countries, such as Germany, Austria and Switzerland; and the Czech Republic and Italy. 	 ኣብ መንጎ ሃገራት ጀርመን ፣ ኦስትሪያ፣ ስዊዘርላንድ ን ቼክ ሪፐብሊክ ኣብ ምስ ናይ ገጽ መሸፈኒ ማስክ ተተሓሒዙ ዘይምርድዳኣት ተፈጢሩ ክምዝነበረ ዘመላኽቱ ጸብጻባት ነይሮም እዮም። 	There have been reports of disagreements between Germany , Austria, Switzerland and the Czech Republic over face masks.
1196	en	ti	 In addition, Turkey seized hundreds of ventilators destined for Spain. 	 ብተወሳኺ፣ ቱርኪ ንስፐይን ተባሂሉ ዝተሰርሐ ኣማኢት ቨንቲሌተር ኣጊዳቶ። 	In addition, Turkey has banned hundreds of ventilators made for Spain.
1197	en	ti	 In early March, the Italian government criticized the European Union's lack of solidarity with coronavirus-affected Italy. 	 ብመጀመርያ ወርሒ ማርች መንግስቲ ጥልያን ነታ ብኮሮናቫይረስ ዝትጠቕዐት ሃገር ኣብ ምሕጋዝ ሕብረት ኤሮጳ ኣብ ዘርኣዮ ዘይሓድነታውነት ነቒፋቶ። 	In early March, the Italian government criticized the EU for its lack of unity in helping the country.
1198	en	ti	" Maurizio Massari, Italy's ambassador to the EU, said that ""Only China responded bilaterally. "	 ናይ ጥልያን EU ኣምባሳደር ማውሪዚዮ ማሳሪ “ቻይና ጥራይ’ያ ሓድሕዳዊ ግብረመልሲ ሂባ” ኢሉ። 	&quot;Only China has responded,&quot; said Italy&#39;s EU ambassador Maurizio Massari.
1199	en	ti	" Certainly, this is not a good sign of European solidarity."" "	" ብርግጽ፣ እዚ ናይ ኣውሮጳውያን ሓድነት ዝገልጽ ኣይኮነን።"" "	Of course, this does not describe European unity.”
1200	en	ti	 On 22 March, after a phone call with Italian Prime Minister Giuseppe Conte, Russian president Vladimir Putin arranged the Russian army to send military medics, special disinfection vehicles, and other medical equipment to Italy. 	 ኣብ ማርች 22፣ ድሕሪ ምስ ናይ ጣልያን ቀዳማይ ሚንስተር ጁሰፔ ኮንቴ ዝተገበረ ናይ ስልኪ ምይይጥ፣ ናይ ሩስያ ፕሬዝዳንት ቭላድሚር ፑቲን ናብ ጣልያን ወታደራዊ ናይ ሕክምና ናውቲን፣ ፍሉያት ናይ ጸረ-ታህዋሲያን መግበሪ ተሽከርከርቲን ካልኦት ናይ ሜዲካል ናውቲን ናብ ጣልያን ንክልእኽ ን ናይ ሩስያ ሓይሊ ምክልኻል ኣተሓባቢሮም ። 	On March 22, after a telephone conversation with Italian Prime Minister Giuseppe Conte, Russian President Vladimir Putin ordered the Russian Defense Forces to send military medical equipment, special antibiotics and other medical equipment to Italy They coordinated.
1201	en	ti	" Italy's La Stampa newspaper cited an anonymous ""high-level political source"" that 80 percent of Russia's aid was ""useless or of little use to Italy"". "	" ክም ናይ ጣልያን ላ ስትማፓ ጋዜጣ ካብ ሓደ ስዉር ""ለዑል ናይ ፖለቲካ ምንጪ"" ረኸብዮ ብዝበለቶ ሓበሬታ ካብ እቲ ሩስያ ን ጣልያን ዝሓገዝቶ እቲ 80% ""ጥቕሚ ዘይብሉ ውይድማ ን ጣልያን ዘይጠቕማ እዩ ነይሩ""። "	According to information obtained by the Italian newspaper La Stampa from a hidden &quot;high political source&quot;, 80% of Russia&#39;s aid to Italy was &quot;useless waste that did not benefit Italy&quot;
1202	en	ti	" The source accused Russia of embarking on a ""geopolitical and diplomatic"" charm offensive. "	" እቲ ምንጪን ሩስያ ኣብ ""ጂኦፖለቲካዊን ዲፕሎማስያዊን"" ምሕዝነታት ኣቶኪራ ብዝብል እቲ ምንጪ ክሲ የቕርብ። "	The source accuses Russia of focusing on &quot;geopolitical and diplomatic&quot; alliances.
1203	en	ti	 The President of Lombardy, Attilio Fontana, and Italian Foreign Minister Luigi Di Maio dismissed the media reports and expressed their gratitude. 	 ፕረዚደንት ሎምባርዲ ኣቲልዮ ፎንታናን ናይ ጥልያን ሚንስተር ወጻኢ ሉዊጂ ዲ ሜዮን ነቲ ናይ ሚድያ ወረታት ብምኹናን፡ ምስገንኦም ኣቕሪቦም። 	Lombardy President Attilio Fontana and Italian Foreign Minister Luigi Di Maio condemned the media reports and expressed their gratitude.
1204	en	ti	 Russia also sent a cargo plane with medical aid to the United States. 	 ሩስያ እውን ናብ ኣሜሪካ ናይ ሕክምና ኣቑሑ ዝጸዓነት ካርጎ ኣወሮፕላን ሰዲዳ ኣላ። 	Russia has also sent a cargo plane carrying medical supplies to the United States.
1205	en	ti	" Kremlin spokesman Dmitry Peskov said that ""when offering assistance to US colleagues, [Putin] assumes that when US manufacturers of medical equipment and materials gain momentum, they will also be able to reciprocate if necessary."" "	 “ኣብ US ንዝርከቡ መሳርሕትና ረድኤት ክንህብ ከለና፡ [ፑቲን] ናይ US ፋብሪካታት መሳርሒ ሕክምና ደሓን ዝኾነ መርገጺ ምስሓዙ፡ ምስዘድሊ ነቲ ሓገዝ ከማልስዎ ብዝብል ርድኢት’ዩ” ይብል ድሚትሪ ፐስኮቭ ዝተባህለ ወኪል ክረምሊን። 	“When we provide aid to our colleagues in the US, [Putin] does so with the understanding that once US medical device manufacturers take a safe stance, they will return the aid if necessary,” said Dmitry Peskov, a Kremlin spokesman.
1206	en	ti	" The planned NATO ""Defender 2020"" military exercise in Germany, Poland, and the Baltic states, the largest NATO war exercise since the end of the Cold War, will be held on a reduced scale. "	 ኣብ መደብ ዝነበረ ናይ NATO“ዲፈንደር 2020” ዝተባህለ፡ ዝዓበየ ናይ NATO ፈተነ-ኲናት ድሕሪ መፈጸምታ ናይ Cold War፡ ኣብ ጀርመን፡ ፖላንድን ባልቲክስን ክግበር ዝተሓስበ ናይ ውትሕድርና ሙከራ፡ ብትሑት መልክዑ ክካየድ ተወሲኑ። 	NATO&#39;s planned “Defender 2020”, NATO&#39;s largest post-Cold War military exercise in Germany, Poland and the Baltics, has been postponed.
1207	en	ti	" The Campaign for Nuclear Disarmament's general secretary Kate Hudson criticized the Defender 2020 exercise: ""In the current public-health crisis, it jeopardizes the lives not only of the troops from the US and the many European countries participating but the inhabitants of the countries in which they are operating.""The Iranian government has been heavily affected by the virus, with around two dozen parliament members infected as well as fifteen other current or former political figures. "	 ናይ ዲፈንደር 2020 ንጥፈት ብኬት ሃድሰን ዝተበሃለት ሓፈሻዊ ጸሓፊት ናይ ኑክሊያር ዲስኣርማመንት ካምፐይን “ኣብ’ዚ ዘለናዮ ቅልውላው ጥዕና፡ እዚ ፈተነ ሂወት ናይ ብዙሓት ተሳተፍቲ ኣሜሪካውያንን ኤሮጵያውያን ወተሓደራትን ከምኡ’ውን ናይ’ቶም ኣብቲ ፈተነ ዝግበረለን ሃገራት ተቀማጦ ሕብረተሰብ ሓደጋ ከውርድ ይኽእል’ዮ” ብምባል ወቒሳ። መንግስቲ ኢራን በቲ ቫይረስ ብከቢድ’ዩ ተጸልዩ። ክሳብ እስራን ኣርባዕተን ኣባላት ናይ’ቲ ፓርላማ ከምኡ’ውን ኣሰርተ ሓሙሽተን ተወሳኺ ፖለቲካውያን፡ ነበር ኮነ ህልው፡ በቲ ቫይረስ ተለኺፎም ኣለዉ። 	Kate Hudson, secretary-general of the Nuclear Disarmament Campaign, condemned Defender 2020 as “in our current health crisis, the test could endanger the lives of many US and European soldiers involved, as well as the communities of the testing countries.” . The Iranian government has been severely affected by the virus. Up to twenty-four members of parliament and fifteen other politicians, past and present, have been infected.
1208	en	ti	 Iran's President Hassan Rouhani wrote a public letter to world leaders asking for help on 14 March 2020, saying that his country is struggling to fight the outbreak due to lack of access to international markets as a result of the United States sanctions against Iran.The outbreak has prompted calls for the United States to adopt social policies common in other wealthy countries, including universal health care, universal child care, paid family leave, and higher levels of funding for public health. 	 ናይ ኢራን ፕሬዝደንት ሃሰን ሮሃኒ፣ ኣብ ማርች14 2020፣ ናብ ዓለም መራሕቲ ርዳእታ ዝሓትት ዕላው ደብዳቤ ጽሒፎም፣ ብሰንኪ ኣሜሪካ ኣብ ኢራን ዘንበረቶ ማዕቀብ ናይ ዓለምለኸ ዕዳጋ ናይ ምርካብ ዕድል ዘይብሎም ምስምዃኑ፣ሃገሮም ነቲ ለበዳ ኣብ ምቅላስ ኣዝዩ በዳሂ ኮይኑዋ ከምዘሎ ሓቢሮም። እቲ ለበዳ ሕቡራት መንግስታት ኣሜሪካ እውን ልክዕ ከም ካልኦት ሃፍታማት ሃገራት ካም ዩኒቨርሳል ናይ ጥ ዕና ክንክን፣ ዩኒቨርሳል ናይ ህጻናት ክንክን፣ ክፍሊት ዘለዎ ናይ ስድራ ቤት ናይ ስራሕ ፍቓድ ዝ ኣምሰሉን ካልኦት ዓበይቲ ደረጃ ናይ ፐብሊክ ጥዕና ናይ ገንዘብ ድጋፋት ዘጠቓለለ ናይ ማሕበራዊ ፖሊሲ ኣብ ስራሕ ንኸተውዕል ኣገዲዱዋ እዩ። 	Iranian President Hassan Rouhani, on March14 2020, wrote an official letter to world leaders asking for help, saying his country is facing a very challenging fight against the epidemic due to the lack of access to international markets due to US sanctions against Iran. The epidemic forced the United States, like other rich countries, to implement social policy that included universal health care, universal child care, paid family work permits, and other large-scale public health financial supports is.
1209	en	ti	 Political analysts anticipated it may negatively affect Donald Trump's chances of re-election in the 2020 presidential election.Diplomatic relations between Japan and South Korea worsened due to the pandemic. 	 ናይ ፖለቲካ ተንተንቲ ክምዝብሉዎ፣ ኣብ ናይ ዶናልድ ትራምፕ ኣብ 2020 ፕሬዝዳንታዊ መረጻ መሊሶም ናይ ምምራጽ ዕድሎም ኣሉታዊ ጽልዋ ክሕድር ይኽእል እዩ ኢሎም። ኣብ መንጎ ደቡብ ኮሪያን ጃፓንን ዘሎ ዲፕሎማሲያዊ ርክብ ብ ሰንኪ እዚ ለበዳ ተጋዲዱ ይርከብ። 	Political analysts say it could have a negative impact on Donald Trump&#39;s chances of re-election in the 2020 presidential election. Diplomatic relations between South Korea and Japan have been strained by the outbreak.
1210	en	ti	" South Korea criticized Japan's ""ambiguous and passive quarantine efforts"" after Japan announced anybody coming from South Korea will be placed in two weeks' quarantine at government-designated sites. "	" ደቡብ ኮሪያ ድሕሪ ጃፓን ማንም ካብ ደቡብ ኮሪያ ዝመጽእ ውልቀ ሰብ ኣብ መንግስቲ ዘዳለዎ ቦታ ን ክልተ ሰሙናት ክቕመጥ እዩ ምባላ፡ ""ግልጽነት ዝጎድሎን ቅልጡፍ ዘይኮነን ናይ ኳራታይን ጻዕሪታት""ብምባል ኮኒናቶ። "	South Korea has condemned Japan&#39;s decision to quarantine anyone coming from South Korea for two weeks.
1211	en	ti	 The South Korean society was initially polarized on President Moon Jae-in's response to the crisis. 	 ሕብረተሰብ ደቡብ ኮርያ ብናይ ፕረዚደንት ሙን ጀይ-ኢን ግብረመልሲ ኣብዚ ግዚ ቕልውላው መጀመርያ ተሓጒሶም። 	South Korean society was initially pleased with President Moon Jae-in&#39;s response to the crisis.
1212	en	ti	 Many Koreans signed petitions either calling for the impeachment of Moon over what they claimed to be government mishandling of the outbreak, or praising his response.The pandemic has allowed countries to pass emergency legislation in response. 	 ብዙሓት ኮሪያውያን ውይ ብሰንኪ እቲ መንግስቲ ነቲ ለበዳ ዝሓዘሉ መንግዲ ግጉይ ብምባል ሙን ናብ ሕጊ ንኽቀርቡ ወይድማ ብ ምውዳስ ናይ ፊርማ ምትእኽኻብ ኣብ ምግባር ይርከቡ። እዚ ለበዳ ሃገራት ህጹጽ ኣዋጃት ንኽሕልፋ ኣኽኢሉ እዩ። 	Many Koreans are collecting signatures either to prosecute Moon or in praise of him for the government&#39;s mishandling of the outbreak. The outbreak has led to states of emergency.
1213	en	ti	 Some commentators have expressed concerns that it could allow governments to strengthen their grip on power. 	 ገለ ርኢቶ ወሃብቲ መንግስቲታት ናይ ስልጣን ትሕዝቶኦም ንኸጠንክሩ ክገብሮም እዩ ኢሎም ስክፍታኦም ይገልጹ ኣለዉ። 	Some commentators are concerned that it will cause governments to strengthen their hold on power.
1214	en	ti	 In Hungary, its parliament voted to allow the prime minister, Viktor Orbán, to rule by decree indefinitely, suspend parliament as well as elections and punish those deemed to have spread false information about the virus and the government's handling of the crisis. 	 ኣብ ሃንጋሪ፣ እቲ ፓርላማ ቀዳማይ ሚኒስተር ቪክቶር ኦርባን፣ ብ ኣዋጅ ነዝይተወሰነ ግዜ ን ኽገዝኡ ድሕሪ ምፍቃድ፣ ፓርላማን መረጻን ጠጠው ከብሉን ኣብቶም ብዛዕባ እቲ ቫይረስን ናይ መንግስቲ ነቲ ጉዳይ ዝሓዘሉ መንገዲታትን ናይ ሓሶት ሓብሬታ ዘጋውሑ ድማ ንኽቅጽዑ ወሲኑ። 	In Hungary, the parliament allowed Prime Minister Viktor Orban to rule indefinitely by decree, suspended parliament and elections and punished those who spread false information about the virus and the government&#39;s handling of the issue.
1215	en	ti	 The coronavirus outbreak has been blamed for several instances of supply shortages, stemming from globally increased usage of equipment to fight the outbreaks, panic buying, and disruption to factory and logistic operations. 	 ናይ ኮሮናቫይረስ ለበዳ ን ብዙሓት ናይ ኣቕርቦት ሕጽረታት፣ ነቲ ቫይረስ ንምቅላስ ክበሃል ናይ ኣቑሑ ምጥቃም ዝወሰኸ ምስ ምዃኑ፣ በ ድንጋጸ ንዝግበሩ ዕድጊታት ፣ ናይ ፋብሪካን ናይ ሎጂስቲክ ስራሕቲ ብምቁርራጽ ክም ምኽኒያት ዝጥቀስ እዩ። 	The coronavirus pandemic is cited as the reason for many supply shortages, with the increased use of goods to fight the virus, by compassionate procurement , shutting down factory and logistics operations.
1216	en	ti	 The United States Food and Drug Administration has issued warnings about shortages of drugs and medical equipment due to increased consumer demand and supplier disruption. 	 ናይ ዩናይትድ ስቴትስ ናይ ምግቢን መድሓኒትን ምምሕዳር ብሰንኪ እቲ ወሲኹ ዘሎ ናይ ዓማዊል ድልየትን ናይ መቕረብቲ ምቁርራጻትን ሕጽረት መድሓኒትን ናይ ሕክምና ኣቑሑን ከጋጥም ክምዝኽ እል ኣጠንቂቑ። 	The US Food and Drug Administration has warned of a shortage of drugs and medical supplies due to increased customer demand and supply disruptions.
1217	en	ti	 Several localities also witnessed panic buying that led to shelves being cleared of grocery essentials such as food, toilet paper, and bottled water, inducing supply shortages. 	 ኣብ ውሱናት ቦታታት ከኣ ካብ ፍርሒ ዝተላዕለ ልዕሊ መጠን ዕድጊ ተራእዩ። በዚ ምኽንያት ምውዳእ መግቢ፡ ናይ ሽቓቅ ሶፍትን ዕሹግ ዝስተ ማይን ሕጽረታት ቀረብ ኣስዒቡ። 	In certain places, there was over-purchasing out of fear. As a result, food shortages, toilet soap and bottled drinking water were in short supply.
1218	en	ti	 The technology industry in particular has been warning about delays to shipments of electronic goods. 	 ናይ ቴክኖሎጂ ኢንዱስትሪ ብዛዕባ ምድንጓያት ምልኣኽ ናይ ኤሌትሮኒክ ኣቑሑት ብፍሉይ ከጠንቅቕ ጸኒሑ እዩ። 	The technology industry has been specifically warning about delays in shipping electronics.
1219	en	ti	 According to WHO director-general Tedros Adhanom, the demand for personal protection equipment has risen 100-fold. 	 ብመሰረት ናይ WHO ዳይሬክተር ዶክተር ቴድሮስ ኣድሓኖም ፣ ን ናይ ወልቀም መሐለዊ ኣቑሑት ድልየት ብ 100 ዕጽፊ ወሲኹ ኣሎ። 	According to WHO Director-General Tedros Adhanom Ghebreyesus , the demand for personal protective equipment has increased 100-fold.
1220	en	ti	 This demand has led to the increase in prices of up to twenty times the normal price and also induced delays on the supply of medical items for four to six months. 	 ብሰንክዚ ጠለብ፡ዋጋታት ክሳብ ስራ ዕጽፊ ንቡር ክብ ክብልን ከምኡ’ውን ምብጽጻሕ ናውቲ ሕክምና ብኣባርባዕተ ክሳብ ሽድሽተ ኣዋርሕ ክደናጎይ ክኢሉ። 	Due to this demand, prices have doubled and deliveries of medical supplies have been delayed by four to six months.
1221	en	ti	 It has also caused a shortage of personal protective equipment worldwide, with the WHO warning that this will endanger health workers. 	 ዓለምለኻዊ ሕጽረት ናይ ነብሰ ምክንኻን ናውቲ’ውን ኣምጺኡ። ክሳብ ኣብ ሂወት ሰራሕተኛታት ሕክምና ሓደጋ ከምዘውርድ ው.ጥ.ዓ የጠንቕቕ። 	It also brought about a global shortage of self-care items. The WTA warns that it can even endanger the lives of medical personnel.
1222	en	ti	 In Australia, the pandemic provided a new opportunity for daigou shoppers to sell Australian products into China. 	 ኣብ ኣውስትራልያ ብምኽንያት እዚ ለበዳ ንደይጉ ሾፐርስ ውጽኢቶም ንቻይና ክሸጡ ዕድል ረኺቦም። 	In Australia, the outbreak has given Daegu shoppers the opportunity to sell their products to China.
1223	en	ti	 The activity has created a shortage of baby formula in some supermarkets and was subsequently banned by the Australian government.Despite the high prevalence of COVID-19 cases in Northern Italy and the Wuhan region, and the ensuing high demand for food products, both areas have been spared from acute food shortages. 	 እዚ ንጥፈት ሕጽረት ናይ ህጻናት ፎርሙላ ኣብ ገለ ሱፐር-ማርኬትታት ስለዘምጸአ ብመንግስቲ ኣውስትራልያ ተኸልኪሉ። ዋላ’ኳ ሰሜናዊ ጥልያንን ዉሃንን ብ COVID-19ን ምስኡ ዝመጽእን ሓያል ጠለብ መግብን ዝያዳ እንተጠቅዓ፡ ክልቲአን ሃገራት ብሕጽረት መግቢ ኣይተሸገራን። 	This activity caused a shortage of baby formula in some supermarkets and was banned by the Australian government. Although northern Italy and Wuhan have been hit hardest by COVID-19 and the strong food demand that comes with it, neither country has suffered from food shortages.
1224	en	ti	 Measures by China and Italy against the hoarding and illicit trade of critical products have been successful, avoiding acute food shortages that were anticipated in Europe as well as in North America. 	 እቲ ብቻይናን ጣልያንን ኣብ ልዕሊ ኣገደስቲ ኣቑሑት ምውህላልን ብኹቡር ምሻጥን ዝተገብረ ስጉምቲ ዕውት ነይሩ፣ ኣብ ኣውሮጳን ሰሜን ኣሜሪካን ክኸውን ዝኽእል እዩ ተባሂሉ ዝተገመተ ከቢድ ሕጽረት ምግቢ፣ ክውገድ እውን ተኻኢሉ እዩ። 	The measures taken by China and Italy to accumulate and sell essential commodities at high prices were successful, and severe food shortages in Europe and North America were avoided.
1225	en	ti	 Northern Italy with its significant agricultural production has not seen a large reduction, but prices may increase according to industry representatives. 	 ሰሜናዊ ጣልያን ምስ እቲ ዓብዪ ሕርሻዊ ምህርቲታታ፣ ዓብዪ ናይ ምህርቲ ምቕናስ እኳ እንተዘየጋጠማ፣ ብመሰረት ናይ ኢንዱስትሪ ወኪላት ግን ናይ ዋጋ ምውሳኽ ክህሉ ክምዝኽእል ገሊጾም። 	Northern Italy, with its large agricultural production, has not experienced a major decline in production, but there is a possibility of price increases, according to industry representatives.
1226	en	ti	 Empty food shelves were only encountered temporarily, even in Wuhan city, while Chinese government officials released pork reserves to assure sufficient nourishment of the population. 	 ባዶ መኽዘናት መግቢ ንግዚኡ ጥራይ’ዩ ተራእዩ፡ ኣብ ከተማ ዉሃን’ውን ዋላ እንተኾነ። ሓለፍቲ መንግስቲ ቻይና ነቲ ኣብ መኽዘን ዝነበረ ስጋ ሓሽማ ንህዝቢ ክቕልብ ናብ ሓፋሽ ዘርጊሖም። 	Empty food pantries have only been seen temporarily, even in Wuhan. Chinese government officials released the warehoused meat to the public.
1227	en	ti	 Similar laws exist in Italy requiring food producers to keep reserves for such emergencies. 	 ኣብ ጣልያን እውን መፍረይቲን ህጹጽ እዋናት ዝኾን መሐለውታ ንክሕዙ ዘገድስ ተመሳሳሊ ሕጊ ኣሎ። 	There is a similar law in Italy that requires manufacturers to hold emergency protection.
1228	en	ti	 Damage to the global economy has been felt in China: according to a media report on 16 March, the economy in China was very hard hit in the first two months of 2020 due to the measures taken by the government to curtail virus spread, and retail sales plunged 20.5%. 	 ኣብ'ቲ ዓለምለኻዊ ቁጠባ ዝበጸሐ ጉድኣት ኣብ ቻይና እዩ ተሰሚዑ ብመሰረት ናይ ማርች 16 ናይ ሚድያ ጸብጻብ፡ ብምኽኒያት መንግስቲ ናይቲ ቫይረስ ምዝማት ንምቁራጽ ዝወሰዶም ስጉምቲታት ናይ ቻይና ቁጠባ ኣብቶም ናይ 2020 መጀምሪያ ክልተ ሰሙናት ኣዝዩ ተሃስዩ ነይሩ፡ ናይ ችርቻሮ ዋጋ ድማ ብ 20.5% ንሂሩ እዩ። 	The damage to the global economy was felt in China According to a March 16 media report, the Chinese economy was hit hard in the first two weeks of 2020 due to the government&#39;s measures to curb the spread of the virus, with retail prices falling 20.5%.
1229	en	ti	 As mainland China is a major economy and manufacturing hub, the viral outbreak has been seen to pose a major destabilizing threat to the global economy. 	 ሜይን ላንድ ቻይና ዓብዪ ናይ ቁጠባን ናይ ፍርያትን ማእኸል ከም ምዃኑ፣ እቲ ናይ ቫይረስ ላብዕ ንናይ ዓለምለኸ ቁጠባዊ ንጥፈታት ኣዝዩ ዓቢዪ ናይ ምዕናው ስግኣት ከምጽኣሉ ከምዝኽእል ተራእዩ እዩ። 	Mainland China is a major economic and manufacturing center, and the pandemic could pose a serious threat to global economic activity.
1230	en	ti	 Agathe Demarais of the Economist Intelligence Unit has forecast that markets will remain volatile until a clearer image emerges on potential outcomes. 	 ኣጋቴ ዴማሪያስ ዝተብሃለ ካብ ኢኮኖሚስት ኢንተለጀንስ ክፍሊ ዝኾነ ኣብ ዕዳጋ ዘሎ ዘይምርግጋዕ ፣ እስካብ ኣብ'ቲ ክመጽእ ዝኽእል ውጽኢት ንጹር ምስሊ እስካብ ዝዝርክብ ክምዝቕጽሉ ትብያኡ ኣቐሚጡ። 	Agate Demarias of the Economist Intelligence division predicted that the volatility in the market , will continue until a clear picture is available on the likely outcome.
1231	en	ti	 In January 2020, some analysts estimated that the economic fallout of the epidemic on global growth could surpass that of the 2002–2004 SARS outbreak. 	 ኣብ ጃኑዋሪ 2020፡ገለ ተንተንቲ እዚ ለብዒ ኣብ ዓለማዊ ዕቤት ከስዕቦ ዝክእል ቁጠባዊ ውድቀታት ነቲ ኣብ 2002-2004 ምስ ምልዓል ሳርስ ዘጋጠመ ውድቀት ክሓልፎ ከምዝክእል ይግምቱ። 	In January 2020, some analysts predict that the pandemic&#39;s economic slowdown in global growth could surpass the fallout from the 2002-2004 SARS outbreak.
1232	en	ti	 One estimate from an expert at Washington University in St. Louis gave a $300+ billion impact on the world's supply chain that could last up to two years. 	 ክም ሓደ ናይ ኣብ St. Louis ዝርከብ ዋሺንግቶን ዩኒቨርሲቲ( Washington University) በዓል ሞያ ትንበያ፣ ኣብ ናይ ዓለም ኣቕርቦት ሰንሰለት እስካብ $300+ ቢልዮን ዝኾን ን ኽልተ ዓመት ዝጸንሕ ጽልዋ ክህሉ እዩ። 	As one of the in St. Louis. Louis, a Washington University forecaster, predicts a two-year impact of up to $300+ billion on the global supply chain.
1233	en	ti	" The Organization of the Petroleum Exporting Countries (OPEC) reportedly ""scrambled"" after a steep decline in oil prices due to lower demand from China. "	" ትካል ናይ ፔትሮሊየም ኤክስፖርት ዝገብራ ሃገራት (OPEC) ብ ሰንኪ ብ ወገን ቻይና ዘጋጠመ ትሑት ናይ ነዳዲ ድልየት ናይ ነዳዲ ዋጋ ኣዝዩ ዝወረድ ምስ ምዃኑ እቲ ትካል ""ክምዝተረበሸ"" ጸብጻባት ይሕብሩ። "	The Organization of Petroleum Exporting Countries (OPEC) is reportedly &quot;upset&quot; as oil prices fall sharply due to low demand from China.
1234	en	ti	 Global stock markets fell on 24 February due to a significant rise in the number of COVID-19 cases outside mainland China. 	 ካብ ቻይና ወጻኢ COVID-19 ዝተረኽቦም ሰባት ቁጽሮም ብምውሳኹ ብ 24 ፌብሩዋሪ ዓለምለኻዊ ዕዳጋታት ወሪደን። 	Global markets fell on February 24 as the number of COVID-19 cases outside China increased.
1235	en	ti	 On 27 February, due to mounting worries about the coronavirus outbreak, various U.S. stock indexes including the NASDAQ-100, the S&amp;P 500 Index, and the Dow Jones Industrial Average posted their sharpest falls since 2008, with the Dow falling 1,191 points, the largest one-day drop since the financial crisis of 2007–08. 	 ኣብ 27 ፌብሩዋሪ፣ ብብዕባ ናይ ኮሮናቫይረስ ለበዳ እኩብ ጭንቀት ምኽንያት፣ ዝተፈላለዩ ናይ U.S. ስቶክ ኢንዴክሳት NASDAQ-100፣ S&amp;P 500 ኢንዴክስን ሓዊሱ ዶው ጆንስ ኢንዳስትርያል ማእኸላይ ካብ 2008 ዝበልሐ ውድቀት ፖስት ጌሮም፣ እቲ ዶው ምስ ምውዳቑ ተተሓሒዙ 1191 ነጥቢታት፣ ድሕሪ ናይ 2007-08 ናይ ፋይናንስ ቅልውላው ኣብ መዓልቲ ዘጋጠመ ልዑል ውድቀት እዩ። 	On February 27, due to collective anxiety over the coronavirus pandemic, various US stock indexes including the NASDAQ-100, S&amp;P 500 index and the Dow Jones Industrial Average posted their biggest fall since 2008, with the Dow falling 1191 points, after 20 years 07-08 of The financial crisis is the high point of the day.
1236	en	ti	 All three indexes ended the week down more than 10%. 	 ኣብ መወዳእታ’ዚ ሰሙን ሰለስቲአን ምልክታት ብ10% ወሪደን። 	By the end of the week, all three brands were down 10%.
1237	en	ti	 On 28 February, Scope Ratings GmbH affirmed China's sovereign credit rating, but maintained a Negative Outlook. 	 ኣብ ፌብሩዋሪ 28፣ Scope Ratings GmbH ናይ ቻይና ናይ ልቓሕ ደረጃ ኣረጋጊጹ፣ እንተኾነ Negative Outlook (ኣሉታዊ ውጽኢት) ረኹቡ። 	On February 28, Scope Ratings GmbH affirmed China’s Credit Rating, but acquired a Negative Outlook.
1238	en	ti	 Stocks plunged again based on coronavirus fears, the largest fall being on 16 March. 	 ብ16 ማርች ዕዳጋታት ካብ ፍርሒ ኮሮናቫይረስ ዝተበገሰ ዝዓበየ ውድቀት ኣርእየን። 	On March 16, markets fell the most on fears of the coronavirus.
1239	en	ti	 Many consider an economic recession to be likely. 	 ብዙሓት ናይ ቁጠባዊ ቅልውላው ከጋጥም ከምዝኽእል ይግምቱ። 	Many predict an economic crisis.
1240	en	ti	 Economist Mohamed El-Erian praised central banks' and states' timely emergency measures. 	 ክኢላ ቁጠባ መሓማድ ኢል-ኢርያን ነተን ብማእከላዊ ባንክታትን ሃገራትን ዝተወስደ እዋናዊ ህጹጽ ስጉምትታት ኣመስጊኑ። 	Economist Mohammad El-Irian thanked the timely emergency measures taken by central banks and countries.
1241	en	ti	 Central banks are reacting more quickly than they did to the 2008 financial crash. 	 ማእኸላዊ ባንክታት ካብ እቲ ናይ 2008 ቁጠባዊ ውድቀት ብዝቐልጠፈ ግብረመልሲ ይህባ ኣለዋ። 	Central banks are reacting faster than the 2008 recession.
1242	en	ti	 Tourism is one of the worst affected sectors due to travel bans, closing of public places including travel attractions, and advice of governments against any travel all over the world. 	 ብ ሰንኪ ናይ ጉዕዞ እገዳታት፣ ናይ ጉዕዞ መስሕባት ሓዊሱ ህዝባዊ ቦታት ምዕጻው፣ ብ መንግስቲታ ኣብ መላእ ዓለም ዝኾነ ዓይነት ጉዕዞ ኽግበር የብሉን ዝብሉ ምኽሪታት፣ ናይ ቱሪዝም ሴክተር ካብቶም ኣዝዮም ዝተሃሰዩ እዩ። 	The tourism sector is among the worst affected by travel bans, closures of public places including travel attractions, and government no-travel advice around the world.
1243	en	ti	 As a consequence, numerous airlines have cancelled flights due to lower demand, including British Airways, China Eastern Airlines, and Qantas, while British regional airline Flybe collapsed. 	 ከም ሓደ ውጽኢቱ፡ ብዙሓት መንገድታት ኣየር፡ ከም ብሪቲሽ ኤርዌይስ፡ ቻይና ኢስተርን ኤርላይንስን ኳንታስ በረራታተን ክስርዛ ከለዋ፡ ብሪቲሽ ሪጅናል ኤርላይን ፍላይቢ ደስኪሉ። 	As one result, many airlines, such as British Airways, China Eastern Airlines and Qantas canceled flights while British regional airline Flybe was suspended.
1244	en	ti	 The impact on the cruise line industry was at a level never seen before. 	 ኣብ ናይ ባህሪ ቱሪዝም ዘምጽኦ ጽልዋ ቅድሚ ሕጂ ተራእዩ ኣብ ዘይፈልጥ ደረጃ’ዩ በጺሁ። 	Its impact on nature tourism has reached an unprecedented level.
1245	en	ti	 Several train stations and ferry ports have also been closed. 	 ብዙሓት ናይ ባቡር ጣብያታትን ናይ ፌሪ ወደባትን እውን ተዓጽየን ይርከባ። 	Many train stations and ferry ports are also closed.
1246	en	ti	 The epidemic coincided with the Chunyun, a major travel season associated with the Chinese New Year holiday. 	 እቲ ለበዳ ምስ እቲ ቹንዩን ተባሂሉ ዝጽዋዕ ምስ ናይ ቻይና ሓዱሽ ዓመት ዝተሓሓዝ ዋና ናይ ጉዕዞ ወቕቲ ተገጣጢሙ። 	The outbreak coincided with the main travel season, called Chunyun, which coincides with the Chinese New Year.
1247	en	ti	 A number of events involving large crowds were cancelled by national and regional governments, including annual New Year festivals, with private companies also independently closing their shops and tourist attractions such as Hong Kong Disneyland and Shanghai Disneyland. 	 ዓበይቲ ምድላዋት ሓዊሱ ብዙሓት ምድላዋት ብ ብሄራዊን ክልላዊን መንግስቲታት ት ኣጊዶም፡ እዞ ኦም ድማ ዓመታዊ ናይ ሓዱሽ ዓመት ፌስቲቫላት ዘጠቓልል ኮይኑ፡ ናይ ውልቀ ትካላት ድማ ብወገኖም ሹቓቶምን ናይ ቱሪስት ቦታት ክም ሆንግ ኮንግ ዲዝኒ ላንድ ዝ ኣምሰሉ ዓጺዮም ። 	Many events, including major events, have been banned by national and regional governments, including annual New Year&#39;s festivals, while private companies have closed their shops and tourist attractions such as Hong Kong Disneyland.
1248	en	ti	 Many Lunar New Year events and tourist attractions have been closed to prevent mass gatherings, including the Forbidden City in Beijing and traditional temple fairs. 	 ብዙሓት መደባት ናይ ቻይናውያን ሓድሽ ዓመትን ሰሓብቲ ቱሪዝምን ከም ናይ በይጂንግ ፎርቢድን ሲቲ ን ካልኦትን ምትእኽኻባት ንምውጋድ ተባሂሉ ከምዝዕጸዋ ተገይሩ እዩ። 	Many Chinese New Year events and tourist attractions such as Beijing Forbidden and City have been closed to avoid gatherings.
1249	en	ti	 In 24 of China's 31 provinces, municipalities and regions, authorities extended the New Year's holiday to 10 February, instructing most workplaces not to re-open until that date. 	 ካብተን 31 ናይ ቻይና ግዝኣታት፣ ማዘጋጃ ቤታት ን ክልላትን፣ ኣብተን 24 ሰብ ስልጣናት ናይ ሓዱሽ ዓመት በዓላት ናብ ፌብሩዋሪ 10 ዘናውሑ እንትኾን ኩሎም ናይ ስራሕ ቦታታት ድማ እስካብ እቲ መዓልቲ ከይኽፍቱ ድማ መምርሒ ሓሊፉ እዩ። 	Of China&#39;s 31 provinces, municipalities and regions, 24 have extended New Year&#39;s holidays to February 10 and all workplaces have been ordered not to open until that date.
1250	en	ti	 These regions represented 80% of the country's GDP and 90% of exports. 	 እዞም ክልላት ካብ ኣጠቓላሊ ናይታ ሃገር GDP 80% ዝውክላ እንትኾና፣ ካብ ኤክስፖርት ድማ ነቲ 90% ዝውክላ እየን። 	These regions represent 80% of the country&#39;s total GDP and 90% of exports.
1251	en	ti	 Hong Kong raised its infectious disease response level to the highest and declared an emergency, closing schools until March and cancelling its New Year celebrations.The retail sector has been impacted globally, with reductions in store hours or temporary closures. 	 ሆንኮንግ ነቲ ናይ ተመሓላለፍቲ ሕማማት ግብረመልሱ ናብቲ ዝለዓለ ጥርዚ ክብ ኣቢሉ፡ቤት-ትምህርታት ክሳብ መጋቢት ብምዕጻውን ጽንብላት ሓድሽ ዓመት ብምስራዝን ኩነት ሕጹጽነት ኣዊጃ። ብምኽንያት ምጉዳል ሰዓታት ሸቐጥን ምዕጻው ድኳናትን ኣብ ዕዳጋታት ዓለም ጽልዋ ኣውሪዱ። 	Hong Kong has declared a state of emergency by closing schools until March and canceling New Year&#39;s celebrations. It affected world markets due to reduced trading hours and shop closures.
1252	en	ti	 Visits to retailers in Europe and Latin America declined by 40%. 	 ብዝሒ በጻሕቲ ድኳናት ኣብ ኤሮጳን ላቲን ኣሜሪካን ብ40% ጎዲሉ። 	The number of store visitors decreased by 40% in Europe and Latin America.
1253	en	ti	 North America and Middle East retailers saw a 50–60% drop. 	 ናይ ሰሜን ኣሜርካን ማእኸላይ ምብራቕን ቸርቸርቲ ካብ 50–60% ዝኾን ቕነሳ ኣጋጢምዎም። 	North American and Middle Eastern retailers experienced discounts of 50–60%.
1254	en	ti	 This also resulted in a 33–43% drop in foot traffic to shopping centres in March compared to February. 	 ብሰንኪ ዚ`ውን ኣብ ናይ ዕድጊ ማእከላት ብ ማርች ዝተራእየ ብዝሂ ናይ እግረኛታት ምስ ናይ ፌብሩዋሪ ክነጻጽር ከሎብ33–43% ጎዲሉ። 	As a result, the number of pedestrians in shopping malls decreased by 33–43% in March compared to February.
1255	en	ti	 Shopping mall operators around the world imposed additional measures, such increased sanitation, installation of thermal scanners to check the temperature of shoppers, and cancellation of events.According to a United Nations Economic Commission for Latin America estimate, the pandemic-induced recession could leave between 14 and 22 million more people in extreme poverty in Latin America than would have been in that situation without the pandemic. 	 ኣብ መላእ ዓለም ዘለው ናይ ዕዳጋ ማእኸላት፣ ከም ናይ ገደብ ምውሳኻት፣ ናይ ሸመትቲ ሙቐት ንምልካዕ ናይ ተርማል ስካነር ምትእትታው፣ ከምኡ እውን ናይ መደባት ምስራዝ ዝበሉ ተወሳኺ ስጉምትታት ኣተኣታትዮም እዮም። ብመሰረት United Nations Economic Commission for Latin America(ናይ ላቲን ኣሜሪካ ናይ ሕቡራት መንግስታት ናይ ቁጠባ ኮሚሽን) ግምት፣ እቲ ለበዳ ዘኸተሎ ዝሕተላ እቲ ለበዳ እንተዘይህሉ ከኸትል ካብ ዝኽእል ኣብ ላቲን ኣሜሪካ ዝያዳ ንኣስታት 14 ክሳብ 22 ሚሊዮን ሰባት ኣብ ኣዝዩ ትሑት ናይ ድኽነት ደረጃ ከብጽሖም ይኽእል እዩ። 	Shopping centers around the world have introduced additional measures, such as increased restrictions, the introduction of thermal scanners to measure shoppers&#39; temperatures, and cancellations. According to the United Nations Economic Commission for Latin America, the slowdown caused by the pandemic could leave about 14 to 22 million people in Latin America at a much lower level of poverty than it would have been in the absence of the pandemic .
1256	en	ti	 In January and February 2020, during the height of the epidemic in Wuhan, about 5 million people in China lost their jobs. 	 ኣብ ጃኑዋሪን ለካቲትን 2020, ኣብ ዉሃን ኣብ ግዜ ልዑል ጻዕቂ ናይ’ዚ ለብዒ፡ ኣስታት 5 ሚልዮን ህዝቢ ቻይና ስራሕ ኣልቦ ኮይኖም። 	In January and February 2020, about 5 million Chinese people lost their jobs in Wuhan during the height of the outbreak.
1257	en	ti	 Many of China's nearly 300 million rural migrant workers have been stranded at home in inland provinces or trapped in Hubei province.In March 2020, more than 10 million Americans lost their jobs and applied for government aid. 	 መብዛሕትኦም ናይ ቻይና 300 ሚሊዮን ናይ ገጠር ስደተኛ ሰራሕተኛታት ኣብ ደሴት ዝርከቡ ገዛውቲ ተበታቲኖም ይርከቡ፣ ወይ ድማ ኣብ ሁበይ ግዝኣት ተሓይሮም ይርከቡ። ኣብ ማርች 2020, ልዕሊ 10 ሚልዮን ኣሜሪካውያን ስራሕ ስኢኖም ናብ ናይ መንግስቲ ድጋፍ ኣመልኪቶም እዮም። 	Most of China&#39;s 300 million rural migrant workers are scattered in island homes, or detained in Hubei province. As of March 2020, more than 10 million Americans were unemployed and applied for government assistance.
1258	en	ti	 The coronavirus outbreak could cost 47 million jobs in the United States and unemployment rate may hit 32%, according to estimates by the Federal Reserve Bank of St. Louis.The lockdown in India has left tens of millions of Indian migrant workers (who are paid through daily wages) unemployed.The survey from the Angus Reid Institute found that 44% of Canadian households have experienced some type of unemployment.Nearly 900,000 workers lost their jobs in Spain since it went into lockdown in mid-March 2020. 	 ክም Federal Reserve Bank of St. Louis፣ ናይ ኮርና ቫይረስ ለበዳ ኣብ ሕቡራት መንግስታት ኣሜሪካ 47 ሚልዮን ዝኮኑ ስራሓት ዝጸሉ ኮይኑ ናይ ስራሕ ስእነት መጠን ድማ 32% ክበጽሕ ይኸእል እዩ። እቲ ምዕጻው ብ ዓሰርተታት ሚልዮናት ዝቑጸሩ ህንዳውያን ስደተኛ ሰራሕተኛታት(መዓልታዊ ክፍሊት ዝረኽቡ ዝነበሩ) ካብ ስራሕ ወጻኢ ገይሩ እዩ።ኣብ ኣንጉስ ሬይድ ዝተገበረ ዳህሳስ ክምዝሕበሮ ካብ ናይ ካናዳ ስድራቤታት እተን 44% ገለ ዓይነት ስእነት ስራሕ ኣጋጢሙወን እዩ። ኣብ ስፔይን ካባቢ 900000 ሰራሕተኛታት በሰንኪ ኣብ ማእኸል ማርች 2020 ዝተነብረ ምዕጻው ስራሖም ክስእኑ ክኢሎም እዮም። 	Like the Federal Reserve Bank of St. Louis. Louis, the coronavirus pandemic will affect 47 million jobs in the United States and the unemployment rate could reach 32%. The closure has left tens of millions of Indian migrant workers(who were earning daily wages) out of work.A survey in Angus Raid found that 44% of Canadian households experienced some form of unemployment. In Spain, around 900,000 workers lost their jobs as a result of the shutdown in mid-March
1259	en	ti	 During the second half of March, 4 million French workers applied for temporary unemployment benefits and 1 million British workers applied for a universal credit scheme.Almost half a million companies in Germany have sent their workers on a government-subsidized short-time working schemes known as Kurzarbeit. 	 ኣብ ካልኣይ ክፋል ወርሒ ማርች፡ 4 ሚልዮን ሰራሕተኛታት ፈረንሳ ብሰንኪ ስራሕ ኣልቦነት ግዝያዊ ሓገዝ ክወሃቦም ሓተታ ኣቅሪቦም። ብተመሳሰሊ ሓገዝ ዝሓተቱ ብዝሒ ሰራሕተኛታት ኣብ ብሪጣንያ 1 ሚልዮን ክበጽሕ ከሎ፡ ኣብ ጀርመን’ውን ልዕሊ ፍርቂ ሚልዮን ትካላት ሰራሕተኝኦም ብመንግስቲ ዝተመወለ ‘ኩርዛባይት’ ዝተባህለ ግዝያዊ ሓገዝ ክረኽቡ ኣኽኢሎም። 	In the second half of March, 4 million French workers applied for temporary unemployment benefits. Similarly, the number of workers who have applied for assistance has reached 1 million in the UK, while more than half a million companies in Germany have enabled their employees to receive state-funded temporary assistance.
1260	en	ti	 The German short-time work compensation scheme has been adopted by France and Britain. 	 ብጀርመን ዝተወጠነ ናይ ስራሕ ካሕሳ መደብ ብፈረንሳን ብሪቴንን ተቐባልነት ረኺቡ። 	A work compensation scheme planned by Germany was accepted by France and Britain.
1261	en	ti	 The performing arts and cultural heritage sectors have been profoundly affected by the pandemic, impacting organizations' operations as well as individuals—both employed and independent—globally. 	 ናይ መድረኽ ስነ-ጥበብ ምድላዋትን ባህላዊ ቅርሲ ሴክተራት በዚ ለበዳ እቶም ኣዚዮም ዝተሃሰዩ እዮም፣ በዚ ድማ ብዓለም ደረጃ ዘለው ናይ ትካላት ከምኡውን ናይ ውልቀ ሰባት ስራሕን ፣ ክልቲኦም ዝትቖጸሩን ዓርሶም ዝኸኣሉን ጽልዋ ሕዲሩዎም እዩ። 	The performing arts and cultural heritage sectors are the most affected by the epidemic, with both corporate and individual work globally , both employed and self-sustaining.
1262	en	ti	 Arts and culture sector organizations attempted to uphold their (often publicly funded) mission to provide access to cultural heritage to the community, maintain the safety of their employees and the public, and support artists where possible. 	 ውዱባት ስነ-ጥበብን ባህልን ባህላዊ ውርሻ ንኮም ክፉት ምግባር፡ ድሕነት ናይ ሰራሕተኝኦምን ሓፋሽን ምሕላው ከምኡ’ውን ንክኢላታት ስነ-ጥበብ ምድጋፍን ዘጠቃልል (መብዛህትኡ ግዜ ብህዝቢ ዝተመወለ)ሸቶኦም ንምትግባር ጽዒሮም። 	Arts and culture organizations sought to achieve their (often publicly funded) goals, which included keeping cultural heritage open to the community, protecting the safety of their employees and the public, and supporting arts professionals.
1263	en	ti	 By March 2020, across the world and to varying degrees, museums, libraries, performance venues, and other cultural institutions had been indefinitely closed with their exhibitions, events and performances cancelled or postponed. 	 ኣብ ማርች 2020፣ ኩሎም ኣብ መላእ ዓለም ን ብዝተፈላለየ ደረጃን፣ሙዝየማት፣ ላይበረሪታት፣ ናይ መድረኽ ስራሕ ቦታታት ን ካልኦት ባህላዊ ትካላት ንዘይተወሰነ ግዜ ተዓጽዮም፣ ዘካይዱዎም ኢግዚቢሽናት፣ ምድላዋት ን ናይ መድረኽ ስራሕቲን ድማ ተሰርዚም ወይድማ ናብ ካሊእ እዋን ተምሓላሊፎም እዮም። 	In March 2020, all museums, libraries, stage venues and other cultural institutions around the world and at various levels were closed indefinitely, and their exhibitions, events and stage performances were canceled or postponed.
1264	en	ti	 In response there were intensive efforts to provide alternative services through digital platforms.Another recent and rapidly accelerating fallout of the disease is the cancellation of religious services, major events in sports, and other social events, such as music festivals and concerts, technology conferences, and fashion shows. 	 ከም ግብረመልሲ ብዲጂታል መርበባት ዝወሃቡ ኣገልግሎታት ኣብ ምሃብ ጽዑቕ ጻዕርታት ተኻይዶም። ብቀረባ እዋን ብቅጽበት ካብዘጋጠሙ ሳዕቤናት እዚ ሕማም ምስራዝ ሃይማኖታዊ መደባት፡ ስፖርታዊ ንጥፈታትን ካልኦት ማሕበራዊ መደባት ከም ናይ ሙዚቃ ፈስቲቫላትን ኮንሰርታት፡ ናይ ቴክኖሎጂ ኣኼባታትን ፋሽን ሾውን የጠቓልሉ። 	In response, intensive efforts have been made to provide services through digital networks. Recent immediate consequences include the cancellation of religious events, sporting events and other social events such as music festivals and concerts, technology meetings and fashion shows.
1265	en	ti	 The film industry has also experienced disruption.The Vatican announced that Holy Week observances in Rome, which occur during the last week of the Christian penitential season of Lent, have been cancelled. 	 ፊልም ኢንዱስትሪ’ውን ዝንባለታት ኣጋጢምዎ ይርከብ። ቫቲካን ነቲ ኣብ ሮማ ዝግበር ጸሎተ ሕማማት፡ ማለት መጨረሽታ ሰሙን ጾም ዓርብዓ፡ ከምዝተሰረዘ ሓቢሩ። 	The film industry is also facing trends. The Vatican has announced the cancellation of the Pentecost prayer in Rome, the weekend of Lent.
1266	en	ti	 Many dioceses have recommended older Christians to stay at home rather than attending Mass on Sundays; some churches have made church services available via radio, online live streaming or television while others are offering drive-in worship. 	 ብዙሓት ዲያቆናት ነቶም ብዕድመ ዝደፍኡ ኣመንቲ ክርስትያን ካብ ሰንበት ምቅዳስ ኣብ ገዝኦም ክጸንሑ ይመኽርዎም ኣለዉ። ገሊአን ቤተ-ክርስትያናት ብመርብብ ራዲዮ፡ ኢንተርኔት ወይ ቴሌቭዥን ይሰብካ ኣለዋ፥ ገሊአን ድማ ኣብ ውሽጢ ማኪና ኮይንካ ከምዝስማእ ይገብራ ኣለዋ። 	Many deacons are advising older Christians to stay home from Sunday Mass. Some churches are preaching over the radio, the Internet, or television, and others are making it heard from inside a car.
1267	en	ti	 With the Roman Catholic Diocese of Rome closing its churches and chapels and St. Peter's Square emptied of Christian pilgrims, other religious bodies also cancelled services and limited public gatherings in churches, mosques, synagogues, temples and gurdwaras. 	 ናይ ሮማን ካቶሊክ ደብሪታት ቤተ ክርስትያናቱ ምዕጻዉን ናይ ቅዱስ ጴጥሮስ ኣደባባይ ካብ ክርስቲያናዊ በጻሕቲ ነጻ ኣብዝኾነሉ፣ ካልኦት ናይ ሃይማኖት ኣካላት እውን ኣገልግሎታቶም ብ ምስራዝ፣ ኣብ ቤተ ክርስትያናት፣መስጊዳት፣ ምኹራባት፣ ቤተ-መቕደሳትን ኣብ ጉርድዋራ ዝግበሩ ህዝባዊ ምትእኽኻባት ወሰን ንኽግበሩ ገይሮም እዮም። 	While Roman Catholic monasteries have closed their churches and St. Peter&#39;s Square has been freed from Christian visitors, other religious bodies have also canceled their services and limited public gatherings in churches, mosques, synagogues, temples and gurdwaras.
1268	en	ti	 Iran's Health Ministry announced the cancellation of Friday prayers in areas affected by the outbreak and shrines were later closed, while Saudi Arabia banned the entry of foreign pilgrims as well as its residents to holy sites in Mecca and Medina. 	 ናይ ኢራን ናይ ጥዕና ሚኒስተር ኣብቶም በቲ ለበዳ ዝተጠቕዑ ቦታት ናይ ዓርቢ ጸሎት ስርዛ ከምዝገበረ ድሕሪ ምእዋጅ ሼሪናት ድማ ጸኒሖም ክዕጸዉ ተገይሮም እዮም ፡ ሱዕዲ ዓረብ ድማ ካብ ወጻኢ ዝመጹ ናይ ሃይማኖት ተጉዓዝቲ ናብ ዓዳ ክይኣትዉ ድሕሪ ምክልኻል ዜጋታታ ድማ ናብቶም ኣብ መካን መዲናን ዝረከቡ ቅዱሳት ቦታት ንኽይኽዱ ኣጊዳ። 	Iran&#39;s health minister announced the cancellation of Friday prayers in the affected areas and sherines were later closed , while Saudi Arabia banned its citizens from visiting the holy sites in Mecca and Medina after preventing foreign pilgrims from entering the country.
1269	en	ti	 The pandemic has caused the most significant disruption to the worldwide sporting calendar since the Second World War. 	 እዚ ለበዳ ድሕሪ ካልኣይ ዂናት ዓለም ኣብ ዓለምለኻዊ ስፖርትዊ ካላንደራት እቲ ዝዐበየ ምቁርራጽ ኣስዒቡ እዩ። 	The epidemic has caused the biggest disruption to international sporting calendars since World War II.
1270	en	ti	 Most major sporting events have been either cancelled or postponed, including the 2019–20 UEFA Champions League, 2019–20 Premier League, UEFA Euro 2020, 2019–20 NBA season, and 2019–20 NHL season. 	 መብዛሕቲኦም ዓበይቲ ንጥፈታት ስፖርት ከም በዓል 2019-20 UEFA Champions League፡ 2019-20 Premier League፡ UEFA Euro 2020፡ 2019-20 NBA season ከምኡ`ውን 2019-20 NHL season ተሰሪዞም ወይ ተሰጋጊሮም። 	Most major sporting events such as the 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 NBA season and 2019-20 NHL season have been canceled or postponed.
1271	en	ti	" The outbreak disrupted plans for the 2020 Summer Olympics, which were originally scheduled to start at the end of July; the International Olympic Committee announced on 24 March that the event will be ""rescheduled to a date beyond 2020 but not later than summer 2021"".Casinos and other gaming venues worldwide have closed and live poker tournaments have been either postponed or cancelled. "	 ብምኽንያት’ዚ ለበዳ ኣብ መወዳእታ ወርሒ ሓምለ ክጅምር ተመዲቡ ዝነበረ ናይ ክረምቲ ኦሊምፒክስ 2020 ተሰሪዙ። “ድሕሪ 2020 ግን ቅድሚ ክረምቲ 2021 ከም ዝሰጋገር” ከኣ ብዓለምለኻዊ ኮሚተ ኦሊምፒክስ ብ24 መጋቢት ተሓቢሩ። ካሲኖታት ብዓለም ደረጃ ክዕጸዋ ከለዋ ናይ ፖከር ወይ ጠላዕ ውድድራት ከኣ ተሰጋጊረን ወይ ተሰሪዝን። 	The 2020 Winter Olympics, which were scheduled to start in late July, have been canceled due to the outbreak. “After 2020 but before the winter of 2021,” the International Olympic Committee said on March Casinos have been closed worldwide, and poker or gambling tournaments have been postponed or cancelled.
1272	en	ti	 This has led many gamblers to move online, with many online gambling sites reporting significant increases in their rates of new sign-ups.The entertainment industry has also been affected, with various music groups suspending or cancelling concert tours. 	 እዚ ንብዙሓት ጠላዕ ተጻወቲ ናብ ኦንላይን ንክኸዱ ገይርዎም፣ ብዙሓት ናይ ኦንላይን ጣልዕ መጻወቲ መርበባት ድማ ኣዝዩ ብዙሕ ወሰኽ ቁጽሪ ተሳተፍቲ ኣብ ሓድሽ መምዝገቢአን ከምዘሎ ጸብጻብ ገይረን። ብዙሓት ናይ ሙዚቃ ጉጅለታት ናይ ኮንሰርት ዙር የቋርጹን ይስርዙን ብምህላዎም፣ እቲ ናይ መዘናግዒ ኢንዱስትሪ እውን ተጸልዩ እዩ። 	This has led many gamblers to go online, and many online gambling sites have reported a huge increase in the number of participants in their new registries. With many music groups discontinuing and canceling concert tours, the entertainment industry has also been affected.
1273	en	ti	 Many large theatres such as those on Broadway also suspended all performances. 	 ካም ኣብ ብሮድዌይ ዘለዋ ዝበላ ብዙሓት ዓበይቲ ቲያትራት ኩሎም ምድላዋትን ጠጠው ኣቢለን ኣለዋ። 	Many of the major theaters that Cam said are on Broadway have stopped all preparations.
1274	en	ti	" Some artists have explored ways to continue to produce and share work over the internet as an alternative to traditional live performance, such as live streaming concerts or creating web-based ""festivals"" for artists to perform, distribute, and publicize their work. "	" ገለ ኣርቲስትታት ኣብ ኢንተርኔት ስራሕቶም ክሰርሑን ከቕርቡሉ ዝኽእሉሉ መንገዲታት ረኽቦም ኣለው፣ ካብ'ቲ ባህላዊ ብቐጥታ ስራሕቲ ካብ ምቕራብ በተጻራሪ፣ ብ ኢንተርኔት ቐጥታ ፈነወታት ዝመሓላለፉ ሙዚቃዊ ምድላዋት ውይድማ ኣብ መርበብ ኢንተርኔት ዝተደረኹ ኣርቲስታት ስርሕቶም ዘቕርቡሉ፣ ዘከፋፍሉሉ፣ ዘሕትሙሉ ""ፌስቲቫላት"" ከም መማረጺ ቐሪቦም ኣለው። "	Some artists have found ways to work and present their work online, as opposed to traditional live performances, live musical performances over the Internet and “festivals” where online-based artists perform, distribute, and publish their work There are.
1275	en	ti	 Online, numerous coronavirus-themed Internet memes have spread as many turn to humour and distraction amid uncertainty. 	 ብዙሓት ኣብ ኦንላይን ዝዝርግሑ ኣብ ኮረና ቫይረስ ዘተኮሩ ሜምማት ኣብ መንጎ እቲ ዘሎ ስጋኣት ብምስሓቅ ን ብምዝንጋዕና ናብ ብዙሓት ተባጺሖም እዮም። 	Many online memes focused on the coronavirus have reached many by laughing and entertaining us amidst the fears.
1276	en	ti	 Since the outbreak of COVID-19, heightened prejudice, xenophobia, and racism have been noted toward people of Chinese and East Asian descent, and against people from hotspots in Europe, the United States and other countries. 	 COVID-19 ካብ ዝዝርጋሕ ኣብ ልዕሊ ቻይናውያን፡ ምብራቕ ኤሽያ ዝመቦቐሎም ሰባትን ካብተን ብዝሒ ሕሙማት ዘለወን ሃገራት ሕቡራት መንግስታትን ኤሮጳን ዝመጹ ሰባትን ምፍልላይ፡ ጽልኢ ወጻእተኛታትን ዘርኣዊ ስጉምትታትን ክውሰድ ተራእዩ። 	Since the outbreak of COVID-19, discrimination, xenophobia and racial measures have been taken against Chinese, people of East Asian origin and people from the United States and Europe with the highest number of cases.
1277	en	ti	 Incidents of fear, suspicion, and hostility have been observed in many countries, particularly in Europe, East Asia, North America, and the Asia-Pacific region. 	 ናይ ፍርሓት፡ ጥርጣረታትን ሕማቕ ሓሳባትን ኣብ ብዙሓት ሃገራት በተለይ ድማ ኣብ ኣውሮፓ፡ምብራቕ ኤሽያ፡ ሰሜን ኣሜሪካ ን ኣብ ናይ ኤሽያ ፓስፊከ ክልላትን ተራእዮም እዮም። 	Fears, suspicions and negative thoughts have been observed in many countries, especially in Europe, East Asia, North America and the Asia Pacific region.
1278	en	ti	 Reports from February (when the majority of the cases had still been confined to China) have documented racist sentiments expressed in various groups worldwide of Chinese people deserving the virus or receiving what has been claimed as justified retribution. 	 ክም ናይ ፌብሩዋሪ ጽብጻባት(ኩሎም ጉዳያት ኣብ ውሽጢ ቻይና ጥራይ እንዳሃለው) ዶክመንት ዝተገበሩ ህዝቢታት ቻይና እቲ ቫይረስ ዝግብኦም እዩ፣ ዝግበኦም ቅጽዓት ድማ እዩ ዝብሉ ኣብ መላእ ዓለም ብዝርከቡ ዝተፈላለዩ ጉጅለታት ዝተውሃቡ ዘርኣዊ መግለጺታት ኣለው። 	There are racist statements made by various groups around the world that the Chinese people deserve the virus and deserve punishment, documented as in the February reports (all cases within China only).
1279	en	ti	 Some countries in Africa have also seen a rise in anti-Chinese sentiment. 	 ገለ ኣብ ኣፍሪካ ዘለዋ ሃገራት ዘሰጉማኦ ጸረ ቻይና ዝኾኑ ኣካይዳታት ምውሳኽ ኣርእዩ እዩ። 	There has been an increase in anti-China behavior promoted by some countries in Africa.
1280	en	ti	 Many residents of Wuhan and Hubei have reported discrimination based on their regional origin. 	 መብዛሕትኦም ናይ ዉሃንን ሁበይን ነበርቲ ብሰንኪ ናይ ኣከባቢያዊ መበቆሎም መድልዎ ከምዝበጽሖም ሪፖርት ገይሮም። 	Most residents of Wuhan and Hubei reported discrimination because of their local origins.
1281	en	ti	 There has been support for the Chinese, both on and offline, and towards those in virus-stricken areas. 	 ኣብ ናይ ኢንተርኔት መርበብን ካብኡ ወጻኢን ፡ ነቶም ኣብ ቻይና ዘለዉ በቲ ለብዳ ኣዝዮም ዝተጠቕዑ ቦታት ድጋፍ ይግበር ነይሩ እዩ። 	On and off the Internet , there has been support for the worst-affected areas in China.
1282	en	ti	 Following the progression of the outbreak to new hotspot countries, people from Italy, the first country in Europe to experience a serious outbreak of COVID-19, could also be subjected to suspicion and xenophobia.Citizens in countries including Malaysia, New Zealand, Singapore, and South Korea initially signed petitions lobbying to ban Chinese people from entering their countries in an effort to stop the disease. 	 ናይ እቲ ለበዳ ናብ ሓደሽቲ ቦታት ምዝማት ስዒቡ፣ ካብ ጣልያን፣ እታ ካብ ኣውሮፓ ሃገራት ብ COVID-19 ለበዳ ዝተጠቕዐት ናይ መጀመሪያ ሃገር፡ ዝኾኑ ስባት፡ ናብ ኣቶም ዘቕነዐ ጥርጣረን ዜኖፎቢያን ክጋጥሞም ይኽእል እዩ። ዜጋታት ማሌይዢያ፡ ኔው ዚላንድ፡ ሲንጋፖርን ደቡብ ኮሪያን ኣብ መጀምሪያ፡ነቲ ሕማም ንምክልኻል ብዝብል፡ ናይ ቻይና ዜጋታት ናብ ሃገሮም ከይ ኣትዉዉ ዝብል ናይ ፊርማ ምስብሳብ ስራሕቲ ክገብሩ ጸኒሖም እዪም። 	Following the spread of the epidemic to new areas, people from Italy, the first European country to be affected by the COVID-19 pandemic, may face suspicion and xenophobia directed at them. Citizens of Malaysia, New Zealand, Singapore and South Korea have initially been collecting signatures to prevent Chinese citizens from entering their country to prevent the disease.
1283	en	ti	 In Japan, the hashtag #ChineseDontComeToJapan trended on Twitter. 	 ኣብ ጃፓን ኣብ ትዊተር ዝተዘርግሀ#ቻይናውያን-ናብ-ጃፓን-ኣይምጽኡ ዝብል ሃሽታግ ብዙሕ ኣዛራቢ ኮይኑ። 	The hashtag #Don&#39;t-Come-Chinese-to-Japan became a hot topic on Twitter in Japan.
1284	en	ti	 Chinese people as well as other Asians in the United Kingdom and the United States have reported increasing levels of racist abuse, as well as assaults. 	 ህዝቢታት ቻይናን ካልኦት ኣብ እንግሊዝ ን ኣብ ኣሜሪካን ዝነበሩ ናይ ኣሽያ ህዝቢታት ካብ ጊዜ ናብ ጊዜ እናወሰኹ ዝመጹ ዘርኣዊ በደላትን መጥቃዕቲታትን ይበጽሖም ከምዘሎ ይዛረቡ። 	The peoples of China and other Asian peoples in the UK and the US say they are experiencing increasing racial abuse and attacks.
1285	en	ti	" U.S. president Donald Trump has faced criticism for referring to the coronavirus as the ""Chinese Virus"", a term considered by critics to be racist and anti-Chinese. "	 US ፕረዚደንት ዶናልድ ትራምፕ ንኮሮና ቫይረስ “እቲ ቻይናዊ ቫይረስ” ኢሉ ብምጽዋዕ ነቐፌታት ወሪዱዎ። እቲ ብሂል ብብዙሓት ከም ዘርኣውን ኣንጻር ቻይናውያንን ኮይኑ ይሕሰብ። 	US President Donald Trump has been criticized for calling the coronavirus “the Chinese virus”. The saying is thought of by many as racist and anti-Chinese.
1286	en	ti	 Protesters in Ukraine attacked buses carrying Ukrainian and foreign evacuees from Wuhan to Novi Sanzhary. 	 ኣብ ዩክረይን ካብ ዉሃን ናብ ኖቪ ሳንዣሪ ዝተመልሱ ዩክሬናውያንን ወጻእተኛታትን ዝሓዘት ኣቶቡስ ብተቓወምቲ ተጠቒዓ። 	In Ukraine, a bus carrying Ukrainians and foreigners returning from Wuhan to Novi Sanzhari was attacked by protesters.
1287	en	ti	 Students who come from Northeast India, which shares a border with China, and study in major Indian cities have reportedly experienced harassment related to the coronavirus outbreak. 	 ካብ ምስ ቻይና ትዳወብ ሰሜናዊ ምብራቅ ህንዲ መጽዮም ኣብ ዓበይቲ ከተማታት ህንዲ ዝመሃሩ ተምሃሮ ብሰንኪ ለበዳ ኮሮናቫይረስ ግፍዒታት ከም ዝወረዶም ተገሊጹ። 	Students from northeastern India bordering China have been harassed in major Indian cities due to the coronavirus outbreak.
1288	en	ti	" The Bharatiya Janata Party's State unit president in West Bengal Dilip Ghosh stated that the Chinese had destroyed nature and ""that's why the God took revenge against them."" "	 ዲሊፕ ጎሽ ዝተባህለ ናይ ባራትያ ጃንታ ፓርቲ ፕረዚደንት ናይ ምዕራብ ቤንጋል “ቻይናውያን ኣንጻር ተፈጥሮ ብምኻዶም’ዩ ኣምላኽ ቀጺኡዎም” ኢሉ ተዛሪቡ። 	&quot;God punished the Chinese for going against nature,&quot; said Dilip Gosh, president of the Bharatiya Janata Party (BJP) in West Bengal.
1289	en	ti	" The remarks were later condemned by the Chinese consulate in Kolkata, calling it ""erroneous"".In China, xenophobia and racism agains non-Chinese residents has been inflamed by the pandemic, with foreigners described as ""foreign garbage"" and targeted for ""disposal"". "	" እቶም ዝተውሃቡ ርኢቶታት ድማ ብ ኣብ ከልካታ ዝርከቡ ሰበ ስልጣን ቻይና ""ገጉይ"" ዝብል ነቐፌታ በጺሑዎም እዩ። ኣብ ቻይና፡ ብዚ ለበዳ ዝተጎሃሃረን ናብ ወጻእተኛታት ዘቕነዐን ወጻእተኛታት ""ባዕዳዊ ጎሓፋ"" ዝብለን ""ይጎሓፉ"" ዝብልን ዜኖፎቢያን ዘረእኛነትን ተራእዮም እዮም። "	The comments have been criticized as &quot;wrong&quot; by Chinese officials in Calcutta. In China, there has been xenophobia and racism, fueled by the epidemic and directed at foreigners, calling them &quot;foreign garbage&quot; and &quot;throwing them away.
1290	en	ti	 Many newspapers with paywalls have removed them for some or all of their coronavirus coverage. 	 ብዙሓት ናይ ክፍሊት ገጽታት ዘለዎም ጋዜጣታት፡ ምእንተ ኮረና ቫይረስ ሽፋን ክብሉ ብ ኸፊል ውይድማ ሙሉእ ብምሉእ ኣልዒሎሞም ኣለው። 	Many newspapers with paid pages have partially lifted them completely for the sake of coronavirus coverage.
1291	en	ti	 Many scientific publishers made scientific papers related to the outbreak available with open access. 	 ብዙሓት ሳይንሳዊ መጽሄታት ነዚ ለበዳ ዝገልጹ ሳይንሳዊ ጽሑፋት ብነጻ ከምዝዝርግሑ ገይሮም። 	Many scientific journals have published free scientific papers describing the epidemic.
1292	en	ti	 Some scientists chose to share their results quickly on preprint servers such as bioRxiv. 	 ገለ ሳይንቲስታት ዝረኸቡዎም ውጽኢታት ኣብ ልከዕ ክም bioRxiv ዝበሉ ቅድመ ምሕታም ሰርቨራት ምዝርጋሕ ይመርጹ። 	Some scientists prefer to publish their findings on prepublishing servers such as bioRxiv.
1293	en	ti	 Emerging infectious disease – Infectious disease of emerging pathogen, often novel in its outbreak range or transmission mode 	 ዝቐላቕሉ ተላባእቲ ሕማማት- ብሓድሽ ዝተቐላቐለ ባእታ ዝመጹ ተላባእቲ ሕማማት፡ ብዙሕ ግዜ ኣብ ዓቕሚ ዝርገሐን ናይ ምትሕልላፍ መንገድታት ሓደሽቲ’ዮም። 	Emerging infectious diseases- Infectious diseases caused by a newly introduced agent are often new in their ability to spread and their routes of transmission.
1294	en	ti	 Globalization and disease – Overview of globalization and disease transmission 	 ግሎባላይዘሽንን ሕማምን- ናይ ግሎባላይዘሽን ናይ ሕማም ምትሕልላፍን ሓፈሻዊ ርኢቶ 	Globalization and disease—an overview of globalization and disease transmission
1295	en	ti	 List of epidemics and pandemics – A list of death tolls due to infectious disease 	 ናይ ለብዒታትን ለበዳታትን ዝርዝር ሊስታ-ዝርዝር መጠነ-ሞት ብሰንኪ ተላባዕቲ ሕማማት 	List of epidemics and epidemics-List of death rates from infectious diseases
1296	en	ti	 Wildlife smuggling and zoonoses – Health risks associated with the trade in exotic wildlife 	 ናይ ዱር እንሰሳት ኮንትሮባንድን ካብ እንሰሳት ናብ ደቂ ሰባት ሕማም ናይ ምምሕልላፍ ተኽእሎ ምህላውን- ምስ ናይ ዱር እንስሳት ንግዲ ዝተትሓሓዙ ናይ ጥዕና ሓደጋታት 	Wildlife smuggling and the potential for transmission of disease from animals to humans—health risks associated with the wildlife trade
1297	en	ti	 Laboratory testing for the respiratory coronavirus disease 2019 (COVID-19) and the associated SARS-CoV-2 virus includes methods that detect the presence of virus and those that detect antibodies produced in response to infection. 	 ን ናይ ሕማም ምስትንፋስ ኮረና ቫይረስ 2019 (COVID-19) ንSARS-CoV-2 ቫይረስን ዝግበሩ ናይ ላብራቶሪ ፈተነታት ህላወ ናይ ቫይረስን ረኽሲ መልሲ ኣብ ምሃብ ዝፈርዩ ጸረ-ነፍሳትን( antibodies) ዘፍልጡ መንገዲታት ዘጠቓለለ እዩ። 	Laboratory tests for the respiratory disease coronavirus 2019 (COVID-19) and SARS-CoV-2 viruses include ways to detect the presence of the virus and the antibodies produced in response to infection.
1298	en	ti	 The presence of viruses in samples is confirmed by RT-PCR, which detects the coronavirus'  RNA. 	 ኣብ ናሙናታት እቲ ቫይረስ ምህላዉ ብ RT-PCR እዩ ዝረጋገጽ፣ ናይቲ ኮሮናቫይረስ ' RNA ስለዘለሊ። 	The presence of the virus in samples is detected by RT-PCR, as it detects the coronavirus &#39; RNA.
1299	en	ti	 This test is specific and is designed to only detect the RNA of the SARS-CoV-2 virus. 	 እዚ ምርመራ እዚ ስፔስፊክ እዩ ናይ SARS-CoV-2 ቫይረስ RNA ንከለሊ ጥራሕ እዩ ድማ ተሰሪሑ። 	This test is specific and is only designed to detect SARS-CoV-2 virus RNA.
1300	en	ti	 It is used to confirm very recent or active infections. 	 ናይ ቀረባ ግዜን ንጡፍ ረኽሲን ንምርግጋጽ ኣብ ጥቕሚ ዝወዓለ እዩ። 	It was used to confirm recent and active infection.
1301	en	ti	 Detection of antibodies (serology) can be used both for diagnosis and population surveillance. 	 ናይ ኣንቲ ቦዲታት ምርመራ (ሴሮሎጂ) ንምርመራን ህዝባዊ ሓለዋን ይጠቅም እዩ። 	Testing for antibodies (serology) is useful for diagnosis and public protection.
1302	en	ti	 Antibody tests show how many people have had the disease, including those whose symptoms were too minor to report or who were asymptomatic. 	 ናይ ጸረ-ነፍሳት ምርመራታት ክንደይ ሰባት በዚ ሕማም ከምዝተተሓዙ እዩ ዘርኢ፣ እቶም ምልክታቶም ኣዝዮም ኣናእሽተይ ዝነበሩ ወይ ምልክት ዘየርአዩ እውን ሓዊሱ። 	Antibiotic tests show how many people are infected, including those whose symptoms were very minor or showed no symptoms.
1303	en	ti	 An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. 	 ትኽክለኛ መጠነ-ሞት ናይዚ ሕማምን ብዝሒ ናይ herd immunityን ብውጽኢት ናይዞም ምርመራታት እዮም ዝፍለጡ። 	The exact mortality rate of the disease and the amount of herd immunity are determined by the results of these tests.
1304	en	ti	 Due to limited testing, as of March 2020 no countries had reliable data on the prevalence of the virus in their population. 	 ውሱን ምርመራ ብምህላዉ፡ ካብ መጋቢት 2020 ጀሚሩ ዝኾነ ሃገር ብዛዕባ ዝርግሐ ናይ'ቲ ለበዳ ኣብ ህዝብታቶም እሙን ዳታ ዘልዎ የለን። 	Due to limited testing, no country has reliable data on the spread of the outbreak in their populations since March
1305	en	ti	 By 23 March, no country had tested more than 3% of their population, and there are massive variations in how much testing has been done across countries. 	 ኣብ 23 መጋቢት፣ ልዕሊ 3% ናይ ብዝሒ ህዝባ ዝመርመረት ማንም ሃገር ኣይነበረትን፣ ኣብ ሃገራት ምርመራታት ዝካየዱሎም መገዲታት ድማ ዓብዪ ኣፈላላይ ኣለዎም። 	As of March 23, no country had tested more than 3% of its population, and testing methods vary greatly across countries.
1306	en	ti	 This variability is also likely to be significantly affecting reported case fatality rates, which are likely to be significantly over-estimated in some countries. 	 እዚ ቁጽሪ ሪፖርት ንዝተገበሩ ናይ ሞት ኬዛት እውን ብዓብዪኡ ዝጸልው እዩ ዝመስል፣ ኣብ ገለ ሃገራት ልዕሊ ዝተገመቱ ክኾኑ ይረኣዩ ስለዘለዉ። 	This number also appears to significantly affect reported death cases, as they appear to be higher than expected in some countries.
1307	en	ti	 Using real-time reverse transcription polymerase chain reaction (rRT-PCR) the test can be done on respiratory samples obtained by various methods, including nasopharyngeal swab or sputum sample. 	 ናይ ብሓቂ ሪቨርስ ትራንስክሪፕሽን ፖሊመሬዝ ቸይን ግብረ መልሲ (rRT-PCR) ብምጥቃም እቲ ምርመራ ብዝተፈላለዩ ሜላታት ካብ ስርዓተ ምትንፋስ ብዝተወሰዱ ናሙናታት፣ ናዞፋሪንጃል ስዋብ ወይ ናይ ዓኽታ ናሙና ሓዊሱ ክካየድ ይኽእል። 	Using true reverse transcription polymerase chain reaction (rRT-PCR) the diagnosis can be performed by a variety of methods including samples from the respiratory tract, nasopharyngeal swab or sputum sample.
1308	en	ti	 Results are generally available within a few hours to 2 days. 	 ውጽኢታት ኣብ ውሽጢ ዝተወሰኑ ሰዓታ ክሳብ 2 መዓልቲታት ክቐርቡ እዮም። 	Results will be available within certain hours and up to 2 days.
1309	en	ti	 The RT-PCR test performed with throat swabs is only reliable in the first week of the disease. 	 እቲ ብናይ ጎሮሮ ስዋብ ዝስራሕ ናይ RT-PCR ምርመራ ኣብ ናይ መጀመርያ ናይቲ ሕማም ሰሙን እዩ ተኣማኒ። 	The RT-PCR test with a throat swab is reliable in the first week of the disease.
1310	en	ti	 Later on the virus can disappear in the throat while it continues to multiply in the lungs. 	 ጸኒሑ ድማ እቲ ቫይረስ ኣብ ሳንቡእ እናተራበሐ እንከሎ ኣብ ጉሮሮ ክጠፍእ ይኽእል እዩ። 	Later, the virus may disappear in the throat as it multiplies in the lungs.
1311	en	ti	 For infected people tested in the second week, alternatively sample material can then be taken from the deep airways by suction catheter or coughing up material (sputum) can be used. 	 ንኣብ ካልኣይ ሰሙን ምርመራ ዝገበሩ ዝተለኸፉ ሰባት፣ ከም መማረጺ ናይ ናሙና ማቴርያል ካብ ውሽጢ መተንፈሲ ኣካላት ብሳክሽን ካቴተር ወይ መስዓሊ ማቴርያል (ዓኽታ) ምጥቃም ይከኣል። 	For infected persons tested in the second week, a suction catheter or drawing material (cough) can be used as an alternative to sampling material from within the respiratory tract.
1312	en	ti	 One of the early PCR tests was developed at Charité in Berlin in January 2020 using real-time reverse transcription polymerase chain reaction (rRT-PCR), and formed the basis of 250,000 kits for distribution by the World Health Organization (WHO). 	 ሓደ ካብ እቶም ናይ መጀመሪያ ናይ PCR ፈተነታት ሓደ ኣብ በርሊን ውሽጢ ኣብ ቻሪቴ( Charité) ብ ወርሒ ጥሪ 2020 real-time reverse transcription polymerase chain reaction (rRT-PCR) ብምጥቃም ማዕቢሉ እዩ፣ በዚ ድማ 250,000 ዝኸውን ኪት( kits) ብ ውድብ ጥዕና ዓለም ተዘርጊሑ እዩ። 	One of the first PCR experiments was developed in Charité in Berlin in January 2020 using real-time reverse transcription polymerase chain reaction (rRT-PCR), thus 250,000 kits by the World Health Organization It has been spread.
1313	en	ti	 The United Kingdom had also developed a test by 23 January 2020.The South Korean company Kogenebiotech developed a clinical grade, PCR-based SARS-CoV-2 detection kit (PowerChek Coronavirus) on 28 January 2020. 	 ዩናይትድ ኪንግደም ኣብ 23 ጥሪ 2020 ምርመራ ኣማዕቢላ እያ።ናይ ደቡብ ኮሪያ ተትካል Kogenebiotech ክሊኒካል ደረጃ ዘለዎ፣ PCR-መሰረት ዝገበረ SARS-CoV-2 መለለዪ ኪት (PowerChek ኮሮናቫይረስ) ኣብ 28 ጥሪ 2020 ኣማዕቢሉ። 	The United Kingdom developed a test on January 23, 2020. South Korean plant Kogenebiotech developed a clinical-grade, PCR-based SARS-CoV-2 detection kit (PowerChek coronavirus) on January 28,
1314	en	ti	" It looks for the ""E"" gene shared by all beta coronaviruses, and the RdRp gene specific to SARS-CoV-2.In China, BGI Group was one of the first companies to receive emergency use approval from China's National Medical Products Administration for a PCR-based SARS-CoV-2 detection kit.In the United States, the Centers for Disease Control and Prevention (CDC) is distributing its 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel to public health labs through the International Reagent Resource. "	" ነቲ ብኹሎም ቤታ ኮሮናቫይረሳት ሼር ዝተገበረ ናይ ""E"" ጂን ይደሊ፣ እቲ RdRp ጂን ድማ ብፍሉይ ን SARS-CoV-2።ኣብ ቻይና፣ BGI ጉጅለ ናይ ቻይና ብሄራዊ ሕክምና ምህርቲታት ምምሕዳር ን PCR-መሰረት ዝገበረ SARS-CoV-2 መለለዪ ኪት ንኢመርጀንሲ ናይ ምጥቃም ፍቓድ ካብ ዝረኸቡ ትካላት ሓደ እዩ ኔሩ።ኣብ ዩናይትድ ስቴትስ፣ ናይ ሕማም ምቁጽጻርን ምክልኻልን ማእኸል (CDC) ናይ 2019-ሓድሽ ኮሮናቫይረስ (2019-nCoV) ናይ ብሓቂ RT-PCR መመርመሪ ፓነል ናብ ናይ ህዘባዊ ጥዕና ሓለዋ ቤተ ፈተነታት ብናይ ዓለምለኻዊ መወሃሃዲ ሓገዛት ኣቢሉ ኣሰራጭዩ። "	It looks for the &quot;E&quot; gene shared by all beta coronaviruses, and the RdRp gene specifically for SARS-CoV-2.In China, BGI Group of China National Medical Products Administration developed a PCR-based SARS-CoV-2 identification kit for emergency of In the United States, the Centers for Disease Control and Prevention (CDC) has provided a real RT-PCR test panel for the 2019-new coronavirus (2019-nCoV) to public health laboratories through global coordination grants It&#39;s a distributor.
1315	en	ti	 One of three genetic tests in older versions of the test kits caused inconclusive results due to faulty reagents, and a bottleneck of testing at the CDC in Atlanta; this resulted in an average of fewer than 100 samples a day being successfully processed throughout the whole of February 2020. 	 ካብ እቶም ሰለስተ ዝጸንሑ ናይ ጄነቲክ ፈተነታት( genetic tests) እቲ ሓደ ብሰንኪ ግጉይ ሪኤጀንትን( reagents) መደምደምታ ዘይብሎም ውጽኢታት እዩ ተረኺቡዎ ከምኡ ድማ ኣብ ኣትላንታ CDC ዝተናወሐ ናይ ፈተነ ኩነታትን ኣስዒቡ፥እዚ’ዩ ድማ ኣብ ሙሉእ ወርሒ ለካቲት 2020 መዓልታዊ ብገምጋም ካብ 100 ዘይበዝሕ ናሙናታት ብዕዉት ንኽካየዱ ዝገበረ። 	One of the three existing genetic tests was due to inconclusive results due to incorrect reagents and resulted in extended testing conditions at the Atlanta CDC, which is an average of no more than 100 samples per day throughout February successfully conducted them.
1316	en	ti	 Tests using two components were not determined to be reliable until 28 February 2020, and it was not until then that state and local laboratories were permitted to begin testing. 	 ክልተ ኣካላት ተጠቒምካ ምረርመራ ምግባር ክሳብ 28 ለካቲት 2020 ተኣማኒ ተገይሩ ኣየተወሰደን ነይሩ፣ ድሕሪኡ ድማ እዩ ናይቲ ግዝኣትን ከባቢያዊን ቤተ ፈተነታት እቲ ምርመራ ክጅምርዎ ተፈቒድዎም። 	Two-body testing was not considered reliable until February 28, 2020, after which state and local laboratories were allowed to begin testing.
1317	en	ti	 The test was approved by the Food and Drug Administration under an Emergency Use Authorization.US commercial labs began testing in early March 2020. 	 እዚ ምርመራ ብናይ መግቢን መድሓኒትን ምምሕዳር ፍቓድ ተዋሂብዎ እዩ ኣብ ትሕቲ ናይ ሃንደበታዊ ግዘ ጥቕሚ ፍቓድ።US ኮመርሻል ቤተ ፈተነታት ኣብ መጋቢት 2020 መጀመርያታት ምርመራ ጀሚሮም። 	This test is approved by the Food and Drug Administration under an emergency benefit license. US commercial laboratories began preliminary testing in March
1318	en	ti	 As of 5 March 2020 LabCorp announced nationwide availability of COVID-19 testing based on RT-PCR. 	 ካብ መጋቢት 5 2020 ጀሚሩ ላብኮርፕ( LabCorp) ኣብ RT-PCR ዝተደረኸ ህላወ ናይ COVID-19 ብሃገር ደረጃ ምርመራ ክገብር ምዃኑ ኣፍሊጡ። 	Starting March 5, 2020, LabCorp( LabCorp) will offer RT-PCR-based testing for the presence of COVID-19 nationwide.
1319	en	ti	 Quest Diagnostics similarly made nationwide COVID-19 testing available as of 9 March 2020. 	 Quest Diagnostics (ኩዌስት ዳያግኖስቲክስ) ብተመሳሳሊ ኣብ 9 መጋቢት 2020 ሃገር ለኻዊ ናይ ኮቪድ-19 ምርመራ ኣቕሪቡ። 	Quest Diagnostics also launched a nationwide COVID-19 test on March 9,
1320	en	ti	 No quantity limitations were announced; specimen collection and processing must be performed according to CDC requirements. 	 ምንም ዓይነት ናይ ገደብ ቁጽሪ ኣይተኣወጀን; ናይ ናሙና ምእካብን ፕሮሰስ ምግባርን ብናይ CDC ረቛሒታት መሰረት ክካየድ ኣለዎ። 	No limit numbers were announced; Sample collection and processing must be conducted in accordance with CDC requirements.
1321	en	ti	 In Russia, the COVID-19 test was developed and produced by the State Research Center of Virology and Biotechnology VECTOR. 	 ኣብ ሩስያ፣ ናይ ኮቪድ-19 ምርመራ ብናይቲ ግዝኣት ናይ ቫይሮሎጂን ባዮቴክኖሎጂን መጽናዕቲ ማእኸል VECTOR ማዕቢሉ ዝቐረበ እዩ። 	In Russia, the H1N1 test is developed and presented by the state&#39;s Virology and Biotechnology Research Center VECTOR.
1322	en	ti	 On 11 February 2020 the test was registered by the Federal Service for Surveillance in Healthcare.On 12 March 2020, Mayo Clinic was reported to have developed a test to detect COVID-19 infection.On 13 March 2020, Roche Diagnostics received FDA approval for a test which could be performed within 3.5 hours in high volume, thus allowing one machine to do approximately 4,128 tests in a 24-hour period. 	 ኣብ 11 ለካቲት 2020 እቲ ምርመራ ብፌደራል ናይ ሓለዋ ኣገልግሎት ናይ ጥዕና ክንክን ዝተመዝገበ እዩ ኔሩ።ኣብ 12 መጋቢት 2020፣ ማዮ ክሊኒክ ናይ ኮቪድ-19 ረኽሲ ዘለሊ ምርመራ ኣማዕቢሉ ተባሂሉ።ኣብ 13 መጋቢት 2020፣ Roche Diagnostics ኣብ 3.5 ሰዓታት ልዑል በዝሒ ምርመራታት ክገብር ንዝኽእእል ምርመራ ናይ FDA ፍቃድ ረኺቡ፣ ስለዚ ድማ ሓደ ማሽን ኣብ24 ሰዓታት 4,128 ዝኾኑ ምርመራታት ከካይድ ይገብር። 	On February 11, 2020, the test was registered by the Federal Protection Service. It received FDA approval, so a machine can perform 4,128 tests in 24 hours.
1323	en	ti	 On 19 March 2020, the FDA issued emergency use authorization (EUA) to Abbott Laboratories for a test on Abbott's m2000 system; the FDA had previously issued similar authorization to Hologic, LabCorp, and Thermo Fisher Scientific. 	 ኣብ 19 መጋቢት 2020፣ FDA ናይ ሃንደበታዊ ጥቕሚ ፍቓድ (EUA) ንናይ Abbott ቤትፈተነታት ሂቡ ኣብ Abbott's m2000 ሲስተም ንዝግበሩ መርመራታት; FDA ተመሳሳሊ ፈቓዳት ን Hologic, LabCorp, ከምኡውን Thermo Fisher Scientific ሂቡ ኔሩ። 	On March 19, 2020, the FDA granted Emergency Use Authorization (EUA) to Abbott Laboratories for testing on Abbott&#39;s m2000 system; The FDA granted similar approvals to Hologic, LabCorp, and Thermo Fisher Scientific.
1324	en	ti	 On 21 March 2020, Cepheid similarly received EUA from the FDA for a test that takes about 45 minutes. 	 ኣብ 21 መጋቢት 2020፣ Cepheid ብተመሳሳሊ ናይ 45 ደቓይቕ ዝወስድ ምርመራ EUA ካብ FDA ተቐቢሉ። ። 	On March 21, 2020, Cepheid received a similar 45-minute EUA test from the FDA. .
1325	en	ti	 The FDA has approved a test that uses isothermal nucleic acid amplification technology instead of PCR. 	 FDA ኣይዞተርማል ኒዩክሊክ ኣሲድ መጉልሂ ቴክኖሎጂ ዝጥቀም ምርመራ ኣብ ክንዲ PCR ንምጥቃም ፈቓድ ሂቡ። 	The FDA approved the use of isothermal nucleic acid amplification technology instead of PCR.
1326	en	ti	 Since this does not require a series of alternating temperature cycles this method can deliver positive results in as little as five minutes and negative results in 13 minutes. 	 እዚ ቀጸልቲ ተቐያየርቲ ሙቐታት ዘየድሊ ስለዝኾነ እዞም ሜላታት ኣብ ውሽጢ ሓሙሽተ ደቓይቕ ዝኸውን ኣዎንታዊ ውጽኢታት ኣብ ውሽጢ 13 ደቓይቕ ድማ ኣሉታዊ ውጽኢታት የቕርቡ። 	These techniques provide positive results within five minutes and negative results within 13 minutes as this continuous temperature variables are unnecessary.
1327	en	ti	 There are currently about 18,000 of these machines in the U.S. and Abbott expects to ramp up manufacturing to deliver 50,000 tests per day.A test which uses a monoclonal antibody which specifically binds to the nucleocapsid protein (N protein) of the novel coronavirus is being developed in Taiwan, with the hope that it can provide results in 15 to 20 minutes just like a rapid influenza test. 	 ኣብዚ ግዜ እዚ 18,000 ዝኾኑ እዞም U.S. ን Abbott ን ዘለዉ ማሽናት 50,000 ምርመራታት ኣብ ሓደ መዓልቲ ንከካይዱ ትጽቢት ይግበሮ ኣሎ።ሞኖክሎናል ጸረ-ነፍሳት ምስ ናይቲ ሓድሽ ኮሮናቫይረስ ኒዩክሎካፕሲድ ፕሮቲን (N ፕሮቲን) ብምትሕሓዝ ዝሰርሕ ምርመራ ኣብ ታይዋን ይምዕብል ኣሎ፣ ምርመራታት ከም ናይ ቅልጡፍ ኢንፍሉዌንዛ ምርመራታት ኣብ 15 ክሳብ 20 ደቓይቕ ከካይድ ተስፋ ተገይርዎ ኣሎ። 	Currently, 18,000 are expected to conduct 50,000 tests in one day for machines and 50,000 machines in the same day. It is expected to run in 15 to 20 minutes.
1328	en	ti	" A March 2020 literature review concluded that ""chest radiographs are of little diagnostic value in early stages, whereas CT [computed tomography] findings may be present even before symptom onset."" "	" ናይ መጋቢት 2020 ናይ ጽሑፋት ገምጋም ናይ ""ኣፍ ልቢ ራድዮግራፋት ኣብ ናይ መጀመርያ ናይቲ ሕማም ደረጃ ነቲ ሕማም ናይ ምርካብ ክእለቶም ውሑድ እዩ፣ CT [computed tomography] ግን ቅድሚ ምልክታት ምፍጣሮም እውን ከለልዮ ይኽእል እዩ "" ክብሉ ሓቢሮም። "	A March 2020 literature review of &quot;Oral cardiac radiographs have little ability to detect the disease in the early stages of the disease, but CT [computed tomography] can detect it even before symptoms develop
1329	en	ti	 Typical features on CT include bilateral multilobar ground-glass opacificities with a peripheral, asymmetric and posterior distribution. 	 ኣብ CT ዝረኣዩ ልሙዳት ባህርያታቱ ክልተኣዊ ማልቲሎቡላር ሳዕሪ ዝመስሉ ምሽፋን ናብ ጸግዓዊ፣ ዘይምቕሩሕ ዳሕረዋይ ኣካል ምስርጫው እዮም። 	Its typical features on CT are bilateral multilobular grass-like coatings with infiltration into the lateral, unresolved hindlimb.
1330	en	ti	 Subpleural dominance, crazy paving and consolidation develop as the disease evolves. 	 ሳብፕሉራል ዓብላሊነት፣ ርግራግ ባይታን ኮንሶሊዴሽነን እቲ ሕማም እንዳገደደ ክኸይድ ከሎ ይምዕብሉ። 	Subplural dominance, background fractures and consolidation develop as the disease progresses.
1331	en	ti	 A study comparing PCR to CT in Wuhan at the point of origin of the current pandemic has suggested that CT is significantly more sensitive than PCR, though less specific, with many of its imaging features overlapping with other pneumonias and disease processes. 	 ኣብ መበቆል ናይዚ ሕዚ ለበዳ ዉሃን PCR ን CT ን ምንጽጻር ኣብ ዝተኻየደ መጽናዕቲ፡ CT ልዕሊ PCR ብዝበለጸ ሕማም ከምዘሎ ዝፈልጥን ዋላ እንተኾነ፣ ብዝተሓተ ግን ኣየናይ ሕማም ኣይፈሊን`ዩ፣ መብዛሕትኦም ስሊታቱ ምስ ኒሞንያን ካልኦት ሕማማትን ዝመሳሰሉ እዮም። 	In a study comparing PCR and CT at the origin of the current Wuhan outbreak, although CT detects disease better than PCR, at least it does not distinguish which disease, most of its cells are similar to pneumonia and other diseases.
1332	en	ti	" As of March 2020, the American College of Radiology recommends that ""CT should not be used to screen for or as a first-line test to diagnose COVID-19"".As of March 2020, the CDC recommends PCR for initial screening. "	" ኣብ መጋቢት 2020 ፡ ናይ ኣሜሪካ ናይ ራዲዮሎጂ ኮሌጅ( American College of Radiology) "" CT ከም ናይ መጀምሪያ መጻረዪ ወይከዓ ናይ መጀምሪያ ደርጃ ናይ COVID-19 መመርመሪ ክኸውን የብሉን"" ክብሉ ተላቢዮም። ካብ መጋቢት 2020 ጀሚሩ ድማ CDC PCR ከም ናይ መጀመሪያ መጻረዪ ንክኸውን ለበዋኡ ኣቕሪቡ። "	In March 2020 , the American College of Radiology recommended that &quot; CT should not be used as a primary screening or first-line test for COVID-1 Starting in March 2020, the CDC recommended PCR as the primary screening test.
1333	en	ti	 Part of the immune response to infection is the production of antibodies including IgM and IgG. 	 ነዚ ሕማም ንምጥቃዕ ዝግበር ናይ ኣካላትና ስርዓተ-ምክልኻል ግብረ መልሲ IgM ን IgG ን ጸረ-ነፍሳት ምምስራት ዘጠቃለለ እዩ። 	The body&#39;s immune response to attack this disease has included the formation of IgM and IgG antibodies.
1334	en	ti	 These can be used to detect infection in individuals starting 7 days or so after the onset of symptoms, to determine immunity, and in population surveillance.Assays can be performed in central laboratories (CLT) or by point-of-care testing (PoCT). 	 እዚኦም ድማ ምልክታት ድሕሪ ምጅማሮም ኣብ 7 መዓልታት ወይ ድሕሪኡ ነቲ ረኽሲ ንምርካብ፣ በዚ ሕማም ዘይጥቅዑ ከምዝኾኑ ንምርግጋጽን፣ ንናይ ብዝሒ ህዝቢ ሓለዋን ይጠቕሙ።መርመራታት ኣብ ማእኸላይ ቤተ ፈተነታት (CLT) ወይ ብናይ ክንክን ነጥቢ ምርመራ (PoCT) ይካየዱ። 	These are useful for detection of the infection at or after 7 days after the onset of symptoms, to ensure that they are immune to the disease, and for population protection.Tests are performed in central laboratories (CLT) or by point-of-care testing (PoCT).
1335	en	ti	 The high-throughput automated systems in many clinical laboratories will be able to perform these assays but their availability will depend on the rate of production for each system. 	 እቲ ልዑል-ዝሓለፈ ኣውቶሜትድ ሲስተም ኣብ መብዛሕትኦም ክሊኒካል ቤተ ፈተነታት እዞም ምርመራታት እዚኦም ከካይዱ ይኽእሉ እዮም ኣቕርቦቶም ግን ኣብ ናይ ሕድሕድ ሲስተም መምርቲ ሬት ዝድገፍ ይኸውን። 	The high-throughput automated system in most clinical laboratories can perform these tests but their delivery is subject to the respective system testers rates.
1336	en	ti	 For CLT a single specimen of peripheral blood is commonly used, although serial specimens can be used to follow the immune response. 	 ሴርያል ናሙናታት ናይ ሕማም ምክልኻል ዓቕሚ ንምክትታልን ዋላ`ኳ እንተጠቀሙ፡ CLT ናይ ደም ነጻላ ናሙና እዩ ብልምዲ ዝጥቀም። 	Although serial samples are used to monitor immune function, CLT is commonly used as an isolated blood sample.
1337	en	ti	 For PoCT a single specimen of blood is usually obtained by skin puncture. 	 ን PoCT ነጸላ ናይ ደም ናሙና መብዛሕትኡ ግዜ ኣብ ቆርበት መርፍእ ብምውጋእ ዝውሰድ እዩ። 	An isolated blood sample for PoCT is usually obtained by injection into the skin.
1338	en	ti	 Unlike PCR methods an extraction step is not needed before assay.On March 26, 2020, the FDA named 29 entities that provided notification to the agency as required and are now therefore able to distribute their antibody tests. 	 ከም ናይ PCR ሜላታት ኤክስትራክሽን ስጉምቲ ቅድሚቲ መርመራ ኣየድሊን።ኣብ መጋቢት 26, 2020, FDA ከምዝተሓተትዎ ነቲ ኤጀንሲ ምልክታ ዝሃቡ 29 ትካላት ሓቢሩ ስለዚ ድማ ሕዚ ናይ ጸረ-ነፍሳት ምርመራታቶም ከሰራጭዉ ክኢሎም ኣለዉ። 	As with PCR methods, the extraction step does not require pre-testing. On March 26, 2020, the FDA said 29 companies had applied to the agency and were now able to disseminate their antibiotic tests.
1339	en	ti	 As of April 7, 2020, only a single test has been approved by the FDA under an emergency use authorization.In late March 2020, Euroimmun Medical Laboratory Diagnostics and Epitope Diagnostics received European approvals for their test kits, which can detect IgG and IgA antibodies against the virus in blood samples. 	 ካብ ሚያዝያ 7, 2020 ጀሚሩ፣ ብናይ ሃንደበታዊ ጥቕሚ ፈቓድ ብ FDA ሓደ ምርመራ ጥራሕ እዩ ተፈቒዱ።ኣብ መጋቢት 2020 መወዳእታታት፣ Euroimmun Medical Laboratory Diagnostics (ዩሮኢሚዩን ናይ ሕክምና ቤተ ፈተነታት ዳያግኖስቲክስ) ን Epitope Diagnostics (ኢፒቶፕ ዳያግኖስቲክስን) ንናይ ምርመራ ኪታቶም ፍቓድ ረኺቦም፣ ኣብ ናይ ደም ናሙናታት ኣንጻር እቲ ቫይረስ ዝምረቱ IgG ን IgA ን ጸረ-ነፍሳት ንምልላይ ይጠቕሙ። 	As of April 7, 2020, only one test has been approved by the FDA under contingency benefit approval.In late March 2020, Euroimmun Medical Laboratory Diagnostics and Epitope Diagnostics received approval for their test kits, at Blood samples are useful for identifying IgG and IgA antibodies produced against the virus.
1340	en	ti	 The testing capacity is several hundred samples within hours and therefore much faster than the conventional PCR assay of viral RNA. 	 ናይ ምምርማር ዓቕሚ ዝተፈላለዩ ሓደ ሚእቲ ናሙናታት ኣብ ውሽጢ ሰዓታት ይምርምር፡ ስለዚ ድማ ልዕሊ እቲ ልሙድ ናይ ቫይረስ RNA PCR ምርመራ ኣዝዩ ዝፈጠነ እዩ። 	Assay capability tests one hundred different samples in a matter of hours, and is therefore much faster than conventional viral RNA PCR testing.
1341	en	ti	 The antibodies are usually detectable 14 days after the onset of the infection.In early April, the UK found none of the antibody test kits it purchased were sufficiently good to use. 	 እዞም ጸረ-ነፍሳት መብዛሕትኡ ግዜ ድሕሪ ናይቲ ረኽሲ ምፍጣር 14 መዓልቲታት እዮም ዝፍለጡ።ኣብ ኣፕሪል መጀመርያ፣ UK ዝዓደገቶም ናይ ጸረ-ነፍሳት ኪታት ንምጥቃም ብቑዓት ከምዘይኮኑ ኣረጋጊጻ። 	These antibiotics are usually diagnosed 14 days after the infection occurs.In April first, the UK confirmed that antibiotic kits it had purchased were not fit for use.
1342	en	ti	" Hong Kong has set up a scheme where suspected patients can stay home, ""emergency department will give a specimen tube to the patient"", they spit into it, send it back and get a test result a while after.The British NHS has announced that it is piloting a scheme to test suspected cases at home, which removes the risk of a patient infecting others if they come to a hospital or having to disinfect an ambulance if one is used.In drive-through testing for COVID-19 for suspected cases, a healthcare professional takes sample using appropriate precautions. "	" ሆንግ ኮንግ ዝተጠርጠሩ ሰባት ኣብ ገዝኦም ክጸንሑሉ ዝኽእሉሉ ሜላ ኣዳልያ፣ ""ናይ ኢመርጀንሲ ክፍሊ ናይ መመርመሪ ናሙና ቱቦ ነቲ ተሓካሚ ይህቦ ""፣ እንትፍ ይብሉሉ ውጽኢቶም ድማ ጸኒሖም ክፈልጡ ይግበሩ።ናይ ብሪታንያ NHS ዝተጠርጠሩ ኬዛት ኣብ ገዛኦም ዝሕከሙሉ ሜላ ክጅምር ከምዝኾነ ሓቢሩ፣ ዝሓመሙ ሰባት ናብ ሆስፒታል ኣብ ዝመጹሉ ግዜ ከስዕብዎ ዝኽእሉ ስርጭት ንምቕናስ ወይ ሕሙማት ዘምጽኣ ኣምቡላስታት ዝግበረለን ዲስኢንፌክት ምግባር ንምቕናስ፡ ኣብ ናይ መኪናኻ ኮይንካ ብዝርከብ ኣገልግሎት ዝግበሩ ናይ ብኮቪድ-19 ዝተጠርጠሩ ኬዛት ምርመራታት፣ ናይ ጥዕና ክንክን ሰብ ሞያ ኣግባባዊ ዝኾኑ ቅድመ ጥንቃቐታት ወሲዱ ናሙናታት ይወስድ። "	Hong Kong has developed a method for suspected cases to stay at home, &quot;the emergency department gives the patient a test sample tube &quot;, they spit in and the results are known later Tests of suspected cases of COVID-19 by in-car service, health care professionals take appropriate precautions to reduce the spread or disinfection of ambulances.
1343	en	ti	 Drive-through centers have helped South Korea do some of the fastest, most-extensive testing of any country.In Germany, the National Association of Statutory Health Insurance Physicians said on 2 March, that it had a capacity for about 12,000 tests per day in the ambulatory setting and 10.700 had been tested in the prior week. 	 ኣብ ጎደናታት ኣብ መኻይን ምርመራ ዝገብሩ ማእኸላት ንደቡብ ኮሪያ ካብ ካልኦት ሃገራት ንላዕሊ ኣዝዩ ብዝቀልጠፈን ዝጸዓቀን መንገዲ ምርመራታት ንኽትገብር ኣኽኢሉዋ እዩ። ኣብ ጀርመን ናይ ሃገራዊ ማሕበር ስታቱቶሪ ጥዕና( National Association of Statutory Health Insurance) ሰብ ሞያታት ጥዕና ኣብ መጋቢት 2፡ ብተንቀሳቐሲ መስርሕ ኣብ መዓልቲ 12000 ምርመራታት ናይ ምግባር ዓቕሚ ከምዘለዎ ብምሕባር ኣብቶም ዝሓለፈ ሰሙን ድማ 10700 ዝኾኑ ምርመራታት ከምዝገበሩ ገሊጾም። 	Street vehicle testing centers have enabled South Korea to conduct tests much faster and more intensively than other countries. In Germany, health professionals from the National Association of Statutory Health Insurance said on March 2 that the mobile process has the capacity to perform 12,000 tests a day, up from 10,700 last week.
1344	en	ti	 Costs are borne by the health insurance when the test is ordered by a physician. 	 አቲ ምርመራ ብዶክተር ዝተኣዘዘ እንተኾይኑ ወጻኢታት ብናይ ጥዕና መድሕን ይሽፈን። 	If the test is prescribed by a doctor, the cost is covered by health insurance.
1345	en	ti	 According to the president of the Robert Koch Institute, Germany has an overall capacity for 160,000 tests per week. 	 ናይ Robert Koch Institute (ሮበርት ኮኽ ትካል) ፕረዚደንት ከምዝበልዎ፣ ጀርመን ኣብ ሰሙን 160,000 ምርመራታት ናይ ምክያድ ሓፈሻዊ ብቕዓት ኣለዋ። 	According to the president of the Robert Koch Institute, Germany has an overall capacity of 160,000 tests a week.
1346	en	ti	 As of 19 March drive in tests were offered in several large cities. 	 ካብ መጋቢት 19 ጀሚሩ ኣብ ብዙሓት ከተማታት ኣብ መኪናታት ዝግበር ምርመራ ይካየድ ኣሎ። 	Since March 19, vehicle inspections have been conducted in many cities.
1347	en	ti	 As of 26 March 2020 the total number of tests performed in Germany was unknown, because only positive results are reported. 	 ካብ 26 መጋቢት 2020 ጀሚሩ ኣብ ጀርመን ዝተኻየደ ሓፈሻዊ ምርመራ ኣይፍለጥን፣ ምኽንያቱ ኣወንታዊ ምርመራታት ጥራሕ እዮም ሪፖርት ዝግበሩ ዘለዉ። 	The total number of tests in Germany since 26 March 2020 is unknown, as only positive tests are being reported.
1348	en	ti	" A first lab survey revealed that as of calendar week 12/2020 a total of at least 483,295 samples were tested up to and including week 12/2020 and 33,491 samples (6.9%) tested positive for SARS-CoV-2.In Israel, researchers at Technion and Rambam Hospital developed and tested a method for testing samples from 64 patients simultaneously, by pooling the samples and only testing further if the combined sample is found to be positive.In Wuhan a makeshift 2000-sq-meter emergency detection laboratory named ""Huo-Yan"" (Chinese: 火眼, or ""Fire Eye"" in English) was opened on 5 February 2020 by BGI, which can process over 10,000 samples a day. "	" ናይ መጀመርያ ናይ ቤተ ፈተነ መጽናዕቲ ካብ ናይ ካላንደር ሰሙን 12/2020 ጀሚሩ እንተንኢሱ ብሓፈሻ 483,295 ናሙናታት ክሳብ 12/2020 ምርመራ ተገይርሎም 33,491 ናሙናታት (6.9%) ድማ ን SARS-CoV-2 ኣዎንታዊ ውጽኢት ኣርእዮም።ኣብ እስራኤል፣ መጽናዕቲ መካየድቲ Technion ን Rambam ሆስፒታልን ናይ 64 ሕሙማት ናሙናታት ብሓደ ግዜ ምምርማር ዝከኣለሉ ሜላ ምሂዞም ፈቲኖሞን፣ እቶም ናሙናታት ብምሕዋስ እቶም ዝተሓወሱ ናሙናታት ኣዎንታዊ ኮይኑ እንተተረኺብዎም ጥራሕ ተወሳኺ ምርመራ ክግበሮም ዝገብር።ኣብ ውሃን 2000-sq-ሜትር ሃንደበታዊ መለለዪ ቤተ ፈተነ ""Huo-Yan"" (ቻይንኛ: 火眼, ወይ ""Fire Eye"" ብኢንግሊሽ) ኣብ 5 ለካቲት 2020 ብ BGI ተኸፊቱ፣ ልዕሊ 10,000 ናሙናታት ኣብ መዓልቲ ፕሮሰስ ዝገብር። "	Initial laboratory tests A total of 483,295 samples were tested at least since calendar week 12/2020 and 33,491 samples (6.9%) tested positive for SARS-CoV-2.In Israel, study conductors Technion and Rambam Hospital They devised and tested a method of simultaneously testing samples of 64 patients, mixing the samples so that they could be further tested only if the mixed samples tested positive. Fire Eye&quot; in English) opened on February 5, 2020 by BGI, processing more than 10,000 samples per day.
1349	en	ti	 With the construction overseen by BGI-founder Wang Jian and taking 5-days, modelling has show cases in Hubei would have been 47% higher and the corresponding cost of the tackling the quarantine would have doubled if this testing capacity hadn't come on line. 	 እዚ ህንጻ ብናይ BGI-መስራቲ Wang Jian እንዳተራኣየ 5-መዓልታት ወሲዱ። እዚ ናይ ምርመራ ዓቕሚ ክምዕብል እንተዘይከኣል ኔሩ፡ ናይ ሁቤይ ኬዛት ካብዚ ናይ ሕዚ 47% ንላዕሊ ምኾኑ ነይሮም ናይ ክትትልን ውሸባን ወጻኢ ድማ ዕጽፊ ክውስኽ ይኽእል ምንባሩ ተረጋጊጹ። 	This building took 5-days being shown by BGI-founder Wang Jian. If this testing capacity had not been developed, Hubei&#39;s cases would have been 47% higher than the current level and the cost of surveillance and quarantine could have doubled.
1350	en	ti	 The Wuhan Laboratory has been promptly followed by Huo-Yan labs in Shenzhen, Tianjin, Beijing, and Shanghai, in a total of 12 cities across China. 	 ናይ ዉሃን ቤተ ፈተነ ብ Huo-Yan ቤተ ፈተነታት ናይ Shenzhen, Tianjin, Beijing, ከምኡውን Shanghai ተኸቲሉ፣ ብጠቕላላ ኣብ ናይ ቻይና 12 ከተማታት። 	The Wuhan lab was followed by the Huo-Yan labs of Shenzhen, Tianjin, Beijing, and Shanghai, in a total of 12 Chinese cities.
1351	en	ti	 By 4 March 2020 the daily throughput totals were 50,000 tests per day.Open source, multiplexed designs released by Origami Assays have been released that can test as many as 1122 patient samples for COVID19 using only 93 assays .  These balanced designs can be run in small laboratories without the need for robotic liquid handlers. 	 ኣብ 4 መጋቢት 2020 መዓልታዊ ምርመራታት ብሓፈሻ 50,000 ምርመራታት ብመዓልቲ ኮይኖም።ክፍቲ ምንጪ፣ ብ Origami ምርመራታት ዝቐረበ ንድፊ ልዕሊ ናይ 1122 ሕሙማት ናይ ኮቪድ-19 ናሙናታት 93 መመርመሪታት ጥራሕ ክምርምር ይገብር።እዞም ዝተመጣጠኑ ንድፊታት ኣብ ኣናእሽተይ ቤተ ፈተነታት ብዘይ ናይ ሮቦት ፈሰስቲ ተሓዝቲ ሓገዝ ክካየዱ ይኽእሉ። 	As of March 4, 2020, daily tests totaled 50,000 tests per day.Open source, the design by Origami Tests allows only 93 tests to test more than 1,122 patients&#39; COVID-19 samples They can .
1352	en	ti	 By March, shortages and insufficient amounts of reagent has become a bottleneck for mass testing in the EU and UK and the US. 	 ኣብ መጋቢት፣ ኣብ EU ን UK ን ከምኡውን US ናይ ሪኤጀንት ሕጽረታትን ዘይብቑዕነትን ብዙሕ ምርመራ ንምክያድ ዓብዪ ውጥረት ኮይኑ ጸኒሑ። 	In March, reagent shortages and inefficiencies in the EU and the UK and the US have been a major stress to conduct a lot of testing.
1353	en	ti	 This has led some authors to explore sample preparation protocols that involve heating samples at 98 °C (208 °F) for 5 minutes to release RNA genomes for further testing.On 31 March it was announced United Arab Emirates was now testing more of its population for Coronavirus per head than any other country, and was on track to scale up the level of testing to reach the bulk of the population. 	 እዚ ሓደሓደ ጸሓፍቲ ንናሙናታት ኣብ 98 °C (208 °F) ን 5 ደቓይቕ ምውዓይ RNA ጄኖማት ንዝበለጸ ምርመራ ምስዳድ እውን ዘካተተ ናይ ናሙና ምድላው ፕሮቶኮላት ንክድህስሱ ጌርዎም እዩ።ኣብ 31 መጋቢት United Arab Emirates (ሕቡራት መንግስታት ዓረብ ኤሜሬትስ) መብሕትኦም ብዝሒ ህዝቡ ልዕሊ ማንም ካልእ ሃገር ናይ ኮሮናቫይረስ ምርመራ እንዳገበረት ከምትርከብ ተሓቢሩ፣ ማዕረ ብዝሒ ህዝባ ምርመራ ንምግባር እንዳሰርሐት ከምትርከብ ድማ ተገሊጹ እዩ። 	This led some authors to explore sample preparation protocols that also included heating samples at 98 °C (208 °F) for 5 minutes and sending RNA genomes for further analysis The country is testing for the virus, and is working to test as much as its population.
1354	en	ti	" This was through a combination of drive-through capability, and purchasing a population-scale mass-throughput laboratory from Group 42 and BGI (based on their ""Huo-Yan"" emergency detection laboratories in China). "	" ናይ ኣብ መኪናኻ ከለኻ ብዝርከብ ኣገልግሎትን፣ ናይ ብዝሒ ህዝቢ ስኬል ካብ ቤተ ፈተነ ጉጅለ 42 ን BGIን(ኣብ ናይ ""Huo-Yan"" ሃንደበታዊ መለለዪ ቤተ ፈተነታት ናይ ቻይና መሰረት ዝገበረ) ምትሕብባር እዩ። "	of by the service available in your car, and the population scale from the laboratory of Group 42 and BGI (based on the &quot;Huo-Yan&quot; random identification laboratories of China).
1355	en	ti	 Constructed in 14 days, the lab is capable of conducting tens of thousands RT-PCR tests per day and is the first in the world of this scale to be operational outside of China. 	 ኣብ 14 መዓልቲታት ዝተሃንጸ ኮይኑ፣ እዚ ቤተ ፈተነ ዓሰርተ ኣሽሓት ናይ RT-PCR ምርመራታት ኣብ ሓደ መዓልቲ ከካይድ ይኽእል እዚ ድማ ካብ ቻይና ወጻኢ እንትካየድ ንመጀመርያ ግዘ እዩ። 	Built in 14 days, the laboratory can conduct tens of thousands of RT-PCR tests in a single day, the first time outside China.
1356	en	ti	 Different testing recipes targeting different parts of the coronavirus genetic profile were developed in China, France, Germany, Hong Kong, Japan, and the United States. 	 ኣብ ናይቲ ኮሮና ቫይረስ ዝተፈላለዩ ጀኒቲክ ገጽታ ዘነጻጸሩ ዝተፈላለዩ መመርመሪ ትእዛዛት ኣብ ቻይና፣ ፈረንሳይ፣ ጀርመን፣ ሆንግ ኮንግ፣ ጃፓንን ዩናይትድ ስቴትስን ማዕቢሎም። 	Various testing protocols comparing different genetic aspects of the coronavirus have been developed in China, France, Germany, Hong Kong, Japan and the United States.
1357	en	ti	 The World Health Organization adopted the German recipe for manufacturing kits sent to low-income countries without the resources to develop their own. 	 ናይ ዓለም ጥዕና ድርጅት ናብ ትሑት ኣታዊ ዘለወን ባዕለን ከምርታ ዘይኽእላ ሃገራት ዝስደድ ዘሎ ናይ ጀርመን ናይ ኪት ምህርቲ ተቐቢልዎ። 	The World Health Organization (WHO) has welcomed German kits being exported to low-income countries that cannot produce themselves.
1358	en	ti	 The German recipe was published on 17 January 2020; the protocol developed by the United States Centers for Disease Control was not available until 28 January, delaying available tests in the U.S.China and the United States had problems with the reliability of test kits early in the outbreak, and these countries and Australia were unable to supply enough kits to satisfy demand and recommendations for testing by health experts. 	 ናይ ጀርመን ቅመማ ኣብ ጥሪ 17 2020 እዩ ተሓቲሙ፡ እቲ ብ ሕቡራት መንግስታት ኣሜሪካ( U.S.) ማእከል ናይ ሕማም ቁጽጽር ዝተዳለወ ፕሮቶኮል ክሳብ ጥሪ 28 ዝርከብ ስለዘይነበረ ናይ ምርመራታት ምድንጓይ ተፈጢሩ ነይር። ቻይናን U.S.ን እቲ ለበዳ ኣብ ምጅማሩ ኣብ ተኣማንነት ናይ ምርመራ ኪታት (test kits) ጸገም ኣጋጢሙወን ነይሩ እዩ፡ እዘን ሃገራት እዚእንን ኣውስትራሊያን ድማ ብሰብ ሞያ ሕክምና ብዝተብሃሎ መሰረትን ጠለብን ኣብ ምምላእ እኹል ኪትስ ክቕርባ ኣይከኣላን። 	The German formulation was published on January 17 2020. The protocol developed by the United States( US) Centers for Disease Control was not available until January 28, causing testing delays. China and the US had problems with the reliability of test kits at the outbreak, and these countries and Australia were unable to supply enough kits to meet the demands of medical professionals.
1359	en	ti	 In contrast, experts say South Korea's broad availability of testing helped reduce the spread of the novel coronavirus. 	 ክነጻጸር ከሎ፣ ሰብ ሞያታት ናይ ደቡብ ኮሪያ ሰፊሕ ናይ ምርመራ ኣቕርቦት ስርጭት ሓድሽ ኮሮና ቫይረስ ቀኒስዎ ይብሉ። 	In comparison, experts say South Korea&#39;s extensive testing supply has reduced the spread of the new coronavirus.
1360	en	ti	 Testing capacity, largely in private sector labs, was built up over several years by the South Korean government. 	 ናይ ምርመራ ዓቕሚ፣ ብዓብይኡ ኣብ ናይ ግሊ ቤተ ፈተነታት፣ ኣብ ብዙሓት ዓመታት ብናይ ደቡብ ኮርያ መንግስቲ ዝተሰርሑ እዮም። 	Testing capabilities, largely in private laboratories, have been built over many years by the South Korean government.
1361	en	ti	 On 16 March, the World Health Organization called for ramping up the testing programmes as the best way to slow the advance of COVID-19 pandemic.High demand for testing due to wide spread of the virus caused backlogs of hundreds of thousands of tests at private U.S. labs, and supplies of swabs and chemical reagents became strained. 	 ኣብ 16 ማርች፣ ናይ ዓለም ጥዕና ድርጅት ናይ ምርመራ ፕሮግራማት ናይ ኮቪድ-19 ንምቕናስ ከሳልጡ ሓቲቱ።በቲ ናይቲ ቫይረስ ሰፊሕ ምስርጫው ብዝፈጠሮ ኣማኢት ኣሽሓት ናይ ግሊ ምርመራታት ኣብ ናይ U.S. ቤት ፈተነታት ስለዝተኻየዱ፣ ከምኡውን ናይ ስዋባትን ኬሚካል ሬጀንትን ኣቕርቦት ስለዝተዳኸመ ናይ ምርመራ ልዑል ሕቶታት ይቐርቡ ኣለዉ። 	On March 16, the World Health Organization called for a reduction in testing programs for COVID-1 .
1362	en	ti	 In March 2020 China reported problems with accuracy in their test kits. 	 ኣብ መጋቢት 2020 ቻይና ኣብ ናይ መመርመሪ ኪቶም ዘጋጠመሞ ናይ ዘይትኽክለኛት ጸገም ሪፕሮት ጌሮም። 	In March 2020, China reported an inaccuracy problem with their test kits.
1363	en	ti	" In the United States, the test kits developed by the CDC had ""flaws;"" the government then removed the bureaucratic barriers that had prevented private testing.Spain purchased test kits from Chinese firm  Shenzhen Bioeasy Biotechnology Co Ltd, but found that results were inaccurate. "	" ኣብ ዩናይትድ ስቴተስ፣ ብ CDC ዝማዕበሉ ናይ ምርመራ ኪታት ""ጸገማት;"" ነይርዎም፣ እቲ መንግስቲ ድሕሪኡ ናይ ግሊ ሕክምናታት ምርመራ ኣጊዱ ዝበረ ቢሮክራቲክ ገደብ ኣልዒሉ።ሰፔን ካብ ናይ ቻይና Shenzhen Bioeasy Biotechnology Co Ltd መመርመሪ ኪታት ዓዲጋ፣ ውጽኢታቶም ድማ ዘይትኽክል ከምዝኾነ ኣረጋጊጻ። "	In the United States, test kits developed by the CDC have &quot;problems;&quot; The government then lifted bureaucratic restrictions that banned testing of private treatments. Spain bought test kits from China&#39;s Shenzhen Bioeasy Biotechnology Co Ltd and confirmed that their results were inaccurate.
1364	en	ti	 The firm explained that the incorrect results may be a result of a failure to collect samples or use the kits correctly. 	 እቲ ትካል እዞም ዘይትኽክለኛ ውጽኢታት ናይ ናሙናታት ኣተኣኻኽባ ጸገም ዘስዐብዎ ወይ እቶም ኪታት ብትኽክል ብዘይ ምጥቃም ዝመጸ ክኾን ይኽእል እዩ ኢሉ። 	The agency said these inaccurate results may have been caused by sample collection problems or by not using the kits correctly.
1365	en	ti	 The Spanish ministry said it will withdraw the kits that returned incorrect results, and would replace them with a different testing kit provided by Shenzhen Bioeasy.80% of test kits the Czech Republic purchased from China gave wrong results.Slovakia purchased 1.2 million test kits from China which were found to be inaccurate. 	 ናይ ስፓኒሽ ሚኒስትሪ ዝተሰሓሓተ ውጽኢት ዘምጽኡ ኪታት ኣወጊዱ፣ ብ Shenzhen Bioeasy ዝቐረቡ ካልኦት መመርመሪ ኪታት ከምዝጥቀም ሓቢሩ።80% ናይ እዞም ቼክ ሪፐብሊክ ካብ ቻይና ዝዓደገቶም መመርመሪ ኪታት ዝተሰሓሓተ ውጽኢት ሂቦም።ስሎቫኪያ ካብ ቻይና 1.2 ሚለዮን ኪታት ዓዲጋ ዘይትኽክለኛታት ኮይኖም ድማ ረኺባቶም። 	The Spanish ministry said it had eliminated kits that gave conflicting results and would use other test kits provided by Shenzhen Bioeasy. 80% of the kits purchased by the Czech Republic from China gave conflicting results.
1366	en	ti	" Prime Minister Matovič suggested these be dumped into the Danube.Ateş Kara of the Turkish Health Ministry said the test kits Turkey purchased from China had a ""high error rate"" and did not ""put them into use.""The UK purchased 3.5 million test kits from China but in early April 2020 announced these were not usable. "	" ቀዳማይ ሚኒስተር Matovič እዚ ናብ Danube ንክድርበ ሓሳብ ሂቦም።Ateş Kara ናይ ቱርኪ ጥዕና ሚኒስትሪ ቱርኪ ካብ ቻይናዝዓደገቶም ናይ ምርመራ ኪታት ""ልዑል ናይ ጌጋ ሬት"" ከምዝነበሮምን ""ከምዘይተጠቐምዎምን"" ሓቢሮም።UK 3.5 ሚልዮን ናይ ምርመራ ኪታት ካብ ቻይና ዓዲጋ ኣብ ሚያዝያ 2020 መጀመርያታት ግን ንጥቅሚ ዝውዕሉ ከምዘይኮኑ ሓቢራ። "	Prime Minister Matovič suggested this be thrown into the Danube.Ateş Kara of the Turkish Health Ministry said test kits Turkey bought from China had a &quot;high error rate&quot; and &quot;were not used She said they weren&#39;t.
1367	en	ti	 Testing, followed with quarantine of those who tested positive and tracing of those with whom the SARS-CoV-2 positive people had had contact, resulted in positive outcomes. 	 ምርመራ፣ ኣወንታዊ ውጽኢት ዘርአዩ ምውሻብን እዞም ናይ SARS-CoV-2 ኣወንታዊ ውጽኢት ዘለዎም ሰባት ዝነኽእዎም ሰባት ምክትታልን፣ ኣወንታዊ ውጽኢታት የርእዩ ኣለዉ። 	Testing, quarantine of positive cases and follow-up of contacts of these SARS-CoV-2 positive cases are showing positive results.
1368	en	ti	 Researchers working in the Italian town of Vò, the site of the first COVID-19 death in Italy, conducted two rounds of testing on the entire population of about 3,400 people, about ten days apart. 	 ኣብ ናይ ጣልያን ከተማ Vò፥ ኣብ ጣልያን ናይ መጀመርያ ናይ ኮቪድ-19 ቦታ ሞት ፣ ዝሰርሑ ዘለዉ ተመራመርቲ ኣብ 3,400 ዝኾኑ ሰባት ክልተ ዙር ምርመራ ኣካይዶም፣ በብ ዓሰርተ መዓልታት ኣፈላላይ። 	In the Italian city of Vò, Italy&#39;s first COVID-19 death site , researchers conducted two rounds of testing on some 3,400 people, ten days apart.
1369	en	ti	 About half the people testing positive had no symptoms, and all discovered cases were quarantined. 	 ዳርጋ ፍርቂ ዝኾኑ ፖዚቲቭ ውጽኢት ዘለዎም ምልክት ዘይብሎም እዮም፣ ኩሎም ዝተረኸቡ ኬዛት ድማ ተወሺቦም። 	Nearly half of positive results are asymptomatic, and all detected cases were quarantined.
1370	en	ti	 With travel to the commune restricted, this eliminated new infections completely. 	 ናብቲ ኮም ጉዕዞ ብምኽልካሉ፣ እዚ ሓደሽቲ ረኽሲታት ከወግድ ይኽእል እዩ። 	By preventing travel to the com, this can prevent new infections.
1371	en	ti	 With aggressive contact tracing, inbound travel restrictions, testing, and quarantining, the 2020 coronavirus pandemic in Singapore has proceeded much more slowly than in other developed countries, but without extreme restrictions like forced closure of restaurants and retail establishments. 	 ብሓያል ናይ ንኽክእ ክትትል፣ ናይ ጉዕዞ እገዳታት፣ ምርመራታትን ውሸባን፣ ናይ 2020 ኮሮናቫይረስ ለበዳ ምስ ካልኦት ዝማዕበላ ሃገራት ክነጻጸር ከሎ ኣብ ሲንጋፖር ኣዝዩ ትሑት ክኸውን ክኢሉ እዩ፣ እዚ ክኸውን ዝኸኣለ ድማ ብዘይ ኣገዳዲ ናይ ሬስቶራንትታትን መሸጣ ቦታታት ምዕጻው እዩ። 	With strong contact surveillance, travel restrictions, testing and quarantine, the 2020 coronavirus outbreak in Singapore has been very low compared to other developing countries, without the mandatory closure of restaurants and outlets.
1372	en	ti	 Many events have been cancelled, and Singapore did start advising residents to stay at home on 28 March, but schools reopened on time after holiday break on 23 March. 	 መብዛሕትኦም ምድላዋት ተሰሪዞም እዮም፣ ሲንጋፖር ድማ ንነበርቲ ኣብ ገዝኦም ንክጸንሑ ኣብ 28 መጋቢት ምልላይ ጀሚራ፣ እንተኾነ ግን ቤት ትምህርቲታት ድሕሪ ናይ በዓል ዕረፍቲ ኣብ 23 መጋቢት ኣብ ግዚኦም ተኸፊቶም። 	Most arrangements were cancelled, and Singapore began promoting residents to stay at home on 28 March, but schools reopened on time on 23 March after the holiday break.
1373	en	ti	 Several other countries have also managed the pandemic with aggressive contact tracing, inbound travel restrictions, testing, and quarantining, but with less aggressive lock-downs, such as Iceland and South Korea. 	 ዝተፈላለዩ ካልኦት ሃገራት ነቲ ለበዳ ብሓያል ናይ ንኽክእ ክትትል፣ ናይ ጉዕዞ እገዳታት፣ ምርመራታትን ኳራንቲንን፣ እሞ ግን ክነንድቲ ኣገዳዲ ብዘይኮነ ምዕጻዋት ክቆጻጸርኦ ክኢለነ እየን፣ ንኣብነት ኣይስላንድን ደቡብ ኮርያን። 	Various other countries have been able to control the outbreak with strong contact surveillance, travel restrictions, testing and quarantine, but not so mandatory closures, such as Iceland and South Korea.
1374	en	ti	 A statistical study has found that countries that have tested more, relative to the number of deaths, have much lower case fatality rates, probably because these countries are better able to detect those with only mild or no symptoms. 	 ስታስቲካዊ መጽናዕቲ ብዙሕ ምርመራ ዝገበራ ሃገራት፣ ምስ ናይ ሞት ቁጽሪ ክነጻጸር ከሎ፣ ዝተሓተ ናይ ሞት መጠን ኣለወን፣ እዚ ድማ እዘን ሃገራት ቀሊል ምልክት ዘለዎምን ምንም ምልክት ዘይብሎምን ሰባት ምፍላይ ብምኽኣለን እዩ ዝኸውን። 	Statistical studies Countries with multiple diagnoses have lower mortality rates, compared to death rates, because these countries are able to distinguish between people with mild symptoms and those with no symptoms.
1375	en	ti	 WHO recommends that countries that do not have testing capacity and national laboratories with limited experience on COVID-19 send their first five positives and the first ten negative COVID-19 samples to one of the 16 WHO reference laboratories for confirmatory testing. 	 ውድብ ዓለም ጥዕና(WHO) ናይ ምምርማር ዓቕሚን ዘይብለንን ከምኡ’ውን ኣብ COVID-19 ወሱን ልምዲ ዘለዎ ሃገራዊ ላብራቶሪ ዘለወን ሃገራትን፡ እቶም ናይ መጀመሪያ ሓሙሽተ ኣዎንታዊን፡ ዓሰርተ ኣሉታዊ ናይ COVID-19 ምርመራ ውጽኢታት ናብ እተን 16 ናይ WHO መወከሲ ላብራቶሪታት ክልእኻ ኣለወን ክብል ተላቢዩ። 	The World Health Organization (WHO) has urged countries without testing capacity and with national laboratories with limited experience in COVID-19 to send the first five positive and ten negative results to the 16 WHO reference laboratories .
1376	en	ti	 Out of the 16 reference laboratories, 7 are in Asia, 5 in Europe, 2 in Africa, 1 in North America and 1 in Australia. 	 ካብ 16 መወከስቲ ቤትፈተነታት፣ 7 ኣብ ኤስያ፣ 5 ኣብ ኣውሮፓ፣ 2 ኣብ ኣፍሪካ፣ 1 ኣብ ሰሜን ኣሜሪካ 1 ድማ ኣብ ኣውስትራሊያ ይርከቡ። 	Of the 16 reference laboratories, 7 are in Asia, 5 in Europe, 2 in Africa, 1 in North America and 1 in Australia.
1377	en	ti	 In the following chart, the column “Positive as % of tests” is influenced by the country's testing policy. 	 ኣብ ዝስዕብ ቻርት፣ ረድፊ “ኣወንታዊናይ % ምርመራታት” ብናይታ ሃገር ናይ ምርመራ ፖሊሲ እዩ ዝውሰን። 	In the following chart, the ranking of “positive % tests” is determined by the country’s testing policy.
1378	en	ti	 A country that only tests people admitted to hospitals will have a higher positive as % of tests than a country that tests all citizens, whether or not they are showing symptoms, other things being equal. 	 ናብ ሆስፒታል ዝመጹ ሰባት ጥራሕ ምርመራ ትገብር ሃገር ካብ ዜጋታታ ኩሎም ትምርምር ሃገር ንላዕሊ ፖዘቲቭ ብ % ምርመራ ይህልዋ፣ ምልክት የርእዩ ኣየርአዩ ብዘየገድስ፣ ካልኦት ነገራት ማዕረ እንከለዉ። 	A country that only tests people who come to the hospital will have a higher % of positive tests than a country that tests all its citizens, regardless of whether they show symptoms or not, other things being equal.
1379	en	ti	 Hand washing (or handwashing), also known as hand hygiene, is the act of cleaning one's hands for the purpose of removing soil, grease, microorganisms, or other unwanted substances. 	 ኢድካ ምሕጻብ፣ ናይ ኢድ ጽሬት እውን ተባሂሉ ዝፍለጥ ኮይኑ፣ ካብ ኢድካ ሓመድ፣ ቅብኣት፣ ማይክሮኦርጋኒዝማት፣ ወይ ካልኦት ዘይተደለዩ ጥረ ነገራት ንምእላይ ዕላማ ዝሓዘ እዩ። 	Hand washing, also known as hand hygiene, contains the goal of removing dust, grease, microorganisms, or other unwanted raw materials from your hands.
1380	en	ti	" Hand washing with soap consistently at certain ""critical moments"" during the day prevents the spread of many diseases, for example diarrhoea and cholera, which are transmitted through fecal–oral route. "	" ኣብ ውሽጢ መዓልቲ ኣብ ዘለዉ ""ኣገደስቲ ግዘታት "" ብቐጻልነት ኣእዳውካ ብሳሙና ምሕጻብ ናይ ብዙሓት ሕማማት ምምሕልላፍ ይቕንስ እዩ፣ ንኣብነት ተቕማጥን ኮሌራን፣ ብ ካብ ፍታን–ናብ ኣፍ መገዲ ዝመሓላለፉ ሕማማት እዮም። "	Washing your hands regularly with soap at “critical times” during the day reduces the transmission of many diseases, such as diarrhea and cholera, which are transmitted by the mouth–to-mouth route.
1381	en	ti	 People can also become infected with respiratory diseases such as influenza or the common cold, for example, if they do not wash their hands before touching their eyes, nose, or mouth (i.e., mucous membranes). 	 ሰባት ንኣብነት፣ ዓይኖም፣ ኣፍንጭኦም፣ ወይ ኣፎም (ንኣብነት፣ ሙከስ መምብሬን) ቅድሚ ምንክኦም ኢዶም እንተዘይተሓጺቦም ብናይ ስርዓተ ምስትንፋስ ሕማማት እውን ክልከፉ ይኽእሉ እዮም ። 	People can also get respiratory diseases if they do not wash their hands before touching, for example, their eyes, nose, or mouth (e.g., mucous membranes).
1382	en	ti	 The five critical moments during the day where washing hands with soap is important include: before and after defecation, after cleaning a child's bottom or changing nappies, before feeding a child, before eating and before and after preparing food or handling raw meat, fish, or poultry. 	 ኣብ መዓልቲኹም ኢድ ብሳሙና ምሕጻብ ዘድልየሎም ሓሙሽተ ወሰንቲ ግዘታት: ቅድሚን ድሕሪን ምፍታንኩም፣ ድሕሪ ናይ ህጻንኩም መዓኮር ምሕባስኩም ወይ ናፒ ምቕያርኩም፣ ቅድሚ ውላድኩም ምምጋብኩም፣ ቅድሚ ምብላዕኩምን ቅድሚ ምግቢ፣ ጥረ ስጋ፣ ዓሳ፣ ጸባን ምድላውኩም እዮም። 	The five key times in your day to wash your hands with soap are: before and after testing, after rubbing your baby’s butt or changing a nappy, before feeding your baby, before eating and before preparing food, raw meat, fish, and dairy.
1383	en	ti	 If water and soap are not available, hands can be cleaned with ash.The World Health Organization recommends washing hands: 	 ማይን ሳሙናን ኣብ ዘይርከበሉ ግዘ፣ ኣእዳውኩም ብሓሞኽሽቲ ምጽራይ ትኽእሉ። ውድብ ጥዕና ዓለም ኣእዳው ምሕጻብ እዩ ዝመክር: 	When soap and water are not available, you can clean your hands with soap. The World Health Organization recommends hand washing:
1384	en	ti	 Before, during, and after preparing food. 	 ምግቢ ቅድሚ ምድላውኩም፣ ኣብተዳልዉሉ ግዘን ድሕሪኡን። 	Before, during and after preparing food.
1385	en	ti	 Before and after caring for a sick person. 	 ንዝሓመመ ሰብ ቅድሚን ድሕሪን ምትንካፍ። 	Before and after touching a sick person.
1386	en	ti	 After changing the diapers or cleaning up a child who has used the toilet. 	 ሽቓቕ ናይ ዝተጠቐመ ህጻን ዳየፐር ድሕሪ ምቕያር ወይ ድሕሪ ምጽራይ። 	After changing or cleaning the toilet of a used baby’s diaper.
1387	en	ti	 After blowing your nose, coughing or sneezing. 	 ድሕሪ ኣፍንጫኹም ምንፋጥኩም፣ ምስዓልኩም ወይ ምህንጣስኩም። 	After you sneeze, cough or sneeze.
1388	en	ti	 After touching animal, animal feed, or animal waste. 	 እንስሳት ድሕሪ ምትንካፍ፣ ምምጋብ፣ ወይ ናይ እንስሳት ቀልቀል ድሕሪ ምትንካፍ። 	After touching, feeding, or touching animal droppings.
1389	en	ti	 Medical hand hygiene refers to hygiene practices related to medical procedures. 	 ሕክምናዊ ናይ ኢድ ጽሬት ምስ ሕክምናዊ ከይዲታት ዝተተሓሓዙ ናይ ጽሬት ተግባራት ይውክሉ። 	Medical hand hygiene represent hygiene practices associated with medical procedures.
1390	en	ti	 Hand washing before administering medicine or medical care can prevent or minimize the spread of disease. 	 ቅድሚ መድሓኒት ወይ ሕክምናዊ ክንክን ምትግባር ኢድካ ምሕጻብ ናይ እቲ ሕማም ስርጭት ክከላኸል ወይ ክቕንስ ይኽእል እዩ። 	Washing your hands before applying medicine or medical care can prevent or reduce the spread of the disease.
1391	en	ti	 The main medical purpose of washing hands is to cleanse the hands of pathogens (bacteria, viruses, or other microorganisms that can cause disease) and chemicals which can cause harm or diseases. 	 ናይ ኢድ ምሕጻብ ዋና ናይ ጥዕና ዕላምኡ ኣእዳው ካብ ፓቶጂናትን (ሕማም ከስዐቡ ዝኽእሉ ባክቴርያ፣ ቫይረስመ፣ ወይ ካልኦት ማይክሮኦርጋኒዛማት) ጉድኣት ወይ ሕማም ከስዕቡ ዝኽእሉ ኬሚካላትን ምጽራይ እዩ። 	The main health purpose of hand washing is to clean hands from pathogens (bacteria, viruses, or other microorganisms that can cause disease) and chemicals that can cause harm or disease.
1392	en	ti	 This is especially important for people who handle food or work in the medical field, but also an important practice for the general public. 	 እዚ ድማ ብፍላይ ምግቢ ንዝሕዙ ሰባት ወይ ኣብ ናይ ሕክምና ፊልድ ዝሰርሑ ሰባት እዩ ዘገልግለል፣ ንሓፈሻዊ ህዝቢ እውን ጠቓሚ እዩ። 	This is especially useful for people who handle food or work in the medical field, but it is also useful for the general public.
1393	en	ti	 Hand washing has many health benefits, including minimizing the spread of influenza, coronavirus, and other infectious diseases; preventing infectious causes of diarrhea; decreasing respiratory infections; 	 ኢድካ ምሕጻብ ናይ ኢንፍሉዌንዛ፣ ኮሮናቫይርስ፣ ከምኡውን ካልኦት ተላባዕቲ ሕማማት ዝርጋሐ ምቕናስ፣ ናይ ተቕማጥ ረኽሲ መምጽኢ ምኽንያታት ምክልኻል፣ ናይ ስርዓተ ምትንፋስ ረኽሲታት ምቕናስ ሓዊሱ፣ ብዙሓት ናይ ጥዕና ጥቕሚታተ ኣለዉዎ። 	Hand washing has many health benefits, including reducing the spread of influenza, coronaviruses, and other infectious diseases, preventing the causes of diarrheal infections, and reducing respiratory infections.
1394	en	ti	 and reducing infant mortality rate at home birth deliveries. 	 ብሰንኪ ኣብ ገዛ ንዘጋጥም ሕርሲ ናይ ናጽላታት ቁጽሪ ሞት ምቕናስ። 	Reduce the number of infant deaths due to home deliveries.
1395	en	ti	 A 2013 study showed that improved hand washing practices may lead to small improvements in the length growth in children under five years of age. 	 ኣብ 2013 ዝተኻየደ መጽናዕቲ ዝተመሓየሸ ናይ ኢድ ምሕጻብ ተግባራት ናብ ኣብ ትሕቲ ሓሙሽተ ዓመት ዝኾኑ ህጻናት ናይ ንውሓት ጸገም ከምዘስዕብ ኣርእዮም እዮም። 	A 2013 study showed that improved hand washing practices lead to height problems in children under five.
1396	en	ti	 In developing countries, childhood mortality rates related to respiratory and diarrheal diseases can be reduced by introducing simple behavioral changes, such as hand washing with soap. 	 ኣብ ዘይማዕበሉ ሃገራት፣ ብሰንኪ ናይ ስርዓተ ምስትንፋስን ናይ ተቕማጥ ሕማማትን ዘጋጥሙ ናይ ህጻናት መጠን ሞት፣ ኢድካ ብሳሙና ብምሕጻብ ካልኦት ቀለልቲ ባህርያዊ ለውጢታትን ብምልላይ ከተጉድሎም ትኽእል። 	In underdeveloped countries, you can reduce child mortality from respiratory and diarrheal diseases by washing your hands with soap and introducing other simple behavioral changes.
1397	en	ti	 This simple action can reduce the rate of mortality from these diseases by almost 50%. 	 እዚ ቀሊል ተግባር በዚ ሕማም ዝመጽእ ሞት ብ 50% የጉድሎ። 	This simple act reduces deaths from the disease by 50%.
1398	en	ti	 Interventions that promote hand washing can reduce diarrhoea episodes by about a third, and this is comparable to providing clean water in low income areas. 	 ኢድ ምሕጻብ ዘበረታትዑ ጎስጓሳት፣ ንብዝሒ ናይ ተቕማጥ ናብ ሓደ ሲሶ የውርድዎ፣ እዚ ድማ ኣብ ትሑት ኣታዊ ዘለዎም ቦታታት ምስ ጽሩይ ማይ ምቕራብ ክነጻጸር ዝኽእል እዩ። 	Campaigns that encourage hand washing, reduce the incidence of diarrhea to one-third, which is comparable to providing clean water in low-income settings.
1399	en	ti	 48% of reductions in diarrhoea episodes can be associated with hand washing with soap.Hand washing with soap is the single most effective and inexpensive way to prevent diarrhea and acute respiratory infections (ARI), as automatic behavior performed in homes, schools, and communities worldwide. 	 ሕማም ተቕማጥ ብ48% ንምጉዳል ኢድ ብሳሙና ምሕጻብ ዓብዪ ግደ ይጻወት። ኣእዳው ብማይን ሳሙናን ምሕጻብ ኣብ ቤት ትምህርቲ፣ ገዛን ማሕበረሰብን ዝተለምዱ ናይ ተቕማጥን ረኽስታት ስርዓተ-ምስትንፋስን ንምክልኻን እቲ ዝነጠፈን ዝሓሰረን ኣማረጺ እዩ። 	Washing hands with soap plays a big role in reducing diarrhea by 48%. Washing hands with soap and water is the most effective and cheapest option to prevent diarrhea and respiratory infections common in school, home and community.
1400	en	ti	 Pneumonia, a major ARI, is the number one cause of mortality among children under five years old, taking the lives of an estimated 1.8 million children per year. 	 ረኽሲ ሳንቡእ፣ ከቢድ ዓይነት ARI ኮይኑ፣ ኣብ ዓመት ህይወት ኣስታት 1.8 ሚልዮን ቆልዑ ብምቕጣፍ፣ ኣብ ትሕቲ ሓሙሽተ ዓመት ዘለዉ ቆልዑ ቁጽሪ ሓደ ቀታሊ ሕማም እዩ ። 	Pneumonia, a serious form of ARI, is the number one killer of children under five, killing about 1.8 million children a year.
1401	en	ti	 Diarrhea and pneumonia together account for almost 3.5 million child deaths annually. 	 በቢዓመቱ ብተቕማጥን ኒሞንያን 3.5 ሚልዮን ዝኾኑ ህጻውንቲ ይሞቱ። 	Every year, 3.5 million children die from diarrhea and pneumonia.
1402	en	ti	 According to UNICEF, turning hand washing with soap before eating and after using the toilet into an ingrained habit can save more lives than any single vaccine or medical intervention, cutting deaths from diarrhea by almost half and deaths from acute respiratory infections by one-quarter. 	 UNICEF ከምዝበሎ፣ ቅድሚ ምግቢ ምብላዕን ድሕሪ ሽንቲ ቤት ምጥቃምን ኢድካ ብሳሙናን ማይን ምሕጻብ ልምዲ ምግባር ልዕሊ ክትባትን ሕክምናን ናይ ብዙሓት ሰባት ህይወት የድሕን። ብሰንኪ ተቕማጥ ዝስዕብ ቁጽሪ ሞት ብፍርቂ፣ ብኸቢድ ረኽሲ ናይ ስርዓት ምትንፋስ ዝመጹ ሞታት ድማ ብርብዒ ይቕንስ። 	According to UNICEF, washing hands with soap and water before eating and after using the toilet saves more lives than vaccines and treatment. Deaths from diarrhea are halved and deaths from severe respiratory infections are reduced by a quarter.
1403	en	ti	 Hand washing is usually integrated together with other sanitation interventions as part of water, sanitation and hygiene (WASH) programmes. 	 ኢድ ምሕጻብ መብዛሕትኡ ግዘ ምስ ካልኦት ጽሬት መሐለዊ ስጉምቲታት ከም ኣካል ናይ ማይ ፣ ጥዕናን ጽሬትን (WASH) ዝኣመሰሉ መደባት ዝተኣሳሰር እዩ። 	Hand washing is often associated with other hygiene measures such as part of water, health and hygiene (WASH) programs.
1404	en	ti	 Hand washing also protects against impetigo which is transmitted through direct physical contact. 	 ኢድካ ምሕጻብ ካብ እቲ ብቀጥተኛ ኣካላዊ ምትንኽኻፍ ዝመሓላለፍ ኢምፔቲጎ(impetigo) እውን ይከላኸል እዩ። 	Washing your hands also protects against impetigo, which is transmitted by direct physical contact.
1405	en	ti	 A small detrimental effect of hand washing is that frequent hand washing can lead to skin damage due to drying of the skin. 	 ንእሽተይ ኣሉታዊ ጎድኒ ናይ ኢድ ምሕጻብ፣ ብተደጋጋሚ ኢድካ ምሕጻብ ንቆርበት ስለዘንቅጽ ናይ ቆርበት ምብልሻው ከስዕብ ይኽእል እዩ። 	A slight downside of hand washing, washing your hands frequently can cause skin damage as it dries out the skin.
1406	en	ti	 A 2012 Danish study found that excessive hand washing can lead to an itchy, flaky skin condition known as hand eczema or hand dermatitis, which is especially common among health-care workers. 	 ናይ 2012 ኣብ ዴንማርክ ዝተገብረ መጽናዕቲ ከምዝረኸቦ፣ ብተደጋጋሚ ኢድ ምሕጻብ ናብ ምኽካኽ፣ ደረቕ ቆርበት ኤክዜማ ወይ ናይ ኢድ ደርማታይተስ ዝበሃል ኩነታት ከምርሕ ይኽእል እዩ፣ እዚ ድማ ኣብ ናይ ጥዕና ክንክን ሰራሕተኛታት ልሙድ እዩ። 	A 2012 study in Denmark found that, frequent hand washing can lead to a condition called itching, dry skin eczema or hand dermatitis, which is common among healthcare workers.
1407	en	ti	 Too frequent hand washing is also seen as one of the symptoms of obsessive-compulsive disorder (OCD). 	 ኣዚኻ ደጋጊምካ ኢድካ ምሕጻብ ከም ናይ obsessive-compulsive disorder (OCD) ምልክት ተገይሩ እዩ ዝርአ። 	Washing your hands too frequently is seen as a sign of obsessive-compulsive disorder (OCD).
1408	en	ti	 There are five critical times during the day where washing hands with soap is important to reduce fecal-oral transmission of disease: after using the bathroom (urination, defecation), after cleaning a child's bottom (changing nappies), before feeding a child, before eating and before/after preparing food or handling raw meat, fish, or poultry. 	 ናይ ካብ ቀልቀል ናብ ኣፍ ናይ ምምሕልላፍ ተኽእሎ ናይ'ዚ ሕማም ንምቕናስ፣ ኣብ መዓልቲ ሓሙሽተ ወሰንቲ ኢድና ንሕጸበሎም ግዘታት ኣለዉ፣ ንሳቶም ድማ ሽንቲ ቤት ድሕሪ ምጥቃም (ድሕሪ ሽንቲ ማይ ወይ ቀልቀል ምሻን)፣ ናይ ቆልዑ መዓኮር ድሕሪ ምጽራግ (ናፒታት ድሕሪ ምቕያር)፣ ቅድሚ ቆልዑ ምምጋብ፣ ቅድሚ ምብላዕን ቅድሚ/ድሕሪ ምግቢ ምድላው ወይ ጥረ ስጋ፣ ዓሳ፣ ወይ ጸባ ምድላው እዮም። 	To reduce the chance of mouth-to-mouth transmission of the disease, there are five critical times a day to wash your hands: after using the toilet (after urinating or urination), after cleaning children&#39;s nipples (after changing diapers), and before Kids are feeding, pre-meal and before/after cooking or preparing raw meat, fish, or dairy.
1409	en	ti	 Other occasions when correct handwashing technique should be practiced in order to prevent the transmission of disease include before and after treating a cut or wound; after sneezing, coughing, or blowing your nose; after touching animal waste or handling animals; and after touching garbage. 	 ናይ ኢድ ምሕጻብ ቴክኒካት ኣብ ካልኦት ኣጋጣሚታት እውን ነቲ ሕማም ምትሕልላፍ ንምግታእ ይሕግዝ እዩ። ገለ ኣብነታት፥ ቁስሊ ቅድሚ ምሕካም ድሕሪኡን ; ድሕሪ ምህንጣስ፣ ምስዓል፣ ወይ ኣፍንጫ ድሕሪ ምንፋጥ; ናይ እንስሳት ቀልቀል ምትንካፍ ወይ እንስሳት ድሕሪ ምሓዝ; ድሕሪ ጎሓፍ ምሓዝ እውን። 	Hand washing techniques also help curb the transmission of the disease in other instances. Some examples are: before and after treatment of wounds; after sneezing, coughing, or blowing the nose; touching animal droppings or after handling animals; Even after garbage handling.
1410	en	ti	 In many countries, there is a low rate of hand washing with soap. 	 ኣብ ብዙሓት ሃገራት፣ ትሑት ናይ ኢድ ብሳሙናን ማይን ምሕጻብ ንጽጽራዊ መጠን እዩ ዘሎ። 	In many countries, there is a relatively low level of hand washing with soap and water.
1411	en	ti	 A study of hand washing in 54 countries in 2015 found that on average, 38.7% of households practiced hand washing with soap.A 2014 study showed that Saudi Arabia had the highest rate of 97 percent; the United States near the middle with 77 percent; and China with the lowest rate of 23 percent.Several behaviour change methodologies now exist to increase uptake of the behaviour of hand washing with soap at the critical times.Group hand washing for school children at set times of the day is one option in developing countries to engrain hand washing in children's behaviors. 	 ኣብ 2015 ኣብ 54 ሃገራት ዝተኻየደ ናይ ኢድ ምሕጻብ መጽናዕቲ ብማእከላይ ገምጋም 38.7% ስድራቤታት ብሳሙና ኢድካ ምሕጻብ ከምዘተግብሩ ኣርእዩ። ኣብ 2014 ዝተኻየደ መጽናዕቲ ሳዑዲ ዓረብያ ዝለዓለ ንጽጽራዊ መጠን 97 ሚእታዊ ከምዘለዋ የረኢ፣ ሕቡራት መንግስቲታት ኣሜሪካ ኣብ ጥቓ ማእኸል 77 ሚእታዊ ፣ ቻይና ድማ ብዝተሓተ ንጽጽራዊ መጠን 23 ሚእታዊ። ኣብ ወሰንቲ ግዘታት ኣእዳውካ ብሳሙና ናይ ምሕጻብ ናይ ባህሪ ለውጢ ንምምዕባል ዝተፈላለዩ ናይ ባህሪታት ለውጢ ሜላታት ኣብ ጥቕሚ እንዳውዓሉ ይርከቡ። ኣብ ዝምዕብሉ ሃገራት ብሳሙና ኢድካ ምሕጻብ ናብ ናይ ቆልዑ ልምዲ/ጠባይ ንምእታው ኣብ ቤት ትምህርቲ ናይ ኢድ ምሕጻብ ግዘ ክፍለየሎም ይግበር እዩ። 	A 2015 hand washing survey conducted in 54 countries showed that an average of 38.7% of households practice hand washing with soap. A 2014 survey shows Saudi Arabia with the highest comparative rate of 97 percent, the United States of America near the middle at 77 percent , and China with the lowest comparative rate of 23 percent. Various behavior change techniques are being used to develop the behavioral change of washing your hands with soap at critical times. In developing countries, hand washing time is set aside in schools to instill hand washing with soap in children&#39;s habits.
1412	en	ti	" The ""Essential Health Care Program"" implemented by the Department of Education in the Philippines is an example of at scale action to promote children's health and education. "	" እቲ ""ወሳኒ ናይ ጥዕና ክንክን ፕሮግራም "" በቲ ናይ ትምህርቲ ክፍሊ ኣብ ተግባር ዝወዓለ ኣብ ፊሊፒኒስ ናይ'ቲ ዝተወሰደ ስጉምቲ ስኬል ናይ ቆልዑ ጥዕናን ትምህርቲን ንምብርትታዕ ኣብነት እዩ። "	The &quot;Critical Health Care Program &quot; implemented by the Department of Education is an example of the scale of action taken in the Philippines to promote children&#39;s health and education.
1413	en	ti	 Deworming twice a year, supplemented with washing hands daily with soap, brushing teeth daily with fluoride, is at the core of this national program. 	 ንዓመት ክልተ ግዘ ካብ ናይ መዓናጡ ሓሳኹ ምሕካም ምስ መዓልታዊ ብሳሙና ኢድ ምሕጻብ ከምኡ'ውን ስኒ መዓለታዊ ብፍሎራይድ ምቡራሽ፣ ናይ እዚ ሃገራዊ ፕሮግራም ቀንዲ ዕላማ እዩ። 	Treatment from intestinal mosquitoes twice a year with daily hand washing with soap and daily fluoride tooth brushing is the main objective of this national program.
1414	en	ti	 It has also been successfully implemented in Indonesia. 	 ኣብ ኢንዶኔዥያ እውን ዕዉት ብዝኾነ መልክዑ ኣብ ስራሕ ውዒሉ እዩ። 	It has also been successfully implemented in Indonesia.
1415	en	ti	 Removal of microorganisms from skin is enhanced by the addition of soaps or detergents to water. 	 ሳሙናን ዲተርጀንትን ናብ ማይ ምሕዋስ ንምውጋድ ማይክሮኦርጋኒዝማት ካብ ቆርበት የመሓያይሾ። 	Mixing soaps and detergents into water improves the elimination of microorganisms from the skin.
1416	en	ti	 The main action of soaps and detergents is to reduce barriers to solution, and increase solubility. 	 ናይ ሳሙናን ዲተርጀንትን ዋና ተግባር ናይ ገደባት ብጽባጽ ምቕናስን ሓቓቒነት ምውሳኽን እዩ። 	The main function of soaps and detergents is to reduce restrictions and increase absorption.
1417	en	ti	 Water alone is an inefficient skin cleanser because fats and proteins, which are components of organic soil, are not readily dissolved in water. 	 ቆርበት ንምጽራይ ማይ ጥራሕ እኹል ኣይኮነን፣ ምኽንያቱ ክፋል ኦርጋኒክ ሓመድ ዝኾኑ ስብሕን ፕሮቲናትን ብማይ ጥራሕ ኣይሓቁን እዮም። 	Water alone is not enough to clean the skin, because fats and proteins that are part of organic soil are not absorbed by water alone.
1418	en	ti	 Cleansing is, however, aided by a reasonable flow of water.. 	 ምጽራይ ግን፣ ብምኽንያታዊ ናይ ማይ ውሕዘት ዝተደገፈ እዩ.. 	Cleaning, however, is supported by reasonable water flow.
1419	en	ti	 Solid soap, because of its reusable nature, may hold bacteria acquired from previous uses. 	 ደረቕ ሳሙና፣ ዳጋጊምካ ስለትጥቀመሉ፣ ካብ ዝሓለፈ ዝተጠቐምካሉ ግዘ ባክቴርያ ሒዙ ክጸንሕ ይኽእል። 	Dry soap, because you use it over and over again, can carry bacteria from the last time you used it.
1420	en	ti	 A small number of studies which have looked at the bacterial transfer from contaminated solid soap have concluded transfer is unlikely as the bacteria are rinsed off with the foam. 	 ብዙሓት መጽናዕቲታት ከምዘካየድዎ ናይ ካብ ዝተበከለ ሓመድ ዝመሓላለፍ ናይ ባክቴርያ ዝርጋሐ ውሑድ እዩ ምኽንያቱ እቲ ባክቴርያ በቲ ዓፍራ ስለዝጠፍእ። 	Many studies have shown that the spread of bacteria from contaminated soil is low because the bacteria are killed by the fungus.
1421	en	ti	" The CDC still states ""liquid soap with hands-free controls for dispensing is preferable"". "	" CDC ክሳብ ሕዚ ""ብኢድካ ከይተንከፍካ ክትጥቀመሉ ትኽእል ፈሳሲ ሳምና እዩ ዝምረጽ "" ኢሉ። "	The CDC has so far said that &quot;liquid soap that can be used without touching your hands is preferred.
1422	en	ti	 Antibacterial soaps have been heavily promoted to a health-conscious public. 	 ጸረ-ባክቴርያ ሳሙናታት ንኽጥቀሙ፣ ኣብ ጥዕናዊ ንቕሓት ዘለዎም ህዝቢ ጽዑቕ ጎስጓስ ተገይሩ እዩ። 	The use of antibacterial soaps, has been intensively campaigned among health conscious population.
1423	en	ti	 To date, there is no evidence that using recommended antiseptics or disinfectants selects for antibiotic-resistant organisms in nature. 	 ክሳብ ሕዚ፣ እዞም ዝምከሩ ጸረ-ነፍሳት ወይ ጸረ-ረኽሲታት ምጥቃም፣ ነቶም ብተፈጥርኦም ተጻዋርነት ናይ ጸረ-ባክተርያ መድሃኒት ዘለዎም ኦርጋኒዝማት መሪጾም ዘጥፍኡ ምዃኖም ዘርኢ መረዳእታ የለን። 	To date, there is no evidence that the use of these recommended antibiotics or antimicrobials selectively eliminates organisms that are inherently resistant to antibiotics.
1424	en	ti	 However, antibacterial soaps contain common antibacterial agents such as triclosan, which has an extensive list of resistant strains of organisms. 	 እንተኾነ ግን፣ ጸረ-ባክቴርያ ሳሙናታት ከም triclosan ዝኣመሰሉ ጸረ -ባክቴርያ ኤጀንትታት ዝሓዙ እዮም፣ ብዙሓት ነዚ ዝጻወርዎ ናይ ስትረይናት ዝርዝር ኣሎ። 	However, antibacterial soaps contain anti -bacterial agents such as triclosan, and there is a range of strains that many are resistant to.
1425	en	ti	 So, even if antibiotic resistant strains aren't selected for by antibacterial soaps, they might not be as effective as they are marketed to be. 	 ስለዚ፣ ጸረ-ረኽሲ ተጻወርቲ ስተርይናት በቲ ጸረ-ባክቴርያ ሳሙና ዋላ ኣይመረጹ ፣ ክንድቲ ዝድለ ኣድማዕቲ ዘይክኾኑ ይኽእሉ እዮም። 	So, even if antimicrobial resistant styrenes are not selected by the antibacterial soap , they may not be as effective.
1426	en	ti	 Besides the surfactant and skin-protecting agent, the sophisticated formulations may contain acids (acetic acid, ascorbic acid, lactic acid) as pH regulator, antimicrobially active benzoic acid and further skin conditioners (aloe vera, vitamins, menthol, plant extracts).A comprehensive analysis from the University of Oregon School of Public Health indicated that plain soaps are as effective as consumer-grade anti-bacterial soaps containing triclosan in preventing illness and removing bacteria from the hands. 	 ምስ'ቲ ስርፋክታንትን ናይ ቆርበት ተኸላኻሊ ኤጀንት ጎኒ ን ጎኒ፣ እዚ ውስብስብ ፎርሙሌሽን ኣሲድ ዝሓዘ ክኸውን ይኽእለል እዩ (ኣሰቲክ ኣሲድ፣ ኣስኮርቢክ ኣሲድ፣ ላክቲክ ኣሲድ) ከም ናይ pH መመጣጠኒ፣ ጸረ ማይክሮቢያል ንጡፍ ዝኾነ ቤንዞኒክ ኣሲድን ተወሳኺ ናይ ቆርበት ኮንዲሽነራትን (ኣሎይ ቬራ፣ ቪታሚናት፣ ሜታኖል፣ ካብ ኣትክልቲ ዝተወሰዱ)። ብ University of Oregon School of Public Health(ኦሪጎን ዩኒቨርሲቲ ናይ ህዝባዊ ጥዕና ቤት ትምህርቲ) ዝተገበረ ሓፈሻዊ ሳይንሳዊ ገምጋም ከም ዘርኣዮ፣ ተራ ሳምና ማዕረ እቶም ኣብ ዕዳጋ ዘለዉ ጸረ-ባክተርያ ሳምናታት ብቑዓት እዮም። 	Accompaniment and leather defender acid to the scab and leather defender acid (asthetic acid, assid, assid, lactic acid) such as a PH qualifier, anti-microbien-offens and additional leaflets (Aloy Vera, Vera, Vira, , methanol, herbal extracts). A comprehensive scientific evaluation by the University of Oregon School of Public Health showed that ordinary soaps are as effective as antibacterial soaps on the market.
1427	en	ti	 Hot water that is comfortable for washing hands is not hot enough to kill bacteria. 	 ኢድካ ንምሕጻብ ዝምችው ውዑይ ማይ፣ ባክቴርያ ንምቕጣል ዘኽእሎ መጠነ ሙቐት የብሉን። 	Hot water that is suitable for washing your hands does not have the temperature to keep bacteria alive.
1428	en	ti	 Bacteria grow much faster at body temperature (37 °C). 	 ባክቴረያ ኣብ ናይ ሰብነት መጠነ ሙቐት (37 °C) ብቕልጡፍ ይዓቢ። 	Bacteria grow rapidly at body temperature (37 °C).
1429	en	ti	 However, warm, soapy water is more effective than cold, soapy water at removing natural oils which hold soils and bacteria. 	 እንተኾነ ግን፣ ውዑይን ሳሙና ዘለዎን ማይ ካብ ዝሑልን ሳሙና ዘለዎን ማይ ሓመድን ባክቴርያን ዝሕዙ ተፈጥሮኣዊ ዘይትታት ኣብ ምውጋድ ዝሓሸ ኣድማዕነት ኣለዎ። 	However, hot, soapy water is more effective than cold, soapy water at removing natural oils that carry soil and bacteria.
1430	en	ti	 Contrary to popular belief however, scientific studies have shown that using warm water has no effect on reducing the microbial load on hands. 	 ኣንጻር እምነት ብዙሓት ግን፣ ሳይንሳዊ መጽናዕቲታት ውዑይ ማይ ብምጥቃም ኣብ ኢድ ንዝርከቡ ብዝሒ ኦርጋኒዝምስ ኣብ ምቕናስ ጥቕሚ ከምዘይብሉ ሓቢሮም። 	Contrary to popular belief, however, scientific studies have shown that using hot water does not reduce the number of organisms on hands.
1431	en	ti	 A hand sanitizer or hand antiseptic is a non-water-based hand hygiene agent. 	 ናይ ኢድ ሳኒታየዘራት ወይ ናይ ኢድ ኣንቲሰፕቲክ ማይ ዘይብሎም ናይ ኢድ መጽረዪ ኤጀንትታት እዮም። 	Hand sanitizers or hand antiseptics are non-aqueous hand cleaning agents.
1432	en	ti	 In the late 1990s and early part of the 21st century, alcohol rub non-water-based hand hygiene agents (also known as alcohol-based hand rubs, antiseptic hand rubs, or hand sanitizers) began to gain popularity. 	 ኣብ መወዳእታ 1990ታትን መፈለምታ 21 ክፍለዘመን፣ ኣልኮል ዘለዎም ማያዊ ዘይኮኑ ናይ ኢድ መጽረዪ ፈሰስቲ (ኣልኮላዊ መጽረዪ ኢድ፣ ኣንቲሰፕቲክ መጽረዪ ኢድ፣ ወይ ሳኒታይዘር) ተጠላብነት ክረኽቡ ጀሚሮም። 	In the late 1990s and early 21st century, alcohol-based non-aqueous hand sanitizers (alcohol hand sanitizers, antiseptic hand sanitizers, or sanitizers) became in demand.
1433	en	ti	 Most are based on isopropyl alcohol or ethanol formulated together with a thickening agent such as Carbomer (polymer of acrylic acid) into a gel, or a humectant such as glycerin into a liquid, or foam for ease of use and to decrease the drying effect of the alcohol. 	 መብዛሕትኦም ናይ ኣይዞፕሮፓይል ኣልኮል ወይ ኢታኖል ምስ መሕፈሲ ኤጀንት ከም ካርቦመር (ናይ ኣክሪሊክ ኣሲድ ፖሊመር) ተሓዊሶም ጄል ይኾኑ፣ ወይ ሂዩመክታንት ይኾኑ ከም ግላይሰሪን ፈሳሲ፣ ወይ ናይ'ቲ ኣልኮል ናይ ምንቃጽ ጽልዋ ንምቕናስ ዓፍራ ዘለዎ ምግባር። 	Most isopropyl alcohol or ethanol is mixed with a harvesting agent such as a carbomer (an acrylic acid polymer) to form a gel, or a humectant such as liquid glycerin, or a foam to reduce the drying effect of the alcohol.
1434	en	ti	 Adding diluted hydrogen-peroxide increases further  the antimicrobial activity.Hand sanitizers containing a minimum of 60 to 95% alcohol are efficient germ killers. 	 ዝተጽበጸበ ሃይድሮጂን-ፐርኦክሳይድ ምጥቃም ተወሳኺ ጸረ-ማይክሮቢያል ንጥፈት ይውስኽ። እንተንኢሱ 60 ክሳብ 95% ኣልኮል ዘለዎም ናይ ኢድ ሳኒታይዘራት ብቑዓት ቀተልቲ ጀርም እዮም። 	The use of compressed hydrogen-peroxide adds additional antimicrobial activity. Hand sanitizers with at least 60 to 95% alcohol are efficient germ killers.
1435	en	ti	 Alcohol rub sanitizers kill bacteria, multi-drug resistant bacteria (MRSA and VRE), tuberculosis, and some viruses (including HIV, herpes, RSV, rhinovirus, vaccinia, influenza, and hepatitis) and fungi. 	 ኣልኮል ዘለዎም ሳኒታይዘራት ባክቴርያ፣ ዝተፈላለዩ መድሓኒታት ዝጻወሩ ባክቴርያ (MRSA ን VRE ን)፣ ቲበርኪሎሲስ፣ ከምኡውን ገለ ቫይረሳት (HIV፣ ሀርፒስ፣ RSV፣ ራይኖቫይረስ፣ ቫክሲንያ፣ ኢንፍሉዌንዛ፣ ከምኡውን ሄፓታይተስ እውን ሓዊሱ) ከምኡ ውን ፋንጋይ ይቐትል። 	Alcohol-based sanitizers kill bacteria, various drug-resistant bacteria (MRSA and VRE), tuberculosis, and some viruses (including HIV, herpes, RSV, rhinovirus, vaccinia, influenza, and hepatitis as well) and fungi.
1436	en	ti	 Alcohol rub sanitizers containing 70% alcohol kill 99.97% (3.5 log reduction, similar to 35 decibel reduction) of the bacteria on hands 30 seconds after application and 99.99% to 99.999% (4 to 5 log reduction) of the bacteria on hands 1 minute after application.Hand sanitizers are most effective against bacteria and less effective against some viruses. 	 70% ኣልኮል ዘለዎም ሳኒታይዘራት ኣብ ኢድካ ድሕሪ ምጥቃም፣ ኣብ ውሽጢ 30 ሰከንድታት 99.97% (3.5 ሎግ ምቕናስ፣ ምስ 35 ዴሲቤል ምቕናስ ብተመሳሳሊ) ናይ'ቶም ባክቴርያ፣ ኣብ ውሽጢ 1 ደቒቕ ድማ 99.99% ክሳብ 99.999% (4 ክሳብ 5 ና ሎግ ምቕናስ) ናይ'ቶም ባክቴርያ የጥፍእ ። ኢድ ሳኒታይዘራት ኣንጻር ባክቴርያ ብሉጻት እዮም፣ ኣንጻር ሓደ ቫይረሳት ግን ክንድቲ ኣድማዕነት የብሎምን። 	After using 70% alcohol hand sanitizers, 99.97% (3.5 log reduction, similar to 35 decibel reduction) of the bacteria in 30 seconds, and 99.99% to 99.999% (4 to 5 na log reduction) in 1 minute. It kills the bacteria of those. Hand sanitizers are great against bacteria, but not so effective against a viruses.
1437	en	ti	 Alcohol-based hand sanitizers are almost entirely ineffective against norovirus (or Norwalk) type viruses, the most common cause of contagious gastroenteritis.Enough hand antiseptic or alcohol rub must be used to thoroughly wet or cover both hands. 	 ኣልኮል ዘለዎም ናይ ኢድ ሳኒታይዘራት ኣንጻር እቶም ንቡር ናይ ተላባዒ ጋስትሮኢንተራይትስ ሕማም መልዐሊ ዝኾኑ ኖሮቫይረስ (ወይ Norwalk) ዓይነት ቫይረሳት ኣድማዕነት የብሎምን። ኣእዳውኩም ንምትርካስ ወይ ክልቲኦም ኣእዳው ንምሽፋን ዘኽእል እኹል ናይ ኢድ ኣንቲሴፕቲክ ወይ ኣልኮል መድረዚ ኣብ ጥቕሚ ክውዕል ኣለዎ። 	Alcohol-based hand sanitizers are ineffective against norovirus (or Norwalk) strains of viruses that are a common pathogen of infectious gastroenteritis. Adequate hand antiseptic or alcohol wipe should be used to disinfect your hands or cover both hands.
1438	en	ti	 The front and back of both hands and between and the ends of all fingers are rubbed for approximately 30 seconds until the liquid, foam or gel is dry. 	 ናይ ክልቲኦም ኣእዳውኩም ቅድሚትን ድሕሪቶምን ከምኡ'ውን ማእኸል ኣጻብዕቲኹም ክሳብ እቲ ፈሳሲ፣ ዓፍራ ወይ ጄል ዝነቅጽ ን 30 ሰከንድታት ዝኸውን ክድረዙ ኣለዎም። 	The front and back of both your hands and the middle of your fingers should be wiped for 30 seconds until the liquid, abrasive or gel dries.
1439	en	ti	 Finger tips must be washed well too, rubbing them in both palms.The US Center for Disease Control and Prevention recommends hand washing over hand sanitizer rubs, particularly when hands are visibly dirty. 	 ናይ ኣጻብዕቲ ጫፋት ብክልቲኡ ከብዲ ኢድ ብምድራዝ ብኣግባቡ ክሕጸቡ ኣለዎም።ናይ US Center for Disease Control and Prevention (ኣሜሪካ ናይ ሕማም ምክልኻልን ቁጽጽርን ማእኸል) ልዕሊ ሳኒታይዘር መድረዚታት ኢድካ ምሕጻብ የበረታትዕ እዩ። 	Fingertips should be washed thoroughly by wiping both abdominal hands.The US Center for Disease Control and Prevention encourages hand washing with wipes over sanitizer.
1440	en	ti	 The increasing use of these agents is based on their ease of use and rapid killing activity against micro-organisms; however, they should not serve as a replacement for proper hand washing unless soap and water are unavailable. 	 ተጠቃምነት ናይ'ዞም ኤጀንትታት ዝዓብየሉ ዘሎ ምኽንያት፣ ኣጠቃቕምኦም ቀሊል ስለዝኾነን ማይክሮኦርጋኒዝማት ቀልጢፎም ስለዝቀትሉን እዩ። እንተኾነ ግን ከም መተካእታ ናይ ትኽክለኛ ኣተሓጽባ ኢድ ሳሙናን ማይን ኣብ ዝርከበሉ ክኾኑ የብሎምን ። 	The use of these agents is growing because they are easy to use and kill microorganisms quickly. However, they should not be in the presence of soap and water as a substitute for proper hand washing.
1441	en	ti	 Frequent use of alcohol-based hand sanitizers can cause dry skin unless emollients and/or skin moisturizers are added to the formula. 	 ኣልኮል ዘለዎም ናይ ኢድ ሳኒታይዘራት ብተደጋጋሚ ምጥቃም ደረቐ ቆርበት ከስዕብ ይኽእል እዩ፣ ስለዚ መተርከስቲ/ወይ ናይ ቆርበት መርሓስቲ ናብቲ ፎርሙላ ክሕወሱ ኣለዎም። 	Frequent use of alcohol-based hand sanitizers can cause dry skin, so conditioners and/or skin conditioners should be incorporated into the formula.
1442	en	ti	 The drying effect of alcohol can be reduced or eliminated by adding glycerin and/or other emollients to the formula. 	 ናይ እቲ ኣልኮል ናይ ምንቃጽ ጽልዋ ግላይስሪንን/ወይ ካልኦት መተርከሲታት ናብ እቲ ፎርሙላ ብምሕዋስ ምቕናስ ወይ ምጥፋእ ይከኣል እዩ። 	The drying effect of the alcohol can be reduced or eliminated by incorporating glycerin and/or other stabilizers into the formula.
1443	en	ti	 In clinical trials, alcohol-based hand sanitizers containing emollients caused substantially less skin irritation and dryness than soaps or antimicrobial detergents. 	 ኣብ ክሊኒካላዊ ፈተነታት፣ ኣልኮል ዘለዎም ሳኒታይዘራት መርሓሲ ዝሓዙ እንትኾኑ ምስ ሳሙናታትን ኣንቲማይክሮቢል ዲተርጀንትን ክነጻጸሩ ከለዉ ትሑት ናይ ቆርበት ምንቃጽን ምብልሻውን ዕድል ኣለዎም። 	In clinical trials, alcohol-based sanitizers contain lead and have a lower risk of skin drying and damage compared to soaps and antimicrobial detergents.
1444	en	ti	 Allergic contact dermatitis, contact urticaria syndrome or hypersensitivity to alcohol or additives present in alcohol hand rubs rarely occur. 	 ኣለርጂክ ኮንታክት ደርማታይቲስን(allergic contact dermatitis) ዩሪቲካርያ ሲንድረምን(urticaria syndrome) ምስ ኣልኮል ዝተሓሓዝ ወይ ምስቶም ናብ ኣልኮል መድረዚ ኢድ ዝኣትዉ ተወሰኽቲ ነገራት ልዕሊ መጠን ተኣፋፍነት(hypersensitivity) ሓልሓሊፉ ዘጋጥሙ እዮም። 	Allergic contact dermatitis and urticaria syndrome are rarely associated with alcohol or hypersensitivity to additives in alcohol hand sanitizers.
1445	en	ti	 The lower tendency to induce irritant contact dermatitis became an attraction as compared to soap and water hand washing. 	 ምስ ብማይን ሳሙናን ብምሕጻብ ዘስዕቦ ክነጻጸር እንከሎ፣ ኢሪታንት ኮንታክት ደርማታይተስ(irritant contact dermatitis) ናይ ምስዓብ ተኽእሎ ውሑድ ስለዝኾነ፣ ሳሓቢ ንክኸውን ዝገበር እዩ። 	Compared to washing with soap and water, it is less likely to cause irritant contact dermatitis, making it attractive.
1446	en	ti	 Despite their effectiveness, non-water agents do not cleanse the hands of organic material, but simply disinfect them. 	 ኣድማዕነቶም ብዘየገድስ፣ ማይ ዘይኮኑ ኤጀንትታት ን ኣእዳው ካብ ኦርጋኒክ ማቴርያል ከጽርዩ ኣይኽእሉን፣ ካብ ረኽሲ ነጻ ክገብሩ ጥራይ እዮም ዝኽእሉ። 	Regardless of their effectiveness, non-aqueous agents cannot clean hands of organic material, they can only disinfect them.
1447	en	ti	 It is for this reason that hand sanitizers are not as effective as soap and water at preventing the spread of many pathogens, since the pathogens still remain on the hands. 	 እቶም ሕማም ዘስዕቡ ባእታታት ኣብ ኢድ ስለዝጸንሑ፣ ናይ ኢድ ሳኒታይዘራት ክንዲ ሳሙናን ማይን ኣብ ናይ ብዙሓት ሕማም ዘስዕቡ ባእታታት ዝርጋሐ ኣብ ምክልኻል ብቑዓት ኣይኮኑን። 	Because the pathogens remain in the hands, hand sanitizers are not as effective as soap and water in preventing the spread of many pathogens.
1448	en	ti	 Alcohol-free hand sanitizer efficacy is heavily dependent on the ingredients and formulation, and historically has significantly under-performed alcohol and alcohol rubs. 	 ኣልኮል ዘይብሎም ናይ ኢድ ሳኒታይዘራት ኣድማዕነት ኣብ እቲ ንጥረ ነገራቱን ፎርሙሌሽንኑን ኣዝዩ መሰረት ዝገበረ እዩ፣ ኣብ ታሪክ እውን ብቕዓቱ ትሕቲ ኣልኮልን ኣልኮል ዘለዎም ናይ ኢድ መድረዚን ኮይኑ ተራእዩ እዩ። 	The effectiveness of non-alcohol hand sanitizers is very much based on the ingredients and formulation, and historically its performance has been shown to be inferior to alcohol and alcohol hand sanitizers.
1449	en	ti	 More recently, formulations that use benzalkonium chloride have been shown to have persistent and cumulative antimicrobial activity after application, unlike alcohol, which has been shown to decrease in efficacy after repeated use, probably due to progressive adverse skin reactions. 	 ኣብ ቀረባ እዋን፣ benzalkonium chloride ዝጥቀሙ ፎርሙሌሽናት ቀጻሊን እኩብን ናይ ጸረ-ማይክሮብስ ንጥፈት ኣርእዮም፣ ኣንጻር ኣልኮል፣ ድሕሪ ብተደጋጋሚ ኣብ ጥቕሚ ምውዓሉ ግን ኣድማዒነቱ ቀኒሱ እዩ፣ ኣብ ቆርበት ብዘለዎ ጎድናዊ ጸገም ክኸውን ይኽእል። 	Recently, formulations using benzalkonium chloride showed sustained and collective antimicrobial activity, against alcohol, but reduced effectiveness after repeated use, possibly due to side effects on the skin.
1450	en	ti	 Many people in low-income communities cannot afford soap and use ash or soil instead. 	 ኣብ ትሑት ኣታዊ ዘለዎም ማሕበረሰባት ዝነብሩ ብዙሓት ሰባት ሳሙና ክዕድጉ ኣይኽእሉን ስለዚ ኣብ ክንድኡ ሓሙኽሽቲ ወይ ሓመድ ዝጥቀሙ ኣለዎም። 	Many people living in low-income communities cannot afford soap so they have ash or dust instead.
1451	en	ti	 Ash or soil may be more effective than water alone, but may be less effective than soap. 	 ካብ ማይ ጥራሕ ምጥቃም ሓሞኽሽቲ ወይ ሓመድ ምጥቃም ዝበለጸ እዩ፣ ክንዲ ሳሙና ግን ኣድማዒ ኣይኮነን። 	It is best to use ashes or soil rather than just water, but it is not as effective as soap.
1452	en	ti	 One concern is that if the soil or ash is contaminated with microorganisms it may increase the spread of disease rather than decrease it. 	 እቲ ሓመድ ወይ ሓሞኽሽቲ ብማይክሮ ኦርጋኒዝማት ዝተለኸፈ ከይኸውን እዩ ዘስግእ፣ ከምዚ እንተኾይኑ ዝርግሐ ናይ'ቲ ቫይረስ ከጉድሎ ዘይኮነ ከብዝሖ እዩ። 	There is a risk that the soil or ash may be infected with microorganisms, which will increase the spread of the virus rather than reduce it.
1453	en	ti	 Like soap, ash is also a disinfecting agent because in contact with water, it forms an alkaline solution. 	 ከም ሳሙና፣ ሓሙኽሽቲ ምስ ማይ ኣብ ዝሕወሰሉ ግዘ ኣልካላይን ብጽባጽ ስለዝፈጥር፣ ዲስኢንፌክት ዝገብር ኤጀንት እዩ ። 	Like soap, ash is a disinfectant agent because it forms alkali in a solution when mixed with water.
1454	en	ti	 WHO recommended ash or sand as alternative to soap when soap is not available. 	 ሳሙና ኣብ ዘይንረኽበሉ ከም መተካእታ ሓሞኽሽቲ ወይ ሑጻ ሳሙና ክንጥቀመሎም ከም ንኽእል ውድብ ጥዕና ዓለም(WHO ) ይላቦ። 	The World Health Organization(WHO ) recommends using them as an alternative to ash or sand soap when soap is not available.
1455	en	ti	 Correct handwashing technique recommended by the US Centers for Disease Control  for prevention of transmission of disease includes the following steps: 	 ናይ US Centers for Disease Control  (ሕብራት መንግስታት ኣሜሪካ ናይ ሕማም ቁጽጽር ማእኸል) ዘቕረብዎ ትኽክለኛ ናይ ኢድ ኣተሓጻጽባ ቴክኒክ ናይ እቲ ሕማም ዝርጋሐ ንምቕናስ እዞም ዝስዕቡ ስጉምቲታት የጠቓልል: 	Proper hand washing techniques proposed by the US Centers for Disease Control include the following steps to reduce the spread of the disease:
1456	en	ti	 Wet hands with warm or cold running water. 	 ኣእዳውኩም ብውዑይ ወይ ዝሑል ፈሳሲ ማይ ኣተርክሱ። 	Get your hands dirty with warm or cold liquid water.
1457	en	ti	 Running water is recommended because standing basins may be contaminated, while the temperature of the water does not seem to make a difference. 	 ዝፈስስ ማይ እዩ ዝምከር ምኽንያቱ ደው ዝበሉ ባዚናት ክብከሉ ይኽእሉ፣ እቲ ናይ ማይ ረስኒ ድማ ኣፈላላይ ዝፈጥር ኣይኮነን። 	Running water is recommended because stagnant basins can become contaminated, and the water spray is not discriminatory.
1458	en	ti	 Lather hands by rubbing them with a generous amount of soap, including the backs of hands, between fingers, and under nails. 	 ዝባን ኢድካ ፣ ኣብ መንጎ ኣጻብዕቲ፣ ትሕቲ ጽፍሪ እውን ሓዊሱ ብብዝሕ ዝበለ ሳሙና ኢድካ ደራሪዝካ ምሕጻብ። 	Wash your hands with plenty of soap, including the tops of your hands , between your fingers, and under your fingernails.
1459	en	ti	 Soap lifts germs from the skin, and studies show that people tend to wash their hands more thoroughly when soap is used rather than water alone. 	 ሳሙና ካብ ቆርበት ነቲ ጀርም የልዕሎ፣ መጽናዕቲታት ከምዘርእይዎ ድማ ሰባት ብማይ ጥራሕ ካብ ዝሕጸብዎ ንላዕሊ ብሳሙና እንተኾይኑ እዮም ብደምቢ ዝሕጸቡ። 	Soap removes germs from the skin, and studies have shown that people wash more thoroughly with soap than with water alone.
1460	en	ti	 Scrub for at least 20 seconds. 	 እንተንኢሱ ን 20 ሰከንድታት ድረዝዎ። 	Wipe for at least 20 seconds.
1461	en	ti	 Scrubbing creates friction, which helps remove germs from skin, and scrubbing for longer periods removes more germs. 	 ኢድካ ምድራዝ ምፍሕፋሕ ይፈጥር፣ ጀርምታት ካብ ቆርበትካ ንክጠፍኡ ድማ ይሕግዝ፣ ንንውሕ ዝበለ ግዘ ምድራዝ ድማ ብዙሓት ጀርምታት የወግድ። 	Wiping your hands creates friction, and helps get rid of germs from your skin, and wiping for longer removes many germs.
1462	en	ti	 Rinse well under running water. 	 ብትሕቲ ዝፈስስ ማይ ኣእዳው ይላቕልቑ። 	Hands are soaked under running water.
1463	en	ti	 Rinsing in a basin can recontaminate hands. 	 ኣብ ባዚን ምጽራይ ንኣእዳው መሊሱ ክብክለን ይኽእል እዩ። 	Cleaning in a basin can contaminate hands again.
1464	en	ti	 Dry with a clean towel or allow to air dry. 	 ብጽሩይ ሽጎማነ ኢድኩም ኣጽርዩ ወይ ብ ናይ ኣየር መንቀጺ ኣንቅጹ። 	Clean your hands with a clean towel or dry with an air dryer.
1465	en	ti	 Wet and moist hands are more easily recontaminated.The most commonly missed areas are the thumb, the wrist, the areas between the fingers, and under fingernails. 	 ርሑስን ትርኩስን ኣእዳው ብቐሊሉ ይብከሉ። ብበዝሒ ዝርስዑ ኣካላት ኣእዳው ዓባይ ኣጻብዕቲ፣ ናይ ኢድ ክሳድ፣ ሞንጎ ኣጻብዕቲን ውሽጢ ጽፍሪን እዮም። 	Clean and dirty hands are easily contaminated. The most commonly forgotten parts of the hands are the thumb, the neck of the hand, the middle finger and the inside of the nail.
1466	en	ti	 Artificial nails and chipped nail polish may harbor microorganisms. 	 ኣርቴፊሻል ጽፍሪታትን ዝቕብኡ ናይ ጽፍሪ ቀለማትን ማይክሮ ኦርጋኒዝማት ክሕዙ ይኽእሉ እዮም። 	Artificial nails and painted nail paints can harbor microorganisms.
1467	en	ti	 Moisturizing lotion is often recommended to keep the hands from drying out; dry skin can lead to skin damage which can increase the risk for the transmission of infection. 	 ደረቕ ቆርበት ሕማም ናይ ምምሕልላፍ ዕድል ክውስኽ ስንዝገብር ናይ ኢድ ሎሽን ኣእዳው ካብ ድርቀት ንምክልኻል ክንጥቀመሎም ይምከር። 	Hand lotions are recommended to protect hands from dryness as dry skin increases the risk of infection.
1468	en	ti	" Various low-cost options can be made to facilitate hand washing where tap-water and/or soap is not available e.g. pouring water from a hanging jerrycan or gourd with suitable holes and/or using ash if needed in developing countries.In situations with limited water supply (such as schools or rural areas in developing countries), there are water-conserving solutions, such as ""tippy-taps"" and other low-cost options. "	" ዝተፈላለዩ ትሑት ዋጋኦም መማረጺታት ናይ ቡንባ ማይን/ ወይ ሳሙና ዘይክህሉ ከሎ ኢድ ምሕጻብ ንምብርትታዕ ክቐርቡ ይኽእሉ ንኣብነት፣ ካብ ዝተንጠልጠለ ጀሪካን ማይ ብምቕዳሕ ወይ ብምንኳልን/ ወይ ኣብ ማዕበልቲ ሃገራት ኣድላዪ እንተኾይኑ ሓሞኽሽቲ ምጥቃም ይከኣል። ወይ ናይ ማይ ኣቕርቦት ዝህልወሉ ኩነታት (ከም ቤት ትምህርቲታት ወይ ናይ ገጠር ቦታታት ኣብ ማዕበልቲ ሃገራት)፣ ኣለዉ፣ ንኣብነት ከም ""tippy-taps"" ከምኡውን ትሑት ዋጋ ዘውጽኡ መማረጺታት ዝበሉ ማይ መዐቀቢ መፍትሒታት ኣለዉ ። "	Various low-cost alternatives can be provided to encourage hand washing when tap water and/or soap is not available, for example, by drawing or pumping water from a suspended jerrycan and/or using ashes if necessary in developing countries. or situations where a water supply is available (such as schools or rural locations in developing countries), there are, for example, water conservation solutions such as &quot;tippy-taps&quot; and low-cost options .
1469	en	ti	 A tippy-tap is a simple technology using a jug suspended by a rope, and a foot-operated lever to pour a small amount of water over the hands and a bar of soap. 	 tippy-tap ብገመድ ዝተኣሰረ ጆክ ብምጥቃም ዝሰርሕ፣ ብእግሪ ድማ ብምርግጋጽ ውሑድ ማይን ሳሙናን ናብ ኢድኩም ብምፍሳስ ንምጥቃም ዘኽእል ቀሊል ቴክኖሎጂ እዩ። 	The tippy-tap is an easy-to-use technology that works by using a wired jock, and by kicking the foot and pouring a small amount of water and soap into your hands.
1470	en	ti	 Effective drying of the hands is an essential part of the hand hygiene process, but there is some debate over the most effective form of drying in public washrooms. 	 ብቑዕ ናይ ኢድ ምንቃጽ ናይ ኢድ ጽሬት ምሕላው ከይዲ ወሳኒ አካል እዩ፣ እንተኾነ ግን ኣብ ናይ ህዝባዊ ሽንቲ ቤታት ዘሎ ናይ ኢድካ ምንቃጽ ከይዲ ክርክራት ኣሎ እዩ። 	Proper hand drying is a critical part of the hand hygiene process, but there are controversies about the hand drying process in public toilets.
1471	en	ti	 A growing volume of research suggests paper towels are much more hygienic than the electric hand dryers found in many washrooms. 	 ብዙሓት መጽናዕቲታት ከምዘርእዩዎ ናይ ወረቐት ፎጣታት ልዕሊ እቶም ኣብ ብዙሓት መሕጸቢ ክፍሊታት ዝርከቡ ናይ ኤሌክትሪክ ናይ ኢድ መንቀጺታት ጽሬየቶም ዝሓለዉ እዮም። 	Many studies have shown that paper towels are cleaner than the electric hand dryers found in many bathrooms.
1472	en	ti	 In 2008, a study was conducted by the University of Westminster, London, and sponsored by the paper-towel industry the European Tissue Symposium, to compare the levels of hygiene offered by paper towels, warm-air hand dryers and the more modern jet-air hand dryers. 	 ኣብ 2008፣ ኣብ ለንደን ዝርከብ፣ University of Westminster (ዌስትሚንስትር ዩኒቨርሲቲ)፣ ወረቐት ፎጣታት ዝህብዎ ናይ ጽሬት ደረጃ ምስ ውዑይ-ኣየር ናይ ኢድ መድረቒን ዘመናዊ ዝኾኑ ጀት-ኤርን(jet-air) ዘነጻጸር መጽናዕቲ ተኻይዱ። እዚ ድማ ብ ናይ ኣውሮፓ ሶፍት ሲምፖዝየም ናይ ወረቐት ፎጣ መምረቲ ስፖንሰር ዝተገበረ መጽናዕቲ እዩ። 	In 2008, a study was conducted at the University of Westminster in London comparing the quality of paper towels with hot-air hand dryers and modern jet-air. This is a study sponsored by the European Soft Symposium of Paper Foil Manufacturers.
1473	en	ti	 After washing and drying hands with the warm-air dryer, the total number of bacteria was found to increase on average on the finger pads by 194% and on the palms by 254%. 	 ኢድካ ተሓጺብካ ብውዑይ ኣየር ኢድካ ምድራቕ፣ ሓፈሻዊ ናይ ባክቴርያታት በዝሒ ኣብ ናይ ኣጻብዕቲ ፓዳት ብ 194% ኣብ ከብዲ ኢድ ድማ 254% ክውስኽ ከምዝገብር ተራእዩ። 	Washing your hands and drying your hands with warm air increased the overall bacterial count on the finger pads by 194% and on the abdomen of the hand by 254%.
1474	en	ti	 Drying with the jet-air dryer resulted in an increase on average of the total number of bacteria on the finger pads by 42% and on the palms by 15%. 	 ብናይ ጀት ኤር( jet-air) መንቀጺ ኢድካ ምንቃጽ፣ ናይ ባክቴርያ ምጥፋእ ዕድሉ ኣብ ውሽጣዊ ኣካል ኣጻብዕቲ ብኣቭሬጅ 42% ክኸውን ከሎ፣ ኣብ ከብዲ ኢድ ድማ 15% እዩ። 	Drying your hands with a jet-air( jet-air) hand dryer, the chance of bacterial destruction is 42% on average on the inside of the fingers, and 15% on the abdomen of the hand.
1475	en	ti	 After washing and drying hands with a paper towel, the total number of bacteria was reduced on average on the finger pads by up to 76% and on the palms by up to 77%.The scientists also carried out tests to establish whether there was the potential for cross contamination of other washroom users and the washroom environment as a result of each type of drying method. 	 ኣእዳውካ ተሓጺብካ ብወረቐት ፎጣ ድሕሪ ምንቃጽ፣ ሓፈሻዊ ናይ ባክቴርያ ብዝሒ ብኣቭሬጅ ኣብ ናይ ኣጻብዕቲ ፓዳት ብ76% የጉድሎ፣ ኣብ ከብዲ ኢድ ድማ ብ77%። ናብ ካልኦት ናይ ሽንቲ ቤት ተጠቀምቲ ናይ ምትሕልላፍ ዕድል እንተሃሊዎ ብዝምልከት መጽዕቲ ተኻይዱ እዩ። 	After washing your hands and drying them with towel paper, it reduces the overall bacterial count by an average of 76% on the finger pads and 77% on the abdomen of the hand. Investigations have been conducted regarding the possibility of transmission to other toilet users.
1476	en	ti	 The jet-air dryer, which blows air out of the unit at claimed speeds of 180 m/s (650 km/h; 400 mph), was capable of blowing micro-organisms from the hands and the unit and potentially contaminating other washroom users and the washroom environment up to 2 metres away. 	 ካብ እቲ ዩኒት ብ 180 m/s (650 km/h; 400 mph) ናህሪ ኣየር ዘውጽእ ናይ ጄት-ኤር(jet-air) መንቀጺ፣ ካብ ኣእዳው ማይክሮኦርጋኒዝማት ኣልዒሉ ናብ ካልኦት ናይ መሕጸቢ ክፍሊ ቦታታት ብምብካል ናይ እቲ መሕጸቢ ቦታ ከባቢ ክሳብ 2 ሜትር ዝኣክል ናይ ምብካል ክእለት ኣለዎ። 	A jet-air dryer that expels air from the unit at 180 m/s (650 km/h; 400 mph) picks up microorganisms from the hands and contaminates the bathroom area up to 2 m It has the ability to contaminate enough.
1477	en	ti	 Use of a warm-air hand dryer spread micro-organisms up to 0.25 metres from the dryer. 	 ናይ ውዑይ ኣየር ኢድ መንቀጺ ንማይክሮ ኦርጋኒዝማት ካብቲ መንቀጺ 0.25 ሜትር ዝኣክል ክነጽጎም ይኽእል እዩ ። 	Hot air hand dryers can spray micro organisms as far as 0.25 m from the dryer .
1478	en	ti	 Paper towels showed no significant spread of micro-organisms.In 2005, in a study conducted by TÜV Produkt und Umwelt, different hand drying methods were evaluated. 	 ናይ ወረቐት ፎጣታት ናይ ማይክሮ ኦርጋኒዝማት ክንድቲ ስርጭት ኣይተራኣዮምን። ኣብ 2005፣ብ TÜV Produkt und Umwelt ዝተኻየደ መጽናዕቲ፣ ዝተፈለየ ናይ ኢድ ምንቃጽ ሜላታት ገምጊሙ ነይሩ። 	Paper foam did not show as much spread of microorganisms. In 2005,a study conducted by TÜV Produkt und Umwelt, evaluated different hand drying techniques.
1479	en	ti	 The following changes in the bacterial count after drying the hands were observed: 	 ድሕሪ ኢድ ምንቃጽ፣ ኣብ ቁጽሪ ባክተርያ እዞም ዝስዕቡ ለውጢታት ዝተረኣዩ እዮም: 	After hand drying, the following changes in bacterial counts were observed:
1480	en	ti	 Many different hand dryer manufacturers exist, and hand driers have been compared against drying with paper towels. 	 ብዙሓት ዝተፈላለዩ ናይ ኢድ መንቀጺ መፍረይቲ ኣለዉ፣ ናይ ኢድ መንቀጽቲ ምስ ናይ ወረቐት ፎጣታት ክነጻጸሩ ጸኒሖም እዮም። 	There are many different hand dryer manufacturers, and hand dryers have been compared to paper towels.
1481	en	ti	 Hand washing using hand sanitizing wipes is an alternative during traveling in the absence of soap and water. 	 ሳሙናን ማይን ኣብዘይርከበሉ እዋን ኢድ ብትርኩስ ሳኒታይዚንግ ሶፍት ምሕጻብ ይመክር። 	Washing hands with dirty sanitizing soft is recommended when soap and water are not available.
1482	en	ti	 Alcohol-based hand sanitizer should contain at least 60% alcohol. 	 ኣልኮል ዘለዎም ናይ ኢድ መጽረይቲ እንተንኢሱ 60% ኣልኮል ዝሓዙ ክኾኑ ኣለዎም። 	Alcohol-based hand sanitizers must contain at least 60% alcohol.
1483	en	ti	 Medical hand-washing became mandatory long after Hungarian physician Ignaz Semmelweis discovered its effectiveness (in 1846) in preventing disease in a hospital environment. 	 ሕክምናዊ ኣተሓጻጽባ ኢድ፣ ኢግናዝ ሰመልውይስ ዝተባህለ ሃንጋሪያዊ ዶክተር ኣብ ውሽጢ ሆስፒታል ሕማም ከይመሓላለፍ ንምግባር ብቑዕነቱ ድሕሪ ምርግጋጹ(ኣብ 1846)፣ ግድን ኣብ ጥቕሚ ዝውዕል ኮይኑ። 	Medical hand washing became compulsory after Ignaz Semelwis, a Hungarian doctor, proved its ability to prevent the spread of disease inside a hospital (in 1846).
1484	en	ti	 There are electronic devices that provide feedback to remind hospital staff to wash their hands when they forget. 	 ናይ ሆስፒታል ሰራሕተኛታት ኣእዳዎም ንክሕጸቡ ዘዘኻኽሩ ኤሌክትሮኒክ መሳርሒታት ኣለዉ። 	There are electronic devices that remind hospital staff to wash their hands.
1485	en	ti	 One study has found decreased infection rates with their use. 	 ኣብ ሓደ መጽናዕቲ ኣጠቓቕምኡ ንመጠነ ምትሕልላፍ ረኽሲ ከምዘጉድል ረኺቡ እዩ። 	In one study he found that its use reduced the rate of infection transmission.
1486	en	ti	 Medical hand-washing is for a minimum of 15 seconds, using generous amounts of soap and water or gel to lather and rub each part of the hands. 	 ሕክምናዊ ኣተሓጻጽባ ኢድ ብውሕዱ ን15 ሰከንድታት እዩ ዝግበር፣ ብዙሕ ሳምናን ማይን ብምጥቃም ወይ ጄል ብምጥቃም ንነፍስ ወከፍ ክፋል ኣእዳው ድረዝዎ። 	Medical hand washing is done for at least 15 seconds, wipe each part of the hands with plenty of soap and water or gel.
1487	en	ti	 Hands should be rubbed together with digits interlocking. 	 ኣእዳው ብሓባር ኣጻብዕቲ ኣቆላሊፍካ ክድረዙ ኣለዎም። 	Hands should be wiped together with fingers curled.
1488	en	ti	 If there is debris under fingernails, a bristle brush may be used to remove it. 	 ኣብ ትሕቲ ኣጻፍር ርስሓት እንተልዩ፣ ጸጓር ብሩሽ ጠጠቒምኩም ምውጻእ ትኽእሉ ኢኹም። 	If there is dirt under the nails, you can use a soft brush to remove it.
1489	en	ti	 Since germs may remain in the water on the hands, it is important to rinse well and wipe dry with a clean towel. 	 ጀርምታት ኣብ እቲ ኣብ ኢድና ዘሎ ማይ ክጸንሑ ስለዝኽእሉ ብኣግባቡ ምፍሕፋሕን ብዝነቐጸ ፎጣ ኢድካ ምንቃጽ ኣገዳሲ እዩ። 	Since germs can remain in the water on our hands, it is important to rinse them thoroughly and dry your hands with a dry cloth.
1490	en	ti	 After drying, the paper towel should be used to turn off the water (and open any exit door if necessary). 	 ድሕሪ ምንቃጽ፣ እቲ ወረቐተ ፎጣ ማይ ንምጥፋእ ተጠቐሙሉ (ኣድላዪ እንተኾይኑ እውን ዝተዓጸወ በሪ ክፈቱሉ)። 	After drying, use the paper towel to turn off the water (also open a closed door if necessary).
1491	en	ti	 This avoids re-contaminating the hands from those surfaces. 	 እዚ ድማ ኣእዳውኩም እቶም ቦታታት ብምንካእ ደጊሞም ከይብከሉ ይሕግዝ። 	This will help prevent your hands from getting contaminated again by touching the areas.
1492	en	ti	" The purpose of hand-washing in the health-care setting is to remove pathogenic microorganisms (""germs"") and avoid transmitting them. "	 ኣብ ክንክን-ጥዕና ቦታ ዘሎ ናይ ምሕጻብ ኣእዳው ዕላማ፡ ተጓዳእቲ ታህዋስያን (ጀርምታት) ካብ ምስፍሕፋሕ ንምዕጋትን ናብ ካልኦት ንኸይመሓላለፍ ድማ ንምዕጋት'ዩ። 	The purpose of hand washing in a health-care setting is to prevent the spread of harmful bacteria (germs) and prevent them from being passed on to others.
1493	en	ti	 The New England Journal of Medicine reports that a lack of hand-washing remains at unacceptable levels in most medical environments, with large numbers of doctors and nurses routinely forgetting to wash their hands before touching patients, thus transmitting microorganisms. 	 ኣብ ናይ New England Journal of Medicine ኣብ መብዛሕትኡ ናይ ሕክምና ከባቢታት ሕጽረት ኢድ ምሕጻብ ተቐባሊነት ዘይብሉ ነገር ከምዝኾነ ሓቢሩ፣ ብዙሓት ዶክተራትን ነርስታትን ሕሙማት ቅድሚ ምትንካፎም ኢዶም ምሕጻብ ብምርሳዖም፣ በዚ ድማ ማይክሮኦርጋኒዝማት የመሓላልፍሎም ኣለዉ። 	In the New England Journal of Medicine he reported that lack of hand washing in most medical environments is something unacceptable, with many doctors and nurses forgetting to wash their hands before touching patients, thereby transmitting microorganisms to them.
1494	en	ti	 One study showed that proper hand-washing and other simple procedures can decrease the rate of catheter-related bloodstream infections by 66 percent.The World Health Organization has published a sheet demonstrating standard hand-washing and hand-rubbing in health-care sectors. 	 ሓደ መጽናዕቲ ከምዘርኣዮ ግቡእ ዝኾነ ኢድ ምሕጻብን ካልኦት ቀለልቲ ከይዲታትን፣ ምስ ካቴተር ዝተተሓሓዙ ናይ ደም ቱቦታት ረኽሲ ብ 66 ሚአታዊ ምቕናስ ይከኣል እዩ። ናይ ወድብ ጥዕና ዓለም ኣብ ናይ ጥዕና ክንክን ሴክተራት ክህሉ ዝግበኦ ናይ ኢድ ምሕጻብን ኢድ ምድራዝን ደረጃታት ጽሬት ዘርእዩ ወረቐት ኣሕቲሙ እዩ። 	One study showed that proper hand washing and other simple procedures can reduce catheter-related blood vessel infections by 66 percent. The World Health Organization has published a paper on hygiene standards for hand washing and hand wiping in health care sectors.
1495	en	ti	 The draft guidance of hand hygiene by the organization can also be found at its website for public comment. 	 እዚ በቶም ትካላት ዝተደለወ ናይ ኢድ ጽሬት ውጥን/መምርሒ፣ ንህዝባዊ ርእይቶ ዝተዳለወ ዌብሳይቶም ምርካብ ይከኣል። 	This hand hygiene plan/guideline, required by the organizations, can be found on their website for public comment.
1496	en	ti	 A relevant review was conducted by Whitby et al. 	 ነዚ ዝምልከት ተተሓሓዚ ገምጋም ብ Whitby et al ተኻይዱ ነይሩ። 	A companion review of this had been carried out by Whitby et al.
1497	en	ti	 Commercial devices can measure and validate hand hygiene, if demonstration of regulatory compliance is required. 	 ሕጋዊ ተገዳዲነት ኣድላዪ እንተኾይኑ፣ ናይ ንግዲ መሳርሒታት ናይ ኢድ ጽሬት ምልካዕን ምግላጽን ይኽእሉ እዮም። 	If legal requirements are necessary, commercial tools can measure and describe hand hygiene.
1498	en	ti	" The World Health Organization has ""Five Moments"" for washing hands: "	" ናይ ውደብ ጥዕና ዓለም ንኢድ ምሕጻብ ""ሓሙሽተ ግዘታት "" ኣለዉዎ፡ "	The World Health Organization has &quot;five times &quot; for hand washing:
1499	en	ti	 after exposure to blood/body fluids 	 ንደም/ናይ ሰውነት ፈሳሲ ድሕሪ ምቅላዕ 	After exposure to blood/body fluids
1500	en	ti	 before an aseptic task, and 	 ቅድሚ ናይ ምምካን ስራሕ፣ ከምኡ'ውን 	Before sterilization work, as well
1501	en	ti	" after patient care.The addition of antiseptic chemicals to soap (""medicated"" or ""antimicrobial"" soaps) confers killing action to a hand-washing agent. "	" ድሕሪ ናይ ተሓካሚ ክንክን። ናይ ጸረ-ታህዋስያን ኬሚካላት ናብ ሳሙና ምሕዋስ (""መድሓኒትነት ዘለዎም"" ወይ ""ጸረ ማይክሮቢያል"" ሳሙናታት) ነቲ ኢድ መሐጸቢ ናይ ምቕታል ስርሑ የበራትዖ። "	After patient care. The addition of antibacterial chemicals to soap (“medicinal” or “antimicrobial” soaps) enhances the killing effect of the hand sanitizer.
1502	en	ti	 Such killing action may be desired prior to performing surgery or in settings in which antibiotic-resistant organisms are highly prevalent.To 'scrub' one's hands for a surgical operation, it is necessary to have a tap that can be turned on and off without touching it with the hands, some chlorhexidine or iodine wash, sterile towels for drying the hands after washing, and a sterile brush for scrubbing and another sterile instrument for cleaning under the fingernails. 	 ከም'ዚ ዓይነት ቀታሊ ስጉምቲ ቅድሚ መጥባሕቲ ምክያድ ወይ ጸረ-ረኽሲ ተጻወርቲ ኦርጋኒዝማት ኣብ ዝበዝሑሉ ኩነታት ምጥቃም ይከኣል። ንናይ መጥባሕቲ ኦፕሬሽን ናይ ሓደ ሰብ ኢድ 'ምድራዝ'፣ ብኣእዳውካ ከይነኻእካ ዝውላዕን ዝጠፍእን ታ ኣድላዪ እዩ፣ ከምኡውን ዝተወሰነ chlorhexidine ወይ iodine መሕጸቢ፣ ስተራይል ፎጣታት ድማ ንመድረቒ ኣእዳው፣ ስተራይል ብሩሸት ድማ ንመድረዚ ካልእ ስተራይል መሳርሒታት ድማ ትሕቲ ጽፍሪ ንምጽራይ ኣድለይቲ እዮም። 	Such a lethal measure can be used before surgery or in situations where antibiotic resistant organisms are prevalent. For a surgical operation &#39;wiping&#39; one&#39;s hands, ta on and off without touching one&#39;s hands is necessary, as well as certain chlorhexidine or iodine rinses, and sterile towels for drying hands, sterile brushes for wiping and other sterile instruments for cleaning under the nails.
1503	en	ti	 All jewelry should be removed. 	 ኩሎም መጋየጺታት ክውገዱ ኣለዎም። 	All decorations must be removed.
1504	en	ti	 This procedure requires washing the hands and forearms up to the elbow, usually 2–6 minutes. 	 እዚ ከይዲ እዚ ኣእዳወኩም ክሳብ ኩርናዕ ኢድኩም፣ መብዛሕትኡ ግዘ ን 2–6 ደቓይቕ ምሕጻብ ዝሓትት እዩ። 	This process requires washing your hands up to the corner of your hand, usually for 2–6 minutes.
1505	en	ti	 Long scrub-times (10 minutes) are not necessary. 	 ንነዊሕ ግዘ ምድራዝ (10 ደቓይቕ) ኣድላዪ ኣይኮነን። 	Prolonged rubbing (10 minutes) is not necessary.
1506	en	ti	 When rinsing, water on the forearms must be prevented from running back to the hands. 	 ላዕለዋይ ክፋል ኢድ እንተነለቕልቕ ማይ ናብ ኣእዳው ከይወርድ ጥንቃቐ ምግባር የድሊ። 	If we wet the upper part of the hand, be careful not to let water get on the hands.
1507	en	ti	 After hand-washing is completed, the hands are dried with a sterile cloth and a surgical gown is donned. 	 ኢድኩም ምሕጻብ ድሕሪ ምውዳእኩም፣ ኣእዳውኩም ብዝመኸነ ደረቕ ፎጣ ኣንቅጹዎ፣ ናይ ሰርጂካል ጋውንኩም ድማ ኣውጽእዎ። 	After you finish washing your hands, dry your hands with a damp dry towel, and remove your surgical gown.
1508	en	ti	 To reduce the spread of germs, it is better to wash the hands or use a hand antiseptic before and after tending to a sick person. 	 ናይ ጀርምታት ዝርጋሐ ንምቕናስ፣ ዝሓመመ ሰብ ቅድሚ ምርካብኩምን ድሕሪኡን ኣእዳውኩም ምሕጸብ ወይ ኣንቲሴፕቲክ ምጥቃም ዝሓሸ እዩ። 	To reduce the spread of germs, it is best to wash your hands or use antiseptics before and after contact with someone who is sick.
1509	en	ti	 For control of staphylococcal infections in hospitals, it has been found that the greatest benefit from hand-cleansing came from the first 20% of washing, and that very little additional benefit was gained when hand cleansing frequency was increased beyond 35%. 	 ኣብ ሆስፒታል ዘለዉ ናይ staphylococcal(ስታፍይሎኮካል) ረኽሲታት ንምቁጽጻር፣ ናይ ኢድ ምጽራይ ካብ'ቶም ዝዓበየ ጥቕሙ ኣብ ውሽጢ 20% ናይ ኢድ ምሕጻብ ግዘ እዩ፣ እቲ ናይ ኢድ ምሕጻብ ተደጋጋሚነት ናብ 35% ምስወሰኸ ድማ ዋላ ንእሽተይ ይኹን እምበር ተወሳኺ ረብሓ ተረኺቡ እዩ። 	To control staphylococcal(staphylococcal) infections in hospitals, hand hygiene is one of the greatest benefits within 20% of hand washing time, and even a small but additional benefit was found when the hand washing frequency increased to 35%.
1510	en	ti	 Washing with plain soap results in more than triple the rate of bacterial infectious disease transmitted to food as compared to washing with antibacterial soap.Comparing hand-rubbing with alcohol-based solution with hand washing with antibacterial soap for a median time of 30 seconds each showed that the alcohol hand-rubbing reduced bacterial contamination 26% more than the antibacterial soap. 	 ብንቡር ሳሙና ምሕጻብ ምስ ጸረ ባክቴርያ ሳሙና ምሕጻብ ክነጻጸር ከሎ ልዕሊ ሰለስተ ዕጽፊ ባክቴርያ ኢንፌክሽን ናብ መግቢ ናይ ምምሕልላፍ ዕድል ኣለዎ። ናይ ኣልኮል ዘለዎ ናይ ኢድ መድረዚ ምስ ብጸረ ባክቴርያ ሳሙና ኢድካ ምሕጻብ ን 30 ሰከንድ ክነጻጸር ከሎ እቲ ኣልኮል ዝሓዘ ኢድ መድረዚ ናይ ባክቴርያ ብከላ ልዕሊ እቲ ጸረ-ባክቴርያ ሳሙና ብ 26% ይቕንስ። 	Washing with normal soap has more than three times the chance of transferring bacterial infection to food compared to washing with antibacterial soap. Compared to washing your hands with antibacterial soap for 30 seconds, the alcohol-based hand wipe reduces bacterial contamination by 26% more than the antibacterial soap.
1511	en	ti	 But soap and water is more effective than alcohol-based hand rubs for reducing H1N1 influenza A virus and Clostridium difficile spores from hands.Interventions to improve hand hygiene in healthcare settings can involve education for staff on hand washing, increasing the availability of alcohol-based hand rub, and written and verbal reminders to staff. 	 እንተኾነ ግን ማይን ሳሙናን ካብ ኣልኮል ዘለዎም ናይ ኢድ መድረዚታት H1N1 ኢንፍሉዌንዛ A ቫይረስን ክሎስትሪዲየም ካብ ኢድ ኣብ ምውጋድ ዝበለጹ እዮም። ኣብ ናይ ጥዕና ክንክን መሰናድኦታት ናይ ኢድ ጽሬት ንምምሕያሽ ዝግበሩ ጣልቃ ምእታዋት፣ ብዛዕባ ኢድ ምሕጻብ ንሰረሕተኛታት ምምሃር፣ ናይ ኣልኮል ዘለዎ መድረዚ ኣቕራቦት ምውሳኽን ጽሑፋዊን ብኣፍን ነቲ ስራሕተኛ መዘኻኸሪታት ምቕራብ ዘጠቓለሉ ክኾኑ ይኽእሉ እዮም። 	However, soap and water are better than alcohol-based hand wipes at removing H1N1 influenza A virus and Clostridium from hands. Interventions to improve hand hygiene in health care settings may have included teaching staff about hand washing, increasing the supply of alcohol-based wipes and providing written and oral reminders to the staff.
1512	en	ti	 There is a need for more research into which of these interventions are most effective in different healthcare settings. 	 ካብ'ዞም ሕክምናታት እዚኦም ኣየኖት ብሉጻት ከምዝኾኑ ንምፍላጥ ተወሰኽቲ መጽናዕቲታት ከድልዩ እዮም። 	Further studies will be needed to determine which of these treatments are best.
1513	en	ti	 In developing countries, hand washing with soap is recognized as a cost-effective, essential tool for achieving good health, and even good nutrition. 	 ኣብ ማዕበልቲ ሃገራት፣ ኢድካ ብሳሙና ምሕጻብ ዋጋ ዘገናዘበ ፣ ጽቡቕ ጥዕና ንምሕላውን ንጽቡቕ ኣመጋግባ እውን ከም ወሳኒ መሳርሒ ተገይሩ እዩ ዝውሰድ። 	In developing countries, hand washing with soap is considered valuable , and is also considered a crucial tool for good health and good nutrition.
1514	en	ti	 However, a lack of reliable water supply, soap or hand washing facilities in people's homes, at schools and at the workplace make it a challenge to achieve universal hand washing behaviors. 	 እንተኾነ ግን፣ ናይ ማይ፣ ሳሙና ወይ ናይ ኢድ መሕጸቢ መሳለጥያታት ሕጽረት ኣብ ገዛ፣ ቤት ትምህርቲታትን ኣብ ናይ ስራሕ ቦታን ዘሎ ናይ ኣቕርቦት ሕጽረት ዓለምለኻዊ ናይ ኢድ ምሕጻብ ባህርያት ንምምዕባል ከቢድ ይገብሮ። 	however, lack of water, soap or hand washing facilities The supply constraints at home, schools and in the workplace make it difficult to develop universal hand washing behaviours.
1515	en	ti	 For example, in most of rural Africa hand washing taps close to every private or public toilet are scarce, even though cheap options exist to build hand washing stations. 	 ንኣብነት፣ ኣብ መብዛሕትኦም ገጠራት ናይ ኣፍሪካ፣ ዋላ'ኳ ሕሱር ኣማረጺታት ከም ባዕልኻ ናይ መሕጸቢ ጣብያ ምህናጽ ተኽእሎ እንተሃለወ፣ ናይ ኢድ መሕጸቢ ቡንባ ዳርጋ ኣብ ነፍስ ወከፍ ሽንቲ ቤታት ሕጽረት ኣሎ። 	For example, in most rural areas of Africa, there is a shortage of hand sanitizers in almost every toilet, despite the possibility of cheap alternatives such as building your own washing stations.
1516	en	ti	 However, low hand washing rates rather can also be the result of engrained habits rather than due to a lack of soap or water. 	 እንተኾነ ግን፣ ትሑት ዝኾነ ናይ ኢድ ምሕጻብ ንጽጽራዊ መጠን ናይ ባህሪ ውጽኢት እምበር ናይ ሳሙናን ማይን ሕጽረት ኣይኮነን። 	however, comparative rates of low hand washing are a result of behavior, not a lack of soap and water.
1517	en	ti	 The promotion and advocacy of hand washing with soap can influence policy decisions, raise awareness about the benefits of hand washing and lead to long-term behavior change of the population. 	 ናይ ኢድካ ብሳሙና ምሕጻብ ምብርትታዕ ናይ ፖሊሲ ውሳነታት ክጸልው ይኽእል እዩ፣ ብዛዕባ ናይ ኢድ ምሕጻብ ጥቕሚ ግንዛበ ክፈጥርን ናይ ነዊሕ ግዘ ናይ እቲ ህዝቢ ናይ ኢድ ምሕጻብ ባህሪ ክፈጥርን ይኽእል እዩ። 	Encouraging hand washing with soap can influence policy decisions, create awareness about the benefits of hand washing and create long-term hand washing behavior of the population.
1518	en	ti	 For this to work effectively, monitoring and evaluation are necessary. 	 እዚ በኣግባቡ ንክሰርሕ፣ ቁጽጽርን ክትትልን ኣገዳሲ እዩ። 	For this to work properly, control and monitoring are essential.
1519	en	ti	" A systematic review of 70 studies found that community-based approaches are effective at increasing hand washing in LMICs, while social marketing campaigns are less effective.One example for hand washing promotion in schools is the ""Three Star Approach"" by UNICEF that encourages schools to take simple, inexpensive steps to ensure that students wash their hands with soap, among other hygienic requirements. "	" ኣብ 70 መጽናዕቲታት ዝተኻየደ ስርዓታዊ ገምጋም ከምዝረኸቦ፣ ማሕበረሰብ መሰረት ዝገበረ ኣቀራርባ ናይ ኢድ ምሕጻብ ኣብ LMICs ኣብ ምዕባይ ኣድማዕቲ እዮም፣ ናይ ማሕበራዊ ዕዳጋ ኣቀራርባታት ክንድቲ ኣድማዕቲ ኣይኮኑን። ሓደ ኣብነት ናይ ቤት ትምህርቲታት ናይ ኢድ ምሕጻብ ጎስጓስ ብ UNICEF ዝቐረበ ""ሰለስተ ኮኾብ ኣቀራርባ "" ዝተብሃለ እዩ፣ ቤት ትምህርቲታት ቀለል፣ ሕሳር ዝኾኑ ስጉምቲታት ብምውሳድ ምስ ካልኦት ናይ ጽሬት ረቛሒታት፣ ተመሃሮ ኣእዳዎም ብሳሙና ንክሕጸቡ ምግባር ዘበረታትዕ እዩ። "	A systematic review of 70 studies found that, community-based approaches are effective in promoting hand washing in LMICs, social marketing approaches are not so effective. One example of a school hand washing campaign offered by UNICEF is the so-called &quot;Three Star Approach &quot;, which encourages schools to take simple, inexpensive measures to encourage students to wash their hands with soap, along with other hygiene factors.
1520	en	ti	 When minimum standards are achieved, schools can move from one to ultimately three stars. 	 ዝተሓተ ስታንዳርድ እንተተማሊኡ፣ ቤት ትምህርቲታት ካብ ሓደ ናብ ሰለስተ ኮኾባት ሓፍ ክብሉ ይኽእሉ። 	If minimum standards are met, schools can be promoted from one to three stars.
1521	en	ti	 Building hand washing stations can be a part of hand washing promotion campaigns that are carried out in order to reduce diseases and child mortality. 	 ናይ እቲ ሕማምን ናይ ህጻናት ሞትን ንምቕናስ፣ ናይ ኢድ መሕጸቢ ጣብያታት ምህናጽ ከም ናይ ኢድ ምሕጻብ መበረታትዒ ጎስጓስ ክኾኑ ይኽእሉ እዮም። 	To reduce the disease and child mortality, building hand washing stations could be used as a hand washing incentive campaign.
1522	en	ti	 Global Hand washing Day is another example of an awareness-raising campaign that is trying to achieve behavior change.As a result of the 2019-20 coronavirus pandemic, UNICEF promoted the adoption of a handwashing emoji. 	 ዓለምለኻዊ ናይ ኢድ ምሕጻብ መዓልቲ ናይ ባህሪ ለውጢ ከምጽእ ዝፍትን ዘሎ ጎስጓስ እዩ። በዚ ናይ 2019-20 ኮሮናቫይረስ ምኽንያት፣ UNICEF ናይ ኢድ ምሕጻብ ኢሞጂ ኣብ ስራሕ ምውዓል ኣፋሊጡ እዩ። 	World Hand Washing Day is a campaign that is trying to bring about behavioral change. Because of the 2019-20 coronavirus, UNICEF has announced the introduction of a hand washing emoji.
1523	en	ti	 Few studies have considered the overall cost effectiveness of hand washing in developing countries in relationship to DALYs averted. 	 ገለ መጽናዕቲታት ኣብ ማዕበልቲ ሃገራት ምስ DALYs ብዝተትሓሓዘ ናይ ኢድ ምሕጻብ ሓፈሻዊ ናይ ወጻኢ ኣድማዒነት ኣብ ግምት ዘአተዉ እዮም። 	Some studies have considered the overall cost effectiveness of handwashing in relation to DALYs in developing countries.
1524	en	ti	 However, one review suggests that promoting hand washing with soap is significantly more cost-effective than other water and sanitation interventions. 	 እንተኾነ ግን፣ ሓደ ገምጋም ብሳሙና ኢድካ ምሐጻብ ምስካልኦት ናይ ማየን ጽሬትን ከይዲታት ክረአ ከሎ ዋጋ ቖጣቢ ከምዝኾነ ኣረጋጊጹ። 	However, one evaluation found that hand washing with soap is cost-effective compared to other water and sanitation processes.
1525	en	ti	" The importance of hand washing for human health – particularly for people in vulnerable circumstances like mothers who had just given birth or wounded soldiers in hospitals – was first recognized in the mid 19th century by two pioneers of hand hygiene: the Hungarian physician Ignaz Semmelweis who worked in Vienna, Austria and Florence Nightingale, the English ""founder of modern nursing"". "	" ናይ ኢድ ምሕጻብ ኣብ ደቂ ሰባተ ዘለዎ ናይ ጥዕና ጥቕሚ – ብፍላይ ኣብ ተጋላጺነት ኩነታት ዘለዉ ሰባት ንኣብነት ኣብ ቀረባ እዋን ዝወለዳ ኣደታት ወይ ዝቖሰሉ ወታደራት ኣብ ሆስፒታላት – መጀመርያ ኣብ መበል 19 ክፍለ ዘመን ማእኸል ብክልተ ናይ ኢድ ጽሬት መስረትቲ እዩ ተፈሊጡ፣ ሃንጋርያዊ ሓኪም Ignaz Semmelweis፣ ኣብ ቬና፣ ኦስትሪያን ዝሰርሐን ናይ ኢንግሊዝ ""ናይ ዘመናዊ ምጥዋብ መስራቲ"" ፍሎረንስ ናይቲንግሌን እዮም። "	The health benefits of hand washing in children – especially people in vulnerable situations such as mothers who have recently given birth or wounded soldiers in hospitals – were first recognized in the mid-19th century by two hand hygiene founders, Hungarian physician Ignaz Semmelweis, in Vienna, Austria and the English &quot;founder of modern tapping&quot; Florence Nightingale.
1526	en	ti	 At that time most people still believed that infections were caused by foul odors called miasmas. 	 ኣብቲ ግዘ እቲ ብዙሓት ሰባት ረኽሲታት ብ ሚያስማስ ዝበሃል ሕማቕ ጨና ዝመጹ እዮም ኢሎም ይአምኑ ኔሮም። 	At the time, many people believed that infections were caused by a bad smell called miasma.
1527	en	ti	 In the 1980s, foodborne outbreaks and healthcare-associated infections led the United States Centers for Disease Control and Prevention to more actively promote hand hygiene as an important way to prevent the spread of infection. 	 ኣብ 1980፣ ብመግቢ ዝመሓለለፉ ለበዳታትን ምስ ናይ ጥዕና ክንክን-ዝተተሓሓዙ ረኽሲታትን ንናይ United States Centers for Disease Control and Prevention( ሕቡራት መንግስቲታት ኣሜሪካ ማእኸላት ሕማም ቁጽጽርን ምክልኻልን) ብዝበለጸ ናይ ኢድ ጽሬት ነቲ ረኽሲ ከም ዋና መከላኸሊ መንገዲ ጌሮም ከበረታትዑ ዝገበረ ነይሩ። 	In 1980, foodborne outbreaks and health care-associated infections led the United States Centers for Disease Control and Prevention to promote better hand hygiene as the main preventive measure against infection.
1528	en	ti	 The outbreak of swine flu in 2009 and the COVID-19 pandemic in 2020 led to increased awareness in many countries of the importance of washing hands with soap to protect oneself from such infectious diseases. 	 እቲ ኣብ 2009 ዘጋጠመ ናይ ስዋይን ፍሉ ለበዳ ን ናይ 2020 ናይ ኮቪድ -19 ለበዳ ኣብ ብዙሓት ሃገራት ካብ ተላባዕቲ ሕማማት ዓርስኻ ንምክልኻል ኢድካ ብሳሙና ምሕጻብ ብዛዕባ ዘለዎ ጥቕሚ ግንዛበ ዝፈጠረ እዩ። 	The 2009 swine flu pandemic and the 2020 COVID-19 pandemic have raised awareness in many countries about the benefits of washing your hands with soap to protect yourself from infectious diseases.
1529	en	ti	" For example, posters with ""correct hand washing techniques"" were hung up next to hand washing sinks in public toilets and in the toilets of office buildings and airports in Germany. "	" ንኣብነት፣ ""ትኽክለኛ ናይ ኢድ ምሕጻብ ቴክኒካት"" ዘርእዩ ፖስተራት ኣብ ጎኒ ናይ ህዝባዊ ሽንቲ-ቤታትን ኢድ መሕጸቢ ሲንክታትን ተንጠልጢሎም ይርከቡ። ኣብ ናይ ቤት ጽሕፈታት ማዕጾን ናይ ጀርመን ኤርፖርትታትን እውን ይርከቡ። "	For example, posters showing “proper hand washing techniques” are hung next to public toilets and hand washing sinks. They are also found at office doors and at German airports.
1530	en	ti	" The phrase ""washing one's hands of"" something, means declaring one's unwillingness to take responsibility for the thing or share complicity in it. "	" እዚ ""ኢድ ምሕጻብ "" ዝብል ሓረግ፣ ማለት ናይ ሓደ ሰብ ነቲ ነገር ሓላፍነት ዘይምውሳድ ወይ ኣብ ገበን ተሳታፍነት ምህላው ዘርኢ እዩ። "	This phrase &quot;washing hands &quot;, means a person&#39;s lack of responsibility for the thing or involvement in a crime.
1531	en	ti	 It originates from the bible passage in Matthew where Pontius Pilate washed his hands of the decision to crucify Jesus Christ, but has become a phrase with a much wider usage in some English communities. 	 ካብ ናይ መጽሓፍ ቅዱስ መልእኽቲ ማቲዎስ መንጌል እዩ መበቆሉ ጴንጥዮስ ጲላጦስ ንኢየሱስ ክርስቶስ ኣብ ናይ ምስቃል ውሳነ ኢዱ ተሓጺቡ፣ እዚ ቃል እዚ ግን ኣብ ኢንግሊሽ ማሕበረሰባት ሰፊሕ ተጠቃሚነት ኣለዎ። 	It originates from the biblical gospel of Matthew Pontius Pilate washed his hands in the decision to crucify Jesus Christ, but this word is widely used in English communities.
1532	en	ti	 In Shakespeare's Macbeth, Lady Macbeth begins to compulsively wash her hands in an attempt to cleanse an imagined stain, representing her guilty conscience regarding crimes she had committed and induced her husband to commit. 	 ኣብ Shakespeare Macbeth፣ Lady Macbeth ዝፈጸመቶ ገበንን ንሰብኣያ እውን ክፍጽሞ ዝደፋፈአቶ ገበን ብዝምልከት ናይ ገበነኛነት ስምዒታ ንምጽራይ፣ ኣእዳዋ ብሓይሊ ክትሕጸብ ትጅምር። 	In Shakespeare&#39;s Macbeth, Lady Macbeth begins to wash her hands vigorously to cleanse herself of guilt over the crime she has committed and the crime she has induced her husband to commit.
1533	en	ti	 It has also been found that people, after having recalled or contemplated unethical acts, tend to wash hands more often than others, and tend to value hand washing equipment more. 	 ሰባት፣ ዘይስነ-ስርዓታዊ ተግባር ምግባሮም እንተዘኪሮም ወይ እንተሓሲቦም፣ ልዕሊ ካልኦት ብተደጋጋሚ ኣእዳዎም ከምዝሕጸቡ ተፈሊጡ፣ ንናይ ኢድ መሕጸቢ ናውቲታት ድማ ልዕሊ ካልእ ዋጋ ይህብዎም። 	It has been found that people, if they remember or think of committing an unethical act, wash their hands more frequently than others, and value hand sanitizers above others.
1534	en	ti	" Furthermore, those who are allowed to wash their hands after such a contemplation are less likely to engage in other ""cleansing"" compensatory actions, such as volunteering. "	" ብተወሳኺ፣ ኣእዳዎም ንክሕጸቡ ዝፍቀደሎም ሰባት ድሕሪ ከምዚ ዓይነት ተግባር ኣብ ካልኦት ወለንታዊ ""ንንጽህና ዝውክሉ"" መከሓሓስቲ ተግባራት ናይ ምፍጻም ክእለቶም ውሱን እዩ። "	In addition, people who are allowed to wash their hands are limited in their ability to perform other voluntary “hygiene” compensatory acts after such an act.
1535	en	ti	 Religions prescribe hand washing for both hygienic and symbolic purposes.Symbolic hand washing, using water but no soap to wash hands, is a part of ritual hand washing featured in many religions, including Bahá'í Faith, Hinduism, tevilah and netilat yadayim in Judaism, Lavabo in Christianity, and Wudhu in Islam.Religions also prescribe hygienic hand washing, especially after certain actions. 	 ሃይማኖታት ኢድ ምሕጻብ ንጉዳይ ጽሬትን ምልክታዊ ተግባርን ዕላማ ገይሮም ይመኽሩ። ምልክታዊ ዝኾነ ኢድ ምሕጻብ፣ ኢድካ ብዘይ ሳሙና ብማይ ጥራሕ ምሕጻብ ዋላ ይኹን፣ ኣብ ናይ ባሃይ እምነት፣ ሂንዱይዝም፣ ኣብ ጁዱይዝም ዝርከቡ ቴቪላህን ኔቲላት ያዳይምን፣ ኣብ ክርስትና ዝርከብ ላቫቦ፣ ኣብ እስልምና ዝርከብ ዉድሁ ሓዊሱ፣ ኣብ ብዙሓት ሃይማኖታት ዝርከብ እምነታዊ ተገባር እዩ። ሃይማኖታት ብፍላይ ድሕሪ ገለ ተግባር ኢድካ ን ምጽራይ ምሕጻብ እውን ይመኽሩ እዮም። 	Religions recommend hand washing for hygiene issues and symbolic functions. Symbolic hand washing, whether it is washing your hands with only water without soap, is a religious practice in many religions, including Baha&#39;iism, Hinduism, Tevilah and Netilat Yadaim in Judaism, Lavabo in Christianity, and Wudhu in Islam. Religions also recommend washing your hands for cleansing, especially after some action.
1536	en	ti	 Hinduism, Judaism and Islam mandate washing of hands after using the toilet. 	 ሂንዱዝም፣ ጁዲዝምን እስላምን ድሕሪ ሽንት-ቤት ምጥቃም ኢድካ ምሕጻብ ሕጎም እዩ። 	Hinduism, Judaism and Islam prescribe washing hands after using the toilet.
1537	en	ti	 And, Hinduism, Buddhism, Sikhism, Judaism and Islam mandate washing of hands before and after every meal. 	 ከምኡ'ውን፣ ሂንዱዝም፣ ቡደሂዝም፣ ስኪዝም፣ ጁዲዝምን እስልምናን ቅድሚ ምግቢ ምብላዕ ኢድ ምሕጻብ የበረታትዑ። 	Also, Hinduism, Buddhism, Schism, Judaism and Islam encourage hand washing before eating.
1538	en	ti	 Workplace hazard controls for COVID-19 	 ናይ ስራሕ ቦታ ሓደጋ ቁጽጽር ናይ ኮቪድ-19 	Workplace risk control of COVID-1
1539	en	ti	 Workplace hazard controls for COVID-19 are the application of occupational safety and health methodologies for hazard controls to the prevention of coronavirus disease 2019 (COVID-19). 	 ኣብ ስራሕ ቦታ ዝግበሩ ናይ COVID-19 ሓደጋታት ቁጽጽራት ማለት ንምክልኻል ሕማም ኮረና ቫይረስ 2019(COVID-19) ዘገልግሉ ናይ ስራሕ ቦታ ድሕንነታትን ን ናይ ሓደጋ ቁጽጽር መንገዲታት ምትግባር ማለት እዩ። 	Workplace COVID-19 risk controls mean the implementation of workplace safety and risk control measures to prevent the spread of the coronavirus 2019(COVID-19).
1540	en	ti	 The proper hazard controls in the workplace depend on the worksite and job task, based on a risk assessment of sources of exposure, disease severity in the community, and risk factors of individual workers who may be vulnerable to contracting COVID-19. 	 ኣግባባዊ ናይ ስራሕ ቦታ ናይ ሓደጋ ቁጽጽራት ኣብቲ ናይ ስራሕ ቦታን ዓይነት ስራሕን፣ ብመሰረት ናይ ምቅላዕ ሓደጋ ምንጪ ምርመራ፣ ናይቲ ከባቢ ናይቲ ሕማም ከቢድነት፣ ከምኡውን ናይ ንኮቪድ-19 ናይ ምቅላዕ ዕድሎም ሰፊሕ ዝኾኑ ሰባት ክቃልዑሎም ዝኽእሉ ምኽንያትን ዝተመርኮሰ እዩ። 	Appropriate workplace risk controls are based on the workplace and type of work, according to the source of exposure risk, the severity of the disease in the area, and the reasons for the exposure of people at high risk of exposure to COVID-1
1541	en	ti	 According to the U.S. Occupational Safety and Health Administration (OSHA), lower exposure risk jobs have minimal occupational contact with the public and other coworkers, for which basic infection prevention measures are recommended, including hand washing, encouraging workers to stay home if they are sick, respiratory etiquette, and maintaining routine cleaning and disinfecting of the work environment. 	 ናይ U.S. ስራሕ ድሕንነትን ጥዕናን ምምሕዳር (OSHA) ብዝበሎ መሰረት፣ ትሑትናይ ምቅላዕ ዕድል ዘለዎም ስራሕቲ ምስቲ ህዝቢ ወይ መሳርሕቲ ትሑት ምንኽኻእ ዘለዎም ኮይኖም፣ መሰረታዊ ናይቲ ረኽሲ ምክልኻል ስጉምቲታት ዝውሰድዎ፣ ከም ኢድ ምሕጻብ፣ ሰራሕተኛታት ክሓሙ ከለዉ ኣብ ገዛ ክጸንሑ ምግባር፣ ናይ መተንፈሲ ስነ ስርዓት፣ በቢ ግዚኡ ናይ ስራሕ ቦታ ምጽራይን ዲስኢንፌክት ምግባርን ዘካተቱ እዮም። 	According to the US Occupational Safety and Health Administration (OSHA), low-exposure jobs have low contact with the public or co-workers, and basic infection prevention measures are taken, such as hand washing, keeping employees home when they are sick, respiratory discipline, They include cleaning and disinfecting the work area periodically.
1542	en	ti	 Medium exposure risk jobs include those that require frequent or close contact with people who are not known or suspected with COVID-19, but may be infected due to ongoing community transmission or international travel. 	 ማእኸላይ ተቓላዕነት ሓደጋ ዘለዎም ስራሕቲ ምስ ብኮቪድ-19 ዝተጠርጠሩ ወይ ብዝተረጋገጸ ዝተተሓዙ ሰባት ብቐጥታ ብተደጋጋሚ ምንኽኻእ ክሰርሑ ዝገብሩ ስራሕቲ ዘካትቱ እዮም፣ በዚ ቀጻላይ ናይ ማሕበረ ሰባዊ ለበዳ ምኽንያት ወይ ናይ ዓለም ለኻዊ ምጉዕዓዝ ግን ክልከፉ ይኽእሉ። 	Moderate exposure risk occupations include occupations that require frequent direct contact with suspected or confirmed cases of COVID-19, but may become infected due to this ongoing community outbreak or international travel.
1543	en	ti	 This includes workers who have contact with the general public such as in schools, high-population-density work environments, and some high-volume retail settings. 	 እዚ ድማ ምስ ሓፈሻዊ ብዝሒ ህዝቢ ከም ቤት ትምህርቲታት፣ ልዑል ብዝሒ ህዝቢ ዝጽዕቖም ናይ ስራሕ ቦታታት፣ ከምኡውን ገለ ልዑል ብዝሒ ዘለዎም ናይ መሸጣ መሰንድኦታት ዝሰርሑ ሰራሕተኛታት እውን የካትት። 	This also includes employees who work with general populations such as schools, high-density workplaces, and some high-density sales channels.
1544	en	ti	 Hazard controls for this group, in addition to basic infection prevention measures, include ventilation using high-efficiency air filters, sneeze guards, and having personal protective equipment available in case a person with COVID-19 is encountered. 	 ናይ ሓደጋ ቁጽጽር ጉጅለ፣ ንናይ መሰረታዊ ናይዚ ረኽሲ ምክልኻል ስጉምቲታት ብተወሳኺ፣ ዝኾነ ሰብ ብኮቪድ-19 እንተታሒዙ ናይ ቬንትሌሽን ተጠቃሚነት ልዑል ናይ ኣየር መጻረይታት፣ ናይ ምህንጣስ መሸፈኒን ናይ ውልቃዊ መከላኸሊ ናውቲን ምጥቃም ይከኣል። 	Risk Control Team, in addition to the basic preventive measures of this infection, if anyone is infected with COVID-19 ventilation utilization high air purifiers, cough masks and personal protective equipment can be used.
1545	en	ti	 OSHA considers healthcare and mortuary workers exposed to known or suspected person with COVID-19 to be at high exposure risk, which increases to very high exposure risk if workers perform aerosol-generating procedures on, or collect or handle specimens from, known or suspected person with COVID-19. 	 OSHA ንዝተረጋገጸ ወይ ዝተጠርጠረ ናይ ኮቪድ-19 ሕሙም ዝጋለጹ ናይ ጥዕና ክንክንን ናይ ቀብሪ ስነስርዓት ሰራሕተኛታትን ልዑል ናይ ምቅላዕ ዕድል ከምዘለዎም ሓበሩ፣ እዞም ሰራሕተኛታት ናይ ኤሮሶል ዘምርቱ ምርመራታት ዘካይዱ እንተኾይኖም፣ ወይ ናይ ዝተረጋገጸ ወይ ዝተጠርጠረ ናይ ኮቪድ-19 ሕሙም ናሙናታት ዝእክቡ እንተኾይኖም ድማ ተቓላዕነቶም ይውስኾ። 	OSHA reported that health care and funeral workers who are exposed to a confirmed or suspected COVID-19 patient have a higher risk of exposure, and their exposure increases if these workers conduct aerosol-producing tests, or collect samples from a confirmed or suspected COVID-19 patient.
1546	en	ti	 Hazard controls appropriate for these workers include engineering controls such as negative pressure ventilation rooms, and personal protective equipment appropriate to the job task. 	 ናይዞም ሰራሕተኛታት ናይ ሓደጋ ምቁጽጻር ከም ኣሉታዊ ጸቕጢ ቨንትሌሽን ክፍሊታት፣ ከምኡውን ነቲ ስራሕ ኣግባባዊ ዝኾነ ውልቃዊ መከላኸሊ ናውቲ ዝኣመሰሉ ዝሓዘ ናይ ምህንድስና ቁጽጽር እውን ዘካተተ እዩ። 	The risk control of these workers also included engineering controls such as negative pressure ventilation compartments, and personal protective equipment appropriate for the job.
1547	en	ti	 COVID-19 outbreaks can have several effects within the workplace. 	 ናይ COVID-19 ለበዳ ኣብ ናይ ስራሕ ቦታ ብዙሕ ጽልዋታት ክህልዎ ይኽእል እዩ። 	The COVID-19 pandemic can have many impacts in the workplace.
1548	en	ti	 Workers may be absent from work due to becoming sick, needing to care for others, or from fear of possible exposure. 	 ሰራሕተኛታት ሓሚሞም፣ ንካልኦት ሰባት ክከናኸኑ ኢሎም፣ ወይ ንከይቃልዑ ፈሪሖም ካብ ስራሕ ክተርፉ ይኽእሉ እዮም። 	Employees may miss work because they are sick, to care for other people, or for fear of exposure.
1549	en	ti	 Patterns of commerce may change, both in terms of what goods are demanded, and the means of acquiring these goods (such as shopping at off-peak hours or through delivery or drive-through services). 	 ናይ ንግዲ ከይዲታት ብክልተ መልክእ ክቕየሩ ይኽእሉ`ዮም፣ እንደልዮም ነገራት ዘሎ ኣቐርቦትን ነዞም እንደልዮም ነገራት ድማ እረኽበሉ መገዲን ብዝምልከት (ከም ኣብ ናይ ዘይተለመዱ ሰዓታት ምዕዳግ ወይ ኣብ መኪናኻ ኮይንካ ኣገልግሎት ምርካብ)። 	Business processes can change in two ways, in terms of the availability of what we want and how I get these things (such as shopping during unusual hours or getting service in your car).
1550	en	ti	 Lastly, shipments of items from geographic areas severely affected by COVID-19 may be interrupted.An infectious disease preparedness and response plan can be used to guide protective actions. 	 ኣብ መወዳእታ፣ ካብ ብኮቪድ-19 ብኸቢዱ ዝተጎድኣ ሃገራት ዝግበሩ መጎዓዓዘዝያታት ክቋረጹ ክግበር ይኽእል እዩ።ናይ ተላባዒ ሕማም ምድላዋትን ናይ ምላሽ ትልሚታትን ናይ ምክልኻል ተግባራት ንምክያድ ክሕግዙ ይኽእሉ። 	Finally, transportation from countries severely affected by COVID-19 may be suspended. Infectious disease preparedness and response plans can help conduct preventive measures.
1551	en	ti	 Plans address the levels of risk associated with various worksites and job tasks, including sources of exposure, risk factors arising from home and community settings, and risk factors of individual workers such as old age or chronic medical conditions. 	 ውጥናት ን ምስ ናይ ስራሕ ቦታታትን ዕዮታትን ዝተሓሓዝ መጠን ሓደጋ፡ ምንጭታት ተቓላዕነት ዘጠቓለለ፡ ምስ ገዛን ናይ ሕበረተሰብ ኣቀማምጣን ዝተተሓሓዙ ናይ ሓደጋ መበገሲታትን፡ ከምኡ’ውን ምስ ነፍስወከፍ ሰራሕተኛ ዝተሓሓዙ ናይ ሓደጋ መበገሲታትን ከምእርጋን ወይ ድማ ሕዱር ሕክምናዊ ጸገማት ኣብ ግምት ዘእተው እዮም። 	Plans take into account the amount of risk associated with workplaces and occupations, including sources of exposure, risk factors related to home and community location, and risk factors associated with each employee such as aging or chronic medical problems.
1552	en	ti	 They also outline controls necessary to address those risks, and contingency plans for situations that may arise as a result of outbreaks. 	 ኣብ እዋን ምልዓል ለበዳ ክፍጠሩ ንዝኽእሉ ኩነታት ንምቁጽጽር፡ ነቶም ናይ ሓደጋን ወዝባዊ ውጥናት ንምፍላጥ ዘኽእሉ ቁጽጽራት ኣቐሚጦም ኣለው። 	They have put in place controls to identify the emergency and emergency plans to control situations that may arise during an outbreak.
1553	en	ti	 Infectious disease preparedness and response plans may be subject to national or subnational recommendations. 	 ናይ ተላባዕቲ ሕማማት ድልውነትን ምላሽ ትልሚን ንናይ ብሄራውን ክፋል ብሄራውን ምኽሪታት ተገዛኢ እዩ። 	Infectious disease preparedness and response planning is subject to ethnic and part-ethnic recommendations.
1554	en	ti	 Objectives for response to an outbreak include reducing transmission among staff, protecting people who are at higher risk for adverse health complications, maintaining business operations, and minimizing adverse effects on other entities in their supply chains. 	 ንለበዳ ምላሽ ናይ ምሃብ ዕላማታት ኣብ መንጎ ስታፍ ምልባዕ ምቕናስ፣ ንዝኸፈአ ጎድናዊ ናይ ጥዕና ሕልኽለኻት ተቓላዕቲ ዝኾኑ ሰባት ምክንኻን፣ ናይ ንግዲ ኦፕሬሽናት ምሕላው፣ ከምኡውን ኣብቲ ናይቲ ኣቕርቦት ሰንሰለት ዘለዉ ከጋጥሞም ዝኽእል ጎድናዊ ጽልዋታት ምቕናስ ዘካተተ እዩ። 	The objectives of responding to an outbreak included reducing contagion among staff, caring for people vulnerable to the worst side health complications, protecting business operations, and minimizing potential side effects for those in the supply chain.
1555	en	ti	 The disease severity in the community where the business is located affects the responses taken. 	 እቲ ንግዲ ናይ ዝርከበሉ ቦታ ናይ ሕማም ከቢድነት ነቲ ዝውስድ ምላሽ ይጸልዎ። 	The disease severity of where the business is located affects the response it takes.
1556	en	ti	 The hierarchy of hazard controls is a framework widely used in occupational safety and health to group hazard controls by effectiveness. 	 መቆጻጸሪ ቅድመ-ተኸተል ሓደጋ መብዛሕቲኡ ጊዜ፡ ኣብ ውሕስነት ስራሓት ጥዕናን ዝተሓሓዝ ኮይኑ ክሳዕ ዕቱብ ናይ ጉጅለ ሓደጋታት መቆጻጸሪ ስርሓት ዘለዎ ባይታ እዩ። 	Pre-accident control is often related to occupational safety and health and is the basis for controlling operations up to serious group accidents.
1557	en	ti	 Where COVID-19 hazards cannot be eliminated, the most effective controls are engineering controls, followed by administrative controls, and lastly personal protective equipment. 	 ናይ ኮቪድ -19 ሓደጋታት ክውገዱ ኣብ ዘይክእሉሉ፣ ብሉጻት ዝበሃሉ ቁጽጽራት ምህንድስናዊ ቁጽጽራት፣ ብምቅጻል ናይ ምምሕዳራዊ ቁጽጽራት፣ ኣብ መወዳእታ ድማ ውልቃዊ መከላኸሊ ናውቲታት እዮም። 	Where the risks of COVID-19 cannot be eliminated, the best controls are engineering controls, followed by administrative controls, and finally personal protective equipment.
1558	en	ti	 Engineering controls involve isolating employees from work-related hazards without relying on worker behavior, and can be the most cost-effective solution to implement. 	 ናይ ኢንጅነሪንግ ቁጽጽራት ኣብ ናይ ሰራሕተኛ ውልቃዊ ባህሪ ከይተደረኽካ ን ሰራሕተኛታት ካብቶም ምስ ስራሕ ዝተትሓዙ ሓደጋታት ምንጻል እንትኾን፡ ብደረጃ ዋጋ እቲ ኣዝዩ ዘዋጽእ ክትግበር ዝኽእል መፍትሒ እዩ። 	Engineering controls are the most cost-effective solution to isolate employees from work-related hazards without relying on employee personal behavior.
1559	en	ti	 Administrative controls are changes in work policy or procedures that require action by the worker or employer. 	 ምምሕዳራዊ ቁጽጽራት ኣብ ናይ ስራሕ ወይ ናይ ምህርቲ ዝግበሩ ናይ ፖሊሲ ለውጢታት ናይ ሰራሕተኛ ወይ ሓላፊ ስጉምቲ ዝደልዩ እዮም። 	Administrative controls are policy changes in operations or production that require employee or manager action.
1560	en	ti	 Personal protective equipment (PPE) is considered less effective than engineering and administrative controls, but can help prevent some exposures. 	 ውልቃዊ መከላኸሊ ናውቲ (PPE) ምስ ናይ ምህንድስናን ምምሕዳራዊን ቁጽጽራት ክነጻጸር ከሎ ትሑት እዩ፣ ገለ ምቅላዓት ግን ንምክልኻል ክጠቅም ይኽእል። 	Personal protective equipment (PPE) is low compared to engineering and administrative controls, but can be useful to prevent certain exposures.
1561	en	ti	 All types of PPE must be selected based upon the hazard to the worker, properly fitted as applicable (e.g., respirators), consistently and properly worn, regularly inspected, maintained, and replaced, as necessary, and properly removed, cleaned, and stored or disposed of to avoid contamination. 	 ኩሎም ዓይነታት ናይ ውልቀ መሐለዊ መሳርሒታት ንምምራጽ ብመሰረት ነቲ ሰራሕተኛ ክወርዶ ዝኽእል ሓደጋ፣ ብዝግባእ ዝገጥሙ ከከም ኣገባብራ(ንኣብነት፣ መሳርሒታት ምስትንፋስ), ብዘይምቁራጽ ብዝግባእ ዝግበር፣ ብስሩዕ ዝምርመር፣ ዝጽገን፣ ቅያር ዝግበረሉ፣ከም ኣድላይነቱ ብዝግባእ ክውገድ፣ ምልኽኻፍ ንምውጋድ ጽርየቱ ኣብ ዝሕለወሉ ዝዕቀብ ወይ ዝጎሓፍ ክኾኑ ኣለዎም። 	Select all types of personal protective equipment according to the potential hazard to the employee, properly fitted depending on the procedure(e.g., respirators), regularly maintained, regularly inspected, repaired, replaced,properly disposed of as necessary, stored or disposed of in hygienic conditions to avoid infection They must be.
1562	en	ti	 According to the U.S. Occupational Safety and Health Administration (OSHA), lower exposure risk jobs have minimal occupational contact with the public and other coworkers. 	 ብመሰረት ናይ U.S. ናይ ስራሕ ድሕንነትን ጥዕናን ምምሕዳር (OSHA)፣ ትሑት ናይ ተቓላዒነት ዕድል ዘለዎም ስራሕቲ ምስ ህዝቢን ምስ መሳርሕቲን ትሑት ናይ ምንኽኻእ ዕድል ዘለዎም እዮም። 	According to the US Occupational Safety and Health Administration (OSHA), jobs with a low chance of exposure are those with a low chance of contact with the public and with co-workers.
1563	en	ti	 Basic infection prevention measures recommended for all workplaces include frequent and thorough hand washing, encouraging workers to stay home if they are sick, respiratory etiquette including covering coughs and sneezes, providing tissues and trash receptacles, preparing for telecommuting or staggered shifts if needed, discouraging workers from using others' tools and equipment, and maintaining routine cleaning and disinfecting of the work environment. 	 ንኹሎም ናይ ስራሕ ቦታታት ዝምከር መሰረታዊ ናይ ረኽሲ ምክልኻል ስጉምቲታት ከም ብተደጋጋሚ ኢድ ብማይን ሳሙናን ምሕጻብ፡ ሰራሕተኛታት እንተ ሓሚሞም ኣብ ገዛ ንኽጸንሑ ምብርታዕ፡ ናይ ምስትንፋስኣካላት ሕግታት ከም ኣፍካ ሸፊንካ ምስዓልን ምህንጣስን ምኽባር፡ ሶፍትን ናይ ጎሓፍ መጠራቐሚን ምሃብ፡ ኣድላዪ ኣብ ዝኾነሉ ናይ ቴሌኮም መራኸቢታት ወይ ድማ ናይ ሺፍት ስርዓት ምዝርጋሕ፡ ሰራሕተኛታት ናይ ካልኦት ሰባት ኣቑሑን መሳርሒታትን ንከይጥቀሙ ምግባር፡ ኣብቲ ናይ ስራሕ ቦታ መዓልታዊ ጽሬት ምሕላውን ጸረ-ህዋስያን ምግባርን ምቕጻልን የጠቃልሉ። 	Basic disinfection measures recommended for all workplaces such as frequent hand washing with soap and water, encouraging employees to stay home if they are sick, following respiratory rules such as covering your mouth and coughing and sneezing, providing soft and garbage bins, telecommunications or Shifts include extending the system, ensuring that employees do not use other people’s goods and equipment, maintaining and maintaining daily hygiene and disinfection in the workplace.
1564	en	ti	 Prompt identification and isolation of potentially infectious individuals is a critical step in protecting workers, customers, visitors, and others at a worksite. 	 ኣላባዕቲ ውልቀሰባት ብቅልጡፍ ምልላይን ምፍላይን ንሰራሕተኛታት፣ ዓማዊል፣ በጻሕቲን ካልኦት ኣብቲ ናይ ስራሕ ቦታ ዘለዉን ሰባት ካብቲ ሕማም ኣብ ምክልኻል ወሳኒ ስጉምቲ እዩ። 	Prompt identification and isolation of infectious individuals is a critical step in protecting employees, customers, visitors, and others in the workplace from the disease.
1565	en	ti	 The U.S. Centers for Disease Control and Prevention (CDC) recommends that employees who have symptoms of acute respiratory illness are to stay home until they are free of fever, signs of a fever, and any other symptoms for at least 24 hours without the use of fever-reducing or other symptom-altering medicines, and that sick leave policies are flexible, permit employees to stay home to care for a sick family member, and that employees are aware of these policies. 	 ናይ ሕቡራት መንግስታት ኣሜሪካ( U.S.) ማእኸል ቁጽጽር ሕማም ን ምክልኻልን( CDC) ከቢድ ናይ ኣካለ ምስትንፋስ ጸገም ዘለዎም ሰራሕተኛታት ፡ ክሳብ ን ኣስታት 24 ሰዓታት ካብ ረስኒ፣ ምልክታት ረስኒ፣ ካብ ዝኾኑ ዓይነት ምልክታት ን ብዘይ ዝኾነ ይኹን ናይ ረስኒ መቐነሲ መድሓኒት ወይድማ ምልክታት ዝቕንሱ መድሓኒታት ከይተጠቐሙ ነጻ ዝኾኑ ኣብ ገዛ ንኽጸንሑ ይላቦ፡ ካልእ ድማ፡ ናይ ሕማም ፍቓድ ፖሊሲታት ድማ ስራሕተኛታት ኣብ ገዛ ንዘሎ ኣባል ስድራ ቤት ንኸተሓምሙ ብዘኽእል መልክዑ ክተዓጻጸፉ እዮም፣ ሰራሕተኛታት ድማ ነዞም ፖሊሲታት ክፈልጡዎም ይግባእ። 	The United States( US) Centers for Disease Control and Prevention( CDC) employees with severe respiratory problems , up to about 24 hours from cough, cough symptoms, from any symptoms and without any cough relievers or symptom relievers It encourages those who are exempt to stay home without using it, and sick leave policies will be adapted to allow employees to make a family member at home sick, and employees should be aware of these policies.
1566	en	ti	 According to OSHA, medium exposure risk jobs include those that require frequent or close contact within six feet (1.8 m) of people who are not known or suspected COVID-19 patients, but may be infected with SARS-CoV-2 due to ongoing community transmission around the business location, or because the individual has recent international travel to a location with widespread COVID-19 transmission. 	 ብመሰረት OSHA፣ ምእከላይ ተቓላዕነት ዕድል ዘለዎም ስራሕቲታት ምስ ዘይተፈለጡ ወይ ዝተጠርጠሩ ናይ ኮቪድ-19 ሕሙማት፣ እሞ ግን ብ SARS-CoV-2 በቲ ኣብ ናይ ንግዲ ቦታታት ዘጋጥም ዘሎ ማሕበረ ሰባዊ ምልባዕ፣ ወይ ናብ ናይ ኮቪድ-19 ሰፊሕ ምልባዕ ዘለዎም ሃገራት ብምጉዓዞም ዝተለኸፉ ክኾኑ ምስ ዝኽእሉ ሰባት ብተደጋጋሚ ወይ ብቐረባ ንኽክእ ኣብ ውሽጢ ሽድሽተ ጫማ (1.8 m) ርሕቐት ክኾኑ ዘገድድ ስራሕ ዘለዎም ሰባት እዮም። 	According to OSHA, moderately exposed jobs with unknown or suspected COVID-19 patients, but infected with SARS-CoV-2 by the community outbreak in businesses, or by travel to countries with widespread COVID-19 outbreaks People with jobs that require them to be within six feet (1.8 m) of frequent or close contact with able-bodied people.
1567	en	ti	 These include workers who have contact with the general public such as in schools, high-population-density work environments, and some high-volume retail settings.Engineering controls for this and higher risk groups include installing high-efficiency air filters, increasing ventilation rates, installing physical barriers such as clear plastic sneeze guards, and installing a drive-through window for customer service.Administrative controls for this and higher risk groups include encouraging sick workers to stay at home, replacing face-to-face meetings with virtual communications, establishing staggered shifts, discontinuing nonessential travel to locations with ongoing COVID-19 outbreaks, developing emergency communications plans including a forum for answering workers’ concerns, providing workers with up-to-date education and training on COVID-19 risk factors and protective behaviors, training workers who need to use protecting clothing and equipment how to use it, providing resources and a work environment that promotes personal hygiene, requiring regular hand washing, limiting customers' and the public's access to the worksite, and posting signage about hand washing and other COVID-19 protective measures.Depending on the work task, workers with at least medium exposure risk may need to wear personal protective equipment including some combination of gloves, a gown, a face shield or face mask, or goggles. 	 እዚ ድማ ምስ ሓፈሻ ሀዝቢ ንኽክእ ዘለዎም ሰራሕተኛታት ዘካትት እዩ ንኣብነት ቤት ትምህርቲታት፣ ልዑል ብዝሒ ህዝቢ ጻዕቒ ዘለዎም ናይ ስራሕ ቦታታት፣ ገለ ልዑል ብዝሒ ናይ መሸጣ መሰንድኦ ዘለዎም ቦታታት እውን ዘካትት እዩ።ነዚን ካብዚ ዝልዕል ናይ ተቓላዒነት ኣጋጣሚ ዘለዎም ጉጅለታትን ናይ ምህንድስና ቁጽጽር ልዑል ብቕዓት ዘለዎም ናይ ኣየር መጻረዪታት ምግጣም፣ ናይ ቬንትሌሽን ሬት ምውሳኽ ኣካላዊ ገደባት ከም ንጹር ፕላስቲክ ናይ ምህንጣስ መከላኸሊ ምግጣምን፣ ንዓማዊል ድማ ኣብ መኪንኦም ኮይኖም ኣገልግሎት ዝረኽቡሌ መስኮት ምኽፋትን ዘካትት እዩ።ነዚን ካብዚ ዝልዕል ናይ ተቓላዒነት ኣጋጣሚ ዘለዎም ጉጅለታትን ምምሕዳራዊ ቁጽጽራት ድማ ዝሓመሙ ሰራሕተኛታት ኣብ ገዝኦም ክጸንሑ ምብርትታዕ፣ ብኣካል ዝግበሩ ኣኼባታት ብቨርችዋል ምቕያር፣ ዘይተለመዱ ሽፍቲታት ምፍጣር፣ ናይ ኮቪድ-19 ብሰፊሑ ናብ ዘለወን ቦታታት ዝግበሩ ወሰንቲ ዘይኮኑ ጉዕዞታት ምቕናስ፣ ከም ናይ ሰራሕተናታት ጭንቀት መመለሲ ፎረም ዘካተተ ናይ ኢመርጀንሲ ርክባት ምምዕባል፣ ንሰራሕተኛታት ብዛዕባ ናይ ኮቪድ-19 መቃለዕቲን መከላኸሊ ባህርያትን ብዝምልከት ሓደሽቲ ዝኾኑ ትምህርቲታትን ስልጠናታትን ምሃብ፣ መከላኸሊ ክዳውንቲን መሳርሒታትን ክጥቀሙ ንዘለዎምሰራሕተኛታት ኣጠቓቕምኡ ምስልጣን፣ ውልቃዊ ንጽህና ዘበረታትዑ ሓገዛትን ናይ ስራሕ ቦታታትን ምፍጣር፣ ተደጋጋሚ ናይ ኢድ ምሕጻብ ምብርትታዕ፣ ናይ ዓማዊልን ብዝሒ ህዝቢን ናይ ስራሐ ቦታ ተጠቓሚነት ምግዳብ፣ ብዛዕባ ኢድ ምሕጻብን ካልኦት ናይ ኮቪድ -19 መከላኸሊ መገዲታትን ዘርእዩ ምልክታት ምልጣፍ ዝኣመሰሉ የካትት።ኣብ ናይ ስራሕ ዓይነት መሰረት ብምግባር፣ ሰፊሕ ናይ ምቅላዕ ዕድል ዘለዎም ሰራሕተኛታት ውልቃዊ መከላኸሊ ናውቲታት ከም ጓንቲ፣ ጋውን፣ ናይ ገጽ መሸፈኒ ወይ ማስክ፣ መነጽር ክገብሩ ኣለዎም። 	This includes employees in contact with the general public for example schools, high population density workplaces, and some high density sales outlets This includes installing air conditioners, increasing ventilation rates, installing physical restrictions such as clear plastic respirators, and opening windows for customers to access services from their cars Virtualize meetings, create unfamiliar shifts, reduce non-critical trips to areas where COVID-19 is widespread, develop emergency communications such as employee anxiety response forums, and educate employees about COVID-19 exposure and prevention behaviors and providing trainings, It includes training employees in the use of protective clothing and equipment, creating personal hygiene aids and workplaces, encouraging frequent hand washing, limiting customer and public use of the workplace, and posting signs about hand washing and other protective measures Depending on the type of work, workers with a wide range of exposures must wear personal protective equipment such as gloves, gowns, face masks or goggles.
1568	en	ti	 Workers in this risk group rarely require use of respirators. 	 እዞም ንሓደጋ ተቓላዕቲ ሰራሕተኛታት ጉጅለ መተንፈሲ ምጥቃም ክንድቲ ኣየድልዮምን። 	These vulnerable group workers do not need to use respirators as much.
1569	en	ti	 If a person becomes sick on an airplane, proper controls to protect workers and other passengers include separating the sick person from others by a distance of 6 feet, designating one crew member to serve the sick person, and offering a face mask to the sick person or asking the sick person to cover their mouth and nose with tissues when coughing or sneezing. 	 ሓደ ሰብ ኣብ ኣውሮፕላን እንተደኣ ሓሚሙ፡ ንሰራሕተኛታትን ንተሳፈርቲን ኣብ ምሕላው ኣግባብ ዘለዎም ቁጽጽራት ፡ ነቲ ዝሓመመ ሰብ ካብ ካልኦት ብ 6 ጫማ ምንጻል፡ ነቲ ዝሓመመ ሰብ ድማ ናይ ገጽን ኣፍንጫኝ መሸፈኒ (mask) ምሃብ ውይድማ ኣብ ዘስዕለሉ ውይድማ ኣብ ዝህንጥሰሉ ሰዓት ኣፉን ኣፍንጫኡን ብ ሶፍት ን ኽሽፍን ምግባር ዘጠቓለለ እዩ። 	If someone is sick on an airplane, appropriate controls in protecting crew and passengers , isolate the sick person from others by 6 feet, and provide the sick person with a face and nose mask It involves doing.
1570	en	ti	 Cabin crew should wear disposable medical gloves when tending to a sick traveler or touching body fluids or potentially contaminated surfaces, and possibly additional personal protective equipment if the sick traveler has fever, persistent cough, or difficulty breathing. 	 ናይ ካቢን ጉጅለታት ዝሓመመ ተጎዓዚ ኣብ ዝከናኸኑሉ ወይ ናይ ሰብነት ፈሳሲ ወይ ተበኪሉ ክኸውን ዝኽእል ቦታ ኣብ ዝነኽኡሉ እዋን ተተጠቒሞም ክድርብይዎም ዝኽእሉ ናይ ሕክምና ጓንቲታት ክጥቀሙ ኣለዎም፣ እቲ ዝሓመመ ተጎዓዚ ረስኒ፣ ቀጻላይ ዝኾነ ሰዓል፣ ወይ ናይ ምትንፋስ ጸገም እንተልይዎ ናይ ውልቃዊ መከላኸሊ ናውቲ እውን ክጥቀሙ ኣለዎም። 	Cabin crews should wear disposable medical gloves when caring for a sick passenger or touching body fluids or potentially contaminated areas, and personal protective equipment if the sick passenger has a runny nose, persistent cough, or breathing problems.
1571	en	ti	 Gloves and other disposable items should be disposed of in a biohazard bag, and contaminated surfaces should be cleaned and disinfected afterwards.For commercial shipping, including cruise ships and other passenger vessels, hazard controls include postponing travel when sick, and self-isolating and informing the onboard medical center immediately if one develops a fever or other symptoms while on board. 	 ጓንቲታትን ካልኦት ተጠቒምካ ምድርባይ ዝከኣሉ ኣቑሑትን ኣብ ባዮሃዛርድ ሳንጣ ክድርበዩ ኣለዎም፣ ዝተበከሉ ቦታታት ድማ ክጸርዩን ዲስኢንፌክት ክግበሩን ኣለዎም።ንናይ ንግዲ መጎዓዓዝያ፣ ናይ መዘናግዒ ጉዕዞ መርከባትን ካልኦት ናይ ተጎዓዓዝቲ ጀልባታትን፣ ናይ ሓደጋ ቁጽጽር ክትሓምም ከለኻ ጉዕዞኻ ምንዋሕ፣ ዓርስኻ ምፍላይን ኣብቲ መርከብ እንከሎ ዝኾነ ሰብ ረስኒ ወይ ካልኦት ምልክታት እንተተርእዩ ድማ ንኣብኡ ዘለዉ ናይ ሕክምናኣባላት ምፍላጥ ዝኣመሰሉ ዘካትት እዩ። 	Gulons and other utensils should be thrown into a baoahzary bag, and contaminated places should be cleaned and disinfected. Other symptoms include notifying medical personnel.
1572	en	ti	 Ideally, medical follow-up should occur in the isolated person's cabin.For schools and childcare facilities, CDC recommends short-term closure to clean or disinfect if an infected person has been in a school building regardless of community spread. 	 ብሓሳብ ደረጃ፣ ሕክምናዊ ክትታላት ኣብቲ ናይቲ ዓርሱ ፈልዩ ዘሎ ሰብ ካቢን ክካየዱ ኣለዎም።ንቤት ትምህርቲታትን ናይ ህጻናት ክንክን ትካላትን፣ እቲ ዝሓመመ ሰብ ኣብ ቤት ትመህርቲ ህንጻ እንተነይሩ ናይ ማሕበረ ሰብ ምስርጫው ብዘየገድስ CDC ነቲ ህጻን ክሳብ ዘጸሪን ዲስ ዲስኢንፌክት ዝግበርን ንክዕጾ ይመክር። 	Ideally, medical observations should be conducted in the isolated person&#39;s cabin. For schools and child care facilities, the CDC recommends that the child be closed until the child is cleaned and disinfected regardless of community exposure if the sick person was in the school building.
1573	en	ti	 When there is minimal to moderate community transmission, social distancing strategies can be implemented such as canceling field trips, assemblies, and other large gatherings such as physical education or choir classes or meals in a cafeteria, increasing the space between desks, staggering arrival and dismissal times, limiting nonessential visitors, and using a separate health office location for children with flu-like symptoms. 	 ትሑት ወይ ማእኸላይ ናይ ማሕበረ ሰብ ስርጭት እንተልዩ፣ ናይ ኣካላዊ ርሕቐት ሜላታት ኣብ ስራሕ ክውዕሉ ኣለዎም ከም ናይ ሜዳ ጉዕዞታት፣ ኣኼባታትን ካልኦት ዓበይቲ ምትእኽኻባትን ንኣብነት ኣካላዊ ብቕዓት ትምህርቲታት ወይ ናይ ኳየር ክላሳት ወይ ኣብ ካፍቴርያ ምግቢ ምምጋብ፣ ኣብ መንጎ ጠረጴዛታት ዘሎ ክፍተት ብምስፋሕ፣ ናይ መእተዊን መውጽኢን ሰዓታት ብምውሳነን፣ ወሰንቲ ዘይኮኑ በጻሕቲ ብምቕናስ፣ ንከም ናይ ጉንፋዕ ዝበለ ምልክት ዘለዎም ህጻናት ፍሉይ ናይ ሕክምና ቦታ ምጥቃም። 	If there is low or moderate community prevalence, physical distancing techniques should be used such as field trips, meetings and other large gatherings such as physical fitness classes or choir classes or eating in a cafeteria, widening the gap between tables, entry and exit Use a special treatment area for children with flu-like symptoms by limiting hours, reducing non-essential visitors.
1574	en	ti	 When there is substantial transmission in the local community, in addition to social distancing strategies, extended school dismissals may be considered.For law enforcement personnel performing daily routine activities, the immediate health risk is considered low by CDC. 	 ኣብ ከባቢያዊ ማሕበረሰባት ምልባዕ እንተልዩ፣ ንናይ ማሕበራዊ ርሕቐት ሜላታት ብተወሳኺ፣ ንነዊሐ ግዘ ቤት ትምህርቲታት ተዓጽዮም ክጸንሑ ክግበር ይኽእል እዩ።ሕጊ ኣስፈጸምቲ መዓልታዊ ንጥፈታት እንዳካየዱ፣ ቀጥታዊ ናይ ጥዕና ሓደጋ ድማ ብ CDC ትሑት እዩ ተባሂሉ ይሕሰብ። 	If there is an outbreak in local communities, schools may be closed for longer periods of time, in addition to social distancing measures. Law enforcement is conducting daily activities, and the direct health risk is considered low by the CDC.
1575	en	ti	 Law enforcement officials who must make contact with individuals confirmed or suspected to have COVID-19 are recommended to follow the same guidelines as emergency medical technicians, including proper personal protective equipment. 	 እቶም ምስ COVID-19 ከይህልዎምዝተጠርጠሩ ወይድማ ከምዘልዎም ዝተረጋገጸ ሰባት ርክብ ክህልዎም ዝኽእል ናይ ሕጊ መኽበርቲ ኣካላት ፡ ናይ ወልቀ መሐለዊ መሳርሒ ሓዊሱ፡ ልክዕ ክም ናይ ሰብ ሞያ ሕክምና ተመሳሳሊ መምርሒታት ክስዕቡ ይግባእ። 	Law enforcement agencies who may have contact with people suspected or confirmed to have COVID-19 , including personal protective equipment, should follow the same guidelines as medical professionals.
1576	en	ti	 If close contact occurs during apprehension, workers should clean and disinfect their duty belt and gear prior to reuse using a household cleaning spray or wipe, and follow standard operating procedures for the containment and disposal of used PPE and for containing and laundering clothes. 	 ብድንጋጸ ናይ ቀረባ ምንኽኻእ እንተተፈጢሩ፣ ሰራሕተኛታት ናይ ግዳጅ ቀበትኦምን መሳርሒታቶምን ደጊሞም ቅድሚ ምጥቃሞም ናይ ገዛ መጽረዪ ስፐረይ ወይ ዋይፕ ተጠቒሞም ከጽርዩን ዲስኢንፌክት ክገብሩን ኣለዎም፣ ዝተጠቐሙሎም PPE ታት ኣቀማምጣን ኣጎሓሕፋን ከምኡውን ክዳውንቲ ላውደሪ ብዛዕባ ምእታው ብዝምልከት ድማ ስታንዳርድ መምርሒታት ይጠቐሙ። 	In the event of sympathetic close contact, employees should clean and disinfect their seat belts and equipment with a household cleaning spray or wipe before reusing them, and use standard guidelines for the placement and disposal of used PPE and laundry clothing.
1577	en	ti	 OSHA considers certain healthcare and mortuary workers to be at high or very high categories of exposure risk. 	 OSHA ገለ ናይ ጥዕና ክንክንን ናይ ቀብሪ ስነ ስርዓትን ሰራሕተኛታት ንምቅላዕ ኣብ ዝለዓለ ሓደጋ ከምዘለዉ ሓቢሩ። 	OSHA said some health care and funeral home workers are at increased risk for exposure.
1578	en	ti	 High exposure risk jobs include healthcare delivery, support, laboratory, and medical transport workers who are exposed to known or suspected COVID-19 patients. 	 ልዑል ናይ ምቅላዕ ዕድል ዘለዎም ስራሕቲ ምስ ዝተጠርጠሩ ወይ ዝተረጋገጹ ናይ ኮቪድ-19 ሕሙማት ተቓላዒነት ዘለዎም ናይ ጥዕና ክንክን ኣቕርቦት፣ ሓገዝ፣ ቤተ ፈተነን ናይ ሕክምና መጎዓዓዝያ ሰራሕተኛታትን ዘካትቱ እዮም። 	High-risk occupations include health care delivery, assistance, laboratory and medical transport workers with exposure to suspected or confirmed COVID-19 patients.
1579	en	ti	 These become very high exposure risk if workers perform aerosol-generating procedures on, or collect or handle specimens from, known or suspected COVID-19 patients. 	 እቶም ሰራሕተኛታት ኤሮሶል ዘምርቱ ምርመራታት ዘካይዱ እንተኾይኖም፣ ወይ ካብ ዝተጠርጠሩ ወይ ዝፍለጡ ናይ ኮቪድ-19 ሕሙማት ናሙናታት ዝወስዱ እንተኾይኖም ኣዚዮም ተቓላዕቲ እዮም። 	The workers are most vulnerable if they conduct tests that produce aerosols, or if they take samples from suspected or known COVID-19 patients.
1580	en	ti	 Aerosol-generating procedures include intubation, cough induction procedures, bronchoscopies, some dental procedures and exams, or invasive specimen collection. 	 ኤሮሶል ዘምርቱ ከይዲታት ኢንቱቤሽን፣ ሰዓል ዘጀምሩ ከይዲታት፣ ብሮንኮስኮፒ፣ ገለ ናይ ስኒ ሕክምናታትን ምርመራታትን፣ ወይ ኢንቫሲቭ ናይ ናሙና ምእካብ ዘካተቱ እዮም። 	Procedures that produce aerosols include intubation, cough-initiating procedures, bronchoscopy, certain dental treatments and examinations, or invasive sample collection.
1581	en	ti	 High exposure risk mortuary jobs include workers involved in preparing the bodies of people who had known or suspected cases of COVID-19 at the time of their death; these become very high exposure risk if they perform an autopsy.Additional engineering controls for these risk groups include isolation rooms for patients with known or suspected COVID-19, including when aerosol-generating procedures are performed. 	 ልዑል ናይ ተቓላዒነት ሓደጋ ዘለዎም ናይ ቀብሪ ስራሕቲ ንናይ ብኮቪድ-19 ከምዝተተሓዙ ዝተጠርጠሩ ወይ ዝተረጋገጹ መወትቲ ሬሳ ዘዳልዉ ሰባት; እዚኦም ናይ ሬሳ ምርመራ እንተካይዶም ናይ ምቅላዕ ዕድሎም ሰፊሕ እዩ።ተወሳኺ ናይቶም ብኮቪድ-19 ከም ዝተተሓዙ ዝተረጋገጹ ወይ ዝተጠርጠሩ ዝፍለዩሉ ክፍሊ ዘካትት ናይ ምህንድስና ቁጽጽራት፣ ናይ ኤሮሶል ዘምርት ከይዲታት ዘካይዱ እውን ዘካተቱ እዮም። 	High-risk funeral operations for people preparing the bodies of deceased suspected or confirmed cases of COVID-19; These are more likely to be exposed if they conduct autopsies.In addition to engineering controls that include the isolation of confirmed or suspected cases, they also include those that conduct aerosol production processes.
1582	en	ti	 Specialized negative pressure ventilation may be appropriate in some healthcare and mortuary settings. 	 ስፔሻላይዝ ዝተገበሩ ኣሉታዊ ቬንትሌሽን ኣብ ገለ ናይ ጥዕና ክንክንን ናይ ቀብሪ መሰንድኦታትን ኣግባባዊ ክኸውን ይኽእል። 	Specialized negative ventilation may be appropriate in some health care and funeral settings.
1583	en	ti	 Specimens should be handled with Biosafety Level 3 precautions. 	 ናሙናታት ብ Biosafety ደረጃ 3 ጥንቃቐታት ክተሓዙ ኣለዎም። 	Samples must be handled with Biosafety Level 3 precautions.
1584	en	ti	 The World Health Organization (WHO) recommends that incoming patients be separated into distinct waiting areas depending on whether they are a suspected COVID-19 case.In addition to other PPE, OSHA recommends respirators for those who work within 6 feet of patients known to be, or suspected of being, infected with SARS-CoV-2, and those performing aerosol-generating procedures. 	 ናይ ዓለም ጥዕና ድርጅት (WHO) ናብ ሕክምና ዝመጹ ተሓከምቲ ናይ ኮቪድ-19 ተጠርጠርቲ ድዮም ኣይኮኑን ብምፍላይ ኣብ ፍሉይ መጸበዪ ቦታ ክጸነንሑ ምግባር ይመክር።ን ካልእ PPE ብተወሳኺ፣ OSHA ምስ ብ SARS-CoV-2 ተታሒዞም ከምዝኾኑ ዝፍለጡ፣ ዝተጠርጠሩ ሰባት ኣብ ውሽጢ 6 እግሪ ጫማ ንዝሰርሑ ሰባት መተንፈሲታት ይመክር፣ ነቶም ኣብ ናይ ኤሮሶል መምረቲ ምርመራ ዝሰርሑ ሰባት እውን። 	The World Health Organization (WHO) recommends that patients coming to the hospital be kept in a separate waiting area by isolating whether they are suspected of having COVID-1 He recommends respirators for shoemakers, as well as those working in aerosol manufacturer testing.
1585	en	ti	 In the United States, NIOSH-approved N95 filtering facepiece respirators or better must be used in the context of a comprehensive, written respiratory protection program that includes fit-testing, training, and medical exams. 	 ኣብ ዩናይትድ ስቴትስ፣ ብ NIOSH-ፍቓድ ዝተወሃቦ N95 ፊልተር ዝገብር ናይ ገጽ መሸፈኒ መተንፈሲ ወይ ዝሐሸ ኣብ ሓፈሻዊ፣ ጽሑፋዊ ናይ ምትንፋስ መከላኸሊ ፕሮግራም እኹል ፈተነ፣ ስልጠናን ናይ ሕክምና ፈተናታትን እውን ሓዊሱ ኣብ ጥቕሚ ይውዕል። 	In the United States, a NIOSH-approved N95 filtering face mask respirator or better is used in a general, written respiratory protection program including adequate testing, training, and clinical trials.
1586	en	ti	 Other types of respirators can provide greater protection and improve worker comfort.The WHO does not recommend coveralls, as COVID-19 is a respiratory disease rather than being transmitted through bodily fluids. 	 ካልኦት ናይ መተንፈሲ ዓይነታት ዝበለጸ ምክልኻልን ዝሓሸ ናይ ሰራሕተኛ ምቾትን ይህቡ።WHO ሙሉእ መሸፈኒታት ኣይመክርን፣ ኮቪድ-19 ብናይ ሰውነት ፈሳሲ ዝመሓላለፍ ዘይኮነስ ናይ ስርዓተ ምስትንፋስ ሕማም ብምዃኑ። 	Other types of respirators provide better protection and better worker comfort.WHO does not recommend full masks, as COVID-19 is not transmitted by body fluids but is a respiratory disease.
1587	en	ti	 WHO recommends only a surgical mask for point-of-entry screening personnel. 	 WHO ንመርመርቲ ሰባት ናይ ሰርጂካል ማስክ ምጥቃም ጥራሕ እዩ ዝመክር። 	The WHO only recommends the use of surgical masks for test subjects.
1588	en	ti	 For those who are collecting respiratory specimens from, caring for, or transporting COVID-19 patients without any aerosol-generating procedures, WHO recommends a surgical mask, goggles, or face shield, gown, and gloves. 	 ብዘይ ኤሮሶል ዘምርቱ ምርመራታት ካብ ኮቪድ-19 ሕሙማት ናይ ምትንፋስ ናሙናታት ዝወስዱ፣ ዝሕብሕቡ፣ ወይ ዘጎዓዕዙ ሰባት፣ WHO ሰርጂካል ማስክ፣ መነጸራት፣ ወይ ናይ ገጽ መሸፈኒ፣ ጋውንን ጓንቲን ክጥቀሙ ይመክር። 	Aerosol-free tests WHO recommends that people who take, care for, or transport breath samples from COVID-19 patients wear a surgical mask, goggles, or a face mask, gown, and gloves.
1589	en	ti	 If an aerosol-generating procedure is performed, the surgical mask is replaced with an N95 or FFP2 respirator. 	 ኤሮሶል ዘምርቱ ምርመራታት ክካየዱ እንተኾይኖም፣ እቲ ሰርጂካል ማስክ ብ N95 ወይ FFP2 መተንፈሲ ክቕየር ኣለዎ። 	If aerosol-producing tests are to be performed, the surgical mask should be replaced with an N95 or FFP2 respirator.
1590	en	ti	 Given that the global supply of PPE is insufficient, WHO recommends minimizing the need for PPE through telemedicine, physical barriers such as clear windows, allowing only those involved in direct care to enter a room with a COVID-19 patient, using only the PPE necessary for the specific task, continuing use of the same respirator without removing it while caring for multiple patients with the same diagnosis, monitoring and coordinating the PPE supply chain, and discouraging the use of masks for asymptomatic individuals. 	 ዓለም ለኻዊ ናይ PPE ኣቕርቦት እኹል ብዘይ ምዃኑ፣ WHO ናይ PPE ኣድላይነት ብቴሌሜዲሲን ንምቕናስ፣ ኣካላዊ መፈላለዪታት ከም ንጹር መስትያት ክጥቀሙ፣ ናይ ቀጥታ ክንክን ዝገብሩ ሰባት ጥራሕ ናቲ ኮቪድ-19 ዝሓመሙ ሰባት ክኣትዉ፣ ነቲ PPE ንንጹር ስራሕ ኣድላዪ ኣብ ዝኾነሉ ጥራሕ ብምጥቃም፣ ንተመሳሳሊ ሕማም ዘለዎም ዝተፈላለዩ ሕሙማት ክንክን ኣብ ዝህቡሉ ግዜ ከየውጽእዎ ምጥቃም ክቕጽሉ፣ ነቲ ናይ PPE ኣቕርቦት ሰንሰለት ክቆጻጸርዎን ከተሓባብሩን፣ ንናይ ሕማም ምልክት ዘየርእዩ ሰባት ማስክ ዘይምጥቃም ብምብርትታዕ ንክሰርሑ ይመክር። 	Due to insufficient international PPE supply, WHO to reduce the need for PPE through telemedicine, use physical separations as a clear mirror, only direct caregivers to enter people with COVID-19, using the PPE only where it is necessary for clear work He recommends that various patients continue to use it without removing it while providing care, monitor and coordinate the PPE supply chain, and encourage people who do not show signs of illness not to wear masks.
1591	en	ti	 FROM: Katherine Maher, Wikimedia Foundation CEO 	 ካብ: ካተሪነ ማሀር፣ Wikimedia Foundation CEO 	From: Katherine Maher, Wikimedia Foundation CEO
1592	en	ti	 TO: All Wikimedia Foundation staff 	 ን: ኩሎም ናይ Wikimedia Foundation staff (ዊኪሚድያ ፋውንዴሽነን ስታፍ) 	To: All Wikimedia Foundation staff
1593	en	ti	 SUBJECT LINE: [Covid-19] Lightening the load and preparing for the future 	 ዋኒን መስመር: [ኮቪድ-19] እቲ ጽዕንቶ ብምቅላል ንመጻኢ ምድላው 	Business Line: [COVID-19] Prepare for the future by mitigating the impact
1594	en	ti	 SEND DATE/TIME: 14 March, 2020, 00:24 UTC 	 መስደዲ ዕለት/ሰዓት: 14 መግጋቢት፣ 2020, 00:24 UTC 	Send Date/Time: March 14, 2020, 00:24 UTC
1595	en	ti	 LICENSING: CC0: No rights reserved 	 ፍቓድ ምሃብ: CC0: ዝተዓቀበ መሰል የለን 	Licensing: CC0: No reserved rights
1596	en	ti	 We find ourselves in remarkable circumstances this month. 	 ኣብዚ ወርሒ እዚ ንባዕልና ኣብ ከቢድ ኩነታት ኢና ረኺብናዮ ዘለና። 	This month we find ourselves in a difficult situation.
1597	en	ti	 The COVID-19 epidemic is something that makes clear our global human interconnectedness and the responsibilities we have to one another. 	 እዚ ናይ ኮቪድ-19 ለበዳ ነንባዕልና ዘለና ዓለምለኻዊ ምትሕሓዛትናን ሓላፍነታትናን ግልጺ ገይሩ ዘርኢ ነገር እዩ። 	This COVID-19 pandemic is something that clearly demonstrates our global relationships and responsibilities to each other.
1598	en	ti	 We don’t have precedent for its challenges, but we do know that our best response relies on the sort of global empathy, cooperation, and community building that sits at the heart of this organization. 	 ንማሕለኻታቱ ኣብነት የብልናን።እንተኾነ ግን ዋና ምላሽና ኣብ ናይ ዓለም ሓዘኔታ፣ ምትሕብባርን ማሕበረ ሰብ ምህናጽን ኣብ ማእከል ናይዚ ድርጅት ልቢ ምፍጣር ከምዝኾነ ንፈልጥ ኢና። 	We have no example of its obstacles. However, we know that our main response is to create a heart in the world of grief, cooperation and community building at the heart of this organization.
1599	en	ti	 The camaraderie and care we have seen among all of our colleagues over email, calls, and chats is a remarkable validation of the incredible humans we are fortunate enough to work with. 	 ብኢመይል፣ ምድውዋልን ቻትን ዝረኣናዮ ኣብ መንጎ መሳርሕቲታትና ዘሎ ምሕዝነትን ምትሕልላይን ምስኦም ክንሰርሕ ዕድል ዝረኸብና ዘደንቑ ሰባት ከምዝኾኑ ዘረጋግጽ እዩ። 	What we have seen through emails, calls and chats is the camaraderie and caring amongst our colleagues which proves that they are amazing people we have the opportunity to work with.
1600	en	ti	 I couldn’t be more grateful and proud to count you all as colleagues. 	 ንኩልኹም ከም መሳርሕተይ ጌረ ክቖጽረኩም ብምኽኣለይ ኣዝየ ሕጉስ እየ። 	I am very happy to be able to consider you all as my colleagues.
1601	en	ti	 Last week, someone shared with me their appreciation for our work. 	 ዝሓለፈ ሰሙን፣ ዝኾነ ሰብ ኣብ ስራሕና ዘለዎ ምስጋና ኣካፊሉኒ። 	Last week, anyone shared their gratitude for our work.
1602	en	ti	 They reminded me how meaningful it is for the world to be able to turn to Wikipedia right now, and what a powerful symbol it is for this critical resource to remain online and available to all. 	 ኣብዚ ግዜ እዚ ዓለም ናብ Wikipedia ገጻ ክትጥምዝዝ ምኽኣላ ክንደይ ትርጉም ከምዘለዎ ኣዘኻኺሮምኒ፣ እዚ ወሳኒ ሓገዝ ኦንላይን ኮይኑ ንኩሉ ሰብ ቅሩብ ኮይኑ ምጽንሑ ሓያል ምልክት እዩ። 	They reminded me how much it means that the world is turning to Wikipedia these days, a powerful sign that this crucial help remains online and available to everyone.
1603	en	ti	 Your work makes this possible, whether you keep the sites stay up or our colleagues paid or our communities safe. 	 ስራሕኩም እዚ ንክሳኻዕ ይገብር፣ እዞም ሳይታት ንክጸንሑ ወይ መሳርሕቲና ክኽፈሉ ክትገብሩ እንተኽኢልኩም ወይ ማሕበረ ሰብና ድሕንነቱ ሓልዩ ንክጸንሕ ይገብር። 	Your work makes this happen, if you can keep these sites or get our colleagues paid or keep our community safe.
1604	en	ti	 The world needs the information that Wikipedia provides, now more than ever. 	 ዓለም Wikipedia ዘቕርቦ ሓበሬታ የድልያ እዩ፣ ብፍላይ ካብ ካልእ ግዜ ንላዕሊ። 	The world needs the information Wikipedia has to offer, especially more than ever.
1605	en	ti	 This is a moment in which not only what we do, but how we do it, will make a meaningful impact on the world. 	 እዚ ግዜ እዚ እንገብሮ ነገር ጥራይ ዘይኮነስ፣ ነቲ ነገር ከመይ ንገብሮ ዝብል ነገር፣ ኣብ ዓለም ትርጉም ዘለዎ ጽልዋ ዘሕድረሉ ግዜ እዩ። 	This is a time when not only what we do, but how we do that thing, makes a meaningful impact on the world.
1606	en	ti	 Because of the importance of this mission and your role in it, we will be making some significant adjustments to how we work together, starting this coming week. 	 ብምኽንያት ናይ'ዚ ተልእኾ ኣድላይነትን ተበርክቱዎ ግደን ፡ ካብ'ዚ ዝመጽእ ዘሎ ሰሙን ጀሚሩ ሓቢርና ኣብ ንሰርሐሉ መንገዲ ዝተወሰኑ ርኡያት ለውጢታት ክንገብር ኢና። 	Because of the need for this mission and your contribution , we will be making some significant changes in the way we work together starting next week.
1607	en	ti	 Adjustments to our work and schedules 	 ናይ ስራሕ መደባትና ምትዕርራያት 	Adjustments to our work schedules
1608	en	ti	 As Robyn mentioned previously, the c-team met last night to discuss our approach and schedule for the coming days and months. 	 Robyn ቅድም ክብል ከምዝበሎ፣ እዚ ናይ c-team ብዛዕባ ኣሰራርሓና ንክመያየጡን ንዝመጹ ዝተወሰኑ መዓልቲታትን ኣዋርሕን መደብ ከውጽኡን ተራኺቦም ነይሮም። 	Robyn said earlier, this c-team met to discuss our process and plan for the next few days and months.
1609	en	ti	 In that conversation, we considered what we thought would be an appropriate response to what we’re facing and the best way to keep the organization sustainable during this time. 	 ኣብዚ ዝርርብ እዚ፣ ነዚ ኣጋጢሙና ዘሎ ኩነታት ኣግባብ ምላሽ እዩ ኢልና ዝሓሰብናዮ ነገርን ኣብዚ ግዜ እዚ እቲ ድርጅት ቀጻሊነት ክህልዎ እንታይ ክንገብር ከምዘለናን ኣብ ግምት ኣእቲና። 	In this conversation, we considered what we thought was the appropriate response to the situation and what we needed to do to keep the organization going at this time.
1610	en	ti	 Overwhelmingly we wanted to remove stress and support our mission for the long term. 	 ብዓብይኡ ጭንቀት ኣወጊድና ተልእኾና ንነዊሕ ግዜ ክንሕግዝ ኢና ደሊና። 	Most importantly, we wanted to eliminate anxiety and help our mission long term.
1611	en	ti	 If you need to dial back, that’s okay. 	 መሊስኩም ክትድውሉ ትደልዩ እንተኾይንኩም፣ ጸገም የብሉን። 	If you want to call again, no problem.
1612	en	ti	 For all staff, contractors, and contract workers: 	 ንኩሎም ስታፋት፣ ኮንትራክተራትን ናይ ኮንትራት ሰራሕተኛታትን: 	To all staff, contractors and contract workers:
1613	en	ti	 our daily working expectations will be about 4 hours a day, or 20 hours a week until further notice. 	 መዓልታዊ ናይ ስራሕ ትጽቢታትና ኣብ መዓልቲ 4 ሰዓታት ዝኾኑ እዮም፣ ወይ 20 ሰዓታት ኣብ ሰሙን ክሳብ ካልእ ሓበሬታ ዝወሃብ። 	Our daily work expectations are 4 hours per day, or 20 hours per week until further notice.
1614	en	ti	 We’re not declaring a holiday - if you are able to work more normal hours, the mission can use you. 	 በዓል ኣይኮንናን ንእውጅ ዘለና - ልዕሊ ልሙዳት ሰዓታት ክትሰርሑ ትኽእሉ እንተኾይንኩም፣ እዚ ተልእኾ ክጥቀመልኩም ይኽእል እዩ። 	We are not declaring a holiday – if you can work above usual hours, this mission could benefit you.
1615	en	ti	 However, the world is unpredictable right now, and whether you need to care for loved ones, get groceries, or go to the doctor, your well-being is our priority. 	 እንተኾነ ግን፣ ዓለም ኣብዚ ግዘ እዚ ምግማታ ከቢድ እዩ፣ ንትፈትውዎም ሰባት ንምክንኻን ኮነ፣ ግሮሰሪ ንምዐዳግ፣ ወይ ናብ ዶክተር ንምኻድ፣ ድሕንነትኩም እዩ ንሕና ቅድሚያ ንህቦ። 	However, the world is hard to predict these days, whether it is to take care of your loved ones, buy groceries, or go to the doctor, your safety is our priority.
1616	en	ti	 We are not tracking your time. 	 ግዜኹም ኣይንከታተሎን ኢና። 	We do not track your time.
1617	en	ti	 If you are sick, do not work. 	 እንድሕር ሓሚምኩም ናብ ስራሕ ኣይትኺዱ። 	If you are sick, do not go to work.
1618	en	ti	 This should go without saying, but we’re saying it. 	 እዚ ብዘይ ምባል ምርዳእ ዝከኣል ነገር እዩ፣ ግን ንብሎ ኣለና። 	This is something that can be understood without saying it, but we are saying it.
1619	en	ti	 No sick days or PTO required - just tell your manager and help your team revise calendars and schedules to make sure key areas of work are covered. 	 ናይ ሕማም መዓልታት ወይ PTO ኣድልዩን - ንማናጀርኩም ንገርዎ ጉጅለኹም ድማ ካላንደሮም ንከስተኻኽሉ ሓግዝዎም እቶም ናይ ስራሕ ቦታታት ምሽፋኖም ንምርግጋጽ ድማ መደብ ኣውጽኡ። 	Sick days or PTO needed – tell your manager and help your team adjust their calendar and make a plan to make sure those positions are covered.
1620	en	ti	 (If you are diagnosed positive for COVID-19, please let Bryan within T&amp;C Ops know so T&amp;C can help with support and make sure your situation gets appropriate attention from management). 	 (ናይ ኮቪድ-19 መርመራ ውጽኢትካ ኣወንታዊ እንተኾይኑ፡ ብኽብረትካ ንBryan ኣብ T&amp:C Ops ኣፍልጦ መታን T&amp:C ደገፍን ነቲ ኩነታትካ ካብ ምሕደራ ዘድሊ ኣተክሮት ክግበረሉ ክሕግዙኻ)። 	(If you test positive for COVID-19, please let Brian in T&amp;:C Ops know so they can help you with T&amp;:C support and the necessary attention from management to your condition).
1621	en	ti	 Hourly folks will be fully paid. 	 ብሰዓት ዝሰርሑ ሰባት ሙሉእ ብሙሉእ ክኽፈሉ እዮም። 	Hourly workers will be paid in full.
1622	en	ti	 We have already said, and are recommitting to honor our commitments to our contractors and hourly staff colleagues. 	 ምስ ኮንትራክተራትናን ሰዓታዊ ስታፍ መሳርሕትናን ዝኣተናዮ ቃል ክነኽብር ኢና። 	We will honor our commitments to our contractors and hourly staff colleagues.
1623	en	ti	 Everyone will be paid on the basis of their usual hours worked during normal circumstances. 	 ኩሉ ሰብ ብመሰረት እቲ ኣብ ልሙድ ኩነታት ዝነበረ ኣብ ስራሕ ዘወዕሎ ሰዓት ክፍሊት ይፍጸመሉ። 	Everyone is paid according to the number of hours spent working under normal circumstances.
1624	en	ti	 This includes if you are sick and unable to work. 	 እዚ ድማ እንተሓሚምኩምን ናብ ስራሕ ክትከዱዘይትኽእሉ እንተኾይንኩምን የጠቓልል። 	This includes if you are ill and unable to go to work.
1625	en	ti	 If you want to work, we support you. 	 ክትሰርሑ ትደልዩ እንተኾይንኩም፣ ክንሕግዘኩም ኢና። 	If you want to work, we will help you.
1626	en	ti	 Many people use work as a way of channeling their stress with the world around us. 	 ብዙሓት ሰባት ንስራሕ ኣብ ዘለናዮ ዓለም ንዘሎ ጭንቀት መወገዲ መንገዲ ጌሮም ይጥቀምዎ። 	Many people use work as a way to relieve stress in today’s world.
1627	en	ti	 What we do can be incredibly rewarding, especially during times like this. 	 እንሰርሖ ስራሕ ኣዝዩ ዘዕግብ ውጽኢት ዘለዎ ክኾን ይኽእል እዩ፣ ብፍላይ ኣብ ከምዚ ዓይነት ግዜ። 	The work we do can be very satisfying, especially at times like this.
1628	en	ti	 Again, this is about your self-care. 	 ሕጂ'ውን፣እዚ ብዛዕባ ንነብስኻምክንኻን እዩ። 	Again,this is about taking care of yourself.
1629	en	ti	 Our ask is that you communicate with your manager, so we know what to expect and can adjust accordingly. 	 ምስ ማናጀርኩም ክትርዳድኡ ኢና ንሓተኩም፣ እንታይ ክንጽበ ከምዘለና ፈሊጥና ንክንዳሎ ምእንታይ። 	We ask that you communicate with your manager, so that we know what to expect and are prepared.
1630	en	ti	 Some work is considered essential. 	 ገለ ስራሕቲ ወሰንቲ ተባሂሎም ይምደቡ። 	Some jobs are classified as critical.
1631	en	ti	 There are some things that we must keep doing. 	 ምግባር ክንቅጽሎም ዝግብኡ ሓደሓደ ነገራት ኣለዉ። 	There are some things we need to keep doing.
1632	en	ti	 The SRE, HR Ops, Trust &amp; Safety, and Fundraising teams (among others) do critical work that may need additional support. 	 ናይ SRE; HR Ops; Trust&ampን ናይ ድሕንነትን ምእካብ ምወላን ጉጅለታት(ምስ ካልኦት) ነቲ ኣድላዪ ስራሕ ሓገዝ ከድልዮ ዝኽእል ይሰርሑ። 	of the SRE; HR Ops; Trust&amp; and security and fundraising teams(among others) do the necessary work that may need assistance.
1633	en	ti	 We’ll begin a process with all departments to assess current objectives and shift our focus to supporting what’s essential for our mission. 	 ናይዚ ግዜ እዚ ዕላማታት ንምኽላስን ንተልእኾና ዋና ኣገዳሲ ዝኾነ ነገር ንምሕጋዝ ብዝብል ትኹረትና ንምቕያርን ከይዲ ንጅምር ኢና። 	We begin the process of revising the goals of this time and changing our focus to help with what is most important to our mission.
1634	en	ti	 There’s plenty to do for all of us, we just will all focus on the most essential projects. 	 ኩላትና ክንገብሮ ዝግባእ ብዙሕ ነገር ኣሎ፡ ኣብቶም ኣዝዮም ኣድለይቲ ዝኾኑ ፕሮጀክቲታት ጠመተ ክንገብር ኢና። 	There is a lot for all of us to do, and we will focus on the most needed projects.
1635	en	ti	 Slowing now won’t hurt later. 	 ሕዚ ቀስ ምባል ጸኒሑ ኣይጎድእን። 	Slowing down now doesn&#39;t hurt later.
1636	en	ti	 We do not plan to go “double-time to catch up” once the pandemic has passed. 	 እዚ ለበዳ እዚ ምስ ሓለፈ “ንምርካብ ክልተ ዕጽፊ ንምኻድ” ኣይተለምናን ኣለና። 	We are not begging to “go twice as much to find” after this pandemic.
1637	en	ti	 You will not be expected to work extra hours to meet deadlines which are now unrealistic. 	 ናይ ሰዓት ገደባት ንምኽባር ተወሰኽቲ ሰዓታት ክትሰርሑ ትጽቢት ኣይግበረኩምን። 	You are not expected to work overtime to comply with hourly restrictions.
1638	en	ti	 We accept that circumstances have changed, and will work to set new targets and timelines where appropriate. 	 ገለ ነገራት ከምዝተቐየሩ ንቕበል፣ ሓደሽቲ ዕላማታትን ግዜ ገደባትን ንምድላው ድማ ንሰርሕ ኣድላዪ እንተኾይኑ። 	We accept that some things have changed, and work to set new goals and deadlines if needed.
1639	en	ti	 What happens with the APP (Annual Planning)? 	 ነቲ APP (ዓመታዊ ትልሚ) እንታይ የጋጥሞ? 	What happens to the APP (annual plan)?
1640	en	ti	 To adjust to our new reality and daily working hour expectations, we intend to adjust the timeline for the delivery of our 2020-2021 Annual Plan. 	 ናብዚ ሓድሽ ነባራዊ ዓለምና ንምእታውን ናይ መዓልታዊ ናይ ስራሕ ሰዓታት ንምስትኽኻልን፣ ናይ 2020-2021 ዓመታዊ ትልሚና ዝርከበሉ ግዘ ገደብ ክነስተኻኽል ንሓስብ ኣለና። 	To accommodate our new residential world and adjust daily working hours, we are considering adjusting the deadline for our 2020-2021 Annual Plan.
1641	en	ti	 Our intention is to propose an extension of our 2019-2020 plan that allows more time for budgeting to allow employees to prioritize critical work, self-care, and care for loved ones while accommodating those who need or wish to work a reduced schedule over the next few weeks. 	 ዕላማና ናይ 2019-2020 ትልሚና ምንዋሕ ሓሳብ ምቕራብ እዩ እዚ ድማ ሰራሕተኛታት ወሳኒ ስራሕ፣ ዓርሶም ምክንኻንን፣ ዝፈትውዎም ሰባት ምክንኻንን ቅድሚያ ንክህቡ ዝፈቅድ ደጀት ንምፍጻም እኹል ግዜ ይህብ፡ ከምኡውን ኣብ ዝቅጽል ዝተወሰኑ ሰሙናት መደቦም ተቐኒሱ ክሰርሑ ዝደልዩ ንምምዳብን እዩ። 	Our goal is to propose an extension of our 2019-2020 plan that will allow employees enough time to complete a budget that allows them to prioritize critical work, self-care, and loved ones, and to assign those who want to reduce their schedule in the next few weeks.
1642	en	ti	 This timeline extension greatly reduces current planning workloads and pressure across the whole organization. 	 እዚ ናይ ግዜ ገደብ ምንዋሕ ናይዚ ግዜ እዚ ዘተተለሙ ናይ ስራሕ ጽዕንቶታትን ጸቕጢታትን ኣብ መላእ እቲ ድርጅት ብሓይሊ ይቕንስ። 	This deadline extension drastically reduces the planned workloads and pressures across the organization.
1643	en	ti	 We will introduce our proposal to the Board next week and will update delegates and teams on the next steps as soon as we have confirmation. 	 ፕሮፖዛልና ናብቲ ቦርድ ኣብ ቀጻላይ ሰሙን ክነቕርብ ኢና ፍቓድ ምስረኸብና ድማ ኣብ ቀጻላይ ስጉምቲና ተወከልቲን ጉጅለታትን ብዝምልከት ክነሐድሶ ኢና። 	We will submit our proposal to the board next week and once we have approval, we will update you on our next steps regarding reps and groups.
1644	en	ti	 Thank you to the APP team for your leadership in this. 	 ን APP ጉጅለ ንናይዚ መሪሕነትኩም ነመስግን። 	Thank you to the APP team for your lead on this.
1645	en	ti	 Office status, exposure, and cleaning 	 ናይ ቤት ጽሕፈት ኩነታት፣ ተቓላዕነትን ምጽራይን 	Office conditions, vulnerabilities and screening
1646	en	ti	 Last week, we learned that one of our SF-based colleagues may have been exposed to the COVID-19 virus. 	 ዝሓለፈ ሰሙን፣ ካብቶም SF-መሰረት ዝገበሩ መሳርሕትና ሓዲኡ ንኮቪድ-19 ተቓሊዑ ክኸውን ከምዝኽእል ፈሊጥና። 	Last week, we learned that one of our SF-based colleagues may have been exposed to COVID-1
1647	en	ti	 However, out of an abundance of caution, we employed an antiviral cleaning crew to disinfect all surfaces in the San Francisco office. 	 እንተኾነ ግን፣ ካብ ናይ ጥንቃቐ ኣድላይነት ዝተለዓለ፣ ናይ ጸረ-ቫይረስ መጽረዪ ጉጅለ ቆጺርና ኣብ ናይ ሳንፍራንሲስኮ ቤት ጽሕፈት ዘለዉ ቦታታት ዲስኢንፌክት ንክገብሩ ኣትዮም ኣለዉ። 	However, out of a precautionary measure, we have hired an antivirus cleaning team to disinfect the areas in the San Francisco office.
1648	en	ti	 They utilized a hospital-grade anti-viral solution to disinfect every surface, as well as the lobby and elevator banks accessing our floor. 	 ናይ ሆስፒታል ደረጃ ጸረ ቫይረስ ብጽባጽ ተጠቒሞም ኩሉ ዝንካእ ቦታ ዲስኢንፌክት ጌሮምዎ፣ ነቲ ሎቢን ናብ ደብሪና ዝመጹ ናይ ሊፍት ባክታትን እውን ከይተረፈ። 	They used hospital grade disinfectant in a blitz and disinfected every touchable area, even the lobby and the elevator backs coming to our floor.
1649	en	ti	 The building is employing its own duty-of-care protocol utilizing products that support the safety of their tenants. 	 እቲ ህንጻ ናይ ተቐማጦኡ ድሕንነት ድጋፍ ዝህቡ ናይ ባዕሉ ሓላፍነታዊ ክንክን ፕሮቶኮል ዝጥቀሙ ፍርያማትይሰርሓሎም ኣሎ። 	The building is manufacturing products that use its own Responsible Care Protocol that support the safety of its occupants.
1650	en	ti	 We feel comfortable that the office will be well-prepared for when we decide to return. 	 ክንምለስ ክንውስን ከለና ቤት ጽሕፈትና ብኣግባቡ ዝተዳለወ ከምዝኸውን ርግጸኛታት ኢና። 	We are confident that when we decide to come back our office will be appropriately set up.
1651	en	ti	 Our DC office is located in a WeWork, which has shared its COVID-19 protocol with us and all DC-based staff members. 	 ናይ DC ቤት ጽሕፈትና ኣብ WeWork እዩ ቦትኡ፣ ናይ ኮቪድ-19 ፕሮቶኮሉ ድማ ምሳናን ምስ ኩሎም ናይ DC-መሰረት ዝገበሩ ናይ ስታፍ ኣባላት ኣካፊልዎ እዩ። 	Our DC office is based in WeWork, and has shared its COVID-19 protocol with us and all DC-based staff members.
1652	en	ti	 As of last week, our DC office moved to a fully remote setup in line with the guidance shared with San Francisco. 	 ካብ ዝሓለፈ ሰሙን ጀሚሩ፣ ናይ DC ቤት ጽሕፈትና ናብ ሙሉእ ብሙሉእ ርሕቐት ዘለዎ ቦታ ምስ ብሳንፍራንሲስኮ ሼር ዝተገበረ መምርሒ ኣተግቢሩ። 	As of last week, our DC office implemented to a fully remote location with guidelines shared by San Francisco.
1653	en	ti	 As some of our NYC-based colleagues know, we have also been in discussion about leasing a location in Brooklyn. 	 ከም ገለ ናይ NYC-መሰረቶም መሳርሕትና፣ ኣብ ብሩክሊን ቦታ ብዛዕባ ምክራይ እንዳተመያየጥና ኢና ኔርና። 	Like some of their NYC-based colleagues, we were discussing leasing a place in Brooklyn.
1654	en	ti	 These discussions are continuing but may be delayed. 	 እዞም ዝርርባት ቀጺሎም እዮም ግን ድማ ክደናጎዩ ይኽእሉ። 	These conversations have continued but may be delayed.
1655	en	ti	 Some of our colleagues are working remotely for the first time. 	 ገለ መሳርሕትና ንመጀመርያ ግዜ እዮም ርሒቖም ዝሰርሑ ዘለዉ። 	Some of our colleagues are working remotely for the first time.
1656	en	ti	 Our long-time remote colleagues know that it can be an adjustment, and wanted to offer you some advice: 	 ናይ ነዊሕ ግዘ ናይ ርሑቕ ቦታ መሳርሕትና ምስትኽኻል እዩ ኢሎም ይኣምኑ፣ ስለዚ ድማ ገለ ምኽሪታት ከቕርቡልኩም ይደልዩ: 	Our long-term remote colleagues believe it is an adjustment, and so they want to offer you some advice:
1657	en	ti	 Limit the length of meetings to at most one or two hour increments. 	 ኣኼባታት ዝካየዱሉ ንውሓት ግዜ ካብ ሓደ ወይ ድማ ክልተ ሰዓት ንላዕሊ ከይውስኽ ምግባር። 	Keep the duration of meetings to no more than one or two hours.
1658	en	ti	 If longer sessions are required, consider how they can be broken up over the course of several days. 	 ነዋሕቲ መደባት ዘድልዩ እንተኾይኖም፣ ኣብ ዝተወሰኑ መዓልታት ብኸመይ ክሰባበሩ ከምዝኽእሉ ኣብ ግምት ኣእትዉ። 	If longer sessions are needed, consider how they can be broken into certain days.
1659	en	ti	 Clearly define the meeting, have an agenda, and send reading materials in advance. 	 እቶም ኣኼባታት ብገልጺ ፍለይዎም፣ ኣጀንዳ ይሃልኹም ኣቐዲምኩም ድማ ዝንበብ ማቴርያል ስደዱ። 	Separate the meetings clearly, have an agenda and send reading material in advance.
1660	en	ti	 Make video the default, with tools like Google Docs and Zoom to facilitate live collaboration and connection. 	 ነዚ ቪድዮ ዲፎልት ግበርዎ፣ ብናይ ጎግል ዶክስን ዙምን ናይ ቀጥታ ሕብረትን ርክባትን ንምስላጥ። 	Make this video the default, to run live feeds and contacts with Google Docs and Zoom.
1661	en	ti	 Have a lead to facilitate every meeting, someone to monitor the chat for questions and track the speaker list, and someone to help take notes (or do collaborative note-taking). 	 ሕድሕድ ኣኼባታት ንምክያድ መምርሒ ይሃሉኻ፣ ዝኾነ ሰብ ነቲ ቻት ይቆጻጸሮ ናይ ተዛረብቲ ዝርዝር ድማ ይከታተል፣ ዝኾነ ሰብ ድማ ማስታወሻ ይውሰድ (ወይ ብሕብረት ማስታወሻ-ይውሰዱ)። 	Have instructions for conducting individual meetings, have someone control the chat and keep track of the speaker list, and have someone take notes (or be note-taken collectively).
1662	en	ti	 Send an email to tech support if you need a comfortable headset. 	 ዝምችው ሄድሴት ኣድሊኩም እንተነይሩ ናብ ናይ ቴክ ሓገዝ ኢመይል ስደዱ። 	Email tech support if you needed a suitable headset.
1663	en	ti	 Use your wellness reimbursement for snacks. 	 ናይ ድሕንነት ካሕሳከም ንምግቢ ተጠቐሙሉ። 	Use your security compensation for food.
1664	en	ti	 Join the #remoties channel in Slack to talk with your colleagues about distributed work 	 ናብ #remoties ቻነል ኣብ ስላክ ብዛዕባ ዘተሰራጨዉ ስራሕቲታት ምስ መሳርሕቲታትኩም ንምዝርራብ ተሓወሱ 	Join the #remoties channel in Slack to chat with your colleagues about distributed tasks
1665	en	ti	 The HR Operations team is looking into webinar-based ergonomics guidance to support the increase in distributed work across the Foundation. 	 እዚ ናይ HR ኦፕሬሽን ጉጅለ ኣብ መላእ እቲ ፋውንዴሽን ምውሳኹ ንምሕጋዝ ንናይ webinar-መሰረት ዝገበሩ ኤርጎኖሚክስ ይከታተሉ ኣለዉ። 	This HR operations team are overseeing webinar-based ergonomics to help with its increase across the foundation.
1666	en	ti	 This past week we asked all community grant recipients to cancel Wikimedia-funded public events, such as editathons, until the WHO declares the pandemic to be over. 	 ኣብ ዝሓለፈ ሰሙን ንኩሎም ማሕበረሰባት ብWikimedia ዝምወሉ ከም editathons ዝኣመሰሉ ህዝባዊ ምድላዋት፡ WHO እቲ ለበዳ ጠፊኡ እዩ ኢሉ ክሳብ ዝእውጅ፡ ከስርዙ ሓቲትናዮም። 	Last week we asked all communities to cancel Wikimedia-sponsored public events, such as editathons, until the WHO declared the outbreak gone.
1667	en	ti	 We let them know that we understood that our request for cancellations and other restrictions could make it impossible to complete their agreed-upon grant activities and that no one would be penalized for having to delay or modify those goals. 	 እዚ ናይ ምስራዝ ሕቶና ወይ ካልኦት ገደባት እቲ ተስማዕሚዕናሉ ዝነበርና ናይ ፈቓድ ንጥፈታቶም ምርካብ ዘይከኣል ከምዝገብሮ ከምዝርደኣናን ንምድንጓዩ ወይ ነዞም ሽቶታት ምምሕያሽ ማንም ሰብ ከምዘይቕጻዕ ክነፍልጦም ንደሊ። 	We understand that this cancellation request or other restrictions will make it impossible to obtain their agreed licensed activities and that no one will be penalized for delaying or improving these goals.
1668	en	ti	 This coming week we will follow up with additional guidance on Wikimania and other regional and thematic community conferences. 	 ኣብ ዝመጽእ ዘሎ ሰሙን ናይ Wikimania ተወሳኺ መምርሒታትን ካልኦት ክልላዊን ቴማቲክ ማሕበረሰባዊ ኮንፈረንስታተን ክንከታተል ኢና። 	Next week we will follow Wikimania&#39;s additional guides and other regional and thematic community conferences.
1669	en	ti	 The general sentiment from around the global community seems to be both sadness at the disruption but relief at the clarity and ability to focus on their own communities, Wikimedia and otherwise. 	 ናይ ዓለም ማሕበረ ሰብ ሓፈሻዊ ስምዒት ሓዘንን ምድንጋጽን እዩ፣ ኣብ ናይ ባዕሎም ማሕበረ ሰባት፡ Wikimedia ወይ ካልእት ኣትኲሮም ክሰርሑ ብምኽኣሎም ድማ ዕረፍቲ ይስምዖም። 	The world community&#39;s general feeling is sadness and pity, and they feel relieved to be able to focus on their own communities, Wikimedia or otherwise.
1670	en	ti	 Going forward, the CRT is working to set up a page on Meta-Wiki to provide a space for the community to monitor the impact and follow our communications with them. 	 ኣብ ምቕጻል፣ CRT ነቲ ማሕበረ ሰብ ጽዕንትኡ ንክቆጻጸርን ምስኦም ዘለና ርክብ ንክንከታተልን ዘኽእል ቦታ ንምፍጣር ኣብ Meta-Wiki ፔጅ ንምፍጣር ይሰርሕ ኣሎ። 	Moving forward, CRT is working to create a page on the Meta-Wiki to create a space for the community to control their impact and track our interactions with them.
1671	en	ti	 Staying in touch around COVID-19 related issues 	 ምስ COVID-19 ዝተሓሓዙ ጉዳያት ኣፍልጦ ምህላው 	Knowledge of COVID-19 related issues
1672	en	ti	 We’ll be sending an invitation to your calendars for next Thursday, 14:00 UTC/07:00 PT for a special staff meeting. 	 ንቀጻላይ ሓሙስ ናይ ዕደመ መልእኽቲ ናብ ካላንደርኩም ክንሰድድ ኢና፣ 14:00 UTC/07:00 PT ንፍሉይ ናይ ስታፍ ኣኼባ። 	We’ll send an invitation to your calendar next Thursday, 14:00 UTC/07:00 PT for a special staff meeting.
1673	en	ti	 We’ll use this time to share additional updates, answer your questions and spend some time connecting with each other. 	 ነዚ ግዜ እዚ ተወሰኽቲ ምሕዳሳት ንምክፋል፣ ሕቶታትኩም ንምምላስን ነን ባዕልና ንምርኻብ ግዜ ንምውሳድን ክንጥቀመሉ ኢና። 	We will use this time to share additional updates, answer your questions and take time to meet each other ourselves.
1674	en	ti	 We’re in this together and here to help however we can. 	 ኣብዚ ነገር እዚ ብሓባር ኢና ኣቲናዮ ዘለና ብዝተኸኣለና ድማ ክንተሓጋገዝ ኣለና። 	We are in this thing together and we need to help each other as much as we can.
1675	en	ti	 In the meantime, you can continue to find the information from this email, and all other essential COVID-19 related information, on Office Wiki. 	 ኣብዚ ግዜ እዚ፣ ነዚ ሓበሬታ ኣብ ኢመይል ምርካብ ክትቅጽሉ ትኽእሉ፣ ካልኦት ምስ ኮቪድ-19 ዝተተሓሓዙ ወሰንቲ ሓበሬታታት እውን፣ ኣብ Office Wiki ይርከቡ። 	In the meantime, you can continue to receive this information by email, and other important information related to COVID-19 is also available on the Office Wiki.
1676	en	ti	 The CRT will keep these pages updated and all the information in one place. 	 CRT እዞም ገጻት ክሕደሱን ኩሎም እዞም ሓበሬታታት ድማ ኣብ ሓደ ቦታ ክኾኑ ይገብር። 	CRT keeps these pages updated and all of this information in one place.
1677	en	ti	 We are also working to maintain regular communications with staff who reside in countries that are currently significantly affected. 	 ኣብዚ ግዜ እዚ ብኸቢዱ ተጠቒዖም ኣብ ዘለዉ ሃገራት ምስ ዝነብሩ ስታፍ ዘለና ርክብ ክንቅጽል ንሰርሕ ኣለና። 	We are currently working to maintain contact with staff living in countries that are severely affected.
1678	en	ti	 If you have any questions about travel, events, a major workstream, or coverage challenge, or anything else you may need help with, please don’t hesitate to notify and work with the CRT. 	 ብዛዕባ ጉዕዞ፣ ምድላዋት፣ ዓብዩ ናይ ስራሕ ከይዲ፣ ወይ ናይ ሽፋን ማሕለኻ፣ ወይ ካልእ ሓገዝ እትደልየሉ ነገር፣ ብኽብረትኩም ን CRT ከተመልክቱን ምስኦም ንኽትሰርሑን ከይትፈርሑ። 	Please don&#39;t be afraid to contact CRT and work with them about travel, preparations, major work processes, or coverage obstacles, or anything else you need help with.
1679	en	ti	 We’re here to help provide support and liaise as needed. 	 ንሕና ሓገዝን ክራይን ከም ኣድላይነቱ ክንህበኩም ኢና ኣብዚ ዘለና። 	We are here to provide assistance and rentals as needed.
1680	en	ti	 If you have a confidential or sensitive matter, please email Bryan Judan - Director of HR International Global Operations. 	 ምስጢራዊ ወይ ዘሕፍረኩም ጉዳይ እንተሊኩም፣ ብኽብረትኩም ናብ Bryan Judan ኢመይል ግበሩ - ናይ HR International Global Operations (ኤች ኣር ዓለም ለኻዊ ኦፕሬሽን) ዳይሬክተር። 	If you have a confidential or embarrassing issue, please email Bryan Judan - Director of HR International Global Operations.
1681	en	ti	 None of these changes should be seen as an abandonment of our work and obligations. 	 እዞም ለውጢታት እዚኦም ስራሕናን ግቡእናን ከምዝገደፍና ክርኣዩ የብሎምን። 	These changes should not be seen as abandoning our jobs and duties.
1682	en	ti	 Rather, they are a recognition that at this moment, our work and obligations will likely need to adapt in a way we have not in the past. 	 እኳ ድኣስ፣ ኣብዚ ግዜ እዚ፣ ስራሕናን ግቡእናን ኣብ ሕሉፍ ካብ ዝነበረ መንገዲና ፍልይ ብዝበለ ክቕየሩ ከምዘለዎም መርአይቲ እዮም። 	Rather, they are indicators that, today, our work and duties must change in a different way than we did in the past.
1683	en	ti	 These are the steps we believe are necessary to support this one another so that we can continue to work, provide our movement with the support they need, and the world with the service they rely on. 	 ነንባዕልና ንክንተሓጋገዝን ሓቢርና ክንሰርሕን ክጠቕሙና ይኽእሉ እዮም ኢልና ንሓስቦም ስጉምቲታት እዚኦም እዮም፣ ዘድልይዎም ሓገዛት ንምንቅስቓሳትና እንዳቕረብና፣ ንዓለም ድማ ብዝድገፉሉ ሓገዝ እንዳሓገዝነና። 	These are the steps we think can help us help each other and work together, providing our movements with the help they need, and helping the world with the help they support.
1684	en	ti	 Our planned work will be there waiting for us when the time comes. 	 ትልሚ ዝተገበሮ ስራሕና እቲ ግዜ ክሳብ ዝመጽእ ክጽበየና ክጸንሕ እዩ። 	Our planned work will be waiting for us until that time comes.
1685	en	ti	 For now, it is time to support one another and create space for the important work that will be coming in the weeks and potentially months ahead. 	 ንግዚኡ ነንሕድሕድና ንተሓጋገዘሉን ነቲ ኣገዳሲ ዝኾነ ኣብ ቀጻሊ ሰሙን ወይድማ ኣብቶም ዝቅጽሉ ኣዋርሕ ንዝመጽእ ስራሕ ባይታ ንፈጥረሉን ግዜ እዩ። 	It is a time to help each other for the time being and pave the way for the more important work to come next week or in the months ahead.
1686	en	ti	 We need all of you to make that happen, and so we need you all to take care of yourself and your families so that you can be at your best when the need arises. 	 ኩልኹም እዚ ክኸውን ንክትሰርሑ ንጽበየኩም፣ ስለዚ ድማ ንባዕልኹምን ቤተ ሰብኩምን ክትከናኸኑ ዘድልየኩም ነገራት ክርከቡ ከለዉ ባዕልኹም ክትረኽብዎ ብቑዓት ክትኾኑ መታን። 	We expect all of you to work to make this happen, so that you are eligible to get what you need to take care of yourself and your family when it becomes available.
1687	en	ti	 Now, please -- wash your hands and don’t touch your face! 	 ሐዚ፣ ብኽብረትኩም -- ኣእዳውኩም ተሓጸቡ ገጽኩም ድማ ኣይትንክኡ! 	Now, please -- wash your hands and don&#39;t touch your face!
1688	en	ti	 Katherine, the CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, and Tony S), and the rest of the Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, and Toby N). 	 Katherine, the CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, ን Tony S), ከምኡውን እቶም ዝተረፉ ኣመራርሓ ጉጅለታት (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, ን Toby N ን)። 	Katherine, the CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, and Tony S), and the rest of the leadership teams (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, and Toby N).
1689	en	ti	b'Angiotensin-converting enzyme 2 (ACE2) is an enzyme attached to the outer surface (cell membranes) of cells in the lungs, arteries, heart, kidney, and intestines.	b'Angiotensin- ኢንዛየም ቀያሪ 2 (ACE2) ኣብ ሳንቡእ፣ ኣብ ልቢ፣ ኣብ ኩላሊትን ኣብ መዓናጡን ኣብ ዝርከቡ መትኒታት ደጋዊ ኣካል (ግድግዳ ዋህዮ) ተጣቢቑ ዝርከብ ኢንዛየም እዩ።	b&#39;Angiotensin- Enzyme converter 2 (ACE2) is an enzyme attached to the membranes of the outer body (cell wall) in the lungs, heart, kidneys, and intestines.
1690	en	ti	ACE2 counters the activity of the related angiotensin-converting enzyme (ACE) by reducing the amount of angiotensin-II and increasing Ang(1-7) making it a promising drug target for treating cardiovascular diseases.ACE2 also serves as the entry point into cells for some coronaviruses.	ACE2 ን ዓቐን ኣንጅዮተንሲን-II ብምጉዳልን ንኣንጅ(1-7) ብምውሳኽን ንንጥፈታት ናይ ኣንጂዮተንሲን ኮንቨርቲንግ ኢንዛይም (ACE) ይጻረር ።እዚ ድማ ንናይ መትነ-ልባዊ ሕማማት ንምፍዋስ ተስፋ ዘለዎ መድሃኒት ይገብሮ ። ACE2 ን ገሊኦም ኮሮናቫይረሳት ከም መእተዊ ናብ ዋህዮታት እውን የገልግል እዩ ።	ACE2 antagonizes the activity of angiotensin converting enzyme (ACE) by decreasing the levels of angiotensin-II and increasing Ang(1-7) , making it a promising drug for the treatment of cardiovascular diseases . ACE2 also serves as an entry point for some coronaviruses into cells.
1691	en	ti	The human version of the enzyme is often referred to as hACE2.	ኣብ ሰባት ዝርከብ ነፍሳዊ ቅመም መብዛሕትኡ ግዜ hACE2ተባሂሉ ይጽዋዕ።	The soul formulation in humans is often referred to as hACE2.
1692	en	ti	Angiotensin-converting enzyme 2 is a zinc containing metalloenzyme located on the surface of endothelial and other cells.	Angiotensin-converting enzyme 2 ዚንክ ዝሓዘ ሜታሎኢኤንዛይም እንትኸዉን ኣብ ናይ ኢንዶቴልያልን ካልኦት ዋህዮትን ደጋዊ ኣካል ይርከብ።	Angiotensin-converting enzyme 2 is a zinc-containing metalloenzyme found on the outer surface of endothelial and other cells.
1693	en	ti	ACE2 protein contains an N-terminal peptidase M2 domain and a C-terminal collectrin renal amino acid transporter domain.	ACE2 ፕሮቲን N-ተርሚናል ፔፕቲዴዝ M2 ዶሜን ከምኡውን C-ተርሚናል ኮሌክትሪን ሬናል ኣሚኖ ኣሲድ መጎዓዓዚ ዶሜን ዝሓዘ እዩ።	ACE2 protein contains an N-terminal peptidase M2 domain and a C-terminal collectrin renal amino acid transporter domain.
1694	en	ti	ACE2 is a single-pass type I membrane protein, with its enzymatically active domain exposed on the surface of cells in lungs and other tissues.	ACE2 ነጸላ መሕለፊ ዘለዎ ዓይነት I መምብሬን ፕሮቲን እዩ፣ ናይ ኤንዛይም ንጡፍ ዝኾነ ዓብላልነት ኣብ ልዕሊ ናይ ሳንቡእን ካልኦት ቲሹታትን ብላዕሊ ተቓሊዑ ዝረኣይ እዩ።	ACE2 is a type I membrane protein with a single passage, enzymatically active with a predominance of surface exposed lung and other tissues.
1695	en	ti	The extracellular domain of ACE2 is cleaved from the transmembrane domain by another enzyme known as sheddase, and the resulting soluble protein is released into the blood stream and ultimately excreted into urine.	ካብ ዋህዮ ወጻኢ ዝኾነ ናይ ACE2 ዶሜን ካብ ትራንስመምብሬን ዶሜን ብካልእ ሼዴዝ ዝበሃል ኢንዛይም ይቑረጽ፣ እቲ ድሕሪኡ ዝፍጠር ሓቓቒ ፐሮቲን ድማ ናብ ናይ ደም ትቦታት ይስደድ ድሕሪኡ ድማ ብሽንቲ ክውገድ ይግበር።	The extracellular domain of ACE2 is cut from the transmembrane domain by another enzyme called shadease, and the resulting digestive perotin is exported to the blood vessels and then eliminated in the urine.
1696	en	ti	ACE2 is present in most organs: ACE2 is attached to the cell membrane of mainly lung type II alveolar cells, enterocytes of the small intestine, arterial and venous endothelial cells and arterial smooth muscle cells in most organs.	ACE2 ኣብ መብዛሕትኦም ኣካላት ሰብነት ይርከብ: ACE2 ብፍላይ ኣብ ናይ ሳንቡእ ዓይነት II ኣልቪዮላር ዋህዮታት፣ ናይ ቀጢን መዓንጣ ኢንትሮሳይታት፣ ናይ ኣርተሪን ቨይንን ኢንዶቴልያል ዋህዮታትን ናይ ኣርተሪ ልሙጽ ጭዋዳታት ዋህዮታትን ናይ ዋሀዮ ሽፋናት መብዛሕትኦም ኦርጋናት ተተሓሒዙ ይርከብ።	ACE2 is found in most organs: ACE2 is specifically bound to pulmonary type II alveolar cells, small intestinal introcytes, arterial and vein endothelial cells, and arterial smooth muscle cells of the cell membranes of most organs.
1697	en	ti	ACE2 mRNA expression is also found in the cerebral cortex, striatum, hypothalamus, and brainstem.	ACE2 mRNA ኣገላልጻ ኣብ ሰረብራል ኮርቴክስ፣ ስትሪያተም፣ ሃይፖታላመስን ብረይንስተምን እወን ይርከብ።	ACE2 mRNA expression is also found in the cerebral cortex, striatum, hypothalamus, and brainstem.
1698	en	ti	The primary function of ACE2 is to act as a counter balance to ACE.	ቀዳማይ ኣገልግሎት ናይ ACE2 ን ACE ንምምዝዝዛን እዩ።	The first use of ACE2 is to displace ACE.
1699	en	ti	ACE cleaves angiotensin I hormone into the vasoconstricting  angiotensin II.	ACE፣angiotensin I hormone ናብ ደም ሰራዉር ዘፅብብ angiotensin II ይኸፍሎ።	ACE,angiotensin I hormone is divided into angiotensin II which narrows blood vessels.
1700	en	ti	ACE2 in turn cleaves the carboxyl-terminal amino acid phenylalanine from angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) and hydrolyses it into the vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).	ACE2 ድማ ብወገኑ ን carboxyl-terminal amino acid phenylalanine ካብ angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) ን ብምፍላይ ናብ vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH) ህይድሮልይሰ ይገብሮ:	ACE2, in turn, cleaves the carboxyl-terminal amino acid phenylalanine from angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) and converts it to the vasodilator angiotensin (1-7), (H-Asp-Arg-Val- Tyr-Ile-His-Pro-OH) hydrolyses:
1701	en	ti	ACE2 can also cleave a number of other peptides including [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, and ghrelin.	ACE2 ከም [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, and ghrelin ዝመሳሰሉ ዝተፈላለዩ ፔፕታይዳት ክመቅል ይኽእል እዩ።	ACE2 can cleave a variety of peptides such as [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, and ghrelin.
1702	en	ti	ACE2 also regulates the membrane trafficking of the neutral amino acid transporter SLC6A19 and has been implicated in Hartnup's disease.	ACE2 ንናይ ገለተኛ ኣጎዓዓዚ ኣሚኖ-ኣሲድ SLC6A19 ምዕጋት መምብራና ይቆጻጸር ከምኡ’ውን ምስ ሕማም ሃርትናፕ እውን ይተኣሳሰር እዩ ።	ACE2 regulates membrane inhibition of the neutral transporter amino-acid SLC6A19 and is also associated with Heartnap disease .
1703	en	ti	As a transmembrane protein, ACE2 serves as the main entry point into cells for some coronaviruses, including HCoV-NL63; SARS-CoV (the virus that causes SARS); and SARS-CoV-2 (the virus that causes COVID-19).	ከም ትራንስመምብሬን ፕሮቲን, ACEI 2 ን HCoV-NL63 ን እንኮላይ ን ገለ ናይ ኮሮና ቫይረስ ከም በዓል SARS-CoV (SARS ንቫይረስ); ከምኡ’ውን SARS-CoV-2 (COVID-19 ን effect ቫይረስ) ዋና መተኣታተዊ ነጥቢ ኮይኑ ዘገልግል እዩ።	as a transmembrane protein, ACEI 2 for HCoV-NL63 and even for some coronaviruses such as SARS-CoV (SARS for virus); It also serves as the main point of entry for SARS-CoV-2 (COVID-19 and effect virus).
1704	en	ti	More specifically, the binding of the spike S1 protein of SARS-CoV and SARS-CoV2 to the enzymatic domain of ACE2 on the surface of cells results in endocytosis and translocation of both the virus and the enzyme into endosomes located within cells.	ብፍላይ ድማ ናይ SARS-CoV S1ን SARS-CoV2ን ፕሮቲን ስፓይክ ምስ ኣብ ደጋዊ ኣካል ናይ እቶም ዋህዮታት ዝርከብ ACE2 ኤንዛይም ዶሜይን ዝግበር ምትእስሳር ኢንዶሳይቶሲስን ትራንስሎኬሽንን ናይ እቲ ቫይረስን ናይ እቲ ኤንዛይምን ኣብ ዋህዮ ዉሽጢ ናብ ዝርከብ ኢንዶሶም ዝፍጠር እዩ።	Specifically, the interaction of the SARS-CoV S1 and SARS-CoV2 protein spikes with the ACE2 enzyme domain on the outer body of the cells results in endocytosis and translocation of the virus and the enzyme to endosomes inside the cell.
1705	en	ti	This entry process also requires priming of the S protein by the host serine protease TMPRSS2, the inhibition of which is under current investigation as a potential therapeutic.This has led some to hypothesize that decreasing the levels of ACE2, in cells, might help in fighting the infection.	እዚ መተኣታተዊ መስርሕ ከዓ TMPRSS2 ዝበሃል ናይ እቲ ተሸካሚ ሴሪን ፕሮቴዝ ንS ፕሮቲን ፕራይም ምግባር የድሊዮ። ምዕጋት እዚ ፕሮቴዝ ድማ ከም መድሃኒት ክንጥቀመሉ ከምንኽእል መፅናዕቲ ይካየድ ኣሎ። እዚ ድማ ካልኦት ኣብ ዋህዮታት ናይ ACE2 ዓቐን ብምቕናስ ነዚ ረኽሲ ምቅላስ ይከኣል ዝብል ሓሳብ ንኸቕርቡ ገይሩዎም እዩ።	This introduction process requires priming of the S protein by the carrier&#39;s serine protease, TMPRSS2. The inhibition of this prosthesis is being studied as a cure. This has led others to propose that it is possible to combat this infection by reducing the amount of ACE2 in cells.
1706	en	ti	However, multiple professional societies and regulatory bodies have recommended continuing standard ACE inhibitor and ARB therapy.	ይኹን እምበር ብዙሓት ሰብ ሞያን ተቖጻጸርቲ ኣካላትን ንምቕጻል ደረጃኡ ዝሓለወ ናይ ACE ገታኢ ን ARB ፍወሳን ይመኽሩ ።	However, many professionals and regulatory bodies recommend continuing standard ACE inhibitor and ARB therapy .
1707	en	ti	"A systematic review and meta-analysis published on July 11, 2012, found that ""use of ACE inhibitors was associated with a significant 34% reduction in risk of pneumonia compared with controls."""	"ኣብ ጁላይ 11, 2012 ዝተሓተመ ስሩዕ ዝኾነ ገምጋምን ሜታ አናላይሲስን ፣ ""ናይ ACE inhibitors ምጥቃም ምስ ቁጽጽራት ክነጻጸር ከሎ 34% ናይ ሳንቡእ ወቕዒ ናይ ምምዕባል ዕድል ከምዝቐነሰ"" ኣርእዩ እዩ።"	A peer-reviewed review and meta-analysis , published July 11, 2012, showed that &quot;the use of ACE inhibitors reduced the risk of developing pulmonary stroke by 34% compared with controls.&quot;
1708	en	ti	"Moreover, ""the risk of pneumonia was also reduced in patients treated with ACE inhibitors who were at higher risk of pneumonia, in particular those with stroke and heart failure."	"ልዕሊ እዚ፣ ""ናይ ሳንቡእ ወቕዒ ምፍጣር ዕድል ብናይ ACE ኢንሂቢተራት ኣብ ዝተሓከሙ ኣብ ከቢድ ናይ ሳንቡእ ወቕዒ ናይ ምምዕባል ዕድል ዝነበሩ ሕሙማት ክቕነስ ተኻኢሉ እዩ፣ ብፍላይ ስትሮክን ናይ ልቢ ውድቀትን ከጋጥሞም ኣብ ዝኽእለሉ ሰባት።"	More than that, &quot;the risk of pulmonary stroke has been reduced in patients treated with ACE inhibitors who were at risk of developing a severe pulmonary stroke, especially in people at risk of stroke and heart failure.&quot;
1709	en	ti	"Use of ACE inhibitors was also associated with a reduction in pneumonia related mortality, although the results were less robust than for overall risk of pneumonia."""	ዋላ እኳ እቲ ውጽኢት ንኒሞንያ ከም ዝንኪ እተዘይኣመተ ምጥቃም ናይ ACE ገታእቲ ምስ ምንካይ ብሰንኪ ኒሞንያ ዝስዕብ ሞት ይተሓሓዝ እዩ ።	Use of ACE inhibitors is associated with reduced mortality from pneumonia , although the results do not suggest a reduction in pneumonia .
1710	en	ti	Recombinant human ACE2 (rhACE2) is surmised to be a novel therapy for acute lung injury, and appeared to improve pulmonary hemodynamics and oxygen saturation in piglets with a lipopolysaccharide-induced acute respiratory distress syndrome.	ሪኮምቢናንት ናይ ሰብ ACE2 (rhACE2) ንህጹጽ ናይ ሳንባ ጉድኣት ሓድሽ ሕክምና እዩ፣ ፑልምናሪ ሃይፖዳይናሚክስን ናይ ኦክሲጅን ሳቹሬሽንን ብ lipopolysaccharide-induced acute respiratory distress syndrome( ሊፖፖሊሳካራይድ-ዝመጸ ህጹጽ ናይ ስርዓተ ምትንፋስ ምጭንናጭ ምልክታት ሕማም) ናይ ዘለወን ውላዳት ሓሳማታት ከመሓይሽ ተራእዩ።	Recombinant human ACE2 (rhACE2) is a new treatment for acute lung injury, pulmonary hypodynamics and oxygen saturation of piglets with lipopolysaccharide-induced acute respiratory distress syndrome( lipopolysaccharide-induced acute respiratory distress syndrome) c Improvements were seen.
1711	en	ti	The half-life of rhACE2 in human beings is about 10 hours and the onset of action is 30 minutes in addition to the course of effect (duration) of 24 hours.	ናይ rhACE2 ካብቲ ዝነበሮ ፃዕቂ ፍርቂ ዝበፅሓሉ ጊዜ ከባቢ 10 ሰዓታት ኮይኑ ፣ ካብቲ ናይ 24 ሰዓታት ኣብ ስራሕ ዝጸንሓሉ (ጻንሒት) ጊዜ በተወሳኺ ናብ ስራሕ ዝኣትወሉ ጊዜ ድማ ኣብ ውሽጢ 30 ደቓይቕ ይኸውን።	The time of rhACE2 to reach half of its concentration is about 10 hours , and the time of action is within 30 minutes in addition to the 24-hour incubation (stay) time.
1712	en	ti	Several findings suggest that rhACE2 may be a promising drug for those with intolerance to classic renin-angiotensin system inhibitors (RAS inhibitors) or in diseases where circulating angiotensin II is elevated.Infused rhACE2 has been evaluated in clinical trials for the treatment of acute respiratory distress syndrome.	ብዙሓት ርካቦታት rhACE2 ንናይ renin-angiotensin system inhibitors (RAS inhibitors) ዘይቕበሉ ሰባት ተስፋ ዘለዎ መድሓኒት ክኸውን ይኽእል እዩ ኣንጂዮቴንሲን II ልዑል ኣብ ዝኾነሎም ሕማማት።ዝተከሉ rhACE2 ንከቢድ ናይ ስርዓተ ምትንፋስ ዲስትረስ ሲንድረም ክሕክም ኣብ ክሊኒካል ፈተነ ተረጋጊጹ እዩ።	Many findings rhACE2 may be a promising therapy for people refractory to renin-angiotensin system inhibitors (RAS inhibitors) in diseases where angiotensin II is elevated.implanted rhACE2 has been shown in clinical trial to treat severe respiratory distress syndrome.
1713	en	ti	"b'COVID-19 apps are mobile software applications designed to aid contact tracing in response to the 2019-20 coronavirus pandemic, i.e. the process of identifying persons (""contacts"") who may have been in contact with an infected individual."	b'COVID-19 ናይ ሞባይል ሶፍትዌር መተግበሪ ማለት ነቲ ኣብ 2019-20 ኮሮና ቫይረስ ለበዳ መልሲ ኣብ ምሃብ፣ ብምትንካፍ ሕማም ምትሕልላፍ ንምክትታል ሓበሬታ ይህቡ እዮም፥ ማለት ምስ ብሕማም ዝተታሕዘ ውልቀ-ሰብ ርክብ ዝነበሮም ሰባት ናይ ምፍላይ መስርሕ እዩ።	b&#39;COVID-19 mobile software application means that in response to the 2019-20 coronavirus pandemic, they provide information to track transmission by contact: the process of isolating people who have had contact with an infected individual.
1714	en	ti	Numerous applications were developed or proposed, with official government support in some territories and jurisdictions.	ኣብ ገሊኦም ግዝኣታትን ሕጋዊ ስልጣናትን ብወግዓዊ ሓገዝ ናይ መንግስቲ ተሰንዮም ብዙሓት ኣፕሊኬሽናት ተኣሚሞምን ተሰሪሖምን።	In some states and jurisdictions, many applications have been approved and developed with official government assistance.
1715	en	ti	Several frameworks for building contact tracing apps have been developed.	ርክባት ንምክትታል ዝሕግዙ ኣፕሊኬሽናት ንምምዕባል ብዙሓት ስርዒታት ተሰሪሖም ኣለዉ ።	Many systems have been developed to develop applications for monitoring communications .
1716	en	ti	Privacy concerns have been raised, especially about systems that are based on tracking the geographical location of app users.	ብፍላይ ኣብ እቶም ናይ እቲ መተግበሪ ተጠቀምቲ ጂኦግራፊያዊ ኣከባቢ ብምክትታል ዝተመስረቱ ስርዓታት ብዛዕባ ብሑትነት ዝምልከት ስግኣት ክለዓሎም ጸኒሑ እዩ።	Privacy concerns have been raised, especially in systems based on tracking the geographical location of the application&#39;s users.
1717	en	ti	Less intrusive alternatives include the use of Bluetooth signals to log a user's proximity to other cellphones.	ካብቶም ናይ ውልቀ ሰባት ብሓትውነት ኣብ ምሕላው ዝሓሹ ዝበሃሉ ኣማራጺታት ብሉቱዝ ብምጥቃም ናይ ተጠቃሚ ደረጃ ቅርበት ናብ ካልኦት ስልክታት ምልኣኽ እዩ።	Alternatives that are supposedly better at fraternizing than individuals are using Bluetooth to send user-level proximity to other phones.
1718	en	ti	On 10 April 2020, Google and Apple jointly announced that they would integrate functionality to support such Bluetooth-based apps directly into their Android and iOS operating systems.	ኣብ 10 ኤፕሪል 2020 ጎግል ምስ ኣፕል ብሓባር ኮይኖም ብሉቱዝ መሰረት ጌሩ ዝሰርሕ መተግበሪ ቀጥታ ናብ ኣንድሮይድን iOS ኦፕሬቲንግ ሲስተምን ኣብ ምዉህሃድ ከምዝሰርሑ ተዛሪቦም።	On April 10, 2020, Google announced that it is working with Apple to integrate a Bluetooth-based application directly into the Android and iOS operating systems.
1719	en	ti	In China, the Chinese government, in conjunction with Alipay, has deployed an app that allows citizens to check if they have been in contact with people that have COVID-19.	ኣብ ቻይና፣ መንግስቲ ቻይና ምስ ኣሊፓይ ብምትሕብባር ዜጋታት ምስ COVID-19 ዝተትሓዘ ሰብ ርክብ ከምዝነበሮም ዝነግሮም መተግበሪ ኣብ ስራሕ ኣውዒሎም።	In China, the Chinese government has partnered with Alipay to launch an application that tells citizens if they have been in contact with someone infected with COVID-1
1720	en	ti	It is in use across more than 200 Chinese cities.In Singapore, an app called TraceTogether is being used.	ኣብ ልዕሊ 200 ከተማታት ቻይና ኣብ ጥቕሚ ኣብ ምውዓል ይርከብ። ኣብ ሲንጋፖር ትሬስ_ቱጌዘር ዝተባህለት ኣፕሊኬሽን ኣብ ጥቕሚ ኣብ ምውዓል ተርከብ።	It is in use in more than 200 cities in China. An application called Trace_Together is in use in Singapore.
1721	en	ti	"The app was developed by local IT community, released as open source and will be handed over to the government.North Macedonia launched ""StopKorona!"", a Bluetooth-based app to trace exposure with potentially infected persons and  provide a fast response to healthcare authorities."	"እዚ መተግበሪ ብናይ ከባብያዊ IT ማሕበረሰብ ዝማዕበለ ኮይኑ ንመንግስቲ ተዋሂቡ ንህዝቢ ድማ ክፍቲ ኮይኑ ይርከብ። ሰሜን ማሴዶኒያ ""StopKorona!"" ብዝብል ዝጀመሮ ብብሉቱዝ መሰረት ዝተሰርሐ መተግበሪ እዩ። ጥቕሙ ድማ ምስ ዝሓመመ ሰብ ርክብ ዘለዎ ሰብ ንምርካብን ንጥዕና ባዓል ሞያ ቅልጡፍ ዝኾነ መልሲ ምሃብን እዩ።"	This application was developed by the local IT community and is available to the government and open to the public. Northern Macedonia &quot;StopKorona!&quot; is a Bluetooth-based application that he started with. The benefit is to find someone who has been in contact with the sick person and to provide a quick response to the health professional.
1722	en	ti	The app was developed by the Ministry of Communication and Technology and Ministry of Health.	እቲ መተግበሪ ብ Ministry of Communication and Technology(ናይ ርክብ ን ቴክኖሎጂ ሚኒስቴር) ን ብ Ministry of Health(ናይ ጥዕና ሚኒስቴር)ን ዝማዕበለ እዩ።	The application is developed by the Ministry of Communication and Technology and the Ministry of Health.
1723	en	ti	As of 14 April 2020, the app was awaiting approval by the Google Play Store and Apple App Store.	ካብ14, ኤፕሪል 2020 ኣቢሉ እቲ መተግበሪ ብጉግል ፕሌይ ስቶርን ኣፕል ስቶር ክሳብ ዚጸድቅ ይጽበ ኔሩ።	Since14, April 2020, the app has been waiting for approval by the Google Play Store and Apple Store.
1724	en	ti	"On 12 April, the government stated that the contact tracing app was in an advanced stage of development, and would be available for deployment within weeks.A similar app is planned in Ireland, and in France (""StopCovid"")."	ኣብ ኣፕሪል 12፡ እታ ርክባት ትከታተል ምምዕባል ኣፕሊኬሽን ከም ዝሰጎመን ኣብ ውሽጢ ሰሙናት ንምስላፍ ቅሩብ ምዃኑን እቲ መንግስቲ ሓቢሩ ።ተመሳሳሊ ኣፕሊኬሽን ንምምዕባል ኣብ ኣየርላንድን ፈረንሳን ይውጠን ኣሎ(“ኮቪድ ግታእ”) ።	On April 12, the government announced that development of the communications tracking application had advanced and was ready to be deployed within weeks. Similar applications are planned in Ireland and France (“Contain COVID”).
1725	en	ti	Both Australia and New Zealand are considering apps based on Singapore's TraceTogether app and BlueTrace protocol.Russia intends to introduce a geofencing app for patients diagnosed with COVID-19 living in Moscow, designed to ensure they do not leave home.	ኣውስትራሊያ ኒውዚላንድን ኣብ ናይ ሲንጋፖር TraceTogether መተግበሪ ን BlueTrace ፐሮቶኮልን መሰረት ዝገበሩ መተግበሪታት ንምጥቃም ኣብ ግምት የእትዋ ኣለዋ።ሩስያ ንዝተረጋጹ ኣብ ሞስኮ ዝነብሩ ናይ ኮቪድ-19 ሕሙማት geofencing መተግበሪ ክተላሊ እያ፣ ካብ ገዝኦም ከምዘይወጹ ንምርግጋጽ ዝተነደፈ መተግበሪ እዩ።	Australia and New Zealand are considering using applications based on Singapore&#39;s TraceTogether application and the BlueTrace protocol.
1726	en	ti	Ross Anderson, professor of security engineering at Cambridge University, listed a number of potential practical problems with app-based systems, including false positives and the potential lack of effectiveness if takeup of the app is limited to only a small fraction of the population.	ሮስ ኣንደርሰን ኣብ ካምብሪጅ ዩኒቨርሲቲ ናይ ድሕነት ምህንድስና ፕሮፌሰር፡ ምስ ኣብ ኣፕሊኬሽን መሰረት ዝገበሩ ስርዓታት ተተሓሒዞም ክመጽኡ ዝኽእሉ ብዙሓት ተግባራዊ ጸገማት ዘርዚሩ ።እዚ ድማ ንግጉይ ኣዎንታዊ ውጽኢት ምሃብን ምስ ምጥቃም እታ ኣፕሊኬሽን ኣብ ውሑድ ክፋል እቲ ህዝቢ ተተሓሒዙ ክመጽእ ዝኽእል ምጉዳል ኣድማዕነትን የጠቓልል።	Ross Anderson, a safety engineering professor at Cambridge University, outlined the many practical problems that can arise with application-based systems .These include false positives and potential lack of effectiveness associated with using the application in a small proportion of the population.
1727	en	ti	"Addressing concerns about the spread of misleading or harmful ""coronavirus"" apps, Apple set limits on which types of organizations could add coronavirus-related apps to its App Store, limiting them to only ""official"" or otherwise reputable organizations."	"ዝተሰሓሓተ ወይ ጎዳኢ ሓበሬታ ናይ ዝህቡ ናይ ""ኮሮናቫይረስ"" መተግበሪታት ስርጭት ንምፍታሕ፣ Apple ምስ ኮሮናቫይረስ ዝተተሓሓዙ መተግበሪታት ናብ App Store ክሓውሱ ዝፈቕደሎም ድርጅታት ገደብ ጌሩ፣ ን ""ዕላዊ"" ወይ ንተኣመንቲ ድርጅታት ጥራሕ እዩ ዝፈቅድ።"	To address the spread of &quot;coronavirus&quot; apps that provide conflicting or harmful information, Apple has limited the number of companies it allows to include coronavirus-related apps into the App Store, allowing only &quot;public&quot; or trusted companies.
1728	en	ti	Google and Amazon have implemented similar restrictions.	ጉግልን ኣማዞንን ተምሳሳልቲ እግዳታት ኣተግቢሮም ኣለዉ።	Google and Amazon have implemented similar bans.
1729	en	ti	Privacy campaigners voiced their concern regarding the implications of mass surveillance using coronavirus apps, in particular about whether surveillance infrastructure created to deal with the coronavirus pandemic will be dismantled once the threat has passed.	ናይ ብሕታውነት ጎስጎስቲ ናይ ኮሮና ቫይረስ መተግበሪታት ብምጥቃም ዝግበር ናይ ሓፋሽ ክትትል ከምጽኦ ዝኽእል ጽልዋ ብዘለዎም ስግኣት ድምጾም ኣስሚዖም፡ ብፍላይ ድማ እዚ ንለበዳ ኮሮናቫይረስ ንምግታእ ኢሉ ዝተሃንጸ ናይ ክትትል ሃዋሁ እቲ ሓደጋ ድሕሪ ምሕላፉ ይፍንጣሕ ድዩ ዋላስ ኣይኮነን ብዝምልከት ።	Privacy advocates have raised concerns about the potential impact of mass surveillance using coronavirus apps, especially whether the surveillance environment built to contain the outbreak will unravel after the disaster.
1730	en	ti	Amnesty International and over 100 other organizations issued a statement calling for limits on this kind of surveillance.	Amnesty Internationalን ካልኦት ልዕሊ 100 ዝኾኑ ትካላትን ኣብ ከም ዚኦም ዓይነታት ስለላታት ገደብ ክግበር መግለጺ ሂቦም።	Amnesty International and more than 100 other organizations have called for restrictions on such espionage.
1731	en	ti	The organisations declared eight conditions on governmental projects:	እቲ ትካል ኣብ ናይ መንግስቲ ፕሮጀክትታት ሸሞንተ ኩነታት ኣዊጁ፡	The agency declared eight conditions on government projects:
1732	en	ti	"surveillance would have to be ""lawful, necessary and proportionate"";"	እቲ ክትትል ‘’ሕጋዊ፣ኣገዳስን ተመጣጠነን’’ ክኸዉን ይግባእ።	The monitoring should be &#39;&#39;legal,relevant and proportionate&#39;
1733	en	ti	extensions of monitoring and surveillance would have to have sunset clauses;	ናይ ምቁጽጻርን ምክትታልን መደባት ናይ ዘብቅዑሉ እዋን መግለጺ የድልዮም እዩ።	Control and monitoring programs require a statement of when they expire.
1734	en	ti	the use of data would have to be limited to COVID-19 purposes;	ናይ ዳታ ጥቕሚ ንCOVID-19 ጥራሕ ክወሰን እዩ።	Data benefits will be limited to COVID-19 only.
1735	en	ti	data security and anonymity would have to be protected and shown to be protected based on evidence;	ናይ ሓበሬታ ድሕነትን ሕቡእነትን ኣብ ጭብጢ መርኩስ ብምግባር ክሕለውን ከምዝሕለው ክረኣይን ኣለዎ ።	The security and confidentiality of information must be protected and ensured to be protected on an evidence-based basis.
1736	en	ti	digital surveillance would have to avoid exacerbating discrimination and marginalisation;	ዲጂታዊ ጽኑዕ-ሓለዋ ንምብኣስ ፍልልይን ጉስያን ከወግድ ኣለዎ፡	Digital fixed-protection must eliminate differences and gussies to fight:
1737	en	ti	any sharing of data with third parties would have to be defined in law;	ዝኾነ ይኹን ዳታ ምስ ሳልሳይ ኣካል ምክፋል ብሕጊ ክግለጽ ኣለዎ;	Sharing any data with third parties must be disclosed by law;
1738	en	ti	there would have to be safeguards against abuse and the rights of citizens to respond to abuses;	ኣንጻር ጥቕዓታትን ናይ ዜጋታት ነዞም ጥቕዓታት እዚኦም መልሲ ናይ ምሃብ መሰል ሓለዋ ክህልዉ ኣለዎ;	There must be protection against attacks and the right of citizens to respond to these attacks;
1739	en	ti	"meaningful participation by all ""relevant stakeholders"" would be required, including that of public health experts and marginalised groups.The German Chaos Computer Club (CCC) and Reporters Without Borders (Reporter ohne Grenzen) (RSF) also issued checklists."	"""ትርጉም ዘለዎ ተሳትፎ"" ብ ኩሎም ""ዝምልከቶም ሼር ተሓዝቲ"" የድሊ እዩ፣ ናይ ህዝባዊ ጥዕና ሰብ ሞያታትን ናይ ዝተሓዋወሱ ጉጅለታትን ሓዊሱ። ናይ ጀርመን ኮኣስ ኮምፒዩተር ክለብን(CCC) ዶብ ዘይግድቦም ጸብጸብቲን(Reporter ohne Grenzen) (RSF) እውን ቼክሊስት ኣውጺኦም እዮም።"	&quot;Meaningful participation&quot; by all &quot;relevant shareholders&quot; is required, including public health professionals and mixed groups. The German Coas Computer Club (CCC) and Reporter ohne Grenzen (RSF) have also issued checklists.
1740	en	ti	The proposed Google/Apple plan intends to address the problem of persistent surveillance by removing the tracing mechanism from their device operating systems once it is no longer needed.	እዚ ቀሪቡ ዘሎ ናይ Google/Apple ትልሚ ኣድላዪ ኣብ ዘይኮነሉ ግዘ እዚ ናይ ክትትልን ሓለዋን ሜላ ካብ ናይ ኤሌክግሮኒክስ መጥቀሚታቶም ብምውጋድ ቀጻላይ ዝኾነ ናይ ሓለዋ ጸገም ክፈትሑ ይደለዩ።	When this proposed Google/Apple plan is not necessary, they want to solve the ongoing security problem by removing this monitoring and protection technique from their electronics devices.
1741	en	ti	Some countries used network-based location tracking instead of apps, eliminating both the need to download an app and the ability to avoid tracking.	ገለ ሃገራት መተግበሪታት ካብ ምጥቃም ኔትዎርክ መሰረት ዝገበረ ናይ ቦታ መድለዪ መገዲታት ተጠቒመን፣ መተግበሪታት ካብ ኢንተርኔት ናይ ምውራድን ኣድላይነትን ናይ ምክትታላት ተኽእሎታት ንምውጋድ ጠቓሚ እዩ።	Some countries have resorted to using network-based location tracking mechanisms rather than applications, useful to avoid the possibility of downloading applications from the Internet and the need for monitors.
1742	en	ti	In Israel, network-based tracking was approved.	ኣብ እስራኤል ኣብ ኔትዎርክ መሰረት ዝገበረ ምክትታል ጸዲቑ ኣሎ ።	Network-based monitoring has been approved in Israel .
1743	en	ti	Network-based solutions that have access to raw location data have significant potential privacy problems.	ንጥረ ናይ ከባቢ ሓበሬታ ክረከብ ዝኽእል ኣብ መርበብ ዝተመስረተ መፍትሒ ዓቢ ዝኾነ ናይ ብሑትነት ፀገም ኣለዎ።	A network-based solution where raw local information can be accessed has a huge privacy problem.
1744	en	ti	However, not all systems with central servers need to have access to personal location data; a number of privacy-preserving systems have been created that use central servers only for intercommunication (see section below).	ኮይኑ ግን ኩሎም ማእኸላይ ሰርቨር ዘለዎም ናብ ውልቃዊ ናይ ኣከባቢ መሐበሪ ክረኸቡ ኣለዎም ማለት ኣይኮነን፡ ማእከላይ ሰርቨር ውሽጣዊ ርክባት ንምስልሳል ጥራይ ኣብ ጥቕሚ ንኽውዕሉ ዝገብሩ ብዙሓት ናይ ብሑትነት ፖሊሲታት ተፈጢሮም ኣለዉ (ኣብ ታሕቲ ዘሎ ክፋል ይርኣዩ)።	However, not all central server owners must have access to private local information, and many privacy policies have been created to allow central servers to be used only for internal communications (see section below).
1745	en	ti	In South Korea, a non-app-based system was used to perform contact tracing.	ኣብ ደቡብ ኮርያ፣ ናይ ንኽክእ ከይዲ ንምክትታል ካብ መተግበሪ ወጻኢ ዝኾነ ስርዓት ኣብ ጥቕሚ ውዒሉ እዩ።	In South Korea, an off-the-shelf system has been used to monitor the contact process.
1746	en	ti	Instead of using a dedicated app, the system gathered tracking information from a variety of sources including mobile device tracking data and card transaction data, and combined these to generate notices via text messages to potentially-infected individuals.	ርእሱ ዝወሰነ መተግበሪ(app) ካብ ምጥቃም፡እዚ መስርሕ መጠቆሚ ሓበሬታ ካብ ዝተፈላለዩ ምንጭታት ከም በዓል ናይ ሞባይል መከታተሊ ዳታ ከምኡ’ውን ናይ ካርታ ሽመታ ዳታ ብምሕዋስ ናብቲ ሕማም ዝተቃልዑ ውልቀ-ሰባት ጽሑፋዊ መልእክትታት ይሰድድ።	Rather than using a self-contained app, this referral process incorporates information from a variety of sources such as mobile tracking data and map appointment data to send text messages to vulnerable individuals.
1747	en	ti	In addition to using this information to alert potential contacts, the government has also made the location information publicly available, something permitted because of far-reaching changes to information privacy laws after the MERS outbreak in that country.	እዚ ሓበሬታ እዚ ተነኻኺኦም ክኾኑ ዝኽእሉ ሰባት ካብ ምንቃሕ ብተወሳኺ፣ እቲ መንግስቲ እቲ ናይ ቦታ ሓበሬታ ንህዝቢ ቅሩብ ጌርዎ፣ ድሕሪ ናይ እታ ሃገር ናይ MERS ለበዳ ምኽንያት ዝተፈጠረ ናይ ሓበሬታ ፖሊሲ ለውጢ ክፍቀድ ዝገበሮ ነገር እዩ።	In addition to alerting people who may have been touched by this information, the government made the location information available to the public, something that allowed for information policy changes that occurred in the wake of the country&#39;s MERS outbreak.
1748	en	ti	This information is available to the public via a number of apps and websites.Countries including Germany considered using both centralized and privacy-preserving systems.	እዚ ሓበሬታ እዚ ብዝተፈላለዩ መተግበሪታትን መርበብ ሓበሬታትን ቅሩብ እዩ።ከም በዓል ጀርመን ዝበላ ሃገራት እውን ማእኸላይን ናይ ውልቃዊነት -ዓቃቢ ስርዓት ይጥቀማ ኣለዋ።	This information is available through various applications and websites. Countries such as Germany are also using a centralized and privacy -protective system.
1749	en	ti	As of 6 April 2020, the details had not yet been released.	ካብ ኣፕሪል 6, 2020 ጀሚሩ ዝርዝራት ኣይወጽኡን።	Details have not been released since April 6,
1750	en	ti	Privacy-preserving contact tracing is a well-established concept, with a substantial body of research literature dating back to at least 2013.As of 7 April 2020, over a dozen expert groups were working on privacy-friendly solutions, such as using Bluetooth Low Energy (BLE) to log a user's proximity to other cellphones.	ብሑትነት ብምሕላው ምስ ሕሙም ርክብ ዘለዎም ሰባት ንምርካብ ዝግበር ኣከያይዳ ብሕጋዊ ኣግባብ ዝተሰረተ ኮይኑ ነዚ ዝምርምር ስነፅሑፍ ኣካል ተነኣሰ ኣብ 2013 ተጀሚሩ። ካብ 7 ሚያዝያ 2020 ጀሚሩ ልዕሊ ደርዘን ዝኾኑ ጉጅለ ባዓል ሞያታት ከም ብሉቱዝ ሎው ኢኔርጂ (BLE) ብምጥቃም ተጠቃማይ ናብ ካልኦት ስልክታት ክንደይ ዝኣክል ይቐርብ ዝብል ብምምዝጋብ ብሑትነት ዘይጎድእ መፍትሒ ምጥቃም ይከኣል እዩ።	The practice of contacting patient contacts by maintaining confidentiality is legally established and a body of literature examining this began at least in 2013. Starting April 7, 2020, more than a dozen teams of professionals will use Bluetooth Low Energy (BLE) to record how close a user is to other phones.
1751	en	ti	However, PEPP-PT is a co-ordination effort which contains both centralised and decentralised approaches, and is not a single protocol.Decentralised protocols include Decentralized Privacy-Preserving Proximity Tracing (DP-PPT/DP-3T), Temporary Contact Numbers (TCN, fka Contact Event Numbers, CEN), Privacy Sensitive Protocols and Mechanisms for Mobile Contact Tracing (PACT) and others.	እንተኾነ ግን፣ PEPP-PT ዝተማእኸለን ዘይተማእኸለን ኣቀራርባ ዝሓዘ ናይ ሕብረት ጻዕሪ እዩ፣ ነጸላ ፕሮቶኮል እውን ኣይኮነን። ዘይተማእኸሉ ፕሮቶኮላት ዝበሃሉ ናይ ውልቃዊነት-ዝሕልዉ ኣቕርቦታት ክትትል (DP-PPT/DP-3T)፣ ግዜያዊ ናይ ንኽክእ ቁጽሪታት (TCN, fka ንኽክእ ምድላው ቁጽሪታት፣ CEN)፣ ውልቃዊ ብቐሊሉ ተቓላዒ ፕሮቶኮላትን ናይ ተንቀሳቓሲ ንኽክእ ምክትታልን (PACT) ከምኡውን ካልኦት ካብ ማእኸለ ምብታን እዩ።	however, PEPP-PT is a fellowship effort with centralized and decentralized approaches, and is not an isolated protocol. Decentralize decentralized protocols such as privacy-preserving presentations monitoring (DP-PPT/DP-3T), temporary contact numbers (TCN, fka contact preparation numbers, CEN), personal vulnerable protocols and mobile contact tracking (PACT) and others is.
1752	en	ti	In these protocols, identifiable personal data never leaves the device, and all matching happens on-device.	ኣብዚኦም ፕሮቶኮላት፡ ዝልለ ውልቃዊ ሓበሬታ ካብ'ዚ መሳርሒ ኣይወጽእን ከምኡ'ውን ኩሉ ምስምማዕ ሓበሬታ ኣብ'ቲ መሳርሒ ይፍጸም።	In these protocols, identifiable personal information does not leave this device and all information synchronization takes place on the device.
1753	en	ti	The Privacy Group at MIT Media Lab has been developing SafePaths, a platform for using privacy-preserving techniques when collecting and using location or path intersection data to track the spread of COVID-19.	ኣብ MIT ሚድያ ላብራቶሪ ዝርከብ ናይ ፅንዓት ጉጅለ ኣንይ ቦታ መረዳእታት ኣብ ምእካብን ኣብ ምጥቃምን ናይ privacy-preserving ቴክኒካት ብምጥቃም ውይድማ path intersection data ብምጥዋም ናይ COVID-19 ናይ ተላባድነት ቅልጣፈ ንምፍላጥ ውሕስ መንገዲ ኣብ ምምዕባል ይርከቡ።	A research team at the MIT Media Laboratory is developing a safe way to determine the speed of COVID-19 infection by using privacy-preserving techniques to collect and use location data.
1754	en	ti	"It is based on research from the whitepaper ""Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic"" released in March 2020.Another similar effort is the SafeTrace platform by Enigma MPC, a company developing privacy technologies that was also originally founded at the MIT Media Lab."	"መሰረቱ ኣብ መጽናዕቲ ካብ ዋይትፔፐር ""ዝወስለቱ ኣፓት፡ ምዕቃብ ውልቃዊ ብሕትና ኣብ ግዜ ለበዳ"" ብምግባር ኣብ ማርች 2020 ዝተዘርግሐ እዩ ።ካልእ ተመሳሳሊ ጻዕሪ ድማ ብ ኤኒግማ ኤምፒሲ ዝበሃል ኣብ ኤምኣይቲ ሜድያ ላብራቶሪ ዝማዕበለ ናይ ብሕቲ ቴክኖሎጂታት ዘማዕብል ትካል ዝተሰርሐ ሴፍ ትሬስ ፕላትፎርም እዩ።"	It is based on research from the whitepaper &quot;Zweslet Apat: Preserving Personal Privacy in a Pandemic,&quot; released in March 2020. Another similar effort is the Safe Trace platform by Enigma MPC, a private technologies developer developed at MIT Media Lab.
1755	en	ti	SafeTrace utilizes secure hardware technologies to allow users to share sensitive location and health data with other users and officials, without compromising the privacy of that data.	ሴፍ ትሬስ ውሕሰነቶም ዝተረጋገጹ ናይ ሃርድዌር ቴክኖሎጂታት ብምጥቃም፡ ተጠቀምቲ ናይ ውልቂ ኣድራሻን ናይ ጥዕና ኩነታት ምስ ካልኦት ተጠቀምቲን ሰራሕተኛታትን ብዘይ ስግኣት ክለዋወጡ ዝገብር እዩ።	Using proven hardware technologies, Safe Trace allows users to safely exchange personal address and health status with other users and employees.
1756	en	ti	On 5 April 2020, the global TCN Coalition was founded by groups that had coalesced around what was essentially the same approach and largely overlapping protocols, with the goal to reduce fragmentation, and enable global interoperability of tracing and alerting apps, a key aspect of achieving widespread adoption.	ኣብ 5 ኣፕሪል 2020፣ ዓለም ለኻዊ TCN ሕብረት ብዛዕባ ተመሳሳሊ ዝኾኑ ኣቀራርባታትን ተደራረብቲ ፕሮቶኮላትን ብዝምልከት ዝሓበሩ ጉጅለታት ዝተመስረተ እዩ፣ ዕላምኡ ድማ ምቁርራጽ ንምቕናስን፣ ዓለም ለኻዊ ናይ መከታተሊን መንቅሒን ኣፓት ኣብ ምፍጣር ብሓባር ምስራሕን እዩ፣ ናይ ብሰፊሑ ዝተሰራጨወ ቁልፊ ከይዲ።	On April 5, 2020, the Global TCN Alliance was formed by groups that reported on similar approaches and overlapping protocols, with the goal of reducing disruption and working together to create a global tracking and alarm app, a widely distributed key process.
1757	en	ti	On 9 April 2020, the Singaporean government announced that it had open-sourced the BlueTrace protocol used by its official government app.	ኣብ ኤፕሪል 9, 2020 መንግስቲ ሲንጋፖር እቲ ስሩዕ ናይ እቲ መንግስቲ መተግበሪ ዝጥቀመሉ ብሉትሬስ ፕሮቶኮል ከምዝተኸፈተ ገሊፁ።	On April 9, 2020, the Singapore government announced that the BlueTrace protocol used by the government&#39;s regular application has been launched.
1758	en	ti	On 10 April 2020, Google and Apple, the companies that control the Android and iOS mobile platforms, announced an initiative for contact tracing, which they claimed would preserve privacy, based on a combination of Bluetooth Low Energy technology and privacy-preserving cryptography.	ኣብ ኣፕሪል 10, 2020 ን ናይ ኣንድሮይድን ኣይ ኦ ኤስን ናይ ሞባይል መድረኽ ዝቆጻጸሩ ጉግልን ኣፕልን፡ ብሕታዊነት ይዕቅብ እዩ ዝበልዎ ብምጽንባር ኣብ ትሑት ሓይሊ ብሉቱዝ ቴክኖሎጂን ውሕስነት መዐቀቢ ክሪፕቶግራፊን መሰረት ዝገበረ ርክባት ናይ ምክትታል ተበግሶ ኣዊጆም።	On April 10, 2020, Google and Apple, which control the Android and iOS mobile platforms, announced an initiative to monitor communications based on low-power Bluetooth technology and secure cryptography.
1759	en	ti	They also published specifications of the core technologies used in the system.	ኣብ እዚ ሲስተም እዚ ናይ ዝተጠቐሙ ወሰንቲ ቴክኖሎጂታት መብራህርሂታት እውን ኣሐቲሞም እዮም።	They also published explanations of the key technologies used in this system.
1760	en	ti	According to Apple and Google, the system is intended to be rolled out in three stages:	ብ መሰረት ኣፕልን ጉግልን ፣ እቲ ስርዓት ኣብ ሰለስተ ብርኪታት እዩ ናብ ስራሕ ክኣቱ።	According to Apple and Google , the system will be launched in three phases.
1761	en	ti	rollout of tools to enable governments to create official privacy-preserving coronavirus tracing apps	መንግስቲታት ዕላዊ ናይ ውልቃውነት-ዓቃቢ ኮሮናቫይረስ መከታተሊ መተግበሪ ንክፈጥሩ ዘኽእሉ መሳርሒታት	Tools to enable governments to create public privacy-preserving coronavirus tracking applications
1762	en	ti	integration of this functionality directly into iOS and AndroidGoogle and Apple plan to address the take-up and persistent surveillance problems by first distributing the system through operating system updates, and later removing it in the same way once the threat has passed.	ናይ'ዚ መስርሕ እዚ ብቐጥታ ናብ 'ቲ OS ን Android ጉግል ን ኣፕልን መጀምሪያ ብ መንገዲ ነቲ ስርዓት ብመንገዲ ናይ ኮምፒውተር ኦፕሬቲንግ ስርዓት ምህዳስ ኣቢልካ ብምዝርጋሕ ደሓር ከዓ እቲ ሓድጋ ምስ ሓለፈ ብተመሳሳሊ መንገዲ ካብቲ ስርዓት ንኸውፅእ ናይ ምግባር ናይ ምውሳድን ቀፀልቲ ናይ ዳህሳስ ፀገማትን ንምፍላጥ ትልሚ ምትእሰሳር እዩ።	Link this process directly to the OS and Android Google and Apple first by way of deploying the system through a computer operating system update and then removing it from the system in the same way after the legacy has passed and planning to identify further survey problems is.
1763	en	ti	b'Drug repositioning (also known as drug repurposing, re-profiling, re-tasking or therapeutic switching) is the repurposing of an approved drug for the treatment of a different disease or medical condition than that for which it was originally developed.	b'Drug ደጊምካ ምመሕያሽ (ናይ መድሓኒት ደጊምካ ንካልእ ዕላማ ምውዓል፣ ሪ -ፕሮፋይሊንግ፣ ንካልእ ስራሕ ምውዓል ወይ ናይ መድሓኒት ምቕያር እውን ተባሂሉ ይፍለጥ) ንካልእ ሕማም ወይ ናይ ጥዕና ኩነታት ክሕክም ኣፍልጦ ዝተወሃቦ መድሓኒት ንካሊእ ሕማም ክውዕል ምግባር ማለት እዩ።	b&#39;Drug Repurposing (also known as drug repurposing, re -profiling, repurposing or drug conversion) is the use of a drug that has been approved to treat another disease or health condition for another disease.
1764	en	ti	This is one line of scientific research which is currently being pursued to develop safe and effective COVID-19 treatments.	እዚ ኣብ’ዚ ግዜ’ዚ ኣድማዕነቱን ድሕነቱ ዘተኣማምንን ናይ COVID-19 ፍወሳታት ንምምዕባል ክትትል ዝግበረሉ ሓደ መስመር ናይ ሳይንሳዊ መጽናዕቲ እዩ።	This is one line of scientific research currently being pursued to develop effective and safe COVID-19 treatments.
1765	en	ti	Other research directions include the development of a COVID-19 vaccine and convalescent plasma transfusion.SARS-CoV-2 has about 66 druggable proteins, each of which has multiple ligand binding sites.	ካልኦት ናይ መጽናዕቲ ኣንፈታት ናይ ኮቪድ -19 ክትባት ምምዕባልን ኮንቨልሰንት ፕላስማ ትራንስፊዩዢንን ዘካትት እዩ። SARS-CoV-2 66 ዝኾኑ መድሓኒት ክስርሖም ዝኽእሉ ፕሮቲናት ኣለዉ፣ ሕድሕዶም ብዙሓት ሊጋንድ መትሓዚ ቦታታት ኣለዎም።	Other research directions include the development of COVID-19 vaccines and convulsive plasma transfusion. SARS-CoV-2 has 66 druggable proteins, each with multiple ligand binding sites.
1766	en	ti	Analyzing those binding sites provide the reasonable project of developing effective antiviral drug against COVID-19 proteins.	መላገቢ ቦታታት ምምርማር ኣንጻር COVID-19 ፕሮቲናት ኣድማዒ ዝኾነ መድሃኒት ንምምዕባል ሓቀኛ ዝኾነ ዕቅድ የቕርብ።	Examining binding sites offers a realistic plan for developing effective drugs against COVID-19 proteins.
1767	en	ti	Of the most important SARS-CoV-2 target proteins are papain-like protease, RNA dependent RNA polymerase, helicase, S protein, and ADP ribophosphatase.	ካብ ናይ SARS-CoV-2 ዕላማ ዝግበሩ ፕሮቲናት ኣዚዮም ጠቐምቲ ፓፓይን-ዓይነት ፕሮቴዝ፣ RNA ጽግዕተኛ RNA ፖሊመሬዝ፣ ሄሊኬዝ፣ S ፕሮቲንን ADP ራይቦፎስፊቴዝን እዮም።	Among the most useful target proteins of SARS-CoV-2 are papain-type protease, RNA dependent RNA polymerase, helicase, S protein and ADP ribophosphitase.
1768	en	ti	Hussein A A, et al studied several candidate compounds which then optimized and analyzed for their skeleton similarity with the highest similar approved drugs in order to accelerate a potent anti-SARS-CoV-2 drug development in his preclinical study to be recommended in a clinical study design.	Hussein AA, et al ዝተፈላለዩ ዉሁዳት ኣጽኒዑ ድሕሪኡ ድማ ምስቲ ልዑል ተመሳሳሊ ኣፍልጦ ዝተወሃቦ መድሓኒት ናይ ብቑዕ ጸረ -SARS-CoV-2 መድሓኒት ምዕባለ ኣብ ቅድመ ክሊኒካዊ መጽናዕቲ ኣብ ክሊኒካል መጽናዕቲ ንድፊ ክውስኽን ክገብር ድማ ክኢሉ።	Hussein AA, et al studied various compounds and then with the highly similar recognized drug of efficient anti -SARS-CoV-2 drug development in preclinical studies and was able to add in clinical study design.
1769	en	ti	Chloroquine is an anti-malarial medication that is also used against some auto-immune diseases.	ክሎሮክዊን ናይ ዓሶ መድሓኒት ኮይኑ ንሓደሓደ ኣዉቶኢምዩን ሕማማት እዉን ይጥቀም እዩ።	Chloroquine is a tuberculosis drug and is also used for some autoimmune diseases.
1770	en	ti	On 18 March, the WHO announced that chloroquine and the related hydroxychloroquine would be among the four drugs studied as part of the Solidarity clinical trial.	ብማርች 18 WHO ክሎሮኪንን ምስኡ ዝዛመድ ሃይድሮክሲክሎሮኪንን ካብቶም ኣርባዕተ ከም ኣካል ስምረት ክሊኒካዊ ፈተነታት ዝተጸንዑ መድሃኒታት ከምዝኾኑ ኣፍሊጡ።	On March 18, the WHO announced that chloroquine and the related hydroxychloroquine were among the four drugs studied as part of Simret clinical trials.
1771	en	ti	New York governor Andrew Cuomo announced that New York State trials of chloroquine and hydroxychloroquine would begin on 24 March.On 28 March, the FDA authorized the use of hydroxychloroquine sulfate and chloroquine phosphate under an Emergency Use Authorization (EUA).	ናይ ኒውዮርክ ኣማሓዳሪ ኣንድሪው ኩዎሞ ናይ ኒውዮርክ ግዝኣት ናይ chloroquine(ክሎሮኲን) ን hydroxychloroquine(ሃይድሮክስይልክሎሮኲን) ን ፈተነ ኣብ 24 ማርች ከምዝጅምር ሓቢሮም።ኣብ 28 ማርች፣ FDA ናይ hydroxychloroquine sulfate(ሃይድሮክስይልክሎሮኲን ሰልፌት)ን chloroquine phosphate(ክሎሮኲን ፎስፌት) ን ኣብ ትሕቲ ሃንደበታዊ ጥቕሚ ፈቓድ (EUA) ንምጥቃም ፈቓድ ሂቡ።	New York Governor Andrew Cuomo announced that New York State will begin testing chloroquine and hydroxychloroquine on March 24. On March 28, the FDA approved hydroxychloroquine sulfate and chloroquine phosphate quinone phosphate) and under contingency benefit license (EUA) to use.
1772	en	ti	The treatment has not been approved by the FDA's clinical trials process and is authorized under the EUA only as an experimental treatment for emergency use in patients who are hospitalized but are not able to receive treatment in a clinical trial.	እቲ ፍወሳ ብ ክሊኒካዊ መጽናዕትታት ናይ FDA ተቐባልነት ዝረኸበ ኣይኮነን ከምኡ’ውን ብ ናይ EUA ህጹጽ እዋን ፍቓድ ኣብ ሆስፒታል ደቂሶም ኣብ ክሊኒካዊ ፈተነታት ግን ፍወሳ ክረኽቡ ንዘይከኣሉ ሕሙማት ከም ናይ ሙከራ ህጹጽ ፍወሳ እዩ ተፈቒዱ።	The therapy has not been approved by FDA clinical studies and is approved as an experimental emergency therapy for patients who have been hospitalized but have not been treated in clinical trials with an EUA emergency approval.
1773	en	ti	"The CDC has said that ""the use, dosing, or duration of hydroxychloroquine for prophylaxis or treatment of SARS-CoV-2 infection"" are not yet established."	CDC ‘’ንSARS-CoV-2 ረኽሲ ሃይድሮክሲክሎሮክዊን ከም መከላኸሊ ወይድማ ከም መድሃኒት ክንጥቀመሉ ከምዝከኣል’’ ገና ኣይተሰረተን ኢሉ።	The CDC said it has not yet been established whether hydroxychloroquine can be used as a prevention or treatment for SARS-CoV-2 infection.
1774	en	ti	"Doctors have said they are using the drug when ""there's no other option""."	ዶክተራት “ካልእ ኣማራጺ ምስ ዘይህልው” ነቲ መድሃኒት ከም ዝጥቀሙሉ ሓቢሮም ኣለዉ።	Doctors have said they will use the drug “when there is no other option”.
1775	en	ti	A Turkish research team in Istanbul is conducting a small study on the use of chloroquine in combination with zinc, vitamin A, vitamin C and vitamin D.	ኣብ ኢስታንቡል ናይ ቱርኪ ናይ መጽናዕቲ ጉጅለ ንእሽተይ ምጽናዕቲ ኣብ ኣጠቓቕማ ክሎሮኪን ምስ ዚንክ፡ ቫይታሚን ኤ፡ ቫይታሚን ሲ ከምኡ’ውን ቫይታሚን ዲ የካይድ ኣሎ ።	A Turkish research team in Istanbul is conducting a small study on the use of chloroquine with zinc, vitamin A, vitamin C and vitamin D
1776	en	ti	Large studies are underway at Duke University and the University of Oxford.	ኣብ ዱክ ዩኒቨርሲቲ ን ኣብ ኦክስፎርድ ዩኒቨርሲቲን ዓባይቲ መፅናዕቲታት እናትኻየዱ ይርክቡ።	Major research is underway at Duke University and Oxford University.
1777	en	ti	NYU Langone Medical School is conducting a trial on the safety and efficacy of preventative use of hydroxychloroquine.	NYU Langone ናይ ሕክምና ቤት ትምህርቲ ንናይ hydroxychloroquine ምክልኻል ኣጠቓቕማ ናይ ደሕንነትን ብቕዓትን ፈተነ የካይድ ኣሎ።	NYU Langone School of Medicine is conducting a safety and efficacy trial for the preventive use of hydroxychloroquine.
1778	en	ti	"Chinese clinical trials in Wuhan and Shenzhen claimed to show favipiravir was ""clearly effective""."	"ናይ ቻይና ክሊኒካል ፈተነታት ኣብ ውሃንን ሺንዘንን favipiravir(ፋቪፒራቪር) ""ብግልጺ ብቑዕ"" ከምዝኾነ ኣርእዮም እዮም።"	Chinese clinical trials in Wuhan and Xinzhen have shown favipiravir to be &quot;clearly eligible.
1779	en	ti	35 patients in Shenzhen tested negative in a median of 4 days, while the length of illness was 11 days in the 45 patients who did not receive it.	ኣብ ሸንጀን ኣብ ዉሽጢ 4 መዓልቲታት ካብቲ ቫይረስ ናፃ ዝተብሃሉ 35 ሰባት፣ እቶም ዘይወሰዱ 45 ሰባት ድማ ን 11 መዓልቲታት ዝኾን ኣብ ሕማም ፀኒሖም እዮም።	In Shenzhen, 35 people were declared free of the virus within four days and 45 people who did not receive it remained sick for 11 days.
1780	en	ti	In a study conducted in Wuhan on 240 patients with pneumonia, half were given favipiravir and half received umifenovir.	ኣብ ውሃን ኣብ 240 ናይ ሳንቡእ ውቕዒ ዘለዎም ሕሙማት ዝተገበረ መጽናዕቲ፣ ፍርቆም favipiravir ፍርቆም ድማ umifenovir ክዋሃቡ ተገይሩ እዩ።	In a study of 240 patients with pulmonary stroke in Wuhan, half were given favipiravir and half umifenovir.
1781	en	ti	The Italian Pharmaceutical Agency reminded the public that the existing evidence in support of the drug is scant and preliminary.	ናይ ጣልያን ፋርማሲቲካዊ ትካል ነቲ መድሃኒት ዝድግፍ ህሉው መርትዖ መባእታዊን ዘይእኹልን ከም ዝኾነ ንህዝቢ ኣዘኻኺሩ።	The Italian Pharmaceutical Agency reminded the public that the current evidence in support of the drug was preliminary and insufficient.
1782	en	ti	On 2 April, Germany announced that it would purchase the drug from Japan for its stockpile, and use the military to deliver the drug to university hospitals, where the drug will be used to treat COVID-19 patients.	ኣብ ማርች 2, ጀርመን ነቲ መድሃኒት ካብ ጃፓን ንምእካብ ከምእትገዝኦን ናብ ሕሙማት COVID-19 ዝሕከሙሉ ሆስፒታላት ዩኒቨርሲቲ ንምዝርጋሕ ሰራዊት ከም ትጥቀምን ኣፍሊጣ።	On March 2, Germany announced that it would buy the drug from Japan and use the army to distribute it to university hospitals where COVID-19 patients are treated.
1783	en	ti	According to the South China Morning Post, Shinzo Abe has made overtures to the Trump administration about purchasing the drug.The drug may be less effective in severe cases of illness where the virus has already multiplied.	ብ መሰረት ናይ ደቡብ ቻይና ሞርኒንግ ፖስት( South China Morning Post) ከምዝበሎ፣ ሺንዞ ኣቤ ብዛዕባ እቲ መድሓኒት ምዕዳግ ንናይ ትራምፕ ምምሕዳር ኣቕርቦታት ከምዘቕረበ ሓቢሩ።እዚ መድሓኒታት ኣብ ከበድቲ ጉዳያት ለበዳ ክንድ'ቲ ዘይክጠቅም ይኽእል እዩ እቲ ቫይረስ ኣዝዩ ዝተባዛሐ ብምዃኑ።	According to the South China Morning Post, Shinzo Abe has made offers to the Trump administration about the drug purchase, which may not be as useful in severe epidemic cases as the virus is so widespread.
1784	en	ti	It may not be safe for use by pregnant women or those trying to conceive.	ብ ጥኑሳት ውይድማ ጥንሲ ንምሓዝ ብዝምኩራ ዘለዋ ደቂ ኣንስትዮ ኣብ ጥቅሚ ምውዓሉ ውሑስ ዘይክኽውን ይኽእል።	It may not be safe to use by pregnant women who are experiencing pregnancy.
1785	en	ti	"One study of lopinavir/ritonavir (Kaletra), a combination of the antivirals lopinavir and ritonavir, concluded that ""no benefit was observed""."	ሓደ መጽናዕቲ ኣብ ሎፒናቪር/ሪቶናቪር(ካሌትራ) ዝተገብረ፡ ውህደት ናይ ጸረ-ቫይረስ መድሃኒታት ሎፒናቪርን ሪቶናቪርን ”ምንም ጥቕሚ ከምዘነበሮም” ደምዲሙ ኣሎ ።	One study of lopinavir/ritonavir(Caletra) concluded that the combination of the antiviral drugs lopinavir and ritonavir ”had no benefit”
1786	en	ti	The drugs were designed to inhibit HIV from replicating by binding to the protease.	እዞም መድሓኒታት HIV ምስ ፕሮቴዛት ብምትሕሓዝ ከይባዛሕ ዝኽእልክሉ እዮም።	These drugs are used to prevent HIV from multiplying by associating it with prostheses.
1787	en	ti	A team of researchers at the University of Colorado are trying to modify the drugs to find a compound that will bind with the protease of SARS-CoV-2.There are criticisms within the scientific community about directing resources to repurposing drugs specifically developed for HIV/AIDS.	ኣብ ኮሎራዶ ዩኒቨርሲቲ ዘለዉ ኣጽናዕቲ ጉጅለ ምስ ናይ SARS-CoV-2 ፕሮቴዝ ዝተሓሓዘ ኮምፓውንድ ንምፍጣር መድሓኒታት ከመሓይሹ ይፍትኑ ኣለዉ።ኣብ እቲ ናይ ሳይንሳዊ ማሕበረ ሰብ ን HIV/AIDS(ኤች ኣይ ቪ/ ኤዲስ) ጥራሕ ተባሂሎም ዝማዕበሉ መድሓኒታት ንካልእ ዓላማ ንምውዓል ሓፍቲታት ኣብጥቕሚ ይውዕሉ ኣለዉ ብዝብል ነቐፌታ ኣሎ።	A team of researchers at the University of Colorado is trying to improve drugs to create a compound that is linked to the SARS-CoV-2 protease There is criticism.
1788	en	ti	The WHO included lopinavir/ritonavir in the international Solidarity trial.	ውድብ ጥዕና ዓለም(WHO) lopinavir/ritonavir(ሎፒናቪር/ሪቶናቪር) ኣብቲ ዓለምለኻዊ ናይ ምትሕግጋዝ ፈተነ ኣጠቓሊሎምዎ ኣለዉ።	The World Health Organization (WHO) has included lopinavir/ritonavir in the international cooperative trial.
1789	en	ti	Remdesivir was created and developed by Gilead Sciences as a treatment for Ebola virus disease and Marburg virus infections . Gilead Sciences subsequently discovered that Remdesivir had antiviral activity in vitro against multiple filo-, pneumo-, paramyxo-, and corona- viruses .	Remdesivir(ሬምድስቪር) ብ Gilead Sciences ን ናይ ኢቦላ ቫይረስ ሕማምን ማርበርግ ቫይረስ ረኽሲን ንክከላኸል ተፈጢሩ።Gilead Sciences እዚ Remdesivir(ሬምድስቪር) ኣንጻር ዝተፈላለዩ ፊሎ -፣ ኒሞ -፣ ማራሚክሶ -፣ከምኡውን ኮሮና- ቫይረሳት ናይ ጸረ ቫይረስ ንጥፈታት ከምዘለውዎ ጸኒሖም ተረዲኦሞ።	Remdesivir(Remdesivir) was developed by Gilead Sciences to prevent Ebola virus disease and Marburg virus infection.Gilead Sciences later discovered that this Remdesivir(Remdesivir) has antiviral activity against various philo -, pneumonia -, maramixo -,and corona- viruses .
1790	en	ti	One issue with antiviral treatment is the development of resistance through mutations that can lead to more severe disease and transmission.	ናይ እዞም ጸረ-ቫይረስ መድሓኒታት ሓደ ጸገም ብሚቹዌሽን ናይ ምጽዋር ዓቕሚ ምምዕባል እዩ፣ እዚ ድማ ናብ ዝኸበደ ሕማምን ዝርጋሐን ከምርሕ ይኽእል እዩ።	One problem with these antiviral drugs is the development of resistance by mutation, which may lead to more severe disease and spread.
1791	en	ti	Some early pretrial studies suggest remdesivir may have a high genetic barrier to resistance.There are several clinical trials underway, including two conducted by Cleveland University Hospitals; one for people with moderate illness and another for those with more severe illness.	ገለ ቅድም ክብሉ ዝወጹ ቅድመ ፈተነ መጽናዕቲታት remdesivir ንምጽዋር ልዑል ጀነቲክ ገደብ ኣለዎ ኢሎም።ብ ክሊቭላንድ ዩኒቨርሲቲ ሆስፒታላት ዝተኻየዱ ክልተ ፈተነታት፡ ሓደ ን ማእኸላይ ሕማም ዘለዎም ሰባት ሓደ ድማ ን ከቢድ ሕማም ዘለዎም ሓዊሱ ብዙሓት ክሊኒካዊ ፈተነታት ይካየዱ ኣለዉ እዮም።	Some previously published preliminary studies have shown that there is a high genetic limit to resistance to remdesivir. Several clinical trials are underway, including two trials conducted by Cleveland University Hospitals, one for people with moderate disease and one for people with severe disease.
1792	en	ti	There are three ongoing clinical trials of intravenous vitamin C for people who are hospitalized and severely ill with COVID-19; two placebo controlled (China, Canada) and one with no control (Italy).	ኣብ እዚ ሕዚ እዋን ብምኽንያት COVID-19 ከቢድ ሕማም ሒዝዎም ናብ ሕክምና ንዝኣተዉ ሕሙማት ብደም ሱር ዝወሃብ ቫይታሚን ሲ ዘፅንዑ ሰለስተ ክሊኒካዊ ፈተነታት ኣለዉ። ካብዚኦም ድማ፡ ክልተ ናይ ፕላሴቦ ቁፅፅር (ቻይና፣ካናዳ) ሓደ ድማ ብዘይ ቁፅፅር (ጣልያን) ኣለዎም።	There are currently three clinical trials studying intravenous vitamin C in patients admitted with severe illness due to COVID-1 Of these, two have placebo controls (China,Canada) and one without controls (Italy).
1793	en	ti	New York State began trials for the antibiotic azithromycin on 24 March 2020.	ኣብ ማርች 24፣ 2020 ናይ ኔውዮርክ ክልል ናይ ኣዚትሮማሲን ዝተብሃለ ፀረ-ተሃዋስያን ሙከራ ጅሚራ ኣላ።	On March 24, 2020, New York State began a trial of the antibiotic azithromycin.
1794	en	ti	Japan's National Center for Global Health and Medicine (NCGM) is planning a clinical trial for Teijin's Alvesco (ciclesonide), an inhaled corticosteroid for asthma, for the treatment of pre-symptomatic patients infected with the novel coronavirus.	ጃፓን ብሄራዊ ናይ ዓለማዊ ጥዕናን ሕክምናን ማእኸል (NCGM) Teijin's Alvesco (ciclesonide) ተባሂሉ ዝፅዋዕ ንኣስሚ ዝጠቅም ዝትንፈስ ኮርቲኮስቴሮይድ ናይ ኖቭል ኮሮና ቫይረስ ምልክት ገና ንዘየርአዩ ሕሙማት ከም ፈዉሲ ዝጠቅም ምዃኑ ንምምርማር ናይ ክሊኒካዊ ፈተነ ከምዝጅምር ኣፍሊጡ።	Japan&#39;s National Center for Global Health and Medicine (NCGM) has announced that it will begin a clinical trial of Teijin&#39;s Alvesco (ciclesonide), an inhaled corticosteroid for asthma, to test its usefulness as a cure for patients who have not yet shown symptoms of the novel coronavirus.
1795	en	ti	A form of angiotensin-converting enzyme 2, a Phase II trial is underway with 200 patients to be recruited from severe, hospitalized cases in Denmark, Germany, and Austria to determine the effectiveness of the treatment.	ካብ ዴንማርክ፣ጀርመንን ኣዉስትሪያን ኣብ ሕክምና ዝርከቡ ከቢድ ሕማም ዘጋጠሞም 200 ሕሙማት ተወሲዶም ንዉፅኢታዉነት ናይ angiotensin-converting enzyme 2 ደረጃ II ፈተነ ኣብ መስርሕ ኣሎ።	A phase II trial of the efficacy of angiotensin-converting enzyme 2 is underway in 200 critically ill patients undergoing treatment from Denmark, Germany and Austria.
1796	en	ti	Researchers from the Montreal Heart Institute in Canada are currently studying the role of colchicine in reducing inflammation and pulmonary complications in patients suffering from mild symptoms of COVID-19.	ናይ ኣብ ካናዳ ዝርከብ Montreal ናይ ልቢ ትካል colchicine(ክሎኪሳይን) ኣብ ቀሊል ኮቪድ-19 ምልክታት ዘለዎም ሰባት ናይ ፑልሙናሪ ሕልኽላኻትን ቁጠዐን ኣብ ምቕናስ ዘለዎ ግደ ኣብ ምጽናዕ ይርከቡ።	The Montreal Heart Institute in Canada is studying the role of colchicine(cloquicine) in reducing pulmonary complications and irritation in people with mild COVID-19 symptoms.
1797	en	ti	The study, named COLCORONA, is recruiting 6000 adults aged 40 and over who were diagnosed with COVID-19 and experience mild symptoms not requiring hospitalization.	እቲ COLCORONA ተባሂሉ ዝፅዋዕ መፅናዕቲ 6000 ዝኾኑ ዕድሜኦም ካብ 40 ንላዕሊ ዝኾኑ ብCOVID-19 ዝተትሓዙን ቀሊል ዝበሃል ምልክታት ዘርኣዩ፡ ሕክምና ዘየድልዮም ሕሙማት ኣብ ምምልማል ይርከብ።	The COLCORONA study is recruiting 6,000 patients over the age of 40 who are infected with COVID-19 and show mild symptoms that do not require treatment.
1798	en	ti	Women who are pregnant or breastfeeding or who do not have an effective contraceptive method are not eligible.	ጥኑሳት ወይ ጸባ ጡብ ዝዕንግላ ኣዴታት ወይ ኣድማዒ ናይ ጥንሲ መከኸሊ ኣገባብ ዘብለን ብቑዓት ኣይኮናን።	Pregnant or breastfeeding mothers or those without effective contraception are not eligible.
1799	en	ti	Several anticoagulants are being tested in Italy.	ብዙሓት ጸረ-ምርጋእ ዝኾኑ ባእታታት ኣብ ጣልያን ይፍተኑ ኣለው ።	Many anti-sedimentation agents are being tested in Italy.
1800	en	ti	Low-molecular-weight heparin is being widely used to treat patients, prompting the Italian Medicines Agency to publish guidelines on its use.	ትሑት ናይ ሞለኪዩላዊ ክብደት ዘለዎ ሄፓሪን ብብዝሒ ሕሙማት ንምሕካም ይጥቅም፡ ብዚ ምኽንያት ከኣ ናይ ጣልያን ሕክምና ኤጀንሲ ናይ ኣጠቃቕማኡ መምርሒታት ንከሐትም ተገዲዱ።	Low molecular weight heparin is used to treat a large number of patients, prompting the Italian Medical Agency to publish guidelines for its use.
1801	en	ti	A multicenter study on 300 patients researching the use of enoxaparin sodium at prophylaxis and therapeutic dosages was announced in Italy on April 14.	ኣብ 300 ሕሙማት ዝተገብረ ናይ ብዙሕ ማእኸል መፅናዕቲ ናይ ኢኖክሳፓሪን ሶድየም ከም መከላኸልን ከም መድሃኒት መጠን ጥቕሚ ንኽፅናዕ ኣብ ጣልያን ኣብ ሚያዝያ 14 ተኣዊጁ።	A multicenter study of enoxaparin sodium in 300 patients was announced in Italy on April
1802	en	ti	Since SARS-CoV-2 is a virus, considerable scientific attention has been focused on repurposing approved anti-viral drugs that were developed for prior outbreaks such as MERS, SARS, and West Nile virus.	SARS-CoV-2 ቫይረስ ስለዝኾነ፡ ብዙሕ ስነፍልጠታዊ ኣድህቦ ኣብ ቅድሚ ዝርግሐ MERS፡SARS ከምኡ’ውን ናይ ምዕራብ ናይል ቫይረስ ማዕቢሎም ተቐባልነት ንዝረኸቡ ጸረ-ቫይረስ መድሃኒታት ዳግማይ ኣብ ዕላማ ኣብ ምእታው ክግበር ጸኒሑ።	Because SARS-CoV-2 is a virus, much scientific attention has been focused on re-targeting antiviral drugs that were developed and approved before the outbreak of MERS, SARS and West Nile virus.
1803	en	ti	Ribavirin: ribavirin was recommended for COVID-19 treatment according to Chinese 7th edition guidelines	ሪባቪሪን: ሪባቪሪን ከም መድሃኒት COVID-19 ኮይኑ ንኽሰርሕ ናይ ቻይና 7ይ ሕታም መምርሒ ይመክር።	Ribavirin: China&#39;s 7th edition guidelines recommend ribavirin as a treatment for COVID-1
1804	en	ti	Umifenovir: umifenovir was recommended for COVID-19 treatment according to Chinese 7th edition guidelines	Umifenovir(ኡሚፈኖቪር): umifenovir(ኡሚፈኖቪር) ብናይ ቻይና መበል 7ይ ሕታም መሰረት ንኮቪድ-19 መሐከሚ ኣብ ጥቕሚ ክውዕል ተመኺሩ ነይሩ	Umifenovir(umifenovir): umifenovir(umifenovir) was recommended for use for the treatment of COVID-19 according to the Chinese 7th edition
1805	en	ti	Some antibiotics that have been identified as potentially repurposable as COVID-19 treatments:	ገለ ጸረ-ረኽሲታት ከም ንኮቪድ-19 መድሓኒት ኮይኖም ክቐርቡ ይኽእሉ እዮም ተባሂሎም ዝተፈለዩ ኣለዉ:	Some antibiotics have been identified as potential cures for COVID-19:
1806	en	ti	Tocilizumab (Anti-IL-6 receptor): Approved by China.	Tocilizumab(ቶሲሊዙማብ) (ጸረ-IL-6 ተቐባሊ): ኣብ ቻይና ፈቓድ ተዋሂብዎ።	Tocilizumab(tocilizumab) (anti-IL-6 receptor): licensed in China.
1807	en	ti	Also trials in Italy and China. and see Tocilizumab#COVID-19.	ከምኡ’ውን ፈተነታት ኣብ ጣልያንን ቻይናንን ቶሲሊዙማብ# COVID-19 ን ርአ።	See also trials in Italy and China for tocilizumab# COVID-1
1808	en	ti	b'A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19).	b'A ናይ COVID-19 ክትባት ኣብ 2019 ንዘጋጠመ ኮሮና ቫይረስ (COVID-19) ዝከላኸል ናይ ስነሓሳብ ክትባት እዩ።	b&#39;A COVID-19 vaccine is an ideological vaccine that protects against the 2019 coronavirus (COVID-19).
1809	en	ti	Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.	ናይ ክሊኒካዊ ፈትነኡ ዝወደአ ዝኾነ ዓይነት ከትባት እኳ እንተዘይ ሃለወ፣ ነዚ ክምዚ ዝበለ ከትባት ንምምዕባል ብዙሓት ፈተነታት ኣብ መስርሕ ይርከቡ።	Although no vaccine has completed its clinical trial, many trials are underway to develop such vaccines.
1810	en	ti	In late February 2020, the World Health Organization (WHO) said it did not expect a vaccine against SARS-CoV-2, the causative virus, to become available in less than 18 months.	ኣብ ፌብሩዋሪ 2020 መወዳእታታት፣ ናይ ውድብ ጥዕና ዓለም(WHO) ኣብ ውሽጢ 18 ኣዋርሕ ኣንጻር SARS-CoV-2፣ ነቲ ሕማም ዘስዕብ ቫይረስ ዝኸውን ክትባት ክምዕብል እዩ ኢሉ ከምዘይጽበ ሓቢሩ።	In late February 2020, the World Health Organization(WHO) said it did not expect a vaccine against SARS-CoV-2, the virus that causes the disease, to be developed within 18 months.
1811	en	ti	Five vaccine candidates were in Phase I safety studies in April.	ኣብ ሚያዝያ ሓሙሽተ ናይ ክታበት ሕጹያት ኣብ መድረኽ I ናይ ድሕነት መስናዕትታት ኔሮም።	In April, five vaccine candidates were in Phase I safety studies.
1812	en	ti	COVID-19 was identified in December 2019.	COVID-19 ኣብ ዲሰምበር 2019 እዩ ህላወኡ ተፈሊጡ።	COVID-19 was diagnosed in December
1813	en	ti	A major outbreak spread around the world in 2020, leading to considerable investment and research activity to develop a vaccine.	ኣብ 2020 ኣብ መላእ ዓለም ዓብዪ ለበዳ ዝተዘርገሐ እንኾን፣ ክትባት ንምምዕባል ድማ ብዝሕ ዝበለ ኢንቨስትመንትን ናይ መጽናዕቲ ንጥፈታት ኣስዒቡ እዩ።	By 2020, there will be a major pandemic around the world, which has led to a lot of investment and research activities to develop vaccines.
1814	en	ti	Many organizations are using published genomes to develop possible vaccines against SARS-CoV-2.	ብዙሓት ትካላት ንSARS-CoV-2 ዝኸዉን ዝተሓተሙ ጄኖማት ብምጥቃም ክትባት ንምምዕባል ይሰርሑ ኣለዉ።	Many companies are working to develop vaccines using imprinted genomes for SARS-CoV-2.
1815	en	ti	Stated in April, imperatives of the CEPI initiative for vaccine development are speed, manufacturing capacity, deployment at scale, and global access.	ኣብ ኣፕሪል ዝተገለጸ፣ ናይ CEPI ትካል ናይ ክትባት ምዕባለ ወሰንቲ ነጥቢታት፣ ፍጥነት፣ ናይ ምምራት ዓቕሚ፣ ብበዝሒ ምርካብ ምኽኣል፣ ከምኡውን ዓለም ለኻዊ ኣቕርቦታት እዮም።	Announced in April, the key points of CEPI&#39;s vaccine development are speed, manufacturability, mass availability, and international offerings.
1816	en	ti	In April, CEPI scientists reported that 10 different technology platforms were under research and development during early 2020 to create an effective vaccine against COVID-19.	ኣብ ሚያዝያ ናይ CEPI ኣይ ተመራመርቲ ስነ-ፍልጠት 10 ዝተፈላለዩ ናይ ቴክኖሎጂ መድረኻት ኣብ መጀመርታ 2020 ኣድማዒ ክትበት ኣንጻር ኮቪድ-19 ንምፍጣር ኣብ ትሕቲ መጽናዕቲን ምዕባለን ከምዝነበሩ ጸብጻብ ሂቦም።	In April, CEPI I scientists reported that 10 different technology platforms were under research and development to create an effective vaccine against COVID-19 by early
1817	en	ti	Major platform targets advanced into Phase I safety studies include:	ናብ ናይ ፌዝ I ናይ ደሕንነት መጽናዕቲ ዝዓበዩ ዋና መድረኻት ነዞም ዝስዕቡ ዘጠቓለሉ እዮም:	The core stages that grew into a Phase I safety study included the following:
1818	en	ti	nucleic acid (DNA and RNA) (Phase I developer and vaccine candidate: Moderna, mRNA-1273)	ኒኩሊክ ኣሲድ (DNA and RNA))( ብርኪ I ኣማዕባሊን ናይ ክትባት ሕፁይን)፡ ሞደርና mRNA-1273)	Nucleic acid (DNA and RNA))( Phase I developer and vaccine candidate), Moderna mRNA-1273)
1819	en	ti	viral vector (Phase I developer and vaccine candidate: CanSino Biologics, adenovirus type 5 vector)	viral vector(ቫይራል ቬክተር) (ፌዝ I መማዕበሊን ናይ ክትባት ሕጹይን: CanSino Biologics(ካንሲኖ ባዮሎጂክስ), ኣድኖቫይረስ ዓይነት 5 ቬክተር)	viral vector(Phase I developer and vaccine candidate: CanSino Biologics(Cansino Biologics), adenovirus type 5 vector)
1820	en	ti	As reported by CEPI scientists in April, 115 total vaccine candidates are in early stages of development, with 78 confirmed as active projects (79, according to the Milken Institute), and 37 others announced, but with little public information available (presumed to be in planning or being designed).	ብናይ CEPI ሳንቲስትታት ኣብ ኣፕሪል ሪፖርት ከምዝተገበረ፣ 115 ሓፈሻዊ ናይ ክትባት ሕጹያት ኣብ ናይ ምዕባለ ናይ መጀመርያ ደረጃታት ይርከቡ፣ ምስ 78 ዝተረጋገጹ ንጡፋት ፕሮጀክትታት (79፣ Milken Institute ከምዝበሎ)፣ 37 ካልኦት ድማ ኣዊጆም፣ እንተኾነግን ንእሽተይ ህዝባዊ ሓበሬታ ብምጥቃም እዩ (ኣብ ትልሚ ክህልዉ ዝሕሰቡ ወይ ዝተነደፉ)።	Reported by CEPI scientists in April, 115 overall vaccine candidates are in the early stages of development, with 78 confirmed active projects (79, Milken Institute said), and 37 others announced, but using little public information or designed).
1821	en	ti	A Phase I-II trial conducts preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, and at multiple sites, while determining more precise, effective doses.	ደረጃ I-II ፈተነ ካብ ኩሉ ንላዕሊ ድሕንነት፣ኢምኖጀነሲቲ ምርመራ፣ዘይስሩዕ ኮይኑ ናይ ፕላሴቦ ቁፅፅር ዘለዎ ከምኡ እውን ኣብ ብዙሕ ቦታታት ዝካየድ ኮይኑ ትኽክለኛን ዉፅኢታዉነትን ናይ መድሓኒት መጠን እዉን ዝዉስን እዩ።	Phase I-II trials are above all safety, immunogenicity testing, randomized, placebo-controlled, and multicenter to determine the accuracy and efficacy of drug dosing.
1822	en	ti	Phase III trials typically involve more participants, including a control group, and test effectiveness of the vaccine to prevent the disease, while monitoring for adverse effects at the optimal dose.	ናይ ፌዝ III ፈተነታት ዝበዝሑ ተሳተፍቲን መምዘኒ ጉጅለ ዘለዎምን ከምኡ’ውን ንምክልኻል ሕማም ናይ ክታበት ኣድማዕነት ፈተነታት ምስ ምቁጽጻር ኣብ ተደላዩ መጠን መድሃኒት ዝመጽኡ ኣሉታዊ ሳዕቤናት የጠቓልል።	Phase III trials include larger numbers of participants and a control group, as well as vaccine efficacy trials to prevent disease with controls for adverse effects at desired doses.
1823	en	ti	"Of 79 vaccine candidates in active development (confirmed as of early April 2020), 74 were not yet in human evaluation (still in ""preclinical"" research)."	ካብ እቶም 79 ኣብ ንጡፍ ምዕባለ ዘለዉ ናይ ክታበት ሕጹያት( April 2020 መጀመርታ ጀሚሩ ዝተረጋገጹ)፡ 74 ኣብ ናይ ወዲ-ሰብ ፈተነ ደረጃ ኣይነበሩን (ሕጂ'ውን ኣብ ቅድመ-ክሊኒካዊ ምርምር እዮም ዘለዉ)።	Of the 79 vaccine candidates in active development( approved as of early April 2020), 74 were not in the human trial stage (they are still in preclinical research).
1824	en	ti	Around 24 January 2020 in Australia, the University of Queensland announced that it is investigating the potential of a molecular clamp vaccine that would genetically modify viral proteins in order to stimulate an immune reaction.	ኣብ ከባቢ ጃንዋሪ 24፣ 2020 ኣብ ኣውስትራሊያ፣ ናይ ኩዊንስ ላንድ ዩኒቨርስቲ ናይ ሞለኪዩላዊ ክላምፕ ን ናይ ቫይርስ ፕሮቲን ብምቕያር ናይ ሰብነት ናይ ሕማም ምክልኻል ተኽእሎ ክነቓቕሕ ዝኽእል ክትባት ዓቕሚ ኣብ ምምርማር ከምዘልው ሓቢሮም ።	Around January 24, 2020 in Australia, the University of Queensland announced that they are investigating the potential of a vaccine that can stimulate the body&#39;s immune system by altering the molecular clamp of a virus protein.
1825	en	ti	Around 24 January 2020 in Canada, the International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan announced the commencement of work on a vaccine, aiming to start human testing in 2021.	ኣብ ከባቢ ጃንዋሪ 24፣ 2020 ኣብ ካናዳ ኣብ ሳስካቻውን ዩኒቨርሲቲ ዝርከብ ዓለምለኻዊ ናይ ክትባት ማእኸል(VIDO-InterVac) ኣብ 2021 ፈተነ ዝግበረሉ ክትባት ስራሕ ክምዝ ጀመሩ ኣፍሊጦም።	Around January 24, 2020, the International Vaccine Center(VIDO-InterVac) at the University of Saskatchewan in Canada announced that they will begin work on a 2021 trial vaccine.
1826	en	ti	Vaccine development projects were announced at the Chinese Center for Disease Control and Prevention on 26 January 2020, and the University of Hong Kong on 28 January.	ክትባት ናይ ምምዕባል ፕሮጀክትታት ጃንዋሪ 26፣ 2020 ኣብ ናይ ቻይና ማእኸል ሕማም ቁፅፅርን ምክልኻልን ኣብ ሆንግ ኮንግ ዩኒቨርሲቲ ድማ ኣብ ጃንዋሪ 28 ተጋዊሖም ኣለዉ።	Vaccine development projects were announced on January 26, 2020 at the China Centers for Disease Control and Prevention and at the University of Hong Kong on January
1827	en	ti	Around 29 January 2020, Janssen Pharmaceutical Companies, led by Hanneke Schuitemaker, announced that it had begun work on developing a vaccine.	ኣብ ከባቢ ጃንዋሪ 29, 2020፡ ጃንሰን ፋርማሰውቲካል ካምፓኒታት ብ መሪሕነት ሃነከ ሽዊተሜከር ንምምዕባል ክታበት ስራሕ ከም ዝጀመሩ ኣፍሊጦም።	Around January 29, 2020, Janssen Pharmaceutical Companies announced that it had begun work on a vaccine under the leadership of Haneke Sweetmaker.
1828	en	ti	Janssen is co-developing an oral vaccine with its biotechnology partner, Vaxart.	ጃንሰን ምስ ቫክሳርት ዝተብሃለ ናይ ባዮቴክኖሎጂ መሻርኽቱ ብምትሕብባር ብኣፍ ዝዉሰድ ክትባት የማዕብል ኣሎ።	Janssen is developing an oral vaccine in collaboration with its biotechnology partner, Vaxart.
1829	en	ti	On 18 March 2020, Emergent BioSolutions announced a manufacturing partnership with Vaxart to develop the vaccine.	ኣብ መጋቢት 18 2020፡ ኢመርጀንት ባዮ_ሶልዩሽንስ ምስ ቫክሳርት ብምዃን ነቲ ክታበት ንኸማዕብሉ ኣዊጆም ።	On March 18, 2020, Emergent Bio_Solutions announced that it would develop the vaccine in partnership with Vaxart
1830	en	ti	On 8 February 2020, the laboratory OncoGen in Romania published a paper on the design of a vaccine with similar technology to the one used for cancer neoantigen vaccination therapy.	ኣብ ፌብሩዋሪ 8፣ 2020 ኣብ ሮማኒያ ዝርከብ ና ኦንኮገን ላብራቶሪ ኣብ ምስ ን ካንሰር ኣብ ጥቕሚ ዘወዓለ ኒዮኣንቲጅን ክትባት ሕክምና ዝመሳሰል ናይ ክትባት ቴክኖሎጂ ንድፊ ኣመልኪቱ ናይ ፅናዓት ወረቐት ኣሕቲሞም ኣለው።	On February 8, 2020, Na Oncogen Laboratory in Romania published a research paper on the design of a vaccine technology similar to the neoantigen vaccine used for cancer treatment.
1831	en	ti	On 25 March the head of the research institute announced that they had finalized the synthesis of the vaccine and were beginning the tests.	ኣብ ማርች 25 ፣ናይ ምርምር ትካል ዋና ሓላፊ ናይ ክታበት ምስራሕ ከምዝወድኡን ፈተነታት ኣብ ምጅማር ከምዘለዉ ኣፍሊጦም።	On March 25 , the research institute&#39;s chief executive announced that they had completed development of the vaccine and that trials were underway.
1832	en	ti	On 27 February 2020, a Generex subsidiary company, NuGenerex Immuno-Oncology, announced they were beginning a vaccine project to create an Ii-Key peptide vaccine against COVID-19.	ኣብ 27 ፌብሩዋሪ 2020፣ ናይ Generex መሓዛ ትካል, NuGenerex Immuno-Oncology፣ ናይ Ii-Key(ሊ-ኪይ) ፔፕታይድ ክትባት ኣንጻር ኮቪድ-19 ንምፍጣር ናይ ክትባት ፕሮጀክት ይጅምሩ ምህላዎም ኣዊጆም።	On February 27, 2020, Generex&#39;s partner company, NuGenerex Immuno-Oncology, announced that they are launching a vaccine project to develop an Ii-Key(Li-Key) peptide vaccine against COVID-1
1833	en	ti	"They wanted to produce a vaccine candidate that could be tested in humans ""within 90 days."""	ኣብ ‘’ዉሽጢ 90 መዓልትታት’’ ኣብ ሰብ ክፍተን ዝኽእል ናይ ክትባት ሕፁይ ንምምዕባል ደልዮም።	They wanted to develop a vaccine candidate that could be tested in humans &#39;&#39;within 90 days.
1834	en	ti	On 5 March 2020, Washington University in St. Louis announced its projects to develop a vaccine.	ኣብ 5 ማርች 2020፣ ናይ Washington University (ዋሽንግተን ዩኒቨርሲቲ) ኣብ St. Louis(ሴንት ሉዊስ) ክትባት ናይ ምምዕባል ፕሮጀክት ኣዊጆም።	On March 5, 2020, the Washington University (Washington University) in St. Louis, Missouri, will hold a press conference. Louis(St. Louis) announced a vaccine development project.
1835	en	ti	On 5 March 2020, the United States Army Medical Research and Materiel Command at Fort Detrick and the Walter Reed Army Institute of Research in Silver Spring, both in western Maryland, announced they were working on a vaccine.	ኣብ 5 ማርች 2020፣ United States Army Medical Research and Materiel Command at Fort Detrick ን ናይ ኣብ ሲልቨር ስፕሪንግ ዘሎ ናይ Walter Reed Army Institute of Research፣ ክልቲኦም ኣብ ምዕራባዊ ሜሪላንድ ዝርከቡ ኮይኖም፣ ክትባት ኣብ ምምዕባል ይሰረሑ ምህላዎም ድማ ኣዊጆም።	On March 5, 2020, the United States Army Medical Research and Materiel Command at Fort Detrick and the Walter Reed Army Institute of Research in Silver Spring, both in western Maryland, announced that they are working on developing a vaccine.
1836	en	ti	Around 10 March 2020, Emergent Biosolutions announced that it had teamed with Novavax Inc.	ኣብ ከባቢ 10 ማርች 2020፣ Emergent Biosolutions ምስ Novavax Inc ብሓባር ምስራሕ ምጅማሩ ኣብሲሩ።	Around March 10, 2020, Emergent Biosolutions announced a partnership with Novavax Inc.
1837	en	ti	in the development and manufacture of a vaccine.	ኣብ ምምዕባልን ምፍራይን ክታበት።	in vaccine development and production.
1838	en	ti	The partners further announced plans for preclinical testing and a Phase I clinical trial by July 2020.	እቶም መሻርኽቲ ናይ ቅድሚ ክሊኒካዊ ምርመራን ደረጃ I ክሊኒካዊ ፈተነን ኣብ ጁላይ 2020 ንምክያድ ትልሚ ከምዘለዎም ኣፍሊጦም።	The partners announced plans to conduct preclinical testing and a Phase I clinical trial in July 2020.
1839	en	ti	On 12 March 2020, India's Health Ministry announced they are working with 11 isolates, and that even on a fast track it would take at least around one-and-a-half to two years to develop a vaccine.	ኣብ ማርች 12, 2020 ናይ ህንዲ ናይ ጥዕና ሚኒስቴር ምስ 11 ዝተነጸሉ ሰባት እንዳሰርሑ ምዃኖም ኣፍሊጡ ፣ ነቲ መድሓኒት ንምስራሕ በቲ ዝቐልጠፈ ኣሰራርሓ እውን እንተኾነ ብንኡሱ ካብ ሓደ ዓመትን ፈረቓን ክሳብ ክልተ ዓመት ከምዝወስድ ኣፍሊጡ።	On March 12, 2020, India&#39;s health ministry announced that it was working with 11 isolates , and that it would take at least a year and a half to two years to develop the drug, even in the fastest way.
1840	en	ti	On 12 March 2020, Medicago, a biotechnology company in Quebec City, Quebec, reported development of a coronavirus-like particle under partial funding from the Canadian Institutes for Health Research.	ኣብ ማርች 12፣ 2020፣ ኣብ ከተማ ኩዩቤክ ዝርከብ መዲካጎ ዝተብሃለ ትካል ኣብ ትሕቲ ናይ ካናዳ ናይ ጥዕና ምርምር ትካል ዝግበር ውሱን ናይ ገንዘብ ሓገዝ ኮይኑ ኮሮና ቫይረስ መሳሊ ባእታ ኣብ ምምዕባል ክምዝርከብ ፀብፃብ ኣቕሪቡ።	On March 12, 2020, Quebec City-based Medicago, a limited funding organization under the Canadian Institutes of Health Research, reported that it was developing a coronavirus-like component.
1841	en	ti	The vaccine candidate is in laboratory research, with human testing planned for July or August 2020.	እዚ ናይ ክትባት ሕጹይ ኣብ ናይ ቤትፈተነ መጽናዕቲ ይርከብ፣ ኣብ ሰብ ምፍታን ድማ ኣብ ጁላይ ወይ ኦገስት 2020 ክካየድ ትልሚ ተታሒዝዎ ኣሎ።	This vaccine candidate is in laboratory studies, and human trials are scheduled for July or August
1842	en	ti	"Earlier that week, The Guardian reported that the US President Donald Trump had offered CureVac ""'large sums of money' for exclusive access to a Covid-19 vaccine"", against which the German government protested."	ኣቐዲሙ ኣብ’ቲ ሰሙን፡ ናይ US ፕሬዝደንት ዶናልድ ትራምፕ ን CureVac ፡ ነቲ መንግስቲ ጀርመን ዝተቓወሞ ንምርካብ ክታበት “Covid-19 ዝውዕል ‘ብዙሕ ገንዘብ’ ኣቕሪቡ“ ክብል ዘ-ጋርዲያን ሓቢሩ።	Earlier that week, US President Donald Trump offered CureVac , a “covid-19 vaccine” that the German government opposed, The Guardian reported.
1843	en	ti	On 17 March 2020, American pharmaceutical company Pfizer announced a partnership with German company BioNTech to jointly develop a mRNA-based vaccine.	ኣብ ማርች 17, 2020 ናይ ኣሜሪካ ናይ መድሓኒት ኩባንያ ፊዘር ምስ ናይ ጀርመን ኩባንያ ባዮኤንቴክ ብሓደ ናይ mRNA-based ክትባት ንምስራሕ ክምዝተውዓዓሉ ኣፍሊጡ።	On March 17, 2020, US pharmaceutical company Pfizer announced an agreement with German company Bioentech to develop an mRNA-based vaccine.
1844	en	ti	mRNA-based vaccine candidate BNT162, currently in pre-clinical testing with clinical trials expected to begin in April 2020.	ኣብ mRNA ዝተመርኮሰ ክትባት ሕፁይ ዝኾነ BNT162 ኣብ ፕሪክሊኒካል ምርምር ዝርከብ እንትኾን፡ ቀፃሊ ናይ ክሊኒካል ፈተነታት ኣብ ሚያዝያ 2020 ክጅመር ከምዝኾነ ተሓቢሩ።	BNT162, an mRNA-based vaccine candidate, is in preclinical research and further clinical trials are expected to begin in April
1845	en	ti	In Italy on 17 March 2020, Takis Biotech, an Italian biotech company announced they will have pre-clinical testing results in April 2020 and their final vaccine candidate could begin human testing by fall.	ኣብ ጣልያን ኣብ ማርች 17፣ 2020 ታኪስ ባዮቴክዝበሃል ናይ ጣልያን ትካል ኣብ ኣፕሪል፣2020 ናይ ክሊኒካዊ ውፂኢታት ብምርካብ እቲ ናይ መጨረሻ ኣብ ወዲ ሰብ ዝግበር ፈተነ ድማ ካብ መስከርም ኣቢሉ ክምዝጅምር ሓቢሮም ።	In Italy on March 17, 2020 Takis Biotech, an Italian company, announced that clinical results will be available in April,2020 and the final human trial will start around Meskerm.
1846	en	ti	In France on 19 March 2020, the Coalition for Epidemic Preparedness Innovations (CEPI) announced a US$4.9 million investment in a COVID-19 vaccine research consortium involving the Institut Pasteur, Themis Bioscience (Vienna, Austria), and the University of Pittsburgh, bringing CEPI's total investment in COVID-19 vaccine development to US$29 million.	ማርች 19 2020 ኣብ ፈረንሳይ ናይ ኤፒደሚክ ኢኖቬሽን ሕብረት (CEPI) ናይ US$4.9 ሚሊዮን ኣብ ናይ COVID-19 ክትባት መፅናዕቲ ኢንቨስትመንት ከምዝገበረ ሓቢሩ። ካብ እዚ ብተወሳኺ ድማ ንኢኒስቲቱት ፓስተር፣ ቴሚስ ባዮሳይንስ (ቪዬና፣ኣዉስትሪያ) ከምኡ’ዉን ዩኒቨርስቲ ፒትስበርግ ብምስታፍ ጠቕላላ ንCOVID-19 ክትባት ምዕባለ ዝዉዕል ናይ CEPI ኢንቨስትመንት ናብ US$29 ሚልዮን ክዓቢ ክኢሉ።	On March 19, 2020, the French Epidemic Innovation Union (CEPI) announced a US$4.9 million investment in COVID-19 vaccine research. In addition, the total CEPI investment for COVID-19 vaccine development has increased to US$29 million with the participation of the Pasteur Institute, Themis Biosciences (Vienna, Austria) and the University of Pittsburgh.
1847	en	ti	CEPI's other investment partners for COVID-19 vaccine development are Moderna, Curevac, Inovio, Novavax, the University of Hong Kong, the University of Oxford, and the University of Queensland.	ናይ CEPI ናይ ኢንቨስትመንት ምሻርኽቲ ንCOVID-19 ዝኸዉን ክትባት ንምምዕባል ዝሳተፉ፡ ሞደርና፣ ኩሬቫክ፣ ኢኖቭዮ፣ ኖቫቫክስ፣ ዩኒቨርስቲ ሆንግ ኮንግ፣ ዩኒቨርስቲ ኦክስፎርድ ከምኡዉን ዩኒቨርስቲ ክዊንስላንድ ኣለዉ።	CEPI&#39;s investment partners involved in the development of vaccines for COVID-19 include Moderna, Curevac, Innovio, Novavax, the University of Hong Kong, the University of Oxford and the University of Queensland.
1848	en	ti	On 20 March 2020, Russian health officials announced that scientists have begun animal testing of six different vaccine candidates.	ኣብ 20 ማርች 2020፣ ናይ ሩስያ ጥዕና ኦፊሻላት ሳይቲስትታት ናይ ሽድሽተ ዝተፈላለዩ ናይ ክትባት ሕጹያት ኣብ እንስሳት ምፍታን ምጅማሮም ገሊጾም።	On March 20, 2020, Russian health officials announced that scientists have begun testing six different vaccine candidates on animals.
1849	en	ti	Imperial College London researchers announced on 20 March 2020 that they are developing a self-amplifying RNA vaccine for COVID-19.	ኣብ ማርች 20፣2020 ናይ ሎንደን ኢምፐሪያል ኮሌጅ ተመራመርቲ ን COVID-19 ዝኾን ዓርሱ ዘጋውሕ ናይ RNA ክትባት ኣብ ምምዕባል ክምዝርከቡ ሓቢሮም።	On March 20,2020, researchers at Imperial College London announced that they are developing a self-promoting RNA vaccine for COVID-1
1850	en	ti	The vaccine candidate was developed within 14 days of receiving the sequence from China.	እቲ ተወዳዳሪ ክታበት ኣብ ውሽጢ 14 መዓልታት ምቕባል ኣሰራርዓ ሕነተ-ሰረት ካብ ቻይና ማዕቢሉ።	The competitive vaccine was developed within 14 days of receiving the baseline regimen from China.
1851	en	ti	In late March, the Canadian government announced C$275 million in funding for 96 research projects on medical countermeasures against COVID-19, including numerous vaccine candidates at Canadian companies and universities, such as the Medicago and University of Saskatchewan initiatives.	ኣብ መወዳእታ ማርች፡ መንግስቲ ካናዳ ከም መዲካጎ ን ተበግሶ ዩኒቨርሲቲ ሳስካቸዋንን ዝመሰሉ ናይ ካናዳ ዩኒቨርሲቲታትን ትካላትን ከም ሕክምናዊ ሰረ-ስጉምቲ ኣንጻር COVID-19 ኣብ ዘቕረብዎም ብዙሓት ሕጹያት ክታበታት ዝትግበሩ 96 ናይ መጽናዕቲ ውጥናት ንምምዋል 275 ሚሊዮን ዶላር ካናዳ ክህብ ምዃኑ ኣዊጁ።	In late March, the Government of Canada announced that it would provide C$275 million to fund 96 research projects on multiple vaccine candidates proposed by Canadian universities and institutions such as Medicago and the University of Saskatchewan Initiative.
1852	en	ti	"Around the same time, the Canadian government announced C$192 million specifically for developing a COVID-19 vaccine, with plans to establish a national ""vaccine bank"" of several new vaccines that could be used if another coronavirus outbreak occurs."	ኣብ ተመሳሳሊ ግዜ መንግስቲ ካናዳ ንምምዕባል ናይ COVID-19 ክታበት ዝውዕል 192 ሚልዮን ዶላር ካናዳ ከምኡ’ውን ካልእ ለበዳ ኮሮና ቫይረስ ምስ ዘጋጥም ዝጠቅም ብዙሓት ሕደስቲ ክታበታት ዝህልዎ “ናይ ክታበት ባንክ” ንምምዕባል መደባት ኣፍሊጡ፡፡	At the same time, the Canadian government announced plans to spend C$192 million to develop a COVID-19 vaccine and a “vaccine bank” with many new vaccines to use in the event of another pandemic.
1853	en	ti	"On 2 April 2020, researchers at the University of Pittsburgh School of Medicine reported on testing of PittCoVacc, a possible COVID-19 vaccine in mice, stating that ""MNA delivered SARS-CoV-2 S1 subunit vaccines elicited potent antigen-specific antibody responses [in the mice] that were evident beginning 2 weeks after immunization."""	ኤፕሪል 2 2020 ናይ ፒትስበርግ ዩኒቨርስቲ ቤት-ትምህርቲ ሕክምና ተመራመርቲ ናይ PittCoVacc ዝበሃል ናይ COVID-19 ክትባት ኣብ ኣናፁ ምርምር ‘’ናይ SARS-CoV-2 S1 ሳብዩኒት ክትባት ጠንካራ ናይ ኣንቲጅን-ስፔስፊክ ኣንቲቦዲ መልሲ [ኣብ ኣናፁ] ከምዘምፀ MNA ኣፍሊጡ። እዚ ድማ ኢምዩናይዜሽን ምስተፈጥረ ድሕሪ 2 ሰሙን ይፍጠር።’’	April 2, 2020 Researchers at the University of Pittsburgh School of Medicine have tested the PittCoVacc COVID-19 vaccine in mice &#39;&#39;The SARS-CoV-2 S1 subunit vaccine has produced a strong antigen-specific antibody response [in mice], MNA reported. This occurs 2 weeks after immunization.”
1854	en	ti	In Canada on 16 April 2020, the University of Waterloo School of Pharmacy announced design of a DNA-based vaccine candidate as a possible nasal spray.	ኤፕሪል 16 2020 ኣብ ካናዳ ውሽጢ ዝርከብ ዋተርሉ ዩኒቨርሲቲ ቤት-ትምህርቲ ፋርማሲ DNA ዝመሰረቱ ናይ ክታበት ብኣፍንጫ ዝንጸግ ሕጹይ ይምስርት ከምዘሎ ሓቢሩ።	April 16, 2020 The University of Waterloo School of Pharmacy in Canada is developing a DNA-based nasal vaccine candidate.
1855	en	ti	Using bacteriophages, the DNA will be designed to replicate inside human bacteria to produce harmless virus-like particles, which may stimulate the immune system to produce antibodies against the SARS-CoV-2 virus.	ባክቴሪዮፌጅስ ኣብ ጥቕሚ ብምዋዓል፣ እቲ DNA ኣብ ውሽጢ ናይ ወዲስብ ኣብ ዝርከብ ባክቴሪያ ውሽጢ ብምርባሕ ጉዳኣት ዘይብሉ ቫይረስ መስል ባእታታት ብምፍራይ እቲ ናይ ሰብነትና ሕማምም ተከላኻሊ ኣናፃር ሳርስ ኮሮና ቫይረስ (SARS-CoV-2) ናይ ባዕዳዊ ነገራት መከለኻሊ የፍሪ።	Using bacteriophages, the DNA multiplies inside the bacteria inside the body to produce harmless virus-like elements that produce the body’s immune system against the SARS-CoV-2 foreign object defense.
1856	en	ti	In March 2020, the US government, industry, and three universities pooled resources to access supercomputers from IBM, combined with cloud computing resources from Hewlett Packard Enterprise, Amazon, Microsoft, and Google.	ኣብ ማርች 2020፣ ናይ US መንግስቲ፣ ኢንዳስትሪን ሰለስተ ዩኒቨርስቲታትን ናይ IBM ሱፐር ኮምፒዩተራት ፣ ምስ ናይ ክላውድ ኮምፒቲንግ ሓገዛት ናይ Hewlett Packard Enterprise፣ Amazon፣ Microsoft፣ ከምኡውን Google ብምትሕብባር ንምጥቃም ፍልፍላት ሃብቲ ኣኪቦም እዮም።	In March 2020, US government, industry, and three universities mobilized resources to use IBM supercomputers , in conjunction with cloud computing services from Hewlett Packard Enterprise, Amazon, Microsoft, and Google.
1857	en	ti	Some vaccines have heterologous effects, also called non-specific effects.	ሓድሓደ ክትባታት ውሱናት ዘይኮኑ ወይድማ ዝበሃሉ ሳዕቤናት ኣለዎም።	Some vaccines have limited or so-called side effects.
1858	en	ti	That means they can have benefits beyond the disease they prevent.	እዚ ማለት ድማ ካብቲ ዝከላኸልዎ ሕማም ንላዕሊ ጥቕሚ ክረኽቡ ይኽእሉ እዮም ማለት እዩ።	This means that they can benefit from more than the disease they prevent.
1859	en	ti	A further randomized trial in Australia is seeking to enrol 4,170 healthcare workers.	ኣብ አውስትራሊያ ዝግበር ተወሳኺ ሃንደበታዊ ሙከራ 4,170 ናይ ጥዕና ሰራሕተኛታት እናጠለበ ይርከብ።	Additional randomized trials in Australia are requiring 4,170 health workers.
1860	en	ti	It is possible vaccines in development will not be safe or effective.	ኣብ ምምዕባል ዝርከቡ ክትባታት ውሕስነቶም ዝተሓለዉ ወይ ኣድማዕቲ ዘይክኾኑ ይኽእሉ እዮም።	Vaccines in development may not be safe or effective.
1861	en	ti	Early research to assess vaccine efficacy using COVID-19-specific animal models, such as ACE2-transgenic mice, other laboratory animals, and non-human primates, indicate a need for biosafety-level 3 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures.	ኣድማዕነት ክታበት ንምፍታሽ ኣብ ን COVID-19 ውሱናት ሞዴል እንስሳታት ዝተገብረ መጽናዕቲ፡ ከም ACE2-ስግረ-ጂናዊ ኣናጹ፡ ካልኦት ናይ ላብራቶሪ እንስሳታት፡ ከምኡ’ውን ኣብ ሰባት ዘይኮኑ መጥበውቲ ቫይረሳት ንምቁጽጻር ኣገዳስነት ናይ ደረጃ 3 ባዮ-ሴፍቲ ናይ ምሓዝ ስጉምትታት ከምኡ’ውን ደረጅኡ ዝሓለወ ናይ ድሕነት መስርሓት ንምውሓስ ኣህጉራዊ ምውህሃድ የመልክት።	The importance and degree of Level 3 biosafety containment measures to control viruses in limited animal models for COVID-19, such as ACE2-transgenic mice, other laboratory animals, and non-human mammals, to examine vaccine effectiveness Refers to international coordination to ensure protected safety processes.
1862	en	ti	Vaccines against SARS and MERS have been tested in non-human animal models.	ን SARS ከምኡ’ውን ንMERS ዝኸውን ክታበት ኣብ ደቂሰብ ዘይኮኑ ናይ እንስሳት ሞዴላት ይፍተኑ ጸኒሖሞ እዮም።	Vaccines for SARS and MERS have been tested in non-human animal models.
1863	en	ti	As of 2020, there is no cure or protective vaccine for SARS that has been shown to be both safe and effective in humans.	ኣብ 2020 SARS ድሕንነቱ ዝሓለወን ዉፅኢታዊ ዝኾነን መድሓኒት ወይድማ ተኻላኸሊ ክትባት የብሉን።	By 2020, SARS will not have a safe and effective cure or vaccine.
1864	en	ti	According to research papers published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and public health agencies around the world.There is also no proven vaccine against MERS.	ኣብ 2005 ን 2006 ን ብዝተሓተሙ ናይ መጽናዕቲ ወረቐታት መሰረት፣ ናይ እዚ SARS ሓድሽ ክትባት ወይ መድሓኒት ምምዕባል ናይ መንግስቲታትን ህዝባዊ ጥዕና ሓለዋን ቀዳምነት ዝህብዎ ነገር እዩ።ኣንጻር MERS እውን ዝተረጋገጸ ክትባት የለን።	According to research papers published in 2005 and 2006, the development of a new vaccine or cure for SARS is a priority for governments and public health. There is no proven vaccine against MERS.
1865	en	ti	When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.	MERS ብጣዕሚ ኣስፋሕፊሑ ኣብ ዝነበረሉ ግዘ ሕጂ ዘሎ ናይ SARS ምርምር ኣንጻር MERS-CoV ረኽሲ ክታበትን መድሓኒታትን ንምምዕባል ጠቓሚ ኣብነት ክህልዎ ከምዝኽእል እምነት ነይሩ እዩ።	At a time when MERS was very prevalent there was a belief that current SARS research could provide a useful example for developing vaccines and drugs against MERS-CoV infection.
1866	en	ti	As of March 2020, there was one (DNA based) MERS vaccine which completed phase I clinical trials in humans, and three others in progress, all of which are viral-vectored vaccines, two adenoviral-vectored (ChAdOx1-MERS,  BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).	ካብ ማርች 2020 ጀሚሩ፣ ሓደ  ብርኪ I ኣብ ደቂ ሰባት ናይ ክሊኒካዊ ፈተነ ዝወደአን ፣ ካልኦት ሰለስተ ድማ ኣብ መሰርሕ ዝርከቡሉን፣ ኩሎም ድማ viral-vectored እቶም ክልተ ድማ adenoviral-vectored (ChAdOx1-MERS,  BVRS-GamVac) ሓድ ድማ MVA-vectored (MVA-MERS-S) ዝኾነ (DNA ዝተድረኸ) ናይ MERS ክትባትት ነይሩ።	As of March 2020, one phase I clinical trial in humans has been completed , and three others are in progress, all viral-vectored, two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac) and one MVA-vectored (MVA). -MERS-S) was any (DNA based) MERS vaccine.
1867	en	ti	Social media posts have promoted a conspiracy theory claiming the virus behind COVID-19 was known and that a vaccine was already available.	ናይ ማሕበራዊ ሚድያ ፖስትታት እቲ ናይ ኮቪድ-19 ቫይረስ ይፍለጥ ከምዝነበረን ክትባት እውን ከምዘለዎን ዝገልጽ ስነ-ሓሳብ ኣቕሪቦም ኣለዉ።	Social media posts have suggested that the virus was known and that there is a vaccine.
1868	en	ti	The patents cited by various social media posts reference existing patents for genetic sequences and vaccines for other strains of coronavirus such as the SARS coronavirus.	እቶም ኣብ ማሕበራዊ ሚድያታት ዝርከቡ ናይ ዋንነት ሰርትፍኬታት ከም SARS ዝመሳሰሉ ናይ ካልኦት ኮሮና ቫይረስ ስትሬናት ጀነቲክ ሲኩዌንስን ክትባትን ዋንነት ሰርትፍኬታት እዮም።	The patents on social media are patents for the genetic sequences and vaccines of other coronavirus strains, such as SARS.
1869	en	ti	b'Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	ሕማም b'ኮሮናቫይረስ 2019 (ኮቪድ-19) ብከቢድን ህጹጽ ናይ ስርዓተ ምስትንፋስ ሲንድረም ኮሮናቫይረስ 2 (SARS-CoV-2) ዝመጽእ ተላባዒ ሕማም እዩ።	Disease b&#39;Coronavirus 2019 (COVID-19) is an infectious disease caused by the severe and acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
1870	en	ti	Common symptoms include fever, cough, and shortness of breath.	ልሙዳት ምልክታት ረስኒ፣ ሰዓልን ትንፋስ ምሕጻርን ዝኣመሰሉ ዘካትቱ እዮም።	Common symptoms include fever, cough and shortness of breath.
1871	en	ti	Other symptoms may include fatigue, muscle pain, diarrhea, sore throat, loss of smell, and abdominal pain.	ካልኦት ምልክታት ድኻም፣ ናይ ጭዋዳ ቃንዛ፣ ተቕማጥ፣ ናይ ጎሮሮ ቃንዛ፣ ናይ ምጭናው ክእለት ምስኣንን ናይ ከብዲ ቃንዛን የካትቱ።	Other symptoms include fatigue, muscle aches, diarrhea, sore throat, loss of ability to carry and abdominal pain.
1872	en	ti	The time from exposure to onset of symptoms is typically around five days but may range from two to fourteen days.	ካብ ግዘ ምቅላዕ ክሳብ ምልክት ምርኣይ ዝጅምረሉ ግዘ ዘሎ ግዘ ከባቢ ሓሙሽተ መዓልቲታት እዩ፣ እንተኾነ ግን ካብ ክልተ ክሳብ ዓሰርተ ኣርባዕተ መዓልቲታት ኣብ ዘሎ ክፈላለ ይኽእል እዩ።	The time from the time of exposure to the onset of symptoms is about five days, but it can vary between two and fourteen days.
1873	en	ti	While the majority of cases result in mild symptoms, some progress to viral pneumonia and multi-organ failure.	መብዛሕትኦም ጉዳያት ናይ ለበዳ ቀለልቲ ምልክታት ዘርእዩ ዋላ እንተኾኑ፣ ገለ ናብ ቫይራል ናይ ሳንቡእ ወቕዒን ናብ ብዙሓት ኦርጋናት ውድቀትን ዘምርሑ እዮም።	Although most cases of epidemics show mild symptoms, some lead to viral pulmonary stroke and multi-organ failure.
1874	en	ti	As of 17 April 2020, more than 2.24 million cases have been reported across 210 countries and territories, resulting in more than 153,000 deaths.	ካብ 17 ኣፕሪል 2020 ጀሚሩ፣ ልዕሊ 2.24 ሚልዮን ጉድያት ለበዳ ኣብ መላእ 210 ሃገራትን ግዝኣታትን ጸብጻብ ተገይሮም እዮም፣ ልዕሊ 153,000 ሞት ድማ ኣስዒቦም።	As of April 17, 2020, more than 2.24 million outbreak cases have been reported across 210 countries and territories, causing more than 153,000 deaths.
1875	en	ti	More than 568,000 people have recovered.The virus is primarily spread between people during close contact, often via small droplets produced by coughing, sneezing, or talking.	ልዕሊ 568,000 ሰባት ካብቲ ሕማም ሓውዮም እዮም። እዚ ቫይረስ መብዛሕትኡ ግዘ ብምስዓል፣ ብምህንጣስ፣ ወይ ብምዝራብ ዝወጹ ኣናእሽተይ ንጣባት ኣብ መንጎ ቀረባ ንኽክእ ዘለዎም ሰባት እዩ ብዋናነት ዝመሓላለፍ ።	More than 568,000 people have recovered from the disease. The virus is usually transmitted mainly by coughing, sneezing, or talking droplets between people with close contact.
1876	en	ti	While these droplets are produced when breathing out, they usually fall to the ground or onto surfaces rather than being infectious over long distances.	እዞም ንጣባት ንደገ ኣብ ምትንፋስ ዝፍጠሩ ዋላ እንተኾኑ፣ ናብ ነዊሕ ርሐቐት ከይዶም ክንዲ ሰብ ምብካል ናብ መሬት ወይ ካልኦት ቦታታት እዮም ዝወድቁ።	Although these droplets are formed by breathing out, they travel long distances and fall to the ground or other places instead of contaminating humans.
1877	en	ti	People may also become infected by touching a contaminated surface and then touching their eyes, nose, or mouth.	ሰባት ዝተበከለ ቦታ ነኺኦም ዓይኖም፣ ኣፍንጭኦም ወይ ኣፎም ብምንካእ ክልከፉ ይኽእሉ እዮም።	People can become infected by touching a contaminated area and touching their eyes, nose or mouth.
1878	en	ti	The virus can survive on surfaces up to 72 hours.	እዚ ቫይረሳት ኣብ ደጋዊ ቦታታት ን 72 ሰዓታት ዝኣክል ክጸንሕ ይኽእል እዩ።	These viruses can stay outdoors for up to 72 hours.
1879	en	ti	It is most contagious during the first three days after the onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease.The standard method of diagnosis is by real-time reverse transcription polymerase chain reaction (rRT-PCR) from a nasopharyngeal swab.	ኣብ ናይቲ ምልክታት ዝጀመረሉ ናይ መጀመርያ ሰለስተ መዓልቲታት ኣዝዩ ተመሓላላፊ እዩ፣ ምምሕልላፍ ኣብ ዳሕራይ ናይቲ ሕማ ደረጃታት እውን ክፍጠር ዝኽእል እንተኾነ እውን። ናይ ሕማም ውጽኢት ምርካብ ስታንዳርድ ሜላ ብናይ ብሓቂ ሪቨርስ ትራንስክሪፕቴዝ ፖሊመሬዝ ቸይን (rRT-PCR) ካብ ናዞፋሬንጃል ስዋብ ብምውሳድ እዩ።	It is highly contagious during the first three days of the onset of symptoms, although transmission can also occur in later stages of the disease. The standard method of obtaining disease results is by real reverse transcriptase polymerase chain reaction (rRT-PCR) from nasopharyngeal swabs.
1880	en	ti	The use of masks is recommended for those who suspect they have the virus and their caregivers.	ማስክ ምጥቃም ነቶም ባዕሎምን ሓብሐብቶምን በቲ ቫይረስ ተታሒዝና ኢና ኢሎም ዝጥርጥሩ እዩ ዝምከር።	Wearing a mask is recommended for those who suspect themselves and their caregivers of being infected.
1881	en	ti	Recommendations for mask use by the general public vary, with some authorities recommending against their use, some recommending their use, and others requiring their use.	እቲ ሓፈሻዊ ህዝቢ ማስክ ናይ ምጥቃም ምኽሪ ዝተፈላለየ እዩ፣ ገለ ሰበ ስልጣናት ክጥቀም የብሉን ይብሉ፣ ገለ ክጥቀም ይመኽሩ፣ ካልኦት ድማ ጠቓሚነቶም ይደልዩ።	The general public&#39;s advice on wearing masks varies, with some authorities saying they shouldn&#39;t be used, some recommending them, and others looking for their usefulness.
1882	en	ti	Currently, there is no vaccine or specific antiviral treatment for COVID-19.	ኣብዚ ግዘ እዚ፣ ንኮቪድ-19 ንጹር ጸረ ቫይረስ መድሓኒት ወይ ክትባት የለን።	At this time, there is no clear antiviral cure or vaccine for COVID-1
1883	en	ti	Local transmission of the disease has been recorded in most countries across all six WHO regions.	ከባቢያዊ ናይ እቲ ሕማም ስርጭት ኣብ መላእ ኩሎም ሽድሽተ ናይ WHO ክልላት ተመዝጊቡ ኣሎ።	Local outbreaks of the disease have been recorded across all six WHO regions.
1884	en	ti	Those infected with the virus may be asymptomatic or develop flu-like symptoms such as fever, cough, fatigue, and shortness of breath.	በዚ ቫይረስ ዝተጠቕዑ ሰባት ምልክት ዘይከርእዩ ይኽእሉ ወይ ድማ ከም ረስኒ፣ ሰዓል፣ ድኻምን ትንፋስ ምሕጻርን ዝኣምሰሉ ናይ ጉንፋዕ ምልክታት ጥራሕ ከማዕብሉ ይኽእሉ እዮም።	People infected with the virus may show no symptoms or may develop only flu symptoms such as fever, cough, fatigue and shortness of breath.
1885	en	ti	Emergency symptoms include difficulty breathing, persistent chest pain or pressure, confusion, difficulty waking, and bluish face or lips; immediate medical attention is advised if these symptoms are present.	ከም ናይ ምስትንፋስ ምሕጻር፣ ቀጻላይ ናይ ኣፍ ልቢ ቃንዛ፣ ምድንጋር፣ ናይ ምስጓም ጸገም፣ ሰመያዊ ገጽ ወይ ከንፈር ዝበሉ ሃንደበታዊ ምልክታት እንተተራእዮም ብቕልጡፍ ናይ ሕክምና ትኹረት የድልዮም እዩ።	Sudden symptoms such as shortness of breath, persistent oral chest pain, confusion, difficulty walking, blue face or lips require immediate medical attention.
1886	en	ti	Less commonly, upper respiratory symptoms such as sneezing, runny nose or sore throat may be seen.	ክንድቲ ዘይተለመዱ፣ ናይ ላዕለዋይ መተንፈሲ ኣካል ምልክታት ከም ምህንጣስ፣ ኣፍንጫ ዘረብረብ ምባል ወይ ናይ ጎሮሮ ቃንዛ ክጠቓለሉ ይኽእሉ እዮም።	As uncommon, upper respiratory symptoms may include coughing, runny nose or sore throat.
1887	en	ti	Gastrointestinal symptoms such as nausea, vomiting and diarrhoea have been observed in varying percentages.	ከም ምቕልውላው፣ ቮሚትን ተቕማጠን ዝበሉ ጋስትሮኢንተስታይናል ምልክታት ብ ዝተፈላለዩ ምኢታዊ መጠናት ተራእዮም ኔሮም እዮም።	Gastrointestinal symptoms such as nausea, vomiting and diarrhea were observed in varying percentages.
1888	en	ti	Some cases in China initially presented only with chest tightness and palpitations.	ገለ ናይ ቻይና ጉዳያት ለበዳ ኣብ መጀመርያ ናይ ኣፍ ልቢ ጸቕጢን ፓልፕቴሽንን ምልክታት ጥራሕ እዮም ኔሮምዎም።	Some Chinese cases of outbreaks initially had only oral cardiac pressure and palpitations.
1889	en	ti	In some, the disease may progress to pneumonia, multi-organ failure, and death.	ኣብ ገለ ሰባት፣ እቲ ሕማም ናብ ናይ ሳንቡእ ወቕዒ፣ ናብ ናይ ብዙሓ ኣካላት ውድቀት ከምኡውን ናብ ሞት ይኽእል።	In some people, the disease can lead to pneumonia, multiorgan failure and death.
1890	en	ti	This is called the incubation period.	እዚ ድማ መራብሒ ግዘ ይበሃል።	This is called multiplication time.
1891	en	ti	The incubation period for COVID-19 is typically five to six days but may range from two to 14 days.	ናይ ኮቪድ -19 መጫጭሒ ግዘ ካብ ሓሙሽተ ክሳብ ሽዱሽተ መዓልቲ ዘሎ ግዘ እዩ እንተኾነ ግን ካብ ክልተ ክሳብ 14 መዓልቲታት እውን ክወስድ ይኽእል እዩ።	The incubation period is five to six days but can also take two to 14 days.
1892	en	ti	97.5% of people who develop symptoms will do so within 11.5 days of infection.Reports indicate that not all who are infected develop symptoms.	97.5% ምልክታት ዘማዕብሉ ሰባት ኣብ ውሽጢ ናይ እቲ ረኸሲ 11.5 መዓልቲታት የርእዩ። ጸብጸባት ከምዘርአይዎ ኩሎም ዝተለኸፉ ምልክት የርእዩ ማለት ኣይኮነን።	97.5% of people who develop symptoms show it within 11.5 days of the infection. Reports show that not all infected people show symptoms.
1893	en	ti	The role of these asymptomatic carriers in transmission is not yet fully known; however, preliminary evidence suggests that they may contribute to the spread of the disease.	ናይ እዞም ምልክት ዘየርእዩ ተሸከምቲ መመሓላለፊ መንገዲ ክሳብ ሕዚ ሙሉእ ብሙሉአ ኣይተፈልጠን; እነተኾነ ግን፣ ናይ መጀመርታ መረዳእታት ነቲ ናየ ቫይረስ ዝርጋሐ ክሕግዙ ይኽእሉ እዮም ዝብል ኣንፈት ይህቡ።	The route of transmission of these asymptomatic carriers is still not fully understood; However, preliminary data suggest that they may help the spread of the virus.
1894	en	ti	The proportion of infected people who do not display symptoms is currently unknown and being studied, with the Korea Centers for Disease Control and Prevention (KCDC) reporting that 20% of all confirmed cases remained asymptomatic during their hospital stay.	ምልክት ናይ ዘየርእዩ ዝተለኸፉ ሰባት በዝሒ ኣብዚ ግዘ እዚ ኣይፍለጥን፣ ጽንዓት ድማ ይግበረሉ ኣሎ፣ ምስ ናይ Korea Centers for Disease Control and Prevention (KCDC) ( ኮርያ ናይ ሕማም ቁጽጽርን ምክልኻልን ማእኸል ) 20% እቶም ዝተረጋገጹ ጉዳይት ለበዳ ኣብ ናይ ሆስፒታል ጻንሒቶም ምልክት ኣይርአዩን ክብል ጸብጻብ ጌሩ።	The number of asymptomatic infected people is currently unknown and is being studied, with the Korea Centers for Disease Control and Prevention (KCDC) reporting that 20% of confirmed cases are asymptomatic during their hospital stay He did it.
1895	en	ti	China's National Health Commission began including asymptomatic cases in its daily cases on 1 April; of the 166 infections on that day, 130 (78%) were asymptomatic at the time of testing.	ናይ China's National Health Commission( ቻይና ብሄራዊ ጥዕና ኮሚሽን) ኣብ 1 ኣፕሪል ምልክት ዘየርእዩ ጉድያት ለበዳ ከጠቓልል ጀሚሩ; ካብ 166 ኣብ እቲ መዓልቲ ዝተመዝገቡ ጉዳያት ለበዳ፣ 130 (78%) ምልክት ዘየርእዩ ኔሮም ክምርመሩ ከለዉ።	China&#39;s National Health Commission( China National Health Commission) began covering asymptomatic outbreak cases on April 1; Of 166 outbreak cases recorded on the day, 130 (78%) were asymptomatic when diagnosed.
1896	en	ti	Both sputum and saliva can carry large viral loads.	ዓኽታን ትፈታፍን ብዙሕ ናይ ቫይረስ በዝሒ ክሕዙ ይኽእሉ እዮም።	Coughs and sneezes can carry large amounts of virus.
1897	en	ti	Loud talking releases more droplets than normal talking.	ዓዊ ኢልካ ምዝራብ ካብ ልሙድ ኣዘራርባ ንላዕሊ ብዙሓት ንጣባት ይሰድድ።	Speaking out loud sends out many more drops than ordinary speech.
1898	en	ti	A study in Singapore found that an uncovered cough can lead to droplets travelling up to 4.5 meters (15 feet).	ኣብ ሲንጋፖር ዝተኻየደ መጽናዕቲ ኣፍካ ከይሸፈንካ ምስዓል ንጣባት ክሳብ 4.5 ሜትር (15 ፊት) ክጎዓዙ ክገብር ከምዝኽእል ኣርእዩ።	A study in Singapore showed that coughing without covering your mouth can cause droplets to travel up to 4.5 meters (15 feet).
1899	en	ti	Though the virus is not generally airborne, the National Academy of Science has suggested that bioaerosol transmission may be possible and air collectors positioned in the hallway outside of people's rooms yielded samples positive for viral RNA.	እዚ ቫይረስ እዚ ሙሉእ ብሙሉእ ብኣየር ዝመሓላለፍ ሕማም ስለዘይኮነ፣ በሄራዊ ናይ ሳይንስ ኣካዳሚ ናይ ባዮኤሮሶል ምምሕልላፋት ክህሉ ይኽእል ኣየር ኣከብቲ ድማ ኣብ ናይ ካልኦት ሰባት ክፍሊ ዝርከቡ ሰባት ናሙና ንናይቲ RNA ፖዚቲቭ ውጽኢት ኣርእዩ።	Since this virus is not entirely an airborne disease, there may be National Academy of Sciences of bioaerosol transmissions and air collectors samples of people in other people&#39;s rooms tested positive for the RNA.
1900	en	ti	Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may cause respiratory secretions to be aerosolised and thus result in airborne spread.	ገለ ናይ ሕክምና ከይዲታት ከም ኢንቱቤሽነንን ካርድዮፕሉምናሪ ሪሰስቴሽን (CPR) ኤሮላይዝድ ክኾኑ ዘለዎም ናይ መተንፈሲ ፈሰስቲ ከስዕቡ ይኽእሉ እዚ ድማ ብኣየር ምምሐልላፍ ከስዕብ ይኽእል።	Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may result in respiratory fluids that need to be aerolized which may result in airway transmission.
1901	en	ti	While there are concerns it may spread via feces, this risk is believed to be low.The virus is most contagious when people are symptomatic; while spread may be possible before symptoms emerge, the risk is low.	ብሰገራ ክመሓላለፍ ይኽእል እዩ ዝብል ስግኣት ዋላ እንተሃለወ፣ እዚ ኣጋጣሚ እዚ ትሑት እዩ ተባሂሉ ይእመን። እዚ ቫይረስ እቶም ሰባት ምልክት የርእዩ እንተልዮም እዩ ብዝበለጸ ዝላባዕ፣ እንቶኾነ ግን ዝርጋሐ ቅድሚ ምልክታት ምፍጣሮም እውን ክፍጠር ይኽእል እዩ፣ ኣጋጣሚኡ ግን ትሑት እዩ።	Although there is a risk of fecal transmission, this incidence is believed to be low. The virus spreads best if people are showing symptoms, but spread can also occur before symptoms develop, but the incidence is low.
1902	en	ti	The European Centre for Disease Prevention and Control (ECDC) says while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.The virus survives for hours to days on surfaces.	ናይ European Centre for Disease Prevention and Control (ECDC) (ኣውሮፓ ናይ ሕማም ምክልኻልን ቁጽጽርን ማእኸል) እቲ ሕማም ክንደየናይ ብቐሊሉ ከምዝመሓላለፍ ግልጺ ከምዘይኮነን፣ ሓደ ሰብ ክልተ ወይ ሰልስተ ዝኾኑ ሰባት ክብል ከምዝኽእልን ሓቢሮም። እዚ ቫይረስ ኣብ ዝኾነ ቦታ ንሰዓታት ክጸንሕ ድማ ይኽእል እዩ።	The European Center for Disease Prevention and Control (ECDC) said it was unclear how easily the disease was transmitted, and one could say two or three people. The virus can stay anywhere for hours.
1903	en	ti	Specifically, the virus was found to be detectable for one day on cardboard, for up to three days on plastic (polypropylene) and stainless steel (AISI 304), and for up to four hours on 99% copper.	ብፍላይ ድማ፣ እቲ ቫየረስ ኣብ ኣርማድዮ ሓደ መዓልቲ ክጸንሕ ክኢሉ እዩ፣ ንሰለስተ መዓልቲታት ድማ ኣብ ፕላስቲክ (polypropylene) ኣብ ስተይንለስ ስቲል እውን (AISI 304)፣ ኣብ 99% ኮፐር ድማ ንኣርባዕተ ሰዓታት ይጸንሕ።	Specifically, the virus was able to survive one day in the cupboard, and three days on plastic (polypropylene) also on stainless steel (AISI 304), and four hours on 99% copper.
1904	en	ti	This, however, varies depending on the humidity and temperature.	እዚ ግን፣ በቲ ራሕሲን ሙቐትን መሰረት ክፈላለ ይኽእል እዩ።	This, however, may vary depending on the roof and temperature.
1905	en	ti	Soap and detergent are also effective if correctly used; soap products degrade the virus' fatty protective layer, deactivating it, as well as freeing them from skin and other surfaces.	ሳሙናን ዲተርጀንትን እውን ብኣግባቡ ኣብ ጥቕሚ እንተውዒሎም ብቑዓት እዮም፣ ናይ ሳሙና ምህርቲታት ናይ እቲ ቫይረስ መከላኸሊ መሸፈኒ ኣካል የዳኽሙ፣ ከይሰርሕ ድማ ይገብርዎ፣ ካብ ቆርበትን ካብ ካልኦት ቦታታት ድማ የጽርይዎ።	Soaps and detergents are also efficient if used appropriately, soap products weaken the protective covering of the virus, making it ineffective, and clean it from the skin and from other areas.
1906	en	ti	Other solutions, such as benzalkonium chloride and chlorhexidine gluconate (a surgical disinfectant), are less effective.In a Hong Kong study, saliva samples were taken a median of two days after the start of hospitalization.	ካልኦት ፈሰስቲ፣ ከም benzalkonium chloride ን chlorhexidine gluconate (ሰርጂካል ዲስኢንፌክታንት)፣ ትሕት ዝበለ ኣድማዒነት ኣለዎም። ኣብ ሆንግ ኮንግ ብዝተገበረ መጽናዕቲ፣ ድሕሪ ኣብ ሆስፒታል ደቂስካ ምሕካ ምጅማሩ ናይ እንትፍታፍ ናሙናታት ብማእኸላይ ኣብ ክልተ መዓልቲታት ተወሲዶም።	Other solvents, such as benzalkonium chloride and chlorhexidine gluconate (surgical disinfectants), are less effective. In a study in Hong Kong, sputum samples were taken on average every two days after hospitalization.
1907	en	ti	In five of six patients, the first sample showed the highest viral load, and the sixth patient showed the highest viral load on the second day tested.	ካብ ሽዱሽተ ተሓከምቲ ሓሙሽቲኦም፣ አቲ ናይ መጀመርያ ናሙና እቲ ዝለዓለ ናይ ቫይረስ በዝሒ ኣርእዩ፣ እቲ ሻዱሻይ ድማ ኣብ ካልኣይ መዓልቱ ክምርመር እንከሎ ዝለዓለ ናይ ቫይረስ በዝሒ ኣርእዩ።	Five of the six patients, the first sample showed the highest viral load, and the sixth showed the highest viral load when tested on the second day.
1908	en	ti	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel severe acute respiratory syndrome coronavirus, first isolated from three people with pneumonia connected to the cluster of acute respiratory illness cases in Wuhan.	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ንመጀመርታ ኣብ ከተማ ዉሃን ሰለስተ ከቢድ ናይ ምትንፋስ ሕማምን ናይ ሳምባ ምቺ ሕማም ኣብዝተረኽቦም ሰለስተ ሰባት ተራእዩ።	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first appeared in Wuhan in three cases of severe respiratory illness and pneumonia.
1909	en	ti	All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.	ናይ እዚ ሓድሽ SARS-CoV-2 ቫይረስ ኩሎም ባህርያታት ብተፈጥሮኦም ምስ ኮሮናቫይረስ ዝመሳሰሉ ኮይኖም እዮም ዝርከቡ።	All the characteristics of the new SARS-CoV-2 virus are similar in nature to the coronavirus.
1910	en	ti	Outside the human body, the virus is killed by household soap, which bursts its protective bubble.SARS-CoV-2 is closely related to the original SARS-CoV.	ካብ ናይ ሰብ ሰብነት ወጻኢ፣ እዚ ቫይረስ በቲ ናይ ዳጋዊ መከላኸሊኡ ዘንተዓሉ፣ ናይ ገዛ ሳሙና ይመውት እዩ፣ SARS-CoV-2 ምስ እቲ ዋና SARS-CoV ተመሳሳሊ እዩ።	Outside the human body, the virus is killed by household soap that has lifted its external defenses, SARS-CoV-2 is similar to the main SARS-CoV.
1911	en	ti	The lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme angiotensin-converting enzyme 2 (ACE2), which is most abundant in the type II alveolar cells of the lungs.	ሳንቡእት እዮም ብኮቪድ-19 ብ ኣብዝሓ ዝጉድኡ ኦርጋናት ምኽንያቱ እቲ ቫይረስ ናብ እቲ ናይ እቲ ሰብ ዋህዮታት ብኤንዛይም ኣንጂዮቴንሲን-ቀያሪ ኤንዛይም 2 (ACE2) ብምጥቃም ይኣቱ፣ እዚ ድማ ኣብ ናይ ሳንቡኣት ዓይነት II ኣሊቪዮላር ዋህዮታት ብበዝሒ እዩ ዝርከብ።	The lungs are the organs most affected by COVID-19 because the virus enters the person&#39;s cells using the enzyme angiotensin-converting enzyme 2 (ACE2), which is found in large quantities in type II alveolar cells of the lungs.
1912	en	ti	"The virus uses a special surface glycoprotein called a ""spike"" (peplomer) to connect to ACE2 and enter the host cell."	"እዚ ቫይረስ ፍሉይ ግላይኮፕሮቲን ""ስፓይክ"" (peplomer) ተጠቒሙ ምስ ACE2 ይተሓሓዝ እሞ ናብ እቲ ናይ እቲ ሰብ ዋህዮ ይኣቱ።"	The virus uses a special glycoprotein &quot;spike&quot; (peplomer) to bind to ACE2 and enter the person&#39;s cell.
1913	en	ti	Acute cardiac injury was found in 12% of infected people admitted in hospital in Wuhan, China, and is more frequent in severe disease.	ከቢድ ናይ ልቢ ጉድኣት ኣብ 12% ዝተለኸፉ ሰባት ተረኺቡ ኣብ ውሃን፣ ቻይና ሆስፒታል ኣብ ዝኣተዉ ሕሙማት ኣጋጢሙ፣ ኣብ ኣዝዮም ዝሓመሙ ሰባት ድማ ይብእስ።	Severe cardiac damage was found in 12% of infected persons and occurred in patients hospitalized in Wuhan, China, and worsens in critically ill persons.
1914	en	ti	Rates of cardiovascular symptoms is high, owing to the systemic inflammatory response and immune system disorders during disease progression, but acute myocardial injury may also be related to ACE2 receptors in the heart.	ናይ ካርድዮቫስኩላር ምልክታት ንጽጽራዊ መጠን ልዑል እዩ፣ እዚ ድማ ብምኽኒያት ኣብ ናይ እዚ ሕማም ከይዲ ዝህሉ ስርዓታዊ ናይ ረኽሲ መልሲን ናይ ሕማም ምክልኻል ዓቕሚ ስርዓትን ጸገምን እዩ፣ እንተኾነ ግን ሓድሽ ማይካርዲያል ጉድኣት ምስ ናይ ልቢ ACE2 ተቐበልቲ ምኽንያት ክኸውን ይኽእል እዩ።	The comparative rate of cardiovascular symptoms is high, due to the systemic infectious response and immune system complications in the course of this disease, but new myocardial damage with cardiac ACE2 receptors may be attributable.
1915	en	ti	ACE2 receptors are highly expressed in the heart and are involved in heart function.	ናይ ACE2 ተቐበልቲ ኣብ ልቢ ብዙሓት እዮም ምስ ናይ ልቢ ስራሕ ድማ ዝተተሓሓዙ እዮም።	ACE2 receptors are numerous in the heart and are associated with cardiac function.
1916	en	ti	A high incidence of thrombosis (31%) and venous thromboembolism (25%) have been found in ICU patients with COVID-19 infections and may be related to poor prognosis.Autopsies of people who died of COVID-19 have found diffuse alveolar damage (DAD), and lymphocyte-containing inflammatory infiltrates within the lung.	ልዑል ናይ ደም ምርጋእ ኣጋጣሚ (31%) ናይ ቬነስ ደም ምርጋእ (25%) ኣብ ናይ ICU ናይ ኮቪደ-19 ሕሙማት ተረኺቡ እዩ እዚ ዳማ ምስ ድኹም ናይ ትንበያ ተኽእሎ ክተሓሓዝ ይኽእል እዩ። ብኮቪድ-19 ምኽንያት ናይ ዝሞቱ ሰባት ሬሳ ምርመራ ዲፊዩዝ ኣሊቮላር ጉድኣት (DAD)፣ ከምኡውን ኣብ ውሽጢ እቲ ሳንባ ሊምፎሳይታት ዝሓዙ ናይ ቁጥዐ ነዃላት ተረኺቦም እዮም።	A high incidence of blood clots (31%) of venous blood clots (25%) has been found in ICU COPD patients which may be associated with poor prognostic probability. Autopsies of people who have died from COVID-19 have found diffuse alivolar damage (DAD), and irritation holes containing lymphocytes within the lungs.
1917	en	ti	Although SARS-COV-2 has a tropism for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyperinflammation.	SARS-COV-2 ን ACE2-ንናይ ስርዓተ ምስትንፋስ ኢፒተልያል ዋህዮታት ዝገልጽ ትሮፒዝም ኣለዎ፣ ከቢድ ኮቪድ-19 ዘለዎም ሰባት ናይ ስርዓታዊ ሃይፐርኢንፍላሜሽን ምልክታት ኣለውዎም።	SARS-COV-2 has a tropism for ACE2-expressing respiratory epithelial cells, people with severe COVID-19 have symptoms of systemic hyperinflammation.
1918	en	ti	In particular, pathogenic GM-CSF-secreting T-cells were shown to correlate with the recruitment of inflammatory IL-6-secreting monocytes and severe lung pathology in COVID-19 patients.	ብፍላይ፣ ኣብ ናይ ኮቪድ-19 ዝሓመሙ ከቢድ ናይ ሳንባ ፓቶሎጂ ዘለዎም ሰባት፣ ሕማም ዘስዕቡ GM-CSF-መምረቲ T-cells ምስ ናይ ኢንፍላማቶሪ IL-6-መምረቲ ሞኖሳይታት ክተሓባበሩ ተራእዮም እዮም ።	Specifically, in COVID-19 patients with severe lung pathology, pathogenic GM-CSF-producing T-cells have been shown to cooperate with inflammatory IL-6-producing monocytes.
1919	en	ti	Lymphocytic infiltrates have also been reported at autopsy.	ሊምፎሳይቲክ ኢንፍልትሬት ኣብ ናይ ሬሳ ምርመራ ክርከቡ ክኢሎም እዮም።	Lymphocytic infiltrates have been found at autopsy.
1920	en	ti	The WHO has published several testing protocols for the disease.	WHO ዝተፈላለዩ ናይ እዚ ሕማም ናይ ምርመራ ፕሮቶኮላት ኣሐቲሙ ኣሎ።	WHO has published various screening protocols for this disease.
1921	en	ti	The standard method of testing is real-time reverse transcription polymerase chain reaction (rRT-PCR).	እቲ ደረጃኡ ዝሓለወ ናይ ምርመራ መንገዲ real-time reverse transcription polymerase chain reaction (rRT-PCR)እዩ።	The standard diagnostic method is real-time reverse transcription polymerase chain reaction (rRT-PCR).
1922	en	ti	The test is typically done on respiratory samples obtained by a nasopharyngeal swab; however, a nasal swab or sputum sample may also be used.	እዚ ምርመራ ኣብ ናይ መተንፈሲ ናሙናታት ብ ናዞፋሪንጃል ስዋብ ዝካየድ እዩ; እንተኾነ ግን ናይ ኣፍንጫ ስዋብ ወይ ዓኽታ እውን ምጥቃም ይከአል እዩ።	This test is performed on respiratory samples with a nasopharyngeal swab; However, a nasal swab or cough can also be used.
1923	en	ti	Results are generally available within a few hours to two days.	ውጽኢታት ብሓፈሻ ኣብ ውሽጢ ዝተወሰኑ ሰዓታት ክሳብ ክልተ መዓልቲታት ምርካብ ይከኣል።	Results can generally be obtained within a few hours to two days.
1924	en	ti	Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value.	ናይ ደም ምርመራታት ምጥቃም ይከኣል፣ እዚ ግን ክልተ ናይ ደም ናሙናታት በቢ ክልተ ሰሙን ኣፈላላይ ክውሰዱ ይሓትት፣ ድማ ውጽኢታት ድማ ቅልጡፍ ዝኾነ ዋጋ ዳርጋ የብሎምን።	Blood tests can be used, but these require two blood samples to be taken every two weeks, and the results are of little value immediately.
1925	en	ti	Chinese scientists were able to isolate a strain of the coronavirus and publish the genetic sequence so laboratories across the world could independently develop polymerase chain reaction (PCR) tests to detect infection by the virus.	ናይ ቻይና ሳይንቲስታት ናይ እቲ ኮሮናቫይረስ ስተረይን ክፈልዩን ናይ ጀነቲክ ተኸታታልነት ከሐትሙን ክኢሎም እዮም፣ በዚድማ ኣብ ዓለም ዘለዉ ቤት ፈተነታት ኩሎም ዓርሶም ክኢሎም ነቶም በቲ ቫይረስ ዝመጽእ ረኽሲ ንምልላይ ዝግበሩ ናይ polymerase chain reaction (PCR)( ፖሊመሬዝ ሰንሰለታዊ ምውሃድ) ፈተነታት ንኸካይዱ እዩ።	Chinese scientists have been able to isolate the coronavirus strain and publish the genetic sequence, so that laboratories around the world can all independently conduct polymerase chain reaction (PCR) tests to identify infections caused by the virus.
1926	en	ti	As of 4 April 2020, antibody tests (which may detect active infections and whether a person had been infected in the past) were in development, but not yet widely used.	ካብ 4 ኣፕሪል 2020 ጀሚሩ፣ ናይ ኣንቲቦዲታት ምርመራ (ንጡፋት ረኽሲታት ከለሊ ይኽእል እቲ ሰብ ድማ ቅድሚ ሕዚ ተለኺፉ ምንባሩ ንፍላጥ የኽእል) ኣብ ምዕባለ ኔሮም፣ ብሰፊሑ ግን ኣብ ጥቕሚ ኣይወዓሉን።	As of April 4, 2020, antibody tests (which can detect active infections and allow the person to know if they have been infected before) have been in development, but have not been widely used.
1927	en	ti	The Chinese experience with testing has shown the accuracy is only 60 to 70%.	ናይ ቻይና ናይ ምርመራ ተሞክሮ እቲ ትኽክለኝነት ካብ 60 ክሳብ 70% ከምዝኾነ ኣርእዩ።	Chinese testing experience showed the accuracy to be between 60 and 70%.
1928	en	ti	The FDA in the United States approved the first point-of-care test on 21 March 2020 for use at the end of that month.Diagnostic guidelines released by Zhongnan Hospital of Wuhan University suggested methods for detecting infections based upon clinical features and epidemiological risk.	ኣብ ኣሜሪካ ዘሎ FDA ነቲ ናይ መጀመርታ ናይ ምርመራ ነጥቢ ኣብ 21 ማርች 2020 ኣብቲ ወርሒ መወዳእታ ኣብ ጥቕሚ ንክውዕል ፈቒዱ። ናይ ምርመራ መምርሒታት ብናይ ውሃን ዩኒቨርሲቲ ጆንግናን ሆስፒታል ብክሊኒካላዊ ባህርያታትን ኢፒደሞሎጂካል ሓደጋታትን ረኽሲታት ናይ ምርካብ ሓሳብ ኣቕሪቦም።	The US FDA approved the first test point on March 21, 2020, by the end of the month. Diagnostic guidelines suggested the detection of infections by clinical features and epidemiological risks by Wuhan University Jongnan Hospital.
1929	en	ti	Bilateral multilobar ground-glass opacities with a peripheral, asymmetric and posterior distribution are common in early infection.	ክልተኣዊ ማልቲሎባር ሳዕሪ ዝመስሉ ፐሪፈራል፣ ኣሲመትሪክን ዳሕረዋይን ዝርጋሐ ኣብ ናይ መጀመርያታት ረኽሲ ልሙድ እዩ።	Bilateral multilobar grass-like peripheral, asymmetric, and posterior spreads are common in primaries of infection.
1930	en	ti	Subpleural dominance, crazy paving (lobular septal thickening with variable alveolar filling), and consolidation may appear as the disease progresses.	ሳብፕሉራል ዓብላሊነት፣ crazy paving (ናይ lobular septal(ሎቡላር ሴፕታል) ምሕፋስ ምስ ተለዋዋጢ ናይ alveolar(ኣልቪዮላር) ምምላእ)፣ እቲ ሕማም እንዳበኣሰ ክኸይድ እንከሎ ቁሳዊ ጥማር እውን ክፈጠር ይኽእል እዩ።	Subpleural dominance, crazy paving (harvesting of the lobular septal with variable alveolar filling), and material lumps may also form as the disease progresses.
1931	en	ti	Few data are available about microscopic lesions and the pathophysiology of COVID-19.	ብዛዕባ ማይሮስኮፒክ ቁስሊታትን ናይ ኮቪድ-19 ፓቶፊዝዮሎጂ ዝተወሰኑ ዳታታት ኣለዉ።	There are limited data on microscopic lesions and the pathophysiology of COPD.
1932	en	ti	The main pathological findings at autopsy are:	ኣብ ናይ ሬሳ ምርመራ ዋና ፓታሎጂካዊ ርካቦታት:	Main pathological findings at autopsy:
1933	en	ti	Macroscopy: pleurisy, pericarditis, lung consolidation and pulmonary oedema	ማክሮስኮፒ፡ ፐሉሪሲ፣ ፔሪካርዳይትስ፣ ናይ ሳንባ ኮንሲዲሌሽንን ፑሉሙናሪ ሕብጠትን	Macroscopy: Peluricy, pericarditis, pulmonary considilation and pulmonary swelling
1934	en	ti	Four types of severity of viral pneumonia can be observed:	ኣርባዕተ ዓይነት ናይ ቫይረስ ኒዩሞንያ ከቢድነት ምርኣይ ይከኣል:	Four types of viral pneumonia severity can be seen:
1935	en	ti	mild pneumonia: pulmonary oedema, pneumocyte hyperplasia, large atypical pneumocytes, interstitial inflammation with lymphocytic infiltration and multinucleated giant cell formation	ቀሊል ናይ ሳንቡእ ወቕዒ: ናይ ፑልሙኒሪ ኢዴማ፣ ኒሞሳይት ሃይፐርፕላዠያ፣ ዓብዪ ኤታይፒካል ኒሞሳይታት፣ ኢንተርስቲሻል ቁጥዐ ምስ ሊምፎሳይቲክ ኢንፍልትሬሸንን ማልቲኒኩሌትድ ዓበይቲ ዋህዮታትን	Simple pulmonary stroke: pulmuniri edema, pneumocyte hyperplasia, large atypical pneumocytes, interstitial irritation with lymphocytic infiltration and multinucleated giant cells
1936	en	ti	severe pneumonia: diffuse alveolar damage (DAD) with diffuse alveolar exudates.	ከቢድ ናይ ሳንቡእ ወቕዒ፣ ዲፊዩዝ ኣልቪዮላር ጉድኣት (DAD) ምስ ዲዩዝ ኣልቪዮላር ኤክሱዴት።	Severe pulmonary stroke, diffuse alveolar damage (DAD) with deuce alveolar exudate.
1937	en	ti	DAD is the cause of acute respiratory distress syndrome (ARDS) and severe hypoxemia.	DAD ብህጹጽ ናይ ስርዓተ ምስትንፋስ ምውዳቕ ሲንድረምን (ARDS) ከቢድ ሃይፖክሲምያን ዘምጽእ እዩ።	DAD brings on acute respiratory failure syndrome (ARDS) and severe hypoxemia.
1938	en	ti	healing pneumonia: organisation of exudates in alveolar cavities and pulmonary interstitial fibrosis	ዝሓዊ ዘሎ ናይ ሳንቡእ ወቕዒ፣ ኣብ ኣልቪዮላር በእታትን ፑልሙናሪ ኢንተርስቲሽያል ፋይብሮሲስ ፈሰስቲ ምእካብ	Recovering pulmonary stroke, fluid collection in alveolar beats and pulmonary interstitial fibrosis
1939	en	ti	Blood: disseminated intravascular coagulation (DIC); leukoerythroblastic reaction	ደም: ዝተበተነ ኢንትራቫስኩላር ምርጋእ (DIC); ሊኮኢሪትሮብላስቲክ ውህደት	Blood: dispersed intravascular coagulation (DIC); Leucoerythroblastic combination
1940	en	ti	Preventive measures to reduce the chances of infection include staying at home, avoiding crowded places, washing hands with soap and water often and for at least 20 seconds, practising good respiratory hygiene and avoiding touching the eyes, nose or mouth with unwashed hands.	ናይ ምልካፍ ዕድል ዝቕንሱ መከላኸሊ መገዲታት ኣብ ገዛኻ ምጽናሕ፣ ሰብ ዝበዝሖም ቦታታት ምውጋድ፣ ኣእዳው ብሳሙናን ማይን እንተንኢሱ ን 20 ሰከንድታት ምሕጻብ፣ ጽቡቕ ናይ ስርዓት ምስትንፋስ ጽሬት ብምሕላውን ዓይኒ፣ ኣፍንጫ ወይ ኣፍ ምንካእ ምውጋድን ዘተቓልል እዩ።	Preventive measures to reduce the risk of infection include staying at home, avoiding crowded places, washing hands with soap and water for at least 20 seconds, maintaining good respiratory hygiene and avoiding eye, nose or mouth contact.
1941	en	ti	The CDC recommends covering the mouth and nose with a tissue when coughing or sneezing and recommends using the inside of the elbow if no tissue is available.	CDC ክትስዕሉ ወይ ክትህንጥሱ ከለኹም ኣፍኩም ብሶፍት ምሽፋንን ሶፍት እንተዘይሃሊኩም ድማ ኩርናዕ ኢድኩም ክትጥቀሙ ይመክር።	The CDC recommends covering your mouth with a soft tissue when coughing or sneezing and using the corner of your hand if you don’t have one.
1942	en	ti	Proper hand hygiene after any cough or sneeze is encouraged.	ግቡእ ናይ ኢድ ጽሬት ድሕሪ ምስዓል ወይ ምህንጣስ ዝበረታታዕ እዩ።	Proper hand hygiene is encouraged after coughing or sneezing.
1943	en	ti	The CDC has recommended the use of cloth face coverings in public settings, in part to limit transmission by asymptomatic individuals.Social distancing strategies aim to reduce contact of infected persons with large groups by closing schools and workplaces, restricting travel and cancelling large public gatherings.	CDC ምልክት ካብ ዘየርእዩ ሰባት ናይ ምምሕልላፍ ክእለት ንምግታእ፣ ብዙሕ ሰብ ኣብ ዘለዎ ቦታ ናይ ገጽ መሸፈኒ ምጥቃም ይመክር። ናይ ማሕበራዊ ርሕቐት ሜላታት ጉዕዞታት ብምግዳብን ናይ ብዙሕ ሰብ ምእካብ ዘለዎ ቦታታት ብምዕጻውን፣ ዝተለኸፉ ሰባት ምስ ብዙሓት ሰባት ንከይራኸቡ ቤት ትምህርቲታትን ናይ ስራሕ ቦታታትን ብምዕጻው ዝተገበሩ እዮም።	The CDC recommends wearing a face mask in public places to prevent transmission from asymptomatic people. Social distancing measures included restricting travel and closing crowded places, and closing schools and workplaces to prevent infected people from coming into contact with large numbers of people.
1944	en	ti	Distancing guidelines also include that people stay at least 6 feet (1.8 m) apart.	ናይ ርሕቐት ምሕላው መምርሒታት ሰባት እንተንኢሱ 6 ጫማ (1.8 ሜ) ክረሓሓቑ ኣለዎም።	DISTANCE GUIDELINES People should stay at least 6 feet (1.8 m) apart.
1945	en	ti	"There is no medication known to be effective at preventing COVID-19.As a vaccine is not expected until 2021 at the earliest, a key part of managing COVID-19 is trying to decrease the epidemic peak, known as ""flattening the curve""."	"ኮቪድ -19 ንምክልኻል ብቑዕ ዝኾነ መድሓት የለን። ከትባት ድማ ዝቐረበ ተባሂሉ ክሳብ 2021 ትጽቢት ኣይግበሮን፣ ናይ ኮቪድ-19 ምቁጽጻር ቁልፊ ሜላ ናይ እዚ ለበዳ ጫፍ ምውራድ እዩ እዚ ድማ፣ ""ነቲ ከርቭ ፍላት ምግባር ""ይበሃል።"	There is no effective insurance to prevent COVID-1 Vaccines are not expected to be available until 2021. The key to controlling COVID-19 is to bring down the peak of the epidemic, which is called &quot;flat the curve.
1946	en	ti	The CDC also recommends that individuals wash hands often with soap and water for at least 20 seconds, especially after going to the toilet or when hands are visibly dirty, before eating and after blowing one's nose, coughing or sneezing.	CDC ውልቀ ሰባት በተደጋጋሚ እንተንኢሱ ን 20 ሰከንድታት ኢዶም ክሕጸቡ ይመክር፣ ብፍላይ ድሕሪ ናብ ሽንቲ ቤት ምኻድኩም ወይ ኣእዳውኩም ዝረአ ርስሓት እንተሊዎ፣ ቅድሚ ምብላዕ ወይ ድሕሪ ኣፍንጫኹም ምንፋጥኩም፣ እንተስዒልኩም ወይ እንተሀንጢስኩም።	The CDC recommends that individuals wash their hands frequently for at least 20 seconds, especially after going to the toilet or if your hands are visiblely dirty, before eating or after sneezing, coughing or sneezing.
1947	en	ti	It further recommends using an alcohol-based hand sanitiser with at least 60% alcohol, but only when soap and water are not readily available.For areas where commercial hand sanitisers are not readily available, the WHO provides two formulations for local production.	ብተወሳኺ ድማ ሳሙናን ማይን እንተዘይህሉዉሉ ግዘ ጥራይ፣ እንተንኢሱ 60% ኣልኮል ዘለዎ ሳኒታይዘር ምጥቃም ዝምከር እዩ።ንግዳዊ ናይ ኢድ ሳኒታይዘራት ኣብ ዘይርከበሉ፣ ውድብ ጥዕና ዓለም(WHO) ክልተ ንከባቢያዊ ምህርቲ መዳላዊ ዝኾኑ ቅመማታት ሂቡ ኣሎ።	In addition, it is recommended to use a sanitizer containing at least 60% alcohol, only when soap and water are not available.
1948	en	ti	In these formulations, the antimicrobial activity arises from ethanol or isopropanol.	ኣብ እዞም ሰነ-ሓሳባት እዚኦም፣ እዞም ጸረ ማይክሮቢያል ንጥፈታት ካብ ethanol ወይ isopropanol ዝመጹ እዮም።	In these theories, these antimicrobial activities are derived from ethanol or isopropanol.
1949	en	ti	"Hydrogen peroxide is used to help eliminate bacterial spores in the alcohol; it is ""not an active substance for hand antisepsis""."	ምስ ኣልኮል ሃይድሮጅን ፐር ኦክሳይድ ናይ ባክቴርያ ተሃዋስያን ኣብ ምጥፋእ ይሕግዝ፤ “ንናይ ኢድ ኣንቲሰፕሲስ ንጡብ ውሁድ ኣይኮነን”	Along with alcohol, hydrogen peroxide helps in destroying bacterial allergens; “Not compound for hand antisepsis for nipples”
1950	en	ti	Glycerol is added as a humectant.	ግላይሴሮል ከም ሂዩመክታንት ዝተሓወሰ እዩ።	Glycerol is included as a humectant.
1951	en	ti	People are managed with supportive care, which may include fluid therapy, oxygen support, and supporting other affected vital organs.	ሰባት ሓገዝቲ ክንክናት እዮም ዝግበሩሎም፣ ናይ ፈሳሲ ሕክምና፣ ናይ ኦክሲጅን ሓገዝን ካልኦት ዝተጎድኡ ዓበይቲ ኦርጋናትን ምሕጋዝ ድማ የጠቓልል።	People are given supportive care, which includes fluid therapy, oxygen assistance and help with other major organ damage.
1952	en	ti	The CDC recommends that those who suspect they carry the virus wear a simple face mask.	CDC እቲ ቫይረስ ከምዘለዎም ዝጥርጥሩ ሰባት ማስክ ክገብሩ ኣለዎም ኢሉ።	The CDC said people suspected of having the virus should wear masks.
1953	en	ti	Extracorporeal membrane oxygenation (ECMO) has been used to address the issue of respiratory failure, but its benefits are still under consideration.	Extracorporeal membrane oxygenation (ECMO) ናይ ስርት ምስትንፋስ ውድቀት ኣብ ምፍታሕ ኣብ ጥቕሚ ዝወዓለ እዩ፣ ዝህቦም ጥቕሚታት ግን ክሳብ ሕዚ ኣብ ግምት ውሽጢ እናኣተዉ እዮም።	Extracorporeal membrane oxygenation (ECMO) has been used in the management of respiratory failure, but its benefits are still under consideration.
1954	en	ti	Personal hygiene and a healthy lifestyle and diet have been recommended to improve immunity.	ውልቃዊ ጽሬታትን ጥዕንኡ ዝሓለወ መነባብሮን ኣመጋግባን ናይ ሕማም ምክልኻል ዓቕሚ ንምምዕባል ዝምከሩ እዮም።	Personal hygiene and a healthy lifestyle and diet are recommended to develop immunity.
1955	en	ti	Supportive treatments may be useful in those with mild symptoms at the early stage of infection.The WHO and Chinese National Health Commission have published recommendations for taking care of people who are hospitalised with COVID-19.	ሓገዝቲ ሕክምናታት ቀለልቲ ምልክታት ኣብ ዘለዎም ሰባት ኣብ ናይ መጀመርያታት ምልክታት እዮም ዝጠቕሙ። WHO ን ናይ ቻይና ብሄራዊ ጥዕና ኮሚሸንን ብኮቪድ-19 ኣብ ሆስፒታል ናይ ዝደቀሱ ሰባት መተሓመሚ መምርሒታት ኣሐቲሞም።	Adjuvant treatments are useful in the first signs in people with mild symptoms. The WHO and China&#39;s National Health Commission have published treatment guidelines for people hospitalized with COVID-1
1956	en	ti	Intensivists and pulmonologists in the U.S. have compiled treatment recommendations from various agencies into a free resource, the IBCC.	ኣብ ኣሜሪካ ዝርከቡ ተመራመርቲ ሕክምና ካብ ዝተፈላለዩ ምንጪታት ዝረኽብዎም ሓበሬታታትን ምኽርታትን ናብ IBCC ብምጥርቓም ብነጻ የቕርቡ።	Medical researchers in the United States compile information and advice from a variety of sources and provide it free of charge to the IBCC.
1957	en	ti	As of April 2020, there is no specific treatment for COVID-19.	ክሳብ ኣፕሪል 2020 ፣ ንኮቪድ-19 ዝኸውን መድሓኒት የለን።	As of April 2020 , there is no cure for COVID-1
1958	en	ti	For symptoms, some medical professionals recommend paracetamol (acetaminophen) over ibuprofen for first-line use.	ንምልክታት፣ ገለ ናይ ሕክምና ሰብ ሞያታት paracetamol (acetaminophen) ኣብ ልዕሊ ibuprofen ከም ናይ መጀመርያ መጥቀሚ መሰመር ገይሮም ይመኽሩ።	For symptoms, some medical professionals recommend paracetamol (acetaminophen) as a first-line use over ibuprofen.
1959	en	ti	Precautions must be taken to minimise the risk of virus transmission, especially in healthcare settings when performing procedures that can generate aerosols, such as intubation or hand ventilation.	ብፍላይ ከም ኢንቲቤሽን ወይ ናይ ኢድ ቬንትሌሽን ዝበሉ ኣብ ናይ ጥዕና ክንክን መሰናድኦ ኤሮሶላት ክፈርዩ ዝኽእሉ ከይዲታት ኣብ ዝስረሐሎም እዋናት ናይ እቲ ቫይረስ ምምሕልላፍ ዓቕሚ ንምቕናስ ቅድመ ጥንቃቐታት ክውሰዱ ኣለዎም ።	Precautions should be taken to reduce the transmission potential of the virus, especially when processes such as initiation or hand ventilation are used to produce aerosols in health care settings.
1960	en	ti	For healthcare professionals caring for people with COVID-19, the CDC recommends placing the person in an Airborne Infection Isolation Room (AIIR) in addition to using standard precautions, contact precautions and airborne precautions.The CDC outlines the guidelines for the use of personal protective equipment (PPE) during the pandemic.	ነቶም ናይ ኮቪድ-19 ዘለዎም ሰባት ዝከናኸኑ ናይ ጥዕና ሰብ ሞያታት፣ እቲ CDC ነቲ ዝሓመመ ሰብ ደረጃ ጽሬት ጥንቃቐታት፣ ናይ ኽንክን ጥንቃቐታትን ናይ ብኣየር ምምሕልላፍ ጥንቃቐታትን ምስ ምጥቃም ብተወሳኺ ኣብ ናይ ብኣየር ዝመሓላለፉ ረኽሲታት መፍለዪ ክፍሊ (AIIR) ከእትውዎ ይመክር። እዚ CDC ኣብ እዚ ናይ እዚ ለበዳ ግዘ እዚ ናይ ውልቃዊ መከላኸሊ ናውቲ (PPE) ኣጠቓቕማ መምርሒ ኣውጺኡ እዩ።	For health professionals caring for people with COVID-19, the CDC recommends that the sick person be admitted to an airborne infection isolation unit (AIIR) in addition to using standard hygiene precautions, care precautions, and airborne precautions. The CDC has issued guidelines for the use of personal protective equipment (PPE) during this pandemic.
1961	en	ti	The recommended gear is: PPE gown, respirator or facemask, eye protection, and medical gloves.When available, respirators (instead of facemasks) are preferred.	እቲ ዝምክር ናይ ዓርሰ ምክልኻል ዕጥቂ: PPE ጋውን፣ መተንፈሲ ወይ ናይ ገጽ ማስክ፣ ናይ ዓይኒ መከለኸሊን ናይ ሕክምና ጓንቲታትን እዮም። ቅሩባት እንተኾይኖም፣ መተንፈሲታት (ኣብ ክንዲ ናይ ገጽ ማስክታት) ይምረጹ።	The recommended self-protection kit is: PPE gown, respirator or face mask, eye protection and medical gloves. If ready, respirators (instead of face masks) are preferred.
1962	en	ti	N95 respirators are approved for industrial settings but the FDA has authorised the masks for use under an Emergency Use Authorisation (EUA).	N95 መተንፈሲታት ንኢንዳስትራያል መሰናድኦ ፈቓድ ረኺቦም እዮም ግን FDA እዞም ማስክታት ኣብ ሃንደበታዊ ናይ ፈቓድ ምጥቃም (EUA) ኣብ ጥቕሚ ክውዕሉ እዩ ዝፈቅድ።	N95 respirators have been approved for industrial preparation but the FDA allows these masks to be used in an emergency approval use (EUA).
1963	en	ti	They are designed to protect from airborne particles like dust but effectiveness against a specific biological agent is not guaranteed for off-label uses.	እዚኦም ካብ ከም ኣቦራ ዝበሉ ናይ ብኣየር ዝመሓላለፉ ንጥረ ነገራ ንክከላኸሉ ተባሂሎም ዝተነደፉ እዮም፣ ይኹን ደኣምበር፣ ኣብ ዝተወሰኑ ስነ-ሂወታውያን ኤጀንታት ንምጥቃም ዘኽእል ውሕስና የብሎምን።	These are designed to protect against airborne particles such as aerosols, however, they are not safe for use in certain biological agents.
1964	en	ti	When masks are not available, the CDC recommends using face shields or, as a last resort, homemade masks.	ማስክ ዘይርከበሉ ግዘ፣ CDC ናይ ገጽ መከላኸሊ ወይ፣ ከም ናይ መወዳእታ መማረጺ ድማ ኣብ ገዛ ዝተሰርሑ ማስክታት ክትጥቀሙ ይመክር።	When masks are not available, the CDC recommends using face shields or, as a last resort, homemade masks.
1965	en	ti	Most cases of COVID-19 are not severe enough to require mechanical ventilation or alternatives, but a percentage of cases are.	መብዛሕትኦም ናይ ኮቪድ-19 ጉዳያት ለበዳ ሜካኒካዊ ቬንትሌሽን ወይ ካልእ መማረጺ ክሳብ ዘድሊ ከበድቲ ኣይኮኑን፣ ዝተወሰኑ ክፋላት ናይ እዞም ጉዳያት ለበዳ ግን ዝደልዩ እዮም።	Most COVID-19 outbreak cases are not severe enough to require mechanical ventilation or other options, but certain parts of these outbreak cases do require it.
1966	en	ti	The type of respiratory support for individuals with COVID-19 related respiratory failure is being actively studied for people in hospital, with some evidence that intubation can be avoided with a high flow nasal cannula or bi-level positive airway pressure.	ንኮቪድ-19 ዘለዎም ናይ ስርዓተ ምስትፋስ ውድቀት ዘጋጥሞም ሰባት ዘድልዮም ናይ ምስትንፋስ ሓገዝ ኣብ ሆስፒታል ንዘለዉ ሰባት ብንጥፈት እንዳተጸንዐ ይርከብ፣ ኢንቱቤሽን ንምውጋድ ብልዑል ፍሰት ዘለዎ ናይ ኣፍንጫ ካኑላ ወይ bi-level ፖዘቲቭ ናይ ኣየር መተንፈሲ ጸቕጢ ምውጋድ ይከኣል።	The ventilatory assistance needed for people experiencing respiratory failure with COVID-19 is being actively studied for people in hospital, and intubation can be avoided with a high-flow nasal cannula or bi-level positive ventilatory pressure.
1967	en	ti	Whether either of these two leads to the same benefit for people who are critically ill is not known.	ካብ እዞም ክልተ እዚኦም ንኣዝዮም ዝሓመሙ ሰባት ናብ ተመሳሳሊ ረብሓ ዘምርሑ እንተኾይኖም ክሳብ ሕዚ ኣይተፈለጠን።	It is not yet known if either of these leads to similar benefits for severely ill people.
1968	en	ti	Some doctors prefer staying with invasive mechanical ventilation when available because this technique limits the spread of aerosol particles compared to a high flow nasal cannula.Severe cases are most common in older adults (those older than 60 years, and especially those older than 80 years).	ገለ ዶክተራት ኢንቫሲቭ ሜካኒካል ቬንትሌሽን ምጥቃም ይመርጹ ቅሩባት እንተኾይኖም ምኽንያቱ እዚ ሜላ እዚ ምስ ልዑል ናይ ኣፈንጫ ውሕዘት ካኑላ ክነጻጸር ከሎ ናይ ኢሮሶል ንጥረ ነገራት ምስርጫው ስለዝቕንስ። ከበድቲ ጉዳያት ለበዳ ኣብ ዕድምኦም ዝደፍኡ ሰባት(ልዕሊ 60 ዓመቶም ኣብ ዝኾኑ፣ ብፍላይ ድማ ኣብ ልዕሊ 80 ዓመቶም ሰባት) እዩ መብዛሕትኡ ዝፍጠር ።	Some doctors prefer to use invasive mechanical ventilation if they are prepared because this technique reduces the infiltration of aerosol particles compared to a high-flow nasal cannula. Severe epidemic cases occur mostly in older people(over 60, especially people over 80).
1969	en	ti	Many developed countries do not have enough hospital beds per capita, which limits a health system's capacity to handle a sudden spike in the number of COVID-19 cases severe enough to require hospitalisation.	ብዙሓት ዝማዕበሉ ሃገራት ንሕድሕድ ሕሙም እኹል ዝኾነ ናይ ሆስፒታል ዓራት የብሎምን፣ እዚ ድማ ንናይ እቲ ሕክምና ስርዓት ዓቕሚ ብኮቪድ -19 ጉዳያት ለበዳ ንዝፍጠሩ ከበድቲ ጉዳያት መከናኸኒ ዓቕሙ ክወድቕ ዝገብሮ እዩ።	Many developing countries do not have enough hospital beds per patient, which reduces the medical system&#39;s ability to care for serious cases caused by the COVID-19 pandemic.
1970	en	ti	One study in China found 5% were admitted to intensive care units, 2.3% needed mechanical support of ventilation, and 1.4% died.	ሓደ ኣብ ቻይና ዝተኻየደ መጽናዕቲ ከምዝረኸቦ 5% ናብ ጽዑቕ ክትትል ዩኒት ኣትዮም፣ 2.3% ሜካኒካል ናይ ምስትንፋስ ሓገዝ የድልዮም ኔሩ፣ 1.4% ድማ ሞይቶም እዮም።	One study in China found that 5% were admitted to an intensive care unit, 2.3% required mechanical ventilatory assistance, and 1.4% died.
1971	en	ti	In China, approximately 30% of people in hospital with COVID-19 are eventually admitted to ICU.	ኣብ ቻይና፣ ዳርጋ 30% ዝኾኑ ብኮቪድ-19 ምኽንያት ኣብ ሆስፒታል ዝነበሩ ሰባት ቀስ እንዳበሉ ናብ ICU ኣትዮም እዮም።	In China, nearly 30% of people hospitalized for COVID-19 have slowly been admitted to the ICU.
1972	en	ti	Mechanical ventilation becomes more complex as acute respiratory distress syndrome (ARDS) develops in COVID-19 and oxygenation becomes increasingly difficult.	ሜካኒካዊ ቬንትሌሽን ኣብ ኮቪድ-19 ህጹጽ ናይ ስርዓተ ምስትንፋስ ዲስትረስ ሲንድረም (ARDS) ክምዕብል ከሎ ውስብስብ ይኸውን ኦክሲጅኔሽን እውን ኣዝዩ ከቢድ ይኸውን።	Mechanical ventilation becomes complicated when acute respiratory distress syndrome (ARDS) develops in COVID-19 and oxygenation becomes very difficult.
1973	en	ti	Ventilators capable of pressure control modes and high PEEP are needed to maximise oxygen delivery while minimising the risk of ventilator-associated lung injury and pneumothorax.	ናይ ጸቕጢ ቁጽጽርን ልዑል PEEP ዘለዎም ቨንቲሌተራት ናይ ኦክሲጅን ምብጽጻሕ ብምውሳኽ ምስ ቬንትሌተር ዝተተሓሓዙ ናይ ሳንባ ጉድኣታትን ኒሞቶራክስን ዝቕንሱ እዮም።	Pressure control and high PEEP ventilators increase oxygen delivery and reduce ventilator-related lung injury and pneumothorax.
1974	en	ti	High PEEP may not be available on older ventilators.	ልዑል PEEP ኣብ ናይ ቀደም ቨንቲሌተራት ዘይክህሉ ይኽእል።	High PEEP may not be present on older ventilators.
1975	en	ti	Research into potential treatments started in January 2020, and several antiviral drugs are in clinical trials.	ኣብቶም ክህልዉ ዝኽእሉ ሕክምናታት ዝግበር መጽናዕቲ ኣብ ጃንዋሪ 2020 ተጀሚሩ፣ ዝተፈላለዩ ጸረ ቫይረስ መድሓታት ድማ ኣብ ክሊኒካላዊ ፈተነታት ይርከቡ።	Studies on the potential treatments began in January 2020, and various antiretroviral drugs are in clinical trials.
1976	en	ti	Remdesivir appears to be the most promising.	Remdesivir(ረምድስቪር) ዝሓሸ ተስፋ ወሃቢ ኮይኑ ተረኺቡ ኣሎ።	Remdesivir has been shown to be more promising.
1977	en	ti	Although new medications may take until 2021 to develop, several of the medications being tested are already approved for other uses or are already in advanced testing.	ዋላ ሓደሽቲ መድሓኒታት ምምዕባል ክሳብ 2021 ክጸንሕ ዝኽኣሉ ይኹኑ፣ መብዛሕትኦም ዝፍተኑ ዘለዉ መድሓኒታት ግን ንካልኦት ጥቕሚታት ፈቓድ ረኺቦም ወይ ኣብ ልዑል ናይ ፈተነ ደረጃ እዮም ዘለዉ።	Although development of new drugs could last until 2021, most of the drugs being tested have been approved for other uses or are in advanced trial stages.
1978	en	ti	Antiviral medication may be tried in people with severe disease.	ጸረ ቫይረስ ሕክምና ኣብ ከቢድ ሕማም ዝተረኣዮም ውልቀ ሰባት ክፍተን ይኽእል።	Antiviral treatment may be tried in individuals who have developed severe illness.
1979	en	ti	The WHO recommended volunteers take part in trials of the effectiveness and safety of potential treatments.The FDA has granted temporary authorisation to convalescent plasma as an experimental treatment in cases where the person's life is seriously or immediately threatened.	ውድብ ጥዕና ዓለም(WHO) ኣብ ናይ ገለ መድሓታት ብቑዕነትን ደሕንነትን ውሕስነትን ንምርግጋጽ ኣብ ዝግበር ፈተነ ወለንታዊያን ን ክሳትፍ ሓቲቱ። FDA ንኮንቨልሰንት ፕላዝማ ናይ እቲ ሰብ ህይወት ብከቢድ ወይ ብቐጠታ ኣብ ሓደጋ ኣብ ዝኣትወሉ ግዘ ከም ናይ ፈተነ መድሓኒት ን ክኾን ግዜኣዊ ፈቓድ ሂቡ ኣሎ።	The World Health Organization (WHO) has asked volunteers to participate in trials to ensure the efficacy, safety and security of some medicines. The FDA has temporarily approved convulsant plasma as an experimental drug when the person&#39;s life is seriously or directly in danger.
1980	en	ti	It has not undergone the clinical studies needed to show it is safe and effective for the disease.	ነቲ ሕማም ደሕንነቱ ዝሓለወን ኣድማዒን ከምዝኾነ ዘርኢ ክሊኒካላዊ መጸናዕቲ ኣይገበረን።	He has not conducted clinical studies to show that the disease is safe and effective.
1981	en	ti	In February 2020, China launched a mobile app to deal with the disease outbreak.	ኣብ ፌብሩዋሪ 2020፣ ቻይና ናይ እዚ ሕማም ለበዳ ንምቁጽጻር ናይ ሞባይል መተግበሪ ኣላልያ እያ።	In February 2020, China introduced a mobile application to control the outbreak.
1982	en	ti	Users are asked to enter their name and ID number.	ተጠቀምቲ ሽሞምን ናይ ID ቁጽሮምን ከእትዉ ይሕተቱ።	Users are prompted to enter their name and ID number.
1983	en	ti	The app is able to detect 'close contact' using surveillance data and therefore a potential risk of infection.	እዚ መተግበሪ ናይ ሰርቬላንስ ዳታ ብምጥቃም ናይ ረኽሱ ሓደጋ ኣጋጣሚ ክኸውን ዝኽእል ናይ 'ቀረባ ንኽክእ ' ክፈልጥ ይኽእል እዩ።	This application can use surveillance data to determine the risk of infection of a potential &#39;close contact&#39;
1984	en	ti	Every user can also check the status of three other users.	ሕድሕድ ተጠቃሚ ናይ ካልኦት ሰለስተ ተጠቀምቲ ኩነታት ክርኢ ይኽእል እዩ።	Each user can view the status of three other users.
1985	en	ti	If a potential risk is detected, the app not only recommends self-quarantine, it also alerts local health officials.Big data analytics on cellphone data, facial recognition technology, mobile phone tracking and artificial intelligence are used to track infected people and people whom they contacted in South Korea, Taiwan and Singapore.	ሓደጋ ከስዕብ ዝኽእል ኣጋጣሚ እንተተፈጢሩ፣ እዚ መተግበሪ ዓርስኻ ምፍላይ ጥራሕ ዘይኮነ ዝመክር፣ ንከባቢያዊ ናይ ጥዕና ሰበ ስልጣናት እውን ይሕብሮም እዩ። ኣብ ደቡብ ኮርያ፣ ታይዋንን ሲንጋፖርን ኣብ ተንቀሳቓሲ ቴሌፎን ዳታ፡ናይ ገጽ መለለዪ ቴክኖሎጂ፣ ናይ ሞባይል ተሌፎን መድለዪን ኣርቴፊሻል ኢንተለጀንስን ዝርከብ ናይ ቢግ ዳታ ኣናላይቲክስ ፣ ዝተለኸፉ ሰባት ንምእላሽን ዝነኽእዎም ሰባት ንምፍላጥን ኣብ ጥቕሚ ዝውዕል እዩ።	If a potentially dangerous incident occurs, the app not only advises self-isolation, but also notifies local health authorities. In South Korea, Taiwan and Singapore, big data analytics in mobile data, facial recognition technology, mobile phone tracking and artificial intelligence are used to track infected people and identify their contacts.
1986	en	ti	In March 2020, the Israeli government enabled security agencies to track mobile phone data of people supposed to have coronavirus.	ኣብ ማርች 2020፣ ናይ እስራኤል መንግስቲ ናይ ደሕንነት ኤጀንሲታት ኮሮናቫይረስ ናይ ዘለዎም ሰባት ሞባይል ተሌፎን ዳታ ንኽከታተሉ ፈቒዱሎም እዩ።	In March 2020, the Israeli government allowed security agencies to track the mobile phone data of people with the coronavirus.
1987	en	ti	The measure was taken to enforce quarantine and protect those who may come into contact with infected citizens.	እዚ ስጉምቲ ኳረንቲን ንምብርትታዕን ምስ ዝተለኸፉ ዜጋታት ዝተነኻኽኡ ሰባት ንምሕብሓን እዩ ተወሲዱ።	The move was taken to strengthen quarantine and to protect people who have been in contact with infected citizens.
1988	en	ti	Also in March 2020, Deutsche Telekom shared aggregated phone location data with the German federal government agency, Robert Koch Institute, in order to research and prevent the spread of the virus.	ኣብ ማርች 2020 እውን፣ Deutsche Telekom ናይ እቲ ቫይረስ ዝርጋሐ ንምጽናዕን ንምክልኻልን፣ ሓፈሻዊ ናይ ተሌፎን ቦታታት ዳታ ንጀርመን ፌደራላዊ ኤጀንሲ፣ Robert Koch ትካል፣ ኣካፊልዎም።	Also in March 2020, Deutsche Telekom shared general telephone location data with the German federal agency, the Robert Koch Institute, to study and prevent the spread of the virus.
1989	en	ti	Russia deployed facial recognition technology to detect quarantine breakers.	ሩስያ ኳረንቲ ሴሮም ዝወጹ ሰበት ንምልላይ ናይ ገጽ መለለዪ ቴክኖሎጂ ናብ ስራሕ ኣእቲያ ኣላ።	Russia has deployed facial recognition technology to identify those who have left the quarantine serum.
1990	en	ti	"Italian regional health commissioner Giulio Gallera said he has been informed by mobile phone operators that ""40% of people are continuing to move around anyway""."	"ናይ ጣልያን ክልላዊ ጥዕና ኮሚሽነር ጁሊዮ ጋሌራ ብሞባይል ተሌፎን አፕሬተራት ""40% ዝኾኑ ሰባት ምንቅስቓሶም ቀጺሎም "" ከምዘለዉ ከምዝተሓበረ ገሊጹ።"	Italy&#39;s regional health commissioner Giulio Galera said mobile phone operators had reported that &quot;40 percent of people continued to move.
1991	en	ti	German government conducted a 48 hours weekend hackathon with more than 42.000 participants.	መንግስቲ ጀርመን ልዕሊ 42,000 ተሳተፍቲ ዝተዓደምሉ ናይ 48 ሰዓታት ሃካቶን ኣካይዱ።	The German government held a 48-hour hackathon to which more than 42,000 participants were invited.
1992	en	ti	Also the president of Estonia, Kersti Kaljulaid, made a global call for creative solutions against the spread of coronavirus.	ናይ Estonia, Kersti Kaljulaid ፕረዚዳንት፣ ኣንጻር ኮሮናይረስ ዝኸውን ዓለምለኻዊ ፈጠራዊ መፍትሒ ክፍጠር ጻውዒት የቕርቡ።	Estonia&#39;s President Kersti Kaljulaid calls for an innovative global solution to the coronavirus.
1993	en	ti	Individuals may experience distress from quarantine, travel restrictions, side effects of treatment or fear of the infection itself.	ውልቀሰባት ኣብ ኳረንቲን፣ ናይ ጉዕዞ እገዳታት፣ ጎድናዊ ጸገማትን ናይ እቲ ረኽሲ ፍርሒ ንባዕሉ ጭንቀት ከሕድረሎም ይኽእል እዩ።	Individuals may be anxious about quarantine, travel restrictions, side effects and the fear of the infection itself.
1994	en	ti	"BBC quoted Rory O'Connor in saying, ""Increased social isolation, loneliness, health anxiety, stress and an economic downturn are a perfect storm to harm people's mental health and wellbeing."""	"BBC ሮርይ ኦኮኖር ኢሉዎ ኣብ ዝበሎ ""ማሕበራዊ ተነጽሎ፣ ጽምዋ፣ጥዕናዊ ጭንቀት፣ ኣዕምሮኣዊ ውጥረትን ኢኮኖሚካዊ ውድቀትን እንትበዝሕ፣ ንናይ ሰባት ስነ ኣእምሮኣዊ ጥዕናን ደሕነነት ዝጎድኡ ነገራት እዮም""።"	BBC Rory O&#39;Connor said that &quot;social isolation, loneliness,health anxiety, mental stress and economic decline are things that are detrimental to people&#39;s mental health and well-being&quot;
1995	en	ti	The disease may take a mild course with few or no symptoms, resembling other common upper respiratory diseases such as the common cold.	እቲ ሕማም ካልኦት ልሙዳት ከም ሰዓል ዝበሉ ናይ ላዕለዋይ መተንፈሲ ኣካል ሕማማት ብዝምስል መልክዑ ዝተወሰኑ ምልክታት ክህልውዎ ይኽእሉ ወይ ምንም ምልክታት ዘይከርኢ ይኽእል።	The disease may have certain symptoms or no symptoms that mimic other common upper respiratory illnesses such as the common cold.
1996	en	ti	Mild cases typically recover within two weeks, while those with severe or critical diseases may take three to six weeks to recover.	ቀለልቲ ጉዳያት ለበዳ ኣብ ውሽጢ ክልተ ሰሙናት ይሓውዩ፣ እቶም ከቢድ ወይ ኣስጋኢ ሕማም ዘለዎም ግን ንክሓውዩ ካብ ሰለስተ ክሳብ ሽድሽተ ሰሙናት ይወስደሎም እዩ።	Mild cases of outbreaks recover within two weeks, but those with severe or dangerous illnesses take three to six weeks to recover.
1997	en	ti	Pregnant women may be at higher risk for severe infection with COVID-19 based on data from other similar viruses, like SARS and MERS, but data for COVID-19 is lacking.In some people, COVID-19 may affect the lungs causing pneumonia.	ካብ ከም SARS ን MERS ን ዝበሉ፣ ናይ ኮቪድ -19 ሓበሬታ ዝተማልእ ኣይኮነን፣ ካልኦት ተመሳሰልቲ ቫይረሳት ዝተወሰደ ሓበሬታ ከምዘርእዮ፣ ጥኑሳት ኣንስቲ ንናይ ኮቪድ-19 ከቢድ ረኽሲ ተጋለጽቲ እየን። ኣብ ገለ ሰባት፣ ኮቪድ-19 ን ሳንቡእ ብምጥቃዕ ናይ ሳንቡእ ወቕዒ ከሰዕብ ይኽእል እዩ።	Data from other similar viruses, such as SARS and MERS, are incomplete. Data from other similar viruses show that pregnant women are more susceptible to severe infection. In some people, COVID-19 can attack the lungs and cause a pneumonia.
1998	en	ti	In those most severely affected, COVID-19 may rapidly progress to acute respiratory distress syndrome (ARDS) causing respiratory failure, septic shock or multi-organ failure.	ኣብ እዞም ብከቢድ ዝተሃሰዩ፣ ኮቪድ-19 ብቕልጡፍ ናብ ከቢድ ናይ ስርዓተ ምትንፋስ ዲስትረስ ሲንድረም (ARDS) ብምዕባይ ናብ ናይ ስርዓተ ምስትንፋስ ውድቀት፣ ሰፕቲክ ሾክ ወይ ናብ ናይ ብዙሓት ኣካላት ሰብነት ውደቀት ከምርሕ ይኽእል እዩ።	In these severely affected, COVID-19 can rapidly progress to severe respiratory distress syndrome (ARDS) leading to respiratory failure, septic shock or multiorgan failure.
1999	en	ti	Complications associated with COVID-19 include sepsis, abnormal clotting and damage to the heart, kidneys and liver.	እቶም ምስ ኮቪድ-19 ዝተተሓሓዙ ዝኸፍኡ ጽልዋታት ሰፕሲስ፣ ዘይስሩዕ ደም ምርጋእን ናይ ልቢ፣ ኩላሊትን ጉበትን ጉድኣትን ዝጠቓለሉ እዮም።	The worst effects associated with COVID-19 include sepsis, irregular blood clots and heart, kidney and liver damage.
2000	en	ti	Clotting abnormalities, specifically an increase in prothrombin time, have been described in 6% of those admitted to hospital with COVID-19, while abnormal kidney function is seen in 4% of this group.	ናይ ደም ምርጋእ ዘይንቡር ኣጋጣሚታት፣ ብፍላይ ናይ ፕሮትሮምቢን ምውሳኽ፣ ኣብቶም ብ ኮቪድ-19 ምኽንያት ኣብ ሆስፒታል ዝደቀሱ 6% ሰባት ተራእዩ፣ ዘይንቡር ናይ ኩሊት ተግባር እውን ኣብ 4% ናይ እዞም ጉጅለ ተራእዩ እዩ።	Blood clotting abnormalities, especially increased prothrombin, were observed in 6% of people hospitalized for COVID-19, and abnormal renal function was also observed in 4% of these groups.
2001	en	ti	Approximately 20-30% of people who present with COVID-19 demonstrate elevated liver enzymes (transaminases).	ዳርጋ ካብ 20-30% ዝኾኑ ብኮቪድ -19 ዝተተሓዙ ሰባት ልዑል ናይ ጸሊም ከበዲ ኤንዛይማት (ትራንሳሚኔዝ) ኣርእዮምእዮም።	Almost 20-30% of people infected with COVID-19 have shown elevated liver enzymes (transaminases).
2002	en	ti	According to the same report, the median time between onset of symptoms and death was ten days, with five being spent hospitalised.	ብመሰረት ተመሳሳሊ ጸብጻብ፣ ኣብ መንጎ ምልክታት ዝረኣዩሉ መዓልቲን ሞትን ዘሎ ኣፈላላይ ዓሰርተ መዓልቲ እዩ፣ ሓሙሽተ መዓልቲ ኣብ ሆስፒታል ዝጽንሑሉ መዓልቲ እዩ።	According to the same report, the difference between the day of symptoms and death is ten days, five days of hospitalization.
2003	en	ti	However, patients transferred to an ICU had a median time of seven days between hospitalisation and death.	እንተኾነ ግን፣ እቶም ናብ ICU ዝተዘዋወሩ ሕሙማት ካብ ኣብ ሆስፒታል ደቂሶም ምሕካም ዝጀመሩሉ ስጋብ ሞት ብማእኸላይ ሸውዓተ መዓልቲታት ኣለዎም።	However, patients transferred to the ICU have an average of seven days from hospitalization to death.
2004	en	ti	In a study of early cases, the median time from exhibiting initial symptoms to death was 14 days, with a full range of six to 41 days.	ኣብ ናይ መጀመርያታት መጽናዕቲ፣ ናይ መጀመርያ ምልክታት ድሕሪ ምርኣይ ክሳብ ሞት ዘሎ ግዘ 14 መዓልቲታት እዩ፣ ካብ ሽድሽተ ክሳብ 41 መዓልቲታት ግን ክኾን ይኽእል እዩ።	In early studies, the time from the first symptoms to death is 14 days, but it can range from six to 41 days.
2005	en	ti	In a study by the National Health Commission (NHC) of China, men had a death rate of 2.8% while women had a death rate of 1.7%.	ብ National Health Commission (NHC) (ናይ ቻይና ብሄራዊ ጥዕና ኮሚሽን) ዝተገበረ ጽንዓት፣ ሰብኡት ናይ 2.8% ናይ ሞት ንጽጽራዊ መጠን እንትህልዎም ኣንስቲ ድማ 1.7% ናይ ሞት ንጽጽራዊ መጠን እዩ ዘለወን።	According to a study by the National Health Commission (NHC), men have a comparative mortality rate of 2.8% and women have a comparative mortality rate of 1.7%.
2006	en	ti	Histopathological examinations of post-mortem lung samples show diffuse alveolar damage with cellular fibromyxoid exudates in both lungs.	ናይ ዝሞተ ሰብ ሳንባ ናይ ሂስቶፓቶሎጂካል ምርመራታት ናሙናታት ዲፊዩዝ ኣልቪዮላር ጉድኣት ኣብ ክልቲኦም ሳንባታት ድማ ፋይብሮሜክሶይድ ኤክሱዴታት ሒዞም ይርከቡ።	Histopathologic examinations of the lungs of a deceased subject contained samples of diffuse alveolar damage and fibromexoid exudates in both lungs.
2007	en	ti	Viral cytopathic changes were observed in the pneumocytes.	ቫይራል ሳይቶ ፓቲክ ለውጢታት ኣብ ኒሞሳይታት ተራይኦም እዮም።	Viral cytopathic changes are their role in pneumocytes.
2008	en	ti	The lung picture resembled acute respiratory distress syndrome (ARDS).	እዚ ናይ ሳንባ ስእሊ ህጹጽ ናይ ስርዓተ ምስትንፋስ ዲስትረስ ሲንድረም (ARDS) ይመስል።	This lung picture looks like acute respiratory distress syndrome (ARDS).
2009	en	ti	In 11.8% of the deaths reported by the National Health Commission of China, heart damage was noted by elevated levels of troponin or cardiac arrest.	ኣብ 11.8% ብናይ ቻይና ናይ ጥዕና ኮሚሽን ጸብጻብ ዝተገበሩ ሞታት፣ ናይ ልቢ ጉድኣት ብናይ ትሮፖኒን ምልዓል ወይ ናይ ልቢ ምዕራፍ ዝመጹ እዮም።	In 11.8% of deaths reported by the Chinese Health Commission, cardiac damage was caused by troponin elevation or cardiac arrest.
2010	en	ti	According to March data from the United States, 89% of those hospitalised had preexisting conditions.Availability of medical resources and the socioeconomics of a region may also affect mortality.	ካብ ሕቡራት መንግስቲታት ኣሜሪካ ዝወጹ ናይ ማርች ዳታታት ብዝብልዎ መሰረት፣ 89% እቶም ደቂሶም ዝሕከሙ ዘለዉ ሰባት ቅድሚኡ ካልእ ናይ ጥዕና ኩነታት ዝነበሮም እዮም። ናይ ሕክምናዊ ምንጪታትን ሶሽዮኢኮኖሚክ ዓቕሚን ንበዝሒ ሞት ይጸልዉ እዮም።	According to March data from the United States, 89% of people being treated for insomnia have previously had other health conditions. Medical sources and socioeconomic capacity affect mortality.
2011	en	ti	Estimates of the mortality from the condition vary because of those regional differences, but also because of methodological difficulties.	ብ ሰንኪ ክልላዊ ፍልልያትን ከምኡውን ብሜትዶሎጂካል ፍልልይ እዚ ናይ ዝሞቱ በዝሒ ግምታት ዝተፈላለዩ እዮም።	Due to regional and methodological differences, these death toll estimates vary.
2012	en	ti	The under-counting of mild cases can cause the mortality rate to be overestimated.	ነቶም ቀለልቲ ጉዳያት ለበዳ ብኣግባቡ ዘይምቑጻር ናይ እቲ ናይ ሞት ንጽጽራዊ መጠን ካብ እቲ ዝተገመተ ንላዕሊ ክገብሮ ይኽእል እዩ።	Not counting the simple epidemic cases significantly could make the comparative mortality rate higher than estimated.
2013	en	ti	However, the fact that deaths are the result of cases contracted in the past can mean the current mortality rate is underestimated.	ይኹን እምበር ሕጂ ዝረኣዩ ሞት ናይ ዝጸንሑ ሕሙማን ብምዃኖም ናይ ሕጂ መጠን ሞት ሙሉእ ብሙሉእ ኣይግልጹን	However, current deaths are of established patients and do not fully reflect current mortality rates
2014	en	ti	Smokers were 1.4 times more likely to have severe symptoms of COVID-19 and approximately 2.4 times more likely to require intensive care or die compared to non-smokers.Concerns have been raised about long-term sequelae of the disease.	ሽጋራ መትከኽቲ 1.4 ግዘ ከቢድ ናይ ኮቪድ-19 ምልክታት ናይ ምርኣይ ተኽእሎ ኣለዎም ዳርጋ 2.4 ግዘ ጽዑቕ ክትትል የድልዮም እዩ፣ ወይ ድማ ምስ ዘየትክኹ ክነጻጸሩ ከለዉ ክሞቱ ዝኽእሉ እዮም። ብዛዕባ ናይ ነዊሕ ግዘ ናይ እቲ ሕማም ሳዕቤን ስግኣታት ነይሮም እዮም።	Smokers are 1.4 times more likely to develop severe symptoms of COVID-19, nearly 2.4 times more likely to require intensive care, or to die compared to nonsmokers. There were concerns about the long-term effects of the disease.
2015	en	ti	The Hong Kong Hospital Authority found a drop of 20% to 30% in lung capacity in some people who recovered from the disease, and lung scans suggested organ damage.	ናይ ሆንግ ኮንግ ሆስፒታላት ምምሕዳር ኣብቶም ካብ እቲ ሕማም ዝሓውዩ ሰባት 20% ክሳብ 30% ዝኸውን ናይ ሳንባ ዓቕሚ ምውራድ ረኺቡ፣ ናይ ሳንባ ስካናት ድማ ናይ ሰብነት ኣካላት ዕንወት ኣርእዮም።	The Hong Kong hospital administration found a 20% to 30% drop in lung capacity in those recovering from the disease, and lung scans showed organ damage.
2016	en	ti	This may also lead to post-intensive care syndrome following recovery.	እዚ ድማ ድሕሪ ምሕዋይ፣ ናብ ድሕሪ-ጽኑዕ ክትትል ሲንድረም ከምርሕ ይኽእል እዩ።	This may lead to post-intensive follow-up syndrome, after recovery.
2017	en	ti	As of March 2020, it was unknown if past infection provides effective and long-term immunity in people who recover from the disease.	ስጋብ ማርች 2020፣ ዝሓለፉ ረኽሲታት ንጡፍን ናይ ነዊሕ ግዘን ናይ ሰብነት ሕማም ናይ ምክልኻል ዓቕሚ ክፈጥሩ ይኽኣሉ ኣይኽኣሉ ኣይፍለጥን እዩ።	As of March 2020, it is not known whether past infections can produce active and long-term immunity.
2018	en	ti	Immunity is seen as likely, based on the behaviour of other coronaviruses, but cases in which recovery from COVID-19 have been followed by positive tests for coronavirus at a later date have been reported.	በቶም ካልኦት ኮሮናቫይረሳት ባህርይ መሰረት ዝገበሩ፣ በዚ ሕማም ዘይምጥቓዕ ተኸእሎታት ኣለዉ እዮም፣ ካብ ኮቨድ-19 ዝሓወዩ ጉዳያት ለበዳ ድሕሪ ግዘ ብ ናይ ኮረናቫይረስ ፖዘቲቭ ውጽኢት ዝተዓጀቡ ምዃኖም ዘርእዩ ጸብጻባት ወጺኦም እዮም።	Based on the behavior of the other coronaviruses, there are reports that cases of recovery from COVID-19 are later accompanied by positive results.
2019	en	ti	These cases are believed to be worsening of a lingering infection rather than re-infection.	እዞም ኬዛት ናይ ኣብ ውሽጢ ዝጸንሐ ረኽሲ ምግዳድ እምበር ዳግም በቲ ረኽሲ ምትሓዝ ኣይኮኑን ተባሂሉ ይእመን።	These cases are believed to be exacerbations of an existing infection, not reinfection.
2020	en	ti	The virus is thought to be natural and have an animal origin, through spillover infection.	እዚ ቫይረስ ተፈጥሮኣዊን ብመንገዲ ካብኡ ዝወሓዘ ረኽሲ ናይ እንስሳ መበቆል ኣለዎ ተባሂሉ ይሕሰብ።	The virus is thought to have natural and animal origin through infection.
2021	en	ti	The actual origin is unknown, but by December 2019 the spread of infection was almost entirely driven by human-to-human transmission.	ትኽክለኛ መበቆሉ ኣይፍለጥን፣ ኣብ ዲሰምበር 2019 ግን ናይ እቲ ረኽሲ ዝርጋሐ ዳርጋ ሙሉእ ብሙሉእ ካብ ሰብ ናብ ሰብ ዝተመሓላለፈ እዩ።	The exact origin is unknown, but in December 2019 the spread of the infection was almost entirely human-to-human transmission.
2022	en	ti	A study of the first 41 cases of confirmed COVID-19, published in January 2020 in The Lancet, revealed the earliest date of onset of symptoms as 1 December 2019.	ኣብ ጃንዋሪ 2020 ኣብ The Lancet ዝተሓተመ ኣብቶም ናይ መጀመርያ ዝተረጋጋጹ 41 ናይ ኮቪድ -19 ጉዳያት ለበዳ ዝተገበረ መጽናዕቲ፣ ጀሚሩ ዘሎ ናይ እቶም ምልክታት ዝተርኣዩሉ መጀመሪ ዕለት 1 ዲሰምበር 2019 ከም ዝኾነ ኣርእዮም።	A study of the first 41 confirmed cases of COVID-19, published in The Lancet in January 2020, showed that the onset of symptoms began on December 1,
2023	en	ti	Official publications from the WHO reported the earliest onset of symptoms as 8 December 2019.	ካብ WHO ዝወጹ ዕላዊ ሕታማት ነቶም ቀዲሞም ዝተርኣዩ ምልክታት ኣብ 8 ዲሰምበር 2019 ጸብጺቦም እዮም።	Official publications from WHO reported the earliest symptoms on 8 December
2024	en	ti	Several measures are commonly used to quantify mortality.	ናይ ሞት በዝሒ ንምቑጻር ብዙሓት ስጉምቲታት ኣለዉ።	There are many steps to counting deaths.
2025	en	ti	These numbers vary by region and over time and are influenced by the volume of testing, healthcare system quality, treatment options, time since initial outbreak and population characteristics such as age, sex and overall health.	እዞም ቁጽሪታት እዚኦም በቢ ክልሉን በቢ ግዜኡን ይፈላለዩ እዮም፣ ብ ናይ ምርመራ በዝሒ፣ ናይ ስርዓት ጥዕና ክንክን ጽፈት፣ ናይ ሕክምና መማረጺታት፣ ካብ እቲ ናይ መጀመርታ ለበዳ ዘጋጠመሉ ግዘ ዘሎ ግዘን ናይ እቲ በዝሒ ህዝቢ ባህርያትን ንኣብነት ከም ዕድመ፣ ጾታን ሓፈሻዊ ጥዕናንን ይጽሎ እዩ።	These numbers vary from region to region and from time to time, influenced by testing rates, health care system efficiency, treatment options, time since the first outbreak and population characteristics such as age, gender and overall health.
2026	en	ti	In late 2019, WHO assigned the emergency ICD-10 disease codes U07.1 for deaths from lab-confirmed SARS-CoV-2 infection and U07.2 for deaths from clinically or epidemiologically diagnosed COVID-19 without lab-confirmed SARS-CoV-2 infection.The death-to-case ratio reflects the number of deaths divided by the number of diagnosed cases within a given time interval.	ኣብ 2019 መወዳእታታት፣ WHO ናይ ሃንደበታዊ ICD-10 ሕማም ኮዳት ሂቡ፣ U07.1 ንካብ ብ ቤተ ፈተነ ዝተረጋገጹ ናይ SARS-CoV-2 ረኽሲ ዘጋጠመ ሞት፣ U07.2 ድማ ብዘይ ናይ ቤተ ፈተነ ዝተረጋገጸ ናይ SARS-CoV-2 ረኽሲ ብክሊኒካላዊ ወይ ኢፒደሞሎጂያዊ መንገዲ ብኮቪድ-19 ንዝሞቱ ሰባት። እዚ ካብ ሞት-ናብ- ጉዳያት ለበዳ ንጽጽራዊ መጠን ዝሞቱ ሰባት በዝሒ ብዝተረጋገጹ ጉዳያት ለበዳ ኣብ ዝተወሃበ ግዘ ክካፈል ከሎ ዝብል እዩ ዘርኢ።	By the end of 2019, WHO assigned sudden ICD-10 disease codes, U07.1 for deaths from laboratory-confirmed SARS-CoV-2 infections, and U07.2 for deaths without laboratory-confirmed SARS-CoV-2 infections by clinical or Epidemiological pathways for people who died from COVID-1 This shows the death-to- epidemic cases comparative rate when the number of deaths is divided by the number of confirmed epidemic cases in a given period.
2027	en	ti	Based on Johns Hopkins University statistics, the global death-to-case ratio is 6.9% (153,822/2,240,191) as of 17 April 2020.	ብመሰረት ናይ Johns Hopkins University ስታትስቲክስ፣ ካብ 17 ኣፕሪል 2020 ጀሚሩ፣ ዓለምለኻዊ ናይ ጉዳይት ለበዳ ሞት ንጽጽራዊ መጠን 6.9% (153,822/2,240,191) እዩ።	According to Johns Hopkins University statistics, as of April 17, 2020, the global case epidemic comparative death rate is 6.9% (153,822/2,240,191).
2028	en	ti	The number varies by region.Other measures include the case fatality rate (CFR), which reflects the percent of diagnosed individuals who die from a disease, and the infection fatality rate (IFR), which reflects the percent of infected individuals (diagnosed and undiagnosed) who die from a disease.	እዚ ቁጽሪ በቢ ክልሉ ይፈላለ እዩ። ካልኦት ስጉምቲታት ናይ ኬዝ ሞት ሬት (CFR) የካትት፣ በቲ ሕማም ናይ ዝሞቱ ሰባት ሚእታዊ ዘንጸባርቕ፣ ናይቲ ረኽሲ ናይ ሞት ሬት (IFR) ሓዊሱ፣ ናይ ዝተለኸፉን በቲ ሕማም ናይ ዝሞቱን ሰባት ሚእታዊ የንጸባርቕ (ተመርመሩን ዘይተመርመሩን)።	This number varies by region. Other measures include the case fatality rate (CFR), which reflects the percentage of people who died of the disease, including the infection fatality rate (IFR), which reflects the percentage of people infected and who died of the disease (diagnosed and undiagnosed).
2029	en	ti	These statistics are not time bound and follow a specific population from infection through case resolution.	እዞም ቁጽራዊ መረዳእታታት እዚኦም ብግዘ ዝተገደቡ ኣይኩኑን፣ ብዝሓወየ ጉዳይ ለበዳ ገለ በዝሒ ህዝቢ ይኽተል።ጉዳይ ለበዳ ኣነጺርካ ብምርኣይ ረኽሲ ዝርከብ በዝሒ ህዝቢ ዝስዕቡ እዮም።	These numerical data are not time-limited, followed by a recovered outbreak.
2030	en	ti	While not all infected people develop antibodies, the presence of antibodies may provide information about how many people have been infected.	ኩሎም ዝተጠቕዑ ሰባት ሕማም ስለዘየማዕብሉ፣ ናይ ኣንቲቦዲታት ምህላው ብዛዕባ ክንደይ ሰባት ተኣኪቦም ዝብል ሓበሬታ ከቕርብ ይኽእል።	Since not all affected people develop disease, the presence of antibodies can provide information about how many people have gathered.
2031	en	ti	In the epicentre of the outbreak in Italy, Castiglione d'Adda, a small village of 4600, 80 (1.7%) are already dead.	ኣብ ጣልያን ናይ መጀመርታ ማዕከል እዚ ለበዳ ዝኾንት ግዝኣት ካብ 4600 ዝኾኑ ነበርቲ 80 (1.7%) ሞይቶም።	In Italy, the first epicenter of the outbreak, 80 (1.7%) of the 4,600 inhabitants died.
2032	en	ti	In Gangelt, the disease was spread by Carnival festivals, and spread to younger people, causing a relatively lower mortality, and not all COVID-19 deaths may have been formally classified as such.	ኣብ ጋንግለት፣ እቲ ሕማም ብናይ ካርኒቫል ፌስቲቫል ምኽንያት አዩ ተላቢዑ፣ ናብ መናእሰይ እዩ ድማ ክላባዕ ክኢሉ በዚ ምኽንያት ድማ ውሑድ ሞት እዩ ኣጋጢሙ፣ ኩሎም ናይ ኮቪድ-19 ሞት ድማ ከምዚ ተባሂሎም ክፍለዩ የብሎምን።	In Ganglet, the disease spread because of the carnival festival, and it was able to spread to young people and as a result there were fewer deaths, and not all COVID-19 deaths should be distinguished as such.
2033	en	ti	Furthermore, the German health system has not been overwhelmed.	ብተወሳኺ፣ ናይ ጀርመን ጥዕና ስርዓት ካብ ዓቕሙ ንላዕሊ ብዝኾነ ዋሕዚ ኣይተውሓጠን።	In addition, the German health system was not overwhelmed.
2034	en	ti	In the Netherlands, about 3% may have antibodies, as assessed from blood donors.	ኣብ ኔዘርላንድስ፣ ብመሰረት ኣብ ደም ለገስቲ ዝተገበረ ዳህሳስ 3% ዝኾኑ ኣንቲቦዲታት ክህልዎም ይኽእል እዩ።	In the Netherlands, 3% of donors may have antibodies according to blood surveys.
2035	en	ti	69 (0.004% of the population) have been confirmed to have died from COVID-19.	69 ሰባት (0.004% ናይ እቲ በዝሒ ህዝቢ) ብኮቪድ-19 ከምዝሞተ ተረጋጊጹ ኣሎ።	69 people (0.004% of the population) have died of COVID-1
2036	en	ti	The impact of the pandemic and its mortality rate are different for men and women.	ናይ እዚ ለበዳ እዚ ጽልዋን ናይ ሞት ንጽጽራዊ መጠኑን ኣብ ደቂ-ተባዕትዮን ደቂ-ኣንስትዮን ዝተፈላለየ እዩ።	The impact of this epidemic and its comparative mortality rate are different in men and women.
2037	en	ti	Mortality is higher in men in studies conducted in China and Italy.	ብመሰረት ኣብ ቻይናን ጣልያንን ዝተገበረ መጽናዕቲ ናይ ሞት መጠን ኣብ ሰብኡት ይበዝሕ።	According to studies in China and Italy, the mortality rate is higher in men.
2038	en	ti	The highest risk for men is in their 50s, with the gap between men and women closing only at 90.	ሰብኡት ናይ እቲ ዝዓበየ ናይ ተጋላጽነ ዕድመኦም ኣብ 50 ታት ዓመቶም እዩ፣ ኣብ መንጎ ኣንስቲን ሰብኡትን ዘሎ ኣፈላላይ ድማ 90 ጥራሕ እዩ።	Men have their peak vulnerability in their 50s, and the difference between women and men is only
2039	en	ti	In China, the death rate was 2.8 percent for men and 1.7 percent for women.	ኣብ ቻይና፣ ናይ ሞት ንጽጽራዊ መጠን ንሰብኡት 2.8 ሚእታዊ እንትኸውን ንኣንስትዮ ድማ 1.7 ሚእታዊ እዩ።	In China, the comparative mortality rate is 2.8 percent for men and 1.7 percent for women.
2040	en	ti	The exact reasons for this sex-difference is not known, but genetic and behavioural factors could be a reason.	ናይ እዚ ጾታ ፍልልይ ትኽክለኛ ምኽንያቱ ኣይተፈለጠን፣ ናይ ዘርኡን ባህሪያውን ምኽንያታት ግን ክኾኑ ይኽእሉ እዮም።	The exact cause of this sex difference is unknown, but racial and behavioral factors are possible.
2041	en	ti	Sex-based immunological differences, lesser prevalence of smoking in women and men developing co-morbid conditions such as hypertension at a younger age than women could have contributed to the higher mortality in men.	ጾታ መሰረት ዝገበረ ናይ ሰበነት ሕማም ናይ ምክልኻል ኣፈላላያት፣ ኣብ ኣንስቲ ዘሎ ትሑት ሽፋን ምትካኽ፣ከም በዝሒ ደም ዝኣመሰሉ፣ በዝሒ ተደረብቲ ሕማማት ኣብ ሰብኡት ምብዝሖም፣ ንናይ ሰብኡት ብበዝሒ ሞት ንጽጽራዊ መጠን እጃም ኣበርኪቱ ክኸውን ይኽእል እዩ።	Gender-based differences in immunity to severe disease, low smoking coverage in women, and higher rates of comorbidities such as high blood pressure in men may have contributed to the comparatively high mortality rate in men.
2042	en	ti	In Europe, 57% of the infected individuals were men and 72% of those died with COVID-19 were men.	ኣብ ኣውሮፓ፣ 57% ዝተለኸፉ ውልቀ ሰባት ሰብኡት እንትኾኑ 72% ናይ ብኮቪድ-19 ዝሞቱ ሰባት እውን ሰብኡት እዮም።	In Europe, 57% of infected individuals are men and 72% of deaths from COVID-19 are also men.
2043	en	ti	As of April 2020, the US government is not tracking sex-related data of COVID-19 infections.	ካብ ኣፕሪል 2020 ጀሚሩ፣ ናይ ኣሜሪካ መንግስቲ ምስ ጾታ ዝተተሓሓዙ ናይ ኮቪድ-19 ረኽሲታት ሓበሬታ ኣይከታተልን እዩ ዘሎ።	As of April 2020, the US government is no longer tracking information on sexually transmitted infections.
2044	en	ti	Research has shown that viral illnesses like Ebola, HIV, influenza and SARS affect men and women differently.	መጽናዕቲታት ቫይራል ሕማማት ከም ኢቦላ፣ HIV፣ ኢንፍሉዌንዛን SARS ንሰብኡትን ኣንስቲን ብዝተፈላለዩ መገዲ እዮም ዘጥቅዑ።	Studies Viral diseases such as Ebola, HIV, influenza, and SARS affect men and women differently.
2045	en	ti	A higher percentage of health workers, particularly nurses, are women, and they have a higher chance of being exposed to the virus.	ልዑል ክፋል ናይ ጥዕና ሰራሕተኛታት፣ ብፍላይ ነርስታት፣ ደቂ ኣንስትዮ እየን፣ ናብ እቲ ቫይረስ ናይ ምቅላዕ ዕድሎም ድማ ልዑል እዩ።	A high proportion of health workers, especially nurses, are women and are at high risk of exposure to the virus.
2046	en	ti	"The World Health Organization announced on 11 February 2020 that the official name of the disease would be ""COVID-19""."	"ትካል ዓለም ጥዕና ኣብ ጥሪ 11,2020 ናይዚ ሕማም መጸውዒ ሽም ""COVID-19"" እዩ ኢሉ ኣዊጁ።"	The World Health Organization declared the disease&#39;s nickname &quot;COVID-19&quot; on January 11,2
2047	en	ti	WHO chief Tedros Adhanom Ghebreyesus explained that CO stands for corona, VI for virus, D for disease, and 19 for when the outbreak was first identified: 31 December 2019.	ናይ ውደብ ጥዕና ዓለም(WHO) ሓላፊ ቴድሮስ ኣድሓኖም ገብረየሱስ፣ CO ኮሮና ዝውክል እንትኸውን ፣ VI ድማ ናይ ቫይረስ፣ D ድማ ሕማም ማለት ከምዝኾነ ኣብራህሪሆም፣ 19 ድማ እቲ ለበዳ መጀመርያ ዝተፈለጠሉ ዓመተ ምህረት የመላኽት: 31 ዲሰምበር 2019።	World Health Organization(WHO) chief Tedros Adhanom Ghebreyesus explained that CO represents coronavirus , VI stands for virus, D stands for disease, and 19 indicates the year the outbreak was first detected: 31 December
2048	en	ti	The name had been chosen to avoid references to a specific geographical location (e.g. China), animal species or group of people, in line with international recommendations for naming aimed at preventing stigmatisation.The virus that causes COVID-19 is named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	እዚ ሽም ናይ እንስሳት ዓሌት ወይ ናይ ሰባት ጉጅለ፣ ሽም እንተውጽእ ኣድልዎ ኣብ ምክልኻል ዝዓለመ ክኸውን ዝብል ዓለምለኻዊ ምኽሪታት መሰረት ብምግባር ንፍሉይ ጂኦግራፊያዊ ቦታ ከይገልጽ ተባሂሉ እዩ ተዋሂብዎ (ንኣብነት፣ ቻይና) ። እቲ ኮቪድ-19 ዘስዕብ ቫይረስ ከቢድ ህጹጽ ናይ ስርዓተ ምትንፋስ ሲንድረም ኮሮናቫይረስ 2 (SARS-CoV-2) እዩ ዝበሃል።	This name of an animal species or group of people was given to it so as not to describe a specific geographical location (e.g., China) based on international recommendations that the name should be aimed at preventing discrimination. The virus that causes COVID-19 is called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
2049	en	ti	"The WHO additionally uses ""the COVID-19 virus"" and ""the virus responsible for COVID-19"" in public communications."	"WHO(ውድብ ጥዕና ዓለም) ብተወሳኺ ን""ናይ ኮቪድ -19 ቫይረስ"" ን ""ንኮቪድ-19 ዘምጽእን ቫይረስ"" ዝብሉ ኣገላልጻታት ኣብ ህዝባዊ መግለጺታት ይጠቀመሎም ኣሎ።"	The WHO(World Health Organization) is also using the terms &quot;COVID -19 virus&quot; and &quot;virus that causes COVID-19&quot; in public statements.
2050	en	ti	"Both the disease and virus are commonly referred to as ""coronavirus""."	"ክልቲኦም እቲ ሕማምን እቲ ቫይረስን ""ኮሮናቫይረስ"" ተባሂሎም ይጽውዑ።"	Both the disease and the virus are called &quot;coronaviruses.
2051	en	ti	"During the initial outbreak in Wuhan, China, the virus and disease were commonly referred to as ""coronavirus"" and ""Wuhan coronavirus""."	"ኣብ ናይ ውሃን፣ቻይና ናይ መጀመርያ ለበዳ ግዘ፣ እቲ ሕማምን ቫይረስን ብሓባር ""ኮሮናቫይረስ"" ከምኡውን ""ውሃን ኮሮናቫይረስ "" ተባሂሎም ይጽውዑ ነይሮም።"	During the first outbreak of Wuhan,China, the disease and virus were collectively referred to as &quot;coronavirus&quot; and &quot;Wuhan coronavirus
2052	en	ti	In January 2020, WHO recommended 2019-nCov and 2019-nCoV acute respiratory disease as interim names for the virus and disease in accordance with 2015 guidance against using locations in disease and virus names.	ኣብ ጃንዋሪ 2020፣ ነቲ ናይ 2015 ኣብ ናይ እቲ ሕማምን ቫይረስን ሽም ቦታታት ምጥቃም ዘይፍቀድ እዩ ዝብል መምርሒ መሰረት ብምግባር፣ ውደብ ጥዕና ዓለም(WHO) ናይ 2019-nCov ን 2019-nCoV ከቢድ ናይ ስርዓተ ምስትንፋስ ሕማም ናይ እቲ ቫይረስን ሕማም ዝብሉ ግዜያዊ መጸውዒ ሽማት ክኾኑ መኺሩ ኣሎ።	In January 2020, based on the 2015 guidelines on the prohibition of use in the disease and virus namespaces, the World Health Organization(WHO) will become the provisional designations for 2019-nCov and 2019-nCoV severe respiratory disease of the virus and disease He has advised.
2053	en	ti	The official names COVID-19 and SARS-CoV-2 were issued on 11 February 2020.	ናይ ኮቪድ-19 ን SARS-CoV-2 ን ዕላዊ ሽማት ኣብ 11 ፌብሩዋሪ 2020 እዮም ዕላዊ ተገይሮም።	The official names for COVID-19 and SARS-CoV-2 were announced on February 11,
2054	en	ti	Due to capacity limitations in the standard supply chains, some digital manufacturers are printing healthcare material such as nasal swabs and ventilator parts.	ብሰንኪ ኣብ እቲ ደረጃኡ ዝሓለወ ናይ ኣቕርቦት ሰንሰለት ዘሎ ናይ ዓቕሚ ሕጽረት፣ ገለ ዲጂታል መፍረይቲ ከም ናይ ኣፍንጫ ስዋባትን ናይ ቨንትሌተር ኣካላትን ዝበሉ ናይ ጥዕና ናውቲታት ኣብ ምሕታም ይርከቡ።	Due to capacity constraints in the standardized supply chain, some digital manufacturers are printing health kits such as nasal swabs and ventilator components.
2055	en	ti	In one example, when an Italian hospital urgently required a ventilator valve, and the supplier was unable to deliver in the timescale required, a local startup reverse-engineered and printed the required 100 valves overnight.	ኣብ ሓደ ኣብነት፣ ናይ ጣልያን ሆስፒታል ብህጹጽ ቬንትሌተር ቫልቭ ከድልዮ ከሎ፣ እቲ መቕረባይ ድማ ኣብቲ ዝተበሃሎ ናይ ግዘ ገደብ ከቕርብ ብዘይምኽኣሉ፣ ናይ እቲ ከባቢ ጀማሪ ብግልባጥ ምህንድስና እቲ ዘድሊ 100 ቫልቭ ኣብ ሓደ ለይቲ ሰሪሑ ወዲኡ።	In one example, an Italian hospital urgently needed ventilator valves, and the supplier failed to deliver them on time, so a local startup reverse-engineered the required 100 valves overnight.
2056	en	ti	After the initial outbreak of COVID-19, conspiracy theories, misinformation and disinformation emerged regarding the origin, scale, prevention, treatment and other aspects of the disease and rapidly spread online.	ድሕሪ ናይ መጀመርያ ናይ ኮቪድ -19 ለበዳ፣ ብዛዕባ መበቆሉ፣ ስኬሉ፣ ምክልኻል መገዱ፣ መድሓኒትን ካልኦት ናይ እቲ ሕማም ኣካላትን ናይ ሴራ ስነ-ሓሳባት፣ ጌጋ ሓበሬታታትን ናይ ሓሶት ሓበሬታታትን ብቕልጡፍ ኣብ ኦንላይን ክሰራጨዉ ጸኒሖም።	After the first outbreak of COVID-19, conspiracy theories, misinformation and false information about its origin, scale, defense mechanism, drugs and other components of the disease have been spreading rapidly online.
2057	en	ti	Humans appear to be capable of spreading the virus to some other animals.	ደቂ ሰባት ነቲ ቫይረስ ናብ እንስሳት ከመሓላልፍዎ ይኽእሉ እዮም።	Humans can transmit the virus to animals.
2058	en	ti	The study failed to find evidence of viral replication in pigs, ducks, and chickens.	እዚ ቫይረስ ኣብ ሓሰማ፣ ማይ ደርሆን ምብዛሕ ንምኽኣሉ እቲ መጽናዕቲ መረዳእታ ክረክብ ኣይከኣለን።	The study could not find data on the replication of the virus in pigs and poultry.
2059	en	ti	No medications or vaccine is approved to treat the disease.	ነዚ ሕማም ንምሕካም ዝተፈቐደ መድሓኒት ኮነ ክትባት የለን።	There is no approved drug or vaccine to treat this disease.
2060	en	ti	International research on vaccines and medicines in COVID-19 are underway by government organisations, academic groups and industry researchers.	ኣብ ኮቪድ-19 ዝግበሩ ናይ ክትባታትን መድሓታትን ዓለምለኻዊ መጽናዕቲ ብመንግስታዊ ትካላትን፣ ኣካዳሚካዊ ጉጅለታትን ናይ ኢንዳስትሪ መጽናዕቲን እንዳተኻየደ ይርከብ።	Global research on vaccines and drugs is being conducted by government agencies, academic groups and industry research.
2061	en	ti	"In March, the World Health Organization initiated the ""SOLIDARITY Trial"" to assess treatment effects of four existing antiviral compounds with the most promise of efficacy."	"ኣብ ማርች፣ ናይ ዓለም ጥዕና ድርጅት ናይ ""SOLIDARITY Trial"" ናይዞም ዘለዉ ኣርባዕተ ጸረ ቫይረስ ኮምፓውንድታት ልዑል ተስፋ ይህቡ ምስ ምህላዎም ፈተነታት ጀሚሩ ኣሎ።"	In March, the World Health Organization launched a &quot;SOLIDARITY Trial&quot; of these four existing antiviral compounds with high promise.
2062	en	ti	There is no available vaccine, but various agencies are actively developing vaccine candidates.	ክትባተ የብሉን ግን፣ ዝተፈላለዩ ኤጀንሲታት ናይ ክትባት ሕጹያት ብንቕሓት የማዕብሉ ኣለዉ።	It should not be vaccinated however, various agencies are consciously developing vaccine candidates.
2063	en	ti	Previous work on SARS-CoV is being utilised because SARS-CoV and SARS-CoV-2 both use the ACE2 receptor to enter human cells.	ቅድም ክብል ኣብ SARS-CoV ዝተኻየዱ ስራሕቲ፣ ኣብ ጥቕሚ ይውዕሉ ኣለው እዚ ድማ SARS-CoV ን SARS-CoV-2ን ክልቲኦም ናብ ናይ ሰብ ዋህዮ ንምእታው ACE2 ተቐባሊ ዝጥቀሙ ብምዃኖም እዩ።	Previous work on SARS-CoV, is being utilized due to the fact that SARS-CoV and SARS-CoV-2 both use the ACE2 receptor to enter human cells.
2064	en	ti	There are three vaccination strategies being investigated.	ሰለስተ ናይ ክትባት ሜላታት ኣብ ምርመረ ይርከቡ።	Three vaccine techniques are under investigation.
2065	en	ti	First, researchers aim to build a whole virus vaccine.	መጀመርታ፣ ተመራመርቲ ሙሉእ ናይ ቫይረስ ክትባት ክሰርሑ እዮም ዝፍትኑ ዘለዉ።	First, researchers are trying to develop a complete virus vaccine.
2066	en	ti	The use of such a virus, be it inactive or dead, aims to elicit a prompt immune response of the human body to a new infection with COVID-19.	ከምዚ ዓይነት ቫይረስ ምጥቃም፣ ዘይንጡፍ ይኹን ምውት፣ ናይ ደቂ ሰብ ሰውነት ነዚ ሓድሽ ኮቪድ-19 ቫይረስ ናይ ምክልኻል ዓቕሚ ንምምዕባል ዕላማ ዝገበረ እዩ።	The use of such viruses, whether inactive or dead, is aimed at developing the human body&#39;s ability to fight off the new COVID-19 virus.
2067	en	ti	A second strategy, subunit vaccines, aims to create a vaccine that sensitises the immune system to certain subunits of the virus.	ካልኣይ ስትራቴጂ፣ ክፋል ዩኒት ክትባታት፣ነቲ ናይ ሰበነት ሕማም ናይ ምክልኻል ስርዓት ን ዝተወሰኑ ናይ እቲ ቫይረስ ናይ ዩኒት ክፋላት ክነቓቓሕ ንምግባር ዝዓለመ እዩ።	The second strategy, fractional unit vaccines, aims to stimulate the immune system for certain unit fractions of the virus.
2068	en	ti	In the case of SARS-CoV-2, such research focuses on the S-spike protein that helps the virus intrude the ACE2 enzyme receptor.	ኣብ እዚ ናይ SARS-CoV-2 ጉዳይ ለበዳ፣ ከምዚ ዓይነት መጽናዕቲ ኣብ S-spike ፕሮቲን ነቲ ቫይረስ ናብ እቲ ACE2 ኢንዛይም ተቐባሊ ንክኣቱ ዝሕግዝ ትኹረት ዝገበረ እዩ።	In this SARS-CoV-2 case epidemic, such studies have focused on the S-spike protein that facilitates entry of the virus into the ACE2 enzyme receptor.
2069	en	ti	A third strategy is that of the nucleic acid vaccines (DNA or RNA vaccines, a novel technique for creating a vaccination).	እቲ ሳልሳይ ሜላ ድማ ናይ ኒዩክሊክ ኣሲድ ክትባታት እዮም (DNA ወይ RNA ክትባታት፣ ሓድሽ ናይ ክትባት ምፍጣር ቴክኒክ)።	The third technique are nucleic acid vaccines (DNA or RNA vaccines, a new vaccine generation technique).
2070	en	ti	Experimental vaccines from any of these strategies would have to be tested for safety and efficacy.On 16 March 2020, the first clinical trial of a vaccine started with four volunteers in Seattle.	ካብዞም ዘዴታት ውሽጢ ናይ ሙከራ ኽትባት ንደሕንነትን ሓቅነትን ብፈተነታት ክሓልፉ ኣለዎም። ብኣቆጻጽራ ኣውሮፓ ኣብ መጋቢት 16፣ 2020 እቲ ናይ መጀመርታ ክትባት ብኣርባዕተ ፈቓደኛ ሰባት ኣብ ሲያትል ተጀሚሩ።	Within these methods, experimental vaccines must undergo testing for safety and validity. On March 16, 2020, the first vaccination was launched by four volunteers in Seattle.
2071	en	ti	The vaccine contains a harmless genetic code copied from the virus that causes the disease.Antibody dependent enhancement has been suggested as a potential challenge for vaccine development for SARS-COV-2, but this is controversial.	እዚ ክትባትካብ እቲ ነቲ ሕማም ዘስዕብ ቫይረስ ዝቐድሖ ዘይጎድእ ጀኒቲክ ኮድ ኣለዎ። ብኣንቲቦዲ ዝድገፍ ምምሕያሽ ኣብ ናይ SARS-COV-2 ክትባት ምዕባለ ዝተመኸረ ነገር እዩ፣ እንተኾነ ግን እዚ እውን መዘራረቢ እዩ።	This vaccine contains a harmless genetic code that is copied by the virus that causes the disease. Antibody-promoted modification is something that has been recommended in SARS-COV-2 vaccine development, but this is also moot.
2072	en	ti	There are more than 300 active clinical trials underway as of April 2020.	ካብ ኣፐሪል 2020 ጀሚሮም፣ ልዕሊ 300 ንጡፋት ክሊኒካል ፈተነታት ይካየዱ ኣለዉ እዮም።	Since April 2020, more than 300 active clinical trials are underway.
2073	en	ti	Seven trials were evaluating already approved treatments for malaria, including four studies on hydroxychloroquine or chloroquine.	ኣብ hydroxychloroquine(ሃይድሮክሲክሎሮኲን) ወይ chloroquine(ክሎሮኲን) ዝገበሩ መጽናዕቲታት ሓዊሱ፣ ሸውዓተ ፈተነታት ዓሶ ንምሕካም ፈቓድ ዘለዎም መድሓኒታት ይፍትኑ ነይሮም።	Eight trials were testing drugs licensed to treat tuberculosis, including studies on hydroxychloroquine or chloroquine.
2074	en	ti	Repurposed antiviral drugs make up most of the Chinese research, with nine phase III trials on remdesivir across several countries due to report by the end of April.	ዳግም ንካልእ ዐላማ ዝተዳለወ ጸረ ቫይረስ መድሓኒት መብዛሕትኡ ናይ ቻይና መጽናዕቲ ዝሓዘ እዩ፣ ምስ ትሽዓተ ፌዝ III ናይ remdesivir ፈተነታት ኣብ ዝተፈላለዩ ሃገራት ኣብ ናይ ኣፕሪል መወዳእታ ዝወጸ ሪፖርት ከምዘርእዮ።	Repurposed antiviral drugs account for most of the Chinese research, with nine Phase III trials of remdesivir in various countries shown in a report released in late April.
2075	en	ti	A dynamic review of clinical development for COVID-19 vaccine and drug candidates was in place, as of April 2020.Several existing antiviral medications are being evaluated for treatment of COVID-19, including remdesivir, chloroquine and hydroxychloroquine, lopinavir/ritonavir and lopinavir/ritonavir combined with interferon beta.	ካብ ኣፕሪል 2020 ጀሚሩ ናይ ኮቪድ-19 ክትባት ምዕባለን ዝተመረጹ መድሓኒታትን ዓብዪ ገምጋም ተኻይዱ እዩ ። remdesivir(ሬምደስቪር)፣ chloroquine(ክሎሮኲን) ን hydroxychloroquine(ሃይድሮክስይክሎሮኲን) ን፣ lopinavir/ritonavir(ሎፒናቪር/ሪቶናቪር) ከምኡውን lopinavir/ritonavir(ሎፒናቪር/ሪቶናቪር) ምስ interferon beta(ኢንተርፈሮን ቤታ) ሓዊሱ ዝተፈላለዩ ጸረ- ቫይረስ መድሓኒታት ንናይ ኮቪድ-19 ምርመራ ገምጋም ይግበሮም ኣሎ ።	Since April 2020, a major evaluation of the development of COVID-19 vaccines and selected drugs has been conducted. Various antivirals including remdesivir, chloroquine and hydroxychloroquine, lopinavir/ritonavir and lopinavir/ritonavir with interferon beta Drugs for COVID-1 They are undergoing an investigation and assessment.
2076	en	ti	There is tentative evidence for efficacy by remdesivir, as of March 2020.	ካብ ማርች 2020 ጀሚሩ ናይ remdesivir ብቕዑነት ዘርኢ ዝተወሰነ መረዳእታ ኣሎ።	As of March 2020, there is some data on the efficacy of remdesivir.
2077	en	ti	Clinical improvement was observed in patients treated with compassionate-use remdesivir.	ክሊኒካዊ ምምሕያሻት ኣብ ቀሊል ናይ remdesivir(ሬምደስቪር) መድሓኒት ኣብ ዝተፈተነሎም ሰባት ተራእዩ እዩ።	Clinical improvements have been seen in people who have been tried on a simple dose of remdesivir(remdesivir).
2078	en	ti	Phase III clinical trials are being conducted in the US, China and Italy.Chloroquine, previously used to treat malaria, was studied in China in February 2020, with preliminary results.	ፌዝ III ክሊኒካዊ ፈተነታት ኣብ US፣ ቻይናን ጣልያንን ይካየዱ ኣለዉ። Chloroquine፣ ዓሶ ንምሕካም ዝጠቅም ዝነበረ መድሓኒት፣ ኣብ ቻይና መጽናዕቲ ተገይሩሉ ኣብ ፌብሩዋሪ 2020፣ናይ መጀመርታ ውጽኢት ድማ ኣርእዩ።	Phase III clinical trials are underway in the US, China and Italy. Chloroquine, a drug used to treat tuberculosis, was studied in China in February 2020,and showed first results.
2079	en	ti	However, there are calls for peer review of the research.	እንተኾነ ግን፣ ናይ እቲ መጽናዕቲ ገምጋም ኣድለይቲ እዮም።	However, the evaluation of the study are necessary.
2080	en	ti	Korean and Chinese Health Authorities recommend the use of chloroquine.	ናይ ኮርያን ቻይናን ናይ ጥዕና ሓለፍቲ chloroquine ምጠቃም ይመኽሩ።	Korean and Chinese health officials recommend the use of chloroquine.
2081	en	ti	However, the Wuhan Institute of Virology, while recommending a daily dose of one gram, notes that twice that dose is highly dangerous and could be lethal.	እንተኾነ ግን፣ Wuhan Institute of Virology (ናይ ውሃን ቫይሮሎጂ ትካል)፣ ናይ ሓደ ግራም መዓልታዊ ዶዝ ዝመክር እንትኸውን፣ ናይ እዚ ዶዝ ክልተ ምውሳድ ግን ኣዝዩ ሓደገኛ ከምዝኾነን ክቐትል እውን ከምዝኽእል ሓቢሩ እዩ።	However, the Wuhan Institute of Virology recommends a daily dose of one gram, but two doses of this dose are very dangerous and can be fatal.
2082	en	ti	On 28 March 2020, the FDA issued an emergency use authorisation for hydroxychloroquine and chloroquine at the discretion of physicians treating people with COVID-19.The Chinese 7th edition guidelines also include interferon, ribavirin or umifenovir for use against COVID-19.	ኣብ 28 መጋቢት 2020፣ FDA ናይ hydroxychloroquineን chloroquineን ንኮቪድ-19 ንታሓከምቲ ዝሐክሙ ዘለዉ ሓካይም ኣብ እዋን ህጹጽ ረድኤት ክጥቀሙ ኣፍቂዱ። እዚ ናይ ቻይና 7ይ ሕታም መምርሒ interferon፣ ribavirin ወይ umifenovir እውን ኣንጻር ኮቪድ-19 ምጥቃም እውን ዘካተተ እዩ።	On March 28, 2020, the FDA approved hydroxychloroquine and chloroquine for emergency use by physicians treating patients with COVID-1 The Chinese 7th edition guidelines also include the use of interferon, ribavirin or umifenovir against COVID-1
2083	en	ti	Preliminary data indicate that high doses of ribavirin are necessary to inhibit SARS-CoV-2 in vitro.	ናይ መጀምርታ መረዳእታ ከምዝሕብሮ ልዑል ናይ ribavirin መጠን SARS-CoV-2 ብቪትሮን ንምግታዕ ኣድላዪ እዩ።	Preliminary data suggest that high doses of ribavirin are necessary to neutralize SARS-CoV-2 in vitro.
2084	en	ti	Nitazoxanide has been recommended for further in vivo study after demonstrating low concentration inhibition of SARS-CoV-2.Studies have demonstrated that initial spike protein priming by transmembrane protease serine 2 (TMPRSS2) is essential for entry of SARS-CoV-2 via interaction with the ACE2 receptor.	Nitazoxanide(ኒታዞሳናይድ) ድሕሪ ኣብ ናይ SARS-CoV-2 ምውጋድ ትሑት ጻዕቒ ምርኣዩ፣ ንተወሳኺ ኣብ vivo ዝግበር መጽናዕቲ ተመኺሩ እዩ። መጽናዕቲታት ናይ መጀመርያ ስፓይክ ፕሮቲናት ብትራንስመምብሬን ፕሮቴዝ ሲሪን 2 (TMPRSS2) ዝተተሓሓዙ ን SARS-CoV-2 ምስ ACE2 ተቐበልቲ ብምትእትታው ንክኣቱ ወሰንቲ እዮም።	Nitazoxanide has been recommended for further in vivo studies after showing low efficacy in SARS-CoV-2 elimination. Studies of initial spike proteins coupled by transmembrane protease serine 2 (TMPRSS2) are critical for entry of SARS-CoV-2 by interacting with ACE2 receptors.
2085	en	ti	The studies of chloroquine and hydroxychloroquine with or without azithromycin have major limitations that have prevented the medical community from embracing these therapies without further study.Oseltamivir does not inhibit SARS-CoV-2 in vitro and has no known role in COVID-19 treatment.	ናይ chloroquine ን hydroxychloroquine ን ምስ azithromycinን ካብኡ ወጻኢ ዝተገበሩ መጽናዕቲታት ብዘይ ተወሳኺ መጽናዕቲ ናይ ሕክምና ማሕበረ ሰብ ክጥቀመሎም ዘይከኣለሉ ምኽንያት ዓበይቲ ግድፈታት ዘለዉዎም ብምዃኖም እዩ። Oseltamivir ን SARS-CoV-2 ኢን ቪትሮ ኣይግድብን ኣብ ናይ ኮቪድ-19 ሕክምና ድማ ዝኾነ ዓይነት እጃም የብሉን።	Studies of chloroquine and hydroxychloroquine with and without azithromycin have not been used by the medical community without further study because of their major flaws. Oseltamivir does not inhibit SARS-CoV-2 in vitro and has no role in the treatment of COVID-1
2086	en	ti	Cytokine storm can be a complication in the later stages of severe COVID-19.	Cytokine storm ናይ ከቢድ ኮቪድ-19 ናይ መጨረሻ ከባቢ ጎድናዊ ጽልዋ እዩ።	Cytokine storm is the last area side effect of severe COVID-1
2087	en	ti	There is evidence that hydroxychloroquine may have anti-cytokine storm properties.Tocilizumab has been included in treatment guidelines by China's National Health Commission after a small study was completed.	hydroxychloroquine ጸረ-ሳይቶኪን ስቶርም ባህሪታት ከምዘለዎ መረጋገጺ ኣሎ።Tocilizumab ኣብ ናይ ቻይና ብሄራዊ ናይ ንእሽተይ መጽናዕቲ ድሕሪ ምክያዱ ኣብ ናይ ሕክምና መምርሒኡ ተጠቓሊሉ እዩ።	hydroxychloroquine has evidence of anti-cytokine storm properties.Tocilizumab has been included in its treatment guidelines after a Chinese national small-scale study.
2088	en	ti	It is undergoing a phase 2 non randomised test at the national level in Italy after showing positive results in people with severe disease.	ኣብ ከቢድ ሕማም ዘለዎም ሰባት ፖዘቲቭ ውጽኢታት ድሕሪ ምርኣይ ብ ብሄራዊ ደረጃ ኣብ ጣልያ ናይ ፌዝ 2 ኣጋጣሚ ዘይኮነ ፈተነ ይካየድ ኣሎ።	After showing positive results in people with severe disease, a national Phase 2 non-random trial is underway in Italy.
2089	en	ti	Combined with a serum ferritin blood test to identify cytokine storms, it is meant to counter such developments, which are thought to be the cause of death in some affected people.	ምስ ሴረም ፌሪቲን ዝተሓወሰ ሳይቶካይን ስቶርም ንምፍላይ ዝግበር ናይ ደም ምርመራ ነዞም ኣብ ገለ ሰባት ናይ ሞቶም ምኽንያት እዮም ተባሂሎም ዝእመኑ ከምዚኦም ዝበሉ ምዕባለታት ጽልዋ ንምቕናስ ተባሂሉ እዩ ተኻይዱ።	Blood tests to detect the cytokine storm combined with serum ferritin were performed to minimize the impact of these developments, which are believed to be the cause of death in some people.
2090	en	ti	The interleukin-6 receptor antagonist was approved by the FDA based on retrospective case studies for treatment of steroid refractory cytokine release syndrome induced by a different cause, CAR T cell therapy, in 2017.	ብ መሰረት ኣብ ሕሉፍ ዝተርኣየ ጉዳይ ንናይ ብዘተፈላለዩ ምኽንያታት ዝፍጠሩ ናይ steroid refractory cytokine ዝሰደዱ ሲንድረማት መሐከሚ interleukin-6 receptor antagonist ብ FDA ተፈቒዱ እዩ፣ CAR T ናይ ዋህየ ሕክምና፣ ኣብ 2017።	On the basis of a case shown in the past for the treatment of steroid refractory cytokine sending syndromes caused by a variety of reasons an interleukin-6 receptor antagonist was approved by the FDA, CAR T cell therapy, in 2017.
2091	en	ti	To date, there is no randomised, controlled evidence that tocilizumab is an efficacious treatment for CRS.	ክሳብ ሕዚ፣ ናይ ኣጋጣሚ ዝኾነ፣ ቁጽጽር ዝተገበሮመረዳእታ tocilizumab ብቑዕ ናይ CRS ከምዝኾነ ዘርኢ የለን።	To date, no incidental, controlleddata have shown that tocilizumab is efficacious of CRS.
2092	en	ti	Transferring purified and concentrated antibodies produced by the immune systems of those who have recovered from COVID-19 to people who need them is being investigated as a non-vaccine method of passive immunisation.	ብ ካብ ኮቪደ-19 ዝሓወዩ ሰባት ናይ ሕማም ምክልኻል ዓቕሚ ዝፈረየ ዘተጻረየን ዝሓፈሰን ኣንቲቦዲ ንዘድልዮም ሰባት ምምሕልላ፣ ከም ክትባት ዘይኮነ ግን ውሽጣዊ ናይ ሕማም ምክልኻል ዓቕሚ ዝሃንጽ ተባሂሉ መጽናዕቲ እንዳተኻየደሉ ይርከብ።	Oath taking of purified and harvested antibodies produced by the immune system of people who have recovered from COVID-19 is being studied for people in need, not as a vaccine but as an internal immune builder.
2093	en	ti	This strategy was tried for SARS with inconclusive results.	እዚ ሜላ እዚ ኣብ SARS ተፈቲኑ ዘየዕግብ ውጽኢት ሂቡ እዩ።	This technique has been tried in SARS with unsatisfactory results.
2094	en	ti	Viral neutralisation is the anticipated mechanism of action by which passive antibody therapy can mediate defence against SARS-CoV-2.	ናይ ቫይረስ ኒውትራላይዜሽን ማለት ፓሲቭ ኣንቲቦዲ ሕክምና ኣንጻር SARS-CoV-2 ንምክልኻል ክገብሮ ዝኽእሎ ኣካይዳ እዩ።	Viral neutralization is the course of action that passive antibody treatment can take to protect against SARS-CoV-2.
2095	en	ti	Other mechanisms however, such as antibody-dependent cellular cytotoxicity and/or phagocytosis, may be possible.	ካልኦት ሜላታት ግን፣ ከም ኣንቲቦዲ -መሰረት ዝገበሩ ሴሉላር ሳይቶክሲሲቲን/ወይ ፋጎሳይቶሲስ፣ እውን ክግበሩ ይኽእሉ እዮም።	But other methods, such as antibody -based cellular cytotoxicity and/or phagocytosis, can also be performed.
2096	en	ti	Other forms of passive antibody therapy, for example, using manufactured monoclonal antibodies, are in development.	ካልኦት ድሑራት ናይ ኣንቲቦዲ ሕክምናታት፣ ንኣብነት፣ ዝተመረቱ ሞኖክሎናል ኣንቲቦዲታት ምጥቃም፣ ኣብ ምምዕባል ይርከብ።	Other late antibody treatments, e.g., the use of mutated monoclonal antibodies, are under development.
2097	en	ti	Production of convalescent serum, which consists of the liquid portion of the blood from recovered patients and contains antibodies specific to this virus, could be increased for quicker deployment.	ናይ ኮንቨልሰት ሴረም ምፍራይ፣ ካብ ካብቲ ሕማም ዝሓወዩ ሰባት ዝተወሰደ ደም ፈሳሲ ክፋል ዝሓዘ እንትኸውን ናይ እቲ ቫይረስ ኣንቲቦዲ ድማ ዝሓዘ እዩ፣ ንቅልጡፍ ኣድማዒነት ድማ ክጠቅም ይኽእል እዩ።	The production of Convelset serum, consists of a liquid fraction of blood taken from persons who have recovered from the disease and contains antibodies to the virus, and may be useful for immediate effectiveness.
2098	en	ti	Coronavirus diseases, a group of closely related syndromes	ናይ ኮሮናቫይረስ ሕማም፣ ብቐረባ ዝተተሓሓዙ ሲንድሮማት ጉጅለ	Coronary disease, a group of closely associated syndromes
2099	en	ti	Li Wenliang, a doctor at Central Hospital of Wuhan, who later contracted and died of COVID-19 after raising awareness of the spread of the virus.	ሊ ወንሊያንግ፣ ናይ ውሃን ማእኸላይ ሆስፒታል ዶክተር፣ብዛዕባ ኮቪድ-19 ቫይረስ ግንዛበ ፈጢሩ፣ ድሕሪ ግዘ ድማ በቲ ቫይረስ ተታሒዙ ዝሞተ እዩ።	Li Wenliang, a doctor at Wuhan Central Hospital, raised awareness about the virus and later died of the virus.
